data_2lll_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lll _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 51.1 p . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 470' ' ' ASN . 18.6 t -89.07 146.46 6.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 165.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 84.6 p -134.62 172.07 13.46 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.029 0.931 . . . . 0.0 108.949 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 42.1 mm -74.19 122.2 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 14.6 tp10 -93.97 -68.05 0.82 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 36.0 mt-10 -135.12 160.09 39.45 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.961 0.904 . . . . 0.0 108.83 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 557' ' ' VAL . 97.0 mt -146.57 142.61 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.87 147.93 48.33 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.02 0.528 . . . . 0.0 110.808 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.641 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.0 pt? -59.37 -35.79 74.56 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.021 0.928 . . . . 0.0 111.786 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.641 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 50.2 mt-10 -103.07 -4.97 23.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.443 1.097 . . . . 0.0 111.298 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 75.49 40.5 32.54 Favored Glycine 0 C--N 1.342 0.911 0 O-C-N 123.469 0.48 . . . . 0.0 113.3 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -78.9 -18.81 53.26 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.241 0.617 . . . . 0.0 110.691 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -155.55 157.33 36.66 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.013 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . 0.522 HG21 ' NH2' ' A' ' 485' ' ' ARG . 15.7 t -111.77 148.29 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 165.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -126.54 121.08 31.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.432 HD21 HD21 ' A' ' 544' ' ' LEU . 87.3 mt -110.01 159.62 17.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.91 0.884 . . . . 0.0 109.804 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -144.84 128.93 17.6 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.554 0.742 . . . . 0.0 109.721 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.521 ' HB2' HD12 ' A' ' 503' ' ' LEU . 64.2 t30 -91.35 109.4 20.67 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -86.93 -1.46 57.86 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.287 1.035 . . . . 0.0 111.139 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 27.0 t -74.95 158.47 33.24 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.51 0.724 . . . . 0.0 111.53 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.33 0.4 56.21 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.403 1.081 . . . . 0.0 112.22 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.53 166.18 23.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.969 0.508 . . . . 0.0 110.821 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -66.18 115.58 6.33 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.909 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 454' ' ' VAL . 61.5 tp60 -80.02 111.08 16.02 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.851 0.719 . . . . 0.0 110.46 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.5 p -64.0 114.34 4.07 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.0 tp -107.99 151.88 25.23 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -170.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 146.87 -65.65 0.42 Allowed Glycine 0 N--CA 1.473 1.111 0 C-N-CA 121.419 -0.42 . . . . 0.0 112.921 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -69.35 -12.75 61.93 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.489 0.716 . . . . 0.0 110.98 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.431 ' CD2' ' HA ' ' A' ' 546' ' ' ASN . 26.3 m95 -67.65 150.86 48.2 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.853 0.861 . . . . 0.0 110.056 169.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -153.09 139.76 18.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.789 0.436 . . . . 0.0 111.364 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . 0.451 HG21 HG22 ' A' ' 466' ' ' VAL . 47.7 mt -101.41 104.6 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.304 0.642 . . . . 0.0 109.552 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.475 ' HE3' HG23 ' A' ' 545' ' ' VAL . 92.0 mttt -86.87 96.91 10.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.74 0.416 . . . . 0.0 109.995 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . 0.542 ' NH2' HG23 ' A' ' 459' ' ' ILE . 39.8 ttm180 -94.7 100.0 12.0 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 172.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -104.14 111.81 24.56 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.445 1.098 . . . . 0.0 110.439 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 540' ' ' PHE . 14.1 t -95.15 135.77 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.19 0.996 . . . . 0.0 109.272 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.4 pp -64.96 -22.89 67.07 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.342 0.657 . . . . 0.0 112.207 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . 0.402 ' H ' HG13 ' A' ' 487' ' ' VAL . 47.7 mt-10 -69.93 -10.83 59.96 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.058 0.943 . . . . 0.0 111.906 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 130.15 -28.31 3.89 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-O 119.387 -0.674 . . . . 0.0 114.232 166.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.24 116.17 22.28 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.834 0.817 . . . . 0.0 110.313 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.39 125.0 28.17 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 13.5 pt -140.82 148.76 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.8 0.84 . . . . 0.0 110.224 -170.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -121.3 112.51 18.69 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.484 0.714 . . . . 0.0 109.533 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -79.94 105.18 11.04 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -80.74 132.56 35.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -77.17 170.25 16.87 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.457 0.646 . . . . 0.0 111.312 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' THR . . . . . 0.438 ' HB ' ' HG2' ' A' ' 500' ' ' LYS . 52.3 p -87.99 120.09 70.63 Favored Pre-proline 0 CA--C 1.553 1.079 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.465 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.19 -5.21 7.57 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.241 2.627 . . . . 0.0 114.753 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . 0.438 ' HG2' ' HB ' ' A' ' 498' ' ' THR . 63.0 pttt -74.55 -25.94 59.64 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.539 0.335 . . . . 0.0 110.425 170.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -92.33 135.57 33.91 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.639 0.776 . . . . 0.0 110.608 -169.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 52.3 mt -126.96 128.58 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . 0.521 HD12 ' HB2' ' A' ' 470' ' ' ASN . 2.3 tm? -95.1 141.5 28.65 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.478 HH22 ' HG2' ' A' ' 523' ' ' PRO . 0.2 OUTLIER -87.43 164.66 16.07 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.019 0.527 . . . . 0.0 111.637 -166.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.76 123.32 19.04 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.366 0.667 . . . . 0.0 110.815 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.01 14.53 76.14 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 123.569 0.543 . . . . 0.0 113.938 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -104.92 175.27 5.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.288 0.635 . . . . 0.0 110.673 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 11.5 ptm -146.34 149.0 32.97 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.468 1.107 . . . . 0.0 110.106 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.89 131.32 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.3 0.64 . . . . 0.0 109.803 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.27 112.73 25.87 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.27 0.628 . . . . 0.0 109.499 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 46.9 t -99.38 99.76 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.185 0.594 . . . . 0.0 109.824 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . 0.519 ' HB2' HG21 ' A' ' 527' ' ' VAL . 43.4 m95 -87.16 172.99 9.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.736 0.814 . . . . 0.0 111.479 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.698 ' HB1' ' HB2' ' A' ' 534' ' ' TRP . . . -91.14 152.94 20.38 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.809 0.844 . . . . 0.0 110.108 172.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . 0.594 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -67.14 -38.57 85.74 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.337 0.589 . . . . 0.0 110.141 172.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -81.2 13.05 34.76 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.662 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -84.69 -6.98 59.38 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.175 0.59 . . . . 0.0 110.712 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 68.52 16.46 69.63 Favored Glycine 0 C--N 1.359 1.833 0 O-C-N 123.357 0.411 . . . . 0.0 113.44 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 512' ' ' TRP . 9.2 p -88.89 150.13 3.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.29 1.036 . . . . 0.0 110.358 -173.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.61 118.16 21.94 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.533 0.733 . . . . 0.0 109.72 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -66.94 110.75 3.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.4 m -124.17 81.19 57.96 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.365 0.666 . . . . 0.0 109.888 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -70.55 154.48 64.59 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.67 2.247 . . . . 0.0 111.79 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . 0.478 ' HG2' HH22 ' A' ' 504' ' ' ARG . 97.1 Cg_endo -97.94 13.57 32.5 Favored 'Cis proline' 0 C--N 1.37 1.691 0 CA-C-N 119.723 0.937 . . . . 0.0 113.48 -2.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.8 m -78.57 -45.7 21.16 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.457 0.646 . . . . 0.0 110.594 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 93.6 m -121.01 96.38 5.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.802 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 10.7 mp -84.11 147.07 27.55 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 512' ' ' TRP . 57.6 t -128.73 123.06 58.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -67.53 91.06 0.27 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 55.2 tptt -72.64 122.56 21.62 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.431 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 106.31 -1.86 37.44 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.759 0.662 . . . . 0.0 112.993 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 44.7 tp60 -119.48 123.0 42.96 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 42.8 p -90.21 -47.04 8.04 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.034 0.534 . . . . 0.0 111.931 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.433 ' O ' HG21 ' A' ' 536' ' ' THR . 69.0 p -87.44 -34.72 18.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.972 -170.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.698 ' HB2' ' HB1' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.73 39.24 28.24 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.533 0.733 . . . . 0.0 109.973 -173.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 74.95 61.2 3.13 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 462' ' ' GLU . 7.9 p -72.93 142.04 47.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.85 0.46 . . . . 0.0 111.01 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 179.09 168.03 37.53 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.821 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.82 -16.57 40.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.063 0.545 . . . . 0.0 110.322 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' SER . . . . . 0.444 ' HB2' HD21 ' A' ' 488' ' ' LEU . 16.6 m -155.82 131.13 9.49 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.758 0.823 . . . . 0.0 108.945 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.45 ' HB3' HG23 ' A' ' 487' ' ' VAL . 23.0 p90 -157.82 145.46 18.54 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.225 0.61 . . . . 0.0 111.13 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 76.0 mtm-85 -97.88 106.15 18.41 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.85 0.86 . . . . 0.0 108.902 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 21.5 m -93.61 105.65 17.68 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.446 HG22 ' SD ' ' A' ' 554' ' ' MET . 12.0 t -103.04 134.47 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.342 1.057 . . . . 0.0 109.706 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.541 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 36.8 tp -103.76 124.11 48.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.475 HG23 ' HE3' ' A' ' 484' ' ' LYS . 84.1 t -118.28 141.55 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.462 1.105 . . . . 0.0 108.872 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . 0.431 ' HA ' ' CD2' ' A' ' 481' ' ' TRP . 1.7 p30 -94.41 -177.17 4.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.652 0.381 . . . . 0.0 111.576 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.08 71.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.666 0.786 . . . . 0.0 112.902 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.21 -29.75 71.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.642 0.777 . . . . 0.0 111.786 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 95.28 25.28 14.38 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.795 -173.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.39 137.87 41.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.242 1.017 . . . . 0.0 108.597 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -75.29 96.89 3.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.791 0.836 . . . . 0.0 109.155 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 35.6 m -85.16 -23.8 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -148.46 162.92 38.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.402 0.681 . . . . 0.0 109.812 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.446 ' SD ' HG22 ' A' ' 543' ' ' VAL . 59.2 ttp -170.52 139.22 1.59 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.963 0.905 . . . . 0.0 109.49 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -139.25 124.27 18.84 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.267 0.627 . . . . 0.0 110.101 170.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 28.2 m -81.73 99.76 9.12 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 459' ' ' ILE . 74.5 t -102.85 142.39 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.501 0.667 . . . . 0.0 109.754 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -126.15 158.44 35.54 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.006 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 461' ' ' LEU . 64.8 tttp . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 121.514 0.674 . . . . 0.0 109.43 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 472' ' ' SER . 67.7 m . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.861 0.362 . . . . 0.0 111.635 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . 0.408 HG22 HD23 ' A' ' 503' ' ' LEU . 13.5 t -123.71 137.1 58.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 162.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 28.7 t -130.22 170.88 13.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.986 0.914 . . . . 0.0 109.239 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 61.8 mt -87.42 117.49 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 122.965 0.506 . . . . 0.0 109.88 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.556 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 8.3 tp10 -84.37 -62.07 1.65 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.358 0.663 . . . . 0.0 110.499 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.556 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 24.6 mt-10 -140.48 158.31 44.19 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.83 0.852 . . . . 0.0 109.669 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.503 ' HB ' HG23 ' A' ' 557' ' ' VAL . 48.1 mt -141.9 140.42 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -77.29 148.94 35.44 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.321 0.648 . . . . 0.0 111.568 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.499 ' HB2' ' HG3' ' A' ' 559' ' ' LYS . 1.6 pp -76.31 -26.19 55.58 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.886 0.875 . . . . 0.0 112.766 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -86.52 -14.38 43.21 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.239 0.616 . . . . 0.0 110.027 168.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 78.12 28.67 55.75 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.741 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -73.03 -18.26 61.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.139 0.576 . . . . 0.0 111.063 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -158.22 155.8 29.63 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 122.958 0.503 . . . . 0.0 111.348 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.6 111.44 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' A' ' 457' ' ' GLU . 15.6 tt0 -88.0 128.33 35.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.58 0.752 . . . . 0.0 110.223 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 483' ' ' ILE . 71.5 mt -114.0 162.66 16.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.448 1.099 . . . . 0.0 109.599 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 469' ' ' LYS . 4.7 tmmm? -147.4 132.12 17.92 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.012 0.925 . . . . 0.0 108.764 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.441 ' OD1' ' HA ' ' A' ' 505' ' ' ALA . 23.6 t-20 -76.76 127.29 32.48 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.968 1.307 . . . . 0.0 111.035 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -111.43 12.17 21.47 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.975 0.91 . . . . 0.0 111.183 172.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' A' ' 453' ' ' SER . 24.1 t -79.05 148.24 32.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.847 0.859 . . . . 0.0 110.322 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -88.15 -7.78 56.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.381 0.672 . . . . 0.0 110.956 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.68 172.55 12.84 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.986 0.914 . . . . 0.0 109.447 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.87 143.39 57.48 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -124.52 113.68 18.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.477 0.711 . . . . 0.0 110.26 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 40.6 p -70.79 119.27 14.69 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.4 0.68 . . . . 0.0 110.682 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . 0.402 HD13 HG23 ' A' ' 454' ' ' VAL . 6.2 mp -100.2 165.18 11.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.117 0.967 . . . . 0.0 109.455 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 144.1 -58.09 0.53 Allowed Glycine 0 N--CA 1.465 0.624 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 547' ' ' ALA . 0.9 OUTLIER -81.03 -13.76 58.51 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 114.299 -0.95 . . . . 0.0 111.014 174.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.425 ' CZ3' HG23 ' A' ' 552' ' ' VAL . 27.8 m95 -72.23 140.12 48.51 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -146.66 135.85 22.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.056 0.542 . . . . 0.0 111.538 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . 0.462 HG12 HD11 ' A' ' 544' ' ' LEU . 45.4 mt -99.99 105.99 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.908 0.883 . . . . 0.0 109.13 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -92.83 102.23 14.61 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.56 1.144 . . . . 0.0 110.42 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . 0.463 ' HE ' ' HE3' ' A' ' 534' ' ' TRP . 51.1 ttm-85 -87.22 96.35 10.3 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.44 100.88 13.07 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 46.6 t -93.62 121.59 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.42 -28.11 68.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.447 0.699 . . . . 0.0 112.629 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -64.53 -15.73 61.4 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.534 1.133 . . . . 0.0 112.574 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 125.27 27.38 1.21 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 114.471 0.548 . . . . 0.0 114.471 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -129.22 99.17 5.13 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.696 0.748 . . . . 0.0 109.971 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.36 96.86 6.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 174.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.3 pt -107.32 168.4 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.15 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -156.44 132.18 9.61 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.728 0.811 . . . . 0.0 109.67 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -125.53 116.19 21.39 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.442 0.697 . . . . 0.0 109.49 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -79.19 157.81 27.79 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -81.4 171.44 14.75 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.665 0.786 . . . . 0.0 110.872 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 74.7 p -81.93 128.83 67.05 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.05 -29.06 63.36 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.445 2.763 . . . . 0.0 113.785 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -68.73 -21.06 64.41 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.28 0.632 . . . . 0.0 112.49 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -78.95 129.53 34.58 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.364 0.666 . . . . 0.0 109.996 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 49.4 mt -126.3 119.85 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . 0.408 HD23 HG22 ' A' ' 454' ' ' VAL . 38.8 tp -83.85 138.6 33.12 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.487 0.715 . . . . 0.0 109.439 178.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -90.63 154.78 19.33 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.222 0.609 . . . . 0.0 110.549 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . 0.441 ' HA ' ' OD1' ' A' ' 470' ' ' ASN . . . -72.8 130.39 40.35 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.455 0.702 . . . . 0.0 111.681 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 75.51 20.13 78.78 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.064 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -115.19 -162.46 0.83 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.163 0.985 . . . . 0.0 110.2 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 19.6 ptp -154.4 166.37 33.44 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.361 0.665 . . . . 0.0 110.992 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.68 126.13 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.091 0.957 . . . . 0.0 109.228 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 25.6 m -116.32 111.53 20.24 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.107 0.563 . . . . 0.0 109.719 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 526' ' ' LEU . 35.5 m -88.67 137.31 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -122.01 174.47 6.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.379 1.072 . . . . 0.0 109.862 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -90.53 147.17 23.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.047 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -58.73 -42.24 88.31 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.503 0.721 . . . . 0.0 110.88 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -88.63 24.16 13.48 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.731 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -88.28 -13.23 41.4 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.262 0.625 . . . . 0.0 110.404 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.45 31.35 68.38 Favored Glycine 0 C--N 1.356 1.648 0 O-C-N 123.512 0.508 . . . . 0.0 112.323 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.67 144.95 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.371 1.068 . . . . 0.0 110.982 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.34 126.12 30.76 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 172.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -73.62 117.44 15.4 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 31.4 m -138.04 73.15 45.86 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.139 0.576 . . . . 0.0 110.335 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.48 148.38 83.76 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.719 2.279 . . . . 0.0 111.589 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.52 -13.54 37.38 Favored 'Cis proline' 0 C--N 1.379 2.173 0 CA-C-N 120.275 1.134 . . . . 0.0 114.424 4.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.6 m -67.6 -32.38 73.06 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.94 0.896 . . . . 0.0 112.431 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 59.8 m -135.48 98.2 3.88 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.623 0.769 . . . . 0.0 110.051 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.501 ' HB2' HG12 ' A' ' 511' ' ' VAL . 82.5 mt -90.87 149.73 21.81 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.33 120.9 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.204 0.602 . . . . 0.0 109.725 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -75.76 109.32 9.26 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 56.4 tptt -72.58 135.97 45.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.966 0.906 . . . . 0.0 110.514 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 99.32 -39.22 2.81 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.921 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -81.55 109.39 15.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.945 0.498 . . . . 0.0 110.482 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 85.9 p -83.4 -37.34 23.38 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.35 0.66 . . . . 0.0 110.292 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.708 ' HB2' HG21 ' A' ' 536' ' ' THR . 55.6 p -94.05 -29.39 15.22 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.794 -173.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.463 ' HE3' ' HE ' ' A' ' 485' ' ' ARG . 0.0 OUTLIER 59.98 34.51 21.5 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.14 0.976 . . . . 0.0 109.258 -171.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 79.41 81.08 0.75 Allowed Glycine 0 C--N 1.364 2.12 0 CA-C-O 119.574 -0.57 . . . . 0.0 113.032 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.708 HG21 ' HB2' ' A' ' 533' ' ' SER . 14.5 p -55.41 148.84 14.32 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.824 0.821 . . . . 0.0 112.51 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 164.8 136.15 1.95 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.585 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.71 -37.55 24.58 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 31.9 m -125.84 124.23 40.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.517 0.727 . . . . 0.0 109.186 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -158.74 161.46 37.04 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.642 0.777 . . . . 0.0 111.091 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 35.0 ptt180 -119.72 111.75 18.41 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.935 0.894 . . . . 0.0 108.689 168.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 61.3 m -89.92 133.14 34.94 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.53 HG21 ' HG3' ' A' ' 554' ' ' MET . 19.3 t -124.13 117.94 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.368 1.067 . . . . 0.0 108.723 -174.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 42.9 tp -87.99 132.35 34.29 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.59 157.58 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.176 1.39 . . . . 0.0 108.113 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . 0.44 ' ND2' ' HG2' ' A' ' 550' ' ' GLU . 1.2 p30 -117.77 -170.68 1.91 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.814 0.445 . . . . 0.0 111.234 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 480' ' ' ASN . . . -51.85 -37.4 51.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.396 1.478 . . . . 0.0 113.839 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.28 -34.47 77.47 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.595 0.758 . . . . 0.0 112.009 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 104.45 -12.95 51.28 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.559 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . 0.44 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 16.3 pt-20 -67.42 148.21 51.87 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 122.784 0.434 . . . . 0.0 110.139 175.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -80.93 101.24 9.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.425 HG23 ' CZ3' ' A' ' 481' ' ' TRP . 22.1 m -79.27 -21.0 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.566 0.347 . . . . 0.0 111.641 -175.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.6 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -158.9 151.71 22.03 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.228 1.011 . . . . 0.0 109.189 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.53 ' HG3' HG21 ' A' ' 543' ' ' VAL . 54.8 ttp -164.21 116.2 1.33 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.661 0.784 . . . . 0.0 109.668 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -133.22 130.59 39.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.549 0.74 . . . . 0.0 110.292 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 79.8 m -90.57 123.1 33.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.363 1.065 . . . . 0.0 109.572 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.503 HG23 ' HB ' ' A' ' 459' ' ' ILE . 86.2 t -123.75 128.87 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.795 0.838 . . . . 0.0 109.72 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 151.46 38.44 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.63 1.172 . . . . 0.0 108.52 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.499 ' HG3' ' HB2' ' A' ' 461' ' ' LEU . 88.0 tttt . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 121.549 0.69 . . . . 0.0 109.319 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 13.8 t -91.77 130.95 40.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.374 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 16.6 m -109.64 155.71 21.13 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.341 1.056 . . . . 0.0 109.407 174.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 39.9 mt -79.23 106.54 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.453 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 11.7 tp10 -73.69 -69.47 0.43 Allowed 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.733 0.646 . . . . 0.0 109.68 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 21.8 mt-10 -133.19 163.73 28.63 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.6 0.76 . . . . 0.0 109.829 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.509 ' HB ' HG21 ' A' ' 557' ' ' VAL . 61.2 mt -142.5 144.34 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 171.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.39 148.62 51.6 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.354 0.662 . . . . 0.0 110.716 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.46 -41.62 98.89 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.065 0.546 . . . . 0.0 111.289 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -80.57 -29.52 37.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.55 0.74 . . . . 0.0 109.362 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . 0.451 ' HA3' ' NH2' ' A' ' 485' ' ' ARG . . . 92.1 39.52 5.42 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.408 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -71.26 -20.19 62.26 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.375 0.67 . . . . 0.0 109.915 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -153.5 161.85 41.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.294 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 81.3 t -130.63 111.8 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.453 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.7 tp-100 -86.81 123.06 31.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.148 0.979 . . . . 0.0 109.955 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 483' ' ' ILE . 62.4 mt -112.49 157.86 20.6 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 471' ' ' ASN . 2.1 tmmm? -148.19 129.98 15.15 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -91.72 130.78 37.45 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.234 0.614 . . . . 0.0 110.252 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.496 ' HB3' ' HE3' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -136.38 84.73 2.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.268 1.027 . . . . 0.0 109.261 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 66.0 m -146.43 -163.32 1.72 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.056 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . 0.511 ' HB2' ' HD3' ' A' ' 474' ' ' LYS . 2.2 m-20 -79.16 -48.78 13.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.308 0.643 . . . . 0.0 111.186 -173.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . 0.511 ' HD3' ' HB2' ' A' ' 473' ' ' ASP . 0.0 OUTLIER -133.93 178.45 6.94 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.587 -172.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 504' ' ' ARG . 8.5 p-10 -53.16 112.46 0.87 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.72 1.208 . . . . 0.0 111.639 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -74.27 113.66 11.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.774 0.83 . . . . 0.0 110.557 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.472 ' HA ' HG12 ' A' ' 502' ' ' ILE . 32.6 t -64.37 100.84 0.38 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.098 0.559 . . . . 0.0 109.508 172.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.8 tp -90.65 165.68 13.58 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 143.22 -65.52 0.47 Allowed Glycine 0 N--CA 1.466 0.684 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.135 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.68 -13.04 58.42 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.153 0.981 . . . . 0.0 112.028 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -74.3 148.53 41.31 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.402 1.081 . . . . 0.0 109.599 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -148.58 134.11 18.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.047 0.539 . . . . 0.0 111.181 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . 0.432 HD13 HD13 ' A' ' 468' ' ' LEU . 49.2 mt -91.58 114.95 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.314 1.046 . . . . 0.0 109.729 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.566 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 67.1 mttm -79.63 144.11 34.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 164.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . 0.451 ' NH2' ' HA3' ' A' ' 463' ' ' GLY . 66.9 ttt180 -143.59 98.71 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.594 0.711 . . . . 0.0 109.282 172.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -96.15 103.6 15.51 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.01 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.527 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 24.3 t -67.58 149.44 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . 0.504 HD23 HG13 ' A' ' 487' ' ' VAL . 2.7 pt? -52.42 -33.11 42.42 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -168.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.93 -34.08 75.92 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.288 0.635 . . . . 0.0 111.248 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 130.57 -2.3 5.7 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.728 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -73.05 114.21 10.96 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.168 0.484 . . . . 0.0 110.384 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.12 143.49 38.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.58 0.752 . . . . 0.0 110.556 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 22.5 pt -127.19 146.16 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.19 0.996 . . . . 0.0 108.679 169.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -125.59 109.81 13.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.557 0.743 . . . . 0.0 109.764 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -97.38 106.03 18.28 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.571 0.748 . . . . 0.0 109.658 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -87.07 153.21 21.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -89.25 170.4 10.62 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.216 0.607 . . . . 0.0 110.936 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.1 p -91.07 131.74 36.21 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.044 0.938 . . . . 0.0 109.649 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.25 -17.06 49.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.783 2.322 . . . . 0.0 113.453 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -72.9 -20.39 61.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.549 0.739 . . . . 0.0 111.662 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -84.2 128.3 34.48 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.408 0.683 . . . . 0.0 109.614 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 477' ' ' SER . 49.2 mt -126.46 133.41 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -114.18 124.55 52.33 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 475' ' ' ASP . 8.1 mpt_? -71.13 155.95 40.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.855 0.862 . . . . 0.0 112.152 -170.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.52 129.23 39.0 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.488 0.715 . . . . 0.0 110.753 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 86.18 -6.45 81.56 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.556 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -92.73 -175.59 3.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.835 0.854 . . . . 0.0 110.62 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 21.9 ptt? -145.03 160.96 40.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.922 0.889 . . . . 0.0 110.61 -176.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . 0.407 HG11 ' HB2' ' A' ' 468' ' ' LEU . 2.5 p -137.81 118.64 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.376 1.07 . . . . 0.0 108.367 175.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.7 m -105.07 110.82 23.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 54.2 t -89.18 99.73 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.152 0.581 . . . . 0.0 109.491 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -87.09 170.07 11.85 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.258 1.023 . . . . 0.0 111.518 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -84.28 148.89 26.44 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.114 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -67.04 -31.77 72.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.347 0.659 . . . . 0.0 111.163 174.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -75.42 -12.68 83.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.91 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -71.18 -14.2 62.18 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.391 0.677 . . . . 0.0 111.735 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 66.58 25.86 72.82 Favored Glycine 0 C--N 1.356 1.675 0 CA-C-O 121.124 0.291 . . . . 0.0 113.207 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 5.7 p -84.03 144.46 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.603 1.161 . . . . 0.0 111.066 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -69.29 107.69 3.37 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.81 0.844 . . . . 0.0 110.046 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -62.74 109.88 1.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.1 m -131.83 76.36 74.31 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.473 0.709 . . . . 0.0 110.413 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.0 145.05 87.58 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.757 2.305 . . . . 0.0 112.33 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.59 -23.76 12.27 Favored 'Cis proline' 0 C--N 1.373 1.838 0 CA-C-N 120.008 1.039 . . . . 0.0 113.923 -1.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.1 m -62.83 -29.82 71.02 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 21.9 m -130.44 95.47 3.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.352 0.661 . . . . 0.0 109.411 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 48.5 mt -91.29 147.14 23.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 168.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.57 118.9 44.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -75.12 94.2 2.89 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -66.72 134.75 52.85 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.96 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 104.78 -35.82 4.81 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -98.05 88.44 4.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.048 0.539 . . . . 0.0 110.256 172.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 60.3 p -68.3 -35.47 77.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.446 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 13.9 m -86.41 -32.58 20.81 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.007 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.56 23.03 5.64 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.028 0.931 . . . . 0.0 110.978 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.18 52.06 52.34 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 122.303 -0.248 . . . . 0.0 113.378 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 3.8 p -76.67 110.6 11.38 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.461 0.704 . . . . 0.0 110.458 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -122.01 169.77 14.85 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 173.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . 0.587 ' HA ' ' HB3' ' A' ' 559' ' ' LYS . 14.2 pt-20 -80.22 -12.02 59.67 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.915 0.358 . . . . 0.0 110.888 176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' SER . . . . . 0.449 ' HB2' HD12 ' A' ' 488' ' ' LEU . 20.3 m -152.9 137.72 17.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.417 1.087 . . . . 0.0 108.118 172.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.527 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 13.8 p90 -166.26 172.0 11.58 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.531 0.681 . . . . 0.0 111.564 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 541' ' ' ARG . 1.4 mpt_? -118.42 157.24 27.56 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.205 1.402 . . . . 0.0 107.532 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 95.3 m -144.2 119.81 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 41.1 t -113.34 146.63 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.074 0.949 . . . . 0.0 109.404 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 26.8 tp -113.24 125.15 53.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 484' ' ' LYS . 61.2 t -111.85 154.8 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.132 1.373 . . . . 0.0 107.839 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -114.51 -174.54 2.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.509 0.324 . . . . 0.0 111.068 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.95 69.23 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.601 1.16 . . . . 0.0 113.217 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.4 -39.34 86.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.886 0.874 . . . . 0.0 111.98 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 107.42 0.47 35.05 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.144 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -87.08 151.7 23.0 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.438 0.619 . . . . 0.0 110.537 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.451 ' HG2' HG21 ' A' ' 545' ' ' VAL . 39.8 mt-10 -85.89 99.27 11.29 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.903 0.881 . . . . 0.0 109.459 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.23 -38.57 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.042 -171.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -136.55 157.02 47.75 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.167 0.587 . . . . 0.0 110.051 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.432 ' HG3' HG23 ' A' ' 543' ' ' VAL . 28.1 ttt -159.02 141.9 14.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.845 0.458 . . . . 0.0 110.973 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -132.8 164.19 27.39 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.146 1.378 . . . . 0.0 108.665 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 74.3 m -139.98 121.96 15.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.509 HG21 ' HB ' ' A' ' 459' ' ' ILE . 55.0 t -124.58 133.94 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.452 0.701 . . . . 0.0 110.686 -174.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -114.46 124.96 53.23 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.698 0.799 . . . . 0.0 109.679 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.587 ' HB3' ' HA ' ' A' ' 538' ' ' GLU . 60.4 tttp . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 166.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 470' ' ' ASN . 9.3 t -95.95 157.74 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.315 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 35.6 t -145.15 165.42 28.36 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.427 0.691 . . . . 0.0 110.148 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 459' ' ' ILE . 24.9 mt -81.62 94.6 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.009 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.89 -50.65 19.22 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.015 0.526 . . . . 0.0 111.722 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -140.6 156.33 46.31 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 456' ' ' ILE . 22.1 mt -141.24 145.45 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.75 152.11 44.14 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.447 0.699 . . . . 0.0 111.339 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 462' ' ' GLU . 2.4 pp -62.21 -37.85 86.92 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.704 0.802 . . . . 0.0 112.379 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.693 ' HG2' ' HE3' ' A' ' 559' ' ' LYS . 27.8 mt-10 -83.4 -23.92 32.16 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.216 0.531 . . . . 0.0 109.786 169.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 85.57 21.01 55.31 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.327 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -70.62 -5.67 31.14 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.109 0.455 . . . . 0.0 110.323 -175.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -149.12 159.07 44.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.695 0.798 . . . . 0.0 110.285 166.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.22 124.03 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.766 1.226 . . . . 0.0 108.049 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -96.74 120.52 37.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.177 0.591 . . . . 0.0 109.731 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.41 HD12 HG12 ' A' ' 483' ' ' ILE . 79.1 mt -118.27 119.44 34.68 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.825 0.85 . . . . 0.0 109.09 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -113.43 131.32 56.06 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 454' ' ' VAL . 49.8 t30 -81.46 109.51 15.99 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.496 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -86.1 -3.68 59.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.929 0.892 . . . . 0.0 111.877 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.6 m -77.42 155.3 31.9 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.335 0.588 . . . . 0.0 112.406 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.95 -24.96 52.35 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.391 174.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . 0.405 ' H ' ' HD3' ' A' ' 474' ' ' LYS . 0.3 OUTLIER -100.97 161.41 13.61 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.791 0.836 . . . . 0.0 109.8 178.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -85.16 121.78 28.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.237 1.015 . . . . 0.0 109.267 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -82.31 115.28 21.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.36 0.664 . . . . 0.0 110.552 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 24.0 p -70.2 99.5 1.52 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.6 tp -85.39 172.04 11.36 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.584 0.753 . . . . 0.0 109.883 -172.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 136.66 -55.76 0.7 Allowed Glycine 0 N--CA 1.471 0.983 0 CA-C-O 121.365 0.425 . . . . 0.0 112.226 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -70.93 -14.56 62.42 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.593 -0.803 . . . . 0.0 110.736 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -79.62 152.67 29.9 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.259 1.024 . . . . 0.0 109.424 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 -156.2 140.37 16.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.129 0.571 . . . . 0.0 110.627 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 12.7 mt -96.64 107.41 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.64 0.776 . . . . 0.0 109.627 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 67.9 mttm -76.3 161.09 29.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.178 0.513 . . . . 0.0 109.641 169.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -156.06 96.82 1.75 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -91.21 102.48 15.21 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.522 0.677 . . . . 0.0 109.49 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 11.4 t -80.11 138.98 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.492 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . 0.508 HD21 ' HG3' ' A' ' 538' ' ' GLU . 4.6 pp -63.11 -17.88 62.81 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.918 0.487 . . . . 0.0 112.075 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -60.93 -22.54 64.49 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.688 0.795 . . . . 0.0 111.163 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 116.68 28.26 2.56 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.79 -0.641 . . . . 0.0 114.361 170.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.67 165.54 26.67 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.473 0.636 . . . . 0.0 111.106 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -141.0 129.54 22.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.799 0.44 . . . . 0.0 110.23 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 29.4 pt -103.72 148.47 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -133.68 107.62 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.778 0.431 . . . . 0.0 110.153 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -83.71 106.31 15.32 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -81.47 152.46 27.35 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.94 0.4 . . . . 0.0 109.965 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.52 169.74 9.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.148 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 68.8 p -88.96 136.25 30.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.518 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 92.8 Cg_endo -73.12 -4.76 16.0 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.896 2.397 . . . . 0.0 113.472 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -90.68 -17.32 27.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.841 0.856 . . . . 0.0 110.837 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -75.53 133.63 40.96 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.776 0.83 . . . . 0.0 109.814 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 67.5 mt -119.89 124.32 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.73 112.1 23.28 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -75.18 163.41 27.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.039 0.447 . . . . 0.0 111.067 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.15 118.07 8.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.765 0.826 . . . . 0.0 111.088 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 85.9 -9.13 70.05 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 123.152 0.283 . . . . 0.0 113.784 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -75.98 171.29 14.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.169 0.588 . . . . 0.0 110.428 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -147.97 129.23 14.71 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.581 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.25 104.4 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 121.953 0.883 . . . . 0.0 109.202 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.9 m -87.43 94.24 9.64 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.2 t -86.96 99.25 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.33 0.652 . . . . 0.0 110.959 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . 0.554 ' HB2' HG22 ' A' ' 527' ' ' VAL . 55.2 m95 -84.96 174.89 9.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.162 0.985 . . . . 0.0 111.889 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -97.35 143.34 28.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.056 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -59.85 -37.75 80.16 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.501 0.72 . . . . 0.0 111.489 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -76.4 -0.57 67.29 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.769 -0.65 . . . . 0.0 114.621 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -78.35 -8.69 58.73 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.879 0.471 . . . . 0.0 111.305 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 69.07 23.23 76.15 Favored Glycine 0 C--N 1.361 1.918 0 C-N-CA 123.221 0.439 . . . . 0.0 113.65 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.17 146.26 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.47 1.108 . . . . 0.0 110.403 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -75.59 114.68 14.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.586 0.755 . . . . 0.0 110.164 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . 0.438 ' NE2' HD12 ' A' ' 526' ' ' LEU . 20.5 t-160 -69.06 117.03 10.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.84 0.456 . . . . 0.0 109.825 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.6 m -134.74 78.47 55.2 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 123.426 0.691 . . . . 0.0 110.001 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.63 151.46 82.71 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.176 1.917 . . . . 0.0 111.061 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.37 -29.64 4.34 Favored 'Cis proline' 0 CA--C 1.559 1.766 0 CA-C-N 120.48 1.207 . . . . 0.0 114.768 4.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 10.0 m -73.38 -26.12 60.86 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.514 0.726 . . . . 0.0 112.619 -164.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 44.6 m -124.32 83.53 2.16 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.438 HD12 ' NE2' ' A' ' 520' ' ' HIS . 20.7 tp -86.77 150.01 24.45 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.404 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 512' ' ' TRP . 67.6 t -134.91 126.05 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.47 -0.769 . . . . 0.0 109.275 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -69.21 95.17 0.74 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 171.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 56.2 tptt -67.46 135.24 52.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.95 0.9 . . . . 0.0 110.052 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 89.57 -15.55 58.52 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.381 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.49 120.64 30.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.042 0.537 . . . . 0.0 109.614 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 14.3 p -78.65 -60.37 2.41 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.194 0.598 . . . . 0.0 112.145 -176.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 17.2 t -116.13 -1.46 12.43 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -166.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 62.72 23.49 13.99 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.212 1.005 . . . . 0.0 110.761 -174.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.43 67.06 2.25 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 112.396 -0.282 . . . . 0.0 112.396 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 13.8 t -72.22 163.57 27.71 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.875 0.47 . . . . 0.0 110.936 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -177.64 165.77 35.68 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . 0.508 ' HG3' HD21 ' A' ' 488' ' ' LEU . 8.8 pt-20 -59.61 -27.94 66.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.011 0.924 . . . . 0.0 111.902 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' SER . . . . . 0.479 ' HB3' HD22 ' A' ' 488' ' ' LEU . 41.1 t -164.3 143.83 7.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.96 0.904 . . . . 0.0 110.167 169.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -156.69 143.92 18.9 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.476 1.11 . . . . 0.0 109.0 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 14.6 ptt-85 -97.29 105.3 17.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.283 0.563 . . . . 0.0 109.776 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 86.0 m -85.16 122.65 29.66 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 71.1 t -121.41 138.35 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.657 1.183 . . . . 0.0 109.857 -171.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 553' ' ' ALA . 29.4 tp -99.88 122.25 42.54 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 171.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.13 154.0 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.182 1.393 . . . . 0.0 108.435 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -117.12 -168.15 1.43 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.93 0.492 . . . . 0.0 111.531 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.2 76.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.787 1.235 . . . . 0.0 113.435 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.25 -38.48 80.17 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.363 0.665 . . . . 0.0 111.403 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 103.24 2.05 47.94 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.378 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -86.64 152.3 22.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.174 0.512 . . . . 0.0 110.541 171.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -80.12 106.51 12.2 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.016 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 15.8 m -82.04 -35.69 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 122.32 0.248 . . . . 0.0 111.338 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 544' ' ' LEU . . . -137.17 149.27 47.14 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.561 0.744 . . . . 0.0 109.562 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.426 ' HG3' HG21 ' A' ' 543' ' ' VAL . 19.2 ttt -150.94 135.24 16.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.138 0.975 . . . . 0.0 109.524 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -145.96 134.22 21.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.984 0.913 . . . . 0.0 109.919 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 36.7 m -97.87 135.86 39.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.437 0.695 . . . . 0.0 109.665 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 459' ' ' ILE . 41.1 t -111.11 129.28 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.789 1.236 . . . . 0.0 108.792 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.27 110.2 22.09 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.693 ' HE3' ' HG2' ' A' ' 462' ' ' GLU . 83.0 tttt . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 43.9 m . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 121.316 0.579 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.49 147.6 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.0 m -142.25 148.28 37.84 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.836 0.854 . . . . 0.0 109.185 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . 0.468 ' HA ' HD12 ' A' ' 468' ' ' LEU . 53.2 mt -69.59 132.53 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.688 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 10.5 tp10 -94.83 -66.28 0.92 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.045 0.538 . . . . 0.0 110.249 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.688 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 34.0 mt-10 -133.81 157.18 46.57 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.497 0.719 . . . . 0.0 109.155 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.505 ' HB ' HG22 ' A' ' 557' ' ' VAL . 77.8 mt -141.91 139.6 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.64 143.64 51.37 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 123.666 0.604 . . . . 0.0 110.187 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.516 HD12 ' HG3' ' A' ' 462' ' ' GLU . 2.9 pp -71.05 -29.91 65.94 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.482 0.713 . . . . 0.0 112.009 -175.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.516 ' HG3' HD12 ' A' ' 461' ' ' LEU . 36.7 mt-10 -82.25 -31.63 30.06 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 170.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 97.58 41.25 3.43 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 114.904 -1.043 . . . . 0.0 112.633 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -76.21 -27.02 56.67 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.817 0.847 . . . . 0.0 110.798 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -159.23 163.3 36.0 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.367 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 42.6 t -122.65 114.9 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.9 tp-100 -85.51 107.17 17.33 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 171.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.5 HD23 HD12 ' A' ' 483' ' ' ILE . 29.6 tp -105.35 132.08 51.99 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 123.943 0.897 . . . . 0.0 108.83 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 54.3 tttm -113.7 142.07 46.47 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.355 0.525 . . . . 0.0 111.101 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -89.06 128.77 35.75 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -117.23 12.5 14.4 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.012 0.925 . . . . 0.0 110.979 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 33.8 t -75.88 160.32 30.05 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.723 0.809 . . . . 0.0 110.342 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -87.54 0.25 55.86 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.435 0.694 . . . . 0.0 111.769 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 179.23 7.89 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.611 1.164 . . . . 0.0 109.314 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -53.39 104.49 0.1 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.328 0.651 . . . . 0.0 109.984 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -78.94 112.11 15.79 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 28.8 t -68.84 98.36 0.92 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.776 0.672 . . . . 0.0 109.585 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.1 tp -86.03 174.31 9.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.927 0.891 . . . . 0.0 108.816 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 134.83 -56.53 0.71 Allowed Glycine 0 N--CA 1.468 0.832 0 O-C-N 122.032 -0.417 . . . . 0.0 112.66 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.9 -13.47 62.26 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.788 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -81.47 162.73 23.15 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.147 0.979 . . . . 0.0 110.177 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . 0.561 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 11.9 ptt180 -157.34 127.8 6.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.61 0.764 . . . . 0.0 110.66 -174.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . 0.5 HD12 HD23 ' A' ' 468' ' ' LEU . 50.3 mt -93.49 109.86 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.11 0.564 . . . . 0.0 109.601 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.712 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 97.8 mttt -81.9 167.41 18.99 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.242 0.617 . . . . 0.0 110.827 171.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 534' ' ' TRP . 42.5 ttm180 -151.69 118.38 5.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 166.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . 0.455 ' OE1' ' HB3' ' A' ' 492' ' ' GLU . 23.4 mm-40 -97.84 102.33 14.06 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.024 1.33 . . . . 0.0 108.568 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.469 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 40.0 t -75.04 156.78 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.21 0.604 . . . . 0.0 109.807 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.2 pp -54.9 -25.82 31.71 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.411 1.085 . . . . 0.0 113.757 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 491' ' ' GLU . 13.1 pt-20 -86.51 -21.15 27.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.082 0.553 . . . . 0.0 111.249 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 117.45 14.07 7.14 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.516 -0.602 . . . . 0.0 114.188 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 489' ' ' GLU . 50.8 mt-10 -76.49 109.78 10.5 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 117.945 0.873 . . . . 0.0 110.305 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.455 ' HB3' ' OE1' ' A' ' 486' ' ' GLN . 7.0 pt-20 -101.11 98.61 9.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.149 0.98 . . . . 0.0 109.815 178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.48 139.37 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -135.49 112.74 10.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.856 0.462 . . . . 0.0 111.09 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -82.9 112.87 20.09 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.71 0.804 . . . . 0.0 110.281 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -84.81 145.41 27.88 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.52 169.57 10.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.415 0.686 . . . . 0.0 109.923 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 82.5 p -89.42 132.55 36.93 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.324 0.65 . . . . 0.0 109.25 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.434 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 52.0 Cg_exo -58.39 -15.98 26.86 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.422 2.748 . . . . 0.0 114.808 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -79.38 -24.05 42.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.243 0.617 . . . . 0.0 111.284 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -74.29 130.68 40.17 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.466 0.706 . . . . 0.0 110.23 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 46.7 mt -134.71 124.41 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.468 0.707 . . . . 0.0 109.23 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.74 135.16 43.76 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -77.12 154.24 33.45 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.602 0.761 . . . . 0.0 112.156 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -59.78 131.28 50.43 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.053 0.941 . . . . 0.0 110.371 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 89.49 -42.4 3.0 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.47 0.481 . . . . 0.0 112.57 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -66.25 178.35 1.21 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.367 1.067 . . . . 0.0 112.257 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 15.9 ptp -153.13 150.24 28.88 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.391 -174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 2.8 p -112.04 118.62 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.256 1.422 . . . . 0.0 108.84 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.6 m -95.33 99.75 11.63 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.27 97.58 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.126 0.57 . . . . 0.0 109.994 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -83.56 172.35 12.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.423 1.089 . . . . 0.0 111.616 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 534' ' ' TRP . . . -89.85 154.05 20.18 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.041 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.56 68.07 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.066 0.46 . . . . 0.0 110.416 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -75.21 -8.48 83.45 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.615 -0.72 . . . . 0.0 113.986 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -74.56 -19.24 60.4 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.261 0.625 . . . . 0.0 110.772 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.06 22.65 77.3 Favored Glycine 0 C--N 1.357 1.744 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.313 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.16 142.27 13.46 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.252 1.021 . . . . 0.0 109.969 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -69.5 127.52 33.28 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.574 0.75 . . . . 0.0 110.367 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -65.79 110.06 2.69 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.2 m -135.59 80.17 45.29 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.364 0.666 . . . . 0.0 109.953 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.61 154.08 44.9 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.918 2.412 . . . . 0.0 112.685 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -84.82 -17.61 25.96 Favored 'Cis proline' 0 C--N 1.374 1.882 0 CA-C-N 119.898 0.999 . . . . 0.0 114.005 -0.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 21.3 m -71.46 -38.96 71.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.311 0.644 . . . . 0.0 112.427 -169.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 74.0 m -121.35 97.49 5.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.022 0.529 . . . . 0.0 110.615 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 9.4 mp -93.04 145.26 24.51 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 166.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 91.9 t -127.97 126.69 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -73.09 96.99 2.27 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.24 130.29 42.81 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.15 0.98 . . . . 0.0 110.545 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 94.85 -45.86 2.11 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.511 0.507 . . . . 0.0 112.907 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -75.24 100.72 4.42 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 55.4 m -76.1 -43.61 42.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.058 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.449 ' O ' HG23 ' A' ' 536' ' ' THR . 16.8 m -85.55 -29.23 24.35 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -165.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.64 27.05 4.81 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 124.001 0.92 . . . . 0.0 110.611 -174.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.04 58.65 11.02 Favored Glycine 0 C--N 1.345 1.028 0 O-C-N 122.474 -0.141 . . . . 0.0 113.08 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 533' ' ' SER . 2.4 p -64.51 121.73 15.1 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.194 0.598 . . . . 0.0 110.523 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -154.67 155.1 25.98 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.703 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -78.82 -11.02 59.97 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.1 0.476 . . . . 0.0 110.503 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 558' ' ' LYS . 20.9 m -151.61 130.66 12.62 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.192 0.997 . . . . 0.0 108.728 173.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.469 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 8.5 p90 -161.24 171.77 17.83 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.098 0.959 . . . . 0.0 110.287 172.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.613 ' HD3' ' SD ' ' A' ' 554' ' ' MET . 7.0 ptp180 -129.4 109.36 11.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' THR . . . . . 0.501 ' HB ' HD11 ' A' ' 459' ' ' ILE . 21.6 m -87.43 122.27 30.95 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.712 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 41.0 t -108.69 143.86 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.134 0.973 . . . . 0.0 110.075 -170.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 67.1 tp -108.39 123.11 48.34 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.017 0.927 . . . . 0.0 108.539 168.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.561 ' HB ' ' HG3' ' A' ' 482' ' ' ARG . 75.7 t -116.25 144.77 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.389 1.076 . . . . 0.0 108.651 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . 0.502 HD22 ' HG2' ' A' ' 550' ' ' GLU . 0.8 OUTLIER -102.42 -172.89 2.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.809 0.843 . . . . 0.0 111.479 177.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.93 80.99 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.836 1.254 . . . . 0.0 113.723 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . 0.475 ' HB3' ' ND2' ' A' ' 546' ' ' ASN . 9.5 t70 -55.87 -39.67 71.86 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.847 0.859 . . . . 0.0 111.899 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.39 -7.71 28.51 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.532 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . 0.502 ' HG2' HD22 ' A' ' 546' ' ' ASN . 9.4 pt-20 -73.39 141.26 46.99 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.14 0.47 . . . . 0.0 110.293 174.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -84.35 82.47 8.37 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.41 -39.85 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.267 -171.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -131.53 154.73 48.49 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.325 0.65 . . . . 0.0 110.027 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.613 ' SD ' ' HD3' ' A' ' 541' ' ' ARG . 60.0 ttp -161.33 135.67 7.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.731 0.812 . . . . 0.0 109.524 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -128.18 114.09 16.54 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.037 0.935 . . . . 0.0 109.138 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 29.7 m -81.3 113.55 19.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.201 0.6 . . . . 0.0 109.389 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.505 HG22 ' HB ' ' A' ' 459' ' ' ILE . 82.1 t -114.53 112.27 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.019 0.928 . . . . 0.0 110.063 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 2.6 mppt? -98.79 137.61 37.13 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 165.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 82.7 tttt . . . . . 0 CA--C 1.545 0.758 0 C-N-CA 123.764 0.825 . . . . 0.0 110.648 -179.229 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 27.9 t -104.13 117.75 50.2 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 25.1 t -113.05 155.01 25.62 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.088 0.555 . . . . 0.0 110.419 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.47 111.96 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -84.36 -69.47 0.64 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.163 0.585 . . . . 0.0 110.414 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 27.6 mt-10 -117.47 150.28 39.18 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.033 -171.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 50.6 mt -139.58 143.69 30.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.02 148.87 48.31 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -15.72 57.61 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.46 1.104 . . . . 0.0 113.605 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -111.44 -30.79 7.26 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.855 1.262 . . . . 0.0 109.167 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 105.27 31.14 4.45 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.339 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 516' ' ' ALA . 1.9 mppt? -73.71 -8.62 56.72 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.703 0.751 . . . . 0.0 110.915 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -156.83 157.26 34.63 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.289 0.636 . . . . 0.0 111.021 172.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 77.3 t -134.27 113.69 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.868 1.267 . . . . 0.0 107.862 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.7 tp-100 -86.03 107.9 18.0 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.876 0.87 . . . . 0.0 109.497 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.443 HD22 HD23 ' A' ' 544' ' ' LEU . 50.4 mt -92.82 160.62 14.85 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 170.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -145.13 127.34 15.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -89.92 97.92 11.47 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -74.46 -10.98 60.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.255 1.022 . . . . 0.0 111.706 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.5 t -63.56 145.69 55.18 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.697 0.799 . . . . 0.0 111.677 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.26 -0.12 48.12 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.176 0.99 . . . . 0.0 111.412 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.13 164.91 27.32 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 124.36 1.064 . . . . 0.0 108.644 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.92 161.39 10.6 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.751 0.821 . . . . 0.0 111.802 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 13.4 tm0? -136.51 112.43 9.59 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.407 ' HA ' HG12 ' A' ' 502' ' ' ILE . 23.4 p -65.24 103.16 0.74 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.312 0.645 . . . . 0.0 109.896 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.67 161.71 16.71 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -172.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 147.94 -66.39 0.4 Allowed Glycine 0 N--CA 1.473 1.162 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.738 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -69.07 -12.61 61.84 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.295 0.638 . . . . 0.0 111.134 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -67.1 145.08 55.68 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.554 1.142 . . . . 0.0 110.387 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . 0.489 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 4.3 ptt85 -148.76 123.86 10.1 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.293 -171.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 45.3 mt -90.51 109.26 20.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 123.916 0.886 . . . . 0.0 109.307 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.0 mttt -77.9 123.95 27.39 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 174.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 49.8 mmm-85 -119.95 92.35 3.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -111.98 116.73 31.06 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.446 HG13 ' H ' ' A' ' 489' ' ' GLU . 13.0 t -103.65 147.78 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.72 -24.45 65.38 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 120.949 0.404 . . . . 0.0 111.392 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . 0.446 ' H ' HG13 ' A' ' 487' ' ' VAL . 22.5 mm-40 -61.53 -23.88 66.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.318 1.047 . . . . 0.0 110.603 171.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 126.0 -21.64 6.16 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-O 119.613 -0.549 . . . . 0.0 113.27 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.15 102.62 0.85 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.185 0.594 . . . . 0.0 111.358 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -126.71 116.25 20.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.612 0.765 . . . . 0.0 110.209 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 20.2 pt -136.55 176.14 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.812 1.245 . . . . 0.0 109.57 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -149.26 108.54 3.94 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -80.56 105.04 11.51 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.25 149.27 31.91 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -91.88 171.74 8.93 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.665 0.786 . . . . 0.0 110.177 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.4 p -90.65 133.19 33.08 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.491 0.716 . . . . 0.0 109.489 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.14 8.5 3.18 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.021 2.481 . . . . 0.0 113.321 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -101.74 -22.84 14.31 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.802 1.241 . . . . 0.0 110.46 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -84.96 123.69 30.81 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 477' ' ' SER . 54.2 mt -104.61 129.99 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.8 127.87 33.42 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 174.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -88.12 158.87 18.44 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.23 127.02 29.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.667 1.187 . . . . 0.0 112.543 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 65.92 14.71 61.45 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.6 0.562 . . . . 0.0 113.747 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -105.52 -164.05 0.99 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.894 0.878 . . . . 0.0 110.282 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -152.7 163.28 39.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.037 0.935 . . . . 0.0 110.448 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.22 116.65 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.19 101.71 13.39 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 59.3 t -87.32 106.03 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 122.75 0.42 . . . . 0.0 110.347 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . 0.506 ' HB2' HG22 ' A' ' 527' ' ' VAL . 36.3 m95 -94.72 179.46 5.24 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.686 0.795 . . . . 0.0 111.312 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.651 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -107.3 155.44 19.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.288 1.035 . . . . 0.0 110.067 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 529' ' ' LYS . . . -65.76 -33.39 75.76 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.19 0.596 . . . . 0.0 110.532 172.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -78.47 -3.91 86.76 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.939 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 464' ' ' LYS . . . -76.58 -8.48 57.31 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.009 0.524 . . . . 0.0 110.562 169.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 73.96 21.11 79.57 Favored Glycine 0 C--N 1.36 1.871 0 C-N-CA 123.517 0.579 . . . . 0.0 113.21 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.38 143.71 16.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.332 1.053 . . . . 0.0 110.391 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -87.15 141.51 28.6 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.525 0.73 . . . . 0.0 110.398 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -61.78 119.17 8.23 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.85 0.86 . . . . 0.0 109.679 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' SER . . . . . 0.41 ' HB2' ' HB ' ' A' ' 525' ' ' THR . 39.6 m -129.97 75.44 79.49 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.594 0.757 . . . . 0.0 109.881 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.66 161.23 39.96 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.735 2.29 . . . . 0.0 112.05 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.49 17.78 41.41 Favored 'Cis proline' 0 C--N 1.379 2.17 0 CA-C-N 119.771 0.954 . . . . 0.0 113.673 0.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.4 m -90.42 -68.3 0.79 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.185 0.594 . . . . 0.0 110.052 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' THR . . . . . 0.437 HG21 ' CD1' ' A' ' 512' ' ' TRP . 72.0 m -90.36 95.05 10.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.115 0.966 . . . . 0.0 110.298 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 10.9 mp -92.47 104.93 17.2 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 173.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 512' ' ' TRP . 96.8 t -91.48 123.64 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -71.53 89.3 0.96 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . 0.5 ' HA ' ' HB1' ' A' ' 514' ' ' ALA . 25.2 tptp -76.28 117.96 18.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.953 -175.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 123.28 -40.42 1.99 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.0 116.18 28.59 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 63.1 p -88.29 -41.65 12.76 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.12 0.568 . . . . 0.0 111.506 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.4 p -79.94 -31.22 40.04 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.651 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 54.49 23.81 4.84 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 123.699 0.799 . . . . 0.0 110.602 -175.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 72.82 67.53 1.79 Allowed Glycine 0 C--N 1.353 1.483 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 -171.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 5.1 p -63.31 140.1 58.84 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.066 0.546 . . . . 0.0 110.733 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -167.59 143.93 8.58 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.628 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.62 -25.55 53.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.287 0.635 . . . . 0.0 110.088 171.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 14.8 m -148.92 120.58 8.04 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.218 1.007 . . . . 0.0 108.484 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -150.64 169.62 21.15 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.989 0.915 . . . . 0.0 110.978 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -117.85 116.99 28.09 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.002 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 40.3 m -96.58 117.34 30.75 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 45.0 t -117.85 139.19 45.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.359 1.064 . . . . 0.0 108.526 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 553' ' ' ALA . 31.5 tp -110.11 115.87 30.53 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.527 HG23 ' HE3' ' A' ' 484' ' ' LYS . 63.8 t -108.47 151.73 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.494 1.118 . . . . 0.0 108.778 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . 0.408 HD22 ' HG2' ' A' ' 550' ' ' GLU . 0.5 OUTLIER -110.16 -173.09 2.17 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.949 0.5 . . . . 0.0 111.119 -176.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -60.92 -35.67 77.3 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.377 1.071 . . . . 0.0 113.069 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.02 -40.74 98.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.079 0.552 . . . . 0.0 110.524 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 112.48 -11.3 26.0 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.595 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . 0.408 ' HG2' HD22 ' A' ' 546' ' ' ASN . 10.6 pt-20 -69.66 146.47 51.61 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 117.78 0.79 . . . . 0.0 110.009 172.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.472 ' HG2' HG22 ' A' ' 545' ' ' VAL . 38.4 mt-10 -84.71 99.1 10.62 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 33.3 m -78.02 -25.85 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.146 -170.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' A' ' 544' ' ' LEU . . . -144.27 156.13 44.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.678 0.791 . . . . 0.0 109.554 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 543' ' ' VAL . 56.9 ttp -160.2 146.93 15.89 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.343 0.657 . . . . 0.0 109.715 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.68 117.08 4.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.902 0.481 . . . . 0.0 110.402 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 62.1 m -87.93 103.72 15.95 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.724 0.81 . . . . 0.0 108.874 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.0 p -114.93 129.56 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.153 0.981 . . . . 0.0 110.432 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.94 163.32 32.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.134 0.973 . . . . 0.0 109.948 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm . . . . . 0 CA--C 1.537 0.468 0 C-N-CA 123.843 0.857 . . . . 0.0 109.597 -175.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 12.3 t -98.53 162.74 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.433 1.093 . . . . 0.0 109.954 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 35.7 t -145.82 152.0 38.82 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.876 1.27 . . . . 0.0 109.366 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.0 mt -86.08 107.67 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -86.68 -53.08 5.15 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -171.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 30.0 mt-10 -136.79 163.02 31.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.626 HG22 HH21 ' A' ' 485' ' ' ARG . 89.0 mt -147.67 143.69 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.098 1.359 . . . . 0.0 107.749 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . 0.46 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 37.2 t70 -66.98 148.33 52.1 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.74 0.416 . . . . 0.0 111.138 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 559' ' ' LYS . 0.4 OUTLIER -64.34 -27.42 69.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.968 0.907 . . . . 0.0 112.634 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.01 -32.01 11.86 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.28 0.632 . . . . 0.0 109.571 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 103.35 44.04 1.77 Allowed Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.545 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -91.04 -9.55 45.45 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.542 0.737 . . . . 0.0 111.15 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.46 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 29.5 p90 -154.71 161.09 41.69 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.33 0.586 . . . . 0.0 112.373 173.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 42.3 t -127.11 117.62 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.473 1.509 . . . . 0.0 107.335 169.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.3 tp-100 -86.03 112.41 21.21 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.484 HD21 HD12 ' A' ' 483' ' ' ILE . 16.5 tp -112.15 121.34 44.66 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.994 0.917 . . . . 0.0 108.736 -176.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -113.41 139.09 49.19 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.024 0.53 . . . . 0.0 111.698 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.448 ' HB2' HD12 ' A' ' 503' ' ' LEU . 52.9 t30 -92.71 137.23 32.54 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -127.62 16.4 6.98 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.48 0.712 . . . . 0.0 109.92 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 41.9 t -73.79 152.85 40.2 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.759 0.824 . . . . 0.0 109.459 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.86 -21.35 62.44 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.376 0.67 . . . . 0.0 111.014 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 174.89 6.9 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.469 0.708 . . . . 0.0 109.687 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . 0.466 ' HB2' HG22 ' A' ' 502' ' ' ILE . 5.1 p-10 -65.13 111.65 3.03 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.037 0.935 . . . . 0.0 109.963 172.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -78.03 122.41 25.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.08 0.952 . . . . 0.0 110.426 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 18.2 p -66.2 98.01 0.43 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.687 0.756 . . . . 0.0 109.626 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.6 tp -89.46 162.6 15.65 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 135.13 -51.16 0.84 Allowed Glycine 0 N--CA 1.471 0.998 0 O-C-N 121.451 -0.78 . . . . 0.0 112.334 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -68.66 -13.5 62.4 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.203 -0.999 . . . . 0.0 111.0 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -91.9 162.63 14.34 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 124.713 1.205 . . . . 0.0 110.294 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -153.43 143.75 22.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.97 0.908 . . . . 0.0 110.337 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . 0.484 HD12 HD21 ' A' ' 468' ' ' LEU . 61.5 mt -102.51 107.73 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.438 0.695 . . . . 0.0 109.618 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.661 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.5 mttt -78.67 162.24 26.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.321 0.649 . . . . 0.0 111.626 172.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . 0.626 HH21 HG22 ' A' ' 459' ' ' ILE . 71.2 mtt180 -153.03 102.46 2.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.201 1.4 . . . . 0.0 108.377 170.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . 0.49 ' HG3' ' HD3' ' A' ' 541' ' ' ARG . 8.4 pt20 -101.8 109.33 21.07 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.727 0.811 . . . . 0.0 109.712 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.48 HG12 HD21 ' A' ' 488' ' ' LEU . 6.6 t -89.44 156.58 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.919 0.888 . . . . 0.0 109.19 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . 0.48 HD21 HG12 ' A' ' 487' ' ' VAL . 2.7 pt? -66.41 -18.15 65.19 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.028 0.442 . . . . 0.0 111.458 173.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -83.08 4.73 25.07 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.49 1.116 . . . . 0.0 111.779 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 102.16 -26.1 25.46 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.145 -0.808 . . . . 0.0 114.469 168.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.53 104.53 0.81 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.677 0.739 . . . . 0.0 111.001 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.53 79.84 1.35 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.4 1.08 . . . . 0.0 108.961 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 35.6 pt -97.54 170.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.741 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -155.49 116.39 3.89 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.735 0.414 . . . . 0.0 110.162 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -80.17 108.49 13.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.966 0.506 . . . . 0.0 109.769 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -76.35 150.3 36.88 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.72 167.76 11.08 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 76.2 p -95.82 132.76 26.56 Favored Pre-proline 0 N--CA 1.477 0.897 0 CA-C-O 118.441 -0.79 . . . . 0.0 108.994 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.492 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 54.3 Cg_exo -55.27 -25.7 48.33 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 123.206 2.604 . . . . 0.0 115.066 -175.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -68.33 -24.67 64.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.038 0.535 . . . . 0.0 111.457 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -73.39 127.34 32.41 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.2 1.0 . . . . 0.0 109.478 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 475' ' ' ASP . 43.4 mt -129.66 118.69 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 470' ' ' ASN . 1.4 tm? -93.36 125.82 38.16 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -67.54 163.34 21.37 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.326 1.05 . . . . 0.0 113.227 -168.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.2 116.69 5.66 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.352 1.061 . . . . 0.0 111.851 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 80.94 -14.93 23.96 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 123.485 0.49 . . . . 0.0 113.926 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -79.29 -172.94 3.42 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.122 0.969 . . . . 0.0 111.068 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -154.42 147.49 24.66 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.33 0.586 . . . . 0.0 112.268 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.76 127.88 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.814 1.245 . . . . 0.0 109.135 172.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.89 99.99 11.12 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.55 97.92 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 122.856 0.462 . . . . 0.0 110.044 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -86.61 178.24 7.12 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.044 0.938 . . . . 0.0 111.506 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.26 158.49 16.0 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.814 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.74 -28.18 67.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.386 0.675 . . . . 0.0 110.591 172.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -76.16 -16.99 80.3 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.466 -0.788 . . . . 0.0 114.066 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -68.32 -29.3 68.02 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.168 0.587 . . . . 0.0 110.729 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.72 26.47 73.99 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 116.321 -0.399 . . . . 0.0 113.635 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 13.4 p -81.09 159.03 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.827 1.251 . . . . 0.0 111.117 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -73.8 113.9 11.48 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.128 0.571 . . . . 0.0 110.139 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -64.85 110.87 2.57 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.093 0.557 . . . . 0.0 109.625 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.9 m -127.39 69.35 74.73 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.16 0.584 . . . . 0.0 110.254 -175.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.88 149.69 60.2 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.35 2.033 . . . . 0.0 111.87 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.42 -13.87 34.77 Favored 'Cis proline' 0 C--N 1.376 2.012 0 N-CA-C 114.442 0.901 . . . . 0.0 114.442 -2.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.3 m -60.12 -28.55 67.95 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.868 0.867 . . . . 0.0 113.048 -172.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 97.1 m -140.75 101.21 4.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.07 0.948 . . . . 0.0 108.878 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.86 138.94 31.21 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 83.4 t -113.67 117.73 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -70.45 92.34 0.81 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.7 tptt -68.45 135.07 51.11 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.121 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 91.54 -14.77 63.06 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.17 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -100.91 110.89 23.0 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 66.1 p -82.34 -50.79 8.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.327 0.584 . . . . 0.0 111.219 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.552 ' HB3' HG21 ' A' ' 536' ' ' THR . 20.3 m -90.11 -28.51 18.93 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.939 -167.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 56.56 38.09 29.33 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.05 0.94 . . . . 0.0 110.142 -176.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.47 52.91 45.69 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.552 HG21 ' HB3' ' A' ' 533' ' ' SER . 14.3 t -72.21 156.01 39.61 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.51 0.724 . . . . 0.0 110.274 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 179.97 167.87 37.79 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.8 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -71.84 -25.29 61.91 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 18.2 m -154.42 121.69 5.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.856 0.862 . . . . 0.0 109.71 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.433 ' HB3' HG23 ' A' ' 487' ' ' VAL . 31.5 p90 -143.65 150.7 39.13 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.431 0.692 . . . . 0.0 111.06 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.49 ' HD3' ' HG3' ' A' ' 486' ' ' GLN . 5.4 mpt_? -101.92 106.21 17.12 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 33.5 m -84.99 106.34 16.41 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.661 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 28.3 t -105.64 133.48 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.058 0.943 . . . . 0.0 110.127 -170.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.569 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 36.2 tp -98.08 119.67 37.13 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.485 HG21 ' HG2' ' A' ' 551' ' ' GLU . 40.2 t -115.86 143.66 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -105.38 -172.89 2.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.499 0.32 . . . . 0.0 110.919 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -52.72 -40.23 62.83 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.844 1.258 . . . . 0.0 113.745 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.01 -36.9 82.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.613 0.765 . . . . 0.0 111.87 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.3 -19.48 29.34 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.035 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.95 134.81 52.75 Favored 'General case' 0 C--O 1.248 1.019 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.485 ' HG2' HG21 ' A' ' 545' ' ' VAL . 44.7 mt-10 -79.33 102.27 8.54 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 28.0 m -74.29 -37.39 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.651 -172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.569 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -133.78 159.95 39.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.59 0.756 . . . . 0.0 109.32 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.512 ' HG3' HG21 ' A' ' 543' ' ' VAL . 27.4 ttt -157.41 125.28 5.4 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -137.32 105.86 5.82 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -172.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 49.8 m -83.63 110.32 18.16 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.243 0.617 . . . . 0.0 109.682 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.9 116.62 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -87.6 147.97 25.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.664 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 461' ' ' LEU . 20.6 tttm . . . . . 0 CA--C 1.544 0.733 0 C-N-CA 123.835 0.854 . . . . 0.0 110.254 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' SER . . . . . 0.402 ' HB3' ' OG ' ' A' ' 472' ' ' SER . 16.6 m . . . . . 0 CA--C 1.545 0.765 0 CA-C-O 120.999 0.428 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.07 150.8 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.964 1.306 . . . . 0.0 107.646 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 22.7 t -137.12 153.21 50.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.866 0.866 . . . . 0.0 109.629 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 64.8 mt -76.64 107.19 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 14.0 tp10 -78.54 -68.68 0.62 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -130.44 167.45 18.58 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.864 0.866 . . . . 0.0 109.16 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 23.4 mt -141.43 147.43 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 20.8 t70 -66.65 145.92 55.05 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.249 0.62 . . . . 0.0 111.245 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.94 -33.6 76.09 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.403 1.081 . . . . 0.0 112.74 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -93.38 -23.75 18.33 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.895 0.878 . . . . 0.0 110.285 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.67 32.46 7.24 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.001 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -79.26 -15.66 57.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.545 0.738 . . . . 0.0 111.215 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 20.5 p90 -155.15 162.17 41.05 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.277 0.56 . . . . 0.0 111.621 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.46 119.59 59.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 125.296 1.438 . . . . 0.0 107.813 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.404 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 6.2 tp-100 -88.48 109.74 20.28 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.526 ' HB2' HG12 ' A' ' 509' ' ' VAL . 87.0 mt -100.13 155.72 17.58 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . 0.499 ' HZ2' ' HB3' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -140.47 129.8 23.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 175.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.72 111.2 17.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.947 0.899 . . . . 0.0 110.163 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.73 -10.84 59.7 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.146 0.979 . . . . 0.0 111.939 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 453' ' ' SER . 50.4 m -59.9 148.58 34.44 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.72 -15.81 63.22 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.653 1.181 . . . . 0.0 111.408 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.17 176.34 8.84 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.317 1.047 . . . . 0.0 110.447 -171.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.11 108.7 0.72 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.143 0.977 . . . . 0.0 110.675 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -79.92 117.34 20.68 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.405 0.682 . . . . 0.0 110.423 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.52 ' HA ' HG12 ' A' ' 502' ' ' ILE . 8.9 p -73.3 105.79 4.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.756 0.822 . . . . 0.0 109.906 175.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.5 tp -98.02 163.5 12.74 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 145.63 -64.59 0.45 Allowed Glycine 0 N--CA 1.47 0.915 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -67.91 -12.07 59.97 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.595 0.758 . . . . 0.0 111.465 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -74.19 151.26 40.03 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.886 0.875 . . . . 0.0 109.926 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -153.42 136.49 15.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.074 0.55 . . . . 0.0 111.184 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 62.4 mt -91.71 140.3 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.052 0.941 . . . . 0.0 109.739 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.728 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 55.2 mttm -115.67 107.44 15.1 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.995 0.918 . . . . 0.0 110.149 175.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -92.78 93.77 8.61 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 171.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 492' ' ' GLU . 43.3 mt-30 -93.46 104.7 16.82 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.474 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 489' ' ' GLU . 9.7 t -98.63 139.83 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.473 0.709 . . . . 0.0 109.306 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.7 pp -65.5 -21.34 66.62 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.024 0.53 . . . . 0.0 111.403 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . 0.468 ' H ' HG12 ' A' ' 487' ' ' VAL . 28.2 tt0 -71.25 -2.98 17.93 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.925 1.29 . . . . 0.0 110.895 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 110.13 11.96 19.03 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 115.509 0.964 . . . . 0.0 115.509 162.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -118.14 106.55 12.97 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.258 1.029 . . . . 0.0 110.771 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 486' ' ' GLN . 8.9 pt-20 -105.01 80.97 1.68 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 122.364 1.078 . . . . 0.0 109.006 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 38.3 pt -85.67 155.6 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.602 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -128.48 139.2 52.45 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.179 0.592 . . . . 0.0 110.16 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -123.02 105.92 10.38 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.072 0.949 . . . . 0.0 108.614 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 152.33 26.71 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -89.93 163.22 15.06 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.248 0.619 . . . . 0.0 110.512 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 75.7 p -80.24 130.02 67.41 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.79 -17.83 56.94 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.795 2.33 . . . . 0.0 113.333 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -72.55 -16.36 61.76 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.9 0.88 . . . . 0.0 111.623 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -89.37 134.76 33.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.746 0.819 . . . . 0.0 110.914 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 477' ' ' SER . 58.3 mt -137.67 141.2 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.89 140.27 52.05 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -73.84 166.2 23.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.082 0.953 . . . . 0.0 113.062 -168.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.72 124.76 22.28 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.234 1.014 . . . . 0.0 112.349 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 74.08 0.65 57.3 Favored Glycine 0 C--N 1.343 0.942 0 O-C-N 123.664 0.602 . . . . 0.0 114.42 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -88.89 -174.9 4.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.35 0.66 . . . . 0.0 109.451 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -133.42 161.01 35.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.404 0.682 . . . . 0.0 110.99 -177.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 468' ' ' LEU . 2.4 p -134.64 105.83 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.554 1.142 . . . . 0.0 109.113 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 3.3 m -89.07 104.09 16.66 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.979 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 34.9 t -91.92 103.5 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -87.47 175.55 7.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.114 0.965 . . . . 0.0 111.694 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 534' ' ' TRP . . . -96.73 156.5 16.32 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.616 171.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . 0.534 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -62.98 -36.2 82.72 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.221 0.609 . . . . 0.0 110.652 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -80.06 4.06 68.23 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.401 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -77.09 -28.28 54.45 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.002 0.521 . . . . 0.0 110.715 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 85.61 9.0 79.42 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.556 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.7 148.57 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.087 0.955 . . . . 0.0 110.642 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -78.64 124.28 28.01 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.294 0.638 . . . . 0.0 109.621 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -63.98 111.32 2.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.814 0.446 . . . . 0.0 109.804 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.4 m -128.38 76.34 78.33 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.414 0.686 . . . . 0.0 109.632 -176.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.12 158.95 55.82 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.716 2.277 . . . . 0.0 111.631 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.69 -38.5 1.66 Allowed 'Cis proline' 0 C--N 1.379 2.15 0 CA-C-N 120.228 1.117 . . . . 0.0 114.757 6.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 60.3 m -63.85 -52.34 60.53 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.006 0.523 . . . . 0.0 112.35 -170.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 40.0 m -87.91 86.43 7.14 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.459 0.647 . . . . 0.0 109.893 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.97 149.82 24.92 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 96.1 t -133.43 121.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -72.66 94.64 1.76 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 53.4 tptt -70.54 136.18 49.12 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.928 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 96.06 -9.74 67.85 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.527 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -116.07 111.24 20.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.243 0.617 . . . . 0.0 109.587 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 49.3 m -81.82 -44.49 16.85 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.953 0.501 . . . . 0.0 111.846 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.577 ' HB3' HG23 ' A' ' 536' ' ' THR . 34.6 m -87.43 -28.42 22.13 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -168.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 60.3 26.58 16.09 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.285 1.034 . . . . 0.0 110.896 -175.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.66 75.68 0.5 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.577 HG23 ' HB3' ' A' ' 533' ' ' SER . 13.1 t -109.36 167.27 10.25 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 123.872 0.869 . . . . 0.0 110.628 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 169.83 -164.97 38.38 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.815 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.43 -54.38 33.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.989 0.916 . . . . 0.0 110.012 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 26.8 m -143.44 132.74 23.26 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -154.01 146.02 23.61 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.776 0.83 . . . . 0.0 109.826 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 13.6 ptp180 -109.67 141.59 42.02 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.313 0.578 . . . . 0.0 110.519 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 47.7 m -95.66 138.36 33.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 169.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.728 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 42.0 t -124.46 150.5 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.48 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 41.8 tp -124.54 113.06 17.59 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.468 HG22 ' HG2' ' A' ' 551' ' ' GLU . 54.0 t -100.49 154.02 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.882 1.273 . . . . 0.0 108.779 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.9 -171.67 1.89 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.845 0.458 . . . . 0.0 111.747 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.5 88.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.341 1.056 . . . . 0.0 112.863 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.37 -38.84 92.44 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.645 0.778 . . . . 0.0 110.97 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 112.57 -5.91 26.29 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.852 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -72.81 146.89 45.98 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 118.793 1.297 . . . . 0.0 110.295 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.468 ' HG2' HG22 ' A' ' 545' ' ' VAL . 47.3 mt-10 -81.37 94.5 6.79 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.641 0.776 . . . . 0.0 108.982 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 18.8 m -79.0 -19.65 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -168.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -149.11 155.06 40.13 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.059 0.544 . . . . 0.0 109.671 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 50.0 ttp -163.74 131.77 3.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.571 0.748 . . . . 0.0 109.624 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -145.38 126.31 14.49 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.024 0.93 . . . . 0.0 108.848 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 13.4 m -92.91 147.21 23.03 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.009 0.523 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.74 121.19 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.388 1.075 . . . . 0.0 109.307 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.54 118.05 35.57 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.564 ' HB3' ' HZ3' ' A' ' 559' ' ' LYS . 4.3 ttpm? . . . . . 0 C--O 1.24 0.603 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 CA--C 1.546 0.801 0 CA-C-O 120.712 0.291 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.28 143.16 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 19.5 m -130.14 150.34 51.45 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.216 1.006 . . . . 0.0 109.577 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 53.4 mt -76.3 106.13 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 11.3 tp10 -78.02 -55.66 5.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.751 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 43.9 mt-10 -140.57 165.7 26.75 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.824 0.85 . . . . 0.0 109.9 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.597 ' HB ' HG21 ' A' ' 557' ' ' VAL . 79.6 mt -143.18 151.39 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.83 149.92 48.4 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.455 0.702 . . . . 0.0 111.002 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.482 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.4 pt? -64.02 -39.99 95.35 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.714 0.806 . . . . 0.0 112.004 -177.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.482 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 18.3 mt-10 -89.18 -27.24 20.81 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.309 1.044 . . . . 0.0 109.199 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 98.32 40.64 3.41 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.789 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -83.9 -10.67 57.81 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.765 0.426 . . . . 0.0 111.387 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -156.02 162.14 40.36 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.91 0.386 . . . . 0.0 111.635 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.07 112.37 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.367 1.467 . . . . 0.0 107.914 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.437 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 14.3 tp60 -86.43 111.58 20.67 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.168 0.987 . . . . 0.0 110.094 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.401 ' HG ' HD23 ' A' ' 544' ' ' LEU . 7.0 mp -92.29 160.55 15.08 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.424 1.09 . . . . 0.0 109.453 168.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . 0.705 ' HE3' ' HB3' ' A' ' 471' ' ' ASN . 3.3 tmmm? -147.0 128.24 14.78 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -88.44 107.84 19.07 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.216 0.606 . . . . 0.0 109.802 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.705 ' HB3' ' HE3' ' A' ' 469' ' ' LYS . 12.0 p-10 -95.77 19.07 11.86 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.611 0.764 . . . . 0.0 112.046 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 45.0 m -76.55 151.94 36.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.674 0.39 . . . . 0.0 110.971 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -78.75 -22.75 46.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.885 0.874 . . . . 0.0 110.612 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -116.69 168.05 10.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.123 0.969 . . . . 0.0 111.247 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.33 111.0 4.35 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.72 0.808 . . . . 0.0 110.342 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.59 109.61 17.56 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 54.6 p -68.95 114.31 7.13 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.083 0.553 . . . . 0.0 110.359 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 7.6 tp -90.78 169.79 10.66 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.033 0.933 . . . . 0.0 109.027 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 143.15 -66.65 0.46 Allowed Glycine 0 N--CA 1.473 1.117 0 O-C-N 121.996 -0.44 . . . . 0.0 112.467 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . 0.439 ' N ' HD21 ' A' ' 480' ' ' ASN . 0.8 OUTLIER -71.99 -9.9 59.03 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.37 0.668 . . . . 0.0 111.009 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -70.39 143.69 51.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.836 0.854 . . . . 0.0 109.796 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 22.9 ptt-85 -140.87 137.79 33.47 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.741 0.416 . . . . 0.0 110.747 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 45.6 mt -96.75 106.92 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.514 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.2 mttt -75.3 147.23 40.37 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.77 91.89 2.29 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -99.55 104.46 16.26 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.487 -170.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 31.7 t -66.44 154.91 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 539' ' ' SER . 4.3 pp -51.79 -32.1 29.85 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -173.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.35 -11.35 58.64 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.377 0.671 . . . . 0.0 112.063 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 125.17 -26.68 5.5 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.979 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.81 111.57 1.93 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.48 0.712 . . . . 0.0 111.633 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.98 145.09 43.87 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.24 0.543 . . . . 0.0 111.385 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.71 153.89 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.89 1.276 . . . . 0.0 108.108 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -133.01 108.45 8.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.407 0.283 . . . . 0.0 110.356 -177.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -85.06 103.7 14.31 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -91.44 143.65 26.39 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.39 0.614 . . . . 0.0 109.489 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -83.93 170.79 13.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.482 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 2.6 t -94.06 140.23 22.83 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.151 0.58 . . . . 0.0 109.715 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.78 -26.1 78.79 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.877 3.052 . . . . 0.0 114.128 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -68.39 -19.41 64.62 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.4 0.68 . . . . 0.0 111.771 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -82.65 136.86 34.66 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.518 0.727 . . . . 0.0 110.617 -174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 66.7 mt -131.03 150.81 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . 0.498 HD22 ' HB ' ' A' ' 509' ' ' VAL . 0.3 OUTLIER -123.99 135.34 53.56 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -81.25 156.76 25.44 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.704 0.801 . . . . 0.0 111.674 -168.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.33 132.76 52.62 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.958 0.903 . . . . 0.0 112.372 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 64.29 15.83 59.46 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.921 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -107.69 -166.53 1.15 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.653 0.781 . . . . 0.0 109.908 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -150.07 171.89 16.14 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.19 0.519 . . . . 0.0 111.731 -177.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . 0.498 ' HB ' HD22 ' A' ' 503' ' ' LEU . 7.4 p -146.49 142.1 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.872 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 5.2 m -118.86 109.08 15.6 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 45.7 t -90.27 100.33 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -82.21 175.93 9.89 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.674 1.19 . . . . 0.0 111.508 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 534' ' ' TRP . . . -101.36 153.45 19.65 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.337 173.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -64.39 -32.11 73.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.115 0.566 . . . . 0.0 110.9 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -71.4 -16.02 75.34 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.992 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -70.79 -23.7 62.43 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.3 0.64 . . . . 0.0 111.473 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 78.46 36.64 29.63 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 123.235 0.334 . . . . 0.0 113.618 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.79 147.18 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.183 0.993 . . . . 0.0 110.386 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -74.72 123.31 24.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.487 0.715 . . . . 0.0 110.961 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -67.46 111.15 3.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.4 0.68 . . . . 0.0 109.681 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.7 m -134.84 80.3 49.65 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.117 0.567 . . . . 0.0 110.091 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.37 156.2 61.46 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.857 2.371 . . . . 0.0 112.164 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -99.9 30.7 11.62 Favored 'Cis proline' 0 C--N 1.38 2.186 0 CA-C-N 119.684 0.923 . . . . 0.0 113.591 -0.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 39.5 m -112.44 -38.61 4.61 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.989 0.516 . . . . 0.0 111.149 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 60.3 m -118.3 96.34 5.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.49 0.716 . . . . 0.0 109.718 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 58.1 mt -87.63 149.91 23.99 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 65.1 t -137.29 116.74 15.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -72.55 98.25 2.27 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 0.4 OUTLIER -66.14 134.11 52.09 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.88 0.872 . . . . 0.0 110.16 -177.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 92.28 -24.79 20.63 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.958 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -87.23 103.61 15.6 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 55.4 p -77.97 -45.27 24.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.815 0.446 . . . . 0.0 111.076 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 536' ' ' THR . 15.2 m -93.37 -30.26 15.2 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -166.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 55.7 32.73 19.94 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 123.644 0.777 . . . . 0.0 110.352 -174.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 72.28 59.92 4.35 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.214 -0.448 . . . . 0.0 113.027 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 533' ' ' SER . 12.2 p -65.28 147.7 52.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.985 0.514 . . . . 0.0 111.761 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 175.97 159.85 22.43 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.87 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -73.11 -9.55 58.84 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.06 0.544 . . . . 0.0 110.818 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 488' ' ' LEU . 29.6 t -157.55 139.43 14.15 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 124.589 1.156 . . . . 0.0 108.252 172.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.97 122.13 5.07 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.021 0.528 . . . . 0.0 111.282 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.602 ' HD2' ' SD ' ' A' ' 554' ' ' MET . 52.9 ttp180 -84.5 105.43 15.31 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 32.2 m -94.25 128.57 40.8 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 22.8 t -120.33 145.94 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.845 0.858 . . . . 0.0 109.427 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.557 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 34.2 tp -114.88 119.42 36.51 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.515 HG21 ' HG2' ' A' ' 551' ' ' GLU . 60.9 t -106.49 154.65 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.009 1.324 . . . . 0.0 108.632 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . 0.507 ' ND2' ' HG2' ' A' ' 550' ' ' GLU . 1.2 p30 -115.52 -173.64 2.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.536 0.335 . . . . 0.0 111.675 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.24 -36.56 71.07 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.753 1.221 . . . . 0.0 112.611 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.65 -38.98 86.65 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.755 0.822 . . . . 0.0 111.635 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.15 -12.44 31.45 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.542 -174.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . 0.507 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 0.7 OUTLIER -74.82 149.65 39.56 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.193 0.497 . . . . 0.0 110.072 177.096 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.515 ' HG2' HG21 ' A' ' 545' ' ' VAL . 34.5 mt-10 -88.54 92.71 9.29 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.562 0.745 . . . . 0.0 109.31 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.53 -34.57 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -168.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.557 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -135.17 165.81 24.55 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.124 0.57 . . . . 0.0 109.86 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.602 ' SD ' ' HD2' ' A' ' 541' ' ' ARG . 50.1 ttm -169.57 115.97 0.57 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.306 0.642 . . . . 0.0 109.519 -176.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 53.0 ttm-85 -124.35 115.42 20.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.483 0.713 . . . . 0.0 109.825 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 17.4 m -92.11 126.31 37.14 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.73 0.812 . . . . 0.0 109.622 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.597 HG21 ' HB ' ' A' ' 459' ' ' ILE . 78.2 t -123.72 123.71 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.623 0.769 . . . . 0.0 109.701 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 138.13 49.81 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.14 0.976 . . . . 0.0 109.718 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 63.0 tttp . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 124.103 0.961 . . . . 0.0 111.383 -179.076 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 121.763 0.792 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 5.0 t -110.53 146.54 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 23.2 t -124.34 177.85 5.67 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.603 1.161 . . . . 0.0 109.587 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.7 mt -98.4 123.27 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.496 ' HG3' ' HG2' ' A' ' 458' ' ' GLU . 6.6 tp10 -87.68 -76.11 0.39 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.496 ' HG2' ' HG3' ' A' ' 457' ' ' GLU . 55.0 mm-40 -122.91 160.94 25.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.393 1.077 . . . . 0.0 109.383 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.438 HG12 HG12 ' A' ' 466' ' ' VAL . 66.2 mt -140.68 148.14 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.26 147.99 51.43 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.3 pp -67.0 -36.34 81.94 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.541 0.736 . . . . 0.0 111.456 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -81.34 -31.88 33.23 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 170.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . 0.519 ' HA3' HH22 ' A' ' 485' ' ' ARG . . . 92.7 51.47 2.31 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.177 -175.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -81.97 -18.97 41.61 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.361 0.665 . . . . 0.0 110.505 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -156.42 158.63 37.64 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.889 0.476 . . . . 0.0 111.554 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . 0.438 HG12 HG12 ' A' ' 459' ' ' ILE . 61.1 t -127.3 107.12 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.889 1.275 . . . . 0.0 108.19 174.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 4.7 tp-100 -85.76 114.61 22.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 109.27 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 70.4 mt -100.96 151.84 21.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.695 1.198 . . . . 0.0 109.334 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 4.6 tmmm? -138.94 136.8 35.84 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.751 0.821 . . . . 0.0 109.568 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.442 ' OD1' ' HA ' ' A' ' 505' ' ' ALA . 25.9 t-20 -90.97 133.24 35.44 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.106 0.963 . . . . 0.0 111.335 -176.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -110.91 7.26 21.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.71 0.804 . . . . 0.0 111.95 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 48.8 m -80.53 155.5 26.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.274 0.63 . . . . 0.0 111.718 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -85.4 -19.4 31.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.61 0.764 . . . . 0.0 110.053 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.24 150.91 42.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.487 1.115 . . . . 0.0 109.108 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -69.01 135.76 51.39 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.296 0.638 . . . . 0.0 111.397 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -89.65 118.33 29.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.517 0.727 . . . . 0.0 109.923 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 15.4 p -65.12 109.82 2.31 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 503' ' ' LEU . 4.8 tp -102.14 175.66 5.46 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -171.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 122.05 -50.57 0.83 Allowed Glycine 0 N--CA 1.469 0.857 0 CA-C-O 121.993 0.774 . . . . 0.0 111.179 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . 0.52 ' HB3' ' HB1' ' A' ' 547' ' ' ALA . 9.0 m120 -65.46 -24.28 67.13 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 113.368 -1.416 . . . . 0.0 110.543 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.462 ' CZ3' HG21 ' A' ' 552' ' ' VAL . 13.6 m0 -77.12 164.23 25.88 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.061 0.945 . . . . 0.0 111.289 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 496' ' ' LYS . 19.7 ptt180 -156.21 138.67 14.9 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.523 -170.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.06 113.57 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.421 1.088 . . . . 0.0 108.61 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -79.61 140.92 36.96 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . 0.519 HH22 ' HA3' ' A' ' 463' ' ' GLY . 74.4 ttt180 -143.8 96.38 2.89 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 173.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . 0.501 ' HG3' ' HB2' ' A' ' 541' ' ' ARG . 5.6 pt20 -98.36 103.87 15.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.864 1.265 . . . . 0.0 109.434 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.71 153.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.602 0.761 . . . . 0.0 109.178 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.23 -14.37 61.81 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.391 0.541 . . . . 0.0 111.679 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -62.01 -23.37 66.4 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.613 0.765 . . . . 0.0 110.939 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 104.37 -8.53 48.41 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.704 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -78.33 105.47 9.6 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 123.44 0.696 . . . . 0.0 110.496 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.08 133.24 51.11 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.514 173.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 24.2 pt -128.58 156.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.16 0.984 . . . . 0.0 108.661 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -131.11 108.01 9.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -87.91 103.56 15.79 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 482' ' ' ARG . 0.0 OUTLIER -87.08 146.54 26.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 170.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -83.43 170.24 14.7 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.08 0.552 . . . . 0.0 110.935 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.9 p -84.79 129.92 54.87 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.213 0.605 . . . . 0.0 109.372 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.544 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 36.3 Cg_endo -62.31 -14.32 37.84 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.893 2.395 . . . . 0.0 113.465 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . 0.528 ' HZ3' ' HB2' ' A' ' 500' ' ' LYS . 0.1 OUTLIER -83.88 1.81 41.52 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.971 0.908 . . . . 0.0 111.977 176.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -103.26 136.92 42.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.606 0.762 . . . . 0.0 111.002 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 69.5 mt -118.12 136.59 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . 0.441 ' HB2' HD23 ' A' ' 478' ' ' LEU . 3.1 tm? -100.54 121.25 41.27 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -79.94 161.95 25.22 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.305 0.642 . . . . 0.0 112.655 -171.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . 0.442 ' HA ' ' OD1' ' A' ' 470' ' ' ASN . . . -73.95 133.96 43.1 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.083 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 70.15 1.26 33.19 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.509 0.505 . . . . 0.0 113.817 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -101.97 174.72 5.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.956 0.902 . . . . 0.0 110.35 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -140.68 144.02 35.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.013 0.525 . . . . 0.0 111.432 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.53 128.97 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.835 0.854 . . . . 0.0 108.907 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.3 m -103.79 103.31 13.17 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 56.7 t -87.4 97.85 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 122.803 0.441 . . . . 0.0 110.167 -176.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . 0.48 ' HB2' HG23 ' A' ' 527' ' ' VAL . 43.9 m95 -90.94 175.47 6.96 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.849 0.859 . . . . 0.0 112.007 -175.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 534' ' ' TRP . . . -104.04 152.85 21.56 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.357 1.063 . . . . 0.0 110.308 174.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -63.54 -38.96 93.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.422 0.689 . . . . 0.0 111.879 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -82.7 -0.63 90.23 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.34 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -83.25 7.0 17.6 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.404 0.681 . . . . 0.0 111.632 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 76.83 38.56 30.89 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 113.572 0.189 . . . . 0.0 113.572 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 4.6 p -146.5 137.33 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.703 0.801 . . . . 0.0 110.617 -170.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -91.09 151.49 20.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.101 0.961 . . . . 0.0 111.139 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -67.05 112.27 4.3 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.5 m -131.78 79.34 68.39 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.672 0.789 . . . . 0.0 109.889 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.95 156.25 56.53 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.716 2.278 . . . . 0.0 111.845 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -93.4 4.42 57.66 Favored 'Cis proline' 0 C--N 1.381 2.244 0 CA-C-N 119.815 0.97 . . . . 0.0 113.491 2.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.0 m -82.81 -30.09 29.04 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.605 0.762 . . . . 0.0 111.595 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 84.0 m -140.75 102.84 4.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.367 0.667 . . . . 0.0 110.658 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 9.7 mp -97.49 103.77 15.73 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.48 HG23 ' HB2' ' A' ' 512' ' ' TRP . 72.0 t -89.29 122.19 40.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -71.07 87.1 0.75 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 22.1 tptp -68.01 116.54 8.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.701 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 120.84 -45.36 1.24 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -172.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.11 105.85 12.65 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 34.2 p -72.18 -47.16 52.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.483 0.713 . . . . 0.0 111.243 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.7 m -99.23 -14.34 19.33 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.489 0.715 . . . . 0.0 112.271 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 61.72 23.76 14.01 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.04 0.936 . . . . 0.0 109.582 -171.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.92 65.2 2.71 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-N 116.54 -0.3 . . . . 0.0 112.717 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 10.8 p -59.55 166.11 2.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.167 0.987 . . . . 0.0 113.624 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 177.72 160.21 23.92 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.034 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -78.4 -27.12 46.68 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.852 0.326 . . . . 0.0 110.399 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 2.7 m -145.71 129.5 17.22 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.87 137.79 20.24 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.843 0.857 . . . . 0.0 110.887 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.501 ' HB2' ' HG3' ' A' ' 486' ' ' GLN . 1.3 mpt_? -91.68 116.14 28.63 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 78.8 m -108.12 119.34 39.2 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . . . . . . . . . 20.4 t -115.67 123.25 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.024 0.93 . . . . 0.0 109.744 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 42.2 tp -81.25 124.43 29.31 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 546' ' ' ASN . 53.5 t -126.45 144.37 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.824 0.85 . . . . 0.0 109.556 -173.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . 0.473 ' O ' HG12 ' A' ' 545' ' ' VAL . 4.1 t30 -84.03 162.69 20.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.907 0.883 . . . . 0.0 109.935 170.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' A' ' 480' ' ' ASN . . . -45.51 -41.49 9.7 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.439 1.495 . . . . 0.0 114.48 -175.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.26 -32.44 68.37 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.557 1.143 . . . . 0.0 112.897 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.85 -6.29 31.07 Favored Glycine 0 N--CA 1.464 0.551 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -168.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.81 117.63 9.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.568 0.747 . . . . 0.0 109.642 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.42 116.81 15.52 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.462 HG21 ' CZ3' ' A' ' 481' ' ' TRP . 16.1 m -95.33 -28.86 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 122.719 0.408 . . . . 0.0 111.546 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -156.89 147.33 21.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.167 0.987 . . . . 0.0 109.251 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 554' ' ' MET . 0.0 OUTLIER -147.26 147.67 30.65 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.119 0.568 . . . . 0.0 109.694 -178.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . 0.438 ' NH1' HG23 ' A' ' 557' ' ' VAL . 2.1 tmt_? -160.86 108.51 1.54 Allowed 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 63.2 m -81.55 138.13 35.46 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.619 0.768 . . . . 0.0 109.573 174.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.438 HG23 ' NH1' ' A' ' 555' ' ' ARG . 36.2 t -115.9 146.63 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.686 1.194 . . . . 0.0 109.133 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 113.1 6.18 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.005 0.922 . . . . 0.0 108.823 166.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 57.8 tttm . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 125.948 1.699 . . . . 0.0 111.384 176.755 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.559 1.321 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.39 128.51 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 171.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 28.6 t -117.18 174.2 6.25 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.17 0.588 . . . . 0.0 109.785 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 36.8 mt -93.03 116.23 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 469' ' ' LYS . 7.2 tp10 -70.33 -71.38 0.25 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.738 0.815 . . . . 0.0 109.92 -177.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.471 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.0 mt-10 -126.56 159.38 33.64 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.183 0.993 . . . . 0.0 108.705 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.503 HD11 ' HB ' ' A' ' 542' ' ' THR . 15.9 mt -137.09 131.3 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.67 127.0 31.16 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.669 ' HB2' ' HA ' ' A' ' 559' ' ' LYS . 0.9 OUTLIER -80.31 -17.83 50.96 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.534 0.521 . . . . 0.0 111.491 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -12.71 60.11 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 165.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 79.09 21.5 67.68 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.107 -0.951 . . . . 0.0 115.144 164.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -91.21 -13.16 33.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.058 0.429 . . . . 0.0 111.109 -176.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -155.29 158.7 39.19 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.5 116.81 46.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.114 1.366 . . . . 0.0 107.693 168.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.404 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.4 tp-100 -89.58 113.64 25.1 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.02 140.48 34.19 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . 0.613 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 21.3 tptm -113.96 129.28 56.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -88.1 100.08 12.68 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -90.94 6.92 42.69 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.14 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.9 t -76.11 161.41 28.87 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.596 0.758 . . . . 0.0 111.066 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.75 -9.55 58.09 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.233 0.613 . . . . 0.0 111.616 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.08 168.41 16.8 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.161 0.584 . . . . 0.0 110.038 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.19 118.42 10.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.484 0.714 . . . . 0.0 109.327 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -94.39 118.78 32.15 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.446 0.698 . . . . 0.0 110.391 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 67.6 p -71.94 116.97 12.97 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.397 0.679 . . . . 0.0 110.273 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.53 177.82 6.0 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 146.05 -67.42 0.41 Allowed Glycine 0 N--CA 1.474 1.2 0 CA-C-O 121.494 0.496 . . . . 0.0 112.743 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -73.23 -9.79 59.08 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.702 -0.749 . . . . 0.0 109.692 167.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -72.05 131.08 42.39 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.97 0.908 . . . . 0.0 109.148 171.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 21.5 ptt-85 -139.93 127.95 22.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.681 0.792 . . . . 0.0 110.375 -173.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . 0.437 ' HB ' ' HH2' ' A' ' 534' ' ' TRP . 10.3 mt -91.23 105.86 16.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.554 ' HE3' HG21 ' A' ' 545' ' ' VAL . 97.8 mttt -76.71 134.2 39.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.661 0.384 . . . . 0.0 110.385 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -118.85 91.4 3.55 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -97.11 102.05 13.75 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.077 0.951 . . . . 0.0 109.052 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.481 HG11 HD23 ' A' ' 488' ' ' LEU . 5.8 t -101.39 147.55 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.098 0.559 . . . . 0.0 110.786 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . 0.481 HD23 HG11 ' A' ' 487' ' ' VAL . 2.3 pt? -60.78 -24.73 66.0 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.544 0.738 . . . . 0.0 111.996 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.91 -27.56 68.9 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.346 1.058 . . . . 0.0 111.898 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 124.18 -26.4 5.83 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.677 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.74 100.29 2.32 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.977 0.894 . . . . 0.0 110.295 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -113.43 97.22 6.33 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.887 -1.052 . . . . 0.0 108.321 175.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 25.4 pt -108.71 178.91 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.547 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -156.3 118.45 4.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.32 0.648 . . . . 0.0 109.473 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -86.72 107.72 18.36 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -85.02 146.72 27.04 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.707 0.765 . . . . 0.0 110.195 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -80.18 173.35 12.68 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.955 1.302 . . . . 0.0 109.917 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 71.8 p -89.42 136.96 29.28 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.429 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 74.6 Cg_exo -52.57 -26.94 30.77 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.175 2.583 . . . . 0.0 114.435 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -79.31 -24.47 42.82 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.731 0.813 . . . . 0.0 112.227 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -66.9 127.78 33.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.232 0.613 . . . . 0.0 109.967 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 45.2 mt -129.81 134.08 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.812 0.845 . . . . 0.0 108.94 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.26 130.9 55.15 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -77.75 155.4 31.22 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.751 0.82 . . . . 0.0 111.553 -170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.97 120.73 13.14 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.723 0.809 . . . . 0.0 110.793 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 88.08 -2.26 85.32 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.575 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -95.98 176.02 6.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.05 0.54 . . . . 0.0 110.173 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -148.01 136.75 21.79 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.756 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 3.4 p -101.78 114.66 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.406 0.682 . . . . 0.0 109.781 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.99 94.95 10.0 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 89.6 t -82.64 104.6 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . 0.513 ' HB2' HG22 ' A' ' 527' ' ' VAL . 37.7 m95 -93.61 176.83 6.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.065 0.946 . . . . 0.0 112.107 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 534' ' ' TRP . . . -98.66 142.07 30.69 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.02 171.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . 0.577 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -66.86 -32.7 74.14 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.191 0.596 . . . . 0.0 111.152 176.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -67.57 -19.59 71.12 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.002 -0.545 . . . . 0.0 113.817 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -66.31 -18.45 65.36 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.153 0.581 . . . . 0.0 110.79 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.17 27.56 72.73 Favored Glycine 0 C--N 1.352 1.454 0 C-N-CA 122.711 0.196 . . . . 0.0 112.878 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.58 149.26 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.436 1.095 . . . . 0.0 110.942 -174.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -68.74 119.55 13.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.279 0.632 . . . . 0.0 110.999 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . 0.44 ' NE2' HD12 ' A' ' 526' ' ' LEU . 15.6 t-160 -76.44 124.69 27.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.439 0.695 . . . . 0.0 110.065 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 58.5 m -152.41 79.35 6.09 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.876 0.87 . . . . 0.0 110.464 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.49 161.05 37.88 Favored 'Trans proline' 0 CA--C 1.565 2.037 0 C-N-CA 122.909 2.406 . . . . 0.0 111.844 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.37 -9.17 43.44 Favored 'Cis proline' 0 C--N 1.382 2.314 0 CA-C-N 120.355 1.162 . . . . 0.0 113.904 1.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.1 m -66.33 -37.15 84.7 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.798 0.839 . . . . 0.0 111.753 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 97.0 m -139.46 89.81 2.36 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.775 0.83 . . . . 0.0 108.946 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 30.5 tp -91.83 138.98 31.11 Favored 'General case' 0 C--O 1.209 -1.078 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 512' ' ' TRP . 96.6 t -125.66 122.7 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.03 0.832 . . . . 0.0 109.15 -175.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -70.17 94.55 0.91 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . 0.577 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 23.0 tptm -71.32 117.62 13.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.428 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 121.44 -36.85 3.14 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.23 127.05 34.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.913 0.485 . . . . 0.0 110.684 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 58.4 p -99.42 -36.23 9.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.852 0.861 . . . . 0.0 110.978 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.438 ' OG ' HG22 ' A' ' 536' ' ' THR . 28.9 t -87.54 -35.51 18.11 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.653 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 51.48 34.51 12.34 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.833 0.853 . . . . 0.0 110.423 -174.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 64.88 64.21 3.69 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.195 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.438 HG22 ' OG ' ' A' ' 533' ' ' SER . 12.4 t -104.7 168.38 9.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.927 0.491 . . . . 0.0 110.673 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 168.0 -162.51 36.29 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.225 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -69.21 -34.64 75.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.208 0.603 . . . . 0.0 111.253 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.7 m -158.59 137.27 11.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.208 1.003 . . . . 0.0 109.021 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.436 ' HB3' HG23 ' A' ' 487' ' ' VAL . 4.7 p90 -149.98 125.38 10.19 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.83 0.824 . . . . 0.0 112.117 -177.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.547 HH21 ' HE2' ' A' ' 554' ' ' MET . 72.7 ttt-85 -77.92 102.04 7.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.722 174.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' THR . . . . . 0.503 ' HB ' HD11 ' A' ' 459' ' ' ILE . 16.3 m -95.86 124.52 39.9 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 46.7 t -125.33 134.92 65.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 C-N-CA 123.696 0.798 . . . . 0.0 109.937 -172.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 26.7 tp -97.69 115.96 28.98 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 166.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.554 HG21 ' HE3' ' A' ' 484' ' ' LYS . 92.3 t -110.06 159.17 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.014 1.326 . . . . 0.0 108.702 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -124.56 -170.35 2.14 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.732 0.413 . . . . 0.0 111.783 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.69 73.97 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.378 1.071 . . . . 0.0 112.948 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.33 -36.64 84.79 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.65 0.78 . . . . 0.0 111.07 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.26 -18.57 27.98 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.646 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.68 160.42 32.25 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.506 0.67 . . . . 0.0 110.59 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -92.71 108.0 19.65 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.186 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.17 -23.73 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.932 0.493 . . . . 0.0 111.494 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -151.63 131.66 13.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.814 0.845 . . . . 0.0 109.065 174.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.547 ' HE2' HH21 ' A' ' 541' ' ' ARG . 12.3 ttm -122.83 108.83 13.44 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -126.76 105.17 8.49 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 66.6 m -84.52 136.62 33.73 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.07 138.91 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.07 137.58 51.99 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.25 1.02 . . . . 0.0 108.695 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.669 ' HA ' ' HB2' ' A' ' 461' ' ' LEU . 55.8 tttm . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 124.477 1.111 . . . . 0.0 109.962 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' SER . . . . . 0.407 ' HB2' ' HH2' ' A' ' 481' ' ' TRP . 23.1 m . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.48 0.181 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 25.9 t -125.41 134.99 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.06 0.944 . . . . 0.0 108.616 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 20.8 m -115.5 173.05 6.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.129 0.972 . . . . 0.0 110.668 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 52.9 mt -94.7 111.9 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 469' ' ' LYS . 9.5 tp10 -82.63 -63.6 1.34 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.743 0.417 . . . . 0.0 110.968 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 28.9 mt-10 -121.29 151.68 39.78 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 58.9 mt -133.32 130.51 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -78.62 129.18 34.47 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.81 0.694 . . . . 0.0 109.882 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.434 HD13 ' HE3' ' A' ' 559' ' ' LYS . 2.2 pp -76.27 -23.72 54.44 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.247 0.342 . . . . 0.0 111.301 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -68.85 -29.4 67.71 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 167.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 83.8 25.3 46.36 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.498 -0.774 . . . . 0.0 114.032 172.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -82.28 -27.4 32.38 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.377 0.589 . . . . 0.0 111.12 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -146.52 160.03 42.66 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-O 121.458 0.647 . . . . 0.0 112.424 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 95.3 t -130.6 119.72 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 125.177 1.391 . . . . 0.0 107.417 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 4.1 tp-100 -89.19 122.31 32.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.832 0.853 . . . . 0.0 109.771 178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 75.5 mt -102.15 162.23 13.07 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.771 0.829 . . . . 0.0 109.629 171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 1.2 tmtp? -146.75 131.05 17.51 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -86.8 111.26 20.57 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.81 -17.5 47.29 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.032 0.933 . . . . 0.0 112.291 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 81.0 p -70.13 158.15 36.28 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.072 0.463 . . . . 0.0 111.669 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.64 0.67 29.26 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.178 0.991 . . . . 0.0 112.326 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.29 175.62 10.38 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.837 0.855 . . . . 0.0 109.281 -174.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.93 125.98 28.58 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.043 0.537 . . . . 0.0 109.593 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -100.36 131.65 46.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.178 0.991 . . . . 0.0 110.493 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 26.4 p -66.89 124.03 21.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.324 0.65 . . . . 0.0 109.714 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 9.5 tp -119.36 152.77 36.22 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.42 -52.53 0.58 Allowed Glycine 0 N--CA 1.475 1.234 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.837 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -69.75 -14.39 62.76 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.646 0.779 . . . . 0.0 110.639 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.407 ' HH2' ' HB2' ' A' ' 453' ' ' SER . 12.4 m95 -82.85 158.72 22.6 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 125.126 1.371 . . . . 0.0 109.95 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -161.27 131.75 5.12 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.838 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 32.5 mt -87.63 118.76 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.811 0.844 . . . . 0.0 109.742 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.665 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 64.8 mttm -84.81 148.7 26.17 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 166.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 492' ' ' GLU . 34.9 ttm180 -132.77 96.66 3.85 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 163.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -85.5 102.38 13.44 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.546 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 27.3 t -72.2 168.95 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.04 0.936 . . . . 0.0 110.277 -176.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . 0.43 HD22 ' H ' ' A' ' 539' ' ' SER . 3.4 pp -55.55 -25.92 40.5 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.643 1.177 . . . . 0.0 113.609 177.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -85.2 4.15 35.95 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.517 0.675 . . . . 0.0 110.812 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 86.21 -7.41 78.38 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.636 0.636 . . . . 0.0 113.349 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.49 102.63 3.26 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.689 0.796 . . . . 0.0 110.295 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 485' ' ' ARG . 8.7 pt-20 -96.39 111.89 23.83 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.583 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 28.4 pt -91.44 147.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.297 173.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -121.39 108.9 14.23 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.349 0.66 . . . . 0.0 110.707 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -83.07 107.74 15.86 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 166.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -91.58 147.67 22.84 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -93.72 170.46 9.55 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.414 0.686 . . . . 0.0 110.714 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 82.7 p -93.5 130.23 36.03 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.024 0.93 . . . . 0.0 108.985 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.517 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 17.7 Cg_endo -58.72 -18.88 43.23 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.257 2.638 . . . . 0.0 114.884 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -75.9 -24.02 55.58 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.951 0.501 . . . . 0.0 111.189 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -75.5 142.72 42.81 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.361 0.664 . . . . 0.0 110.528 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 61.9 mt -133.39 136.58 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.081 0.952 . . . . 0.0 108.713 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.39 116.72 33.43 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -73.27 162.26 29.57 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.197 0.599 . . . . 0.0 112.108 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -60.63 124.4 20.29 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.234 1.014 . . . . 0.0 112.302 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 74.43 -6.42 23.46 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.58 0.55 . . . . 0.0 114.297 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -81.02 155.1 26.53 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.456 0.702 . . . . 0.0 109.857 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 55.4 mtm -120.42 126.52 50.65 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.248 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.7 112.65 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 2.1 m -92.7 101.94 14.34 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.521 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.42 HG12 ' HE1' ' A' ' 534' ' ' TRP . 59.0 t -88.74 98.25 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.015 0.436 . . . . 0.0 109.981 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -86.05 176.64 7.91 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.397 1.079 . . . . 0.0 111.509 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -95.05 164.06 13.04 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.092 0.957 . . . . 0.0 110.726 174.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -64.79 -45.48 86.09 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.429 0.692 . . . . 0.0 111.302 174.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -82.91 5.97 73.0 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.683 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -75.6 -1.05 22.7 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.502 0.721 . . . . 0.0 111.842 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 68.41 31.25 73.82 Favored Glycine 0 C--N 1.356 1.683 0 C-N-CA 123.125 0.393 . . . . 0.0 113.699 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 6.4 p -123.74 135.86 62.06 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 C-N-CA 124.42 1.088 . . . . 0.0 109.968 -172.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -76.95 134.1 39.01 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.292 0.637 . . . . 0.0 110.4 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -64.51 110.89 2.46 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.356 0.663 . . . . 0.0 110.228 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.5 m -126.42 74.22 73.65 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.605 0.762 . . . . 0.0 110.129 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.33 150.91 76.53 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 122.27 1.98 . . . . 0.0 111.435 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -93.23 11.47 53.01 Favored 'Cis proline' 0 C--N 1.376 1.981 0 CA-C-N 119.971 1.025 . . . . 0.0 113.72 -1.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.3 m -82.8 -28.85 29.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.391 0.676 . . . . 0.0 111.833 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 76.7 m -143.58 104.42 4.21 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.727 0.811 . . . . 0.0 109.968 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 66.5 mt -91.35 144.07 25.97 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 169.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 50.3 t -120.85 120.95 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.635 0.774 . . . . 0.0 108.975 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -75.2 96.42 3.3 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.9 tptt -66.7 136.39 55.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.792 0.837 . . . . 0.0 110.335 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 88.67 -4.97 85.07 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 123.479 0.487 . . . . 0.0 113.325 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -112.99 114.06 26.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 34.2 p -73.56 -56.69 4.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.085 0.554 . . . . 0.0 111.942 -172.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.624 ' HB2' HG22 ' A' ' 536' ' ' THR . 86.6 p -114.45 9.72 16.83 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.267 0.627 . . . . 0.0 112.215 -169.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.42 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 59.44 23.87 12.47 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 124.422 1.089 . . . . 0.0 110.545 -174.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.87 71.12 0.9 Allowed Glycine 0 C--N 1.35 1.34 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.624 HG22 ' HB2' ' A' ' 533' ' ' SER . 17.3 p -59.67 129.93 44.33 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.449 0.7 . . . . 0.0 111.949 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -137.0 154.93 22.47 Favored Glycine 0 C--O 1.238 0.371 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 170.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.14 -60.58 2.17 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 558' ' ' LYS . 7.3 m -107.16 125.1 50.65 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.086 0.954 . . . . 0.0 109.026 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.546 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 5.6 p90 -151.28 145.1 25.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.649 0.738 . . . . 0.0 111.883 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.422 HH11 ' HE1' ' A' ' 554' ' ' MET . 4.3 tmm_? -96.91 102.08 13.78 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.763 1.225 . . . . 0.0 108.468 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 47.7 m -86.44 140.21 30.19 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.452 0.701 . . . . 0.0 109.202 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 40.0 t -133.8 146.2 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.484 1.114 . . . . 0.0 109.619 -175.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 38.6 tp -113.61 133.09 55.48 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 163.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.569 HG23 ' HE2' ' A' ' 484' ' ' LYS . 85.4 t -124.26 156.24 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.605 1.162 . . . . 0.0 108.369 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . 0.561 HD22 ' HG3' ' A' ' 550' ' ' GLU . 6.4 p30 -119.58 -170.23 1.9 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.398 0.679 . . . . 0.0 111.814 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.61 64.09 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.156 1.382 . . . . 0.0 113.755 -174.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . 0.577 ' HB3' ' HG2' ' A' ' 550' ' ' GLU . 16.8 t70 -67.31 -37.81 83.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.403 0.681 . . . . 0.0 112.1 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.76 -15.97 28.73 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.078 -173.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . 0.577 ' HG2' ' HB3' ' A' ' 548' ' ' ASP . 9.9 pt-20 -62.64 137.68 58.32 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.633 0.773 . . . . 0.0 110.325 172.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -81.47 87.72 6.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.807 0.843 . . . . 0.0 109.543 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . 0.459 ' HB ' ' ND2' ' A' ' 546' ' ' ASN . 7.6 p -64.02 -35.8 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.694 -170.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -133.37 150.75 51.81 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.518 0.727 . . . . 0.0 109.054 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.422 ' HE1' HH11 ' A' ' 541' ' ' ARG . 51.6 ttm -161.56 121.68 2.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.466 0.706 . . . . 0.0 109.629 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.71 118.74 13.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.29 0.636 . . . . 0.0 109.315 175.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 28.2 m -86.21 140.43 30.15 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.976 0.911 . . . . 0.0 109.276 174.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.42 131.18 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.66 0.784 . . . . 0.0 109.124 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 0.0 OUTLIER -122.15 125.52 46.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.651 0.78 . . . . 0.0 109.034 175.213 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.434 ' HE3' HD13 ' A' ' 461' ' ' LEU . 86.9 tttt . . . . . 0 C--O 1.242 0.695 0 C-N-CA 124.786 1.234 . . . . 0.0 110.052 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 47.2 m . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 110.926 -0.028 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 15.8 t -92.63 103.19 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.6 m -97.92 143.87 28.06 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.963 0.905 . . . . 0.0 110.647 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 28.7 mt -78.16 96.33 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -78.4 -69.66 0.54 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -120.48 154.11 35.7 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.528 ' HB ' HG23 ' A' ' 557' ' ' VAL . 70.4 mt -146.73 143.13 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 168.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . 0.4 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 31.1 t70 -60.63 151.87 27.9 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.47 0.708 . . . . 0.0 110.801 174.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.2 pp -55.54 -29.82 59.62 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.789 1.236 . . . . 0.0 113.771 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -118.58 10.37 12.53 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.388 1.075 . . . . 0.0 111.252 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.19 42.7 90.98 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.901 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -78.69 -7.12 57.39 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.4 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 36.1 p90 -157.85 147.07 19.66 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 124.419 1.088 . . . . 0.0 109.956 170.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 76.1 t -120.36 122.96 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' A' ' 508' ' ' MET . 0.1 OUTLIER -103.92 114.13 28.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.122 1.369 . . . . 0.0 108.603 -174.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 65.4 mt -107.68 161.73 14.61 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.08 1.352 . . . . 0.0 109.91 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -150.13 132.51 15.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.961 0.504 . . . . 0.0 109.754 -176.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -85.35 131.92 34.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.281 0.632 . . . . 0.0 110.686 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -112.25 -0.14 15.58 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.016 1.327 . . . . 0.0 110.775 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 49.1 m -63.9 147.61 51.5 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.794 0.438 . . . . 0.0 110.654 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -69.62 -11.15 60.61 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.033 0.933 . . . . 0.0 111.778 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.2 OUTLIER -134.69 176.23 8.83 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 125.272 1.429 . . . . 0.0 108.82 -177.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.69 114.8 5.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.526 0.73 . . . . 0.0 109.508 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -74.87 108.34 7.54 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.657 0.783 . . . . 0.0 110.0 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.406 ' HA ' HG12 ' A' ' 502' ' ' ILE . 29.1 p -63.78 104.88 0.73 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 7.6 tp -93.81 -176.59 4.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.89 0.876 . . . . 0.0 109.208 -173.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 134.3 -66.5 0.57 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 112.549 -0.221 . . . . 0.0 112.549 172.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . 0.439 ' N ' HD21 ' A' ' 480' ' ' ASN . 0.8 OUTLIER -67.92 -11.63 59.13 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.372 0.669 . . . . 0.0 111.679 -179.308 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -67.59 141.79 56.68 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.971 0.908 . . . . 0.0 109.387 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -143.31 131.59 22.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.102 0.561 . . . . 0.0 110.701 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 45.0 mt -88.13 110.33 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.024 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.48 ' HE2' HG22 ' A' ' 545' ' ' VAL . 64.7 mttm -82.67 150.42 26.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.442 0.697 . . . . 0.0 109.202 166.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -144.59 104.87 4.09 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -99.16 108.57 21.21 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.431 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 30.0 t -83.61 160.42 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 124.316 1.046 . . . . 0.0 110.796 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 539' ' ' SER . 4.6 pp -51.3 -26.91 8.19 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.947 1.299 . . . . 0.0 113.614 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -77.65 -10.42 59.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.981 0.913 . . . . 0.0 111.42 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 90.78 1.91 72.99 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -79.92 148.18 31.35 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.077 0.951 . . . . 0.0 109.303 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.87 157.01 47.3 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.036 0.446 . . . . 0.0 110.111 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 30.4 pt -136.75 163.82 32.08 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 C-N-CA 124.493 1.117 . . . . 0.0 108.384 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -136.47 105.67 6.01 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.313 0.645 . . . . 0.0 109.673 172.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -81.62 142.38 32.82 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -131.43 144.41 51.16 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -84.38 163.14 19.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.739 0.815 . . . . 0.0 110.802 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 59.5 p -79.68 132.4 61.52 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.886 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.507 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 35.2 Cg_endo -61.1 -16.96 49.3 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.172 2.581 . . . . 0.0 113.533 -175.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -86.57 -20.52 27.82 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.75 0.82 . . . . 0.0 111.855 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -66.04 136.9 56.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.132 0.573 . . . . 0.0 110.153 -177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 477' ' ' SER . 52.0 mt -131.18 121.86 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.836 0.854 . . . . 0.0 108.976 174.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.71 130.91 34.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -81.32 155.14 26.15 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.159 0.583 . . . . 0.0 110.898 -175.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -61.64 117.65 6.06 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.853 0.861 . . . . 0.0 111.177 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 88.51 -22.38 20.8 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.368 0.417 . . . . 0.0 113.612 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -75.79 173.72 10.77 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.402 0.681 . . . . 0.0 111.242 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.424 ' HB3' ' OE1' ' A' ' 467' ' ' GLN . 37.2 mtm -124.62 172.46 9.23 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.482 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.18 127.09 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 5.2 m -121.73 113.84 20.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.045 0.538 . . . . 0.0 109.58 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.85 99.11 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.271 0.628 . . . . 0.0 109.974 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -79.85 176.65 9.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.65 1.18 . . . . 0.0 111.754 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -99.16 156.46 16.95 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.23 1.012 . . . . 0.0 110.633 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -62.26 -36.59 82.51 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.541 0.736 . . . . 0.0 111.207 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -88.48 10.16 72.79 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.515 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -80.91 -17.07 51.81 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.294 0.637 . . . . 0.0 110.729 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 71.48 18.87 77.34 Favored Glycine 0 C--N 1.357 1.737 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.511 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.92 149.58 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.461 1.105 . . . . 0.0 110.458 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -77.63 130.46 36.89 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.604 0.762 . . . . 0.0 110.618 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -67.45 113.08 5.01 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' SER . . . . . 0.407 ' HB2' ' HB ' ' A' ' 525' ' ' THR . 10.9 m -125.41 69.68 61.94 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 123.492 0.717 . . . . 0.0 109.827 -177.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.79 150.72 68.39 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.217 1.945 . . . . 0.0 111.628 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.42 -8.01 49.85 Favored 'Cis proline' 0 C--N 1.371 1.749 0 N-CA-C 114.507 0.926 . . . . 0.0 114.507 3.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.2 m -67.14 -60.53 2.53 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.475 0.71 . . . . 0.0 111.466 -173.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 521' ' ' SER . 90.6 m -105.19 93.58 4.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.93 0.892 . . . . 0.0 109.198 -177.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 73.0 mt -81.71 143.69 31.68 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 82.1 t -126.04 131.16 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -74.93 95.06 2.91 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -65.2 124.48 22.29 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.793 0.837 . . . . 0.0 110.698 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 94.41 -27.27 14.18 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.799 0.687 . . . . 0.0 114.129 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.54 99.28 9.09 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 29.3 p -85.15 -34.07 22.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.126 0.97 . . . . 0.0 113.165 -167.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 536' ' ' THR . 87.1 p -75.47 -28.39 59.22 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.635 0.374 . . . . 0.0 111.3 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 58.77 32.23 22.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.896 1.279 . . . . 0.0 108.917 -169.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 70.36 76.81 0.51 Allowed Glycine 0 C--N 1.358 1.798 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -172.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 533' ' ' SER . 9.6 t -52.23 143.03 15.38 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.408 1.083 . . . . 0.0 113.431 -167.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 158.61 131.74 1.31 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -84.21 -15.78 45.71 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.1 0.56 . . . . 0.0 111.216 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' SER . . . . . 0.505 ' HB2' HD22 ' A' ' 488' ' ' LEU . 17.9 m -137.71 132.48 32.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.237 0.615 . . . . 0.0 109.772 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.431 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 30.8 p90 -168.19 176.7 5.85 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.699 1.2 . . . . 0.0 110.308 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.91 114.59 16.67 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.191 0.997 . . . . 0.0 108.82 169.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 83.6 m -86.61 125.42 33.81 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.075 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.521 HG23 ' HG3' ' A' ' 554' ' ' MET . 43.8 t -115.44 117.83 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.14 0.976 . . . . 0.0 108.679 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 553' ' ' ALA . 24.9 tp -88.63 132.28 34.62 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.48 HG22 ' HE2' ' A' ' 484' ' ' LYS . 50.9 t -115.51 142.99 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 124.838 1.255 . . . . 0.0 108.122 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . 0.464 ' ND2' ' HG2' ' A' ' 550' ' ' GLU . 0.2 OUTLIER -96.99 -167.24 1.51 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.877 0.471 . . . . 0.0 111.338 -179.396 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.04 -37.03 83.4 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -75.4 -0.98 21.8 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.31 15.85 80.39 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 123.258 0.348 . . . . 0.0 113.67 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . 0.464 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 5.7 pt-20 -97.45 149.75 21.81 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.281 0.632 . . . . 0.0 109.298 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.78 90.21 3.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.165 0.986 . . . . 0.0 109.296 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.15 -32.99 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.431 -173.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 544' ' ' LEU . . . -142.66 157.63 44.49 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.459 0.703 . . . . 0.0 110.245 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.521 ' HG3' HG23 ' A' ' 543' ' ' VAL . 26.1 ttt -157.44 146.4 19.77 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.98 0.912 . . . . 0.0 109.334 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -159.83 117.88 2.69 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.701 0.401 . . . . 0.0 110.956 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 87.4 m -88.73 116.51 27.05 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.611 0.764 . . . . 0.0 110.359 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.528 HG23 ' HB ' ' A' ' 459' ' ' ILE . 81.1 t -102.37 131.91 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.523 1.129 . . . . 0.0 109.628 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . 0.44 ' HD2' ' HB3' ' A' ' 539' ' ' SER . 13.3 mmmm -131.28 117.84 19.54 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.015 1.326 . . . . 0.0 107.868 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt . . . . . 0 N--CA 1.482 1.144 0 CA-C-N 118.55 0.613 . . . . 0.0 109.423 176.896 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 53.5 m . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.655 0.264 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . 0.493 HG22 HD22 ' A' ' 478' ' ' LEU . 17.9 t -93.24 107.77 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 165.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 80.6 p -88.54 160.59 17.39 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.336 0.654 . . . . 0.0 110.006 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . 0.421 HG13 ' HB1' ' A' ' 553' ' ' ALA . 48.5 mt -81.53 96.3 3.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 170.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.631 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 14.6 tp10 -68.41 -55.91 10.3 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.494 -171.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.631 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.0 mt-10 -142.0 154.03 44.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.904 0.882 . . . . 0.0 108.896 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.558 ' HB ' HG23 ' A' ' 557' ' ' VAL . 56.2 mt -136.0 135.28 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.62 141.4 57.82 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 123.358 0.411 . . . . 0.0 110.131 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.82 -39.41 94.23 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.665 0.603 . . . . 0.0 110.895 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 559' ' ' LYS . 27.9 mt-10 -74.71 -33.47 62.42 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.33 33.35 6.89 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.064 -0.971 . . . . 0.0 113.109 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -84.19 -15.52 46.69 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.173 0.589 . . . . 0.0 110.46 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -157.89 161.05 38.24 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 123.236 0.614 . . . . 0.0 110.773 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . 0.422 HG21 ' HD2' ' A' ' 485' ' ' ARG . 89.2 t -133.6 121.28 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.674 1.19 . . . . 0.0 108.356 174.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 23.0 tp60 -92.37 119.76 32.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.087 0.955 . . . . 0.0 109.718 174.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 69.1 mt -108.85 153.18 23.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.146 0.979 . . . . 0.0 108.716 169.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -147.5 144.52 28.61 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.843 0.457 . . . . 0.0 111.115 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.52 ' HB2' HD11 ' A' ' 503' ' ' LEU . 52.7 t30 -89.53 126.9 35.78 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 174.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.46 ' N ' HD21 ' A' ' 471' ' ' ASN . 0.7 OUTLIER -99.01 -17.72 18.14 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.912 0.885 . . . . 0.0 110.097 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' SER . . . . . 0.521 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 28.8 m -79.29 155.96 28.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.968 0.907 . . . . 0.0 112.49 -173.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.1 -37.42 66.73 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.755 0.822 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . 0.521 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.1 OUTLIER -78.7 148.37 33.11 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.098 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.81 140.72 56.63 Favored 'General case' 0 C--O 1.244 0.767 0 O-C-N 123.776 0.673 . . . . 0.0 109.392 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.424 ' HG3' HG23 ' A' ' 454' ' ' VAL . 0.0 OUTLIER -112.18 111.44 22.33 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 39.9 m -75.98 122.98 24.99 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.613 0.765 . . . . 0.0 110.624 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . 0.493 HD22 HG22 ' A' ' 454' ' ' VAL . 95.6 mt -98.02 167.03 11.15 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.495 0.718 . . . . 0.0 109.932 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 143.48 -53.27 0.6 Allowed Glycine 0 N--CA 1.466 0.691 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . 0.457 ' N ' HD21 ' A' ' 480' ' ' ASN . 0.7 OUTLIER -81.32 -12.19 59.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.324 1.049 . . . . 0.0 110.239 175.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -83.84 139.83 32.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.663 0.785 . . . . 0.0 109.762 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -130.5 145.53 51.87 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.603 0.761 . . . . 0.0 110.576 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 34.8 mt -106.7 95.19 3.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -78.66 129.65 34.97 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 124.052 0.941 . . . . 0.0 109.172 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . 0.422 ' HD2' HG21 ' A' ' 466' ' ' VAL . 74.4 mtp85 -135.04 93.35 2.99 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -94.09 102.73 14.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.944 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.511 HG13 HD22 ' A' ' 488' ' ' LEU . 39.2 t -76.34 151.58 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.032 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . 0.511 HD22 HG13 ' A' ' 487' ' ' VAL . 2.5 pt? -59.5 -20.42 55.23 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.424 0.69 . . . . 0.0 112.743 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -73.17 -11.49 60.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.616 1.167 . . . . 0.0 112.69 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 109.31 -16.83 31.96 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-N 116.352 -0.385 . . . . 0.0 112.916 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.57 103.07 0.79 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.753 0.821 . . . . 0.0 111.448 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -107.17 119.94 40.75 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.425 HG22 ' NE2' ' A' ' 531' ' ' GLN . 31.6 pt -130.92 146.4 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.743 0.817 . . . . 0.0 109.601 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -129.35 109.01 10.75 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.89 0.476 . . . . 0.0 110.066 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -79.83 103.18 9.55 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . 0.431 ' HD3' ' H ' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -85.05 134.11 34.22 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.161 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -72.73 164.44 26.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.196 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.3 p -80.19 135.68 54.2 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.436 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 54.1 Cg_endo -66.81 -9.69 25.59 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.668 2.246 . . . . 0.0 113.799 -174.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -92.44 -9.66 40.75 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.404 0.681 . . . . 0.0 111.629 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -87.92 119.11 27.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.778 0.431 . . . . 0.0 109.895 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 40.3 mt -108.02 129.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 470' ' ' ASN . 0.9 OUTLIER -84.87 117.06 23.67 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.195 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -76.03 148.79 37.77 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.309 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.75 118.24 9.33 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.385 0.674 . . . . 0.0 110.685 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 103.35 -23.34 33.43 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.287 0.367 . . . . 0.0 112.552 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -88.02 -178.76 6.06 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.637 0.775 . . . . 0.0 111.368 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -157.57 146.28 19.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.808 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . 0.401 HG23 HD11 ' A' ' 526' ' ' LEU . 7.2 p -109.6 127.89 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.848 0.859 . . . . 0.0 109.342 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 2.7 m -111.47 105.88 14.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 47.7 t -93.19 112.26 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . 0.488 ' HB2' HG23 ' A' ' 527' ' ' VAL . 46.9 m95 -98.41 173.46 6.95 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.041 0.936 . . . . 0.0 111.522 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 516' ' ' ALA . . . -84.07 148.5 26.8 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.452 172.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.7 86.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.486 0.66 . . . . 0.0 110.316 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -88.56 14.3 60.13 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.879 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 513' ' ' ALA . . . -84.78 -11.46 55.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.449 0.7 . . . . 0.0 111.47 176.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.69 23.23 77.96 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.109 0.403 . . . . 0.0 114.109 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 11.5 p -98.45 149.82 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.3 1.04 . . . . 0.0 109.98 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.23 122.21 26.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.09 0.556 . . . . 0.0 110.41 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -65.31 110.12 2.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.067 0.547 . . . . 0.0 109.778 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 17.3 m -132.99 78.01 66.68 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.363 0.665 . . . . 0.0 110.626 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.46 154.9 50.38 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.749 2.299 . . . . 0.0 112.834 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -92.06 4.19 63.3 Favored 'Cis proline' 0 C--N 1.376 2.021 0 CA-C-N 119.841 0.979 . . . . 0.0 113.517 3.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.0 m -84.96 -58.17 2.8 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.781 0.432 . . . . 0.0 110.497 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 38.9 m -97.53 89.56 4.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.062 0.545 . . . . 0.0 109.872 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 10.8 mp -86.17 138.64 31.75 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' A' ' 512' ' ' TRP . 86.9 t -125.54 128.56 72.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -72.96 88.97 1.39 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -64.04 112.41 2.96 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.508 -1.223 . . . . 0.0 108.702 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 122.89 -38.29 2.56 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 123.458 0.474 . . . . 0.0 112.411 -173.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . 0.425 ' NE2' HG22 ' A' ' 493' ' ' ILE . 28.5 tp60 -86.49 96.61 10.11 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 13.8 p -63.53 -52.53 60.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.198 0.999 . . . . 0.0 112.199 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 536' ' ' THR . 96.0 p -88.78 -30.66 18.85 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 122.839 0.456 . . . . 0.0 111.927 -176.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 6.3 t-105 56.57 34.94 25.28 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.402 1.096 . . . . 0.0 110.3 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 69.53 51.6 25.25 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.996 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 533' ' ' SER . 15.9 p -74.65 123.44 24.87 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 170.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -156.35 179.95 31.83 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.485 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -77.14 -38.71 51.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.407 0.622 . . . . 0.0 109.508 176.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 19.3 m -147.92 125.85 12.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.562 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -146.29 144.78 30.06 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.777 0.831 . . . . 0.0 109.855 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 41.2 ttm180 -107.37 116.78 32.54 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.79 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 59.0 m -94.04 121.93 36.03 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.538 HG22 ' HG3' ' A' ' 554' ' ' MET . 59.9 t -124.53 117.93 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.332 1.053 . . . . 0.0 108.837 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 553' ' ' ALA . 40.3 tp -89.52 111.59 22.54 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 51.6 t -102.02 149.78 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.207 1.003 . . . . 0.0 109.114 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . 0.498 HD22 ' HG2' ' A' ' 550' ' ' GLU . 1.1 p30 -111.75 -172.59 2.07 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.969 0.507 . . . . 0.0 111.737 -172.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.6 73.01 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.884 1.274 . . . . 0.0 113.15 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . 0.419 ' HB3' HD22 ' A' ' 546' ' ' ASN . 12.5 t70 -59.8 -40.61 88.91 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.583 0.753 . . . . 0.0 111.127 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.24 -17.76 26.27 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.436 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . 0.498 ' HG2' HD22 ' A' ' 546' ' ' ASN . 14.0 pt-20 -69.16 148.21 50.25 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.101 0.477 . . . . 0.0 110.665 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.99 99.97 9.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.077 0.951 . . . . 0.0 108.775 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 27.1 m -85.11 -19.86 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.054 0.542 . . . . 0.0 112.284 -172.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.59 ' HB2' ' HB3' ' A' ' 544' ' ' LEU . . . -147.65 139.76 24.29 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.538 ' HG3' HG22 ' A' ' 543' ' ' VAL . 44.5 ttm -151.12 132.36 14.49 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.628 0.771 . . . . 0.0 109.252 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -157.78 117.62 3.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.264 0.626 . . . . 0.0 109.627 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 8.8 m -103.47 112.34 25.2 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.74 0.816 . . . . 0.0 109.435 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.558 HG23 ' HB ' ' A' ' 459' ' ' ILE . 58.1 t -105.64 122.12 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.503 0.721 . . . . 0.0 110.65 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.97 117.75 35.29 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.467 ' HD3' ' HA ' ' A' ' 462' ' ' GLU . 25.8 ttpp . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 124.132 0.973 . . . . 0.0 110.565 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 120.785 0.326 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.77 145.05 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.452 1.101 . . . . 0.0 108.208 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 43.9 t -130.55 150.35 51.8 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.378 1.071 . . . . 0.0 109.988 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.3 mt -84.71 108.86 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -80.71 -72.16 0.43 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.807 0.337 . . . . 0.0 110.824 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -119.25 149.86 41.06 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.993 0.517 . . . . 0.0 109.688 -169.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.45 ' HB ' HG23 ' A' ' 557' ' ' VAL . 80.6 mt -144.56 138.13 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 170.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . 0.407 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 20.1 t70 -59.91 142.04 54.39 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 123.488 0.493 . . . . 0.0 110.74 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 462' ' ' GLU . 2.3 pp -66.71 -35.16 79.48 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.074 0.859 . . . . 0.0 111.432 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.505 ' HG3' HD11 ' A' ' 461' ' ' LEU . 29.0 mt-10 -75.37 -33.22 61.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.31 0.576 . . . . 0.0 109.687 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.84 52.0 1.86 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.422 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -96.19 -18.43 20.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.254 0.622 . . . . 0.0 111.194 175.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.407 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 32.0 p90 -150.85 161.1 43.33 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.067 0.461 . . . . 0.0 112.007 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 49.6 t -126.85 141.24 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.314 1.445 . . . . 0.0 107.493 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.72 104.61 9.72 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.425 HD21 HD21 ' A' ' 544' ' ' LEU . 57.8 mt -94.82 162.02 13.93 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.815 1.246 . . . . 0.0 110.204 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -144.28 130.14 19.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.484 ' HB2' HD13 ' A' ' 503' ' ' LEU . 46.9 t30 -78.29 107.58 11.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.118 0.567 . . . . 0.0 109.951 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -81.29 -5.71 58.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.646 0.779 . . . . 0.0 112.332 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 15.0 m -74.7 137.43 42.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.116 0.566 . . . . 0.0 110.715 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.61 -13.6 61.82 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.23 1.012 . . . . 0.0 110.998 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.0 OUTLIER -110.39 170.57 8.0 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.856 1.262 . . . . 0.0 108.457 172.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.9 145.03 50.43 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -107.88 118.24 36.22 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 41.2 p -71.6 118.27 14.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 171.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.3 mt -98.78 169.58 9.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 128.78 -56.51 0.74 Allowed Glycine 0 CA--C 1.492 -1.406 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -74.14 -13.16 60.78 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.886 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -82.16 149.49 27.92 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.566 1.147 . . . . 0.0 110.288 170.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -149.56 145.45 26.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.62 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 10.2 mt -107.25 106.19 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 62.1 mttm -75.87 159.79 30.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.112 0.565 . . . . 0.0 109.832 175.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 542' ' ' THR . 42.8 ttm180 -152.92 100.2 2.48 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -88.58 102.45 14.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.098 0.959 . . . . 0.0 108.575 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.21 127.8 40.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 539' ' ' SER . 4.5 pp -65.79 -16.39 63.76 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.539 0.736 . . . . 0.0 112.468 -176.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -73.59 -0.45 15.32 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.866 0.867 . . . . 0.0 111.761 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 106.15 27.45 5.61 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 166.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -132.06 101.12 5.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.168 0.587 . . . . 0.0 110.207 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -106.34 121.96 45.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.89 179.57 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.149 0.98 . . . . 0.0 110.18 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -161.32 118.06 2.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.8 0.84 . . . . 0.0 110.064 172.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -79.18 117.48 20.24 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.548 0.739 . . . . 0.0 109.324 172.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.01 141.71 31.88 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -84.63 169.13 14.66 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 166.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.6 p -91.7 130.2 39.76 Favored Pre-proline 0 CA--C 1.556 1.186 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.508 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 32.4 Cg_exo -60.3 -20.42 62.55 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.249 2.633 . . . . 0.0 114.023 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -72.61 -22.35 60.98 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.66 0.784 . . . . 0.0 111.855 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -83.81 123.78 30.25 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.717 0.807 . . . . 0.0 110.447 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 54.1 mt -116.41 132.92 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 168.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . 0.484 HD13 ' HB2' ' A' ' 470' ' ' ASN . 2.4 tm? -93.96 138.32 32.2 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.55 161.88 29.32 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -57.99 120.07 7.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.925 1.29 . . . . 0.0 112.428 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 66.87 14.74 63.64 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -97.16 -163.56 1.06 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.236 0.614 . . . . 0.0 109.851 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 19.3 ptp -146.06 164.08 33.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.783 0.833 . . . . 0.0 110.835 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.0 p -143.93 124.68 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.099 0.96 . . . . 0.0 109.152 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 4.0 m -114.51 110.05 19.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.827 0.851 . . . . 0.0 109.591 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 41.0 t -96.71 102.07 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.266 0.626 . . . . 0.0 109.861 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -83.69 175.25 9.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.622 1.169 . . . . 0.0 111.457 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -97.05 158.48 15.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.985 0.914 . . . . 0.0 110.195 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -65.05 -25.23 67.74 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.211 0.604 . . . . 0.0 111.865 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . 0.4 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -111.45 21.12 22.17 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.755 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -79.97 -1.0 37.59 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.25 0.62 . . . . 0.0 110.814 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 74.4 38.22 45.72 Favored Glycine 0 C--N 1.358 1.8 0 O-C-N 123.285 0.366 . . . . 0.0 112.379 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.78 148.48 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.135 0.974 . . . . 0.0 110.149 -171.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -91.66 160.45 15.36 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.606 0.762 . . . . 0.0 110.139 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -79.99 122.86 27.25 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 39.0 m -133.18 80.68 58.56 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.692 0.797 . . . . 0.0 109.111 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.94 154.37 58.16 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.739 2.293 . . . . 0.0 112.48 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.54 -18.38 24.04 Favored 'Cis proline' 0 C--N 1.378 2.119 0 C-N-CA 124.787 -0.922 . . . . 0.0 113.741 1.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.2 m -64.98 -52.36 56.65 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.573 0.749 . . . . 0.0 111.708 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 32.6 m -104.01 91.09 3.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 55.6 mt -83.15 148.31 27.55 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.4 127.81 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.417 0.687 . . . . 0.0 109.23 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -70.76 88.07 0.71 Allowed 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -71.93 131.47 43.01 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.714 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 107.51 -36.49 4.35 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.281 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.17 112.05 23.12 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.275 0.559 . . . . 0.0 110.703 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 22.6 p -85.39 -21.61 28.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.677 1.191 . . . . 0.0 112.702 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.5 t -87.48 -32.95 19.19 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -170.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 53.35 22.84 2.97 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 124.056 0.942 . . . . 0.0 110.932 -168.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.79 60.98 6.61 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -171.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 15.1 t -64.76 149.79 48.61 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.568 0.747 . . . . 0.0 110.25 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -163.12 162.15 34.51 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 116.405 -0.361 . . . . 0.0 112.22 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -76.13 -34.96 59.45 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.975 0.91 . . . . 0.0 109.167 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' SER . . . . . 0.411 ' HB2' HD23 ' A' ' 488' ' ' LEU . 50.5 m -150.04 142.26 24.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.674 1.19 . . . . 0.0 108.71 170.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -164.22 -179.8 6.36 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.482 1.113 . . . . 0.0 109.631 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -140.0 125.71 19.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.497 0.665 . . . . 0.0 110.078 170.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 485' ' ' ARG . 24.1 m -101.87 120.86 41.05 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.765 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 57.4 t -103.62 148.39 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.32 1.048 . . . . 0.0 109.365 -177.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.548 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 43.7 tp -110.42 136.19 49.96 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.34 150.02 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.735 1.214 . . . . 0.0 108.348 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -116.99 -170.94 1.93 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.864 0.866 . . . . 0.0 112.134 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -61.3 -26.34 67.72 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.072 0.949 . . . . 0.0 112.91 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.67 -37.49 84.89 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.086 0.554 . . . . 0.0 110.842 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 100.07 5.03 55.14 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.189 -172.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -88.06 149.54 23.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.309 0.643 . . . . 0.0 110.012 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.03 95.32 6.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.596 0.758 . . . . 0.0 108.96 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.75 -28.91 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.771 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -149.99 160.9 43.26 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.618 0.367 . . . . 0.0 110.639 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 50.6 ttp -158.67 143.44 16.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.792 0.837 . . . . 0.0 109.272 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -142.21 108.66 5.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.029 0.931 . . . . 0.0 109.172 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 42.2 m -82.34 109.48 16.63 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.488 0.715 . . . . 0.0 109.489 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.45 HG23 ' HB ' ' A' ' 459' ' ' ILE . 57.3 t -109.22 132.31 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.222 1.009 . . . . 0.0 110.161 -175.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 558' ' ' LYS . 0.0 OUTLIER -132.67 118.4 19.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.603 1.161 . . . . 0.0 108.627 -177.38 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 461' ' ' LEU . 33.3 tttm . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 124.861 1.264 . . . . 0.0 109.883 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.43 0.157 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 43.0 t -99.61 121.56 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 16.9 m -108.78 143.66 37.63 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.306 1.042 . . . . 0.0 109.581 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 55.5 mt -77.43 130.32 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.439 ' HB2' ' HG3' ' A' ' 467' ' ' GLN . 36.1 mm-40 -81.01 -74.19 0.34 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.65 0.262 . . . . 0.0 110.649 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -128.25 155.32 44.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.753 0.821 . . . . 0.0 109.916 -171.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.432 ' HB ' HG11 ' A' ' 557' ' ' VAL . 48.4 mm -131.12 141.57 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.635 0.774 . . . . 0.0 109.0 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.66 153.86 31.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.246 1.018 . . . . 0.0 111.398 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 559' ' ' LYS . 2.2 pt? -109.31 0.31 19.48 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.156 0.582 . . . . 0.0 110.251 166.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -120.83 0.82 10.4 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.137 0.975 . . . . 0.0 112.544 -171.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 73.58 45.87 27.28 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 123.073 0.233 . . . . 0.0 113.597 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -108.31 -50.49 3.03 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.39 0.676 . . . . 0.0 111.295 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -164.59 152.08 11.68 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . 0.403 HG13 HD11 ' A' ' 483' ' ' ILE . 71.1 t -112.15 112.0 38.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.673 1.189 . . . . 0.0 108.692 173.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.439 ' HG3' ' HB2' ' A' ' 457' ' ' GLU . 57.4 tp60 -87.32 102.19 14.27 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 544' ' ' LEU . 81.9 mt -94.95 165.11 12.61 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.432 1.093 . . . . 0.0 110.106 172.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 508' ' ' MET . 50.9 tttm -149.91 137.7 20.12 Favored 'General case' 0 C--O 1.219 -0.522 0 C-N-CA 123.215 0.606 . . . . 0.0 110.207 172.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -88.36 136.61 32.9 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -130.61 9.4 5.05 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.167 0.987 . . . . 0.0 110.133 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 46.5 t -77.87 145.8 36.03 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 123.374 0.669 . . . . 0.0 109.732 170.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -70.2 -25.1 63.26 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.249 1.02 . . . . 0.0 111.648 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -112.95 166.07 11.75 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.016 0.927 . . . . 0.0 110.834 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -70.53 120.44 16.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.422 0.689 . . . . 0.0 109.963 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -87.62 118.85 27.39 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.645 0.778 . . . . 0.0 109.767 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 54.5 p -70.68 101.83 2.15 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.639 0.776 . . . . 0.0 110.375 176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 17.9 tp -91.16 152.69 20.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.712 0.805 . . . . 0.0 109.62 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.08 -58.62 0.51 Allowed Glycine 0 N--CA 1.472 1.049 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.703 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.36 -11.9 61.2 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.288 0.635 . . . . 0.0 111.075 177.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 546' ' ' ASN . 14.1 m95 -75.14 166.03 24.28 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 124.452 1.101 . . . . 0.0 110.927 170.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -160.7 145.81 14.41 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.975 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 49.7 mt -101.42 107.54 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.158 0.583 . . . . 0.0 109.535 176.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 60.7 mttm -78.13 159.35 28.68 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 170.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 534' ' ' TRP . 36.8 ttm180 -158.08 100.37 1.71 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.05 111.56 23.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.284 0.633 . . . . 0.0 109.712 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.447 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 53.1 t -68.87 157.52 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.0 0.92 . . . . 0.0 109.797 174.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.0 pp -52.15 -28.12 16.86 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.232 1.013 . . . . 0.0 112.256 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -69.39 -33.33 72.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.493 1.117 . . . . 0.0 111.383 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 131.61 -21.24 4.52 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.792 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.32 109.59 2.32 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.36 1.064 . . . . 0.0 111.461 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 485' ' ' ARG . 15.0 pt-20 -107.77 117.3 33.75 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.402 0.62 . . . . 0.0 110.804 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 40.2 pt -105.85 142.46 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.923 0.889 . . . . 0.0 109.367 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -125.25 116.36 21.85 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.903 0.481 . . . . 0.0 110.931 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -78.98 106.35 10.96 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -81.48 121.63 26.52 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -73.26 169.16 17.67 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 120.819 0.342 . . . . 0.0 110.794 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 68.9 p -93.27 120.78 66.43 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 123.054 0.542 . . . . 0.0 110.32 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.523 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 34.6 Cg_exo -60.37 -15.56 36.17 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.934 3.089 . . . . 0.0 115.199 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -72.48 -23.51 61.05 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.542 0.737 . . . . 0.0 111.64 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -89.02 142.79 27.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.495 1.118 . . . . 0.0 110.884 -171.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 62.2 mt -129.43 132.96 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.391 0.676 . . . . 0.0 109.213 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . 0.59 HD21 ' HB ' ' A' ' 509' ' ' VAL . 0.3 OUTLIER -93.85 134.69 35.95 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.026 0.93 . . . . 0.0 109.025 177.482 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -78.16 156.49 29.85 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.131 0.491 . . . . 0.0 111.682 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.04 126.93 29.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.256 1.022 . . . . 0.0 112.031 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 77.97 -12.34 18.06 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.62 0.575 . . . . 0.0 114.395 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -86.71 159.48 19.15 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.661 0.784 . . . . 0.0 110.232 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 23.5 ptt? -108.57 169.69 8.5 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.613 0.765 . . . . 0.0 111.517 -175.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . 0.59 ' HB ' HD21 ' A' ' 503' ' ' LEU . 7.4 p -145.95 148.89 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 4.2 m -131.09 105.46 7.72 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 71.5 t -86.02 98.63 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.055 0.455 . . . . 0.0 110.224 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -82.34 176.41 9.47 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.905 0.882 . . . . 0.0 111.3 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -103.64 152.14 22.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.826 0.851 . . . . 0.0 110.128 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -67.84 -20.06 65.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.874 0.87 . . . . 0.0 112.021 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -103.76 16.63 51.05 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.692 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -90.76 -3.61 57.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.328 0.651 . . . . 0.0 110.713 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.33 33.92 68.71 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 113.995 0.358 . . . . 0.0 113.995 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 12.9 p -130.79 144.25 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 123.412 0.685 . . . . 0.0 110.341 -175.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -81.81 142.9 32.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.57 0.748 . . . . 0.0 111.42 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 526' ' ' LEU . 17.3 t-80 -61.85 109.33 1.21 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.418 0.687 . . . . 0.0 109.827 172.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 17.8 m -132.74 80.49 61.35 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.019 0.928 . . . . 0.0 109.556 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.72 160.85 44.46 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.916 2.41 . . . . 0.0 112.175 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -90.31 16.77 43.79 Favored 'Cis proline' 0 C--N 1.381 2.265 0 CA-C-N 119.652 0.911 . . . . 0.0 113.385 3.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.2 m -97.99 -70.88 0.71 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.739 0.815 . . . . 0.0 109.836 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 20.2 m -85.65 86.28 7.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.182 0.593 . . . . 0.0 110.372 -173.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 11.1 mp -91.66 105.19 17.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 171.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 90.3 t -89.46 117.98 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -69.27 91.74 0.54 Allowed 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . 0.548 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 27.7 tptp -75.07 131.03 40.27 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.399 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 104.31 -5.08 44.71 Favored Glycine 0 N--CA 1.472 1.094 0 O-C-N 123.606 0.566 . . . . 0.0 111.988 -172.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -121.95 109.82 15.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.854 0.862 . . . . 0.0 109.179 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 37.2 p -71.72 -61.72 1.68 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.992 0.517 . . . . 0.0 111.21 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 23.7 m -121.16 25.26 9.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.815 0.446 . . . . 0.0 112.108 -167.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.432 ' HB3' ' NH1' ' A' ' 485' ' ' ARG . 0.0 OUTLIER 51.89 30.93 7.69 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.384 1.074 . . . . 0.0 112.541 171.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.88 68.7 1.56 Allowed Glycine 0 C--N 1.352 1.43 0 N-CA-C 112.371 -0.291 . . . . 0.0 112.371 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 2.7 p -64.4 142.57 58.37 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.504 0.722 . . . . 0.0 112.66 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -162.86 169.57 38.1 Favored Glycine 0 C--O 1.242 0.599 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.244 172.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -70.48 -26.78 63.77 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.336 0.568 . . . . 0.0 110.105 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 80.8 p -155.13 142.52 19.55 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.841 0.857 . . . . 0.0 109.35 172.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.447 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 8.0 p90 -155.5 136.67 13.85 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.684 0.794 . . . . 0.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.609 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 34.6 ptt180 -87.93 111.25 21.25 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 23.1 m -94.03 110.73 22.41 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 21.9 t -102.86 144.93 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.828 1.251 . . . . 0.0 109.606 -174.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 468' ' ' LEU . 34.7 tp -112.17 125.47 54.17 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.485 HG23 ' HG2' ' A' ' 551' ' ' GLU . 22.0 t -124.33 160.14 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.135 1.374 . . . . 0.0 108.485 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 481' ' ' TRP . 2.9 p30 -126.35 -174.83 3.21 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.017 0.371 . . . . 0.0 111.577 175.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -50.08 -34.47 21.88 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.432 1.493 . . . . 0.0 113.189 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.64 -33.68 76.5 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.262 1.025 . . . . 0.0 111.929 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 102.97 -12.12 56.02 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.049 -174.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . 0.48 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 13.2 pt-20 -72.79 139.36 47.01 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.21 0.604 . . . . 0.0 109.384 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.485 ' HG2' HG23 ' A' ' 545' ' ' VAL . 38.5 mt-10 -92.0 93.3 8.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.116 0.966 . . . . 0.0 108.994 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 18.0 m -71.67 -16.64 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -167.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -159.36 156.28 28.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.067 0.547 . . . . 0.0 110.482 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.577 ' SD ' ' HD2' ' A' ' 541' ' ' ARG . 67.0 ttp -154.94 109.93 3.04 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.25 0.62 . . . . 0.0 110.097 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -104.14 104.19 14.09 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 30.4 m -85.19 99.04 10.83 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.432 HG11 ' HB ' ' A' ' 459' ' ' ILE . 35.1 m -98.96 147.29 7.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 121.621 0.724 . . . . 0.0 110.383 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.48 168.88 9.77 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.08 175.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.436 ' HA ' HD13 ' A' ' 461' ' ' LEU . 38.7 ttpt . . . . . 0 C--O 1.238 0.478 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . 0.419 ' HB ' HD21 ' A' ' 544' ' ' LEU . 4.1 t -95.55 163.74 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.357 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 21.1 t -155.69 150.66 26.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.566 0.746 . . . . 0.0 109.671 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . 0.412 ' HA ' HD13 ' A' ' 468' ' ' LEU . 31.7 mt -77.7 102.41 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.286 0.634 . . . . 0.0 109.863 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.469 ' HG2' ' HG3' ' A' ' 458' ' ' GLU . 42.0 tt0 -81.18 -57.49 3.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.353 0.261 . . . . 0.0 111.602 -170.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.469 ' HG3' ' HG2' ' A' ' 457' ' ' GLU . 29.4 mt-10 -137.88 153.36 49.57 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.256 0.622 . . . . 0.0 109.394 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.0 mt -151.84 138.18 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.61 148.84 38.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.45 HD13 ' HG3' ' A' ' 462' ' ' GLU . 3.5 pp -74.38 -16.51 60.89 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -169.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.45 ' HG3' HD13 ' A' ' 461' ' ' LEU . 2.7 mt-10 -82.02 -31.91 30.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.199 0.6 . . . . 0.0 110.427 174.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 86.97 51.63 3.33 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.986 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -97.1 -19.48 18.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.54 0.736 . . . . 0.0 110.867 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -154.35 163.52 40.03 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.935 0.494 . . . . 0.0 111.872 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.37 117.65 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.017 1.327 . . . . 0.0 108.164 170.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.7 tp60 -88.06 113.35 23.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.989 0.916 . . . . 0.0 109.039 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . 0.51 HD22 HD13 ' A' ' 483' ' ' ILE . 22.6 tp -120.21 116.69 26.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.137 0.975 . . . . 0.0 109.495 -172.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . 0.408 ' HG2' ' HB3' ' A' ' 508' ' ' MET . 1.8 tmmm? -114.03 130.52 56.55 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.992 0.36 . . . . 0.0 110.368 -169.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -82.62 115.32 21.52 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.436 0.694 . . . . 0.0 109.84 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -85.49 -15.76 41.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.911 0.884 . . . . 0.0 112.033 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' SER . . . . . 0.529 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 69.8 m -65.57 156.45 32.64 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.57 2.36 33.53 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.832 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . 0.529 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.1 OUTLIER -135.38 168.49 19.1 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.24 1.016 . . . . 0.0 108.822 173.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -73.59 122.05 21.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.428 0.691 . . . . 0.0 109.475 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -83.36 123.02 29.23 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.497 0.719 . . . . 0.0 110.204 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 30.2 p -71.01 106.67 3.76 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.1 mp -91.09 -179.81 5.54 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 0.0 109.97 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 133.28 -67.23 0.56 Allowed Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 480' ' ' ASN . 0.8 OUTLIER -74.64 -11.5 60.2 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.499 177.302 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 33.1 m95 -69.84 145.4 52.11 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -149.47 136.27 19.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.882 0.473 . . . . 0.0 111.123 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . 0.51 HD13 HD22 ' A' ' 468' ' ' LEU . 57.8 mt -97.41 107.28 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.619 0.768 . . . . 0.0 109.472 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.443 ' HE2' HG21 ' A' ' 545' ' ' VAL . 68.0 mttm -78.86 148.17 32.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.363 0.665 . . . . 0.0 110.531 172.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . 0.42 ' NH2' ' HB3' ' A' ' 534' ' ' TRP . 20.6 mtm180 -140.49 123.3 16.38 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -116.98 114.06 23.27 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.417 0.687 . . . . 0.0 109.83 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.44 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 13.4 t -84.72 159.31 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.792 1.237 . . . . 0.0 110.645 -177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.2 -22.87 61.69 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.959 0.904 . . . . 0.0 111.98 173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.57 -22.14 66.13 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.585 1.154 . . . . 0.0 112.407 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 99.86 1.96 56.19 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.339 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.95 122.05 21.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.596 0.758 . . . . 0.0 110.073 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.81 112.56 13.71 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 22.0 pt -132.17 170.09 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.236 1.014 . . . . 0.0 109.629 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -150.22 127.32 11.23 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.893 0.477 . . . . 0.0 110.681 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -80.29 108.98 14.34 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 169.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -84.73 128.3 34.54 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -70.45 169.14 14.67 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.645 0.736 . . . . 0.0 111.327 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 65.9 p -87.36 132.34 41.45 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.871 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.503 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 26.8 Cg_endo -58.78 -21.41 56.58 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.094 2.529 . . . . 0.0 113.302 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -72.31 -25.42 61.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.193 0.597 . . . . 0.0 111.903 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -75.78 126.19 30.52 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 122.825 0.45 . . . . 0.0 110.189 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 41.5 mt -122.55 113.9 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.25 120.14 21.88 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -69.75 160.89 30.85 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.9 119.08 10.67 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.166 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.6 6.09 65.55 Favored Glycine 0 C--N 1.343 0.925 0 O-C-N 123.585 0.553 . . . . 0.0 113.666 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -101.59 177.97 4.77 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.642 0.777 . . . . 0.0 109.677 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.408 ' HB3' ' HG2' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -139.92 162.53 34.96 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.537 0.684 . . . . 0.0 112.039 -175.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . 0.495 HG23 HD11 ' A' ' 526' ' ' LEU . 6.3 p -123.79 117.49 51.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 125.201 1.401 . . . . 0.0 107.926 176.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 7.8 m -96.48 95.02 7.73 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.89 97.42 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.927 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -79.71 171.74 14.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.635 0.774 . . . . 0.0 110.819 171.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.652 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -91.91 165.0 13.45 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.676 0.791 . . . . 0.0 110.109 173.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -63.51 -34.2 77.26 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.102 0.477 . . . . 0.0 110.379 171.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -89.41 20.65 33.0 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.305 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -85.07 -24.43 28.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.315 0.646 . . . . 0.0 110.554 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 71.05 35.76 64.47 Favored Glycine 0 C--N 1.35 1.322 0 O-C-N 123.872 0.733 . . . . 0.0 112.917 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 8.6 p -114.44 143.77 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.014 0.926 . . . . 0.0 110.276 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -72.79 123.23 22.94 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.284 0.634 . . . . 0.0 110.227 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -63.92 110.69 2.19 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.425 0.69 . . . . 0.0 110.473 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.8 m -132.24 72.26 78.84 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.063 0.545 . . . . 0.0 110.909 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.93 159.4 53.09 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.739 2.292 . . . . 0.0 112.352 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.23 0.94 50.48 Favored 'Cis proline' 0 C--N 1.382 2.32 0 CA-C-N 120.141 1.086 . . . . 0.0 114.077 -0.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 32.9 t -74.78 -63.22 1.3 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.415 0.686 . . . . 0.0 111.08 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 27.5 m -104.19 98.58 8.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.108 0.963 . . . . 0.0 110.265 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.495 HD11 HG23 ' A' ' 509' ' ' VAL . 11.2 mp -93.64 146.86 23.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 81.9 t -129.82 117.27 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -73.47 89.34 1.65 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . 0.521 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 27.3 tptp -75.77 123.27 25.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.386 177.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 120.75 -24.26 7.59 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -173.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -121.5 109.61 15.04 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 32.9 p -82.53 -34.94 27.69 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.853 0.461 . . . . 0.0 111.634 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 536' ' ' THR . 23.6 m -90.28 -29.74 17.95 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.189 0.596 . . . . 0.0 112.167 -174.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.652 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 59.74 22.26 11.08 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 123.224 0.61 . . . . 0.0 109.401 -173.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.99 69.08 1.46 Allowed Glycine 0 C--N 1.345 1.037 0 O-C-N 121.653 -0.654 . . . . 0.0 111.949 -171.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 533' ' ' SER . 8.1 p -71.82 159.92 33.47 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.612 0.765 . . . . 0.0 110.231 172.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 172.72 176.43 41.35 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.404 -0.362 . . . . 0.0 113.038 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -84.07 -26.96 28.62 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.756 0.422 . . . . 0.0 110.073 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 66.9 m -152.24 128.23 10.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.531 1.132 . . . . 0.0 108.743 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.44 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 6.8 p90 -154.48 122.47 5.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.96 0.904 . . . . 0.0 110.091 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.541 ' HD3' ' H ' ' A' ' 541' ' ' ARG . 0.0 OUTLIER -86.27 123.39 31.47 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.423 0.63 . . . . 0.0 109.727 -178.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 39.3 m -94.31 140.17 30.13 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.252 1.021 . . . . 0.0 109.506 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 99.9 t -132.93 130.9 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.482 1.113 . . . . 0.0 109.279 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 53.1 tp -93.96 129.48 40.41 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.443 HG21 ' HE2' ' A' ' 484' ' ' LYS . 81.4 t -118.13 143.73 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.754 1.222 . . . . 0.0 108.226 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . 0.462 HD22 ' HG2' ' A' ' 550' ' ' GLU . 2.0 p30 -103.0 -173.54 2.34 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.514 0.326 . . . . 0.0 111.155 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -64.17 -22.97 67.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.803 0.841 . . . . 0.0 113.234 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -65.24 -39.46 92.72 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.162 0.506 . . . . 0.0 110.453 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.37 -11.26 33.44 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.398 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . 0.462 ' HG2' HD22 ' A' ' 546' ' ' ASN . 16.3 pt-20 -80.39 153.87 28.05 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 117.259 0.53 . . . . 0.0 110.549 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 545' ' ' VAL . 42.0 mt-10 -88.65 104.6 17.01 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.673 1.189 . . . . 0.0 110.171 -174.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.74 -29.47 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.566 0.746 . . . . 0.0 112.813 -170.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -139.12 161.11 38.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.072 0.549 . . . . 0.0 110.137 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.43 ' HG3' HG21 ' A' ' 543' ' ' VAL . 40.7 ttp -159.27 108.25 1.86 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.33 0.652 . . . . 0.0 109.795 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -119.46 123.63 44.52 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.755 0.822 . . . . 0.0 109.207 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 26.7 m -79.12 134.0 36.73 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.54 139.9 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -161.53 146.34 13.33 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 122.916 0.486 . . . . 0.0 111.074 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 461' ' ' LEU . 86.2 tttt . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.19 0.996 . . . . 0.0 110.23 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 121.059 0.457 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . 0.448 HG23 ' HG2' ' A' ' 476' ' ' GLN . 21.2 t -85.61 129.82 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 171.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 44.0 t -110.51 145.7 37.27 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.129 1.372 . . . . 0.0 109.497 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 50.8 mt -81.93 95.11 2.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.85 -65.14 1.04 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.652 0.381 . . . . 0.0 110.404 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 20.5 mt-10 -116.49 153.13 32.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.1 0.56 . . . . 0.0 110.368 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.484 HG23 HG23 ' A' ' 466' ' ' VAL . 47.8 mt -140.06 142.53 31.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 170.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.76 145.87 51.9 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.307 0.38 . . . . 0.0 110.474 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.589 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.4 pt? -58.93 -41.16 86.68 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.134 0.974 . . . . 0.0 111.886 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.589 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 43.7 mt-10 -91.45 -22.03 20.63 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.159 0.984 . . . . 0.0 110.066 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 83.92 50.82 4.23 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.053 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -87.71 -16.76 33.41 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.06 163.35 40.01 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.031 0.532 . . . . 0.0 111.166 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . 0.484 HG23 HG23 ' A' ' 459' ' ' ILE . 97.2 t -134.9 122.76 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.669 1.188 . . . . 0.0 108.088 168.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . 0.582 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 13.5 tt0 -89.8 111.48 22.51 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.287 0.565 . . . . 0.0 110.103 170.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.85 159.95 18.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.21 165.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . 0.49 ' HG2' ' HB3' ' A' ' 508' ' ' MET . 1.6 tmtp? -152.58 129.01 10.63 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.505 ' HB3' HD11 ' A' ' 503' ' ' LEU . 50.6 t30 -99.07 100.35 11.48 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -76.75 -11.63 59.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.254 0.622 . . . . 0.0 111.511 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 44.9 t -63.73 152.54 38.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.338 1.055 . . . . 0.0 112.847 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -73.11 -12.01 60.75 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.095 1.358 . . . . 0.0 111.296 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -99.01 143.69 29.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.763 0.825 . . . . 0.0 110.893 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.46 102.5 2.68 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.448 ' HG2' HG23 ' A' ' 454' ' ' VAL . 57.2 tp60 -70.29 115.48 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.3 0.64 . . . . 0.0 111.87 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.4 m -64.28 99.71 0.3 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.3 tp -96.49 159.53 14.89 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -175.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 143.83 -65.88 0.46 Allowed Glycine 0 N--CA 1.47 0.95 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.64 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.27 -11.66 59.76 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.698 0.799 . . . . 0.0 111.078 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -75.89 135.0 40.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.832 0.853 . . . . 0.0 108.887 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -128.19 145.61 50.98 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 49.6 mt -106.3 103.93 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.625 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 59.3 mttm -78.89 96.19 5.62 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 19.5 tpp85 -79.53 96.82 6.22 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 168.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -102.05 100.92 11.22 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 15.7 t -94.06 141.9 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.2 pp -65.91 -14.88 62.33 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.52 -8.42 33.68 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.238 0.615 . . . . 0.0 110.847 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 105.95 28.27 5.36 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.504 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -121.38 103.83 9.24 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.178 0.591 . . . . 0.0 110.571 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -107.87 80.96 1.44 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.436 1.112 . . . . 0.0 109.226 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 34.9 pt -95.07 134.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.012 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -108.21 110.71 22.4 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.875 0.47 . . . . 0.0 110.067 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.96 104.38 9.55 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . 0.436 ' HD3' ' H ' ' A' ' 496' ' ' LYS . 0.2 OUTLIER -91.0 129.66 36.98 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -76.79 170.06 17.16 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.995 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.0 p -88.55 124.66 65.45 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 19.8 Cg_endo -60.16 -10.0 11.75 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.985 2.456 . . . . 0.0 114.871 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -75.17 -24.66 57.93 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.888 0.475 . . . . 0.0 111.273 172.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -82.08 128.06 33.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.599 0.759 . . . . 0.0 110.198 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 59.8 mt -122.46 123.81 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 470' ' ' ASN . 1.0 OUTLIER -90.2 123.79 34.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -74.49 169.32 17.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.89 0.876 . . . . 0.0 112.109 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -70.43 121.43 17.73 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.402 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 76.59 12.46 84.38 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.812 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -104.09 -176.4 3.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.201 0.6 . . . . 0.0 110.773 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.49 ' HB3' ' HG2' ' A' ' 469' ' ' LYS . 1.5 ppp? -141.63 164.64 29.66 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.976 0.91 . . . . 0.0 111.196 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.67 135.03 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.402 1.081 . . . . 0.0 108.295 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 7.2 m -116.69 115.55 25.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.521 HG13 ' HB2' ' A' ' 526' ' ' LEU . 16.0 m -101.54 98.61 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.171 0.988 . . . . 0.0 110.436 -176.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -87.55 172.91 9.4 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.165 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.679 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -92.3 156.47 17.24 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.949 0.9 . . . . 0.0 110.43 175.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -59.9 -28.06 67.26 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.286 0.635 . . . . 0.0 112.125 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -111.45 23.86 17.03 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.291 -0.413 . . . . 0.0 113.479 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -89.17 11.27 19.12 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 69.66 36.95 76.53 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-O 121.343 0.413 . . . . 0.0 112.71 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.56 147.92 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.908 0.883 . . . . 0.0 111.319 -167.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -99.13 130.51 45.45 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.915 0.886 . . . . 0.0 109.588 171.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -65.25 112.6 3.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.4 m -131.5 71.18 81.47 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.355 0.662 . . . . 0.0 109.613 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.81 153.34 78.29 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.868 2.379 . . . . 0.0 112.247 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -80.51 -19.87 21.27 Favored 'Cis proline' 0 C--N 1.38 2.19 0 CA-C-N 119.957 1.02 . . . . 0.0 113.608 0.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.2 m -63.14 -35.91 81.86 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.306 1.043 . . . . 0.0 112.588 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 25.8 m -127.83 91.21 3.24 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.47 0.708 . . . . 0.0 109.415 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.521 ' HB2' HG13 ' A' ' 511' ' ' VAL . 66.7 mt -84.75 148.37 26.39 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 54.5 t -132.06 127.9 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -68.57 87.77 0.33 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -70.14 128.5 36.49 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.769 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 98.09 -21.46 45.94 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.729 -0.669 . . . . 0.0 113.188 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.83 103.85 10.38 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 42.5 p -85.37 -17.56 36.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.372 1.069 . . . . 0.0 113.822 -166.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 46.5 m -96.45 -29.39 13.95 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.679 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 58.44 21.8 8.85 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.187 0.995 . . . . 0.0 110.76 -168.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 66.74 70.65 1.07 Allowed Glycine 0 C--N 1.349 1.29 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 -172.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 14.6 p -63.3 162.07 12.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.614 0.766 . . . . 0.0 112.455 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -176.53 149.58 9.84 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.82 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.66 -21.09 38.35 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' SER . . . . . 0.498 ' HB2' HD21 ' A' ' 488' ' ' LEU . 19.4 m -148.25 132.83 17.75 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.727 0.811 . . . . 0.0 109.672 167.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -160.38 -176.41 5.59 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.028 0.931 . . . . 0.0 110.395 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 11.0 ptp180 -136.7 155.48 49.81 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.786 170.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' THR . . . . . 0.421 ' HB ' HD11 ' A' ' 459' ' ' ILE . 86.4 m -130.97 118.81 21.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 19.6 t -112.63 151.42 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.442 1.097 . . . . 0.0 108.698 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.524 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 39.8 tp -123.94 106.83 10.74 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 6.2 p -96.59 147.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.682 1.193 . . . . 0.0 109.215 175.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -107.44 -171.96 1.98 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.697 0.399 . . . . 0.0 110.334 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.41 66.78 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . 0.552 ' HB2' ' HG2' ' A' ' 550' ' ' GLU . 68.4 m-20 -71.75 -23.74 61.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.085 0.554 . . . . 0.0 111.981 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 93.95 -2.73 69.59 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . 0.552 ' HG2' ' HB2' ' A' ' 548' ' ' ASP . 11.7 pt-20 -89.53 141.37 28.64 Favored 'General case' 0 C--O 1.247 0.966 0 C-N-CA 123.189 0.596 . . . . 0.0 109.696 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -81.76 111.05 17.65 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.588 0.755 . . . . 0.0 109.214 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.05 -22.71 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.595 0.758 . . . . 0.0 112.549 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -146.55 157.34 43.72 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.867 0.867 . . . . 0.0 109.361 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.43 ' HG3' HG22 ' A' ' 543' ' ' VAL . 28.5 ttt -168.51 140.51 2.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.427 0.691 . . . . 0.0 110.37 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -152.03 123.66 7.89 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.14 0.976 . . . . 0.0 109.427 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 36.3 m -86.34 124.63 32.91 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.778 0.831 . . . . 0.0 109.853 175.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.422 HG23 ' HB ' ' A' ' 459' ' ' ILE . 35.2 t -135.04 142.71 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.929 0.892 . . . . 0.0 109.507 -177.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 152.99 41.66 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.754 -177.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . 0.554 ' HD2' ' HG2' ' A' ' 462' ' ' GLU . 88.7 tttt . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 121.717 0.77 . . . . 0.0 109.153 170.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 44.1 t . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 19.0 t -114.94 142.18 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.032 0.933 . . . . 0.0 108.616 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 56.3 p -122.57 164.94 17.25 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.287 0.635 . . . . 0.0 110.628 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 43.7 mt -84.66 98.81 6.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 9.5 tp10 -69.27 -59.77 2.79 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.399 -174.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 36.0 mt-10 -137.25 160.32 39.38 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.045 0.938 . . . . 0.0 108.86 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.442 ' HB ' HG22 ' A' ' 557' ' ' VAL . 64.8 mt -139.57 141.39 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 172.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 465' ' ' PHE . 26.0 t70 -66.23 148.39 51.91 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.706 0.628 . . . . 0.0 111.312 175.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -36.16 83.02 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.203 1.001 . . . . 0.0 112.079 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.35 -31.26 24.88 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 167.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 95.9 36.42 5.27 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.142 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -72.29 -20.5 61.5 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.321 0.648 . . . . 0.0 110.487 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 460' ' ' ASP . 33.2 p90 -151.6 161.79 42.09 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.526 0.679 . . . . 0.0 111.542 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.33 112.9 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.351 1.46 . . . . 0.0 107.542 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -86.98 118.74 26.56 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 85.8 mt -113.65 134.0 54.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.046 0.938 . . . . 0.0 108.713 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 4.4 tmmm? -116.8 131.12 57.03 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.436 ' HB2' HD13 ' A' ' 503' ' ' LEU . 58.9 t30 -79.79 124.56 28.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.374 0.669 . . . . 0.0 110.709 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -102.65 15.42 29.33 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.228 1.011 . . . . 0.0 110.703 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' SER . . . . . 0.454 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 49.0 m -86.55 149.42 24.96 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.954 0.501 . . . . 0.0 111.353 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.06 -13.8 59.9 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.009 0.924 . . . . 0.0 110.406 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.0 OUTLIER -129.7 175.73 8.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.597 1.159 . . . . 0.0 109.127 178.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.66 115.96 6.38 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.393 0.677 . . . . 0.0 109.757 172.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -82.18 113.82 20.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.046 0.538 . . . . 0.0 110.417 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.486 ' HA ' HG12 ' A' ' 502' ' ' ILE . 35.0 p -66.89 110.27 3.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.175 0.59 . . . . 0.0 110.113 173.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.7 tp -103.03 171.88 7.13 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.654 1.182 . . . . 0.0 109.08 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 145.69 -62.99 0.46 Allowed Glycine 0 N--CA 1.472 1.052 0 CA-C-O 121.399 0.444 . . . . 0.0 112.923 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 480' ' ' ASN . 0.8 OUTLIER -70.6 -12.3 61.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.267 0.627 . . . . 0.0 110.975 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -69.57 146.52 51.72 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.112 0.965 . . . . 0.0 109.57 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -148.56 125.26 11.13 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.317 0.647 . . . . 0.0 111.002 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 19.4 mt -87.16 117.27 30.98 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 C-N-CA 123.638 0.775 . . . . 0.0 109.219 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.599 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 98.7 mttt -84.33 152.01 24.38 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.002 0.521 . . . . 0.0 109.817 168.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -150.47 104.73 3.25 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -116.48 103.59 10.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.88 0.872 . . . . 0.0 109.608 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.28 154.35 3.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.346 0.659 . . . . 0.0 109.91 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 45.4 tp -53.04 -43.15 66.4 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.989 1.316 . . . . 0.0 111.312 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.36 -24.18 67.21 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.713 0.805 . . . . 0.0 111.96 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 133.97 -22.95 3.77 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-O 118.561 -1.133 . . . . 0.0 115.505 173.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -59.96 100.15 0.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.433 1.117 . . . . 0.0 111.129 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.46 80.78 1.41 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.494 1.14 . . . . 0.0 108.316 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 18.0 pt -113.2 169.72 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.747 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -152.86 116.02 4.63 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.31 0.644 . . . . 0.0 110.42 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -99.36 115.28 28.85 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.556 0.742 . . . . 0.0 109.866 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -90.81 148.02 22.8 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -77.72 169.58 18.05 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.774 0.83 . . . . 0.0 110.845 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 52.0 p -82.55 133.23 50.1 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.66 -26.29 29.18 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.69 2.926 . . . . 0.0 114.346 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.29 -21.49 28.97 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.251 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -63.83 136.74 57.65 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.261 0.624 . . . . 0.0 110.376 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . 0.486 HG12 ' HA ' ' A' ' 477' ' ' SER . 40.9 mt -132.14 125.91 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . 0.436 HD13 ' HB2' ' A' ' 470' ' ' ASN . 0.5 OUTLIER -90.04 117.79 29.1 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.307 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -72.97 160.82 31.51 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.007 0.523 . . . . 0.0 111.691 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.32 119.74 10.88 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.666 0.786 . . . . 0.0 112.202 -173.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 80.07 -3.48 70.99 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.498 0.498 . . . . 0.0 114.073 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -83.03 -176.0 6.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.358 0.663 . . . . 0.0 110.082 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -149.52 137.25 20.25 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.137 0.575 . . . . 0.0 110.823 -176.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.95 111.86 32.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.1 m -90.58 96.28 10.57 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 65.1 t -83.91 106.99 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . 0.499 ' HB2' HG22 ' A' ' 527' ' ' VAL . 51.5 m95 -99.02 172.36 7.45 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.286 0.634 . . . . 0.0 112.221 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 534' ' ' TRP . . . -90.32 148.12 23.06 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.92 170.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.03 92.9 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.866 0.466 . . . . 0.0 110.678 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -79.32 -1.22 85.63 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.697 -0.683 . . . . 0.0 114.329 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -69.38 -26.48 64.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.304 0.642 . . . . 0.0 110.925 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 80.88 38.12 17.04 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.753 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.95 150.63 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.483 1.113 . . . . 0.0 110.308 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -78.54 124.08 27.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.588 0.755 . . . . 0.0 110.694 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -72.91 110.8 7.49 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.0 m -128.71 84.5 62.94 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.366 0.666 . . . . 0.0 110.217 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.88 148.04 93.92 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.594 2.196 . . . . 0.0 112.347 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -85.64 -17.94 24.06 Favored 'Cis proline' 0 C--N 1.375 1.973 0 C-N-CA 124.62 -0.992 . . . . 0.0 113.769 -2.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 17.0 m -73.95 -15.12 61.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.85 0.86 . . . . 0.0 113.239 -166.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 66.1 m -135.27 96.94 3.58 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 30.0 tp -105.3 104.48 14.22 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 512' ' ' TRP . 76.2 t -93.36 120.45 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.009 0.524 . . . . 0.0 110.056 -173.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -68.57 97.81 0.82 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -68.41 126.86 30.93 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.493 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 112.46 -25.18 12.56 Favored Glycine 0 C--N 1.342 0.864 0 O-C-N 123.239 0.337 . . . . 0.0 112.912 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.15 114.22 27.95 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 66.3 p -79.14 -32.23 44.32 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.675 0.79 . . . . 0.0 111.369 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.497 ' O ' HG23 ' A' ' 536' ' ' THR . 49.8 m -98.08 -33.44 11.16 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.511 ' HB2' ' HB1' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 53.51 32.82 14.87 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.459 0.647 . . . . 0.0 109.84 -171.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 66.99 55.77 15.27 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.606 -0.724 . . . . 0.0 113.008 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 533' ' ' SER . 4.6 p -73.35 153.78 40.35 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.038 0.447 . . . . 0.0 110.285 170.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 165.28 -161.63 35.01 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.074 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -79.15 -61.8 1.9 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.415 0.686 . . . . 0.0 110.341 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 15.8 p -132.66 127.96 35.99 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.232 1.013 . . . . 0.0 109.531 -170.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.99 133.92 14.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.176 0.59 . . . . 0.0 111.893 -170.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.09 99.52 6.97 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.822 1.249 . . . . 0.0 108.498 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 26.9 m -92.03 113.09 25.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 39.8 t -119.67 141.28 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 123.949 0.9 . . . . 0.0 109.787 -174.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.501 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 36.0 tp -109.25 128.74 55.31 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 171.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.535 HG23 ' HE3' ' A' ' 484' ' ' LYS . 78.9 t -117.93 149.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.152 1.381 . . . . 0.0 108.684 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -103.49 -171.93 2.02 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.018 0.527 . . . . 0.0 111.199 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -61.1 -32.81 72.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.996 0.918 . . . . 0.0 113.394 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.87 -36.29 83.02 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.633 0.773 . . . . 0.0 111.65 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.0 -8.01 29.3 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.714 -0.492 . . . . 0.0 113.423 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.88 151.76 25.86 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 117.385 0.592 . . . . 0.0 110.76 172.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -80.21 113.38 18.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.024 0.93 . . . . 0.0 109.299 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 17.7 m -89.23 -25.81 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.978 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -144.93 148.89 34.36 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.527 0.731 . . . . 0.0 109.736 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' MET . . . . . 0.502 ' HG3' HG23 ' A' ' 543' ' ' VAL . 25.9 ttt -151.97 136.32 16.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.589 0.756 . . . . 0.0 109.552 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -155.38 110.84 3.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.54 0.736 . . . . 0.0 109.118 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 91.6 m -95.95 117.28 30.32 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.509 0.724 . . . . 0.0 110.405 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . 0.442 HG22 ' HB ' ' A' ' 459' ' ' ILE . 85.5 t -107.05 128.19 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.551 0.74 . . . . 0.0 109.415 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.95 157.71 26.24 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.313 1.045 . . . . 0.0 109.547 175.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? . . . . . 0 N--CA 1.477 0.89 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.716 -173.536 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.46 144.8 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 168.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 60.7 m -134.27 169.99 16.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.334 0.654 . . . . 0.0 110.542 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 51.0 mt -91.74 113.09 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.374 0.67 . . . . 0.0 110.144 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.427 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 11.6 tp10 -81.37 -58.19 3.15 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.132 0.973 . . . . 0.0 110.265 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.427 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.4 mt-10 -135.01 162.67 31.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.564 0.746 . . . . 0.0 109.992 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.4 mt -144.26 135.53 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.68 142.07 51.57 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.861 0.464 . . . . 0.0 110.101 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.503 HD13 ' HG3' ' A' ' 462' ' ' GLU . 3.2 pp -66.25 -39.55 89.58 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.894 0.478 . . . . 0.0 111.645 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.503 ' HG3' HD13 ' A' ' 461' ' ' LEU . 43.3 mt-10 -72.66 -25.21 61.19 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.199 0.523 . . . . 0.0 110.144 174.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 92.59 31.17 9.0 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.548 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -77.44 -19.85 55.39 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.825 0.85 . . . . 0.0 110.971 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -160.18 163.2 33.84 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 121.779 0.8 . . . . 0.0 112.789 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 93.7 t -126.93 130.65 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.006 1.722 . . . . 0.0 107.395 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.49 133.96 42.12 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.2 mt -117.89 161.71 19.31 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.178 0.991 . . . . 0.0 108.84 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -146.89 131.82 18.12 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.611 ' HB2' ' HG ' ' A' ' 503' ' ' LEU . 65.2 t30 -81.89 117.4 22.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.229 0.612 . . . . 0.0 110.396 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -78.31 -23.74 46.97 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.269 0.628 . . . . 0.0 111.071 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 19.3 m -62.09 145.22 53.9 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.748 0.819 . . . . 0.0 111.266 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -86.75 17.88 3.74 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.88 0.872 . . . . 0.0 110.991 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.5 176.61 12.19 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.142 0.977 . . . . 0.0 110.05 -174.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.38 107.83 0.72 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.268 1.027 . . . . 0.0 111.082 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -88.69 111.31 21.81 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 170.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.6 p -63.53 113.4 3.28 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.012 0.525 . . . . 0.0 109.903 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.6 tp -104.27 155.97 18.3 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -175.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.37 -55.96 0.54 Allowed Glycine 0 N--CA 1.473 1.125 0 CA-C-O 121.694 0.608 . . . . 0.0 112.141 -176.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -72.72 -11.36 60.59 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.976 0.91 . . . . 0.0 111.399 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -79.48 140.68 37.23 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.637 0.775 . . . . 0.0 109.042 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -133.4 130.42 38.7 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.956 0.502 . . . . 0.0 110.804 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.67 109.75 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.635 0.774 . . . . 0.0 110.03 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' LYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 62.7 mttm -79.15 100.44 7.44 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 167.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' ARG . . . . . 0.55 ' HB3' ' HA3' ' A' ' 535' ' ' GLY . 6.3 mmt85 -82.0 90.3 6.48 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 165.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' GLN . . . . . 0.464 ' HG2' ' HB3' ' A' ' 492' ' ' GLU . 21.3 tm0? -99.12 104.97 17.01 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.227 -173.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.46 126.28 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.6 -12.18 50.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.08 -6.62 40.58 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.337 1.055 . . . . 0.0 112.046 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 115.58 28.25 2.81 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 114.427 0.531 . . . . 0.0 114.427 167.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -135.48 141.44 45.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 116.998 0.399 . . . . 0.0 110.078 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 486' ' ' GLN . 10.0 pt-20 -150.35 114.58 5.13 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.24 0.543 . . . . 0.0 109.727 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 28.5 pt -107.69 144.93 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -118.75 108.52 14.98 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.496 0.718 . . . . 0.0 109.637 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -89.23 104.89 17.4 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -84.22 134.81 34.54 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -69.5 164.9 22.12 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.851 0.86 . . . . 0.0 111.746 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.4 p -75.78 126.04 87.64 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' PRO . . . . . 0.5 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 60.2 Cg_endo -68.16 -12.46 35.15 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.647 2.231 . . . . 0.0 113.565 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -74.19 -23.53 59.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.738 0.815 . . . . 0.0 111.504 173.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -79.65 136.25 36.76 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-O 120.975 0.417 . . . . 0.0 109.91 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.71 130.01 74.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' LEU . . . . . 0.611 ' HG ' ' HB2' ' A' ' 470' ' ' ASN . 23.3 tp -95.54 113.4 25.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -76.55 164.0 26.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.214 1.005 . . . . 0.0 112.054 -172.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -55.59 120.3 7.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.372 1.069 . . . . 0.0 112.566 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.73 -5.24 17.92 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 114.338 0.495 . . . . 0.0 114.338 176.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -84.92 154.72 22.03 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.147 0.579 . . . . 0.0 109.883 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 59.7 mtt -113.94 145.15 41.93 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.76 0.824 . . . . 0.0 110.585 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.2 p -125.48 119.18 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.591 0.756 . . . . 0.0 109.225 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.81 107.01 19.41 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 16.8 t -87.0 98.88 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.571 0.749 . . . . 0.0 110.002 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' TRP . . . . . 0.509 ' HB2' HG21 ' A' ' 527' ' ' VAL . 39.5 m95 -90.14 174.19 7.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.603 0.761 . . . . 0.0 111.336 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.51 152.42 20.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.025 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.03 75.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.038 0.535 . . . . 0.0 110.528 173.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -72.62 -8.63 72.41 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.571 -0.74 . . . . 0.0 114.429 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.52 60.15 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.978 0.511 . . . . 0.0 111.28 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 75.77 38.44 36.69 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-O 121.139 0.299 . . . . 0.0 112.503 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.11 140.04 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 124.107 0.963 . . . . 0.0 110.146 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.53 138.42 36.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.928 0.891 . . . . 0.0 110.751 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -64.36 110.7 2.34 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.246 0.618 . . . . 0.0 109.525 173.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.4 m -129.29 78.52 75.77 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.598 0.759 . . . . 0.0 110.02 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.28 156.39 64.74 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.443 2.095 . . . . 0.0 111.811 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -83.57 -14.28 35.64 Favored 'Cis proline' 0 C--N 1.377 2.039 0 CA-C-N 119.698 0.928 . . . . 0.0 113.968 -1.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.9 m -66.43 -31.72 72.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.962 0.905 . . . . 0.0 112.736 -171.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 94.2 m -136.59 102.1 4.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.295 0.638 . . . . 0.0 110.636 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 67.1 mt -92.24 132.85 36.34 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 167.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 512' ' ' TRP . 99.4 t -118.92 126.44 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -70.54 100.95 1.9 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 172.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.59 133.13 49.67 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.151 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 89.57 -28.56 6.87 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 123.644 0.59 . . . . 0.0 113.591 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -82.99 118.12 23.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.723 0.409 . . . . 0.0 109.987 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 33.4 m -96.28 -39.51 9.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.88 0.472 . . . . 0.0 111.248 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' SER . . . . . 0.447 ' HB2' HG23 ' A' ' 536' ' ' THR . 67.0 p -79.04 -35.7 42.22 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.464 0.477 . . . . 0.0 111.848 -171.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' TRP . . . . . 0.546 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.39 31.19 9.19 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.119 0.967 . . . . 0.0 111.366 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 485' ' ' ARG . . . 70.4 59.17 5.48 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -174.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 533' ' ' SER . 10.4 t -79.2 145.31 33.71 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.219 1.008 . . . . 0.0 110.151 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -169.56 165.25 38.68 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.132 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -75.69 -30.94 59.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.8 m -146.29 118.42 8.3 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -142.37 -178.95 5.99 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.565 0.746 . . . . 0.0 110.802 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -147.98 128.33 13.92 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.39 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 87.3 m -86.69 128.07 34.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 65.5 t -124.38 117.5 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.6 tp -90.84 107.95 19.52 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . 0.44 HG22 ' HG2' ' A' ' 551' ' ' GLU . 83.3 t -96.03 149.56 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.644 1.178 . . . . 0.0 108.585 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -108.29 -172.84 2.14 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.475 0.31 . . . . 0.0 110.965 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -52.16 -39.63 60.3 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.856 1.263 . . . . 0.0 113.27 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.34 -37.56 87.76 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.711 0.804 . . . . 0.0 112.424 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.21 -13.41 28.57 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.041 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.1 148.89 39.32 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.278 0.539 . . . . 0.0 110.567 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.44 ' HG2' HG22 ' A' ' 545' ' ' VAL . 30.0 mt-10 -87.57 98.27 11.31 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.942 0.897 . . . . 0.0 109.027 -177.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 26.0 m -79.65 -19.06 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.05 -173.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' ALA . . . . . 0.616 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -145.71 145.66 30.96 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.275 0.63 . . . . 0.0 109.425 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 16.9 ttt -151.64 110.55 3.86 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -125.52 106.87 10.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.917 0.887 . . . . 0.0 108.917 -173.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 53.2 m -86.24 140.02 30.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.14 0.576 . . . . 0.0 110.578 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.3 p -144.97 111.02 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 124.43 1.092 . . . . 0.0 109.585 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -92.76 116.57 29.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 172.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 124.339 1.055 . . . . 0.0 110.492 -178.733 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -76.77 77.85 3.39 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.507 0.723 . . . . 0.0 110.477 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 19.5 m -81.85 88.54 6.32 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.808 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.89 29.3 35.14 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.019 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 51.1 p -65.96 -56.81 9.76 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 172.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 470' ' ' ASN . 18.6 t -89.07 146.46 6.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 165.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 84.6 p -134.62 172.07 13.46 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.029 0.931 . . . . 0.0 108.949 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 42.1 mm -74.19 122.2 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 14.6 tp10 -93.97 -68.05 0.82 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.497 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 36.0 mt-10 -135.12 160.09 39.45 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.961 0.904 . . . . 0.0 108.83 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 557' ' ' VAL . 97.0 mt -146.57 142.61 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.87 147.93 48.33 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.02 0.528 . . . . 0.0 110.808 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.641 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.0 pt? -59.37 -35.79 74.56 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.021 0.928 . . . . 0.0 111.786 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.641 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 50.2 mt-10 -103.07 -4.97 23.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.443 1.097 . . . . 0.0 111.298 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 75.49 40.5 32.54 Favored Glycine 0 C--N 1.342 0.911 0 O-C-N 123.469 0.48 . . . . 0.0 113.3 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -78.9 -18.81 53.26 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.241 0.617 . . . . 0.0 110.691 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -155.55 157.33 36.66 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.013 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . 0.522 HG21 ' NH2' ' A' ' 485' ' ' ARG . 15.7 t -111.77 148.29 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 165.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -126.54 121.08 31.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.432 HD21 HD21 ' A' ' 544' ' ' LEU . 87.3 mt -110.01 159.62 17.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.91 0.884 . . . . 0.0 109.804 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -144.84 128.93 17.6 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.554 0.742 . . . . 0.0 109.721 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.521 ' HB2' HD12 ' A' ' 503' ' ' LEU . 64.2 t30 -91.35 109.4 20.67 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -86.93 -1.46 57.86 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.287 1.035 . . . . 0.0 111.139 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 27.0 t -74.95 158.47 33.24 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.51 0.724 . . . . 0.0 111.53 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.33 0.4 56.21 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.403 1.081 . . . . 0.0 112.22 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.53 166.18 23.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.969 0.508 . . . . 0.0 110.821 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -66.18 115.58 6.33 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.909 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 454' ' ' VAL . 61.5 tp60 -80.02 111.08 16.02 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.851 0.719 . . . . 0.0 110.46 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.5 p -64.0 114.34 4.07 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.0 tp -107.99 151.88 25.23 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -170.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 146.87 -65.65 0.42 Allowed Glycine 0 N--CA 1.473 1.111 0 C-N-CA 121.419 -0.42 . . . . 0.0 112.921 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -69.35 -12.75 61.93 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.489 0.716 . . . . 0.0 110.98 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.431 ' CD2' ' HA ' ' A' ' 546' ' ' ASN . 26.3 m95 -67.65 150.86 48.2 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.853 0.861 . . . . 0.0 110.056 169.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -153.09 139.76 18.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.789 0.436 . . . . 0.0 111.364 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . 0.451 HG21 HG22 ' A' ' 466' ' ' VAL . 47.7 mt -101.41 104.6 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.304 0.642 . . . . 0.0 109.552 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.475 ' HE3' HG23 ' A' ' 545' ' ' VAL . 92.0 mttt -86.87 96.91 10.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.74 0.416 . . . . 0.0 109.995 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . 0.542 ' NH2' HG23 ' A' ' 459' ' ' ILE . 39.8 ttm180 -94.7 100.0 12.0 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 172.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -104.14 111.81 24.56 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.445 1.098 . . . . 0.0 110.439 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 540' ' ' PHE . 14.1 t -95.15 135.77 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.19 0.996 . . . . 0.0 109.272 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.4 pp -64.96 -22.89 67.07 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.342 0.657 . . . . 0.0 112.207 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . 0.402 ' H ' HG13 ' A' ' 487' ' ' VAL . 47.7 mt-10 -69.93 -10.83 59.96 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.058 0.943 . . . . 0.0 111.906 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 130.15 -28.31 3.89 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-O 119.387 -0.674 . . . . 0.0 114.232 166.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.24 116.17 22.28 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.834 0.817 . . . . 0.0 110.313 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.39 125.0 28.17 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 13.5 pt -140.82 148.76 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.8 0.84 . . . . 0.0 110.224 -170.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -121.3 112.51 18.69 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.484 0.714 . . . . 0.0 109.533 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -79.94 105.18 11.04 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -80.74 132.56 35.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -77.17 170.25 16.87 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.457 0.646 . . . . 0.0 111.312 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' THR . . . . . 0.438 ' HB ' ' HG2' ' A' ' 500' ' ' LYS . 52.3 p -87.99 120.09 70.63 Favored Pre-proline 0 CA--C 1.553 1.079 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.465 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.19 -5.21 7.57 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.241 2.627 . . . . 0.0 114.753 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . 0.438 ' HG2' ' HB ' ' A' ' 498' ' ' THR . 63.0 pttt -74.55 -25.94 59.64 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.539 0.335 . . . . 0.0 110.425 170.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -92.33 135.57 33.91 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.639 0.776 . . . . 0.0 110.608 -169.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 52.3 mt -126.96 128.58 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . 0.521 HD12 ' HB2' ' A' ' 470' ' ' ASN . 2.3 tm? -95.1 141.5 28.65 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.478 HH22 ' HG2' ' A' ' 523' ' ' PRO . 0.2 OUTLIER -87.43 164.66 16.07 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.019 0.527 . . . . 0.0 111.637 -166.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.76 123.32 19.04 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.366 0.667 . . . . 0.0 110.815 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.01 14.53 76.14 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 123.569 0.543 . . . . 0.0 113.938 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -104.92 175.27 5.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.288 0.635 . . . . 0.0 110.673 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 11.5 ptm -146.34 149.0 32.97 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.468 1.107 . . . . 0.0 110.106 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.89 131.32 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.3 0.64 . . . . 0.0 109.803 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.27 112.73 25.87 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.27 0.628 . . . . 0.0 109.499 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 46.9 t -99.38 99.76 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.185 0.594 . . . . 0.0 109.824 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . 0.519 ' HB2' HG21 ' A' ' 527' ' ' VAL . 43.4 m95 -87.16 172.99 9.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.736 0.814 . . . . 0.0 111.479 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.698 ' HB1' ' HB2' ' A' ' 534' ' ' TRP . . . -91.14 152.94 20.38 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.809 0.844 . . . . 0.0 110.108 172.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . 0.594 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -67.14 -38.57 85.74 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.337 0.589 . . . . 0.0 110.141 172.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -81.2 13.05 34.76 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.662 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -84.69 -6.98 59.38 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.175 0.59 . . . . 0.0 110.712 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 68.52 16.46 69.63 Favored Glycine 0 C--N 1.359 1.833 0 O-C-N 123.357 0.411 . . . . 0.0 113.44 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 512' ' ' TRP . 9.2 p -88.89 150.13 3.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.29 1.036 . . . . 0.0 110.358 -173.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.61 118.16 21.94 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.533 0.733 . . . . 0.0 109.72 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -66.94 110.75 3.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.4 m -124.17 81.19 57.96 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.365 0.666 . . . . 0.0 109.888 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -70.55 154.48 64.59 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.67 2.247 . . . . 0.0 111.79 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . 0.478 ' HG2' HH22 ' A' ' 504' ' ' ARG . 97.1 Cg_endo -97.94 13.57 32.5 Favored 'Cis proline' 0 C--N 1.37 1.691 0 CA-C-N 119.723 0.937 . . . . 0.0 113.48 -2.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.8 m -78.57 -45.7 21.16 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.457 0.646 . . . . 0.0 110.594 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 93.6 m -121.01 96.38 5.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.802 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 10.7 mp -84.11 147.07 27.55 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 512' ' ' TRP . 57.6 t -128.73 123.06 58.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -67.53 91.06 0.27 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 55.2 tptt -72.64 122.56 21.62 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.431 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 106.31 -1.86 37.44 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.759 0.662 . . . . 0.0 112.993 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 44.7 tp60 -119.48 123.0 42.96 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 42.8 p -90.21 -47.04 8.04 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.034 0.534 . . . . 0.0 111.931 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.433 ' O ' HG21 ' A' ' 536' ' ' THR . 69.0 p -87.44 -34.72 18.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.972 -170.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.698 ' HB2' ' HB1' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.73 39.24 28.24 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.533 0.733 . . . . 0.0 109.973 -173.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 74.95 61.2 3.13 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 462' ' ' GLU . 7.9 p -72.93 142.04 47.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.85 0.46 . . . . 0.0 111.01 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 179.09 168.03 37.53 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.821 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.82 -16.57 40.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.063 0.545 . . . . 0.0 110.322 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' SER . . . . . 0.444 ' HB2' HD21 ' A' ' 488' ' ' LEU . 16.6 m -155.82 131.13 9.49 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.758 0.823 . . . . 0.0 108.945 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.45 ' HB3' HG23 ' A' ' 487' ' ' VAL . 23.0 p90 -157.82 145.46 18.54 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.225 0.61 . . . . 0.0 111.13 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 76.0 mtm-85 -97.88 106.15 18.41 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.85 0.86 . . . . 0.0 108.902 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 21.5 m -93.61 105.65 17.68 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.446 HG22 ' SD ' ' A' ' 554' ' ' MET . 12.0 t -103.04 134.47 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.342 1.057 . . . . 0.0 109.706 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.541 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 36.8 tp -103.76 124.11 48.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.475 HG23 ' HE3' ' A' ' 484' ' ' LYS . 84.1 t -118.28 141.55 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.462 1.105 . . . . 0.0 108.872 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . 0.431 ' HA ' ' CD2' ' A' ' 481' ' ' TRP . 1.7 p30 -94.41 -177.17 4.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.652 0.381 . . . . 0.0 111.576 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.08 71.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.666 0.786 . . . . 0.0 112.902 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.21 -29.75 71.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.642 0.777 . . . . 0.0 111.786 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 95.28 25.28 14.38 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.795 -173.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.39 137.87 41.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.242 1.017 . . . . 0.0 108.597 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -75.29 96.89 3.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.791 0.836 . . . . 0.0 109.155 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 35.6 m -85.16 -23.8 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -148.46 162.92 38.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.402 0.681 . . . . 0.0 109.812 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.446 ' SD ' HG22 ' A' ' 543' ' ' VAL . 59.2 ttp -170.52 139.22 1.59 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.963 0.905 . . . . 0.0 109.49 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -139.25 124.27 18.84 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.267 0.627 . . . . 0.0 110.101 170.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 28.2 m -81.73 99.76 9.12 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 459' ' ' ILE . 74.5 t -102.85 142.39 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.501 0.667 . . . . 0.0 109.754 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -126.15 158.44 35.54 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.006 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 461' ' ' LEU . 64.8 tttp -77.51 82.91 3.93 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.514 0.674 . . . . 0.0 109.43 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 17.0 m -124.39 15.39 8.96 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.701 1.2 . . . . 0.0 109.77 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' SER . . . . . 0.575 ' HA ' HD12 ' A' ' 461' ' ' LEU . 16.5 m 61.15 90.7 0.06 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.962 1.305 . . . . 0.0 110.556 -170.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 23.3 m -90.37 -31.0 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.202 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 70.8 mtm -86.38 107.34 17.97 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -90.1 146.55 24.22 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.765 0.826 . . . . 0.0 110.373 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 64.37 30.71 13.14 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.722 1.209 . . . . 0.0 110.766 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -83.96 10.98 8.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.946 0.898 . . . . 0.0 110.954 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.15 -8.36 7.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.775 1.63 . . . . 0.0 114.013 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -116.6 101.29 8.48 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.222 0.609 . . . . 0.0 109.491 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 CA-C-O 119.162 -0.799 . . . . 0.0 113.251 177.902 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.409 ' HB2' ' OG ' ' A' ' 453' ' ' SER . . . -70.64 83.66 0.62 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.976 0.91 . . . . 0.0 111.653 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 23.7 p -87.84 99.48 12.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.078 0.951 . . . . 0.0 110.613 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . 0.471 ' H ' ' HB ' ' A' ' 552' ' ' VAL . . . 98.48 4.63 57.16 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.909 175.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 472' ' ' SER . 67.7 m -60.55 -32.92 71.96 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.378 0.671 . . . . 0.0 111.635 176.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . 0.408 HG22 HD23 ' A' ' 503' ' ' LEU . 13.5 t -123.71 137.1 58.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 162.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 28.7 t -130.22 170.88 13.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.986 0.914 . . . . 0.0 109.239 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 61.8 mt -87.42 117.49 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 122.965 0.506 . . . . 0.0 109.88 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.556 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 8.3 tp10 -84.37 -62.07 1.65 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.358 0.663 . . . . 0.0 110.499 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.556 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 24.6 mt-10 -140.48 158.31 44.19 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.83 0.852 . . . . 0.0 109.669 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.503 ' HB ' HG23 ' A' ' 557' ' ' VAL . 48.1 mt -141.9 140.42 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -77.29 148.94 35.44 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.321 0.648 . . . . 0.0 111.568 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.499 ' HB2' ' HG3' ' A' ' 559' ' ' LYS . 1.6 pp -76.31 -26.19 55.58 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.886 0.875 . . . . 0.0 112.766 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -86.52 -14.38 43.21 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.239 0.616 . . . . 0.0 110.027 168.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 78.12 28.67 55.75 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.741 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -73.03 -18.26 61.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.139 0.576 . . . . 0.0 111.063 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -158.22 155.8 29.63 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 122.958 0.503 . . . . 0.0 111.348 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.6 111.44 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' A' ' 457' ' ' GLU . 15.6 tt0 -88.0 128.33 35.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.58 0.752 . . . . 0.0 110.223 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 483' ' ' ILE . 71.5 mt -114.0 162.66 16.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.448 1.099 . . . . 0.0 109.599 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 469' ' ' LYS . 4.7 tmmm? -147.4 132.12 17.92 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.012 0.925 . . . . 0.0 108.764 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.441 ' OD1' ' HA ' ' A' ' 505' ' ' ALA . 23.6 t-20 -76.76 127.29 32.48 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.968 1.307 . . . . 0.0 111.035 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -111.43 12.17 21.47 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.975 0.91 . . . . 0.0 111.183 172.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' A' ' 453' ' ' SER . 24.1 t -79.05 148.24 32.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.847 0.859 . . . . 0.0 110.322 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -88.15 -7.78 56.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.381 0.672 . . . . 0.0 110.956 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.68 172.55 12.84 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.986 0.914 . . . . 0.0 109.447 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.87 143.39 57.48 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -124.52 113.68 18.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.477 0.711 . . . . 0.0 110.26 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 40.6 p -70.79 119.27 14.69 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.4 0.68 . . . . 0.0 110.682 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.402 HD13 HG23 ' A' ' 454' ' ' VAL . 6.2 mp -100.2 165.18 11.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.117 0.967 . . . . 0.0 109.455 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 144.1 -58.09 0.53 Allowed Glycine 0 N--CA 1.465 0.624 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 547' ' ' ALA . 0.9 OUTLIER -81.03 -13.76 58.51 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 114.299 -0.95 . . . . 0.0 111.014 174.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.425 ' CZ3' HG23 ' A' ' 552' ' ' VAL . 27.8 m95 -72.23 140.12 48.51 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -146.66 135.85 22.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.056 0.542 . . . . 0.0 111.538 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . 0.462 HG12 HD11 ' A' ' 544' ' ' LEU . 45.4 mt -99.99 105.99 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.908 0.883 . . . . 0.0 109.13 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -92.83 102.23 14.61 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.56 1.144 . . . . 0.0 110.42 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . 0.463 ' HE ' ' HE3' ' A' ' 534' ' ' TRP . 51.1 ttm-85 -87.22 96.35 10.3 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.44 100.88 13.07 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 46.6 t -93.62 121.59 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.42 -28.11 68.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.447 0.699 . . . . 0.0 112.629 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -64.53 -15.73 61.4 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.534 1.133 . . . . 0.0 112.574 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 125.27 27.38 1.21 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 114.471 0.548 . . . . 0.0 114.471 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -129.22 99.17 5.13 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.696 0.748 . . . . 0.0 109.971 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.36 96.86 6.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 174.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.3 pt -107.32 168.4 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.15 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -156.44 132.18 9.61 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.728 0.811 . . . . 0.0 109.67 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -125.53 116.19 21.39 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.442 0.697 . . . . 0.0 109.49 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -79.19 157.81 27.79 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -81.4 171.44 14.75 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.665 0.786 . . . . 0.0 110.872 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 74.7 p -81.93 128.83 67.05 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.05 -29.06 63.36 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.445 2.763 . . . . 0.0 113.785 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -68.73 -21.06 64.41 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.28 0.632 . . . . 0.0 112.49 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -78.95 129.53 34.58 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.364 0.666 . . . . 0.0 109.996 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 49.4 mt -126.3 119.85 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . 0.408 HD23 HG22 ' A' ' 454' ' ' VAL . 38.8 tp -83.85 138.6 33.12 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.487 0.715 . . . . 0.0 109.439 178.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -90.63 154.78 19.33 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.222 0.609 . . . . 0.0 110.549 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . 0.441 ' HA ' ' OD1' ' A' ' 470' ' ' ASN . . . -72.8 130.39 40.35 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.455 0.702 . . . . 0.0 111.681 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 75.51 20.13 78.78 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.064 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -115.19 -162.46 0.83 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.163 0.985 . . . . 0.0 110.2 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 19.6 ptp -154.4 166.37 33.44 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.361 0.665 . . . . 0.0 110.992 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.68 126.13 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.091 0.957 . . . . 0.0 109.228 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 25.6 m -116.32 111.53 20.24 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.107 0.563 . . . . 0.0 109.719 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' A' ' 526' ' ' LEU . 35.5 m -88.67 137.31 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -122.01 174.47 6.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.379 1.072 . . . . 0.0 109.862 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -90.53 147.17 23.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.047 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -58.73 -42.24 88.31 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.503 0.721 . . . . 0.0 110.88 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -88.63 24.16 13.48 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.731 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -88.28 -13.23 41.4 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.262 0.625 . . . . 0.0 110.404 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.45 31.35 68.38 Favored Glycine 0 C--N 1.356 1.648 0 O-C-N 123.512 0.508 . . . . 0.0 112.323 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.67 144.95 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.371 1.068 . . . . 0.0 110.982 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.34 126.12 30.76 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 172.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -73.62 117.44 15.4 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 31.4 m -138.04 73.15 45.86 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.139 0.576 . . . . 0.0 110.335 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.48 148.38 83.76 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.719 2.279 . . . . 0.0 111.589 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.52 -13.54 37.38 Favored 'Cis proline' 0 C--N 1.379 2.173 0 CA-C-N 120.275 1.134 . . . . 0.0 114.424 4.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.6 m -67.6 -32.38 73.06 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.94 0.896 . . . . 0.0 112.431 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 59.8 m -135.48 98.2 3.88 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.623 0.769 . . . . 0.0 110.051 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.501 ' HB2' HG12 ' A' ' 511' ' ' VAL . 82.5 mt -90.87 149.73 21.81 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.33 120.9 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.204 0.602 . . . . 0.0 109.725 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -75.76 109.32 9.26 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 56.4 tptt -72.58 135.97 45.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.966 0.906 . . . . 0.0 110.514 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 99.32 -39.22 2.81 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.921 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -81.55 109.39 15.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.945 0.498 . . . . 0.0 110.482 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 85.9 p -83.4 -37.34 23.38 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.35 0.66 . . . . 0.0 110.292 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.708 ' HB2' HG21 ' A' ' 536' ' ' THR . 55.6 p -94.05 -29.39 15.22 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.794 -173.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.463 ' HE3' ' HE ' ' A' ' 485' ' ' ARG . 0.0 OUTLIER 59.98 34.51 21.5 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.14 0.976 . . . . 0.0 109.258 -171.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 79.41 81.08 0.75 Allowed Glycine 0 C--N 1.364 2.12 0 CA-C-O 119.574 -0.57 . . . . 0.0 113.032 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.708 HG21 ' HB2' ' A' ' 533' ' ' SER . 14.5 p -55.41 148.84 14.32 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.824 0.821 . . . . 0.0 112.51 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 164.8 136.15 1.95 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.585 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.71 -37.55 24.58 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 31.9 m -125.84 124.23 40.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.517 0.727 . . . . 0.0 109.186 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -158.74 161.46 37.04 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.642 0.777 . . . . 0.0 111.091 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 35.0 ptt180 -119.72 111.75 18.41 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.935 0.894 . . . . 0.0 108.689 168.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 61.3 m -89.92 133.14 34.94 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.53 HG21 ' HG3' ' A' ' 554' ' ' MET . 19.3 t -124.13 117.94 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.368 1.067 . . . . 0.0 108.723 -174.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 42.9 tp -87.99 132.35 34.29 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.59 157.58 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.176 1.39 . . . . 0.0 108.113 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . 0.44 ' ND2' ' HG2' ' A' ' 550' ' ' GLU . 1.2 p30 -117.77 -170.68 1.91 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.814 0.445 . . . . 0.0 111.234 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 480' ' ' ASN . . . -51.85 -37.4 51.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.396 1.478 . . . . 0.0 113.839 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.28 -34.47 77.47 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.595 0.758 . . . . 0.0 112.009 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 104.45 -12.95 51.28 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.559 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . 0.44 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 16.3 pt-20 -67.42 148.21 51.87 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 122.784 0.434 . . . . 0.0 110.139 175.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -80.93 101.24 9.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.471 ' HB ' ' H ' ' A' ' 452' ' ' GLY . 22.1 m -79.27 -21.0 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.566 0.347 . . . . 0.0 111.641 -175.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.6 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -158.9 151.71 22.03 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.228 1.011 . . . . 0.0 109.189 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.53 ' HG3' HG21 ' A' ' 543' ' ' VAL . 54.8 ttp -164.21 116.2 1.33 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.661 0.784 . . . . 0.0 109.668 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -133.22 130.59 39.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.549 0.74 . . . . 0.0 110.292 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 79.8 m -90.57 123.1 33.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.363 1.065 . . . . 0.0 109.572 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.503 HG23 ' HB ' ' A' ' 459' ' ' ILE . 86.2 t -123.75 128.87 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.795 0.838 . . . . 0.0 109.72 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 151.46 38.44 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.63 1.172 . . . . 0.0 108.52 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.499 ' HG3' ' HB2' ' A' ' 461' ' ' LEU . 88.0 tttt -75.49 83.34 2.56 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.549 0.69 . . . . 0.0 109.319 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 35.9 t -131.23 94.89 3.66 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.996 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 50.0 m -146.86 129.85 16.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.776 0.83 . . . . 0.0 109.251 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . 0.404 HG12 ' HG3' ' A' ' 563' ' ' MET . 5.0 p -137.68 -43.68 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.844 0.858 . . . . 0.0 108.991 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.404 ' HG3' HG12 ' A' ' 562' ' ' VAL . 60.7 mtt -111.55 177.52 4.63 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.3 1.04 . . . . 0.0 109.242 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 69.9 111.36 0.05 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.026 1.33 . . . . 0.0 109.548 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -97.34 88.39 4.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.96 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -106.78 39.96 1.74 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.53 1.132 . . . . 0.0 109.433 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -62.14 -49.84 74.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.785 1.234 . . . . 0.0 112.324 -167.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -81.99 117.65 22.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.256 0 CA-C-O 118.359 -1.245 . . . . 0.0 111.959 179.371 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.792 0.329 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -99.01 93.08 5.81 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 78.5 p -76.23 80.06 3.02 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.594 0.712 . . . . 0.0 110.784 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 76.39 -49.31 2.64 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.62 1.105 . . . . 0.0 112.806 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.9 m -176.98 -62.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.418 1.887 . . . . 0.0 108.241 174.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 13.8 t -91.77 130.95 40.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.374 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 16.6 m -109.64 155.71 21.13 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.341 1.056 . . . . 0.0 109.407 174.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 39.9 mt -79.23 106.54 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.453 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 11.7 tp10 -73.69 -69.47 0.43 Allowed 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.733 0.646 . . . . 0.0 109.68 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 21.8 mt-10 -133.19 163.73 28.63 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.6 0.76 . . . . 0.0 109.829 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.509 ' HB ' HG21 ' A' ' 557' ' ' VAL . 61.2 mt -142.5 144.34 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 171.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.39 148.62 51.6 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.354 0.662 . . . . 0.0 110.716 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.46 -41.62 98.89 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.065 0.546 . . . . 0.0 111.289 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -80.57 -29.52 37.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.55 0.74 . . . . 0.0 109.362 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . 0.451 ' HA3' ' NH2' ' A' ' 485' ' ' ARG . . . 92.1 39.52 5.42 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.408 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -71.26 -20.19 62.26 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.375 0.67 . . . . 0.0 109.915 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -153.5 161.85 41.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.294 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 81.3 t -130.63 111.8 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.453 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.7 tp-100 -86.81 123.06 31.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.148 0.979 . . . . 0.0 109.955 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 483' ' ' ILE . 62.4 mt -112.49 157.86 20.6 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 471' ' ' ASN . 2.1 tmmm? -148.19 129.98 15.15 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -91.72 130.78 37.45 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.234 0.614 . . . . 0.0 110.252 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.496 ' HB3' ' HE3' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -136.38 84.73 2.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.268 1.027 . . . . 0.0 109.261 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 66.0 m -146.43 -163.32 1.72 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.056 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . 0.511 ' HB2' ' HD3' ' A' ' 474' ' ' LYS . 2.2 m-20 -79.16 -48.78 13.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.308 0.643 . . . . 0.0 111.186 -173.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.511 ' HD3' ' HB2' ' A' ' 473' ' ' ASP . 0.0 OUTLIER -133.93 178.45 6.94 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.587 -172.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 504' ' ' ARG . 8.5 p-10 -53.16 112.46 0.87 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.72 1.208 . . . . 0.0 111.639 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -74.27 113.66 11.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.774 0.83 . . . . 0.0 110.557 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.472 ' HA ' HG12 ' A' ' 502' ' ' ILE . 32.6 t -64.37 100.84 0.38 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.098 0.559 . . . . 0.0 109.508 172.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.8 tp -90.65 165.68 13.58 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 143.22 -65.52 0.47 Allowed Glycine 0 N--CA 1.466 0.684 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.135 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.68 -13.04 58.42 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.153 0.981 . . . . 0.0 112.028 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -74.3 148.53 41.31 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.402 1.081 . . . . 0.0 109.599 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -148.58 134.11 18.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.047 0.539 . . . . 0.0 111.181 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . 0.432 HD13 HD13 ' A' ' 468' ' ' LEU . 49.2 mt -91.58 114.95 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.314 1.046 . . . . 0.0 109.729 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.566 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 67.1 mttm -79.63 144.11 34.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 164.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . 0.451 ' NH2' ' HA3' ' A' ' 463' ' ' GLY . 66.9 ttt180 -143.59 98.71 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.594 0.711 . . . . 0.0 109.282 172.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -96.15 103.6 15.51 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.01 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.527 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 24.3 t -67.58 149.44 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . 0.504 HD23 HG13 ' A' ' 487' ' ' VAL . 2.7 pt? -52.42 -33.11 42.42 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -168.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.93 -34.08 75.92 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.288 0.635 . . . . 0.0 111.248 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 130.57 -2.3 5.7 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.728 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -73.05 114.21 10.96 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.168 0.484 . . . . 0.0 110.384 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.12 143.49 38.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.58 0.752 . . . . 0.0 110.556 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 22.5 pt -127.19 146.16 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.19 0.996 . . . . 0.0 108.679 169.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -125.59 109.81 13.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.557 0.743 . . . . 0.0 109.764 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -97.38 106.03 18.28 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.571 0.748 . . . . 0.0 109.658 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -87.07 153.21 21.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -89.25 170.4 10.62 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.216 0.607 . . . . 0.0 110.936 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.1 p -91.07 131.74 36.21 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.044 0.938 . . . . 0.0 109.649 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.25 -17.06 49.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.783 2.322 . . . . 0.0 113.453 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -72.9 -20.39 61.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.549 0.739 . . . . 0.0 111.662 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -84.2 128.3 34.48 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.408 0.683 . . . . 0.0 109.614 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 477' ' ' SER . 49.2 mt -126.46 133.41 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -114.18 124.55 52.33 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 475' ' ' ASP . 8.1 mpt_? -71.13 155.95 40.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.855 0.862 . . . . 0.0 112.152 -170.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.52 129.23 39.0 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.488 0.715 . . . . 0.0 110.753 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 86.18 -6.45 81.56 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.556 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -92.73 -175.59 3.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.835 0.854 . . . . 0.0 110.62 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 21.9 ptt? -145.03 160.96 40.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.922 0.889 . . . . 0.0 110.61 -176.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . 0.407 HG11 ' HB2' ' A' ' 468' ' ' LEU . 2.5 p -137.81 118.64 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.376 1.07 . . . . 0.0 108.367 175.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.7 m -105.07 110.82 23.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 54.2 t -89.18 99.73 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.152 0.581 . . . . 0.0 109.491 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -87.09 170.07 11.85 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.258 1.023 . . . . 0.0 111.518 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -84.28 148.89 26.44 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.114 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -67.04 -31.77 72.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.347 0.659 . . . . 0.0 111.163 174.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -75.42 -12.68 83.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.91 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -71.18 -14.2 62.18 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.391 0.677 . . . . 0.0 111.735 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 66.58 25.86 72.82 Favored Glycine 0 C--N 1.356 1.675 0 CA-C-O 121.124 0.291 . . . . 0.0 113.207 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 5.7 p -84.03 144.46 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.603 1.161 . . . . 0.0 111.066 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -69.29 107.69 3.37 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.81 0.844 . . . . 0.0 110.046 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -62.74 109.88 1.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.1 m -131.83 76.36 74.31 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.473 0.709 . . . . 0.0 110.413 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.0 145.05 87.58 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.757 2.305 . . . . 0.0 112.33 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.59 -23.76 12.27 Favored 'Cis proline' 0 C--N 1.373 1.838 0 CA-C-N 120.008 1.039 . . . . 0.0 113.923 -1.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.1 m -62.83 -29.82 71.02 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 21.9 m -130.44 95.47 3.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.352 0.661 . . . . 0.0 109.411 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 48.5 mt -91.29 147.14 23.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 168.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.57 118.9 44.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -75.12 94.2 2.89 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -66.72 134.75 52.85 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.96 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 104.78 -35.82 4.81 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -98.05 88.44 4.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.048 0.539 . . . . 0.0 110.256 172.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 60.3 p -68.3 -35.47 77.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.446 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 13.9 m -86.41 -32.58 20.81 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.007 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.56 23.03 5.64 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.028 0.931 . . . . 0.0 110.978 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.18 52.06 52.34 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 122.303 -0.248 . . . . 0.0 113.378 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 3.8 p -76.67 110.6 11.38 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.461 0.704 . . . . 0.0 110.458 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -122.01 169.77 14.85 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 173.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . 0.587 ' HA ' ' HB3' ' A' ' 559' ' ' LYS . 14.2 pt-20 -80.22 -12.02 59.67 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.915 0.358 . . . . 0.0 110.888 176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' SER . . . . . 0.449 ' HB2' HD12 ' A' ' 488' ' ' LEU . 20.3 m -152.9 137.72 17.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.417 1.087 . . . . 0.0 108.118 172.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.527 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 13.8 p90 -166.26 172.0 11.58 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.531 0.681 . . . . 0.0 111.564 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 541' ' ' ARG . 1.4 mpt_? -118.42 157.24 27.56 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.205 1.402 . . . . 0.0 107.532 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 95.3 m -144.2 119.81 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 41.1 t -113.34 146.63 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.074 0.949 . . . . 0.0 109.404 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 26.8 tp -113.24 125.15 53.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.499 HG22 ' HE2' ' A' ' 484' ' ' LYS . 61.2 t -111.85 154.8 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.132 1.373 . . . . 0.0 107.839 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -114.51 -174.54 2.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.509 0.324 . . . . 0.0 111.068 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.95 69.23 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.601 1.16 . . . . 0.0 113.217 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.4 -39.34 86.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.886 0.874 . . . . 0.0 111.98 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 107.42 0.47 35.05 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.144 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -87.08 151.7 23.0 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.438 0.619 . . . . 0.0 110.537 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.451 ' HG2' HG21 ' A' ' 545' ' ' VAL . 39.8 mt-10 -85.89 99.27 11.29 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.903 0.881 . . . . 0.0 109.459 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.23 -38.57 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.042 -171.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -136.55 157.02 47.75 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.167 0.587 . . . . 0.0 110.051 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.432 ' HG3' HG23 ' A' ' 543' ' ' VAL . 28.1 ttt -159.02 141.9 14.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.845 0.458 . . . . 0.0 110.973 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -132.8 164.19 27.39 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.146 1.378 . . . . 0.0 108.665 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 74.3 m -139.98 121.96 15.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.509 HG21 ' HB ' ' A' ' 459' ' ' ILE . 55.0 t -124.58 133.94 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.452 0.701 . . . . 0.0 110.686 -174.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -114.46 124.96 53.23 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.698 0.799 . . . . 0.0 109.679 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.587 ' HB3' ' HA ' ' A' ' 538' ' ' GLU . 60.4 tttp -69.83 100.43 1.54 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 166.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 51.1 m -98.89 -44.05 6.5 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.24 0.616 . . . . 0.0 109.398 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 28.3 m 61.74 105.76 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.87 1.268 . . . . 0.0 111.315 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.19 -5.31 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 124.066 0.946 . . . . 0.0 111.865 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.2 mtm -103.51 154.26 19.66 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.979 0.912 . . . . 0.0 110.469 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 179.57 5.39 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 66.05 104.1 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.646 1.178 . . . . 0.0 111.434 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -113.66 56.08 0.71 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.016 0.926 . . . . 0.0 109.268 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.09 -52.1 63.98 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.133 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -94.88 114.68 26.56 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.96 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -177.057 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -77.16 79.6 3.68 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.731 0.412 . . . . 0.0 110.277 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 68.0 m -73.84 84.41 1.69 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.705 0.802 . . . . 0.0 109.921 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.32 -46.71 3.06 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.905 -169.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 58.0 m -167.89 -57.68 0.02 OUTLIER 'General case' 0 C--N 1.354 0.78 0 C-N-CA 125.756 1.622 . . . . 0.0 108.66 172.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 470' ' ' ASN . 9.3 t -95.95 157.74 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.315 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 35.6 t -145.15 165.42 28.36 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.427 0.691 . . . . 0.0 110.148 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 459' ' ' ILE . 24.9 mt -81.62 94.6 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.009 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.89 -50.65 19.22 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.015 0.526 . . . . 0.0 111.722 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -140.6 156.33 46.31 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 456' ' ' ILE . 22.1 mt -141.24 145.45 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.75 152.11 44.14 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.447 0.699 . . . . 0.0 111.339 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 462' ' ' GLU . 2.4 pp -62.21 -37.85 86.92 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.704 0.802 . . . . 0.0 112.379 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.693 ' HG2' ' HE3' ' A' ' 559' ' ' LYS . 27.8 mt-10 -83.4 -23.92 32.16 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.216 0.531 . . . . 0.0 109.786 169.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 85.57 21.01 55.31 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.327 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -70.62 -5.67 31.14 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.109 0.455 . . . . 0.0 110.323 -175.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -149.12 159.07 44.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.695 0.798 . . . . 0.0 110.285 166.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.22 124.03 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.766 1.226 . . . . 0.0 108.049 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -96.74 120.52 37.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.177 0.591 . . . . 0.0 109.731 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.41 HD12 HG12 ' A' ' 483' ' ' ILE . 79.1 mt -118.27 119.44 34.68 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.825 0.85 . . . . 0.0 109.09 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -113.43 131.32 56.06 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 454' ' ' VAL . 49.8 t30 -81.46 109.51 15.99 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.496 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -86.1 -3.68 59.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.929 0.892 . . . . 0.0 111.877 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.6 m -77.42 155.3 31.9 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.335 0.588 . . . . 0.0 112.406 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.95 -24.96 52.35 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.391 174.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.405 ' H ' ' HD3' ' A' ' 474' ' ' LYS . 0.3 OUTLIER -100.97 161.41 13.61 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.791 0.836 . . . . 0.0 109.8 178.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -85.16 121.78 28.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.237 1.015 . . . . 0.0 109.267 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -82.31 115.28 21.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.36 0.664 . . . . 0.0 110.552 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 24.0 p -70.2 99.5 1.52 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.6 tp -85.39 172.04 11.36 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.584 0.753 . . . . 0.0 109.883 -172.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 136.66 -55.76 0.7 Allowed Glycine 0 N--CA 1.471 0.983 0 CA-C-O 121.365 0.425 . . . . 0.0 112.226 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -70.93 -14.56 62.42 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.593 -0.803 . . . . 0.0 110.736 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -79.62 152.67 29.9 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.259 1.024 . . . . 0.0 109.424 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 -156.2 140.37 16.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.129 0.571 . . . . 0.0 110.627 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 12.7 mt -96.64 107.41 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.64 0.776 . . . . 0.0 109.627 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 67.9 mttm -76.3 161.09 29.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.178 0.513 . . . . 0.0 109.641 169.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -156.06 96.82 1.75 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -91.21 102.48 15.21 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.522 0.677 . . . . 0.0 109.49 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 11.4 t -80.11 138.98 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.492 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . 0.508 HD21 ' HG3' ' A' ' 538' ' ' GLU . 4.6 pp -63.11 -17.88 62.81 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.918 0.487 . . . . 0.0 112.075 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -60.93 -22.54 64.49 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.688 0.795 . . . . 0.0 111.163 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 116.68 28.26 2.56 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.79 -0.641 . . . . 0.0 114.361 170.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.67 165.54 26.67 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.473 0.636 . . . . 0.0 111.106 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -141.0 129.54 22.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.799 0.44 . . . . 0.0 110.23 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 29.4 pt -103.72 148.47 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -133.68 107.62 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.778 0.431 . . . . 0.0 110.153 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -83.71 106.31 15.32 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -81.47 152.46 27.35 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.94 0.4 . . . . 0.0 109.965 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.52 169.74 9.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.148 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 68.8 p -88.96 136.25 30.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.518 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 92.8 Cg_endo -73.12 -4.76 16.0 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.896 2.397 . . . . 0.0 113.472 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -90.68 -17.32 27.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.841 0.856 . . . . 0.0 110.837 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -75.53 133.63 40.96 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.776 0.83 . . . . 0.0 109.814 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 67.5 mt -119.89 124.32 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.73 112.1 23.28 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -75.18 163.41 27.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.039 0.447 . . . . 0.0 111.067 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.15 118.07 8.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.765 0.826 . . . . 0.0 111.088 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 85.9 -9.13 70.05 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 123.152 0.283 . . . . 0.0 113.784 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -75.98 171.29 14.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.169 0.588 . . . . 0.0 110.428 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -147.97 129.23 14.71 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.581 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.25 104.4 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 121.953 0.883 . . . . 0.0 109.202 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.9 m -87.43 94.24 9.64 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.2 t -86.96 99.25 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.33 0.652 . . . . 0.0 110.959 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . 0.554 ' HB2' HG22 ' A' ' 527' ' ' VAL . 55.2 m95 -84.96 174.89 9.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.162 0.985 . . . . 0.0 111.889 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -97.35 143.34 28.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.056 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -59.85 -37.75 80.16 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.501 0.72 . . . . 0.0 111.489 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -76.4 -0.57 67.29 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.769 -0.65 . . . . 0.0 114.621 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -78.35 -8.69 58.73 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.879 0.471 . . . . 0.0 111.305 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 69.07 23.23 76.15 Favored Glycine 0 C--N 1.361 1.918 0 C-N-CA 123.221 0.439 . . . . 0.0 113.65 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.17 146.26 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.47 1.108 . . . . 0.0 110.403 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -75.59 114.68 14.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.586 0.755 . . . . 0.0 110.164 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . 0.438 ' NE2' HD12 ' A' ' 526' ' ' LEU . 20.5 t-160 -69.06 117.03 10.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.84 0.456 . . . . 0.0 109.825 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.6 m -134.74 78.47 55.2 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 123.426 0.691 . . . . 0.0 110.001 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.63 151.46 82.71 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.176 1.917 . . . . 0.0 111.061 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.37 -29.64 4.34 Favored 'Cis proline' 0 CA--C 1.559 1.766 0 CA-C-N 120.48 1.207 . . . . 0.0 114.768 4.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 10.0 m -73.38 -26.12 60.86 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.514 0.726 . . . . 0.0 112.619 -164.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 44.6 m -124.32 83.53 2.16 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.438 HD12 ' NE2' ' A' ' 520' ' ' HIS . 20.7 tp -86.77 150.01 24.45 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.404 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.554 HG22 ' HB2' ' A' ' 512' ' ' TRP . 67.6 t -134.91 126.05 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.47 -0.769 . . . . 0.0 109.275 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -69.21 95.17 0.74 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 171.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 56.2 tptt -67.46 135.24 52.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.95 0.9 . . . . 0.0 110.052 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 89.57 -15.55 58.52 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.381 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.49 120.64 30.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.042 0.537 . . . . 0.0 109.614 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 14.3 p -78.65 -60.37 2.41 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.194 0.598 . . . . 0.0 112.145 -176.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 17.2 t -116.13 -1.46 12.43 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -166.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 62.72 23.49 13.99 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.212 1.005 . . . . 0.0 110.761 -174.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.43 67.06 2.25 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 112.396 -0.282 . . . . 0.0 112.396 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 13.8 t -72.22 163.57 27.71 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.875 0.47 . . . . 0.0 110.936 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -177.64 165.77 35.68 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . 0.508 ' HG3' HD21 ' A' ' 488' ' ' LEU . 8.8 pt-20 -59.61 -27.94 66.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.011 0.924 . . . . 0.0 111.902 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' SER . . . . . 0.479 ' HB3' HD22 ' A' ' 488' ' ' LEU . 41.1 t -164.3 143.83 7.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.96 0.904 . . . . 0.0 110.167 169.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -156.69 143.92 18.9 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.476 1.11 . . . . 0.0 109.0 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 14.6 ptt-85 -97.29 105.3 17.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.283 0.563 . . . . 0.0 109.776 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 86.0 m -85.16 122.65 29.66 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 71.1 t -121.41 138.35 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.657 1.183 . . . . 0.0 109.857 -171.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 553' ' ' ALA . 29.4 tp -99.88 122.25 42.54 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 171.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.13 154.0 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.182 1.393 . . . . 0.0 108.435 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -117.12 -168.15 1.43 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.93 0.492 . . . . 0.0 111.531 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.2 76.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.787 1.235 . . . . 0.0 113.435 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.25 -38.48 80.17 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.363 0.665 . . . . 0.0 111.403 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 103.24 2.05 47.94 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.378 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -86.64 152.3 22.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.174 0.512 . . . . 0.0 110.541 171.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -80.12 106.51 12.2 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.016 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 15.8 m -82.04 -35.69 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 122.32 0.248 . . . . 0.0 111.338 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 544' ' ' LEU . . . -137.17 149.27 47.14 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.561 0.744 . . . . 0.0 109.562 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.426 ' HG3' HG21 ' A' ' 543' ' ' VAL . 19.2 ttt -150.94 135.24 16.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.138 0.975 . . . . 0.0 109.524 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -145.96 134.22 21.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.984 0.913 . . . . 0.0 109.919 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 36.7 m -97.87 135.86 39.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.437 0.695 . . . . 0.0 109.665 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 459' ' ' ILE . 41.1 t -111.11 129.28 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.789 1.236 . . . . 0.0 108.792 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.27 110.2 22.09 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.693 ' HE3' ' HG2' ' A' ' 462' ' ' GLU . 83.0 tttt -66.32 133.89 51.46 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 11.3 m -64.87 -56.44 13.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.658 0.783 . . . . 0.0 110.466 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 34.8 p -175.44 179.31 1.49 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.074 1.35 . . . . 0.0 109.123 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.06 12.56 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.792 0.837 . . . . 0.0 109.614 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 61.3 mtt -68.7 102.18 1.46 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 123.673 0.789 . . . . 0.0 110.316 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -101.17 149.95 23.45 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.923 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -76.8 111.77 12.67 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.558 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -112.82 6.28 17.92 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.474 0.71 . . . . 0.0 111.177 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.19 -20.08 63.99 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.856 0.863 . . . . 0.0 112.498 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -147.94 21.88 1.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.398 1.079 . . . . 0.0 109.267 173.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.22 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.715 -178.221 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.57 90.97 0.57 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.482 0.713 . . . . 0.0 110.079 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 18.4 m -104.99 105.06 14.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.691 0.797 . . . . 0.0 110.114 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 97.06 4.79 58.55 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.971 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 43.9 m -63.53 -38.16 90.06 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.342 0.657 . . . . 0.0 110.562 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.49 147.6 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.0 m -142.25 148.28 37.84 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.836 0.854 . . . . 0.0 109.185 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . 0.468 ' HA ' HD12 ' A' ' 468' ' ' LEU . 53.2 mt -69.59 132.53 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.688 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 10.5 tp10 -94.83 -66.28 0.92 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.045 0.538 . . . . 0.0 110.249 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.688 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 34.0 mt-10 -133.81 157.18 46.57 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.497 0.719 . . . . 0.0 109.155 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.505 ' HB ' HG22 ' A' ' 557' ' ' VAL . 77.8 mt -141.91 139.6 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.64 143.64 51.37 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 123.666 0.604 . . . . 0.0 110.187 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.516 HD12 ' HG3' ' A' ' 462' ' ' GLU . 2.9 pp -71.05 -29.91 65.94 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.482 0.713 . . . . 0.0 112.009 -175.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.516 ' HG3' HD12 ' A' ' 461' ' ' LEU . 36.7 mt-10 -82.25 -31.63 30.06 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 170.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 97.58 41.25 3.43 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 114.904 -1.043 . . . . 0.0 112.633 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -76.21 -27.02 56.67 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.817 0.847 . . . . 0.0 110.798 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -159.23 163.3 36.0 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.367 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 42.6 t -122.65 114.9 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.9 tp-100 -85.51 107.17 17.33 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 171.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.5 HD23 HD12 ' A' ' 483' ' ' ILE . 29.6 tp -105.35 132.08 51.99 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 123.943 0.897 . . . . 0.0 108.83 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 54.3 tttm -113.7 142.07 46.47 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.355 0.525 . . . . 0.0 111.101 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -89.06 128.77 35.75 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -117.23 12.5 14.4 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.012 0.925 . . . . 0.0 110.979 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 33.8 t -75.88 160.32 30.05 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.723 0.809 . . . . 0.0 110.342 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -87.54 0.25 55.86 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.435 0.694 . . . . 0.0 111.769 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 179.23 7.89 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.611 1.164 . . . . 0.0 109.314 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -53.39 104.49 0.1 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.328 0.651 . . . . 0.0 109.984 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -78.94 112.11 15.79 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 28.8 t -68.84 98.36 0.92 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.776 0.672 . . . . 0.0 109.585 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.1 tp -86.03 174.31 9.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.927 0.891 . . . . 0.0 108.816 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 134.83 -56.53 0.71 Allowed Glycine 0 N--CA 1.468 0.832 0 O-C-N 122.032 -0.417 . . . . 0.0 112.66 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.9 -13.47 62.26 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.788 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -81.47 162.73 23.15 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.147 0.979 . . . . 0.0 110.177 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . 0.561 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 11.9 ptt180 -157.34 127.8 6.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.61 0.764 . . . . 0.0 110.66 -174.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . 0.5 HD12 HD23 ' A' ' 468' ' ' LEU . 50.3 mt -93.49 109.86 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.11 0.564 . . . . 0.0 109.601 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.712 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 97.8 mttt -81.9 167.41 18.99 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.242 0.617 . . . . 0.0 110.827 171.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 534' ' ' TRP . 42.5 ttm180 -151.69 118.38 5.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 166.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . 0.455 ' OE1' ' HB3' ' A' ' 492' ' ' GLU . 23.4 mm-40 -97.84 102.33 14.06 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.024 1.33 . . . . 0.0 108.568 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.469 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 40.0 t -75.04 156.78 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.21 0.604 . . . . 0.0 109.807 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.2 pp -54.9 -25.82 31.71 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.411 1.085 . . . . 0.0 113.757 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 491' ' ' GLU . 13.1 pt-20 -86.51 -21.15 27.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.082 0.553 . . . . 0.0 111.249 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 117.45 14.07 7.14 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.516 -0.602 . . . . 0.0 114.188 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 489' ' ' GLU . 50.8 mt-10 -76.49 109.78 10.5 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 117.945 0.873 . . . . 0.0 110.305 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.455 ' HB3' ' OE1' ' A' ' 486' ' ' GLN . 7.0 pt-20 -101.11 98.61 9.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.149 0.98 . . . . 0.0 109.815 178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.48 139.37 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -135.49 112.74 10.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.856 0.462 . . . . 0.0 111.09 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -82.9 112.87 20.09 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.71 0.804 . . . . 0.0 110.281 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -84.81 145.41 27.88 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.52 169.57 10.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.415 0.686 . . . . 0.0 109.923 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 82.5 p -89.42 132.55 36.93 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.324 0.65 . . . . 0.0 109.25 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.434 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 52.0 Cg_exo -58.39 -15.98 26.86 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.422 2.748 . . . . 0.0 114.808 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -79.38 -24.05 42.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.243 0.617 . . . . 0.0 111.284 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -74.29 130.68 40.17 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.466 0.706 . . . . 0.0 110.23 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 46.7 mt -134.71 124.41 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.468 0.707 . . . . 0.0 109.23 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.74 135.16 43.76 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -77.12 154.24 33.45 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.602 0.761 . . . . 0.0 112.156 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -59.78 131.28 50.43 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.053 0.941 . . . . 0.0 110.371 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 89.49 -42.4 3.0 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.47 0.481 . . . . 0.0 112.57 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -66.25 178.35 1.21 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.367 1.067 . . . . 0.0 112.257 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 15.9 ptp -153.13 150.24 28.88 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.391 -174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 2.8 p -112.04 118.62 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.256 1.422 . . . . 0.0 108.84 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.6 m -95.33 99.75 11.63 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.27 97.58 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.126 0.57 . . . . 0.0 109.994 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -83.56 172.35 12.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.423 1.089 . . . . 0.0 111.616 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 534' ' ' TRP . . . -89.85 154.05 20.18 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.041 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.56 68.07 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.066 0.46 . . . . 0.0 110.416 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -75.21 -8.48 83.45 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.615 -0.72 . . . . 0.0 113.986 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -74.56 -19.24 60.4 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.261 0.625 . . . . 0.0 110.772 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.06 22.65 77.3 Favored Glycine 0 C--N 1.357 1.744 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.313 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.16 142.27 13.46 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.252 1.021 . . . . 0.0 109.969 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -69.5 127.52 33.28 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.574 0.75 . . . . 0.0 110.367 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -65.79 110.06 2.69 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.2 m -135.59 80.17 45.29 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.364 0.666 . . . . 0.0 109.953 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.61 154.08 44.9 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.918 2.412 . . . . 0.0 112.685 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -84.82 -17.61 25.96 Favored 'Cis proline' 0 C--N 1.374 1.882 0 CA-C-N 119.898 0.999 . . . . 0.0 114.005 -0.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 21.3 m -71.46 -38.96 71.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.311 0.644 . . . . 0.0 112.427 -169.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 74.0 m -121.35 97.49 5.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.022 0.529 . . . . 0.0 110.615 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 9.4 mp -93.04 145.26 24.51 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 166.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 91.9 t -127.97 126.69 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -73.09 96.99 2.27 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.24 130.29 42.81 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.15 0.98 . . . . 0.0 110.545 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 94.85 -45.86 2.11 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.511 0.507 . . . . 0.0 112.907 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -75.24 100.72 4.42 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 55.4 m -76.1 -43.61 42.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.058 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.449 ' O ' HG23 ' A' ' 536' ' ' THR . 16.8 m -85.55 -29.23 24.35 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -165.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.64 27.05 4.81 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 124.001 0.92 . . . . 0.0 110.611 -174.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.04 58.65 11.02 Favored Glycine 0 C--N 1.345 1.028 0 O-C-N 122.474 -0.141 . . . . 0.0 113.08 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 533' ' ' SER . 2.4 p -64.51 121.73 15.1 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.194 0.598 . . . . 0.0 110.523 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -154.67 155.1 25.98 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.703 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -78.82 -11.02 59.97 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.1 0.476 . . . . 0.0 110.503 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 558' ' ' LYS . 20.9 m -151.61 130.66 12.62 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.192 0.997 . . . . 0.0 108.728 173.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.469 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 8.5 p90 -161.24 171.77 17.83 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.098 0.959 . . . . 0.0 110.287 172.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.613 ' HD3' ' SD ' ' A' ' 554' ' ' MET . 7.0 ptp180 -129.4 109.36 11.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' THR . . . . . 0.501 ' HB ' HD11 ' A' ' 459' ' ' ILE . 21.6 m -87.43 122.27 30.95 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.712 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 41.0 t -108.69 143.86 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.134 0.973 . . . . 0.0 110.075 -170.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 67.1 tp -108.39 123.11 48.34 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.017 0.927 . . . . 0.0 108.539 168.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.561 ' HB ' ' HG3' ' A' ' 482' ' ' ARG . 75.7 t -116.25 144.77 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.389 1.076 . . . . 0.0 108.651 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . 0.502 HD22 ' HG2' ' A' ' 550' ' ' GLU . 0.8 OUTLIER -102.42 -172.89 2.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.809 0.843 . . . . 0.0 111.479 177.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.93 80.99 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.836 1.254 . . . . 0.0 113.723 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . 0.475 ' HB3' ' ND2' ' A' ' 546' ' ' ASN . 9.5 t70 -55.87 -39.67 71.86 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.847 0.859 . . . . 0.0 111.899 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.39 -7.71 28.51 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.532 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . 0.502 ' HG2' HD22 ' A' ' 546' ' ' ASN . 9.4 pt-20 -73.39 141.26 46.99 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.14 0.47 . . . . 0.0 110.293 174.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -84.35 82.47 8.37 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.41 -39.85 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.267 -171.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -131.53 154.73 48.49 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.325 0.65 . . . . 0.0 110.027 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.613 ' SD ' ' HD3' ' A' ' 541' ' ' ARG . 60.0 ttp -161.33 135.67 7.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.731 0.812 . . . . 0.0 109.524 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -128.18 114.09 16.54 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.037 0.935 . . . . 0.0 109.138 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 29.7 m -81.3 113.55 19.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.201 0.6 . . . . 0.0 109.389 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.505 HG22 ' HB ' ' A' ' 459' ' ' ILE . 82.1 t -114.53 112.27 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.019 0.928 . . . . 0.0 110.063 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 2.6 mppt? -98.79 137.61 37.13 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 165.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -56.76 97.15 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.764 0.825 . . . . 0.0 110.648 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 23.6 m -119.37 110.69 17.25 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.438 1.095 . . . . 0.0 108.236 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 34.8 m -65.2 99.95 0.42 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.633 0.773 . . . . 0.0 110.686 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.5 p -122.6 -13.31 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.814 0.846 . . . . 0.0 111.176 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.56 125.54 27.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -118.37 -162.19 0.88 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.56 81.81 2.58 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 121.165 0.507 . . . . 0.0 109.838 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -171.31 78.17 0.07 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.702 1.201 . . . . 0.0 108.247 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -73.66 -49.86 23.81 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -156.82 110.62 2.66 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.687 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.255 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 177.636 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.759 0.314 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -143.42 100.59 3.64 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.69 0.796 . . . . 0.0 109.91 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 50.9 m -85.64 79.77 9.24 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.27 -42.44 2.89 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 114.901 -1.045 . . . . 0.0 114.061 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 43.4 m 70.76 -0.72 2.87 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.536 1.535 . . . . 0.0 113.167 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 27.9 t -104.13 117.75 50.2 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 25.1 t -113.05 155.01 25.62 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.088 0.555 . . . . 0.0 110.419 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.47 111.96 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -84.36 -69.47 0.64 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.163 0.585 . . . . 0.0 110.414 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 27.6 mt-10 -117.47 150.28 39.18 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.033 -171.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 50.6 mt -139.58 143.69 30.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.02 148.87 48.31 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -15.72 57.61 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.46 1.104 . . . . 0.0 113.605 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -111.44 -30.79 7.26 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.855 1.262 . . . . 0.0 109.167 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 105.27 31.14 4.45 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.339 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 516' ' ' ALA . 1.9 mppt? -73.71 -8.62 56.72 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.703 0.751 . . . . 0.0 110.915 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -156.83 157.26 34.63 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.289 0.636 . . . . 0.0 111.021 172.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 77.3 t -134.27 113.69 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.868 1.267 . . . . 0.0 107.862 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.7 tp-100 -86.03 107.9 18.0 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.876 0.87 . . . . 0.0 109.497 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.443 HD22 HD23 ' A' ' 544' ' ' LEU . 50.4 mt -92.82 160.62 14.85 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 170.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -145.13 127.34 15.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -89.92 97.92 11.47 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -74.46 -10.98 60.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.255 1.022 . . . . 0.0 111.706 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.5 t -63.56 145.69 55.18 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.697 0.799 . . . . 0.0 111.677 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.26 -0.12 48.12 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.176 0.99 . . . . 0.0 111.412 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.13 164.91 27.32 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 124.36 1.064 . . . . 0.0 108.644 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.92 161.39 10.6 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.751 0.821 . . . . 0.0 111.802 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 13.4 tm0? -136.51 112.43 9.59 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.407 ' HA ' HG12 ' A' ' 502' ' ' ILE . 23.4 p -65.24 103.16 0.74 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.312 0.645 . . . . 0.0 109.896 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.67 161.71 16.71 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -172.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 147.94 -66.39 0.4 Allowed Glycine 0 N--CA 1.473 1.162 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.738 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -69.07 -12.61 61.84 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.295 0.638 . . . . 0.0 111.134 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -67.1 145.08 55.68 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.554 1.142 . . . . 0.0 110.387 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . 0.489 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 4.3 ptt85 -148.76 123.86 10.1 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.293 -171.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 45.3 mt -90.51 109.26 20.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 123.916 0.886 . . . . 0.0 109.307 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.0 mttt -77.9 123.95 27.39 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 174.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 49.8 mmm-85 -119.95 92.35 3.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -111.98 116.73 31.06 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.446 HG13 ' H ' ' A' ' 489' ' ' GLU . 13.0 t -103.65 147.78 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.72 -24.45 65.38 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 120.949 0.404 . . . . 0.0 111.392 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . 0.446 ' H ' HG13 ' A' ' 487' ' ' VAL . 22.5 mm-40 -61.53 -23.88 66.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.318 1.047 . . . . 0.0 110.603 171.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 126.0 -21.64 6.16 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-O 119.613 -0.549 . . . . 0.0 113.27 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.15 102.62 0.85 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.185 0.594 . . . . 0.0 111.358 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -126.71 116.25 20.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.612 0.765 . . . . 0.0 110.209 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 20.2 pt -136.55 176.14 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.812 1.245 . . . . 0.0 109.57 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -149.26 108.54 3.94 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -80.56 105.04 11.51 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.25 149.27 31.91 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -91.88 171.74 8.93 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.665 0.786 . . . . 0.0 110.177 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.4 p -90.65 133.19 33.08 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.491 0.716 . . . . 0.0 109.489 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.14 8.5 3.18 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.021 2.481 . . . . 0.0 113.321 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -101.74 -22.84 14.31 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.802 1.241 . . . . 0.0 110.46 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -84.96 123.69 30.81 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 477' ' ' SER . 54.2 mt -104.61 129.99 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.8 127.87 33.42 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 174.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -88.12 158.87 18.44 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.23 127.02 29.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.667 1.187 . . . . 0.0 112.543 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 65.92 14.71 61.45 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.6 0.562 . . . . 0.0 113.747 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -105.52 -164.05 0.99 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.894 0.878 . . . . 0.0 110.282 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -152.7 163.28 39.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.037 0.935 . . . . 0.0 110.448 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.22 116.65 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.19 101.71 13.39 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 59.3 t -87.32 106.03 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 122.75 0.42 . . . . 0.0 110.347 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . 0.506 ' HB2' HG22 ' A' ' 527' ' ' VAL . 36.3 m95 -94.72 179.46 5.24 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.686 0.795 . . . . 0.0 111.312 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.651 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -107.3 155.44 19.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.288 1.035 . . . . 0.0 110.067 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 529' ' ' LYS . . . -65.76 -33.39 75.76 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.19 0.596 . . . . 0.0 110.532 172.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -78.47 -3.91 86.76 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.939 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 464' ' ' LYS . . . -76.58 -8.48 57.31 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.009 0.524 . . . . 0.0 110.562 169.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 73.96 21.11 79.57 Favored Glycine 0 C--N 1.36 1.871 0 C-N-CA 123.517 0.579 . . . . 0.0 113.21 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.38 143.71 16.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.332 1.053 . . . . 0.0 110.391 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -87.15 141.51 28.6 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.525 0.73 . . . . 0.0 110.398 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -61.78 119.17 8.23 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.85 0.86 . . . . 0.0 109.679 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' SER . . . . . 0.41 ' HB2' ' HB ' ' A' ' 525' ' ' THR . 39.6 m -129.97 75.44 79.49 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.594 0.757 . . . . 0.0 109.881 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.66 161.23 39.96 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.735 2.29 . . . . 0.0 112.05 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.49 17.78 41.41 Favored 'Cis proline' 0 C--N 1.379 2.17 0 CA-C-N 119.771 0.954 . . . . 0.0 113.673 0.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.4 m -90.42 -68.3 0.79 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.185 0.594 . . . . 0.0 110.052 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' THR . . . . . 0.437 HG21 ' CD1' ' A' ' 512' ' ' TRP . 72.0 m -90.36 95.05 10.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.115 0.966 . . . . 0.0 110.298 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 10.9 mp -92.47 104.93 17.2 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 173.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 512' ' ' TRP . 96.8 t -91.48 123.64 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -71.53 89.3 0.96 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . 0.5 ' HA ' ' HB1' ' A' ' 514' ' ' ALA . 25.2 tptp -76.28 117.96 18.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.953 -175.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 123.28 -40.42 1.99 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.0 116.18 28.59 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 63.1 p -88.29 -41.65 12.76 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.12 0.568 . . . . 0.0 111.506 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.4 p -79.94 -31.22 40.04 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.651 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 54.49 23.81 4.84 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 123.699 0.799 . . . . 0.0 110.602 -175.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 72.82 67.53 1.79 Allowed Glycine 0 C--N 1.353 1.483 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 -171.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 5.1 p -63.31 140.1 58.84 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.066 0.546 . . . . 0.0 110.733 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -167.59 143.93 8.58 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.628 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.62 -25.55 53.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.287 0.635 . . . . 0.0 110.088 171.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 14.8 m -148.92 120.58 8.04 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.218 1.007 . . . . 0.0 108.484 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -150.64 169.62 21.15 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.989 0.915 . . . . 0.0 110.978 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -117.85 116.99 28.09 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.002 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 40.3 m -96.58 117.34 30.75 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 45.0 t -117.85 139.19 45.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.359 1.064 . . . . 0.0 108.526 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 553' ' ' ALA . 31.5 tp -110.11 115.87 30.53 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.527 HG23 ' HE3' ' A' ' 484' ' ' LYS . 63.8 t -108.47 151.73 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.494 1.118 . . . . 0.0 108.778 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . 0.408 HD22 ' HG2' ' A' ' 550' ' ' GLU . 0.5 OUTLIER -110.16 -173.09 2.17 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.949 0.5 . . . . 0.0 111.119 -176.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -60.92 -35.67 77.3 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.377 1.071 . . . . 0.0 113.069 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.02 -40.74 98.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.079 0.552 . . . . 0.0 110.524 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 112.48 -11.3 26.0 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.595 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . 0.408 ' HG2' HD22 ' A' ' 546' ' ' ASN . 10.6 pt-20 -69.66 146.47 51.61 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 117.78 0.79 . . . . 0.0 110.009 172.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.472 ' HG2' HG22 ' A' ' 545' ' ' VAL . 38.4 mt-10 -84.71 99.1 10.62 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 33.3 m -78.02 -25.85 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.146 -170.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' A' ' 544' ' ' LEU . . . -144.27 156.13 44.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.678 0.791 . . . . 0.0 109.554 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 543' ' ' VAL . 56.9 ttp -160.2 146.93 15.89 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.343 0.657 . . . . 0.0 109.715 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.68 117.08 4.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.902 0.481 . . . . 0.0 110.402 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 62.1 m -87.93 103.72 15.95 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.724 0.81 . . . . 0.0 108.874 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.0 p -114.93 129.56 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.153 0.981 . . . . 0.0 110.432 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.94 163.32 32.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.134 0.973 . . . . 0.0 109.948 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -85.14 100.32 11.65 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.843 0.857 . . . . 0.0 109.597 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 48.9 m -105.44 -8.39 18.15 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.935 0.894 . . . . 0.0 110.638 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 43.4 m -114.98 115.3 26.65 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.968 0.907 . . . . 0.0 110.021 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.28 -8.39 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.945 0.898 . . . . 0.0 111.125 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -65.52 145.82 55.62 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.745 0.818 . . . . 0.0 111.557 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 -177.92 3.5 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 62.24 57.81 1.91 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.478 1.111 . . . . 0.0 110.742 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -158.87 105.83 1.81 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.052 170.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -96.42 -6.58 37.09 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.548 0.739 . . . . 0.0 112.094 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.18 101.16 5.89 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.402 0.681 . . . . 0.0 111.007 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 119.166 -0.796 . . . . 0.0 112.231 179.412 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 471' ' ' ASN . . . -152.02 89.26 1.44 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.888 0.875 . . . . 0.0 109.425 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 552' ' ' VAL . 17.9 p -78.65 94.87 5.13 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 88.27 -44.52 3.2 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.077 -173.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 19.8 p 177.26 -42.55 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.407 1.483 . . . . 0.0 109.3 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 12.3 t -98.53 162.74 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.433 1.093 . . . . 0.0 109.954 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 35.7 t -145.82 152.0 38.82 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.876 1.27 . . . . 0.0 109.366 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.0 mt -86.08 107.67 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -86.68 -53.08 5.15 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -171.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 30.0 mt-10 -136.79 163.02 31.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.626 HG22 HH21 ' A' ' 485' ' ' ARG . 89.0 mt -147.67 143.69 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.098 1.359 . . . . 0.0 107.749 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . 0.46 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 37.2 t70 -66.98 148.33 52.1 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.74 0.416 . . . . 0.0 111.138 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 559' ' ' LYS . 0.4 OUTLIER -64.34 -27.42 69.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.968 0.907 . . . . 0.0 112.634 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.01 -32.01 11.86 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.28 0.632 . . . . 0.0 109.571 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 103.35 44.04 1.77 Allowed Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.545 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -91.04 -9.55 45.45 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.542 0.737 . . . . 0.0 111.15 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.46 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 29.5 p90 -154.71 161.09 41.69 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.33 0.586 . . . . 0.0 112.373 173.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 42.3 t -127.11 117.62 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.473 1.509 . . . . 0.0 107.335 169.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.3 tp-100 -86.03 112.41 21.21 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.484 HD21 HD12 ' A' ' 483' ' ' ILE . 16.5 tp -112.15 121.34 44.66 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.994 0.917 . . . . 0.0 108.736 -176.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -113.41 139.09 49.19 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.024 0.53 . . . . 0.0 111.698 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.448 ' HB2' HD12 ' A' ' 503' ' ' LEU . 52.9 t30 -92.71 137.23 32.54 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.472 ' HB2' ' HB1' ' A' ' 450' ' ' ALA . 30.5 m-80 -127.62 16.4 6.98 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.48 0.712 . . . . 0.0 109.92 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 41.9 t -73.79 152.85 40.2 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.759 0.824 . . . . 0.0 109.459 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.86 -21.35 62.44 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.376 0.67 . . . . 0.0 111.014 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 174.89 6.9 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.469 0.708 . . . . 0.0 109.687 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . 0.466 ' HB2' HG22 ' A' ' 502' ' ' ILE . 5.1 p-10 -65.13 111.65 3.03 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.037 0.935 . . . . 0.0 109.963 172.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -78.03 122.41 25.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.08 0.952 . . . . 0.0 110.426 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 18.2 p -66.2 98.01 0.43 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.687 0.756 . . . . 0.0 109.626 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.6 tp -89.46 162.6 15.65 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 135.13 -51.16 0.84 Allowed Glycine 0 N--CA 1.471 0.998 0 O-C-N 121.451 -0.78 . . . . 0.0 112.334 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -68.66 -13.5 62.4 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.203 -0.999 . . . . 0.0 111.0 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -91.9 162.63 14.34 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 124.713 1.205 . . . . 0.0 110.294 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -153.43 143.75 22.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.97 0.908 . . . . 0.0 110.337 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . 0.484 HD12 HD21 ' A' ' 468' ' ' LEU . 61.5 mt -102.51 107.73 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.438 0.695 . . . . 0.0 109.618 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.661 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.5 mttt -78.67 162.24 26.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.321 0.649 . . . . 0.0 111.626 172.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . 0.626 HH21 HG22 ' A' ' 459' ' ' ILE . 71.2 mtt180 -153.03 102.46 2.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.201 1.4 . . . . 0.0 108.377 170.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . 0.49 ' HG3' ' HD3' ' A' ' 541' ' ' ARG . 8.4 pt20 -101.8 109.33 21.07 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.727 0.811 . . . . 0.0 109.712 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.48 HG12 HD21 ' A' ' 488' ' ' LEU . 6.6 t -89.44 156.58 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.919 0.888 . . . . 0.0 109.19 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . 0.48 HD21 HG12 ' A' ' 487' ' ' VAL . 2.7 pt? -66.41 -18.15 65.19 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.028 0.442 . . . . 0.0 111.458 173.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -83.08 4.73 25.07 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.49 1.116 . . . . 0.0 111.779 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 102.16 -26.1 25.46 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.145 -0.808 . . . . 0.0 114.469 168.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.53 104.53 0.81 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.677 0.739 . . . . 0.0 111.001 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.53 79.84 1.35 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.4 1.08 . . . . 0.0 108.961 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 35.6 pt -97.54 170.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.741 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -155.49 116.39 3.89 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.735 0.414 . . . . 0.0 110.162 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -80.17 108.49 13.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.966 0.506 . . . . 0.0 109.769 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -76.35 150.3 36.88 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.72 167.76 11.08 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 76.2 p -95.82 132.76 26.56 Favored Pre-proline 0 N--CA 1.477 0.897 0 CA-C-O 118.441 -0.79 . . . . 0.0 108.994 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.492 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 54.3 Cg_exo -55.27 -25.7 48.33 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 123.206 2.604 . . . . 0.0 115.066 -175.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -68.33 -24.67 64.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.038 0.535 . . . . 0.0 111.457 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -73.39 127.34 32.41 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.2 1.0 . . . . 0.0 109.478 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 475' ' ' ASP . 43.4 mt -129.66 118.69 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 470' ' ' ASN . 1.4 tm? -93.36 125.82 38.16 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -67.54 163.34 21.37 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.326 1.05 . . . . 0.0 113.227 -168.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.2 116.69 5.66 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.352 1.061 . . . . 0.0 111.851 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 80.94 -14.93 23.96 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 123.485 0.49 . . . . 0.0 113.926 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -79.29 -172.94 3.42 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.122 0.969 . . . . 0.0 111.068 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -154.42 147.49 24.66 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.33 0.586 . . . . 0.0 112.268 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.76 127.88 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.814 1.245 . . . . 0.0 109.135 172.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.89 99.99 11.12 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.55 97.92 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 122.856 0.462 . . . . 0.0 110.044 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . 0.525 ' HH2' ' HA ' ' A' ' 567' ' ' GLU . 39.3 m95 -86.61 178.24 7.12 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.044 0.938 . . . . 0.0 111.506 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.26 158.49 16.0 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.814 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.74 -28.18 67.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.386 0.675 . . . . 0.0 110.591 172.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -76.16 -16.99 80.3 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.466 -0.788 . . . . 0.0 114.066 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -68.32 -29.3 68.02 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.168 0.587 . . . . 0.0 110.729 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.72 26.47 73.99 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 116.321 -0.399 . . . . 0.0 113.635 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 13.4 p -81.09 159.03 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.827 1.251 . . . . 0.0 111.117 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -73.8 113.9 11.48 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.128 0.571 . . . . 0.0 110.139 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -64.85 110.87 2.57 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.093 0.557 . . . . 0.0 109.625 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.9 m -127.39 69.35 74.73 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.16 0.584 . . . . 0.0 110.254 -175.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.88 149.69 60.2 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.35 2.033 . . . . 0.0 111.87 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.42 -13.87 34.77 Favored 'Cis proline' 0 C--N 1.376 2.012 0 N-CA-C 114.442 0.901 . . . . 0.0 114.442 -2.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.3 m -60.12 -28.55 67.95 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.868 0.867 . . . . 0.0 113.048 -172.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 97.1 m -140.75 101.21 4.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.07 0.948 . . . . 0.0 108.878 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.86 138.94 31.21 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 83.4 t -113.67 117.73 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -70.45 92.34 0.81 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.7 tptt -68.45 135.07 51.11 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.121 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 91.54 -14.77 63.06 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.17 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -100.91 110.89 23.0 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 66.1 p -82.34 -50.79 8.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.327 0.584 . . . . 0.0 111.219 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.552 ' HB3' HG21 ' A' ' 536' ' ' THR . 20.3 m -90.11 -28.51 18.93 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.939 -167.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 56.56 38.09 29.33 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.05 0.94 . . . . 0.0 110.142 -176.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.47 52.91 45.69 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.552 HG21 ' HB3' ' A' ' 533' ' ' SER . 14.3 t -72.21 156.01 39.61 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.51 0.724 . . . . 0.0 110.274 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 179.97 167.87 37.79 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.8 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -71.84 -25.29 61.91 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 18.2 m -154.42 121.69 5.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.856 0.862 . . . . 0.0 109.71 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.433 ' HB3' HG23 ' A' ' 487' ' ' VAL . 31.5 p90 -143.65 150.7 39.13 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.431 0.692 . . . . 0.0 111.06 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.49 ' HD3' ' HG3' ' A' ' 486' ' ' GLN . 5.4 mpt_? -101.92 106.21 17.12 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 33.5 m -84.99 106.34 16.41 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.661 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 28.3 t -105.64 133.48 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.058 0.943 . . . . 0.0 110.127 -170.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.569 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 36.2 tp -98.08 119.67 37.13 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.485 HG21 ' HG2' ' A' ' 551' ' ' GLU . 40.2 t -115.86 143.66 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -105.38 -172.89 2.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.499 0.32 . . . . 0.0 110.919 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -52.72 -40.23 62.83 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.844 1.258 . . . . 0.0 113.745 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.01 -36.9 82.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.613 0.765 . . . . 0.0 111.87 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.3 -19.48 29.34 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.035 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.95 134.81 52.75 Favored 'General case' 0 C--O 1.248 1.019 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.485 ' HG2' HG21 ' A' ' 545' ' ' VAL . 44.7 mt-10 -79.33 102.27 8.54 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 451' ' ' SER . 28.0 m -74.29 -37.39 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.651 -172.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.569 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -133.78 159.95 39.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.59 0.756 . . . . 0.0 109.32 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.512 ' HG3' HG21 ' A' ' 543' ' ' VAL . 27.4 ttt -157.41 125.28 5.4 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -137.32 105.86 5.82 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -172.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 49.8 m -83.63 110.32 18.16 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.243 0.617 . . . . 0.0 109.682 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.9 116.62 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -87.6 147.97 25.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.664 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.515 ' HE2' HG13 ' A' ' 562' ' ' VAL . 20.6 tttm -59.8 98.96 0.06 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.835 0.854 . . . . 0.0 110.254 176.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 36.7 p -71.75 -44.04 64.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.812 0.845 . . . . 0.0 110.365 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 23.1 t -162.57 175.61 11.25 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.235 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . 0.515 HG13 ' HE2' ' A' ' 559' ' ' LYS . 17.2 m -117.84 -14.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.666 1.186 . . . . 0.0 109.78 170.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.9 mtt -91.34 147.69 22.86 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.659 1.184 . . . . 0.0 110.134 -171.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 67.73 128.76 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.402 1.481 . . . . 0.0 110.683 -168.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -111.65 132.32 54.67 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.798 0.839 . . . . 0.0 110.34 -173.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -100.1 10.92 40.52 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . 0.525 ' HA ' ' HH2' ' A' ' 512' ' ' TRP . 37.3 tt0 -82.3 -46.71 13.29 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.617 1.167 . . . . 0.0 111.058 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 59.48 85.1 0.1 Allowed 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.138 0.899 . . . . 0.0 110.68 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.087 0 CA-C-O 119.009 -0.884 . . . . 0.0 111.532 -179.43 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 37.2 m . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -75.99 90.55 3.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.815 0.446 . . . . 0.0 109.839 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 51.3 p -127.91 117.43 21.76 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.78 0.832 . . . . 0.0 109.583 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 93.19 5.31 63.92 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.726 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' SER . . . . . 0.402 ' HB3' ' OG ' ' A' ' 472' ' ' SER . 16.6 m -63.62 -38.33 90.7 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.26 1.024 . . . . 0.0 111.688 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.07 150.8 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.964 1.306 . . . . 0.0 107.646 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 22.7 t -137.12 153.21 50.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.866 0.866 . . . . 0.0 109.629 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 64.8 mt -76.64 107.19 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 14.0 tp10 -78.54 -68.68 0.62 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -130.44 167.45 18.58 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.864 0.866 . . . . 0.0 109.16 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 23.4 mt -141.43 147.43 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 20.8 t70 -66.65 145.92 55.05 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.249 0.62 . . . . 0.0 111.245 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.94 -33.6 76.09 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.403 1.081 . . . . 0.0 112.74 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -93.38 -23.75 18.33 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.895 0.878 . . . . 0.0 110.285 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.67 32.46 7.24 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.001 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -79.26 -15.66 57.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.545 0.738 . . . . 0.0 111.215 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 20.5 p90 -155.15 162.17 41.05 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.277 0.56 . . . . 0.0 111.621 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.46 119.59 59.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 125.296 1.438 . . . . 0.0 107.813 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.404 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 6.2 tp-100 -88.48 109.74 20.28 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.526 ' HB2' HG12 ' A' ' 509' ' ' VAL . 87.0 mt -100.13 155.72 17.58 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . 0.499 ' HZ2' ' HB3' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -140.47 129.8 23.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 175.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.72 111.2 17.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.947 0.899 . . . . 0.0 110.163 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.73 -10.84 59.7 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.146 0.979 . . . . 0.0 111.939 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 453' ' ' SER . 50.4 m -59.9 148.58 34.44 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.72 -15.81 63.22 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.653 1.181 . . . . 0.0 111.408 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.17 176.34 8.84 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.317 1.047 . . . . 0.0 110.447 -171.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.11 108.7 0.72 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.143 0.977 . . . . 0.0 110.675 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -79.92 117.34 20.68 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.405 0.682 . . . . 0.0 110.423 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.52 ' HA ' HG12 ' A' ' 502' ' ' ILE . 8.9 p -73.3 105.79 4.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.756 0.822 . . . . 0.0 109.906 175.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.5 tp -98.02 163.5 12.74 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 145.63 -64.59 0.45 Allowed Glycine 0 N--CA 1.47 0.915 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -67.91 -12.07 59.97 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.595 0.758 . . . . 0.0 111.465 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -74.19 151.26 40.03 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.886 0.875 . . . . 0.0 109.926 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -153.42 136.49 15.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.074 0.55 . . . . 0.0 111.184 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 62.4 mt -91.71 140.3 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.052 0.941 . . . . 0.0 109.739 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.728 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 55.2 mttm -115.67 107.44 15.1 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.995 0.918 . . . . 0.0 110.149 175.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -92.78 93.77 8.61 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 171.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 492' ' ' GLU . 43.3 mt-30 -93.46 104.7 16.82 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.474 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 489' ' ' GLU . 9.7 t -98.63 139.83 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.473 0.709 . . . . 0.0 109.306 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.7 pp -65.5 -21.34 66.62 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.024 0.53 . . . . 0.0 111.403 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . 0.468 ' H ' HG12 ' A' ' 487' ' ' VAL . 28.2 tt0 -71.25 -2.98 17.93 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.925 1.29 . . . . 0.0 110.895 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 110.13 11.96 19.03 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 115.509 0.964 . . . . 0.0 115.509 162.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -118.14 106.55 12.97 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.258 1.029 . . . . 0.0 110.771 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 486' ' ' GLN . 8.9 pt-20 -105.01 80.97 1.68 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 122.364 1.078 . . . . 0.0 109.006 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 38.3 pt -85.67 155.6 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.602 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -128.48 139.2 52.45 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.179 0.592 . . . . 0.0 110.16 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -123.02 105.92 10.38 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.072 0.949 . . . . 0.0 108.614 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 152.33 26.71 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -89.93 163.22 15.06 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.248 0.619 . . . . 0.0 110.512 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 75.7 p -80.24 130.02 67.41 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.79 -17.83 56.94 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.795 2.33 . . . . 0.0 113.333 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -72.55 -16.36 61.76 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.9 0.88 . . . . 0.0 111.623 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -89.37 134.76 33.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.746 0.819 . . . . 0.0 110.914 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 477' ' ' SER . 58.3 mt -137.67 141.2 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.89 140.27 52.05 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -73.84 166.2 23.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.082 0.953 . . . . 0.0 113.062 -168.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.72 124.76 22.28 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.234 1.014 . . . . 0.0 112.349 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 74.08 0.65 57.3 Favored Glycine 0 C--N 1.343 0.942 0 O-C-N 123.664 0.602 . . . . 0.0 114.42 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -88.89 -174.9 4.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.35 0.66 . . . . 0.0 109.451 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -133.42 161.01 35.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.404 0.682 . . . . 0.0 110.99 -177.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 468' ' ' LEU . 2.4 p -134.64 105.83 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.554 1.142 . . . . 0.0 109.113 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 3.3 m -89.07 104.09 16.66 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.979 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 34.9 t -91.92 103.5 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -87.47 175.55 7.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.114 0.965 . . . . 0.0 111.694 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 534' ' ' TRP . . . -96.73 156.5 16.32 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.616 171.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . 0.534 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -62.98 -36.2 82.72 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.221 0.609 . . . . 0.0 110.652 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -80.06 4.06 68.23 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.401 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -77.09 -28.28 54.45 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.002 0.521 . . . . 0.0 110.715 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 85.61 9.0 79.42 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.556 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.7 148.57 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.087 0.955 . . . . 0.0 110.642 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -78.64 124.28 28.01 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.294 0.638 . . . . 0.0 109.621 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -63.98 111.32 2.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.814 0.446 . . . . 0.0 109.804 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.4 m -128.38 76.34 78.33 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.414 0.686 . . . . 0.0 109.632 -176.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.12 158.95 55.82 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.716 2.277 . . . . 0.0 111.631 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.69 -38.5 1.66 Allowed 'Cis proline' 0 C--N 1.379 2.15 0 CA-C-N 120.228 1.117 . . . . 0.0 114.757 6.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 60.3 m -63.85 -52.34 60.53 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.006 0.523 . . . . 0.0 112.35 -170.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 40.0 m -87.91 86.43 7.14 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.459 0.647 . . . . 0.0 109.893 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.97 149.82 24.92 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 96.1 t -133.43 121.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -72.66 94.64 1.76 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 53.4 tptt -70.54 136.18 49.12 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.928 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 96.06 -9.74 67.85 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.527 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -116.07 111.24 20.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.243 0.617 . . . . 0.0 109.587 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 49.3 m -81.82 -44.49 16.85 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.953 0.501 . . . . 0.0 111.846 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.577 ' HB3' HG23 ' A' ' 536' ' ' THR . 34.6 m -87.43 -28.42 22.13 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -168.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 60.3 26.58 16.09 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.285 1.034 . . . . 0.0 110.896 -175.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.66 75.68 0.5 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.577 HG23 ' HB3' ' A' ' 533' ' ' SER . 13.1 t -109.36 167.27 10.25 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 123.872 0.869 . . . . 0.0 110.628 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 169.83 -164.97 38.38 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.815 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.43 -54.38 33.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.989 0.916 . . . . 0.0 110.012 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 26.8 m -143.44 132.74 23.26 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -154.01 146.02 23.61 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.776 0.83 . . . . 0.0 109.826 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 13.6 ptp180 -109.67 141.59 42.02 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.313 0.578 . . . . 0.0 110.519 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 47.7 m -95.66 138.36 33.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 169.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.728 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 42.0 t -124.46 150.5 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.48 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 41.8 tp -124.54 113.06 17.59 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.468 HG22 ' HG2' ' A' ' 551' ' ' GLU . 54.0 t -100.49 154.02 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.882 1.273 . . . . 0.0 108.779 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.9 -171.67 1.89 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.845 0.458 . . . . 0.0 111.747 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.5 88.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.341 1.056 . . . . 0.0 112.863 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.37 -38.84 92.44 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.645 0.778 . . . . 0.0 110.97 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 112.57 -5.91 26.29 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.852 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -72.81 146.89 45.98 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 118.793 1.297 . . . . 0.0 110.295 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.468 ' HG2' HG22 ' A' ' 545' ' ' VAL . 47.3 mt-10 -81.37 94.5 6.79 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.641 0.776 . . . . 0.0 108.982 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 18.8 m -79.0 -19.65 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -168.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -149.11 155.06 40.13 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.059 0.544 . . . . 0.0 109.671 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 50.0 ttp -163.74 131.77 3.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.571 0.748 . . . . 0.0 109.624 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -145.38 126.31 14.49 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.024 0.93 . . . . 0.0 108.848 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 13.4 m -92.91 147.21 23.03 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.009 0.523 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.74 121.19 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.388 1.075 . . . . 0.0 109.307 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.54 118.05 35.57 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.564 ' HB3' ' HZ3' ' A' ' 559' ' ' LYS . 4.3 ttpm? -76.91 86.27 3.46 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 45.1 m -73.7 -14.81 61.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.641 0.776 . . . . 0.0 109.552 171.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' SER . . . . . 0.581 ' HB2' ' HG2' ' A' ' 563' ' ' MET . 16.5 m 70.22 -174.66 0.18 Allowed 'General case' 0 C--N 1.365 1.248 0 C-N-CA 125.676 1.59 . . . . 0.0 110.858 176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.07 -1.14 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 CA-C-O 121.295 0.569 . . . . 0.0 110.77 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.581 ' HG2' ' HB2' ' A' ' 561' ' ' SER . 26.5 ptt? -92.89 168.42 11.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.225 1.01 . . . . 0.0 110.557 176.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 13.4 ttt85 -86.65 146.12 26.44 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.789 0.836 . . . . 0.0 109.537 169.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.74 133.09 35.31 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.423 0.689 . . . . 0.0 110.095 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -86.64 71.66 10.34 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.78 -67.22 0.48 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.081 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -98.38 77.21 2.34 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.818 -0.99 . . . . 0.0 112.489 178.16 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' SER . . . . . 0.512 ' HA ' ' HB2' ' A' ' 548' ' ' ASP . 41.3 m . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 120.567 0.222 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -93.79 67.91 3.87 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 171.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 14.5 m -79.97 112.17 17.0 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.016 -170.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 66.37 30.56 76.84 Favored Glycine 0 C--N 1.345 1.037 0 O-C-N 123.717 0.636 . . . . 0.0 113.659 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 24.8 m -76.33 -45.37 32.54 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.414 0.685 . . . . 0.0 110.297 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.28 143.16 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 19.5 m -130.14 150.34 51.45 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.216 1.006 . . . . 0.0 109.577 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 53.4 mt -76.3 106.13 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 11.3 tp10 -78.02 -55.66 5.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.751 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 43.9 mt-10 -140.57 165.7 26.75 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.824 0.85 . . . . 0.0 109.9 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.597 ' HB ' HG21 ' A' ' 557' ' ' VAL . 79.6 mt -143.18 151.39 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.83 149.92 48.4 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.455 0.702 . . . . 0.0 111.002 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.482 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.4 pt? -64.02 -39.99 95.35 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.714 0.806 . . . . 0.0 112.004 -177.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.482 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 18.3 mt-10 -89.18 -27.24 20.81 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.309 1.044 . . . . 0.0 109.199 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 98.32 40.64 3.41 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.789 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -83.9 -10.67 57.81 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.765 0.426 . . . . 0.0 111.387 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -156.02 162.14 40.36 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.91 0.386 . . . . 0.0 111.635 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.07 112.37 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.367 1.467 . . . . 0.0 107.914 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.437 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 14.3 tp60 -86.43 111.58 20.67 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.168 0.987 . . . . 0.0 110.094 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.401 ' HG ' HD23 ' A' ' 544' ' ' LEU . 7.0 mp -92.29 160.55 15.08 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.424 1.09 . . . . 0.0 109.453 168.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . 0.705 ' HE3' ' HB3' ' A' ' 471' ' ' ASN . 3.3 tmmm? -147.0 128.24 14.78 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -88.44 107.84 19.07 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.216 0.606 . . . . 0.0 109.802 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.705 ' HB3' ' HE3' ' A' ' 469' ' ' LYS . 12.0 p-10 -95.77 19.07 11.86 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.611 0.764 . . . . 0.0 112.046 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 45.0 m -76.55 151.94 36.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.674 0.39 . . . . 0.0 110.971 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -78.75 -22.75 46.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.885 0.874 . . . . 0.0 110.612 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -116.69 168.05 10.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.123 0.969 . . . . 0.0 111.247 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.33 111.0 4.35 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.72 0.808 . . . . 0.0 110.342 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.59 109.61 17.56 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 54.6 p -68.95 114.31 7.13 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.083 0.553 . . . . 0.0 110.359 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 7.6 tp -90.78 169.79 10.66 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.033 0.933 . . . . 0.0 109.027 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 143.15 -66.65 0.46 Allowed Glycine 0 N--CA 1.473 1.117 0 O-C-N 121.996 -0.44 . . . . 0.0 112.467 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . 0.439 ' N ' HD21 ' A' ' 480' ' ' ASN . 0.8 OUTLIER -71.99 -9.9 59.03 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.37 0.668 . . . . 0.0 111.009 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -70.39 143.69 51.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.836 0.854 . . . . 0.0 109.796 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 22.9 ptt-85 -140.87 137.79 33.47 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.741 0.416 . . . . 0.0 110.747 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 45.6 mt -96.75 106.92 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.514 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.2 mttt -75.3 147.23 40.37 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.77 91.89 2.29 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -99.55 104.46 16.26 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.487 -170.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 31.7 t -66.44 154.91 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 539' ' ' SER . 4.3 pp -51.79 -32.1 29.85 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -173.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.35 -11.35 58.64 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.377 0.671 . . . . 0.0 112.063 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 125.17 -26.68 5.5 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.979 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.81 111.57 1.93 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.48 0.712 . . . . 0.0 111.633 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.98 145.09 43.87 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.24 0.543 . . . . 0.0 111.385 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.71 153.89 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.89 1.276 . . . . 0.0 108.108 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -133.01 108.45 8.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.407 0.283 . . . . 0.0 110.356 -177.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -85.06 103.7 14.31 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -91.44 143.65 26.39 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.39 0.614 . . . . 0.0 109.489 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -83.93 170.79 13.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.482 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 2.6 t -94.06 140.23 22.83 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.151 0.58 . . . . 0.0 109.715 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.78 -26.1 78.79 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.877 3.052 . . . . 0.0 114.128 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -68.39 -19.41 64.62 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.4 0.68 . . . . 0.0 111.771 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -82.65 136.86 34.66 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.518 0.727 . . . . 0.0 110.617 -174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 66.7 mt -131.03 150.81 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . 0.498 HD22 ' HB ' ' A' ' 509' ' ' VAL . 0.3 OUTLIER -123.99 135.34 53.56 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -81.25 156.76 25.44 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.704 0.801 . . . . 0.0 111.674 -168.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.33 132.76 52.62 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.958 0.903 . . . . 0.0 112.372 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 64.29 15.83 59.46 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.921 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -107.69 -166.53 1.15 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.653 0.781 . . . . 0.0 109.908 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -150.07 171.89 16.14 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.19 0.519 . . . . 0.0 111.731 -177.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . 0.498 ' HB ' HD22 ' A' ' 503' ' ' LEU . 7.4 p -146.49 142.1 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.872 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 5.2 m -118.86 109.08 15.6 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 45.7 t -90.27 100.33 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -82.21 175.93 9.89 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.674 1.19 . . . . 0.0 111.508 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 534' ' ' TRP . . . -101.36 153.45 19.65 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.337 173.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -64.39 -32.11 73.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.115 0.566 . . . . 0.0 110.9 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -71.4 -16.02 75.34 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.992 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -70.79 -23.7 62.43 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.3 0.64 . . . . 0.0 111.473 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 78.46 36.64 29.63 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 123.235 0.334 . . . . 0.0 113.618 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.79 147.18 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.183 0.993 . . . . 0.0 110.386 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -74.72 123.31 24.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.487 0.715 . . . . 0.0 110.961 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -67.46 111.15 3.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.4 0.68 . . . . 0.0 109.681 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.7 m -134.84 80.3 49.65 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.117 0.567 . . . . 0.0 110.091 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.37 156.2 61.46 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.857 2.371 . . . . 0.0 112.164 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -99.9 30.7 11.62 Favored 'Cis proline' 0 C--N 1.38 2.186 0 CA-C-N 119.684 0.923 . . . . 0.0 113.591 -0.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 39.5 m -112.44 -38.61 4.61 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.989 0.516 . . . . 0.0 111.149 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 60.3 m -118.3 96.34 5.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.49 0.716 . . . . 0.0 109.718 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 58.1 mt -87.63 149.91 23.99 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 65.1 t -137.29 116.74 15.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -72.55 98.25 2.27 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 0.4 OUTLIER -66.14 134.11 52.09 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.88 0.872 . . . . 0.0 110.16 -177.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 92.28 -24.79 20.63 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.958 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -87.23 103.61 15.6 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 55.4 p -77.97 -45.27 24.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.815 0.446 . . . . 0.0 111.076 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 536' ' ' THR . 15.2 m -93.37 -30.26 15.2 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -166.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 55.7 32.73 19.94 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 123.644 0.777 . . . . 0.0 110.352 -174.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 72.28 59.92 4.35 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.214 -0.448 . . . . 0.0 113.027 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 533' ' ' SER . 12.2 p -65.28 147.7 52.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.985 0.514 . . . . 0.0 111.761 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 175.97 159.85 22.43 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.87 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -73.11 -9.55 58.84 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.06 0.544 . . . . 0.0 110.818 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 488' ' ' LEU . 29.6 t -157.55 139.43 14.15 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 124.589 1.156 . . . . 0.0 108.252 172.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.97 122.13 5.07 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.021 0.528 . . . . 0.0 111.282 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.602 ' HD2' ' SD ' ' A' ' 554' ' ' MET . 52.9 ttp180 -84.5 105.43 15.31 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 32.2 m -94.25 128.57 40.8 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 22.8 t -120.33 145.94 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.845 0.858 . . . . 0.0 109.427 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.557 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 34.2 tp -114.88 119.42 36.51 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.515 HG21 ' HG2' ' A' ' 551' ' ' GLU . 60.9 t -106.49 154.65 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.009 1.324 . . . . 0.0 108.632 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . 0.507 ' ND2' ' HG2' ' A' ' 550' ' ' GLU . 1.2 p30 -115.52 -173.64 2.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.536 0.335 . . . . 0.0 111.675 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.24 -36.56 71.07 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.753 1.221 . . . . 0.0 112.611 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 449' ' ' SER . 20.1 t70 -60.65 -38.98 86.65 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.755 0.822 . . . . 0.0 111.635 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.15 -12.44 31.45 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.542 -174.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . 0.507 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 0.7 OUTLIER -74.82 149.65 39.56 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.193 0.497 . . . . 0.0 110.072 177.096 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.515 ' HG2' HG21 ' A' ' 545' ' ' VAL . 34.5 mt-10 -88.54 92.71 9.29 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.562 0.745 . . . . 0.0 109.31 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.53 -34.57 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -168.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.557 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -135.17 165.81 24.55 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.124 0.57 . . . . 0.0 109.86 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.602 ' SD ' ' HD2' ' A' ' 541' ' ' ARG . 50.1 ttm -169.57 115.97 0.57 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.306 0.642 . . . . 0.0 109.519 -176.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 53.0 ttm-85 -124.35 115.42 20.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.483 0.713 . . . . 0.0 109.825 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 17.4 m -92.11 126.31 37.14 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.73 0.812 . . . . 0.0 109.622 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.597 HG21 ' HB ' ' A' ' 459' ' ' ILE . 78.2 t -123.72 123.71 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.623 0.769 . . . . 0.0 109.701 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 138.13 49.81 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.14 0.976 . . . . 0.0 109.718 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -72.27 91.9 1.35 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.103 0.961 . . . . 0.0 111.383 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 23.5 t -106.58 2.46 26.07 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.807 164.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 30.3 m -107.48 135.49 48.86 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.86 0.864 . . . . 0.0 110.835 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 34.9 m -96.01 19.49 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.075 0.95 . . . . 0.0 110.139 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 79.6 mtp -53.85 117.35 3.11 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.547 1.139 . . . . 0.0 110.956 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -82.3 133.56 35.24 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.02 0.528 . . . . 0.0 109.921 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -160.44 110.28 1.77 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -153.55 142.88 21.56 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.352 0.661 . . . . 0.0 109.833 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -162.77 -44.86 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -69.63 106.48 3.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.776 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 119.18 -0.789 . . . . 0.0 111.362 -177.01 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -147.79 67.97 1.11 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.706 0.765 . . . . 0.0 109.654 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' SER . . . . . 0.47 ' HA ' HG13 ' A' ' 552' ' ' VAL . 27.0 p -81.26 94.99 6.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.851 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . 0.401 ' H ' ' HB ' ' A' ' 552' ' ' VAL . . . 92.5 34.27 7.1 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.968 171.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.6 m -71.08 -51.4 25.4 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.763 0.792 . . . . 0.0 108.945 170.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 5.0 t -110.53 146.54 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 23.2 t -124.34 177.85 5.67 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.603 1.161 . . . . 0.0 109.587 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.7 mt -98.4 123.27 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.496 ' HG3' ' HG2' ' A' ' 458' ' ' GLU . 6.6 tp10 -87.68 -76.11 0.39 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.496 ' HG2' ' HG3' ' A' ' 457' ' ' GLU . 55.0 mm-40 -122.91 160.94 25.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.393 1.077 . . . . 0.0 109.383 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.438 HG12 HG12 ' A' ' 466' ' ' VAL . 66.2 mt -140.68 148.14 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.26 147.99 51.43 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.3 pp -67.0 -36.34 81.94 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.541 0.736 . . . . 0.0 111.456 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -81.34 -31.88 33.23 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 170.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . 0.519 ' HA3' HH22 ' A' ' 485' ' ' ARG . . . 92.7 51.47 2.31 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.177 -175.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -81.97 -18.97 41.61 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.361 0.665 . . . . 0.0 110.505 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -156.42 158.63 37.64 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.889 0.476 . . . . 0.0 111.554 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . 0.438 HG12 HG12 ' A' ' 459' ' ' ILE . 61.1 t -127.3 107.12 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.889 1.275 . . . . 0.0 108.19 174.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 4.7 tp-100 -85.76 114.61 22.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 109.27 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 70.4 mt -100.96 151.84 21.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.695 1.198 . . . . 0.0 109.334 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 4.6 tmmm? -138.94 136.8 35.84 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.751 0.821 . . . . 0.0 109.568 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.442 ' OD1' ' HA ' ' A' ' 505' ' ' ALA . 25.9 t-20 -90.97 133.24 35.44 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.106 0.963 . . . . 0.0 111.335 -176.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -110.91 7.26 21.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.71 0.804 . . . . 0.0 111.95 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 48.8 m -80.53 155.5 26.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.274 0.63 . . . . 0.0 111.718 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -85.4 -19.4 31.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.61 0.764 . . . . 0.0 110.053 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.24 150.91 42.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.487 1.115 . . . . 0.0 109.108 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -69.01 135.76 51.39 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.296 0.638 . . . . 0.0 111.397 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -89.65 118.33 29.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.517 0.727 . . . . 0.0 109.923 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 15.4 p -65.12 109.82 2.31 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 503' ' ' LEU . 4.8 tp -102.14 175.66 5.46 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -171.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 122.05 -50.57 0.83 Allowed Glycine 0 N--CA 1.469 0.857 0 CA-C-O 121.993 0.774 . . . . 0.0 111.179 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . 0.52 ' HB3' ' HB1' ' A' ' 547' ' ' ALA . 9.0 m120 -65.46 -24.28 67.13 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 113.368 -1.416 . . . . 0.0 110.543 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.462 ' CZ3' HG21 ' A' ' 552' ' ' VAL . 13.6 m0 -77.12 164.23 25.88 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.061 0.945 . . . . 0.0 111.289 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 496' ' ' LYS . 19.7 ptt180 -156.21 138.67 14.9 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.523 -170.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.06 113.57 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.421 1.088 . . . . 0.0 108.61 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -79.61 140.92 36.96 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . 0.519 HH22 ' HA3' ' A' ' 463' ' ' GLY . 74.4 ttt180 -143.8 96.38 2.89 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 173.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . 0.501 ' HG3' ' HB2' ' A' ' 541' ' ' ARG . 5.6 pt20 -98.36 103.87 15.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.864 1.265 . . . . 0.0 109.434 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.71 153.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.602 0.761 . . . . 0.0 109.178 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.23 -14.37 61.81 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.391 0.541 . . . . 0.0 111.679 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -62.01 -23.37 66.4 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.613 0.765 . . . . 0.0 110.939 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 104.37 -8.53 48.41 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.704 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -78.33 105.47 9.6 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 123.44 0.696 . . . . 0.0 110.496 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.08 133.24 51.11 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.514 173.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 24.2 pt -128.58 156.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.16 0.984 . . . . 0.0 108.661 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -131.11 108.01 9.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -87.91 103.56 15.79 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 482' ' ' ARG . 0.0 OUTLIER -87.08 146.54 26.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 170.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -83.43 170.24 14.7 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.08 0.552 . . . . 0.0 110.935 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.9 p -84.79 129.92 54.87 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.213 0.605 . . . . 0.0 109.372 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.544 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 36.3 Cg_endo -62.31 -14.32 37.84 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.893 2.395 . . . . 0.0 113.465 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . 0.528 ' HZ3' ' HB2' ' A' ' 500' ' ' LYS . 0.1 OUTLIER -83.88 1.81 41.52 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.971 0.908 . . . . 0.0 111.977 176.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -103.26 136.92 42.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.606 0.762 . . . . 0.0 111.002 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 69.5 mt -118.12 136.59 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . 0.441 ' HB2' HD23 ' A' ' 478' ' ' LEU . 3.1 tm? -100.54 121.25 41.27 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -79.94 161.95 25.22 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.305 0.642 . . . . 0.0 112.655 -171.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . 0.442 ' HA ' ' OD1' ' A' ' 470' ' ' ASN . . . -73.95 133.96 43.1 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.083 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 70.15 1.26 33.19 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.509 0.505 . . . . 0.0 113.817 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -101.97 174.72 5.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.956 0.902 . . . . 0.0 110.35 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -140.68 144.02 35.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.013 0.525 . . . . 0.0 111.432 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.53 128.97 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.835 0.854 . . . . 0.0 108.907 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.3 m -103.79 103.31 13.17 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 56.7 t -87.4 97.85 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 122.803 0.441 . . . . 0.0 110.167 -176.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . 0.48 ' HB2' HG23 ' A' ' 527' ' ' VAL . 43.9 m95 -90.94 175.47 6.96 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.849 0.859 . . . . 0.0 112.007 -175.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 534' ' ' TRP . . . -104.04 152.85 21.56 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.357 1.063 . . . . 0.0 110.308 174.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -63.54 -38.96 93.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.422 0.689 . . . . 0.0 111.879 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -82.7 -0.63 90.23 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.34 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -83.25 7.0 17.6 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.404 0.681 . . . . 0.0 111.632 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 76.83 38.56 30.89 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 113.572 0.189 . . . . 0.0 113.572 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 4.6 p -146.5 137.33 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.703 0.801 . . . . 0.0 110.617 -170.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -91.09 151.49 20.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.101 0.961 . . . . 0.0 111.139 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -67.05 112.27 4.3 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.5 m -131.78 79.34 68.39 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.672 0.789 . . . . 0.0 109.889 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.95 156.25 56.53 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.716 2.278 . . . . 0.0 111.845 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -93.4 4.42 57.66 Favored 'Cis proline' 0 C--N 1.381 2.244 0 CA-C-N 119.815 0.97 . . . . 0.0 113.491 2.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.0 m -82.81 -30.09 29.04 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.605 0.762 . . . . 0.0 111.595 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 84.0 m -140.75 102.84 4.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.367 0.667 . . . . 0.0 110.658 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 9.7 mp -97.49 103.77 15.73 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.48 HG23 ' HB2' ' A' ' 512' ' ' TRP . 72.0 t -89.29 122.19 40.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -71.07 87.1 0.75 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 22.1 tptp -68.01 116.54 8.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.701 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 120.84 -45.36 1.24 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -172.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.11 105.85 12.65 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 34.2 p -72.18 -47.16 52.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.483 0.713 . . . . 0.0 111.243 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.7 m -99.23 -14.34 19.33 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.489 0.715 . . . . 0.0 112.271 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 61.72 23.76 14.01 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.04 0.936 . . . . 0.0 109.582 -171.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.92 65.2 2.71 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-N 116.54 -0.3 . . . . 0.0 112.717 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 10.8 p -59.55 166.11 2.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.167 0.987 . . . . 0.0 113.624 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 177.72 160.21 23.92 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.034 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -78.4 -27.12 46.68 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.852 0.326 . . . . 0.0 110.399 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 2.7 m -145.71 129.5 17.22 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 168.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.87 137.79 20.24 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.843 0.857 . . . . 0.0 110.887 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.501 ' HB2' ' HG3' ' A' ' 486' ' ' GLN . 1.3 mpt_? -91.68 116.14 28.63 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 78.8 m -108.12 119.34 39.2 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . . . . . . . . . 20.4 t -115.67 123.25 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.024 0.93 . . . . 0.0 109.744 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 42.2 tp -81.25 124.43 29.31 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 546' ' ' ASN . 53.5 t -126.45 144.37 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.824 0.85 . . . . 0.0 109.556 -173.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . 0.473 ' O ' HG12 ' A' ' 545' ' ' VAL . 4.1 t30 -84.03 162.69 20.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.907 0.883 . . . . 0.0 109.935 170.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' A' ' 480' ' ' ASN . . . -45.51 -41.49 9.7 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.439 1.495 . . . . 0.0 114.48 -175.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.26 -32.44 68.37 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.557 1.143 . . . . 0.0 112.897 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.85 -6.29 31.07 Favored Glycine 0 N--CA 1.464 0.551 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -168.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.81 117.63 9.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.568 0.747 . . . . 0.0 109.642 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.42 116.81 15.52 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 451' ' ' SER . 16.1 m -95.33 -28.86 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 122.719 0.408 . . . . 0.0 111.546 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -156.89 147.33 21.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.167 0.987 . . . . 0.0 109.251 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 554' ' ' MET . 0.0 OUTLIER -147.26 147.67 30.65 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.119 0.568 . . . . 0.0 109.694 -178.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . 0.438 ' NH1' HG23 ' A' ' 557' ' ' VAL . 2.1 tmt_? -160.86 108.51 1.54 Allowed 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 63.2 m -81.55 138.13 35.46 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.619 0.768 . . . . 0.0 109.573 174.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.438 HG23 ' NH1' ' A' ' 555' ' ' ARG . 36.2 t -115.9 146.63 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.686 1.194 . . . . 0.0 109.133 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 113.1 6.18 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.005 0.922 . . . . 0.0 108.823 166.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -54.02 105.77 0.16 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.948 1.699 . . . . 0.0 111.384 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 36.4 p -160.65 -41.64 0.05 OUTLIER 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.642 1.177 . . . . 0.0 108.886 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 17.3 m -62.74 143.68 57.21 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.557 0.743 . . . . 0.0 110.573 172.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.3 86.36 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.392 1.091 . . . . 0.0 109.719 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 62.0 mtt -119.12 179.39 4.18 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.289 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -74.03 148.95 41.51 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.862 0.465 . . . . 0.0 110.173 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.78 133.98 48.05 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.008 0.923 . . . . 0.0 112.01 -171.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -93.88 73.93 4.19 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . 0.474 ' HA ' ' HZ2' ' A' ' 512' ' ' TRP . 11.2 pt-20 -71.49 -27.88 63.53 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.759 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 57.0 t30 59.51 83.86 0.12 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.72 1.208 . . . . 0.0 112.158 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.317 0 CA-C-O 118.761 -1.022 . . . . 0.0 112.487 178.596 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 120.534 0.207 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -73.82 138.5 44.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.566 0.746 . . . . 0.0 109.422 170.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 15.7 m -74.86 84.97 2.21 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.409 0.683 . . . . 0.0 111.849 -171.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.0 -37.74 2.53 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 115.349 0.899 . . . . 0.0 115.349 170.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 8.2 t 70.1 1.36 3.49 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 125.665 1.586 . . . . 0.0 112.139 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.39 128.51 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 171.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 28.6 t -117.18 174.2 6.25 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.17 0.588 . . . . 0.0 109.785 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 36.8 mt -93.03 116.23 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 469' ' ' LYS . 7.2 tp10 -70.33 -71.38 0.25 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.738 0.815 . . . . 0.0 109.92 -177.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.471 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.0 mt-10 -126.56 159.38 33.64 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.183 0.993 . . . . 0.0 108.705 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.503 HD11 ' HB ' ' A' ' 542' ' ' THR . 15.9 mt -137.09 131.3 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.67 127.0 31.16 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.669 ' HB2' ' HA ' ' A' ' 559' ' ' LYS . 0.9 OUTLIER -80.31 -17.83 50.96 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.534 0.521 . . . . 0.0 111.491 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -12.71 60.11 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 165.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 79.09 21.5 67.68 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.107 -0.951 . . . . 0.0 115.144 164.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -91.21 -13.16 33.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.058 0.429 . . . . 0.0 111.109 -176.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -155.29 158.7 39.19 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.5 116.81 46.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.114 1.366 . . . . 0.0 107.693 168.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.404 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.4 tp-100 -89.58 113.64 25.1 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.02 140.48 34.19 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . 0.613 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 21.3 tptm -113.96 129.28 56.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -88.1 100.08 12.68 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -90.94 6.92 42.69 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.14 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.9 t -76.11 161.41 28.87 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.596 0.758 . . . . 0.0 111.066 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.75 -9.55 58.09 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.233 0.613 . . . . 0.0 111.616 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.08 168.41 16.8 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.161 0.584 . . . . 0.0 110.038 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.19 118.42 10.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.484 0.714 . . . . 0.0 109.327 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -94.39 118.78 32.15 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.446 0.698 . . . . 0.0 110.391 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 67.6 p -71.94 116.97 12.97 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.397 0.679 . . . . 0.0 110.273 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.53 177.82 6.0 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 146.05 -67.42 0.41 Allowed Glycine 0 N--CA 1.474 1.2 0 CA-C-O 121.494 0.496 . . . . 0.0 112.743 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -73.23 -9.79 59.08 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.702 -0.749 . . . . 0.0 109.692 167.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -72.05 131.08 42.39 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.97 0.908 . . . . 0.0 109.148 171.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 21.5 ptt-85 -139.93 127.95 22.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.681 0.792 . . . . 0.0 110.375 -173.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . 0.437 ' HB ' ' HH2' ' A' ' 534' ' ' TRP . 10.3 mt -91.23 105.86 16.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.554 ' HE3' HG21 ' A' ' 545' ' ' VAL . 97.8 mttt -76.71 134.2 39.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.661 0.384 . . . . 0.0 110.385 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -118.85 91.4 3.55 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -97.11 102.05 13.75 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.077 0.951 . . . . 0.0 109.052 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.481 HG11 HD23 ' A' ' 488' ' ' LEU . 5.8 t -101.39 147.55 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.098 0.559 . . . . 0.0 110.786 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . 0.481 HD23 HG11 ' A' ' 487' ' ' VAL . 2.3 pt? -60.78 -24.73 66.0 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.544 0.738 . . . . 0.0 111.996 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.91 -27.56 68.9 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.346 1.058 . . . . 0.0 111.898 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 124.18 -26.4 5.83 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.677 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.74 100.29 2.32 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.977 0.894 . . . . 0.0 110.295 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -113.43 97.22 6.33 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.887 -1.052 . . . . 0.0 108.321 175.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 25.4 pt -108.71 178.91 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.547 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -156.3 118.45 4.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.32 0.648 . . . . 0.0 109.473 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -86.72 107.72 18.36 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -85.02 146.72 27.04 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.707 0.765 . . . . 0.0 110.195 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -80.18 173.35 12.68 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.955 1.302 . . . . 0.0 109.917 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 71.8 p -89.42 136.96 29.28 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.429 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 74.6 Cg_exo -52.57 -26.94 30.77 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.175 2.583 . . . . 0.0 114.435 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -79.31 -24.47 42.82 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.731 0.813 . . . . 0.0 112.227 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -66.9 127.78 33.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.232 0.613 . . . . 0.0 109.967 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 45.2 mt -129.81 134.08 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.812 0.845 . . . . 0.0 108.94 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.26 130.9 55.15 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -77.75 155.4 31.22 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.751 0.82 . . . . 0.0 111.553 -170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.97 120.73 13.14 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.723 0.809 . . . . 0.0 110.793 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 88.08 -2.26 85.32 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.575 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -95.98 176.02 6.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.05 0.54 . . . . 0.0 110.173 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -148.01 136.75 21.79 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.756 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 3.4 p -101.78 114.66 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.406 0.682 . . . . 0.0 109.781 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.99 94.95 10.0 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 89.6 t -82.64 104.6 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . 0.513 ' HB2' HG22 ' A' ' 527' ' ' VAL . 37.7 m95 -93.61 176.83 6.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.065 0.946 . . . . 0.0 112.107 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 534' ' ' TRP . . . -98.66 142.07 30.69 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.02 171.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . 0.577 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -66.86 -32.7 74.14 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.191 0.596 . . . . 0.0 111.152 176.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -67.57 -19.59 71.12 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.002 -0.545 . . . . 0.0 113.817 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -66.31 -18.45 65.36 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.153 0.581 . . . . 0.0 110.79 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.17 27.56 72.73 Favored Glycine 0 C--N 1.352 1.454 0 C-N-CA 122.711 0.196 . . . . 0.0 112.878 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.58 149.26 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.436 1.095 . . . . 0.0 110.942 -174.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -68.74 119.55 13.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.279 0.632 . . . . 0.0 110.999 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . 0.44 ' NE2' HD12 ' A' ' 526' ' ' LEU . 15.6 t-160 -76.44 124.69 27.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.439 0.695 . . . . 0.0 110.065 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 58.5 m -152.41 79.35 6.09 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.876 0.87 . . . . 0.0 110.464 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.49 161.05 37.88 Favored 'Trans proline' 0 CA--C 1.565 2.037 0 C-N-CA 122.909 2.406 . . . . 0.0 111.844 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.37 -9.17 43.44 Favored 'Cis proline' 0 C--N 1.382 2.314 0 CA-C-N 120.355 1.162 . . . . 0.0 113.904 1.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.1 m -66.33 -37.15 84.7 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.798 0.839 . . . . 0.0 111.753 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 97.0 m -139.46 89.81 2.36 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.775 0.83 . . . . 0.0 108.946 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 30.5 tp -91.83 138.98 31.11 Favored 'General case' 0 C--O 1.209 -1.078 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 512' ' ' TRP . 96.6 t -125.66 122.7 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.03 0.832 . . . . 0.0 109.15 -175.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -70.17 94.55 0.91 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . 0.577 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 23.0 tptm -71.32 117.62 13.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.428 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 121.44 -36.85 3.14 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.23 127.05 34.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.913 0.485 . . . . 0.0 110.684 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 58.4 p -99.42 -36.23 9.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.852 0.861 . . . . 0.0 110.978 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.438 ' OG ' HG22 ' A' ' 536' ' ' THR . 28.9 t -87.54 -35.51 18.11 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.653 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 51.48 34.51 12.34 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.833 0.853 . . . . 0.0 110.423 -174.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 64.88 64.21 3.69 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.195 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.438 HG22 ' OG ' ' A' ' 533' ' ' SER . 12.4 t -104.7 168.38 9.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.927 0.491 . . . . 0.0 110.673 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 168.0 -162.51 36.29 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.225 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -69.21 -34.64 75.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.208 0.603 . . . . 0.0 111.253 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.7 m -158.59 137.27 11.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.208 1.003 . . . . 0.0 109.021 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.436 ' HB3' HG23 ' A' ' 487' ' ' VAL . 4.7 p90 -149.98 125.38 10.19 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.83 0.824 . . . . 0.0 112.117 -177.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.547 HH21 ' HE2' ' A' ' 554' ' ' MET . 72.7 ttt-85 -77.92 102.04 7.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.722 174.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' THR . . . . . 0.503 ' HB ' HD11 ' A' ' 459' ' ' ILE . 16.3 m -95.86 124.52 39.9 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 46.7 t -125.33 134.92 65.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 C-N-CA 123.696 0.798 . . . . 0.0 109.937 -172.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 26.7 tp -97.69 115.96 28.98 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 166.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.554 HG21 ' HE3' ' A' ' 484' ' ' LYS . 92.3 t -110.06 159.17 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.014 1.326 . . . . 0.0 108.702 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -124.56 -170.35 2.14 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.732 0.413 . . . . 0.0 111.783 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.69 73.97 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.378 1.071 . . . . 0.0 112.948 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.33 -36.64 84.79 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.65 0.78 . . . . 0.0 111.07 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.26 -18.57 27.98 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.646 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.68 160.42 32.25 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.506 0.67 . . . . 0.0 110.59 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -92.71 108.0 19.65 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.186 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.17 -23.73 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.932 0.493 . . . . 0.0 111.494 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -151.63 131.66 13.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.814 0.845 . . . . 0.0 109.065 174.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.547 ' HE2' HH21 ' A' ' 541' ' ' ARG . 12.3 ttm -122.83 108.83 13.44 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -126.76 105.17 8.49 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 66.6 m -84.52 136.62 33.73 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.07 138.91 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.07 137.58 51.99 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.25 1.02 . . . . 0.0 108.695 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.669 ' HA ' ' HB2' ' A' ' 461' ' ' LEU . 55.8 tttm -75.99 77.28 2.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.477 1.111 . . . . 0.0 109.962 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 17.7 m -101.96 -13.52 17.55 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.294 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 47.2 t -86.84 165.63 15.82 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.324 0.649 . . . . 0.0 110.802 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.18 2.78 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 C-N-CA 123.968 0.907 . . . . 0.0 110.693 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 74.2 mtm -66.06 152.0 45.64 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.381 0.673 . . . . 0.0 111.596 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.13 170.87 7.83 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.608 0.763 . . . . 0.0 111.564 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.68 136.76 57.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.758 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 19.1 m120 74.34 -29.39 0.19 Allowed 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.303 1.441 . . . . 0.0 112.717 -178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -58.2 -26.58 62.97 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.185 0.994 . . . . 0.0 111.25 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 5.1 t30 74.01 -75.39 0.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.608 1.163 . . . . 0.0 111.624 165.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.468 0 CA-C-O 118.566 -1.13 . . . . 0.0 111.042 -177.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -59.44 93.44 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.856 0.862 . . . . 0.0 111.548 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 552' ' ' VAL . 27.6 p -106.31 121.28 43.89 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.3 1.04 . . . . 0.0 109.821 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 83.34 14.0 75.15 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-N 115.915 -0.584 . . . . 0.0 114.096 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' SER . . . . . 0.407 ' HB2' ' HH2' ' A' ' 481' ' ' TRP . 23.1 m -70.39 -51.65 28.13 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 117.236 0.518 . . . . 0.0 110.572 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 25.9 t -125.41 134.99 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.06 0.944 . . . . 0.0 108.616 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 20.8 m -115.5 173.05 6.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.129 0.972 . . . . 0.0 110.668 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 52.9 mt -94.7 111.9 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 469' ' ' LYS . 9.5 tp10 -82.63 -63.6 1.34 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.743 0.417 . . . . 0.0 110.968 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 28.9 mt-10 -121.29 151.68 39.78 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 58.9 mt -133.32 130.51 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -78.62 129.18 34.47 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.81 0.694 . . . . 0.0 109.882 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.434 HD13 ' HE3' ' A' ' 559' ' ' LYS . 2.2 pp -76.27 -23.72 54.44 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.247 0.342 . . . . 0.0 111.301 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -68.85 -29.4 67.71 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 167.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 83.8 25.3 46.36 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.498 -0.774 . . . . 0.0 114.032 172.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -82.28 -27.4 32.38 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.377 0.589 . . . . 0.0 111.12 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -146.52 160.03 42.66 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-O 121.458 0.647 . . . . 0.0 112.424 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 95.3 t -130.6 119.72 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 125.177 1.391 . . . . 0.0 107.417 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 4.1 tp-100 -89.19 122.31 32.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.832 0.853 . . . . 0.0 109.771 178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 75.5 mt -102.15 162.23 13.07 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.771 0.829 . . . . 0.0 109.629 171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 1.2 tmtp? -146.75 131.05 17.51 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -86.8 111.26 20.57 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.81 -17.5 47.29 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.032 0.933 . . . . 0.0 112.291 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 81.0 p -70.13 158.15 36.28 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.072 0.463 . . . . 0.0 111.669 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.64 0.67 29.26 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.178 0.991 . . . . 0.0 112.326 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.29 175.62 10.38 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.837 0.855 . . . . 0.0 109.281 -174.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.93 125.98 28.58 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.043 0.537 . . . . 0.0 109.593 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -100.36 131.65 46.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.178 0.991 . . . . 0.0 110.493 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 26.4 p -66.89 124.03 21.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.324 0.65 . . . . 0.0 109.714 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 9.5 tp -119.36 152.77 36.22 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.42 -52.53 0.58 Allowed Glycine 0 N--CA 1.475 1.234 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.837 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -69.75 -14.39 62.76 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.646 0.779 . . . . 0.0 110.639 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.407 ' HH2' ' HB2' ' A' ' 453' ' ' SER . 12.4 m95 -82.85 158.72 22.6 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 125.126 1.371 . . . . 0.0 109.95 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -161.27 131.75 5.12 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.838 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 32.5 mt -87.63 118.76 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.811 0.844 . . . . 0.0 109.742 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.665 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 64.8 mttm -84.81 148.7 26.17 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 166.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 492' ' ' GLU . 34.9 ttm180 -132.77 96.66 3.85 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 163.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -85.5 102.38 13.44 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.546 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 27.3 t -72.2 168.95 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.04 0.936 . . . . 0.0 110.277 -176.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . 0.43 HD22 ' H ' ' A' ' 539' ' ' SER . 3.4 pp -55.55 -25.92 40.5 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.643 1.177 . . . . 0.0 113.609 177.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -85.2 4.15 35.95 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.517 0.675 . . . . 0.0 110.812 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 86.21 -7.41 78.38 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.636 0.636 . . . . 0.0 113.349 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.49 102.63 3.26 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.689 0.796 . . . . 0.0 110.295 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 485' ' ' ARG . 8.7 pt-20 -96.39 111.89 23.83 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.583 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 28.4 pt -91.44 147.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.297 173.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -121.39 108.9 14.23 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.349 0.66 . . . . 0.0 110.707 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -83.07 107.74 15.86 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 166.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -91.58 147.67 22.84 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -93.72 170.46 9.55 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.414 0.686 . . . . 0.0 110.714 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 82.7 p -93.5 130.23 36.03 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.024 0.93 . . . . 0.0 108.985 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.517 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 17.7 Cg_endo -58.72 -18.88 43.23 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.257 2.638 . . . . 0.0 114.884 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -75.9 -24.02 55.58 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.951 0.501 . . . . 0.0 111.189 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -75.5 142.72 42.81 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.361 0.664 . . . . 0.0 110.528 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 61.9 mt -133.39 136.58 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.081 0.952 . . . . 0.0 108.713 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.39 116.72 33.43 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -73.27 162.26 29.57 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.197 0.599 . . . . 0.0 112.108 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -60.63 124.4 20.29 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.234 1.014 . . . . 0.0 112.302 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 74.43 -6.42 23.46 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.58 0.55 . . . . 0.0 114.297 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -81.02 155.1 26.53 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.456 0.702 . . . . 0.0 109.857 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 55.4 mtm -120.42 126.52 50.65 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.248 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.7 112.65 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 2.1 m -92.7 101.94 14.34 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.521 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.42 HG12 ' HE1' ' A' ' 534' ' ' TRP . 59.0 t -88.74 98.25 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.015 0.436 . . . . 0.0 109.981 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -86.05 176.64 7.91 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.397 1.079 . . . . 0.0 111.509 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -95.05 164.06 13.04 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.092 0.957 . . . . 0.0 110.726 174.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -64.79 -45.48 86.09 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.429 0.692 . . . . 0.0 111.302 174.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -82.91 5.97 73.0 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.683 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -75.6 -1.05 22.7 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.502 0.721 . . . . 0.0 111.842 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 68.41 31.25 73.82 Favored Glycine 0 C--N 1.356 1.683 0 C-N-CA 123.125 0.393 . . . . 0.0 113.699 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 6.4 p -123.74 135.86 62.06 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 C-N-CA 124.42 1.088 . . . . 0.0 109.968 -172.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -76.95 134.1 39.01 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.292 0.637 . . . . 0.0 110.4 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -64.51 110.89 2.46 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.356 0.663 . . . . 0.0 110.228 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.5 m -126.42 74.22 73.65 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.605 0.762 . . . . 0.0 110.129 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.33 150.91 76.53 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 122.27 1.98 . . . . 0.0 111.435 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -93.23 11.47 53.01 Favored 'Cis proline' 0 C--N 1.376 1.981 0 CA-C-N 119.971 1.025 . . . . 0.0 113.72 -1.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.3 m -82.8 -28.85 29.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.391 0.676 . . . . 0.0 111.833 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 76.7 m -143.58 104.42 4.21 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.727 0.811 . . . . 0.0 109.968 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 66.5 mt -91.35 144.07 25.97 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 169.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 50.3 t -120.85 120.95 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.635 0.774 . . . . 0.0 108.975 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -75.2 96.42 3.3 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.9 tptt -66.7 136.39 55.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.792 0.837 . . . . 0.0 110.335 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 88.67 -4.97 85.07 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 123.479 0.487 . . . . 0.0 113.325 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -112.99 114.06 26.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 34.2 p -73.56 -56.69 4.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.085 0.554 . . . . 0.0 111.942 -172.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.624 ' HB2' HG22 ' A' ' 536' ' ' THR . 86.6 p -114.45 9.72 16.83 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.267 0.627 . . . . 0.0 112.215 -169.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.42 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 59.44 23.87 12.47 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 124.422 1.089 . . . . 0.0 110.545 -174.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.87 71.12 0.9 Allowed Glycine 0 C--N 1.35 1.34 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.624 HG22 ' HB2' ' A' ' 533' ' ' SER . 17.3 p -59.67 129.93 44.33 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.449 0.7 . . . . 0.0 111.949 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -137.0 154.93 22.47 Favored Glycine 0 C--O 1.238 0.371 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 170.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.14 -60.58 2.17 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 558' ' ' LYS . 7.3 m -107.16 125.1 50.65 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.086 0.954 . . . . 0.0 109.026 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.546 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 5.6 p90 -151.28 145.1 25.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.649 0.738 . . . . 0.0 111.883 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.422 HH11 ' HE1' ' A' ' 554' ' ' MET . 4.3 tmm_? -96.91 102.08 13.78 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.763 1.225 . . . . 0.0 108.468 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 47.7 m -86.44 140.21 30.19 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.452 0.701 . . . . 0.0 109.202 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 40.0 t -133.8 146.2 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.484 1.114 . . . . 0.0 109.619 -175.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 38.6 tp -113.61 133.09 55.48 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 163.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.569 HG23 ' HE2' ' A' ' 484' ' ' LYS . 85.4 t -124.26 156.24 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.605 1.162 . . . . 0.0 108.369 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . 0.561 HD22 ' HG3' ' A' ' 550' ' ' GLU . 6.4 p30 -119.58 -170.23 1.9 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.398 0.679 . . . . 0.0 111.814 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.61 64.09 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.156 1.382 . . . . 0.0 113.755 -174.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . 0.577 ' HB3' ' HG2' ' A' ' 550' ' ' GLU . 16.8 t70 -67.31 -37.81 83.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.403 0.681 . . . . 0.0 112.1 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.76 -15.97 28.73 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.078 -173.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . 0.577 ' HG2' ' HB3' ' A' ' 548' ' ' ASP . 9.9 pt-20 -62.64 137.68 58.32 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.633 0.773 . . . . 0.0 110.325 172.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -81.47 87.72 6.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.807 0.843 . . . . 0.0 109.543 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.459 ' HB ' ' ND2' ' A' ' 546' ' ' ASN . 7.6 p -64.02 -35.8 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.694 -170.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -133.37 150.75 51.81 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.518 0.727 . . . . 0.0 109.054 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.422 ' HE1' HH11 ' A' ' 541' ' ' ARG . 51.6 ttm -161.56 121.68 2.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.466 0.706 . . . . 0.0 109.629 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.71 118.74 13.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.29 0.636 . . . . 0.0 109.315 175.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 28.2 m -86.21 140.43 30.15 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.976 0.911 . . . . 0.0 109.276 174.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.42 131.18 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.66 0.784 . . . . 0.0 109.124 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 0.0 OUTLIER -122.15 125.52 46.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.651 0.78 . . . . 0.0 109.034 175.213 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.434 ' HE3' HD13 ' A' ' 461' ' ' LEU . 86.9 tttt -73.91 104.64 4.85 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.786 1.234 . . . . 0.0 110.052 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 36.0 t -69.75 -42.85 73.37 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.307 0.643 . . . . 0.0 109.391 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 32.3 t -161.65 175.27 12.21 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.836 0.854 . . . . 0.0 110.152 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.77 69.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 122.997 1.38 . . . . 0.0 109.463 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 12.9 ptp -157.82 112.5 2.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.366 -1.743 . . . . 0.0 108.593 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -76.01 134.89 40.01 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.207 0.527 . . . . 0.0 110.402 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.24 161.14 13.94 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.117 172.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -62.82 -39.81 95.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.52 0.328 . . . . 0.0 111.075 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 56.73 -80.16 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.676 1.59 . . . . 0.0 111.921 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -121.64 123.32 41.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.615 1.166 . . . . 0.0 108.042 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.354 179.229 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -63.11 86.59 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.424 0.69 . . . . 0.0 110.302 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 36.3 p -80.27 123.06 27.64 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.831 0.852 . . . . 0.0 110.611 -176.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 100.39 -8.09 58.52 Favored Glycine 0 N--CA 1.468 0.821 0 O-C-N 123.456 0.472 . . . . 0.0 112.696 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 47.2 m -66.57 -69.69 0.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.714 0.806 . . . . 0.0 110.926 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 15.8 t -92.63 103.19 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.6 m -97.92 143.87 28.06 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.963 0.905 . . . . 0.0 110.647 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 28.7 mt -78.16 96.33 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -78.4 -69.66 0.54 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -120.48 154.11 35.7 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.528 ' HB ' HG23 ' A' ' 557' ' ' VAL . 70.4 mt -146.73 143.13 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 168.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . 0.4 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 31.1 t70 -60.63 151.87 27.9 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.47 0.708 . . . . 0.0 110.801 174.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.2 pp -55.54 -29.82 59.62 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.789 1.236 . . . . 0.0 113.771 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -118.58 10.37 12.53 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.388 1.075 . . . . 0.0 111.252 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.19 42.7 90.98 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.901 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -78.69 -7.12 57.39 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.4 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 36.1 p90 -157.85 147.07 19.66 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 124.419 1.088 . . . . 0.0 109.956 170.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 76.1 t -120.36 122.96 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' A' ' 508' ' ' MET . 0.1 OUTLIER -103.92 114.13 28.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.122 1.369 . . . . 0.0 108.603 -174.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 65.4 mt -107.68 161.73 14.61 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.08 1.352 . . . . 0.0 109.91 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -150.13 132.51 15.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.961 0.504 . . . . 0.0 109.754 -176.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -85.35 131.92 34.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.281 0.632 . . . . 0.0 110.686 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -112.25 -0.14 15.58 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.016 1.327 . . . . 0.0 110.775 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 49.1 m -63.9 147.61 51.5 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.794 0.438 . . . . 0.0 110.654 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -69.62 -11.15 60.61 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.033 0.933 . . . . 0.0 111.778 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.421 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.2 OUTLIER -134.69 176.23 8.83 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 125.272 1.429 . . . . 0.0 108.82 -177.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.69 114.8 5.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.526 0.73 . . . . 0.0 109.508 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -74.87 108.34 7.54 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.657 0.783 . . . . 0.0 110.0 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.406 ' HA ' HG12 ' A' ' 502' ' ' ILE . 29.1 p -63.78 104.88 0.73 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 7.6 tp -93.81 -176.59 4.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.89 0.876 . . . . 0.0 109.208 -173.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 134.3 -66.5 0.57 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 112.549 -0.221 . . . . 0.0 112.549 172.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . 0.439 ' N ' HD21 ' A' ' 480' ' ' ASN . 0.8 OUTLIER -67.92 -11.63 59.13 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.372 0.669 . . . . 0.0 111.679 -179.308 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -67.59 141.79 56.68 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.971 0.908 . . . . 0.0 109.387 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -143.31 131.59 22.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.102 0.561 . . . . 0.0 110.701 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 45.0 mt -88.13 110.33 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.024 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.48 ' HE2' HG22 ' A' ' 545' ' ' VAL . 64.7 mttm -82.67 150.42 26.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.442 0.697 . . . . 0.0 109.202 166.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -144.59 104.87 4.09 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -99.16 108.57 21.21 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.431 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 30.0 t -83.61 160.42 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 124.316 1.046 . . . . 0.0 110.796 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 539' ' ' SER . 4.6 pp -51.3 -26.91 8.19 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.947 1.299 . . . . 0.0 113.614 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -77.65 -10.42 59.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.981 0.913 . . . . 0.0 111.42 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 90.78 1.91 72.99 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -79.92 148.18 31.35 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.077 0.951 . . . . 0.0 109.303 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.87 157.01 47.3 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.036 0.446 . . . . 0.0 110.111 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 30.4 pt -136.75 163.82 32.08 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 C-N-CA 124.493 1.117 . . . . 0.0 108.384 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -136.47 105.67 6.01 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.313 0.645 . . . . 0.0 109.673 172.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -81.62 142.38 32.82 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -131.43 144.41 51.16 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -84.38 163.14 19.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.739 0.815 . . . . 0.0 110.802 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 59.5 p -79.68 132.4 61.52 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.886 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.507 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 35.2 Cg_endo -61.1 -16.96 49.3 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.172 2.581 . . . . 0.0 113.533 -175.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -86.57 -20.52 27.82 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.75 0.82 . . . . 0.0 111.855 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -66.04 136.9 56.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.132 0.573 . . . . 0.0 110.153 -177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 477' ' ' SER . 52.0 mt -131.18 121.86 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.836 0.854 . . . . 0.0 108.976 174.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.71 130.91 34.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -81.32 155.14 26.15 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.159 0.583 . . . . 0.0 110.898 -175.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -61.64 117.65 6.06 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.853 0.861 . . . . 0.0 111.177 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 88.51 -22.38 20.8 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.368 0.417 . . . . 0.0 113.612 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -75.79 173.72 10.77 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.402 0.681 . . . . 0.0 111.242 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.424 ' HB3' ' OE1' ' A' ' 467' ' ' GLN . 37.2 mtm -124.62 172.46 9.23 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.482 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.18 127.09 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 5.2 m -121.73 113.84 20.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.045 0.538 . . . . 0.0 109.58 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.85 99.11 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.271 0.628 . . . . 0.0 109.974 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -79.85 176.65 9.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.65 1.18 . . . . 0.0 111.754 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -99.16 156.46 16.95 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.23 1.012 . . . . 0.0 110.633 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -62.26 -36.59 82.51 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.541 0.736 . . . . 0.0 111.207 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -88.48 10.16 72.79 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.515 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -80.91 -17.07 51.81 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.294 0.637 . . . . 0.0 110.729 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 71.48 18.87 77.34 Favored Glycine 0 C--N 1.357 1.737 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.511 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.92 149.58 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.461 1.105 . . . . 0.0 110.458 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -77.63 130.46 36.89 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.604 0.762 . . . . 0.0 110.618 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -67.45 113.08 5.01 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' SER . . . . . 0.407 ' HB2' ' HB ' ' A' ' 525' ' ' THR . 10.9 m -125.41 69.68 61.94 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 123.492 0.717 . . . . 0.0 109.827 -177.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.79 150.72 68.39 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.217 1.945 . . . . 0.0 111.628 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.42 -8.01 49.85 Favored 'Cis proline' 0 C--N 1.371 1.749 0 N-CA-C 114.507 0.926 . . . . 0.0 114.507 3.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.2 m -67.14 -60.53 2.53 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.475 0.71 . . . . 0.0 111.466 -173.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 521' ' ' SER . 90.6 m -105.19 93.58 4.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.93 0.892 . . . . 0.0 109.198 -177.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 73.0 mt -81.71 143.69 31.68 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 82.1 t -126.04 131.16 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -74.93 95.06 2.91 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -65.2 124.48 22.29 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.793 0.837 . . . . 0.0 110.698 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 94.41 -27.27 14.18 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.799 0.687 . . . . 0.0 114.129 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.54 99.28 9.09 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 29.3 p -85.15 -34.07 22.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.126 0.97 . . . . 0.0 113.165 -167.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 536' ' ' THR . 87.1 p -75.47 -28.39 59.22 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.635 0.374 . . . . 0.0 111.3 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 58.77 32.23 22.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.896 1.279 . . . . 0.0 108.917 -169.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 70.36 76.81 0.51 Allowed Glycine 0 C--N 1.358 1.798 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -172.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 533' ' ' SER . 9.6 t -52.23 143.03 15.38 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.408 1.083 . . . . 0.0 113.431 -167.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 158.61 131.74 1.31 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -84.21 -15.78 45.71 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.1 0.56 . . . . 0.0 111.216 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' SER . . . . . 0.505 ' HB2' HD22 ' A' ' 488' ' ' LEU . 17.9 m -137.71 132.48 32.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.237 0.615 . . . . 0.0 109.772 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.431 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 30.8 p90 -168.19 176.7 5.85 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.699 1.2 . . . . 0.0 110.308 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.91 114.59 16.67 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.191 0.997 . . . . 0.0 108.82 169.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 83.6 m -86.61 125.42 33.81 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.075 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.521 HG23 ' HG3' ' A' ' 554' ' ' MET . 43.8 t -115.44 117.83 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.14 0.976 . . . . 0.0 108.679 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 553' ' ' ALA . 24.9 tp -88.63 132.28 34.62 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.48 HG22 ' HE2' ' A' ' 484' ' ' LYS . 50.9 t -115.51 142.99 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 124.838 1.255 . . . . 0.0 108.122 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . 0.464 ' ND2' ' HG2' ' A' ' 550' ' ' GLU . 0.2 OUTLIER -96.99 -167.24 1.51 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.877 0.471 . . . . 0.0 111.338 -179.396 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.04 -37.03 83.4 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -75.4 -0.98 21.8 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.31 15.85 80.39 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 123.258 0.348 . . . . 0.0 113.67 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . 0.464 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 5.7 pt-20 -97.45 149.75 21.81 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.281 0.632 . . . . 0.0 109.298 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.78 90.21 3.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.165 0.986 . . . . 0.0 109.296 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.15 -32.99 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.431 -173.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 544' ' ' LEU . . . -142.66 157.63 44.49 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.459 0.703 . . . . 0.0 110.245 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.521 ' HG3' HG23 ' A' ' 543' ' ' VAL . 26.1 ttt -157.44 146.4 19.77 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.98 0.912 . . . . 0.0 109.334 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -159.83 117.88 2.69 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.701 0.401 . . . . 0.0 110.956 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 87.4 m -88.73 116.51 27.05 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.611 0.764 . . . . 0.0 110.359 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.528 HG23 ' HB ' ' A' ' 459' ' ' ILE . 81.1 t -102.37 131.91 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.523 1.129 . . . . 0.0 109.628 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . 0.44 ' HD2' ' HB3' ' A' ' 539' ' ' SER . 13.3 mmmm -131.28 117.84 19.54 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.015 1.326 . . . . 0.0 107.868 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -67.36 96.42 0.5 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.55 0.613 . . . . 0.0 109.423 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 19.1 m -114.55 86.47 2.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 51.8 p -147.31 124.04 11.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.319 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 10.4 p -78.68 -8.89 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.362 0.665 . . . . 0.0 110.311 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 65.7 mtt -52.33 126.24 18.49 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 124.184 0.994 . . . . 0.0 110.635 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -67.27 159.24 29.62 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 124.053 0.845 . . . . 0.0 110.368 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.11 97.45 0.09 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.413 0.625 . . . . 0.0 112.12 -174.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -121.89 75.33 1.2 Allowed 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -47.16 -57.23 5.35 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.664 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 56.37 83.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.471 1.108 . . . . 0.0 110.742 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.962 0 CA-C-O 119.091 -0.838 . . . . 0.0 111.914 -179.408 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 N--CA 1.476 0.844 0 CA-C-O 120.528 0.204 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -65.08 89.33 0.08 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.83 0.852 . . . . 0.0 110.462 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 44.5 m -78.23 81.0 4.62 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.266 1.027 . . . . 0.0 111.265 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . 0.425 ' H ' ' HB ' ' A' ' 552' ' ' VAL . . . 73.4 27.68 67.35 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.712 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 53.5 m -56.75 -48.61 77.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.425 0.69 . . . . 0.0 110.581 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . 0.493 HG22 HD22 ' A' ' 478' ' ' LEU . 17.9 t -93.24 107.77 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 165.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 80.6 p -88.54 160.59 17.39 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.336 0.654 . . . . 0.0 110.006 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . 0.421 HG13 ' HB1' ' A' ' 553' ' ' ALA . 48.5 mt -81.53 96.3 3.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 170.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.631 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 14.6 tp10 -68.41 -55.91 10.3 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.494 -171.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.631 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.0 mt-10 -142.0 154.03 44.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.904 0.882 . . . . 0.0 108.896 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.558 ' HB ' HG23 ' A' ' 557' ' ' VAL . 56.2 mt -136.0 135.28 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.62 141.4 57.82 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 123.358 0.411 . . . . 0.0 110.131 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.82 -39.41 94.23 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.665 0.603 . . . . 0.0 110.895 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 559' ' ' LYS . 27.9 mt-10 -74.71 -33.47 62.42 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.33 33.35 6.89 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.064 -0.971 . . . . 0.0 113.109 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -84.19 -15.52 46.69 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.173 0.589 . . . . 0.0 110.46 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -157.89 161.05 38.24 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 123.236 0.614 . . . . 0.0 110.773 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . 0.422 HG21 ' HD2' ' A' ' 485' ' ' ARG . 89.2 t -133.6 121.28 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.674 1.19 . . . . 0.0 108.356 174.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 23.0 tp60 -92.37 119.76 32.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.087 0.955 . . . . 0.0 109.718 174.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 69.1 mt -108.85 153.18 23.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.146 0.979 . . . . 0.0 108.716 169.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -147.5 144.52 28.61 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.843 0.457 . . . . 0.0 111.115 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.52 ' HB2' HD11 ' A' ' 503' ' ' LEU . 52.7 t30 -89.53 126.9 35.78 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 174.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.46 ' N ' HD21 ' A' ' 471' ' ' ASN . 0.7 OUTLIER -99.01 -17.72 18.14 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.912 0.885 . . . . 0.0 110.097 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' SER . . . . . 0.521 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 28.8 m -79.29 155.96 28.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.968 0.907 . . . . 0.0 112.49 -173.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.1 -37.42 66.73 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.755 0.822 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.521 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.1 OUTLIER -78.7 148.37 33.11 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.098 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.81 140.72 56.63 Favored 'General case' 0 C--O 1.244 0.767 0 O-C-N 123.776 0.673 . . . . 0.0 109.392 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.424 ' HG3' HG23 ' A' ' 454' ' ' VAL . 0.0 OUTLIER -112.18 111.44 22.33 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 39.9 m -75.98 122.98 24.99 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.613 0.765 . . . . 0.0 110.624 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.493 HD22 HG22 ' A' ' 454' ' ' VAL . 95.6 mt -98.02 167.03 11.15 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.495 0.718 . . . . 0.0 109.932 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 143.48 -53.27 0.6 Allowed Glycine 0 N--CA 1.466 0.691 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . 0.457 ' N ' HD21 ' A' ' 480' ' ' ASN . 0.7 OUTLIER -81.32 -12.19 59.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.324 1.049 . . . . 0.0 110.239 175.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -83.84 139.83 32.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.663 0.785 . . . . 0.0 109.762 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -130.5 145.53 51.87 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.603 0.761 . . . . 0.0 110.576 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 34.8 mt -106.7 95.19 3.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -78.66 129.65 34.97 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 124.052 0.941 . . . . 0.0 109.172 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . 0.422 ' HD2' HG21 ' A' ' 466' ' ' VAL . 74.4 mtp85 -135.04 93.35 2.99 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -94.09 102.73 14.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.944 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.511 HG13 HD22 ' A' ' 488' ' ' LEU . 39.2 t -76.34 151.58 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.032 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . 0.511 HD22 HG13 ' A' ' 487' ' ' VAL . 2.5 pt? -59.5 -20.42 55.23 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.424 0.69 . . . . 0.0 112.743 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -73.17 -11.49 60.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.616 1.167 . . . . 0.0 112.69 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 109.31 -16.83 31.96 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-N 116.352 -0.385 . . . . 0.0 112.916 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.57 103.07 0.79 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.753 0.821 . . . . 0.0 111.448 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -107.17 119.94 40.75 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.425 HG22 ' NE2' ' A' ' 531' ' ' GLN . 31.6 pt -130.92 146.4 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.743 0.817 . . . . 0.0 109.601 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -129.35 109.01 10.75 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.89 0.476 . . . . 0.0 110.066 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -79.83 103.18 9.55 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . 0.431 ' HD3' ' H ' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -85.05 134.11 34.22 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.161 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -72.73 164.44 26.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.196 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.3 p -80.19 135.68 54.2 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.436 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 54.1 Cg_endo -66.81 -9.69 25.59 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.668 2.246 . . . . 0.0 113.799 -174.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -92.44 -9.66 40.75 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.404 0.681 . . . . 0.0 111.629 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -87.92 119.11 27.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.778 0.431 . . . . 0.0 109.895 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 40.3 mt -108.02 129.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 470' ' ' ASN . 0.9 OUTLIER -84.87 117.06 23.67 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.195 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -76.03 148.79 37.77 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.309 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.75 118.24 9.33 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.385 0.674 . . . . 0.0 110.685 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 103.35 -23.34 33.43 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.287 0.367 . . . . 0.0 112.552 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -88.02 -178.76 6.06 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.637 0.775 . . . . 0.0 111.368 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -157.57 146.28 19.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.808 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . 0.401 HG23 HD11 ' A' ' 526' ' ' LEU . 7.2 p -109.6 127.89 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.848 0.859 . . . . 0.0 109.342 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 2.7 m -111.47 105.88 14.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 47.7 t -93.19 112.26 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . 0.488 ' HB2' HG23 ' A' ' 527' ' ' VAL . 46.9 m95 -98.41 173.46 6.95 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.041 0.936 . . . . 0.0 111.522 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 516' ' ' ALA . . . -84.07 148.5 26.8 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.452 172.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.7 86.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.486 0.66 . . . . 0.0 110.316 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -88.56 14.3 60.13 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.879 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 513' ' ' ALA . . . -84.78 -11.46 55.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.449 0.7 . . . . 0.0 111.47 176.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.69 23.23 77.96 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.109 0.403 . . . . 0.0 114.109 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 11.5 p -98.45 149.82 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.3 1.04 . . . . 0.0 109.98 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.23 122.21 26.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.09 0.556 . . . . 0.0 110.41 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -65.31 110.12 2.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.067 0.547 . . . . 0.0 109.778 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 17.3 m -132.99 78.01 66.68 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.363 0.665 . . . . 0.0 110.626 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.46 154.9 50.38 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.749 2.299 . . . . 0.0 112.834 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -92.06 4.19 63.3 Favored 'Cis proline' 0 C--N 1.376 2.021 0 CA-C-N 119.841 0.979 . . . . 0.0 113.517 3.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.0 m -84.96 -58.17 2.8 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.781 0.432 . . . . 0.0 110.497 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 38.9 m -97.53 89.56 4.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.062 0.545 . . . . 0.0 109.872 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 10.8 mp -86.17 138.64 31.75 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' A' ' 512' ' ' TRP . 86.9 t -125.54 128.56 72.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -72.96 88.97 1.39 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -64.04 112.41 2.96 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.508 -1.223 . . . . 0.0 108.702 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 122.89 -38.29 2.56 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 123.458 0.474 . . . . 0.0 112.411 -173.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . 0.425 ' NE2' HG22 ' A' ' 493' ' ' ILE . 28.5 tp60 -86.49 96.61 10.11 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 13.8 p -63.53 -52.53 60.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.198 0.999 . . . . 0.0 112.199 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 536' ' ' THR . 96.0 p -88.78 -30.66 18.85 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 122.839 0.456 . . . . 0.0 111.927 -176.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 6.3 t-105 56.57 34.94 25.28 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.402 1.096 . . . . 0.0 110.3 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 69.53 51.6 25.25 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.996 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 533' ' ' SER . 15.9 p -74.65 123.44 24.87 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 170.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -156.35 179.95 31.83 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.485 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -77.14 -38.71 51.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.407 0.622 . . . . 0.0 109.508 176.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 19.3 m -147.92 125.85 12.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.562 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -146.29 144.78 30.06 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.777 0.831 . . . . 0.0 109.855 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 41.2 ttm180 -107.37 116.78 32.54 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.79 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 59.0 m -94.04 121.93 36.03 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.538 HG22 ' HG3' ' A' ' 554' ' ' MET . 59.9 t -124.53 117.93 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.332 1.053 . . . . 0.0 108.837 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 553' ' ' ALA . 40.3 tp -89.52 111.59 22.54 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 51.6 t -102.02 149.78 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.207 1.003 . . . . 0.0 109.114 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . 0.498 HD22 ' HG2' ' A' ' 550' ' ' GLU . 1.1 p30 -111.75 -172.59 2.07 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.969 0.507 . . . . 0.0 111.737 -172.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.6 73.01 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.884 1.274 . . . . 0.0 113.15 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . 0.419 ' HB3' HD22 ' A' ' 546' ' ' ASN . 12.5 t70 -59.8 -40.61 88.91 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.583 0.753 . . . . 0.0 111.127 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.24 -17.76 26.27 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.436 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . 0.498 ' HG2' HD22 ' A' ' 546' ' ' ASN . 14.0 pt-20 -69.16 148.21 50.25 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.101 0.477 . . . . 0.0 110.665 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.99 99.97 9.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.077 0.951 . . . . 0.0 108.775 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.425 ' HB ' ' H ' ' A' ' 452' ' ' GLY . 27.1 m -85.11 -19.86 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.054 0.542 . . . . 0.0 112.284 -172.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.59 ' HB2' ' HB3' ' A' ' 544' ' ' LEU . . . -147.65 139.76 24.29 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.538 ' HG3' HG22 ' A' ' 543' ' ' VAL . 44.5 ttm -151.12 132.36 14.49 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.628 0.771 . . . . 0.0 109.252 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -157.78 117.62 3.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.264 0.626 . . . . 0.0 109.627 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 8.8 m -103.47 112.34 25.2 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.74 0.816 . . . . 0.0 109.435 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.558 HG23 ' HB ' ' A' ' 459' ' ' ILE . 58.1 t -105.64 122.12 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.503 0.721 . . . . 0.0 110.65 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.97 117.75 35.29 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.467 ' HD3' ' HA ' ' A' ' 462' ' ' GLU . 25.8 ttpp -60.68 94.05 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.132 0.973 . . . . 0.0 110.565 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 42.7 t -84.57 -72.45 0.47 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.513 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 21.0 p -163.84 172.87 13.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.5 0.72 . . . . 0.0 111.042 -170.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.61 24.77 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.091 0.956 . . . . 0.0 110.97 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 63.3 mtm -64.2 -22.77 67.07 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.52 0.728 . . . . 0.0 112.085 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -118.02 159.7 22.75 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.858 0.863 . . . . 0.0 109.493 174.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 69.74 65.95 0.24 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.954 1.301 . . . . 0.0 111.229 168.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -70.4 96.39 1.14 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.351 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.47 -9.51 27.06 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.312 0.645 . . . . 0.0 112.107 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.72 -34.21 30.67 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.935 0.494 . . . . 0.0 110.149 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.147 0 CA-C-O 119.042 -0.865 . . . . 0.0 111.887 176.594 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -141.84 78.01 1.61 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.491 0.716 . . . . 0.0 109.24 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 26.9 p -81.14 84.94 6.41 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.531 -175.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.36 29.4 12.41 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.056 -0.974 . . . . 0.0 113.631 172.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 28.1 m -68.58 -38.76 80.94 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.785 0.326 . . . . 0.0 110.182 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.77 145.05 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.452 1.101 . . . . 0.0 108.208 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 43.9 t -130.55 150.35 51.8 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.378 1.071 . . . . 0.0 109.988 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 38.3 mt -84.71 108.86 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -80.71 -72.16 0.43 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.807 0.337 . . . . 0.0 110.824 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -119.25 149.86 41.06 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.993 0.517 . . . . 0.0 109.688 -169.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.45 ' HB ' HG23 ' A' ' 557' ' ' VAL . 80.6 mt -144.56 138.13 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 170.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . 0.407 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 20.1 t70 -59.91 142.04 54.39 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 123.488 0.493 . . . . 0.0 110.74 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 462' ' ' GLU . 2.3 pp -66.71 -35.16 79.48 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.074 0.859 . . . . 0.0 111.432 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.505 ' HG3' HD11 ' A' ' 461' ' ' LEU . 29.0 mt-10 -75.37 -33.22 61.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.31 0.576 . . . . 0.0 109.687 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.84 52.0 1.86 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.422 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -96.19 -18.43 20.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.254 0.622 . . . . 0.0 111.194 175.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.407 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 32.0 p90 -150.85 161.1 43.33 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.067 0.461 . . . . 0.0 112.007 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 49.6 t -126.85 141.24 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.314 1.445 . . . . 0.0 107.493 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.72 104.61 9.72 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.425 HD21 HD21 ' A' ' 544' ' ' LEU . 57.8 mt -94.82 162.02 13.93 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.815 1.246 . . . . 0.0 110.204 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -144.28 130.14 19.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.484 ' HB2' HD13 ' A' ' 503' ' ' LEU . 46.9 t30 -78.29 107.58 11.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.118 0.567 . . . . 0.0 109.951 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -81.29 -5.71 58.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.646 0.779 . . . . 0.0 112.332 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 15.0 m -74.7 137.43 42.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.116 0.566 . . . . 0.0 110.715 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.61 -13.6 61.82 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.23 1.012 . . . . 0.0 110.998 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.0 OUTLIER -110.39 170.57 8.0 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.856 1.262 . . . . 0.0 108.457 172.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.9 145.03 50.43 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -107.88 118.24 36.22 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 41.2 p -71.6 118.27 14.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 171.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.3 mt -98.78 169.58 9.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 128.78 -56.51 0.74 Allowed Glycine 0 CA--C 1.492 -1.406 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -74.14 -13.16 60.78 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.886 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -82.16 149.49 27.92 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.566 1.147 . . . . 0.0 110.288 170.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -149.56 145.45 26.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.62 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 10.2 mt -107.25 106.19 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 62.1 mttm -75.87 159.79 30.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.112 0.565 . . . . 0.0 109.832 175.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 542' ' ' THR . 42.8 ttm180 -152.92 100.2 2.48 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -88.58 102.45 14.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.098 0.959 . . . . 0.0 108.575 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.21 127.8 40.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 539' ' ' SER . 4.5 pp -65.79 -16.39 63.76 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.539 0.736 . . . . 0.0 112.468 -176.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -73.59 -0.45 15.32 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.866 0.867 . . . . 0.0 111.761 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 106.15 27.45 5.61 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 166.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -132.06 101.12 5.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.168 0.587 . . . . 0.0 110.207 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -106.34 121.96 45.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.89 179.57 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.149 0.98 . . . . 0.0 110.18 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -161.32 118.06 2.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.8 0.84 . . . . 0.0 110.064 172.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -79.18 117.48 20.24 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.548 0.739 . . . . 0.0 109.324 172.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.01 141.71 31.88 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -84.63 169.13 14.66 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 166.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.6 p -91.7 130.2 39.76 Favored Pre-proline 0 CA--C 1.556 1.186 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.508 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 32.4 Cg_exo -60.3 -20.42 62.55 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.249 2.633 . . . . 0.0 114.023 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -72.61 -22.35 60.98 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.66 0.784 . . . . 0.0 111.855 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -83.81 123.78 30.25 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.717 0.807 . . . . 0.0 110.447 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 54.1 mt -116.41 132.92 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 168.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . 0.484 HD13 ' HB2' ' A' ' 470' ' ' ASN . 2.4 tm? -93.96 138.32 32.2 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.55 161.88 29.32 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -57.99 120.07 7.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.925 1.29 . . . . 0.0 112.428 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 66.87 14.74 63.64 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -97.16 -163.56 1.06 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.236 0.614 . . . . 0.0 109.851 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 19.3 ptp -146.06 164.08 33.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.783 0.833 . . . . 0.0 110.835 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.0 p -143.93 124.68 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.099 0.96 . . . . 0.0 109.152 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 4.0 m -114.51 110.05 19.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.827 0.851 . . . . 0.0 109.591 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 41.0 t -96.71 102.07 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.266 0.626 . . . . 0.0 109.861 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -83.69 175.25 9.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.622 1.169 . . . . 0.0 111.457 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -97.05 158.48 15.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.985 0.914 . . . . 0.0 110.195 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -65.05 -25.23 67.74 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.211 0.604 . . . . 0.0 111.865 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . 0.4 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -111.45 21.12 22.17 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.755 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -79.97 -1.0 37.59 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.25 0.62 . . . . 0.0 110.814 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 74.4 38.22 45.72 Favored Glycine 0 C--N 1.358 1.8 0 O-C-N 123.285 0.366 . . . . 0.0 112.379 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.78 148.48 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.135 0.974 . . . . 0.0 110.149 -171.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -91.66 160.45 15.36 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.606 0.762 . . . . 0.0 110.139 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -79.99 122.86 27.25 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 39.0 m -133.18 80.68 58.56 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.692 0.797 . . . . 0.0 109.111 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.94 154.37 58.16 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.739 2.293 . . . . 0.0 112.48 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.54 -18.38 24.04 Favored 'Cis proline' 0 C--N 1.378 2.119 0 C-N-CA 124.787 -0.922 . . . . 0.0 113.741 1.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.2 m -64.98 -52.36 56.65 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.573 0.749 . . . . 0.0 111.708 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 32.6 m -104.01 91.09 3.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 55.6 mt -83.15 148.31 27.55 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.4 127.81 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.417 0.687 . . . . 0.0 109.23 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -70.76 88.07 0.71 Allowed 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -71.93 131.47 43.01 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.714 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 107.51 -36.49 4.35 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.281 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.17 112.05 23.12 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.275 0.559 . . . . 0.0 110.703 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 22.6 p -85.39 -21.61 28.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.677 1.191 . . . . 0.0 112.702 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.5 t -87.48 -32.95 19.19 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -170.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 53.35 22.84 2.97 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 124.056 0.942 . . . . 0.0 110.932 -168.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.79 60.98 6.61 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -171.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 15.1 t -64.76 149.79 48.61 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.568 0.747 . . . . 0.0 110.25 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -163.12 162.15 34.51 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 116.405 -0.361 . . . . 0.0 112.22 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -76.13 -34.96 59.45 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.975 0.91 . . . . 0.0 109.167 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' SER . . . . . 0.411 ' HB2' HD23 ' A' ' 488' ' ' LEU . 50.5 m -150.04 142.26 24.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.674 1.19 . . . . 0.0 108.71 170.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -164.22 -179.8 6.36 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.482 1.113 . . . . 0.0 109.631 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -140.0 125.71 19.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.497 0.665 . . . . 0.0 110.078 170.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 485' ' ' ARG . 24.1 m -101.87 120.86 41.05 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.765 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 57.4 t -103.62 148.39 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.32 1.048 . . . . 0.0 109.365 -177.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.548 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 43.7 tp -110.42 136.19 49.96 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.34 150.02 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.735 1.214 . . . . 0.0 108.348 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -116.99 -170.94 1.93 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.864 0.866 . . . . 0.0 112.134 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -61.3 -26.34 67.72 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.072 0.949 . . . . 0.0 112.91 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.67 -37.49 84.89 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.086 0.554 . . . . 0.0 110.842 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 100.07 5.03 55.14 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.189 -172.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -88.06 149.54 23.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.309 0.643 . . . . 0.0 110.012 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.03 95.32 6.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.596 0.758 . . . . 0.0 108.96 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.75 -28.91 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.771 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -149.99 160.9 43.26 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.618 0.367 . . . . 0.0 110.639 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 50.6 ttp -158.67 143.44 16.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.792 0.837 . . . . 0.0 109.272 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -142.21 108.66 5.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.029 0.931 . . . . 0.0 109.172 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 42.2 m -82.34 109.48 16.63 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.488 0.715 . . . . 0.0 109.489 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.45 HG23 ' HB ' ' A' ' 459' ' ' ILE . 57.3 t -109.22 132.31 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.222 1.009 . . . . 0.0 110.161 -175.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 558' ' ' LYS . 0.0 OUTLIER -132.67 118.4 19.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.603 1.161 . . . . 0.0 108.627 -177.38 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 461' ' ' LEU . 33.3 tttm -69.56 90.53 0.56 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.861 1.264 . . . . 0.0 109.883 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 29.4 m -111.54 -40.86 4.23 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.963 0.905 . . . . 0.0 109.598 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 40.9 m 63.91 107.11 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.805 1.242 . . . . 0.0 113.333 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.59 -24.5 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.687 0.795 . . . . 0.0 110.804 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -66.87 136.84 56.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.512 0.725 . . . . 0.0 110.436 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -94.23 172.22 8.35 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.258 0.623 . . . . 0.0 110.702 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -79.02 100.11 7.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.841 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -156.38 31.46 0.33 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.01 0.924 . . . . 0.0 109.888 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -81.74 -35.3 29.84 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.808 0.843 . . . . 0.0 111.567 -175.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 63.35 95.23 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.814 1.246 . . . . 0.0 111.199 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.281 0 CA-C-O 118.995 -0.891 . . . . 0.0 112.263 177.937 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -161.66 90.53 0.79 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 26.1 t -75.16 85.89 2.39 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.868 0.867 . . . . 0.0 111.299 -172.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . 0.475 ' HA2' ' HB ' ' A' ' 552' ' ' VAL . . . 74.05 26.51 68.57 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.41 -0.813 . . . . 0.0 114.226 175.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 41.5 m -57.03 -52.58 64.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.125 0.57 . . . . 0.0 110.922 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 43.0 t -99.61 121.56 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 16.9 m -108.78 143.66 37.63 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.306 1.042 . . . . 0.0 109.581 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 55.5 mt -77.43 130.32 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.439 ' HB2' ' HG3' ' A' ' 467' ' ' GLN . 36.1 mm-40 -81.01 -74.19 0.34 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.65 0.262 . . . . 0.0 110.649 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -128.25 155.32 44.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.753 0.821 . . . . 0.0 109.916 -171.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.432 ' HB ' HG11 ' A' ' 557' ' ' VAL . 48.4 mm -131.12 141.57 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.635 0.774 . . . . 0.0 109.0 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.66 153.86 31.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.246 1.018 . . . . 0.0 111.398 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 559' ' ' LYS . 2.2 pt? -109.31 0.31 19.48 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.156 0.582 . . . . 0.0 110.251 166.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -120.83 0.82 10.4 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.137 0.975 . . . . 0.0 112.544 -171.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 73.58 45.87 27.28 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 123.073 0.233 . . . . 0.0 113.597 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -108.31 -50.49 3.03 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.39 0.676 . . . . 0.0 111.295 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -164.59 152.08 11.68 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . 0.403 HG13 HD11 ' A' ' 483' ' ' ILE . 71.1 t -112.15 112.0 38.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.673 1.189 . . . . 0.0 108.692 173.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.439 ' HG3' ' HB2' ' A' ' 457' ' ' GLU . 57.4 tp60 -87.32 102.19 14.27 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 544' ' ' LEU . 81.9 mt -94.95 165.11 12.61 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.432 1.093 . . . . 0.0 110.106 172.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 508' ' ' MET . 50.9 tttm -149.91 137.7 20.12 Favored 'General case' 0 C--O 1.219 -0.522 0 C-N-CA 123.215 0.606 . . . . 0.0 110.207 172.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -88.36 136.61 32.9 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -130.61 9.4 5.05 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.167 0.987 . . . . 0.0 110.133 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 46.5 t -77.87 145.8 36.03 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 123.374 0.669 . . . . 0.0 109.732 170.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -70.2 -25.1 63.26 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.249 1.02 . . . . 0.0 111.648 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -112.95 166.07 11.75 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.016 0.927 . . . . 0.0 110.834 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -70.53 120.44 16.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.422 0.689 . . . . 0.0 109.963 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -87.62 118.85 27.39 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.645 0.778 . . . . 0.0 109.767 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 54.5 p -70.68 101.83 2.15 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.639 0.776 . . . . 0.0 110.375 176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 17.9 tp -91.16 152.69 20.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.712 0.805 . . . . 0.0 109.62 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.08 -58.62 0.51 Allowed Glycine 0 N--CA 1.472 1.049 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.703 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.36 -11.9 61.2 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.288 0.635 . . . . 0.0 111.075 177.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 546' ' ' ASN . 14.1 m95 -75.14 166.03 24.28 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 124.452 1.101 . . . . 0.0 110.927 170.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -160.7 145.81 14.41 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.975 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 49.7 mt -101.42 107.54 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.158 0.583 . . . . 0.0 109.535 176.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.726 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 60.7 mttm -78.13 159.35 28.68 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 170.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 534' ' ' TRP . 36.8 ttm180 -158.08 100.37 1.71 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.05 111.56 23.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.284 0.633 . . . . 0.0 109.712 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.447 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 53.1 t -68.87 157.52 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.0 0.92 . . . . 0.0 109.797 174.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.0 pp -52.15 -28.12 16.86 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.232 1.013 . . . . 0.0 112.256 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -69.39 -33.33 72.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.493 1.117 . . . . 0.0 111.383 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 131.61 -21.24 4.52 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.792 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.32 109.59 2.32 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.36 1.064 . . . . 0.0 111.461 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 485' ' ' ARG . 15.0 pt-20 -107.77 117.3 33.75 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.402 0.62 . . . . 0.0 110.804 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 40.2 pt -105.85 142.46 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.923 0.889 . . . . 0.0 109.367 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -125.25 116.36 21.85 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.903 0.481 . . . . 0.0 110.931 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -78.98 106.35 10.96 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -81.48 121.63 26.52 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -73.26 169.16 17.67 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 120.819 0.342 . . . . 0.0 110.794 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 68.9 p -93.27 120.78 66.43 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 123.054 0.542 . . . . 0.0 110.32 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.523 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 34.6 Cg_exo -60.37 -15.56 36.17 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.934 3.089 . . . . 0.0 115.199 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -72.48 -23.51 61.05 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.542 0.737 . . . . 0.0 111.64 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -89.02 142.79 27.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.495 1.118 . . . . 0.0 110.884 -171.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 62.2 mt -129.43 132.96 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.391 0.676 . . . . 0.0 109.213 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . 0.59 HD21 ' HB ' ' A' ' 509' ' ' VAL . 0.3 OUTLIER -93.85 134.69 35.95 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.026 0.93 . . . . 0.0 109.025 177.482 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -78.16 156.49 29.85 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.131 0.491 . . . . 0.0 111.682 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.04 126.93 29.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.256 1.022 . . . . 0.0 112.031 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 77.97 -12.34 18.06 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.62 0.575 . . . . 0.0 114.395 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -86.71 159.48 19.15 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.661 0.784 . . . . 0.0 110.232 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 23.5 ptt? -108.57 169.69 8.5 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.613 0.765 . . . . 0.0 111.517 -175.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . 0.59 ' HB ' HD21 ' A' ' 503' ' ' LEU . 7.4 p -145.95 148.89 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 4.2 m -131.09 105.46 7.72 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 71.5 t -86.02 98.63 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.055 0.455 . . . . 0.0 110.224 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -82.34 176.41 9.47 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.905 0.882 . . . . 0.0 111.3 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -103.64 152.14 22.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.826 0.851 . . . . 0.0 110.128 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -67.84 -20.06 65.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.874 0.87 . . . . 0.0 112.021 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -103.76 16.63 51.05 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.692 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -90.76 -3.61 57.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.328 0.651 . . . . 0.0 110.713 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.33 33.92 68.71 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 113.995 0.358 . . . . 0.0 113.995 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 12.9 p -130.79 144.25 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 123.412 0.685 . . . . 0.0 110.341 -175.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -81.81 142.9 32.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.57 0.748 . . . . 0.0 111.42 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 526' ' ' LEU . 17.3 t-80 -61.85 109.33 1.21 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.418 0.687 . . . . 0.0 109.827 172.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 17.8 m -132.74 80.49 61.35 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.019 0.928 . . . . 0.0 109.556 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.72 160.85 44.46 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.916 2.41 . . . . 0.0 112.175 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -90.31 16.77 43.79 Favored 'Cis proline' 0 C--N 1.381 2.265 0 CA-C-N 119.652 0.911 . . . . 0.0 113.385 3.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.2 m -97.99 -70.88 0.71 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.739 0.815 . . . . 0.0 109.836 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 20.2 m -85.65 86.28 7.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.182 0.593 . . . . 0.0 110.372 -173.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 11.1 mp -91.66 105.19 17.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 171.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 90.3 t -89.46 117.98 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -69.27 91.74 0.54 Allowed 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . 0.548 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 27.7 tptp -75.07 131.03 40.27 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.399 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 104.31 -5.08 44.71 Favored Glycine 0 N--CA 1.472 1.094 0 O-C-N 123.606 0.566 . . . . 0.0 111.988 -172.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -121.95 109.82 15.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.854 0.862 . . . . 0.0 109.179 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 37.2 p -71.72 -61.72 1.68 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.992 0.517 . . . . 0.0 111.21 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 23.7 m -121.16 25.26 9.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.815 0.446 . . . . 0.0 112.108 -167.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.432 ' HB3' ' NH1' ' A' ' 485' ' ' ARG . 0.0 OUTLIER 51.89 30.93 7.69 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.384 1.074 . . . . 0.0 112.541 171.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.88 68.7 1.56 Allowed Glycine 0 C--N 1.352 1.43 0 N-CA-C 112.371 -0.291 . . . . 0.0 112.371 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 2.7 p -64.4 142.57 58.37 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.504 0.722 . . . . 0.0 112.66 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -162.86 169.57 38.1 Favored Glycine 0 C--O 1.242 0.599 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.244 172.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -70.48 -26.78 63.77 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.336 0.568 . . . . 0.0 110.105 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 80.8 p -155.13 142.52 19.55 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.841 0.857 . . . . 0.0 109.35 172.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.447 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 8.0 p90 -155.5 136.67 13.85 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.684 0.794 . . . . 0.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.609 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 34.6 ptt180 -87.93 111.25 21.25 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 23.1 m -94.03 110.73 22.41 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 21.9 t -102.86 144.93 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.828 1.251 . . . . 0.0 109.606 -174.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.498 HD23 HD23 ' A' ' 468' ' ' LEU . 34.7 tp -112.17 125.47 54.17 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.485 HG23 ' HG2' ' A' ' 551' ' ' GLU . 22.0 t -124.33 160.14 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.135 1.374 . . . . 0.0 108.485 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 481' ' ' TRP . 2.9 p30 -126.35 -174.83 3.21 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.017 0.371 . . . . 0.0 111.577 175.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -50.08 -34.47 21.88 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.432 1.493 . . . . 0.0 113.189 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.64 -33.68 76.5 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.262 1.025 . . . . 0.0 111.929 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 102.97 -12.12 56.02 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.049 -174.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . 0.48 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 13.2 pt-20 -72.79 139.36 47.01 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.21 0.604 . . . . 0.0 109.384 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.485 ' HG2' HG23 ' A' ' 545' ' ' VAL . 38.5 mt-10 -92.0 93.3 8.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.116 0.966 . . . . 0.0 108.994 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . 0.475 ' HB ' ' HA2' ' A' ' 452' ' ' GLY . 18.0 m -71.67 -16.64 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -167.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -159.36 156.28 28.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.067 0.547 . . . . 0.0 110.482 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.577 ' SD ' ' HD2' ' A' ' 541' ' ' ARG . 67.0 ttp -154.94 109.93 3.04 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.25 0.62 . . . . 0.0 110.097 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -104.14 104.19 14.09 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 30.4 m -85.19 99.04 10.83 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.432 HG11 ' HB ' ' A' ' 459' ' ' ILE . 35.1 m -98.96 147.29 7.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 121.621 0.724 . . . . 0.0 110.383 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.48 168.88 9.77 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.08 175.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.436 ' HA ' HD13 ' A' ' 461' ' ' LEU . 38.7 ttpt -75.73 86.2 2.75 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 32.1 t -91.61 -8.38 47.44 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.088 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 43.9 m 60.19 98.92 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.483 1.513 . . . . 0.0 110.963 -172.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.04 74.33 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 122.452 1.12 . . . . 0.0 109.568 -174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.02 121.53 23.65 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.382 168.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.47 -167.04 0.22 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.992 0.917 . . . . 0.0 108.957 -168.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 73.37 -59.17 0.57 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.601 1.161 . . . . 0.0 112.657 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -62.83 102.4 0.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.421 0.688 . . . . 0.0 110.041 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.64 -78.43 0.09 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 62.43 142.11 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.025 1.33 . . . . 0.0 113.085 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.604 -1.109 . . . . 0.0 111.675 178.088 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -75.23 101.72 4.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.285 0.634 . . . . 0.0 110.82 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 18.8 m -81.72 80.66 7.99 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.654 0.74 . . . . 0.0 109.208 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 85.96 -44.62 3.37 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.424 -170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 32.0 p -174.68 -52.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.73 1.212 . . . . 0.0 108.939 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . 0.419 ' HB ' HD21 ' A' ' 544' ' ' LEU . 4.1 t -95.55 163.74 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.357 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 21.1 t -155.69 150.66 26.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.566 0.746 . . . . 0.0 109.671 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . 0.412 ' HA ' HD13 ' A' ' 468' ' ' LEU . 31.7 mt -77.7 102.41 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.286 0.634 . . . . 0.0 109.863 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.469 ' HG2' ' HG3' ' A' ' 458' ' ' GLU . 42.0 tt0 -81.18 -57.49 3.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.353 0.261 . . . . 0.0 111.602 -170.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.469 ' HG3' ' HG2' ' A' ' 457' ' ' GLU . 29.4 mt-10 -137.88 153.36 49.57 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.256 0.622 . . . . 0.0 109.394 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.0 mt -151.84 138.18 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.61 148.84 38.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.45 HD13 ' HG3' ' A' ' 462' ' ' GLU . 3.5 pp -74.38 -16.51 60.89 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -169.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.45 ' HG3' HD13 ' A' ' 461' ' ' LEU . 2.7 mt-10 -82.02 -31.91 30.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.199 0.6 . . . . 0.0 110.427 174.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 86.97 51.63 3.33 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.986 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -97.1 -19.48 18.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.54 0.736 . . . . 0.0 110.867 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -154.35 163.52 40.03 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.935 0.494 . . . . 0.0 111.872 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.37 117.65 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.017 1.327 . . . . 0.0 108.164 170.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.7 tp60 -88.06 113.35 23.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.989 0.916 . . . . 0.0 109.039 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.51 HD22 HD13 ' A' ' 483' ' ' ILE . 22.6 tp -120.21 116.69 26.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.137 0.975 . . . . 0.0 109.495 -172.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . 0.408 ' HG2' ' HB3' ' A' ' 508' ' ' MET . 1.8 tmmm? -114.03 130.52 56.55 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.992 0.36 . . . . 0.0 110.368 -169.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -82.62 115.32 21.52 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.436 0.694 . . . . 0.0 109.84 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -85.49 -15.76 41.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.911 0.884 . . . . 0.0 112.033 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' SER . . . . . 0.529 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 69.8 m -65.57 156.45 32.64 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.57 2.36 33.53 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.832 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.529 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.1 OUTLIER -135.38 168.49 19.1 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.24 1.016 . . . . 0.0 108.822 173.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -73.59 122.05 21.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.428 0.691 . . . . 0.0 109.475 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -83.36 123.02 29.23 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.497 0.719 . . . . 0.0 110.204 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 30.2 p -71.01 106.67 3.76 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.1 mp -91.09 -179.81 5.54 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 0.0 109.97 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 133.28 -67.23 0.56 Allowed Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 480' ' ' ASN . 0.8 OUTLIER -74.64 -11.5 60.2 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.499 177.302 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 33.1 m95 -69.84 145.4 52.11 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -149.47 136.27 19.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.882 0.473 . . . . 0.0 111.123 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . 0.51 HD13 HD22 ' A' ' 468' ' ' LEU . 57.8 mt -97.41 107.28 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.619 0.768 . . . . 0.0 109.472 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.443 ' HE2' HG21 ' A' ' 545' ' ' VAL . 68.0 mttm -78.86 148.17 32.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.363 0.665 . . . . 0.0 110.531 172.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . 0.42 ' NH2' ' HB3' ' A' ' 534' ' ' TRP . 20.6 mtm180 -140.49 123.3 16.38 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -116.98 114.06 23.27 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.417 0.687 . . . . 0.0 109.83 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.44 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 13.4 t -84.72 159.31 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.792 1.237 . . . . 0.0 110.645 -177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.2 -22.87 61.69 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.959 0.904 . . . . 0.0 111.98 173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.57 -22.14 66.13 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.585 1.154 . . . . 0.0 112.407 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 99.86 1.96 56.19 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.339 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.95 122.05 21.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.596 0.758 . . . . 0.0 110.073 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.81 112.56 13.71 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 22.0 pt -132.17 170.09 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.236 1.014 . . . . 0.0 109.629 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -150.22 127.32 11.23 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.893 0.477 . . . . 0.0 110.681 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -80.29 108.98 14.34 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 169.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -84.73 128.3 34.54 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -70.45 169.14 14.67 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.645 0.736 . . . . 0.0 111.327 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 65.9 p -87.36 132.34 41.45 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.871 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.503 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 26.8 Cg_endo -58.78 -21.41 56.58 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.094 2.529 . . . . 0.0 113.302 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -72.31 -25.42 61.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.193 0.597 . . . . 0.0 111.903 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -75.78 126.19 30.52 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 122.825 0.45 . . . . 0.0 110.189 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 41.5 mt -122.55 113.9 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.25 120.14 21.88 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -69.75 160.89 30.85 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.9 119.08 10.67 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.166 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.6 6.09 65.55 Favored Glycine 0 C--N 1.343 0.925 0 O-C-N 123.585 0.553 . . . . 0.0 113.666 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -101.59 177.97 4.77 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.642 0.777 . . . . 0.0 109.677 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.408 ' HB3' ' HG2' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -139.92 162.53 34.96 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.537 0.684 . . . . 0.0 112.039 -175.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . 0.495 HG23 HD11 ' A' ' 526' ' ' LEU . 6.3 p -123.79 117.49 51.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 125.201 1.401 . . . . 0.0 107.926 176.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 7.8 m -96.48 95.02 7.73 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.89 97.42 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.927 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -79.71 171.74 14.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.635 0.774 . . . . 0.0 110.819 171.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.652 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -91.91 165.0 13.45 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.676 0.791 . . . . 0.0 110.109 173.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' A' ' 529' ' ' LYS . . . -63.51 -34.2 77.26 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.102 0.477 . . . . 0.0 110.379 171.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -89.41 20.65 33.0 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.305 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -85.07 -24.43 28.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.315 0.646 . . . . 0.0 110.554 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 71.05 35.76 64.47 Favored Glycine 0 C--N 1.35 1.322 0 O-C-N 123.872 0.733 . . . . 0.0 112.917 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 8.6 p -114.44 143.77 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.014 0.926 . . . . 0.0 110.276 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -72.79 123.23 22.94 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.284 0.634 . . . . 0.0 110.227 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -63.92 110.69 2.19 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.425 0.69 . . . . 0.0 110.473 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.8 m -132.24 72.26 78.84 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.063 0.545 . . . . 0.0 110.909 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.93 159.4 53.09 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.739 2.292 . . . . 0.0 112.352 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.23 0.94 50.48 Favored 'Cis proline' 0 C--N 1.382 2.32 0 CA-C-N 120.141 1.086 . . . . 0.0 114.077 -0.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 32.9 t -74.78 -63.22 1.3 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.415 0.686 . . . . 0.0 111.08 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 27.5 m -104.19 98.58 8.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.108 0.963 . . . . 0.0 110.265 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.495 HD11 HG23 ' A' ' 509' ' ' VAL . 11.2 mp -93.64 146.86 23.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 81.9 t -129.82 117.27 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -73.47 89.34 1.65 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . 0.521 ' HA ' ' HB3' ' A' ' 514' ' ' ALA . 27.3 tptp -75.77 123.27 25.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.386 177.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 120.75 -24.26 7.59 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -173.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -121.5 109.61 15.04 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 32.9 p -82.53 -34.94 27.69 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.853 0.461 . . . . 0.0 111.634 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 536' ' ' THR . 23.6 m -90.28 -29.74 17.95 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.189 0.596 . . . . 0.0 112.167 -174.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.652 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 59.74 22.26 11.08 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 123.224 0.61 . . . . 0.0 109.401 -173.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.99 69.08 1.46 Allowed Glycine 0 C--N 1.345 1.037 0 O-C-N 121.653 -0.654 . . . . 0.0 111.949 -171.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 533' ' ' SER . 8.1 p -71.82 159.92 33.47 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.612 0.765 . . . . 0.0 110.231 172.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 172.72 176.43 41.35 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.404 -0.362 . . . . 0.0 113.038 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -84.07 -26.96 28.62 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.756 0.422 . . . . 0.0 110.073 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 66.9 m -152.24 128.23 10.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.531 1.132 . . . . 0.0 108.743 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.44 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 6.8 p90 -154.48 122.47 5.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.96 0.904 . . . . 0.0 110.091 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.541 ' HD3' ' H ' ' A' ' 541' ' ' ARG . 0.0 OUTLIER -86.27 123.39 31.47 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.423 0.63 . . . . 0.0 109.727 -178.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 39.3 m -94.31 140.17 30.13 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.252 1.021 . . . . 0.0 109.506 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 99.9 t -132.93 130.9 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.482 1.113 . . . . 0.0 109.279 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 53.1 tp -93.96 129.48 40.41 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.443 HG21 ' HE2' ' A' ' 484' ' ' LYS . 81.4 t -118.13 143.73 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.754 1.222 . . . . 0.0 108.226 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . 0.462 HD22 ' HG2' ' A' ' 550' ' ' GLU . 2.0 p30 -103.0 -173.54 2.34 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.514 0.326 . . . . 0.0 111.155 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -64.17 -22.97 67.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.803 0.841 . . . . 0.0 113.234 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -65.24 -39.46 92.72 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.162 0.506 . . . . 0.0 110.453 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.37 -11.26 33.44 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.398 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . 0.462 ' HG2' HD22 ' A' ' 546' ' ' ASN . 16.3 pt-20 -80.39 153.87 28.05 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 117.259 0.53 . . . . 0.0 110.549 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 545' ' ' VAL . 42.0 mt-10 -88.65 104.6 17.01 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.673 1.189 . . . . 0.0 110.171 -174.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.74 -29.47 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.566 0.746 . . . . 0.0 112.813 -170.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -139.12 161.11 38.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.072 0.549 . . . . 0.0 110.137 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.43 ' HG3' HG21 ' A' ' 543' ' ' VAL . 40.7 ttp -159.27 108.25 1.86 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.33 0.652 . . . . 0.0 109.795 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -119.46 123.63 44.52 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.755 0.822 . . . . 0.0 109.207 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 26.7 m -79.12 134.0 36.73 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.54 139.9 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -161.53 146.34 13.33 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 122.916 0.486 . . . . 0.0 111.074 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.569 ' HG3' ' SD ' ' A' ' 563' ' ' MET . 86.2 tttt -53.84 113.28 1.15 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.19 0.996 . . . . 0.0 110.23 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 61.1 m -144.07 67.75 1.27 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.463 0.705 . . . . 0.0 109.488 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 38.3 m 65.23 -175.59 0.18 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.84 1.256 . . . . 0.0 111.399 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 13.0 t 52.31 56.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 124.189 0.995 . . . . 0.0 111.087 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.569 ' SD ' ' HG3' ' A' ' 559' ' ' LYS . 92.4 mmm -79.81 125.89 30.27 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.235 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -78.72 125.26 29.13 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -79.58 79.22 6.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.321 0.582 . . . . 0.0 110.085 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -77.62 -3.04 38.88 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.052 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . 0.418 ' HG3' HD21 ' A' ' 568' ' ' ASN . 10.0 pt-20 -56.23 -31.26 63.35 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.341 1.056 . . . . 0.0 112.518 175.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . 0.418 HD21 ' HG3' ' A' ' 567' ' ' GLU . 50.3 m-80 -140.71 158.59 43.76 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.943 0.897 . . . . 0.0 109.342 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.039 178.629 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -68.97 130.85 43.96 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.443 0.697 . . . . 0.0 111.296 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 49.2 m -122.51 106.61 11.17 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.209 0.604 . . . . 0.0 111.306 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.02 8.86 68.47 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.471 174.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 20.0 m -63.11 -55.22 27.21 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.398 0.679 . . . . 0.0 110.837 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . 0.448 HG23 ' HG2' ' A' ' 476' ' ' GLN . 21.2 t -85.61 129.82 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 171.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 44.0 t -110.51 145.7 37.27 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.129 1.372 . . . . 0.0 109.497 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 50.8 mt -81.93 95.11 2.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.85 -65.14 1.04 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.652 0.381 . . . . 0.0 110.404 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 20.5 mt-10 -116.49 153.13 32.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.1 0.56 . . . . 0.0 110.368 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.484 HG23 HG23 ' A' ' 466' ' ' VAL . 47.8 mt -140.06 142.53 31.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 170.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.76 145.87 51.9 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.307 0.38 . . . . 0.0 110.474 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.589 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.4 pt? -58.93 -41.16 86.68 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.134 0.974 . . . . 0.0 111.886 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.589 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 43.7 mt-10 -91.45 -22.03 20.63 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.159 0.984 . . . . 0.0 110.066 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 83.92 50.82 4.23 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.053 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -87.71 -16.76 33.41 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.06 163.35 40.01 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.031 0.532 . . . . 0.0 111.166 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . 0.484 HG23 HG23 ' A' ' 459' ' ' ILE . 97.2 t -134.9 122.76 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.669 1.188 . . . . 0.0 108.088 168.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . 0.582 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 13.5 tt0 -89.8 111.48 22.51 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.287 0.565 . . . . 0.0 110.103 170.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.85 159.95 18.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.21 165.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . 0.49 ' HG2' ' HB3' ' A' ' 508' ' ' MET . 1.6 tmtp? -152.58 129.01 10.63 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.505 ' HB3' HD11 ' A' ' 503' ' ' LEU . 50.6 t30 -99.07 100.35 11.48 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -76.75 -11.63 59.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.254 0.622 . . . . 0.0 111.511 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 44.9 t -63.73 152.54 38.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.338 1.055 . . . . 0.0 112.847 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -73.11 -12.01 60.75 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.095 1.358 . . . . 0.0 111.296 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -99.01 143.69 29.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.763 0.825 . . . . 0.0 110.893 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.46 102.5 2.68 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.448 ' HG2' HG23 ' A' ' 454' ' ' VAL . 57.2 tp60 -70.29 115.48 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.3 0.64 . . . . 0.0 111.87 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.4 m -64.28 99.71 0.3 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.3 tp -96.49 159.53 14.89 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -175.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 143.83 -65.88 0.46 Allowed Glycine 0 N--CA 1.47 0.95 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.64 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.27 -11.66 59.76 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.698 0.799 . . . . 0.0 111.078 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -75.89 135.0 40.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.832 0.853 . . . . 0.0 108.887 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -128.19 145.61 50.98 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 49.6 mt -106.3 103.93 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.625 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 59.3 mttm -78.89 96.19 5.62 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 19.5 tpp85 -79.53 96.82 6.22 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 168.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -102.05 100.92 11.22 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 15.7 t -94.06 141.9 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.2 pp -65.91 -14.88 62.33 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.52 -8.42 33.68 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.238 0.615 . . . . 0.0 110.847 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 105.95 28.27 5.36 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.504 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -121.38 103.83 9.24 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.178 0.591 . . . . 0.0 110.571 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -107.87 80.96 1.44 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.436 1.112 . . . . 0.0 109.226 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 34.9 pt -95.07 134.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.012 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -108.21 110.71 22.4 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.875 0.47 . . . . 0.0 110.067 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.96 104.38 9.55 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . 0.436 ' HD3' ' H ' ' A' ' 496' ' ' LYS . 0.2 OUTLIER -91.0 129.66 36.98 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -76.79 170.06 17.16 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.995 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.0 p -88.55 124.66 65.45 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.515 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 19.8 Cg_endo -60.16 -10.0 11.75 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.985 2.456 . . . . 0.0 114.871 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -75.17 -24.66 57.93 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.888 0.475 . . . . 0.0 111.273 172.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -82.08 128.06 33.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.599 0.759 . . . . 0.0 110.198 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 59.8 mt -122.46 123.81 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 470' ' ' ASN . 1.0 OUTLIER -90.2 123.79 34.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -74.49 169.32 17.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.89 0.876 . . . . 0.0 112.109 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -70.43 121.43 17.73 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.402 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 76.59 12.46 84.38 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.812 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -104.09 -176.4 3.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.201 0.6 . . . . 0.0 110.773 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.49 ' HB3' ' HG2' ' A' ' 469' ' ' LYS . 1.5 ppp? -141.63 164.64 29.66 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.976 0.91 . . . . 0.0 111.196 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.67 135.03 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.402 1.081 . . . . 0.0 108.295 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 7.2 m -116.69 115.55 25.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.521 HG13 ' HB2' ' A' ' 526' ' ' LEU . 16.0 m -101.54 98.61 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.171 0.988 . . . . 0.0 110.436 -176.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -87.55 172.91 9.4 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.165 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.679 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -92.3 156.47 17.24 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.949 0.9 . . . . 0.0 110.43 175.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -59.9 -28.06 67.26 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.286 0.635 . . . . 0.0 112.125 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -111.45 23.86 17.03 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.291 -0.413 . . . . 0.0 113.479 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -89.17 11.27 19.12 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 69.66 36.95 76.53 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-O 121.343 0.413 . . . . 0.0 112.71 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.56 147.92 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.908 0.883 . . . . 0.0 111.319 -167.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -99.13 130.51 45.45 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.915 0.886 . . . . 0.0 109.588 171.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -65.25 112.6 3.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.4 m -131.5 71.18 81.47 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.355 0.662 . . . . 0.0 109.613 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.81 153.34 78.29 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.868 2.379 . . . . 0.0 112.247 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -80.51 -19.87 21.27 Favored 'Cis proline' 0 C--N 1.38 2.19 0 CA-C-N 119.957 1.02 . . . . 0.0 113.608 0.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.2 m -63.14 -35.91 81.86 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.306 1.043 . . . . 0.0 112.588 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 25.8 m -127.83 91.21 3.24 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.47 0.708 . . . . 0.0 109.415 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.521 ' HB2' HG13 ' A' ' 511' ' ' VAL . 66.7 mt -84.75 148.37 26.39 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 54.5 t -132.06 127.9 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -68.57 87.77 0.33 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -70.14 128.5 36.49 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.769 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 98.09 -21.46 45.94 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.729 -0.669 . . . . 0.0 113.188 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.83 103.85 10.38 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 42.5 p -85.37 -17.56 36.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.372 1.069 . . . . 0.0 113.822 -166.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 46.5 m -96.45 -29.39 13.95 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.679 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 58.44 21.8 8.85 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.187 0.995 . . . . 0.0 110.76 -168.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 66.74 70.65 1.07 Allowed Glycine 0 C--N 1.349 1.29 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 -172.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 14.6 p -63.3 162.07 12.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.614 0.766 . . . . 0.0 112.455 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -176.53 149.58 9.84 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.82 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.66 -21.09 38.35 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' SER . . . . . 0.498 ' HB2' HD21 ' A' ' 488' ' ' LEU . 19.4 m -148.25 132.83 17.75 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.727 0.811 . . . . 0.0 109.672 167.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -160.38 -176.41 5.59 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.028 0.931 . . . . 0.0 110.395 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 11.0 ptp180 -136.7 155.48 49.81 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.786 170.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' THR . . . . . 0.421 ' HB ' HD11 ' A' ' 459' ' ' ILE . 86.4 m -130.97 118.81 21.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 19.6 t -112.63 151.42 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.442 1.097 . . . . 0.0 108.698 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.524 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 39.8 tp -123.94 106.83 10.74 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 6.2 p -96.59 147.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.682 1.193 . . . . 0.0 109.215 175.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -107.44 -171.96 1.98 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.697 0.399 . . . . 0.0 110.334 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.41 66.78 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . 0.552 ' HB2' ' HG2' ' A' ' 550' ' ' GLU . 68.4 m-20 -71.75 -23.74 61.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.085 0.554 . . . . 0.0 111.981 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 93.95 -2.73 69.59 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . 0.552 ' HG2' ' HB2' ' A' ' 548' ' ' ASP . 11.7 pt-20 -89.53 141.37 28.64 Favored 'General case' 0 C--O 1.247 0.966 0 C-N-CA 123.189 0.596 . . . . 0.0 109.696 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -81.76 111.05 17.65 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.588 0.755 . . . . 0.0 109.214 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.05 -22.71 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.595 0.758 . . . . 0.0 112.549 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -146.55 157.34 43.72 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.867 0.867 . . . . 0.0 109.361 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.43 ' HG3' HG22 ' A' ' 543' ' ' VAL . 28.5 ttt -168.51 140.51 2.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.427 0.691 . . . . 0.0 110.37 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -152.03 123.66 7.89 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.14 0.976 . . . . 0.0 109.427 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 36.3 m -86.34 124.63 32.91 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.778 0.831 . . . . 0.0 109.853 175.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.422 HG23 ' HB ' ' A' ' 459' ' ' ILE . 35.2 t -135.04 142.71 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.929 0.892 . . . . 0.0 109.507 -177.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 152.99 41.66 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.754 -177.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.554 ' HD2' ' HG2' ' A' ' 462' ' ' GLU . 88.7 tttt -75.15 81.21 2.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.717 0.77 . . . . 0.0 109.153 170.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 25.4 t -98.04 -46.43 5.89 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 20.2 m -76.14 123.07 25.25 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 164.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 13.8 p -69.4 -25.7 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.131 0.491 . . . . 0.0 110.31 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.3 mtt -84.94 158.39 20.55 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.414 1.085 . . . . 0.0 110.764 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -63.36 113.87 3.5 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.39 135.26 55.96 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.597 0.759 . . . . 0.0 111.694 -172.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -86.15 106.33 17.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.044 0.938 . . . . 0.0 110.323 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -135.62 -87.57 0.35 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 7.0 t30 21.42 76.8 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 126.652 1.981 . . . . 0.0 114.257 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.176 0 CA-C-O 118.869 -0.962 . . . . 0.0 112.066 -175.67 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -61.21 94.15 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.452 0.701 . . . . 0.0 111.214 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 22.0 m -118.39 79.93 1.45 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.106 0.962 . . . . 0.0 109.027 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.86 -45.86 3.02 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.649 0.643 . . . . 0.0 112.76 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 44.1 t -179.96 -46.79 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.454 1.502 . . . . 0.0 108.707 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 19.0 t -114.94 142.18 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.032 0.933 . . . . 0.0 108.616 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 56.3 p -122.57 164.94 17.25 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.287 0.635 . . . . 0.0 110.628 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 43.7 mt -84.66 98.81 6.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 9.5 tp10 -69.27 -59.77 2.79 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.399 -174.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 36.0 mt-10 -137.25 160.32 39.38 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.045 0.938 . . . . 0.0 108.86 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.442 ' HB ' HG22 ' A' ' 557' ' ' VAL . 64.8 mt -139.57 141.39 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 172.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 465' ' ' PHE . 26.0 t70 -66.23 148.39 51.91 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.706 0.628 . . . . 0.0 111.312 175.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -36.16 83.02 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.203 1.001 . . . . 0.0 112.079 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.35 -31.26 24.88 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 167.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 95.9 36.42 5.27 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.142 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -72.29 -20.5 61.5 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.321 0.648 . . . . 0.0 110.487 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 460' ' ' ASP . 33.2 p90 -151.6 161.79 42.09 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.526 0.679 . . . . 0.0 111.542 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.33 112.9 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.351 1.46 . . . . 0.0 107.542 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -86.98 118.74 26.56 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 85.8 mt -113.65 134.0 54.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.046 0.938 . . . . 0.0 108.713 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 4.4 tmmm? -116.8 131.12 57.03 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.436 ' HB2' HD13 ' A' ' 503' ' ' LEU . 58.9 t30 -79.79 124.56 28.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.374 0.669 . . . . 0.0 110.709 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -102.65 15.42 29.33 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.228 1.011 . . . . 0.0 110.703 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' SER . . . . . 0.454 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 49.0 m -86.55 149.42 24.96 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.954 0.501 . . . . 0.0 111.353 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.06 -13.8 59.9 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.009 0.924 . . . . 0.0 110.406 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.0 OUTLIER -129.7 175.73 8.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.597 1.159 . . . . 0.0 109.127 178.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.66 115.96 6.38 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.393 0.677 . . . . 0.0 109.757 172.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -82.18 113.82 20.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.046 0.538 . . . . 0.0 110.417 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.486 ' HA ' HG12 ' A' ' 502' ' ' ILE . 35.0 p -66.89 110.27 3.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.175 0.59 . . . . 0.0 110.113 173.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.7 tp -103.03 171.88 7.13 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.654 1.182 . . . . 0.0 109.08 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 145.69 -62.99 0.46 Allowed Glycine 0 N--CA 1.472 1.052 0 CA-C-O 121.399 0.444 . . . . 0.0 112.923 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 480' ' ' ASN . 0.8 OUTLIER -70.6 -12.3 61.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.267 0.627 . . . . 0.0 110.975 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -69.57 146.52 51.72 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.112 0.965 . . . . 0.0 109.57 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -148.56 125.26 11.13 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.317 0.647 . . . . 0.0 111.002 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 19.4 mt -87.16 117.27 30.98 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 C-N-CA 123.638 0.775 . . . . 0.0 109.219 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.599 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 98.7 mttt -84.33 152.01 24.38 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.002 0.521 . . . . 0.0 109.817 168.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -150.47 104.73 3.25 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -116.48 103.59 10.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.88 0.872 . . . . 0.0 109.608 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.28 154.35 3.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.346 0.659 . . . . 0.0 109.91 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 45.4 tp -53.04 -43.15 66.4 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.989 1.316 . . . . 0.0 111.312 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.36 -24.18 67.21 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.713 0.805 . . . . 0.0 111.96 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 133.97 -22.95 3.77 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-O 118.561 -1.133 . . . . 0.0 115.505 173.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -59.96 100.15 0.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.433 1.117 . . . . 0.0 111.129 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.46 80.78 1.41 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.494 1.14 . . . . 0.0 108.316 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 18.0 pt -113.2 169.72 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.747 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -152.86 116.02 4.63 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.31 0.644 . . . . 0.0 110.42 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -99.36 115.28 28.85 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.556 0.742 . . . . 0.0 109.866 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -90.81 148.02 22.8 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -77.72 169.58 18.05 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.774 0.83 . . . . 0.0 110.845 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 52.0 p -82.55 133.23 50.1 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.66 -26.29 29.18 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.69 2.926 . . . . 0.0 114.346 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.29 -21.49 28.97 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.251 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -63.83 136.74 57.65 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.261 0.624 . . . . 0.0 110.376 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . 0.486 HG12 ' HA ' ' A' ' 477' ' ' SER . 40.9 mt -132.14 125.91 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . 0.436 HD13 ' HB2' ' A' ' 470' ' ' ASN . 0.5 OUTLIER -90.04 117.79 29.1 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.307 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -72.97 160.82 31.51 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.007 0.523 . . . . 0.0 111.691 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.32 119.74 10.88 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.666 0.786 . . . . 0.0 112.202 -173.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 80.07 -3.48 70.99 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.498 0.498 . . . . 0.0 114.073 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -83.03 -176.0 6.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.358 0.663 . . . . 0.0 110.082 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -149.52 137.25 20.25 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.137 0.575 . . . . 0.0 110.823 -176.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.95 111.86 32.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.1 m -90.58 96.28 10.57 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 65.1 t -83.91 106.99 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . 0.499 ' HB2' HG22 ' A' ' 527' ' ' VAL . 51.5 m95 -99.02 172.36 7.45 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.286 0.634 . . . . 0.0 112.221 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 534' ' ' TRP . . . -90.32 148.12 23.06 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.92 170.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.03 92.9 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.866 0.466 . . . . 0.0 110.678 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -79.32 -1.22 85.63 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.697 -0.683 . . . . 0.0 114.329 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -69.38 -26.48 64.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.304 0.642 . . . . 0.0 110.925 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 80.88 38.12 17.04 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.753 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.95 150.63 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.483 1.113 . . . . 0.0 110.308 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -78.54 124.08 27.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.588 0.755 . . . . 0.0 110.694 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -72.91 110.8 7.49 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.0 m -128.71 84.5 62.94 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.366 0.666 . . . . 0.0 110.217 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.88 148.04 93.92 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.594 2.196 . . . . 0.0 112.347 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -85.64 -17.94 24.06 Favored 'Cis proline' 0 C--N 1.375 1.973 0 C-N-CA 124.62 -0.992 . . . . 0.0 113.769 -2.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 17.0 m -73.95 -15.12 61.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.85 0.86 . . . . 0.0 113.239 -166.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 66.1 m -135.27 96.94 3.58 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 30.0 tp -105.3 104.48 14.22 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 512' ' ' TRP . 76.2 t -93.36 120.45 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.009 0.524 . . . . 0.0 110.056 -173.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -68.57 97.81 0.82 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -68.41 126.86 30.93 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.493 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 112.46 -25.18 12.56 Favored Glycine 0 C--N 1.342 0.864 0 O-C-N 123.239 0.337 . . . . 0.0 112.912 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.15 114.22 27.95 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 66.3 p -79.14 -32.23 44.32 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.675 0.79 . . . . 0.0 111.369 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.497 ' O ' HG23 ' A' ' 536' ' ' THR . 49.8 m -98.08 -33.44 11.16 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.511 ' HB2' ' HB1' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 53.51 32.82 14.87 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.459 0.647 . . . . 0.0 109.84 -171.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 66.99 55.77 15.27 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.606 -0.724 . . . . 0.0 113.008 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 533' ' ' SER . 4.6 p -73.35 153.78 40.35 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.038 0.447 . . . . 0.0 110.285 170.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 165.28 -161.63 35.01 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.074 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -79.15 -61.8 1.9 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.415 0.686 . . . . 0.0 110.341 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 15.8 p -132.66 127.96 35.99 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.232 1.013 . . . . 0.0 109.531 -170.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.99 133.92 14.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.176 0.59 . . . . 0.0 111.893 -170.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.09 99.52 6.97 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.822 1.249 . . . . 0.0 108.498 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 26.9 m -92.03 113.09 25.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 39.8 t -119.67 141.28 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 123.949 0.9 . . . . 0.0 109.787 -174.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.501 ' HB3' ' HB1' ' A' ' 553' ' ' ALA . 36.0 tp -109.25 128.74 55.31 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 171.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.535 HG23 ' HE3' ' A' ' 484' ' ' LYS . 78.9 t -117.93 149.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.152 1.381 . . . . 0.0 108.684 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -103.49 -171.93 2.02 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.018 0.527 . . . . 0.0 111.199 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -61.1 -32.81 72.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.996 0.918 . . . . 0.0 113.394 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.87 -36.29 83.02 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.633 0.773 . . . . 0.0 111.65 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.0 -8.01 29.3 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.714 -0.492 . . . . 0.0 113.423 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.88 151.76 25.86 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 117.385 0.592 . . . . 0.0 110.76 172.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -80.21 113.38 18.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.024 0.93 . . . . 0.0 109.299 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 17.7 m -89.23 -25.81 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.978 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 544' ' ' LEU . . . -144.93 148.89 34.36 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.527 0.731 . . . . 0.0 109.736 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' MET . . . . . 0.502 ' HG3' HG23 ' A' ' 543' ' ' VAL . 25.9 ttt -151.97 136.32 16.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.589 0.756 . . . . 0.0 109.552 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -155.38 110.84 3.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.54 0.736 . . . . 0.0 109.118 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 91.6 m -95.95 117.28 30.32 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.509 0.724 . . . . 0.0 110.405 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . 0.442 HG22 ' HB ' ' A' ' 459' ' ' ILE . 85.5 t -107.05 128.19 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.551 0.74 . . . . 0.0 109.415 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.95 157.71 26.24 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.313 1.045 . . . . 0.0 109.547 175.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.42 99.72 0.15 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.716 -173.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 16.9 p -169.17 84.88 0.14 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 125.265 1.426 . . . . 0.0 107.398 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 44.3 p -64.33 112.59 3.14 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.454 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 32.9 m -74.61 -21.41 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.372 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 45.5 mtm 73.31 124.39 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.222 1.409 . . . . 0.0 111.162 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 32.1 mmm180 -74.75 105.66 5.92 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.722 0.809 . . . . 0.0 109.256 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -101.63 171.2 7.7 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.513 0.725 . . . . 0.0 111.322 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.08 40.47 1.12 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 171.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.6 -42.65 99.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.181 0.993 . . . . 0.0 109.576 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -78.52 121.7 24.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.442 -1.254 . . . . 0.0 107.686 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.44 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.506 -176.511 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.414 0.15 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -74.07 81.51 1.75 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.072 0.549 . . . . 0.0 110.35 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 18.8 p -76.79 96.67 4.32 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.281 1.033 . . . . 0.0 111.7 -174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 64.8 24.62 69.99 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.66 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 20.0 m -60.96 -34.42 74.73 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.845 0.858 . . . . 0.0 112.126 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.46 144.8 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 168.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 60.7 m -134.27 169.99 16.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.334 0.654 . . . . 0.0 110.542 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 51.0 mt -91.74 113.09 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.374 0.67 . . . . 0.0 110.144 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.427 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 11.6 tp10 -81.37 -58.19 3.15 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.132 0.973 . . . . 0.0 110.265 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.427 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.4 mt-10 -135.01 162.67 31.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.564 0.746 . . . . 0.0 109.992 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.4 mt -144.26 135.53 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.68 142.07 51.57 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.861 0.464 . . . . 0.0 110.101 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.727 HD11 ' HG3' ' A' ' 563' ' ' MET . 3.2 pp -66.25 -39.55 89.58 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.894 0.478 . . . . 0.0 111.645 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.503 ' HG3' HD13 ' A' ' 461' ' ' LEU . 43.3 mt-10 -72.66 -25.21 61.19 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.199 0.523 . . . . 0.0 110.144 174.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 92.59 31.17 9.0 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.548 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -77.44 -19.85 55.39 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.825 0.85 . . . . 0.0 110.971 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -160.18 163.2 33.84 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 121.779 0.8 . . . . 0.0 112.789 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 93.7 t -126.93 130.65 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.006 1.722 . . . . 0.0 107.395 169.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.49 133.96 42.12 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.2 mt -117.89 161.71 19.31 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.178 0.991 . . . . 0.0 108.84 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -146.89 131.82 18.12 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.611 ' HB2' ' HG ' ' A' ' 503' ' ' LEU . 65.2 t30 -81.89 117.4 22.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.229 0.612 . . . . 0.0 110.396 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -78.31 -23.74 46.97 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.269 0.628 . . . . 0.0 111.071 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 19.3 m -62.09 145.22 53.9 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.748 0.819 . . . . 0.0 111.266 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -86.75 17.88 3.74 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.88 0.872 . . . . 0.0 110.991 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.5 176.61 12.19 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.142 0.977 . . . . 0.0 110.05 -174.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.38 107.83 0.72 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.268 1.027 . . . . 0.0 111.082 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -88.69 111.31 21.81 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 170.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.6 p -63.53 113.4 3.28 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.012 0.525 . . . . 0.0 109.903 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.6 tp -104.27 155.97 18.3 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -175.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.37 -55.96 0.54 Allowed Glycine 0 N--CA 1.473 1.125 0 CA-C-O 121.694 0.608 . . . . 0.0 112.141 -176.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -72.72 -11.36 60.59 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.976 0.91 . . . . 0.0 111.399 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -79.48 140.68 37.23 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.637 0.775 . . . . 0.0 109.042 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -133.4 130.42 38.7 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.956 0.502 . . . . 0.0 110.804 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.67 109.75 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.635 0.774 . . . . 0.0 110.03 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 62.7 mttm -79.15 100.44 7.44 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 167.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' ARG . . . . . 0.55 ' HB3' ' HA3' ' A' ' 535' ' ' GLY . 6.3 mmt85 -82.0 90.3 6.48 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 165.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' GLN . . . . . 0.464 ' HG2' ' HB3' ' A' ' 492' ' ' GLU . 21.3 tm0? -99.12 104.97 17.01 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.227 -173.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.46 126.28 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.6 -12.18 50.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.08 -6.62 40.58 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.337 1.055 . . . . 0.0 112.046 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 115.58 28.25 2.81 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 114.427 0.531 . . . . 0.0 114.427 167.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -135.48 141.44 45.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 116.998 0.399 . . . . 0.0 110.078 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 486' ' ' GLN . 10.0 pt-20 -150.35 114.58 5.13 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.24 0.543 . . . . 0.0 109.727 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 28.5 pt -107.69 144.93 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -118.75 108.52 14.98 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.496 0.718 . . . . 0.0 109.637 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -89.23 104.89 17.4 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -84.22 134.81 34.54 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -69.5 164.9 22.12 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.851 0.86 . . . . 0.0 111.746 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.4 p -75.78 126.04 87.64 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' PRO . . . . . 0.5 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 60.2 Cg_endo -68.16 -12.46 35.15 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.647 2.231 . . . . 0.0 113.565 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -74.19 -23.53 59.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.738 0.815 . . . . 0.0 111.504 173.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -79.65 136.25 36.76 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-O 120.975 0.417 . . . . 0.0 109.91 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.71 130.01 74.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' LEU . . . . . 0.611 ' HG ' ' HB2' ' A' ' 470' ' ' ASN . 23.3 tp -95.54 113.4 25.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -76.55 164.0 26.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.214 1.005 . . . . 0.0 112.054 -172.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -55.59 120.3 7.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.372 1.069 . . . . 0.0 112.566 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.73 -5.24 17.92 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 114.338 0.495 . . . . 0.0 114.338 176.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -84.92 154.72 22.03 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.147 0.579 . . . . 0.0 109.883 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 59.7 mtt -113.94 145.15 41.93 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.76 0.824 . . . . 0.0 110.585 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.2 p -125.48 119.18 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.591 0.756 . . . . 0.0 109.225 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.81 107.01 19.41 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 16.8 t -87.0 98.88 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.571 0.749 . . . . 0.0 110.002 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' TRP . . . . . 0.509 ' HB2' HG21 ' A' ' 527' ' ' VAL . 39.5 m95 -90.14 174.19 7.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.603 0.761 . . . . 0.0 111.336 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.51 152.42 20.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.025 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.03 75.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.038 0.535 . . . . 0.0 110.528 173.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -72.62 -8.63 72.41 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.571 -0.74 . . . . 0.0 114.429 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.52 60.15 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.978 0.511 . . . . 0.0 111.28 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 75.77 38.44 36.69 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-O 121.139 0.299 . . . . 0.0 112.503 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.11 140.04 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 124.107 0.963 . . . . 0.0 110.146 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.53 138.42 36.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.928 0.891 . . . . 0.0 110.751 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -64.36 110.7 2.34 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.246 0.618 . . . . 0.0 109.525 173.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.4 m -129.29 78.52 75.77 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.598 0.759 . . . . 0.0 110.02 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.28 156.39 64.74 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.443 2.095 . . . . 0.0 111.811 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -83.57 -14.28 35.64 Favored 'Cis proline' 0 C--N 1.377 2.039 0 CA-C-N 119.698 0.928 . . . . 0.0 113.968 -1.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.9 m -66.43 -31.72 72.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.962 0.905 . . . . 0.0 112.736 -171.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 94.2 m -136.59 102.1 4.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.295 0.638 . . . . 0.0 110.636 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 67.1 mt -92.24 132.85 36.34 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 167.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 512' ' ' TRP . 99.4 t -118.92 126.44 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -70.54 100.95 1.9 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 172.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.59 133.13 49.67 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.151 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 89.57 -28.56 6.87 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 123.644 0.59 . . . . 0.0 113.591 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -82.99 118.12 23.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.723 0.409 . . . . 0.0 109.987 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 33.4 m -96.28 -39.51 9.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.88 0.472 . . . . 0.0 111.248 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' SER . . . . . 0.447 ' HB2' HG23 ' A' ' 536' ' ' THR . 67.0 p -79.04 -35.7 42.22 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.464 0.477 . . . . 0.0 111.848 -171.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' TRP . . . . . 0.546 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.39 31.19 9.19 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.119 0.967 . . . . 0.0 111.366 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 485' ' ' ARG . . . 70.4 59.17 5.48 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -174.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 533' ' ' SER . 10.4 t -79.2 145.31 33.71 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.219 1.008 . . . . 0.0 110.151 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -169.56 165.25 38.68 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.132 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -75.69 -30.94 59.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.8 m -146.29 118.42 8.3 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -142.37 -178.95 5.99 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.565 0.746 . . . . 0.0 110.802 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -147.98 128.33 13.92 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.39 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 87.3 m -86.69 128.07 34.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 65.5 t -124.38 117.5 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.6 tp -90.84 107.95 19.52 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . 0.44 HG22 ' HG2' ' A' ' 551' ' ' GLU . 83.3 t -96.03 149.56 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.644 1.178 . . . . 0.0 108.585 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -108.29 -172.84 2.14 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.475 0.31 . . . . 0.0 110.965 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -52.16 -39.63 60.3 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.856 1.263 . . . . 0.0 113.27 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.34 -37.56 87.76 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.711 0.804 . . . . 0.0 112.424 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.21 -13.41 28.57 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.041 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.1 148.89 39.32 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.278 0.539 . . . . 0.0 110.567 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.44 ' HG2' HG22 ' A' ' 545' ' ' VAL . 30.0 mt-10 -87.57 98.27 11.31 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.942 0.897 . . . . 0.0 109.027 -177.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 26.0 m -79.65 -19.06 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.05 -173.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.616 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -145.71 145.66 30.96 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.275 0.63 . . . . 0.0 109.425 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 16.9 ttt -151.64 110.55 3.86 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -125.52 106.87 10.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.917 0.887 . . . . 0.0 108.917 -173.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 53.2 m -86.24 140.02 30.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.14 0.576 . . . . 0.0 110.578 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.3 p -144.97 111.02 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 124.43 1.092 . . . . 0.0 109.585 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -92.76 116.57 29.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 172.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' LYS . . . . . 0.597 ' HE2' HG12 ' A' ' 562' ' ' VAL . 86.7 tttt -66.38 100.63 0.66 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.339 1.055 . . . . 0.0 110.492 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 47.8 p -97.82 -7.03 31.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.125 0.97 . . . . 0.0 111.619 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 561' ' ' SER . . . . . 0.491 ' HB3' HD22 ' A' ' 461' ' ' LEU . 44.7 t -138.59 149.59 45.41 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.82 0.848 . . . . 0.0 109.691 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . 0.597 HG12 ' HE2' ' A' ' 559' ' ' LYS . 35.0 m -110.17 9.11 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.115 0.966 . . . . 0.0 109.924 172.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.727 ' HG3' HD11 ' A' ' 461' ' ' LEU . 66.7 mtt 63.22 -170.06 0.18 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.898 1.279 . . . . 0.0 110.571 -168.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -99.54 171.68 7.78 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.529 0.681 . . . . 0.0 111.067 173.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.23 25.76 0.96 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.993 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -72.77 80.18 1.13 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.373 0.669 . . . . 0.0 109.275 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -97.2 -38.43 9.7 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.633 1.173 . . . . 0.0 109.485 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -169.05 123.41 0.84 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.548 1.139 . . . . 0.0 107.987 -176.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 CA-C-O 118.832 -0.982 . . . . 0.0 111.313 -178.981 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 51.1 p . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 454' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 470' ' ' ASN . 18.6 t -89.07 146.46 6.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 165.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 84.6 p -134.62 172.07 13.46 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.029 0.931 . . . . 0.0 108.949 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 42.1 mm -74.19 122.2 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 14.6 tp10 -93.97 -68.05 0.82 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 36.0 mt-10 -135.12 160.09 39.45 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.961 0.904 . . . . 0.0 108.83 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.548 HG23 ' NH2' ' A' ' 485' ' ' ARG . 97.0 mt -146.57 142.61 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.87 147.93 48.33 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.02 0.528 . . . . 0.0 110.808 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.64 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.0 pt? -59.37 -35.79 74.56 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.021 0.928 . . . . 0.0 111.786 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.64 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 50.2 mt-10 -103.07 -4.97 23.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.443 1.097 . . . . 0.0 111.298 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 75.49 40.5 32.54 Favored Glycine 0 C--N 1.342 0.911 0 O-C-N 123.469 0.48 . . . . 0.0 113.3 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -78.9 -18.81 53.26 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.241 0.617 . . . . 0.0 110.691 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -155.55 157.33 36.66 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.013 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' VAL . . . . . 0.566 HG22 ' NH2' ' A' ' 485' ' ' ARG . 15.7 t -111.77 148.29 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 165.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 21.0 tp60 -126.54 121.08 31.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.456 HD22 HD22 ' A' ' 544' ' ' LEU . 87.3 mt -110.01 159.62 17.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.91 0.884 . . . . 0.0 109.804 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -144.84 128.93 17.6 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.554 0.742 . . . . 0.0 109.721 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.555 ' HB2' HD12 ' A' ' 503' ' ' LEU . 64.2 t30 -91.35 109.4 20.67 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -86.93 -1.46 57.86 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.287 1.035 . . . . 0.0 111.139 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 27.0 t -74.95 158.47 33.24 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.51 0.724 . . . . 0.0 111.53 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.33 0.4 56.21 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.403 1.081 . . . . 0.0 112.22 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.53 166.18 23.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.969 0.508 . . . . 0.0 110.821 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -66.18 115.58 6.33 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.909 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.439 ' HG2' HG23 ' A' ' 454' ' ' VAL . 10.4 tp-100 -80.02 111.08 16.02 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.851 0.719 . . . . 0.0 110.46 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.5 p -64.0 114.34 4.07 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.0 tp -107.99 151.88 25.23 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -170.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 146.87 -65.65 0.42 Allowed Glycine 0 N--CA 1.473 1.111 0 C-N-CA 121.419 -0.42 . . . . 0.0 112.921 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -69.35 -12.75 61.93 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.489 0.716 . . . . 0.0 110.98 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.437 ' CD2' ' HA ' ' A' ' 546' ' ' ASN . 26.3 m95 -67.65 150.86 48.2 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.853 0.861 . . . . 0.0 110.056 169.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 482' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 495' ' ' TYR . 30.1 ptt-85 -153.09 139.76 18.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.789 0.436 . . . . 0.0 111.364 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 483' ' ' ILE . . . . . 0.495 HG21 HG21 ' A' ' 466' ' ' VAL . 47.7 mt -101.41 104.6 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.304 0.642 . . . . 0.0 109.552 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.461 ' HE3' HG21 ' A' ' 545' ' ' VAL . 92.0 mttt -86.87 96.91 10.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.74 0.416 . . . . 0.0 109.995 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 485' ' ' ARG . . . . . 0.566 ' NH2' HG22 ' A' ' 466' ' ' VAL . 39.8 ttm180 -94.7 100.0 12.0 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 172.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -104.14 111.81 24.56 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.445 1.098 . . . . 0.0 110.439 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.474 HG12 ' H ' ' A' ' 489' ' ' GLU . 14.1 t -95.15 135.77 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.19 0.996 . . . . 0.0 109.272 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.4 pp -64.96 -22.89 67.07 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.342 0.657 . . . . 0.0 112.207 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 489' ' ' GLU . . . . . 0.474 ' H ' HG12 ' A' ' 487' ' ' VAL . 47.7 mt-10 -69.93 -10.83 59.96 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.058 0.943 . . . . 0.0 111.906 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 130.15 -28.31 3.89 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-O 119.387 -0.674 . . . . 0.0 114.232 166.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.24 116.17 22.28 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.834 0.817 . . . . 0.0 110.313 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.39 125.0 28.17 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 13.5 pt -140.82 148.76 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.8 0.84 . . . . 0.0 110.224 -170.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -121.3 112.51 18.69 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.484 0.714 . . . . 0.0 109.533 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 495' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 482' ' ' ARG . 50.4 t80 -79.94 105.18 11.04 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -80.74 132.56 35.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -77.17 170.25 16.87 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.457 0.646 . . . . 0.0 111.312 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 498' ' ' THR . . . . . 0.438 ' HB ' ' HG2' ' A' ' 500' ' ' LYS . 52.3 p -87.99 120.09 70.63 Favored Pre-proline 0 CA--C 1.553 1.079 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.465 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.19 -5.21 7.57 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.241 2.627 . . . . 0.0 114.753 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 500' ' ' LYS . . . . . 0.438 ' HG2' ' HB ' ' A' ' 498' ' ' THR . 63.0 pttt -74.55 -25.94 59.64 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.539 0.335 . . . . 0.0 110.425 170.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -92.33 135.57 33.91 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.639 0.776 . . . . 0.0 110.608 -169.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 52.3 mt -126.96 128.58 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 503' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 470' ' ' ASN . 2.3 tm? -95.1 141.5 28.65 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.515 HH22 ' HG2' ' A' ' 523' ' ' PRO . 0.2 OUTLIER -87.43 164.66 16.07 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.019 0.527 . . . . 0.0 111.637 -166.33 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.76 123.32 19.04 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.366 0.667 . . . . 0.0 110.815 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.01 14.53 76.14 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 123.569 0.543 . . . . 0.0 113.938 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -104.92 175.27 5.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.288 0.635 . . . . 0.0 110.673 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 11.5 ptm -146.34 149.0 32.97 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.468 1.107 . . . . 0.0 110.106 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.89 131.32 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.3 0.64 . . . . 0.0 109.803 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.27 112.73 25.87 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.27 0.628 . . . . 0.0 109.499 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.418 HG12 ' HE1' ' A' ' 534' ' ' TRP . 46.9 t -99.38 99.76 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.185 0.594 . . . . 0.0 109.824 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 512' ' ' TRP . . . . . 0.541 ' HB2' HG22 ' A' ' 527' ' ' VAL . 43.4 m95 -87.16 172.99 9.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.736 0.814 . . . . 0.0 111.479 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -91.14 152.94 20.38 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.809 0.844 . . . . 0.0 110.108 172.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 514' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.14 -38.57 85.74 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.337 0.589 . . . . 0.0 110.141 172.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -81.2 13.05 34.76 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.662 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -84.69 -6.98 59.38 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.175 0.59 . . . . 0.0 110.712 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 68.52 16.46 69.63 Favored Glycine 0 C--N 1.359 1.833 0 O-C-N 123.357 0.411 . . . . 0.0 113.44 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.2 p -88.89 150.13 3.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.29 1.036 . . . . 0.0 110.358 -173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.61 118.16 21.94 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.533 0.733 . . . . 0.0 109.72 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -66.94 110.75 3.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.4 m -124.17 81.19 57.96 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.365 0.666 . . . . 0.0 109.888 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -70.55 154.48 64.59 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.67 2.247 . . . . 0.0 111.79 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 523' ' ' PRO . . . . . 0.515 ' HG2' HH22 ' A' ' 504' ' ' ARG . 97.1 Cg_endo -97.94 13.57 32.5 Favored 'Cis proline' 0 C--N 1.37 1.691 0 CA-C-N 119.723 0.937 . . . . 0.0 113.48 -2.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.8 m -78.57 -45.7 21.16 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.457 0.646 . . . . 0.0 110.594 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 93.6 m -121.01 96.38 5.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.802 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 10.7 mp -84.11 147.07 27.55 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 512' ' ' TRP . 57.6 t -128.73 123.06 58.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -67.53 91.06 0.27 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 529' ' ' LYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 55.2 tptt -72.64 122.56 21.62 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.431 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 106.31 -1.86 37.44 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.759 0.662 . . . . 0.0 112.993 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 534' ' ' TRP . 44.7 tp60 -119.48 123.0 42.96 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 42.8 p -90.21 -47.04 8.04 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.034 0.534 . . . . 0.0 111.931 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 536' ' ' THR . 69.0 p -87.44 -34.72 18.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.972 -170.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.734 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.73 39.24 28.24 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.533 0.733 . . . . 0.0 109.973 -173.423 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 74.95 61.2 3.13 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 462' ' ' GLU . 7.9 p -72.93 142.04 47.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.85 0.46 . . . . 0.0 111.01 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 179.09 168.03 37.53 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.821 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.82 -16.57 40.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.063 0.545 . . . . 0.0 110.322 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.425 ' HB2' HD21 ' A' ' 488' ' ' LEU . 16.6 m -155.82 131.13 9.49 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.758 0.823 . . . . 0.0 108.945 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.469 ' HB3' HG22 ' A' ' 487' ' ' VAL . 23.0 p90 -157.82 145.46 18.54 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.225 0.61 . . . . 0.0 111.13 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 76.0 mtm-85 -97.88 106.15 18.41 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.85 0.86 . . . . 0.0 108.902 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 21.5 m -93.61 105.65 17.68 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.447 HG22 ' SD ' ' A' ' 554' ' ' MET . 12.0 t -103.04 134.47 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.342 1.057 . . . . 0.0 109.706 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.8 tp -103.76 124.11 48.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.461 HG21 ' HE3' ' A' ' 484' ' ' LYS . 84.1 t -118.28 141.55 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.462 1.105 . . . . 0.0 108.872 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.437 ' HA ' ' CD2' ' A' ' 481' ' ' TRP . 1.7 p30 -94.41 -177.17 4.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.652 0.381 . . . . 0.0 111.576 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.08 71.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.666 0.786 . . . . 0.0 112.902 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.21 -29.75 71.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.642 0.777 . . . . 0.0 111.786 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 95.28 25.28 14.38 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.795 -173.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.39 137.87 41.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.242 1.017 . . . . 0.0 108.597 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -75.29 96.89 3.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.791 0.836 . . . . 0.0 109.155 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 35.6 m -85.16 -23.8 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -148.46 162.92 38.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.402 0.681 . . . . 0.0 109.812 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 543' ' ' VAL . 59.2 ttp -170.52 139.22 1.59 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.963 0.905 . . . . 0.0 109.49 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -139.25 124.27 18.84 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.267 0.627 . . . . 0.0 110.101 170.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 28.2 m -81.73 99.76 9.12 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 459' ' ' ILE . 74.5 t -102.85 142.39 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.501 0.667 . . . . 0.0 109.754 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -126.15 158.44 35.54 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.006 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 559' ' ' LYS . . . . . 0.464 ' HG3' HD12 ' A' ' 461' ' ' LEU . 64.8 tttp . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 121.514 0.674 . . . . 0.0 109.43 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 472' ' ' SER . 67.7 m . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.861 0.362 . . . . 0.0 111.635 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 478' ' ' LEU . 13.5 t -123.71 137.1 58.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 162.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 28.7 t -130.22 170.88 13.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.986 0.914 . . . . 0.0 109.239 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 459' ' ' ILE . 61.8 mt -87.42 117.49 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 122.965 0.506 . . . . 0.0 109.88 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 8.3 tp10 -84.37 -62.07 1.65 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.358 0.663 . . . . 0.0 110.499 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 24.6 mt-10 -140.48 158.31 44.19 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.83 0.852 . . . . 0.0 109.669 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.51 ' HB ' HG21 ' A' ' 557' ' ' VAL . 48.1 mt -141.9 140.42 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -77.29 148.94 35.44 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.321 0.648 . . . . 0.0 111.568 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 559' ' ' LYS . 1.6 pp -76.31 -26.19 55.58 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.886 0.875 . . . . 0.0 112.766 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -86.52 -14.38 43.21 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.239 0.616 . . . . 0.0 110.027 168.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 78.12 28.67 55.75 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.741 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -73.03 -18.26 61.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.139 0.576 . . . . 0.0 111.063 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -158.22 155.8 29.63 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 122.958 0.503 . . . . 0.0 111.348 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.6 111.44 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 457' ' ' GLU . 15.6 tt0 -88.0 128.33 35.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.58 0.752 . . . . 0.0 110.223 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 483' ' ' ILE . 71.5 mt -114.0 162.66 16.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.448 1.099 . . . . 0.0 109.599 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 469' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 469' ' ' LYS . 4.7 tmmm? -147.4 132.12 17.92 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.012 0.925 . . . . 0.0 108.764 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' A' ' 505' ' ' ALA . 23.6 t-20 -76.76 127.29 32.48 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.968 1.307 . . . . 0.0 111.035 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -111.43 12.17 21.47 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.975 0.91 . . . . 0.0 111.183 172.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 453' ' ' SER . 24.1 t -79.05 148.24 32.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.847 0.859 . . . . 0.0 110.322 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -88.15 -7.78 56.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.381 0.672 . . . . 0.0 110.956 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.4 OUTLIER -135.68 172.55 12.84 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.986 0.914 . . . . 0.0 109.447 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.87 143.39 57.48 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -124.52 113.68 18.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.477 0.711 . . . . 0.0 110.26 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 40.6 p -70.79 119.27 14.69 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.4 0.68 . . . . 0.0 110.682 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.413 HD11 HG21 ' A' ' 454' ' ' VAL . 6.2 mp -100.2 165.18 11.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.117 0.967 . . . . 0.0 109.455 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 144.1 -58.09 0.53 Allowed Glycine 0 N--CA 1.465 0.624 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 480' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 547' ' ' ALA . 5.6 m-20 -81.03 -13.76 58.51 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 114.299 -0.95 . . . . 0.0 111.014 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.431 ' CZ3' HG21 ' A' ' 552' ' ' VAL . 27.8 m95 -72.23 140.12 48.51 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -146.66 135.85 22.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.056 0.542 . . . . 0.0 111.538 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' ILE . . . . . 0.477 HG12 HD13 ' A' ' 544' ' ' LEU . 45.4 mt -99.99 105.99 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.908 0.883 . . . . 0.0 109.13 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -92.83 102.23 14.61 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.56 1.144 . . . . 0.0 110.42 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' ARG . . . . . 0.511 ' HE ' ' HE3' ' A' ' 534' ' ' TRP . 51.1 ttm-85 -87.22 96.35 10.3 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.44 100.88 13.07 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 46.6 t -93.62 121.59 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.42 -28.11 68.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.447 0.699 . . . . 0.0 112.629 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -64.53 -15.73 61.4 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.534 1.133 . . . . 0.0 112.574 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 125.27 27.38 1.21 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 114.471 0.548 . . . . 0.0 114.471 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -129.22 99.17 5.13 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.696 0.748 . . . . 0.0 109.971 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.36 96.86 6.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 174.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.3 pt -107.32 168.4 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.15 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -156.44 132.18 9.61 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.728 0.811 . . . . 0.0 109.67 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -125.53 116.19 21.39 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.442 0.697 . . . . 0.0 109.49 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -79.19 157.81 27.79 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -81.4 171.44 14.75 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.665 0.786 . . . . 0.0 110.872 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 74.7 p -81.93 128.83 67.05 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.05 -29.06 63.36 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.445 2.763 . . . . 0.0 113.785 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -68.73 -21.06 64.41 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.28 0.632 . . . . 0.0 112.49 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -78.95 129.53 34.58 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.364 0.666 . . . . 0.0 109.996 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 49.4 mt -126.3 119.85 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' LEU . . . . . 0.406 HD23 HG22 ' A' ' 454' ' ' VAL . 38.8 tp -83.85 138.6 33.12 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.487 0.715 . . . . 0.0 109.439 178.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -90.63 154.78 19.33 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.222 0.609 . . . . 0.0 110.549 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' ALA . . . . . 0.457 ' HA ' ' OD1' ' A' ' 470' ' ' ASN . . . -72.8 130.39 40.35 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.455 0.702 . . . . 0.0 111.681 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 75.51 20.13 78.78 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.064 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -115.19 -162.46 0.83 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.163 0.985 . . . . 0.0 110.2 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 19.6 ptp -154.4 166.37 33.44 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.361 0.665 . . . . 0.0 110.992 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.68 126.13 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.091 0.957 . . . . 0.0 109.228 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 25.6 m -116.32 111.53 20.24 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.107 0.563 . . . . 0.0 109.719 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 526' ' ' LEU . 35.5 m -88.67 137.31 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -122.01 174.47 6.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.379 1.072 . . . . 0.0 109.862 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -90.53 147.17 23.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.047 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -58.73 -42.24 88.31 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.503 0.721 . . . . 0.0 110.88 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 515' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -88.63 24.16 13.48 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.731 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -88.28 -13.23 41.4 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.262 0.625 . . . . 0.0 110.404 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.45 31.35 68.38 Favored Glycine 0 C--N 1.356 1.648 0 O-C-N 123.512 0.508 . . . . 0.0 112.323 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.67 144.95 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.371 1.068 . . . . 0.0 110.982 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.34 126.12 30.76 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 172.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -73.62 117.44 15.4 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 31.4 m -138.04 73.15 45.86 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.139 0.576 . . . . 0.0 110.335 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.48 148.38 83.76 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.719 2.279 . . . . 0.0 111.589 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.52 -13.54 37.38 Favored 'Cis proline' 0 C--N 1.379 2.173 0 CA-C-N 120.275 1.134 . . . . 0.0 114.424 4.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.6 m -67.6 -32.38 73.06 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.94 0.896 . . . . 0.0 112.431 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 59.8 m -135.48 98.2 3.88 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.623 0.769 . . . . 0.0 110.051 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.502 ' HB2' HG12 ' A' ' 511' ' ' VAL . 82.5 mt -90.87 149.73 21.81 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.33 120.9 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.204 0.602 . . . . 0.0 109.725 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -75.76 109.32 9.26 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 529' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 56.4 tptt -72.58 135.97 45.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.966 0.906 . . . . 0.0 110.514 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 99.32 -39.22 2.81 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.921 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -81.55 109.39 15.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.945 0.498 . . . . 0.0 110.482 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 532' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 85.9 p -83.4 -37.34 23.38 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.35 0.66 . . . . 0.0 110.292 174.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.739 ' HB2' HG23 ' A' ' 536' ' ' THR . 55.6 p -94.05 -29.39 15.22 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.794 -173.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.511 ' HE3' ' HE ' ' A' ' 485' ' ' ARG . 0.0 OUTLIER 59.98 34.51 21.5 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.14 0.976 . . . . 0.0 109.258 -171.163 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 79.41 81.08 0.75 Allowed Glycine 0 C--N 1.364 2.12 0 CA-C-O 119.574 -0.57 . . . . 0.0 113.032 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.739 HG23 ' HB2' ' A' ' 533' ' ' SER . 14.5 p -55.41 148.84 14.32 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.824 0.821 . . . . 0.0 112.51 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 164.8 136.15 1.95 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.585 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.71 -37.55 24.58 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 31.9 m -125.84 124.23 40.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.517 0.727 . . . . 0.0 109.186 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -158.74 161.46 37.04 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.642 0.777 . . . . 0.0 111.091 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 35.0 ptt180 -119.72 111.75 18.41 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.935 0.894 . . . . 0.0 108.689 168.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 61.3 m -89.92 133.14 34.94 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.532 HG22 ' HG3' ' A' ' 554' ' ' MET . 19.3 t -124.13 117.94 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.368 1.067 . . . . 0.0 108.723 -174.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 42.9 tp -87.99 132.35 34.29 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.59 157.58 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.176 1.39 . . . . 0.0 108.113 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 548' ' ' ASP . 0.8 OUTLIER -117.77 -170.68 1.91 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.814 0.445 . . . . 0.0 111.234 -178.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 547' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 480' ' ' ASN . . . -51.85 -37.4 51.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.396 1.478 . . . . 0.0 113.839 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 548' ' ' ASP . . . . . 0.485 ' H ' ' ND2' ' A' ' 546' ' ' ASN . 33.7 t70 -67.28 -34.47 77.47 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.595 0.758 . . . . 0.0 112.009 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 104.45 -12.95 51.28 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.559 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.42 148.21 51.87 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 122.784 0.434 . . . . 0.0 110.139 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -80.93 101.24 9.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.431 HG21 ' CZ3' ' A' ' 481' ' ' TRP . 22.1 m -79.27 -21.0 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.566 0.347 . . . . 0.0 111.641 -175.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -158.9 151.71 22.03 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.228 1.011 . . . . 0.0 109.189 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.532 ' HG3' HG22 ' A' ' 543' ' ' VAL . 54.8 ttp -164.21 116.2 1.33 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.661 0.784 . . . . 0.0 109.668 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -133.22 130.59 39.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.549 0.74 . . . . 0.0 110.292 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 79.8 m -90.57 123.1 33.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.363 1.065 . . . . 0.0 109.572 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.51 HG21 ' HB ' ' A' ' 459' ' ' ILE . 86.2 t -123.75 128.87 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.795 0.838 . . . . 0.0 109.72 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 151.46 38.44 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.63 1.172 . . . . 0.0 108.52 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 559' ' ' LYS . . . . . 0.489 ' HG3' ' HB2' ' A' ' 461' ' ' LEU . 88.0 tttt . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 121.549 0.69 . . . . 0.0 109.319 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 13.8 t -91.77 130.95 40.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.374 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 16.6 m -109.64 155.71 21.13 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.341 1.056 . . . . 0.0 109.407 174.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 39.9 mt -79.23 106.54 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.463 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 11.7 tp10 -73.69 -69.47 0.43 Allowed 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.733 0.646 . . . . 0.0 109.68 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.42 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 21.8 mt-10 -133.19 163.73 28.63 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.6 0.76 . . . . 0.0 109.829 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.503 ' HB ' HG21 ' A' ' 557' ' ' VAL . 61.2 mt -142.5 144.34 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 171.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.39 148.62 51.6 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.354 0.662 . . . . 0.0 110.716 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.46 -41.62 98.89 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.065 0.546 . . . . 0.0 111.289 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -80.57 -29.52 37.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.55 0.74 . . . . 0.0 109.362 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' GLY . . . . . 0.453 ' HA3' ' NH2' ' A' ' 485' ' ' ARG . . . 92.1 39.52 5.42 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.408 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -71.26 -20.19 62.26 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.375 0.67 . . . . 0.0 109.915 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -153.5 161.85 41.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.294 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 81.3 t -130.63 111.8 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.463 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.7 tp-100 -86.81 123.06 31.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.148 0.979 . . . . 0.0 109.955 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 483' ' ' ILE . 62.4 mt -112.49 157.86 20.6 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 469' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 471' ' ' ASN . 2.1 tmmm? -148.19 129.98 15.15 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -91.72 130.78 37.45 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.234 0.614 . . . . 0.0 110.252 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.516 ' HB3' ' HE3' ' A' ' 469' ' ' LYS . 16.2 p-10 -136.38 84.73 2.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.268 1.027 . . . . 0.0 109.261 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 66.0 m -146.43 -163.32 1.72 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.056 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' ASP . . . . . 0.534 ' HB2' ' HD3' ' A' ' 474' ' ' LYS . 2.2 m-20 -79.16 -48.78 13.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.308 0.643 . . . . 0.0 111.186 -173.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.534 ' HD3' ' HB2' ' A' ' 473' ' ' ASP . 0.0 OUTLIER -133.93 178.45 6.94 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.587 -172.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 475' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 504' ' ' ARG . 8.5 p-10 -53.16 112.46 0.87 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.72 1.208 . . . . 0.0 111.639 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -74.27 113.66 11.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.774 0.83 . . . . 0.0 110.557 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.494 ' HA ' HG12 ' A' ' 502' ' ' ILE . 32.6 t -64.37 100.84 0.38 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.098 0.559 . . . . 0.0 109.508 172.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.8 tp -90.65 165.68 13.58 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 143.22 -65.52 0.47 Allowed Glycine 0 N--CA 1.466 0.684 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.135 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.68 -13.04 58.42 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.153 0.981 . . . . 0.0 112.028 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -74.3 148.53 41.31 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.402 1.081 . . . . 0.0 109.599 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' ARG . . . . . 0.4 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 19.1 ptt-85 -148.58 134.11 18.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.047 0.539 . . . . 0.0 111.181 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 483' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 468' ' ' LEU . 49.2 mt -91.58 114.95 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.314 1.046 . . . . 0.0 109.729 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.569 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 67.1 mttm -79.63 144.11 34.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 164.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 485' ' ' ARG . . . . . 0.453 ' NH2' ' HA3' ' A' ' 463' ' ' GLY . 66.9 ttt180 -143.59 98.71 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.594 0.711 . . . . 0.0 109.282 172.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -96.15 103.6 15.51 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.01 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.547 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 24.3 t -67.58 149.44 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.495 HD23 HG12 ' A' ' 487' ' ' VAL . 2.7 pt? -52.42 -33.11 42.42 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -168.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.93 -34.08 75.92 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.288 0.635 . . . . 0.0 111.248 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 130.57 -2.3 5.7 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.728 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -73.05 114.21 10.96 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.168 0.484 . . . . 0.0 110.384 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.12 143.49 38.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.58 0.752 . . . . 0.0 110.556 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 22.5 pt -127.19 146.16 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.19 0.996 . . . . 0.0 108.679 169.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -125.59 109.81 13.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.557 0.743 . . . . 0.0 109.764 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -97.38 106.03 18.28 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.571 0.748 . . . . 0.0 109.658 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -87.07 153.21 21.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -89.25 170.4 10.62 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.216 0.607 . . . . 0.0 110.936 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.1 p -91.07 131.74 36.21 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.044 0.938 . . . . 0.0 109.649 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.25 -17.06 49.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.783 2.322 . . . . 0.0 113.453 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -72.9 -20.39 61.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.549 0.739 . . . . 0.0 111.662 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -84.2 128.3 34.48 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.408 0.683 . . . . 0.0 109.614 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 502' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 477' ' ' SER . 49.2 mt -126.46 133.41 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -114.18 124.55 52.33 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 475' ' ' ASP . 8.1 mpt_? -71.13 155.95 40.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.855 0.862 . . . . 0.0 112.152 -170.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.52 129.23 39.0 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.488 0.715 . . . . 0.0 110.753 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 86.18 -6.45 81.56 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.556 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -92.73 -175.59 3.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.835 0.854 . . . . 0.0 110.62 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 21.9 ptt? -145.03 160.96 40.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.922 0.889 . . . . 0.0 110.61 -176.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 509' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 468' ' ' LEU . 2.5 p -137.81 118.64 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.376 1.07 . . . . 0.0 108.367 175.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.7 m -105.07 110.82 23.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 54.2 t -89.18 99.73 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.152 0.581 . . . . 0.0 109.491 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -87.09 170.07 11.85 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.258 1.023 . . . . 0.0 111.518 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -84.28 148.89 26.44 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.114 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -67.04 -31.77 72.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.347 0.659 . . . . 0.0 111.163 174.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -75.42 -12.68 83.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.91 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -71.18 -14.2 62.18 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.391 0.677 . . . . 0.0 111.735 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 66.58 25.86 72.82 Favored Glycine 0 C--N 1.356 1.675 0 CA-C-O 121.124 0.291 . . . . 0.0 113.207 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 5.7 p -84.03 144.46 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.603 1.161 . . . . 0.0 111.066 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -69.29 107.69 3.37 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.81 0.844 . . . . 0.0 110.046 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -62.74 109.88 1.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.1 m -131.83 76.36 74.31 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.473 0.709 . . . . 0.0 110.413 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.0 145.05 87.58 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.757 2.305 . . . . 0.0 112.33 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.59 -23.76 12.27 Favored 'Cis proline' 0 C--N 1.373 1.838 0 CA-C-N 120.008 1.039 . . . . 0.0 113.923 -1.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.1 m -62.83 -29.82 71.02 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 21.9 m -130.44 95.47 3.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.352 0.661 . . . . 0.0 109.411 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 48.5 mt -91.29 147.14 23.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 168.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.57 118.9 44.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -75.12 94.2 2.89 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -66.72 134.75 52.85 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.96 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 104.78 -35.82 4.81 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -98.05 88.44 4.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.048 0.539 . . . . 0.0 110.256 172.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 60.3 p -68.3 -35.47 77.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.446 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 13.9 m -86.41 -32.58 20.81 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.007 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.56 23.03 5.64 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.028 0.931 . . . . 0.0 110.978 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.18 52.06 52.34 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 122.303 -0.248 . . . . 0.0 113.378 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 3.8 p -76.67 110.6 11.38 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.461 0.704 . . . . 0.0 110.458 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -122.01 169.77 14.85 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 173.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 559' ' ' LYS . 14.2 pt-20 -80.22 -12.02 59.67 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.915 0.358 . . . . 0.0 110.888 176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.472 ' HB2' HD13 ' A' ' 488' ' ' LEU . 20.3 m -152.9 137.72 17.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.417 1.087 . . . . 0.0 108.118 172.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.547 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 13.8 p90 -166.26 172.0 11.58 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.531 0.681 . . . . 0.0 111.564 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 541' ' ' ARG . 1.4 mpt_? -118.42 157.24 27.56 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.205 1.402 . . . . 0.0 107.532 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 95.3 m -144.2 119.81 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 41.1 t -113.34 146.63 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.074 0.949 . . . . 0.0 109.404 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 26.8 tp -113.24 125.15 53.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.507 HG21 ' HE2' ' A' ' 484' ' ' LYS . 61.2 t -111.85 154.8 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.132 1.373 . . . . 0.0 107.839 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.415 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.6 p30 -114.51 -174.54 2.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.509 0.324 . . . . 0.0 111.068 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.95 69.23 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.601 1.16 . . . . 0.0 113.217 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.4 -39.34 86.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.886 0.874 . . . . 0.0 111.98 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 107.42 0.47 35.05 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.144 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 550' ' ' GLU . . . . . 0.415 ' HG2' HD21 ' A' ' 546' ' ' ASN . 8.4 pt-20 -87.08 151.7 23.0 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.438 0.619 . . . . 0.0 110.537 172.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 545' ' ' VAL . 39.8 mt-10 -85.89 99.27 11.29 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.903 0.881 . . . . 0.0 109.459 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.23 -38.57 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.042 -171.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -136.55 157.02 47.75 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.167 0.587 . . . . 0.0 110.051 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.437 ' HG3' HG22 ' A' ' 543' ' ' VAL . 28.1 ttt -159.02 141.9 14.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.845 0.458 . . . . 0.0 110.973 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -132.8 164.19 27.39 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.146 1.378 . . . . 0.0 108.665 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 74.3 m -139.98 121.96 15.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.503 HG21 ' HB ' ' A' ' 459' ' ' ILE . 55.0 t -124.58 133.94 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.452 0.701 . . . . 0.0 110.686 -174.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -114.46 124.96 53.23 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.698 0.799 . . . . 0.0 109.679 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 559' ' ' LYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 538' ' ' GLU . 60.4 tttp . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 166.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 454' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 470' ' ' ASN . 9.3 t -95.95 157.74 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.315 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 35.6 t -145.15 165.42 28.36 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.427 0.691 . . . . 0.0 110.148 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 459' ' ' ILE . 24.9 mt -81.62 94.6 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.009 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.89 -50.65 19.22 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.015 0.526 . . . . 0.0 111.722 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -140.6 156.33 46.31 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 456' ' ' ILE . 22.1 mt -141.24 145.45 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.75 152.11 44.14 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.447 0.699 . . . . 0.0 111.339 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 462' ' ' GLU . 2.4 pp -62.21 -37.85 86.92 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.704 0.802 . . . . 0.0 112.379 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.686 ' HG2' ' HE3' ' A' ' 559' ' ' LYS . 27.8 mt-10 -83.4 -23.92 32.16 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.216 0.531 . . . . 0.0 109.786 169.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 85.57 21.01 55.31 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.327 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -70.62 -5.67 31.14 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.109 0.455 . . . . 0.0 110.323 -175.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -149.12 159.07 44.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.695 0.798 . . . . 0.0 110.285 166.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.22 124.03 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.766 1.226 . . . . 0.0 108.049 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -96.74 120.52 37.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.177 0.591 . . . . 0.0 109.731 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 483' ' ' ILE . 79.1 mt -118.27 119.44 34.68 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.825 0.85 . . . . 0.0 109.09 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -113.43 131.32 56.06 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 454' ' ' VAL . 49.8 t30 -81.46 109.51 15.99 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.496 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -86.1 -3.68 59.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.929 0.892 . . . . 0.0 111.877 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.6 m -77.42 155.3 31.9 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.335 0.588 . . . . 0.0 112.406 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.95 -24.96 52.35 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.391 174.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.3 OUTLIER -100.97 161.41 13.61 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.791 0.836 . . . . 0.0 109.8 178.618 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -85.16 121.78 28.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.237 1.015 . . . . 0.0 109.267 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -82.31 115.28 21.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.36 0.664 . . . . 0.0 110.552 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 24.0 p -70.2 99.5 1.52 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.6 tp -85.39 172.04 11.36 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.584 0.753 . . . . 0.0 109.883 -172.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 136.66 -55.76 0.7 Allowed Glycine 0 N--CA 1.471 0.983 0 CA-C-O 121.365 0.425 . . . . 0.0 112.226 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -70.93 -14.56 62.42 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.593 -0.803 . . . . 0.0 110.736 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -79.62 152.67 29.9 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.259 1.024 . . . . 0.0 109.424 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 -156.2 140.37 16.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.129 0.571 . . . . 0.0 110.627 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 12.7 mt -96.64 107.41 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.64 0.776 . . . . 0.0 109.627 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.647 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 67.9 mttm -76.3 161.09 29.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.178 0.513 . . . . 0.0 109.641 169.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -156.06 96.82 1.75 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -91.21 102.48 15.21 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.522 0.677 . . . . 0.0 109.49 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 489' ' ' GLU . 11.4 t -80.11 138.98 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.492 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 538' ' ' GLU . 4.6 pp -63.11 -17.88 62.81 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.918 0.487 . . . . 0.0 112.075 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 489' ' ' GLU . . . . . 0.41 ' H ' HG12 ' A' ' 487' ' ' VAL . 43.8 tt0 -60.93 -22.54 64.49 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.688 0.795 . . . . 0.0 111.163 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 116.68 28.26 2.56 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.79 -0.641 . . . . 0.0 114.361 170.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.67 165.54 26.67 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.473 0.636 . . . . 0.0 111.106 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -141.0 129.54 22.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.799 0.44 . . . . 0.0 110.23 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 29.4 pt -103.72 148.47 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -133.68 107.62 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.778 0.431 . . . . 0.0 110.153 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -83.71 106.31 15.32 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -81.47 152.46 27.35 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.94 0.4 . . . . 0.0 109.965 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.52 169.74 9.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.148 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 68.8 p -88.96 136.25 30.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 92.8 Cg_endo -73.12 -4.76 16.0 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.896 2.397 . . . . 0.0 113.472 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -90.68 -17.32 27.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.841 0.856 . . . . 0.0 110.837 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -75.53 133.63 40.96 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.776 0.83 . . . . 0.0 109.814 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 67.5 mt -119.89 124.32 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.73 112.1 23.28 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.444 ' H ' ' HD2' ' A' ' 504' ' ' ARG . 2.3 mpt_? -75.18 163.41 27.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.039 0.447 . . . . 0.0 111.067 -172.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.15 118.07 8.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.765 0.826 . . . . 0.0 111.088 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 85.9 -9.13 70.05 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 123.152 0.283 . . . . 0.0 113.784 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -75.98 171.29 14.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.169 0.588 . . . . 0.0 110.428 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -147.97 129.23 14.71 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.581 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.25 104.4 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 121.953 0.883 . . . . 0.0 109.202 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.9 m -87.43 94.24 9.64 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.407 HG12 ' HE1' ' A' ' 534' ' ' TRP . 48.2 t -86.96 99.25 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.33 0.652 . . . . 0.0 110.959 -177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 512' ' ' TRP . . . . . 0.57 ' HB2' HG22 ' A' ' 527' ' ' VAL . 55.2 m95 -84.96 174.89 9.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.162 0.985 . . . . 0.0 111.889 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -97.35 143.34 28.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.056 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -59.85 -37.75 80.16 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.501 0.72 . . . . 0.0 111.489 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -76.4 -0.57 67.29 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.769 -0.65 . . . . 0.0 114.621 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -78.35 -8.69 58.73 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.879 0.471 . . . . 0.0 111.305 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 69.07 23.23 76.15 Favored Glycine 0 C--N 1.361 1.918 0 C-N-CA 123.221 0.439 . . . . 0.0 113.65 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.17 146.26 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.47 1.108 . . . . 0.0 110.403 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -75.59 114.68 14.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.586 0.755 . . . . 0.0 110.164 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 520' ' ' HIS . . . . . 0.445 ' NE2' HD12 ' A' ' 526' ' ' LEU . 20.5 t-160 -69.06 117.03 10.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.84 0.456 . . . . 0.0 109.825 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.6 m -134.74 78.47 55.2 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 123.426 0.691 . . . . 0.0 110.001 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.63 151.46 82.71 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.176 1.917 . . . . 0.0 111.061 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.37 -29.64 4.34 Favored 'Cis proline' 0 CA--C 1.559 1.766 0 CA-C-N 120.48 1.207 . . . . 0.0 114.768 4.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 10.0 m -73.38 -26.12 60.86 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.514 0.726 . . . . 0.0 112.619 -164.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 44.6 m -124.32 83.53 2.16 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.445 HD12 ' NE2' ' A' ' 520' ' ' HIS . 20.7 tp -86.77 150.01 24.45 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.404 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 512' ' ' TRP . 67.6 t -134.91 126.05 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.47 -0.769 . . . . 0.0 109.275 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -69.21 95.17 0.74 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 171.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 529' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 56.2 tptt -67.46 135.24 52.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.95 0.9 . . . . 0.0 110.052 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 89.57 -15.55 58.52 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.381 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.49 120.64 30.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.042 0.537 . . . . 0.0 109.614 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 14.3 p -78.65 -60.37 2.41 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.194 0.598 . . . . 0.0 112.145 -176.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 17.2 t -116.13 -1.46 12.43 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -166.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.407 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 62.72 23.49 13.99 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.212 1.005 . . . . 0.0 110.761 -174.201 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.43 67.06 2.25 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 112.396 -0.282 . . . . 0.0 112.396 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 13.8 t -72.22 163.57 27.71 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.875 0.47 . . . . 0.0 110.936 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -177.64 165.77 35.68 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' GLU . . . . . 0.536 ' HG3' HD21 ' A' ' 488' ' ' LEU . 8.8 pt-20 -59.61 -27.94 66.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.011 0.924 . . . . 0.0 111.902 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.53 ' HB3' HD23 ' A' ' 488' ' ' LEU . 41.1 t -164.3 143.83 7.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.96 0.904 . . . . 0.0 110.167 169.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -156.69 143.92 18.9 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.476 1.11 . . . . 0.0 109.0 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 14.6 ptt-85 -97.29 105.3 17.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.283 0.563 . . . . 0.0 109.776 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 86.0 m -85.16 122.65 29.66 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 71.1 t -121.41 138.35 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.657 1.183 . . . . 0.0 109.857 -171.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 29.4 tp -99.88 122.25 42.54 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 171.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.13 154.0 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.182 1.393 . . . . 0.0 108.435 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.43 HD21 ' HG2' ' A' ' 550' ' ' GLU . 2.5 p30 -117.12 -168.15 1.43 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.93 0.492 . . . . 0.0 111.531 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.2 76.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.787 1.235 . . . . 0.0 113.435 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.25 -38.48 80.17 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.363 0.665 . . . . 0.0 111.403 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 103.24 2.05 47.94 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.378 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 550' ' ' GLU . . . . . 0.43 ' HG2' HD21 ' A' ' 546' ' ' ASN . 10.3 pt-20 -86.64 152.3 22.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.174 0.512 . . . . 0.0 110.541 171.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -80.12 106.51 12.2 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.016 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 15.8 m -82.04 -35.69 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 122.32 0.248 . . . . 0.0 111.338 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -137.17 149.27 47.14 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.561 0.744 . . . . 0.0 109.562 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.429 ' HG3' HG22 ' A' ' 543' ' ' VAL . 19.2 ttt -150.94 135.24 16.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.138 0.975 . . . . 0.0 109.524 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -145.96 134.22 21.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.984 0.913 . . . . 0.0 109.919 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 36.7 m -97.87 135.86 39.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.437 0.695 . . . . 0.0 109.665 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 459' ' ' ILE . 41.1 t -111.11 129.28 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.789 1.236 . . . . 0.0 108.792 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.27 110.2 22.09 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 559' ' ' LYS . . . . . 0.686 ' HE3' ' HG2' ' A' ' 462' ' ' GLU . 83.0 tttt . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 43.9 m . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 121.316 0.579 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.49 147.6 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.0 m -142.25 148.28 37.84 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.836 0.854 . . . . 0.0 109.185 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' ILE . . . . . 0.46 ' HA ' HD12 ' A' ' 468' ' ' LEU . 53.2 mt -69.59 132.53 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.699 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 10.5 tp10 -94.83 -66.28 0.92 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.045 0.538 . . . . 0.0 110.249 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.699 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 34.0 mt-10 -133.81 157.18 46.57 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.497 0.719 . . . . 0.0 109.155 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.535 HD13 ' HB ' ' A' ' 542' ' ' THR . 77.8 mt -141.91 139.6 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.64 143.64 51.37 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 123.666 0.604 . . . . 0.0 110.187 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.566 HD12 ' HG3' ' A' ' 462' ' ' GLU . 2.9 pp -71.05 -29.91 65.94 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.482 0.713 . . . . 0.0 112.009 -175.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.566 ' HG3' HD12 ' A' ' 461' ' ' LEU . 36.7 mt-10 -82.25 -31.63 30.06 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 170.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 97.58 41.25 3.43 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 114.904 -1.043 . . . . 0.0 112.633 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -76.21 -27.02 56.67 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.817 0.847 . . . . 0.0 110.798 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -159.23 163.3 36.0 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.367 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 42.6 t -122.65 114.9 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.9 tp-100 -85.51 107.17 17.33 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 171.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.55 HD22 HD11 ' A' ' 483' ' ' ILE . 29.6 tp -105.35 132.08 51.99 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 123.943 0.897 . . . . 0.0 108.83 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 469' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 54.3 tttm -113.7 142.07 46.47 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.355 0.525 . . . . 0.0 111.101 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -89.06 128.77 35.75 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -117.23 12.5 14.4 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.012 0.925 . . . . 0.0 110.979 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 33.8 t -75.88 160.32 30.05 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.723 0.809 . . . . 0.0 110.342 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -87.54 0.25 55.86 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.435 0.694 . . . . 0.0 111.769 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 179.23 7.89 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.611 1.164 . . . . 0.0 109.314 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -53.39 104.49 0.1 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.328 0.651 . . . . 0.0 109.984 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -78.94 112.11 15.79 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 28.8 t -68.84 98.36 0.92 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.776 0.672 . . . . 0.0 109.585 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.1 tp -86.03 174.31 9.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.927 0.891 . . . . 0.0 108.816 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 134.83 -56.53 0.71 Allowed Glycine 0 N--CA 1.468 0.832 0 O-C-N 122.032 -0.417 . . . . 0.0 112.66 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.9 -13.47 62.26 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.788 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -81.47 162.73 23.15 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.147 0.979 . . . . 0.0 110.177 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' ARG . . . . . 0.575 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 11.9 ptt180 -157.34 127.8 6.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.61 0.764 . . . . 0.0 110.66 -174.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 483' ' ' ILE . . . . . 0.55 HD11 HD22 ' A' ' 468' ' ' LEU . 50.3 mt -93.49 109.86 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.11 0.564 . . . . 0.0 109.601 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.714 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 97.8 mttt -81.9 167.41 18.99 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.242 0.617 . . . . 0.0 110.827 171.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 485' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 534' ' ' TRP . 42.5 ttm180 -151.69 118.38 5.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 166.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 486' ' ' GLN . . . . . 0.461 ' OE1' ' HB3' ' A' ' 492' ' ' GLU . 23.4 mm-40 -97.84 102.33 14.06 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.024 1.33 . . . . 0.0 108.568 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 40.0 t -75.04 156.78 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.21 0.604 . . . . 0.0 109.807 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 539' ' ' SER . 4.2 pp -54.9 -25.82 31.71 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.411 1.085 . . . . 0.0 113.757 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 489' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 491' ' ' GLU . 13.1 pt-20 -86.51 -21.15 27.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.082 0.553 . . . . 0.0 111.249 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 117.45 14.07 7.14 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.516 -0.602 . . . . 0.0 114.188 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 491' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 489' ' ' GLU . 50.8 mt-10 -76.49 109.78 10.5 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 117.945 0.873 . . . . 0.0 110.305 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.461 ' HB3' ' OE1' ' A' ' 486' ' ' GLN . 7.0 pt-20 -101.11 98.61 9.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.149 0.98 . . . . 0.0 109.815 178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.48 139.37 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.43 ' HB2' ' HG2' ' A' ' 484' ' ' LYS . . . -135.49 112.74 10.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.856 0.462 . . . . 0.0 111.09 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -82.9 112.87 20.09 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.71 0.804 . . . . 0.0 110.281 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -84.81 145.41 27.88 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.52 169.57 10.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.415 0.686 . . . . 0.0 109.923 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 82.5 p -89.42 132.55 36.93 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.324 0.65 . . . . 0.0 109.25 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.44 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 52.0 Cg_exo -58.39 -15.98 26.86 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.422 2.748 . . . . 0.0 114.808 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -79.38 -24.05 42.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.243 0.617 . . . . 0.0 111.284 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -74.29 130.68 40.17 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.466 0.706 . . . . 0.0 110.23 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 46.7 mt -134.71 124.41 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.468 0.707 . . . . 0.0 109.23 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.74 135.16 43.76 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -77.12 154.24 33.45 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.602 0.761 . . . . 0.0 112.156 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -59.78 131.28 50.43 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.053 0.941 . . . . 0.0 110.371 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 89.49 -42.4 3.0 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.47 0.481 . . . . 0.0 112.57 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -66.25 178.35 1.21 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.367 1.067 . . . . 0.0 112.257 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 15.9 ptp -153.13 150.24 28.88 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.391 -174.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 2.8 p -112.04 118.62 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.256 1.422 . . . . 0.0 108.84 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.6 m -95.33 99.75 11.63 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.27 97.58 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.126 0.57 . . . . 0.0 109.994 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -83.56 172.35 12.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.423 1.089 . . . . 0.0 111.616 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -89.85 154.05 20.18 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.041 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.56 68.07 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.066 0.46 . . . . 0.0 110.416 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -75.21 -8.48 83.45 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.615 -0.72 . . . . 0.0 113.986 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -74.56 -19.24 60.4 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.261 0.625 . . . . 0.0 110.772 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.06 22.65 77.3 Favored Glycine 0 C--N 1.357 1.744 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.313 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.16 142.27 13.46 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.252 1.021 . . . . 0.0 109.969 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -69.5 127.52 33.28 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.574 0.75 . . . . 0.0 110.367 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -65.79 110.06 2.69 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.2 m -135.59 80.17 45.29 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.364 0.666 . . . . 0.0 109.953 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.61 154.08 44.9 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.918 2.412 . . . . 0.0 112.685 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -84.82 -17.61 25.96 Favored 'Cis proline' 0 C--N 1.374 1.882 0 CA-C-N 119.898 0.999 . . . . 0.0 114.005 -0.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 21.3 m -71.46 -38.96 71.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.311 0.644 . . . . 0.0 112.427 -169.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 74.0 m -121.35 97.49 5.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.022 0.529 . . . . 0.0 110.615 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 9.4 mp -93.04 145.26 24.51 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 166.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 91.9 t -127.97 126.69 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -73.09 96.99 2.27 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.24 130.29 42.81 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.15 0.98 . . . . 0.0 110.545 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 94.85 -45.86 2.11 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.511 0.507 . . . . 0.0 112.907 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -75.24 100.72 4.42 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 55.4 m -76.1 -43.61 42.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.058 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 536' ' ' THR . 16.8 m -85.55 -29.23 24.35 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -165.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.64 27.05 4.81 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 124.001 0.92 . . . . 0.0 110.611 -174.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.04 58.65 11.02 Favored Glycine 0 C--N 1.345 1.028 0 O-C-N 122.474 -0.141 . . . . 0.0 113.08 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 533' ' ' SER . 2.4 p -64.51 121.73 15.1 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.194 0.598 . . . . 0.0 110.523 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -154.67 155.1 25.98 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.703 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -78.82 -11.02 59.97 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.1 0.476 . . . . 0.0 110.503 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 558' ' ' LYS . 20.9 m -151.61 130.66 12.62 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.192 0.997 . . . . 0.0 108.728 173.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.474 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 8.5 p90 -161.24 171.77 17.83 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.098 0.959 . . . . 0.0 110.287 172.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.615 ' HD3' ' SD ' ' A' ' 554' ' ' MET . 7.0 ptp180 -129.4 109.36 11.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 542' ' ' THR . . . . . 0.535 ' HB ' HD13 ' A' ' 459' ' ' ILE . 21.6 m -87.43 122.27 30.95 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.714 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 41.0 t -108.69 143.86 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.134 0.973 . . . . 0.0 110.075 -170.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 67.1 tp -108.39 123.11 48.34 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.017 0.927 . . . . 0.0 108.539 168.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.575 ' HB ' ' HG3' ' A' ' 482' ' ' ARG . 75.7 t -116.25 144.77 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.389 1.076 . . . . 0.0 108.651 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.557 HD22 ' HG3' ' A' ' 550' ' ' GLU . 8.9 p30 -102.42 -172.89 2.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.809 0.843 . . . . 0.0 111.479 177.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.93 80.99 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.836 1.254 . . . . 0.0 113.723 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -55.87 -39.67 71.86 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.847 0.859 . . . . 0.0 111.899 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.39 -7.71 28.51 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.532 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 550' ' ' GLU . . . . . 0.557 ' HG3' HD22 ' A' ' 546' ' ' ASN . 9.4 pt-20 -73.39 141.26 46.99 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.14 0.47 . . . . 0.0 110.293 174.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -84.35 82.47 8.37 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.41 -39.85 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.267 -171.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -131.53 154.73 48.49 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.325 0.65 . . . . 0.0 110.027 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.615 ' SD ' ' HD3' ' A' ' 541' ' ' ARG . 60.0 ttp -161.33 135.67 7.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.731 0.812 . . . . 0.0 109.524 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -128.18 114.09 16.54 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.037 0.935 . . . . 0.0 109.138 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 29.7 m -81.3 113.55 19.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.201 0.6 . . . . 0.0 109.389 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.509 HG21 ' HB ' ' A' ' 459' ' ' ILE . 82.1 t -114.53 112.27 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.019 0.928 . . . . 0.0 110.063 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 558' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 2.6 mppt? -98.79 137.61 37.13 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 165.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 82.7 tttt . . . . . 0 CA--C 1.545 0.758 0 C-N-CA 123.764 0.825 . . . . 0.0 110.648 -179.229 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 27.9 t -104.13 117.75 50.2 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 25.1 t -113.05 155.01 25.62 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.088 0.555 . . . . 0.0 110.419 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.47 111.96 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -84.36 -69.47 0.64 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.163 0.585 . . . . 0.0 110.414 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 27.6 mt-10 -117.47 150.28 39.18 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.033 -171.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 50.6 mt -139.58 143.69 30.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.02 148.87 48.31 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -15.72 57.61 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.46 1.104 . . . . 0.0 113.605 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -111.44 -30.79 7.26 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.855 1.262 . . . . 0.0 109.167 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 105.27 31.14 4.45 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.339 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 516' ' ' ALA . 1.9 mppt? -73.71 -8.62 56.72 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.703 0.751 . . . . 0.0 110.915 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -156.83 157.26 34.63 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.289 0.636 . . . . 0.0 111.021 172.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 77.3 t -134.27 113.69 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.868 1.267 . . . . 0.0 107.862 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.7 tp-100 -86.03 107.9 18.0 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.876 0.87 . . . . 0.0 109.497 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.482 HD22 HD22 ' A' ' 544' ' ' LEU . 50.4 mt -92.82 160.62 14.85 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 170.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -145.13 127.34 15.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -89.92 97.92 11.47 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -74.46 -10.98 60.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.255 1.022 . . . . 0.0 111.706 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.5 t -63.56 145.69 55.18 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.697 0.799 . . . . 0.0 111.677 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.26 -0.12 48.12 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.176 0.99 . . . . 0.0 111.412 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.13 164.91 27.32 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 124.36 1.064 . . . . 0.0 108.644 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.92 161.39 10.6 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.751 0.821 . . . . 0.0 111.802 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 13.4 tm0? -136.51 112.43 9.59 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.423 ' HA ' HG12 ' A' ' 502' ' ' ILE . 23.4 p -65.24 103.16 0.74 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.312 0.645 . . . . 0.0 109.896 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.67 161.71 16.71 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -172.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 147.94 -66.39 0.4 Allowed Glycine 0 N--CA 1.473 1.162 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.738 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -69.07 -12.61 61.84 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.295 0.638 . . . . 0.0 111.134 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -67.1 145.08 55.68 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.554 1.142 . . . . 0.0 110.387 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' ARG . . . . . 0.5 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 4.3 ptt85 -148.76 123.86 10.1 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.293 -171.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 483' ' ' ILE . . . . . 0.4 HD11 HD11 ' A' ' 468' ' ' LEU . 45.3 mt -90.51 109.26 20.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 123.916 0.886 . . . . 0.0 109.307 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.613 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.0 mttt -77.9 123.95 27.39 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 174.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 49.8 mmm-85 -119.95 92.35 3.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -111.98 116.73 31.06 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 489' ' ' GLU . 13.0 t -103.65 147.78 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.72 -24.45 65.38 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 120.949 0.404 . . . . 0.0 111.392 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' GLU . . . . . 0.54 ' H ' HG12 ' A' ' 487' ' ' VAL . 22.5 mm-40 -61.53 -23.88 66.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.318 1.047 . . . . 0.0 110.603 171.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 126.0 -21.64 6.16 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-O 119.613 -0.549 . . . . 0.0 113.27 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.15 102.62 0.85 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.185 0.594 . . . . 0.0 111.358 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -126.71 116.25 20.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.612 0.765 . . . . 0.0 110.209 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.4 HD12 ' CZ3' ' A' ' 528' ' ' TRP . 20.2 pt -136.55 176.14 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.812 1.245 . . . . 0.0 109.57 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -149.26 108.54 3.94 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -80.56 105.04 11.51 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.25 149.27 31.91 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -91.88 171.74 8.93 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.665 0.786 . . . . 0.0 110.177 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.4 p -90.65 133.19 33.08 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.491 0.716 . . . . 0.0 109.489 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.14 8.5 3.18 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.021 2.481 . . . . 0.0 113.321 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -101.74 -22.84 14.31 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.802 1.241 . . . . 0.0 110.46 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -84.96 123.69 30.81 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 502' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 477' ' ' SER . 54.2 mt -104.61 129.99 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.8 127.87 33.42 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 174.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -88.12 158.87 18.44 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.23 127.02 29.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.667 1.187 . . . . 0.0 112.543 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 65.92 14.71 61.45 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.6 0.562 . . . . 0.0 113.747 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -105.52 -164.05 0.99 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.894 0.878 . . . . 0.0 110.282 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -152.7 163.28 39.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.037 0.935 . . . . 0.0 110.448 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.22 116.65 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.19 101.71 13.39 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 59.3 t -87.32 106.03 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 122.75 0.42 . . . . 0.0 110.347 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 512' ' ' TRP . . . . . 0.529 ' HB2' HG22 ' A' ' 527' ' ' VAL . 36.3 m95 -94.72 179.46 5.24 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.686 0.795 . . . . 0.0 111.312 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.687 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -107.3 155.44 19.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.288 1.035 . . . . 0.0 110.067 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 514' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -65.76 -33.39 75.76 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.19 0.596 . . . . 0.0 110.532 172.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 515' ' ' GLY . . . . . 0.451 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -78.47 -3.91 86.76 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.939 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . . . -76.58 -8.48 57.31 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.009 0.524 . . . . 0.0 110.562 169.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 73.96 21.11 79.57 Favored Glycine 0 C--N 1.36 1.871 0 C-N-CA 123.517 0.579 . . . . 0.0 113.21 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.38 143.71 16.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.332 1.053 . . . . 0.0 110.391 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -87.15 141.51 28.6 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.525 0.73 . . . . 0.0 110.398 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -61.78 119.17 8.23 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.85 0.86 . . . . 0.0 109.679 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 39.6 m -129.97 75.44 79.49 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.594 0.757 . . . . 0.0 109.881 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.66 161.23 39.96 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.735 2.29 . . . . 0.0 112.05 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.49 17.78 41.41 Favored 'Cis proline' 0 C--N 1.379 2.17 0 CA-C-N 119.771 0.954 . . . . 0.0 113.673 0.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.4 m -90.42 -68.3 0.79 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.185 0.594 . . . . 0.0 110.052 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 525' ' ' THR . . . . . 0.443 HG23 ' CD1' ' A' ' 512' ' ' TRP . 72.0 m -90.36 95.05 10.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.115 0.966 . . . . 0.0 110.298 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 10.9 mp -92.47 104.93 17.2 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 173.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 512' ' ' TRP . 96.8 t -91.48 123.64 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 528' ' ' TRP . . . . . 0.4 ' CZ3' HD12 ' A' ' 493' ' ' ILE . 7.0 t90 -71.53 89.3 0.96 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 173.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 529' ' ' LYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 25.2 tptp -76.28 117.96 18.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.953 -175.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 123.28 -40.42 1.99 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.0 116.18 28.59 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 532' ' ' SER . . . . . 0.451 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 63.1 p -88.29 -41.65 12.76 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.12 0.568 . . . . 0.0 111.506 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.4 p -79.94 -31.22 40.04 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.687 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 54.49 23.81 4.84 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 123.699 0.799 . . . . 0.0 110.602 -175.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 72.82 67.53 1.79 Allowed Glycine 0 C--N 1.353 1.483 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 -171.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 5.1 p -63.31 140.1 58.84 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.066 0.546 . . . . 0.0 110.733 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -167.59 143.93 8.58 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.628 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.62 -25.55 53.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.287 0.635 . . . . 0.0 110.088 171.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 14.8 m -148.92 120.58 8.04 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.218 1.007 . . . . 0.0 108.484 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -150.64 169.62 21.15 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.989 0.915 . . . . 0.0 110.978 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -117.85 116.99 28.09 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.002 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 40.3 m -96.58 117.34 30.75 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 45.0 t -117.85 139.19 45.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.359 1.064 . . . . 0.0 108.526 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 31.5 tp -110.11 115.87 30.53 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.523 HG21 ' HE3' ' A' ' 484' ' ' LYS . 63.8 t -108.47 151.73 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.494 1.118 . . . . 0.0 108.778 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.446 HD21 ' HG2' ' A' ' 550' ' ' GLU . 0.5 OUTLIER -110.16 -173.09 2.17 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.949 0.5 . . . . 0.0 111.119 -176.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -60.92 -35.67 77.3 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.377 1.071 . . . . 0.0 113.069 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.02 -40.74 98.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.079 0.552 . . . . 0.0 110.524 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 112.48 -11.3 26.0 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.595 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 550' ' ' GLU . . . . . 0.446 ' HG2' HD21 ' A' ' 546' ' ' ASN . 10.6 pt-20 -69.66 146.47 51.61 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 117.78 0.79 . . . . 0.0 110.009 172.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.442 ' HG2' HG22 ' A' ' 545' ' ' VAL . 38.4 mt-10 -84.71 99.1 10.62 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 33.3 m -78.02 -25.85 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.146 -170.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -144.27 156.13 44.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.678 0.791 . . . . 0.0 109.554 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.518 ' HG3' HG22 ' A' ' 543' ' ' VAL . 56.9 ttp -160.2 146.93 15.89 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.343 0.657 . . . . 0.0 109.715 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.68 117.08 4.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.902 0.481 . . . . 0.0 110.402 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 62.1 m -87.93 103.72 15.95 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.724 0.81 . . . . 0.0 108.874 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.0 p -114.93 129.56 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.153 0.981 . . . . 0.0 110.432 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.94 163.32 32.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.134 0.973 . . . . 0.0 109.948 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm . . . . . 0 CA--C 1.537 0.468 0 C-N-CA 123.843 0.857 . . . . 0.0 109.597 -175.938 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 12.3 t -98.53 162.74 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.433 1.093 . . . . 0.0 109.954 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 35.7 t -145.82 152.0 38.82 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.876 1.27 . . . . 0.0 109.366 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.0 mt -86.08 107.67 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -86.68 -53.08 5.15 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -171.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 30.0 mt-10 -136.79 163.02 31.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.637 HG23 HH21 ' A' ' 485' ' ' ARG . 89.0 mt -147.67 143.69 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.098 1.359 . . . . 0.0 107.749 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' ASP . . . . . 0.462 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 37.2 t70 -66.98 148.33 52.1 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.74 0.416 . . . . 0.0 111.138 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 559' ' ' LYS . 0.4 OUTLIER -64.34 -27.42 69.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.968 0.907 . . . . 0.0 112.634 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.01 -32.01 11.86 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.28 0.632 . . . . 0.0 109.571 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 103.35 44.04 1.77 Allowed Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.545 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -91.04 -9.55 45.45 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.542 0.737 . . . . 0.0 111.15 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 29.5 p90 -154.71 161.09 41.69 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.33 0.586 . . . . 0.0 112.373 173.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 42.3 t -127.11 117.62 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.473 1.509 . . . . 0.0 107.335 169.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.3 tp-100 -86.03 112.41 21.21 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.499 HD22 HD11 ' A' ' 483' ' ' ILE . 16.5 tp -112.15 121.34 44.66 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.994 0.917 . . . . 0.0 108.736 -176.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -113.41 139.09 49.19 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.024 0.53 . . . . 0.0 111.698 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.488 ' HB2' HD12 ' A' ' 503' ' ' LEU . 52.9 t30 -92.71 137.23 32.54 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -127.62 16.4 6.98 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.48 0.712 . . . . 0.0 109.92 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 41.9 t -73.79 152.85 40.2 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.759 0.824 . . . . 0.0 109.459 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.86 -21.35 62.44 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.376 0.67 . . . . 0.0 111.014 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.442 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.0 OUTLIER -122.97 174.89 6.9 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.469 0.708 . . . . 0.0 109.687 176.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 475' ' ' ASP . . . . . 0.492 ' HB2' HG22 ' A' ' 502' ' ' ILE . 5.1 p-10 -65.13 111.65 3.03 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.037 0.935 . . . . 0.0 109.963 172.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -78.03 122.41 25.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.08 0.952 . . . . 0.0 110.426 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 18.2 p -66.2 98.01 0.43 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.687 0.756 . . . . 0.0 109.626 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.6 tp -89.46 162.6 15.65 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 135.13 -51.16 0.84 Allowed Glycine 0 N--CA 1.471 0.998 0 O-C-N 121.451 -0.78 . . . . 0.0 112.334 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -68.66 -13.5 62.4 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.203 -0.999 . . . . 0.0 111.0 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -91.9 162.63 14.34 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 124.713 1.205 . . . . 0.0 110.294 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -153.43 143.75 22.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.97 0.908 . . . . 0.0 110.337 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' ILE . . . . . 0.499 HD11 HD22 ' A' ' 468' ' ' LEU . 61.5 mt -102.51 107.73 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.438 0.695 . . . . 0.0 109.618 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.668 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.5 mttt -78.67 162.24 26.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.321 0.649 . . . . 0.0 111.626 172.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 485' ' ' ARG . . . . . 0.637 HH21 HG23 ' A' ' 459' ' ' ILE . 71.2 mtt180 -153.03 102.46 2.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.201 1.4 . . . . 0.0 108.377 170.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 486' ' ' GLN . . . . . 0.491 ' HG3' ' HD3' ' A' ' 541' ' ' ARG . 8.4 pt20 -101.8 109.33 21.07 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.727 0.811 . . . . 0.0 109.712 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.475 HG12 HD23 ' A' ' 488' ' ' LEU . 6.6 t -89.44 156.58 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.919 0.888 . . . . 0.0 109.19 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 487' ' ' VAL . 2.7 pt? -66.41 -18.15 65.19 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.028 0.442 . . . . 0.0 111.458 173.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 489' ' ' GLU . . . . . 0.405 ' H ' HG12 ' A' ' 487' ' ' VAL . 37.4 mt-10 -83.08 4.73 25.07 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.49 1.116 . . . . 0.0 111.779 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 102.16 -26.1 25.46 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.145 -0.808 . . . . 0.0 114.469 168.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.53 104.53 0.81 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.677 0.739 . . . . 0.0 111.001 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.53 79.84 1.35 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.4 1.08 . . . . 0.0 108.961 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 35.6 pt -97.54 170.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.741 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -155.49 116.39 3.89 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.735 0.414 . . . . 0.0 110.162 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -80.17 108.49 13.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.966 0.506 . . . . 0.0 109.769 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -76.35 150.3 36.88 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.72 167.76 11.08 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 76.2 p -95.82 132.76 26.56 Favored Pre-proline 0 N--CA 1.477 0.897 0 CA-C-O 118.441 -0.79 . . . . 0.0 108.994 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.486 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 54.3 Cg_exo -55.27 -25.7 48.33 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 123.206 2.604 . . . . 0.0 115.066 -175.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -68.33 -24.67 64.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.038 0.535 . . . . 0.0 111.457 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -73.39 127.34 32.41 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.2 1.0 . . . . 0.0 109.478 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 475' ' ' ASP . 43.4 mt -129.66 118.69 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 503' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 470' ' ' ASN . 1.4 tm? -93.36 125.82 38.16 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -67.54 163.34 21.37 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.326 1.05 . . . . 0.0 113.227 -168.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.2 116.69 5.66 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.352 1.061 . . . . 0.0 111.851 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 80.94 -14.93 23.96 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 123.485 0.49 . . . . 0.0 113.926 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -79.29 -172.94 3.42 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.122 0.969 . . . . 0.0 111.068 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -154.42 147.49 24.66 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.33 0.586 . . . . 0.0 112.268 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.76 127.88 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.814 1.245 . . . . 0.0 109.135 172.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.89 99.99 11.12 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.55 97.92 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 122.856 0.462 . . . . 0.0 110.044 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -86.61 178.24 7.12 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.044 0.938 . . . . 0.0 111.506 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.612 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.26 158.49 16.0 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.814 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 514' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.74 -28.18 67.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.386 0.675 . . . . 0.0 110.591 172.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -76.16 -16.99 80.3 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.466 -0.788 . . . . 0.0 114.066 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -68.32 -29.3 68.02 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.168 0.587 . . . . 0.0 110.729 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.72 26.47 73.99 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 116.321 -0.399 . . . . 0.0 113.635 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 13.4 p -81.09 159.03 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.827 1.251 . . . . 0.0 111.117 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -73.8 113.9 11.48 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.128 0.571 . . . . 0.0 110.139 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -64.85 110.87 2.57 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.093 0.557 . . . . 0.0 109.625 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.9 m -127.39 69.35 74.73 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.16 0.584 . . . . 0.0 110.254 -175.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.88 149.69 60.2 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.35 2.033 . . . . 0.0 111.87 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.42 -13.87 34.77 Favored 'Cis proline' 0 C--N 1.376 2.012 0 N-CA-C 114.442 0.901 . . . . 0.0 114.442 -2.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.3 m -60.12 -28.55 67.95 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.868 0.867 . . . . 0.0 113.048 -172.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 97.1 m -140.75 101.21 4.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.07 0.948 . . . . 0.0 108.878 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.86 138.94 31.21 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 83.4 t -113.67 117.73 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -70.45 92.34 0.81 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 529' ' ' LYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.7 tptt -68.45 135.07 51.11 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.121 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 91.54 -14.77 63.06 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.17 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -100.91 110.89 23.0 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 66.1 p -82.34 -50.79 8.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.327 0.584 . . . . 0.0 111.219 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.597 ' HB3' HG22 ' A' ' 536' ' ' THR . 20.3 m -90.11 -28.51 18.93 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.939 -167.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 56.56 38.09 29.33 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.05 0.94 . . . . 0.0 110.142 -176.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.47 52.91 45.69 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.597 HG22 ' HB3' ' A' ' 533' ' ' SER . 14.3 t -72.21 156.01 39.61 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.51 0.724 . . . . 0.0 110.274 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 179.97 167.87 37.79 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.8 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -71.84 -25.29 61.91 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 18.2 m -154.42 121.69 5.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.856 0.862 . . . . 0.0 109.71 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.45 ' HB3' HG22 ' A' ' 487' ' ' VAL . 31.5 p90 -143.65 150.7 39.13 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.431 0.692 . . . . 0.0 111.06 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.491 ' HD3' ' HG3' ' A' ' 486' ' ' GLN . 5.4 mpt_? -101.92 106.21 17.12 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 33.5 m -84.99 106.34 16.41 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.668 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 28.3 t -105.64 133.48 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.058 0.943 . . . . 0.0 110.127 -170.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.2 tp -98.08 119.67 37.13 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.466 HG22 ' HG2' ' A' ' 551' ' ' GLU . 40.2 t -115.86 143.66 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.428 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.6 p30 -105.38 -172.89 2.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.499 0.32 . . . . 0.0 110.919 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -52.72 -40.23 62.83 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.844 1.258 . . . . 0.0 113.745 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.01 -36.9 82.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.613 0.765 . . . . 0.0 111.87 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.3 -19.48 29.34 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.035 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' GLU . . . . . 0.428 ' HG2' HD21 ' A' ' 546' ' ' ASN . 11.3 pt-20 -66.95 134.81 52.75 Favored 'General case' 0 C--O 1.248 1.019 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.466 ' HG2' HG22 ' A' ' 545' ' ' VAL . 44.7 mt-10 -79.33 102.27 8.54 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 28.0 m -74.29 -37.39 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.651 -172.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -133.78 159.95 39.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.59 0.756 . . . . 0.0 109.32 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.52 ' HG3' HG22 ' A' ' 543' ' ' VAL . 27.4 ttt -157.41 125.28 5.4 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -137.32 105.86 5.82 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -172.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 49.8 m -83.63 110.32 18.16 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.243 0.617 . . . . 0.0 109.682 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.9 116.62 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -87.6 147.97 25.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.664 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 559' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 461' ' ' LEU . 20.6 tttm . . . . . 0 CA--C 1.544 0.733 0 C-N-CA 123.835 0.854 . . . . 0.0 110.254 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' SER . . . . . 0.405 ' HB3' ' OG ' ' A' ' 472' ' ' SER . 16.6 m . . . . . 0 CA--C 1.545 0.765 0 CA-C-O 120.999 0.428 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.07 150.8 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.964 1.306 . . . . 0.0 107.646 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 22.7 t -137.12 153.21 50.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.866 0.866 . . . . 0.0 109.629 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 64.8 mt -76.64 107.19 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 14.0 tp10 -78.54 -68.68 0.62 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 28.9 mt-10 -130.44 167.45 18.58 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.864 0.866 . . . . 0.0 109.16 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 23.4 mt -141.43 147.43 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 20.8 t70 -66.65 145.92 55.05 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.249 0.62 . . . . 0.0 111.245 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 462' ' ' GLU . 0.4 OUTLIER -63.94 -33.6 76.09 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.403 1.081 . . . . 0.0 112.74 -178.05 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.417 ' H ' HD12 ' A' ' 461' ' ' LEU . 44.8 mt-10 -93.38 -23.75 18.33 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.895 0.878 . . . . 0.0 110.285 173.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.67 32.46 7.24 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.001 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -79.26 -15.66 57.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.545 0.738 . . . . 0.0 111.215 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 20.5 p90 -155.15 162.17 41.05 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.277 0.56 . . . . 0.0 111.621 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.46 119.59 59.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 125.296 1.438 . . . . 0.0 107.813 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.413 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 29.3 tp60 -88.48 109.74 20.28 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.56 ' HB2' HG13 ' A' ' 509' ' ' VAL . 87.0 mt -100.13 155.72 17.58 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 469' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 508' ' ' MET . 0.0 OUTLIER -140.47 129.8 23.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 175.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.72 111.2 17.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.947 0.899 . . . . 0.0 110.163 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.73 -10.84 59.7 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.146 0.979 . . . . 0.0 111.939 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 453' ' ' SER . 50.4 m -59.9 148.58 34.44 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.72 -15.81 63.22 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.653 1.181 . . . . 0.0 111.408 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.17 176.34 8.84 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.317 1.047 . . . . 0.0 110.447 -171.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.11 108.7 0.72 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.143 0.977 . . . . 0.0 110.675 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -79.92 117.34 20.68 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.405 0.682 . . . . 0.0 110.423 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.539 ' HA ' HG12 ' A' ' 502' ' ' ILE . 8.9 p -73.3 105.79 4.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.756 0.822 . . . . 0.0 109.906 175.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.5 tp -98.02 163.5 12.74 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 145.63 -64.59 0.45 Allowed Glycine 0 N--CA 1.47 0.915 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -67.91 -12.07 59.97 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.595 0.758 . . . . 0.0 111.465 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -74.19 151.26 40.03 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.886 0.875 . . . . 0.0 109.926 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -153.42 136.49 15.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.074 0.55 . . . . 0.0 111.184 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 483' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 62.4 mt -91.71 140.3 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.052 0.941 . . . . 0.0 109.739 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.73 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 55.2 mttm -115.67 107.44 15.1 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.995 0.918 . . . . 0.0 110.149 175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -92.78 93.77 8.61 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 171.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 486' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 492' ' ' GLU . 43.3 mt-30 -93.46 104.7 16.82 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.474 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 489' ' ' GLU . 9.7 t -98.63 139.83 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.473 0.709 . . . . 0.0 109.306 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 539' ' ' SER . 4.7 pp -65.5 -21.34 66.62 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.024 0.53 . . . . 0.0 111.403 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 489' ' ' GLU . . . . . 0.556 ' H ' HG12 ' A' ' 487' ' ' VAL . 28.2 tt0 -71.25 -2.98 17.93 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.925 1.29 . . . . 0.0 110.895 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 110.13 11.96 19.03 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 115.509 0.964 . . . . 0.0 115.509 162.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -118.14 106.55 12.97 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.258 1.029 . . . . 0.0 110.771 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 486' ' ' GLN . 8.9 pt-20 -105.01 80.97 1.68 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 122.364 1.078 . . . . 0.0 109.006 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 38.3 pt -85.67 155.6 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.602 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -128.48 139.2 52.45 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.179 0.592 . . . . 0.0 110.16 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -123.02 105.92 10.38 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.072 0.949 . . . . 0.0 108.614 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 152.33 26.71 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -89.93 163.22 15.06 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.248 0.619 . . . . 0.0 110.512 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 75.7 p -80.24 130.02 67.41 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.79 -17.83 56.94 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.795 2.33 . . . . 0.0 113.333 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -72.55 -16.36 61.76 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.9 0.88 . . . . 0.0 111.623 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -89.37 134.76 33.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.746 0.819 . . . . 0.0 110.914 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 477' ' ' SER . 58.3 mt -137.67 141.2 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.89 140.27 52.05 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -73.84 166.2 23.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.082 0.953 . . . . 0.0 113.062 -168.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.72 124.76 22.28 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.234 1.014 . . . . 0.0 112.349 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 74.08 0.65 57.3 Favored Glycine 0 C--N 1.343 0.942 0 O-C-N 123.664 0.602 . . . . 0.0 114.42 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -88.89 -174.9 4.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.35 0.66 . . . . 0.0 109.451 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' MET . . . . . 0.49 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -133.42 161.01 35.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.404 0.682 . . . . 0.0 110.99 -177.649 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 509' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 468' ' ' LEU . 2.4 p -134.64 105.83 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.554 1.142 . . . . 0.0 109.113 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 3.3 m -89.07 104.09 16.66 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.979 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 34.9 t -91.92 103.5 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -87.47 175.55 7.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.114 0.965 . . . . 0.0 111.694 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -96.73 156.5 16.32 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.616 171.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 514' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -62.98 -36.2 82.72 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.221 0.609 . . . . 0.0 110.652 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -80.06 4.06 68.23 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.401 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -77.09 -28.28 54.45 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.002 0.521 . . . . 0.0 110.715 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 85.61 9.0 79.42 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.556 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.7 148.57 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.087 0.955 . . . . 0.0 110.642 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -78.64 124.28 28.01 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.294 0.638 . . . . 0.0 109.621 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -63.98 111.32 2.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.814 0.446 . . . . 0.0 109.804 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.4 m -128.38 76.34 78.33 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.414 0.686 . . . . 0.0 109.632 -176.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.12 158.95 55.82 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.716 2.277 . . . . 0.0 111.631 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.69 -38.5 1.66 Allowed 'Cis proline' 0 C--N 1.379 2.15 0 CA-C-N 120.228 1.117 . . . . 0.0 114.757 6.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 60.3 m -63.85 -52.34 60.53 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.006 0.523 . . . . 0.0 112.35 -170.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 40.0 m -87.91 86.43 7.14 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.459 0.647 . . . . 0.0 109.893 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.97 149.82 24.92 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 96.1 t -133.43 121.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -72.66 94.64 1.76 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 529' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.4 tptt -70.54 136.18 49.12 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.928 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 96.06 -9.74 67.85 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.527 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -116.07 111.24 20.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.243 0.617 . . . . 0.0 109.587 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 49.3 m -81.82 -44.49 16.85 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.953 0.501 . . . . 0.0 111.846 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.627 ' HB3' HG22 ' A' ' 536' ' ' THR . 34.6 m -87.43 -28.42 22.13 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -168.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 60.3 26.58 16.09 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.285 1.034 . . . . 0.0 110.896 -175.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.66 75.68 0.5 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 533' ' ' SER . 13.1 t -109.36 167.27 10.25 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 123.872 0.869 . . . . 0.0 110.628 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 169.83 -164.97 38.38 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.815 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.43 -54.38 33.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.989 0.916 . . . . 0.0 110.012 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.418 ' HB2' HD23 ' A' ' 488' ' ' LEU . 26.8 m -143.44 132.74 23.26 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -154.01 146.02 23.61 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.776 0.83 . . . . 0.0 109.826 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 13.6 ptp180 -109.67 141.59 42.02 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.313 0.578 . . . . 0.0 110.519 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 47.7 m -95.66 138.36 33.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 169.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.73 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 42.0 t -124.46 150.5 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 41.8 tp -124.54 113.06 17.59 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.464 HG22 ' HG2' ' A' ' 551' ' ' GLU . 54.0 t -100.49 154.02 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.882 1.273 . . . . 0.0 108.779 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.9 -171.67 1.89 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.845 0.458 . . . . 0.0 111.747 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.5 88.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.341 1.056 . . . . 0.0 112.863 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.37 -38.84 92.44 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.645 0.778 . . . . 0.0 110.97 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 112.57 -5.91 26.29 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.852 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -72.81 146.89 45.98 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 118.793 1.297 . . . . 0.0 110.295 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 545' ' ' VAL . 47.3 mt-10 -81.37 94.5 6.79 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.641 0.776 . . . . 0.0 108.982 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 18.8 m -79.0 -19.65 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -168.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -149.11 155.06 40.13 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.059 0.544 . . . . 0.0 109.671 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 50.0 ttp -163.74 131.77 3.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.571 0.748 . . . . 0.0 109.624 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -145.38 126.31 14.49 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.024 0.93 . . . . 0.0 108.848 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 13.4 m -92.91 147.21 23.03 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.009 0.523 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.74 121.19 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.388 1.075 . . . . 0.0 109.307 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.54 118.05 35.57 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? . . . . . 0 C--O 1.24 0.603 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.779 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 CA--C 1.546 0.801 0 CA-C-O 120.712 0.291 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.28 143.16 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 19.5 m -130.14 150.34 51.45 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.216 1.006 . . . . 0.0 109.577 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 53.4 mt -76.3 106.13 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.449 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 11.3 tp10 -78.02 -55.66 5.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.751 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 43.9 mt-10 -140.57 165.7 26.75 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.824 0.85 . . . . 0.0 109.9 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.62 ' HB ' HG21 ' A' ' 557' ' ' VAL . 79.6 mt -143.18 151.39 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.83 149.92 48.4 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.455 0.702 . . . . 0.0 111.002 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.483 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.4 pt? -64.02 -39.99 95.35 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.714 0.806 . . . . 0.0 112.004 -177.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.483 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 18.3 mt-10 -89.18 -27.24 20.81 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.309 1.044 . . . . 0.0 109.199 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 98.32 40.64 3.41 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.789 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 516' ' ' ALA . 1.5 mppt? -83.9 -10.67 57.81 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.765 0.426 . . . . 0.0 111.387 176.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -156.02 162.14 40.36 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.91 0.386 . . . . 0.0 111.635 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' VAL . . . . . 0.41 HG13 HG12 ' A' ' 459' ' ' ILE . 59.0 t -133.07 112.37 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.367 1.467 . . . . 0.0 107.914 174.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.449 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 14.3 tp60 -86.43 111.58 20.67 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.168 0.987 . . . . 0.0 110.094 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 7.0 mp -92.29 160.55 15.08 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.424 1.09 . . . . 0.0 109.453 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' LYS . . . . . 0.717 ' HE3' ' HB3' ' A' ' 471' ' ' ASN . 3.3 tmmm? -147.0 128.24 14.78 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -88.44 107.84 19.07 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.216 0.606 . . . . 0.0 109.802 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.717 ' HB3' ' HE3' ' A' ' 469' ' ' LYS . 12.0 p-10 -95.77 19.07 11.86 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.611 0.764 . . . . 0.0 112.046 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 45.0 m -76.55 151.94 36.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.674 0.39 . . . . 0.0 110.971 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -78.75 -22.75 46.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.885 0.874 . . . . 0.0 110.612 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -116.69 168.05 10.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.123 0.969 . . . . 0.0 111.247 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.33 111.0 4.35 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.72 0.808 . . . . 0.0 110.342 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.59 109.61 17.56 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 54.6 p -68.95 114.31 7.13 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.083 0.553 . . . . 0.0 110.359 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 7.6 tp -90.78 169.79 10.66 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.033 0.933 . . . . 0.0 109.027 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 143.15 -66.65 0.46 Allowed Glycine 0 N--CA 1.473 1.117 0 O-C-N 121.996 -0.44 . . . . 0.0 112.467 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -71.99 -9.9 59.03 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.37 0.668 . . . . 0.0 111.009 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -70.39 143.69 51.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.836 0.854 . . . . 0.0 109.796 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 22.9 ptt-85 -140.87 137.79 33.47 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.741 0.416 . . . . 0.0 110.747 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 45.6 mt -96.75 106.92 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.2 mttt -75.3 147.23 40.37 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.77 91.89 2.29 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -99.55 104.46 16.26 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.487 -170.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 31.7 t -66.44 154.91 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 539' ' ' SER . 4.3 pp -51.79 -32.1 29.85 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -173.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.35 -11.35 58.64 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.377 0.671 . . . . 0.0 112.063 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 125.17 -26.68 5.5 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.979 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.81 111.57 1.93 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.48 0.712 . . . . 0.0 111.633 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.98 145.09 43.87 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.24 0.543 . . . . 0.0 111.385 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.71 153.89 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.89 1.276 . . . . 0.0 108.108 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -133.01 108.45 8.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.407 0.283 . . . . 0.0 110.356 -177.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -85.06 103.7 14.31 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -91.44 143.65 26.39 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.39 0.614 . . . . 0.0 109.489 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -83.93 170.79 13.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.482 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 2.6 t -94.06 140.23 22.83 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.151 0.58 . . . . 0.0 109.715 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.78 -26.1 78.79 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.877 3.052 . . . . 0.0 114.128 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -68.39 -19.41 64.62 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.4 0.68 . . . . 0.0 111.771 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -82.65 136.86 34.66 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.518 0.727 . . . . 0.0 110.617 -174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 66.7 mt -131.03 150.81 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 503' ' ' LEU . . . . . 0.497 HD21 ' HB ' ' A' ' 509' ' ' VAL . 0.3 OUTLIER -123.99 135.34 53.56 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -81.25 156.76 25.44 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.704 0.801 . . . . 0.0 111.674 -168.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.33 132.76 52.62 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.958 0.903 . . . . 0.0 112.372 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 64.29 15.83 59.46 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.921 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -107.69 -166.53 1.15 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.653 0.781 . . . . 0.0 109.908 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 171.89 16.14 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.19 0.519 . . . . 0.0 111.731 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 509' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 503' ' ' LEU . 7.4 p -146.49 142.1 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.872 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 5.2 m -118.86 109.08 15.6 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 45.7 t -90.27 100.33 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -82.21 175.93 9.89 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.674 1.19 . . . . 0.0 111.508 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.36 153.45 19.65 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.337 173.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 514' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -64.39 -32.11 73.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.115 0.566 . . . . 0.0 110.9 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -71.4 -16.02 75.34 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.992 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . . . -70.79 -23.7 62.43 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.3 0.64 . . . . 0.0 111.473 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 78.46 36.64 29.63 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 123.235 0.334 . . . . 0.0 113.618 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.79 147.18 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.183 0.993 . . . . 0.0 110.386 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -74.72 123.31 24.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.487 0.715 . . . . 0.0 110.961 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -67.46 111.15 3.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.4 0.68 . . . . 0.0 109.681 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.7 m -134.84 80.3 49.65 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.117 0.567 . . . . 0.0 110.091 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.37 156.2 61.46 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.857 2.371 . . . . 0.0 112.164 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -99.9 30.7 11.62 Favored 'Cis proline' 0 C--N 1.38 2.186 0 CA-C-N 119.684 0.923 . . . . 0.0 113.591 -0.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 39.5 m -112.44 -38.61 4.61 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.989 0.516 . . . . 0.0 111.149 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 60.3 m -118.3 96.34 5.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.49 0.716 . . . . 0.0 109.718 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 58.1 mt -87.63 149.91 23.99 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 65.1 t -137.29 116.74 15.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -72.55 98.25 2.27 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 529' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 0.4 OUTLIER -66.14 134.11 52.09 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.88 0.872 . . . . 0.0 110.16 -177.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 92.28 -24.79 20.63 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.958 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -87.23 103.61 15.6 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 55.4 p -77.97 -45.27 24.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.815 0.446 . . . . 0.0 111.076 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 536' ' ' THR . 15.2 m -93.37 -30.26 15.2 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -166.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 55.7 32.73 19.94 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 123.644 0.777 . . . . 0.0 110.352 -174.557 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 72.28 59.92 4.35 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.214 -0.448 . . . . 0.0 113.027 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 533' ' ' SER . 12.2 p -65.28 147.7 52.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.985 0.514 . . . . 0.0 111.761 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 175.97 159.85 22.43 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.87 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -73.11 -9.55 58.84 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.06 0.544 . . . . 0.0 110.818 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 488' ' ' LEU . 29.6 t -157.55 139.43 14.15 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 124.589 1.156 . . . . 0.0 108.252 172.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.97 122.13 5.07 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.021 0.528 . . . . 0.0 111.282 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.603 ' HD2' ' SD ' ' A' ' 554' ' ' MET . 52.9 ttp180 -84.5 105.43 15.31 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 32.2 m -94.25 128.57 40.8 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 22.8 t -120.33 145.94 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.845 0.858 . . . . 0.0 109.427 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 34.2 tp -114.88 119.42 36.51 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.5 HG22 ' HG2' ' A' ' 551' ' ' GLU . 60.9 t -106.49 154.65 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.009 1.324 . . . . 0.0 108.632 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 550' ' ' GLU . 1.2 p30 -115.52 -173.64 2.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.536 0.335 . . . . 0.0 111.675 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.24 -36.56 71.07 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.753 1.221 . . . . 0.0 112.611 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 548' ' ' ASP . . . . . 0.424 ' HB3' HD21 ' A' ' 546' ' ' ASN . 20.1 t70 -60.65 -38.98 86.65 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.755 0.822 . . . . 0.0 111.635 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.15 -12.44 31.45 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.542 -174.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' GLU . . . . . 0.518 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 0.7 OUTLIER -74.82 149.65 39.56 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.193 0.497 . . . . 0.0 110.072 177.096 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.5 ' HG2' HG22 ' A' ' 545' ' ' VAL . 34.5 mt-10 -88.54 92.71 9.29 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.562 0.745 . . . . 0.0 109.31 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.53 -34.57 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -168.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.574 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -135.17 165.81 24.55 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.124 0.57 . . . . 0.0 109.86 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.603 ' SD ' ' HD2' ' A' ' 541' ' ' ARG . 50.1 ttm -169.57 115.97 0.57 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.306 0.642 . . . . 0.0 109.519 -176.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 53.0 ttm-85 -124.35 115.42 20.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.483 0.713 . . . . 0.0 109.825 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 17.4 m -92.11 126.31 37.14 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.73 0.812 . . . . 0.0 109.622 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.62 HG21 ' HB ' ' A' ' 459' ' ' ILE . 78.2 t -123.72 123.71 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.623 0.769 . . . . 0.0 109.701 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 138.13 49.81 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.14 0.976 . . . . 0.0 109.718 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 63.0 tttp . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 124.103 0.961 . . . . 0.0 111.383 -179.076 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 121.763 0.792 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 5.0 t -110.53 146.54 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 23.2 t -124.34 177.85 5.67 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.603 1.161 . . . . 0.0 109.587 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.7 mt -98.4 123.27 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.504 ' HG3' ' HG2' ' A' ' 458' ' ' GLU . 6.6 tp10 -87.68 -76.11 0.39 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 457' ' ' GLU . 55.0 mm-40 -122.91 160.94 25.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.393 1.077 . . . . 0.0 109.383 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.447 HG12 HG13 ' A' ' 466' ' ' VAL . 66.2 mt -140.68 148.14 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.26 147.99 51.43 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.42 HD12 ' HG3' ' A' ' 462' ' ' GLU . 3.3 pp -67.0 -36.34 81.94 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.541 0.736 . . . . 0.0 111.456 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.42 ' HG3' HD12 ' A' ' 461' ' ' LEU . 40.2 mt-10 -81.34 -31.88 33.23 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 170.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' GLY . . . . . 0.547 ' HA3' HH22 ' A' ' 485' ' ' ARG . . . 92.7 51.47 2.31 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.177 -175.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -81.97 -18.97 41.61 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.361 0.665 . . . . 0.0 110.505 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -156.42 158.63 37.64 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.889 0.476 . . . . 0.0 111.554 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' VAL . . . . . 0.447 HG13 HG12 ' A' ' 459' ' ' ILE . 61.1 t -127.3 107.12 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.889 1.275 . . . . 0.0 108.19 174.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 4.7 tp-100 -85.76 114.61 22.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 109.27 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 70.4 mt -100.96 151.84 21.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.695 1.198 . . . . 0.0 109.334 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 4.6 tmmm? -138.94 136.8 35.84 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.751 0.821 . . . . 0.0 109.568 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.455 ' OD1' ' HA ' ' A' ' 505' ' ' ALA . 25.9 t-20 -90.97 133.24 35.44 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.106 0.963 . . . . 0.0 111.335 -176.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -110.91 7.26 21.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.71 0.804 . . . . 0.0 111.95 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 48.8 m -80.53 155.5 26.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.274 0.63 . . . . 0.0 111.718 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -85.4 -19.4 31.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.61 0.764 . . . . 0.0 110.053 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.492 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.1 OUTLIER -123.24 150.91 42.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.487 1.115 . . . . 0.0 109.108 -178.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -69.01 135.76 51.39 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.296 0.638 . . . . 0.0 111.397 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -89.65 118.33 29.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.517 0.727 . . . . 0.0 109.923 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 15.4 p -65.12 109.82 2.31 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 503' ' ' LEU . 4.8 tp -102.14 175.66 5.46 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -171.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 122.05 -50.57 0.83 Allowed Glycine 0 N--CA 1.469 0.857 0 CA-C-O 121.993 0.774 . . . . 0.0 111.179 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 480' ' ' ASN . . . . . 0.595 ' HB3' ' HB2' ' A' ' 547' ' ' ALA . 9.0 m120 -65.46 -24.28 67.13 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 113.368 -1.416 . . . . 0.0 110.543 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.475 ' CZ3' HG21 ' A' ' 552' ' ' VAL . 13.6 m0 -77.12 164.23 25.88 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.061 0.945 . . . . 0.0 111.289 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -156.21 138.67 14.9 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.523 -170.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.06 113.57 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.421 1.088 . . . . 0.0 108.61 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -79.61 140.92 36.96 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' ARG . . . . . 0.547 HH22 ' HA3' ' A' ' 463' ' ' GLY . 74.4 ttt180 -143.8 96.38 2.89 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 173.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 486' ' ' GLN . . . . . 0.519 ' HG3' ' HB2' ' A' ' 541' ' ' ARG . 5.6 pt20 -98.36 103.87 15.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.864 1.265 . . . . 0.0 109.434 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.71 153.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.602 0.761 . . . . 0.0 109.178 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.419 HD23 ' HB2' ' A' ' 539' ' ' SER . 2.4 pp -66.23 -14.37 61.81 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.391 0.541 . . . . 0.0 111.679 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -62.01 -23.37 66.4 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.613 0.765 . . . . 0.0 110.939 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 104.37 -8.53 48.41 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.704 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -78.33 105.47 9.6 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 123.44 0.696 . . . . 0.0 110.496 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.08 133.24 51.11 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.514 173.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 24.2 pt -128.58 156.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.16 0.984 . . . . 0.0 108.661 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -131.11 108.01 9.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -87.91 103.56 15.79 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -87.08 146.54 26.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 170.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -83.43 170.24 14.7 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.08 0.552 . . . . 0.0 110.935 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.9 p -84.79 129.92 54.87 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.213 0.605 . . . . 0.0 109.372 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.526 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 36.3 Cg_endo -62.31 -14.32 37.84 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.893 2.395 . . . . 0.0 113.465 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.88 1.81 41.52 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.971 0.908 . . . . 0.0 111.977 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -103.26 136.92 42.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.606 0.762 . . . . 0.0 111.002 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 69.5 mt -118.12 136.59 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 503' ' ' LEU . . . . . 0.479 ' HB2' HD22 ' A' ' 478' ' ' LEU . 3.1 tm? -100.54 121.25 41.27 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -79.94 161.95 25.22 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.305 0.642 . . . . 0.0 112.655 -171.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' ALA . . . . . 0.455 ' HA ' ' OD1' ' A' ' 470' ' ' ASN . . . -73.95 133.96 43.1 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.083 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 70.15 1.26 33.19 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.509 0.505 . . . . 0.0 113.817 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -101.97 174.72 5.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.956 0.902 . . . . 0.0 110.35 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -140.68 144.02 35.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.013 0.525 . . . . 0.0 111.432 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.53 128.97 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.835 0.854 . . . . 0.0 108.907 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.3 m -103.79 103.31 13.17 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 56.7 t -87.4 97.85 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 122.803 0.441 . . . . 0.0 110.167 -176.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 512' ' ' TRP . . . . . 0.543 ' HB2' HG22 ' A' ' 527' ' ' VAL . 43.9 m95 -90.94 175.47 6.96 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.849 0.859 . . . . 0.0 112.007 -175.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -104.04 152.85 21.56 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.357 1.063 . . . . 0.0 110.308 174.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 514' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -63.54 -38.96 93.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.422 0.689 . . . . 0.0 111.879 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -82.7 -0.63 90.23 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.34 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -83.25 7.0 17.6 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.404 0.681 . . . . 0.0 111.632 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 76.83 38.56 30.89 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 113.572 0.189 . . . . 0.0 113.572 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 4.6 p -146.5 137.33 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.703 0.801 . . . . 0.0 110.617 -170.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -91.09 151.49 20.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.101 0.961 . . . . 0.0 111.139 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -67.05 112.27 4.3 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.5 m -131.78 79.34 68.39 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.672 0.789 . . . . 0.0 109.889 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.95 156.25 56.53 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.716 2.278 . . . . 0.0 111.845 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -93.4 4.42 57.66 Favored 'Cis proline' 0 C--N 1.381 2.244 0 CA-C-N 119.815 0.97 . . . . 0.0 113.491 2.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.0 m -82.81 -30.09 29.04 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.605 0.762 . . . . 0.0 111.595 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 84.0 m -140.75 102.84 4.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.367 0.667 . . . . 0.0 110.658 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 9.7 mp -97.49 103.77 15.73 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 512' ' ' TRP . 72.0 t -89.29 122.19 40.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -71.07 87.1 0.75 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' LYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 22.1 tptp -68.01 116.54 8.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.701 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 120.84 -45.36 1.24 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -172.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.11 105.85 12.65 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 532' ' ' SER . . . . . 0.455 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 34.2 p -72.18 -47.16 52.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.483 0.713 . . . . 0.0 111.243 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 536' ' ' THR . 48.7 m -99.23 -14.34 19.33 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.489 0.715 . . . . 0.0 112.271 -173.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 61.72 23.76 14.01 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.04 0.936 . . . . 0.0 109.582 -171.02 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.92 65.2 2.71 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-N 116.54 -0.3 . . . . 0.0 112.717 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 533' ' ' SER . 10.8 p -59.55 166.11 2.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.167 0.987 . . . . 0.0 113.624 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 177.72 160.21 23.92 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.034 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -78.4 -27.12 46.68 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.852 0.326 . . . . 0.0 110.399 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.419 ' HB2' HD23 ' A' ' 488' ' ' LEU . 2.7 m -145.71 129.5 17.22 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 168.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.87 137.79 20.24 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.843 0.857 . . . . 0.0 110.887 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.519 ' HB2' ' HG3' ' A' ' 486' ' ' GLN . 1.3 mpt_? -91.68 116.14 28.63 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 78.8 m -108.12 119.34 39.2 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 543' ' ' VAL . . . . . . . . . . . . . 20.4 t -115.67 123.25 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.024 0.93 . . . . 0.0 109.744 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 42.2 tp -81.25 124.43 29.31 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 546' ' ' ASN . 53.5 t -126.45 144.37 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.824 0.85 . . . . 0.0 109.556 -173.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.471 ' O ' HG12 ' A' ' 545' ' ' VAL . 11.3 t-20 -84.03 162.69 20.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.907 0.883 . . . . 0.0 109.935 170.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 547' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 480' ' ' ASN . . . -45.51 -41.49 9.7 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.439 1.495 . . . . 0.0 114.48 -175.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.26 -32.44 68.37 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.557 1.143 . . . . 0.0 112.897 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.85 -6.29 31.07 Favored Glycine 0 N--CA 1.464 0.551 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -168.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.81 117.63 9.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.568 0.747 . . . . 0.0 109.642 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.42 116.81 15.52 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 552' ' ' VAL . . . . . 0.475 HG21 ' CZ3' ' A' ' 481' ' ' TRP . 16.1 m -95.33 -28.86 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 122.719 0.408 . . . . 0.0 111.546 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -156.89 147.33 21.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.167 0.987 . . . . 0.0 109.251 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 554' ' ' MET . 0.0 OUTLIER -147.26 147.67 30.65 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.119 0.568 . . . . 0.0 109.694 -178.215 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 555' ' ' ARG . . . . . 0.435 ' NH1' HG22 ' A' ' 557' ' ' VAL . 2.1 tmt_? -160.86 108.51 1.54 Allowed 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 63.2 m -81.55 138.13 35.46 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.619 0.768 . . . . 0.0 109.573 174.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.435 HG22 ' NH1' ' A' ' 555' ' ' ARG . 36.2 t -115.9 146.63 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.686 1.194 . . . . 0.0 109.133 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 113.1 6.18 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.005 0.922 . . . . 0.0 108.823 166.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 57.8 tttm . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 125.948 1.699 . . . . 0.0 111.384 176.755 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.559 1.321 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.39 128.51 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 171.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 28.6 t -117.18 174.2 6.25 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.17 0.588 . . . . 0.0 109.785 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 36.8 mt -93.03 116.23 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 469' ' ' LYS . 7.2 tp10 -70.33 -71.38 0.25 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.738 0.815 . . . . 0.0 109.92 -177.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.0 mt-10 -126.56 159.38 33.64 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.183 0.993 . . . . 0.0 108.705 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.59 HD13 ' HB ' ' A' ' 542' ' ' THR . 15.9 mt -137.09 131.3 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.67 127.0 31.16 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.655 ' HB2' ' HA ' ' A' ' 559' ' ' LYS . 0.9 OUTLIER -80.31 -17.83 50.96 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.534 0.521 . . . . 0.0 111.491 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -12.71 60.11 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 165.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 79.09 21.5 67.68 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.107 -0.951 . . . . 0.0 115.144 164.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -91.21 -13.16 33.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.058 0.429 . . . . 0.0 111.109 -176.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -155.29 158.7 39.19 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.5 116.81 46.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.114 1.366 . . . . 0.0 107.693 168.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.416 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.4 tp-100 -89.58 113.64 25.1 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.02 140.48 34.19 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' LYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 21.3 tptm -113.96 129.28 56.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.425 ' HB2' HD12 ' A' ' 503' ' ' LEU . 48.2 t30 -88.1 100.08 12.68 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -90.94 6.92 42.69 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.14 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.9 t -76.11 161.41 28.87 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.596 0.758 . . . . 0.0 111.066 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.75 -9.55 58.09 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.233 0.613 . . . . 0.0 111.616 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.403 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.3 OUTLIER -130.08 168.41 16.8 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.161 0.584 . . . . 0.0 110.038 177.732 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.19 118.42 10.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.484 0.714 . . . . 0.0 109.327 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -94.39 118.78 32.15 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.446 0.698 . . . . 0.0 110.391 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 67.6 p -71.94 116.97 12.97 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.397 0.679 . . . . 0.0 110.273 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.53 177.82 6.0 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 146.05 -67.42 0.41 Allowed Glycine 0 N--CA 1.474 1.2 0 CA-C-O 121.494 0.496 . . . . 0.0 112.743 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -73.23 -9.79 59.08 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.702 -0.749 . . . . 0.0 109.692 167.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -72.05 131.08 42.39 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.97 0.908 . . . . 0.0 109.148 171.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 21.5 ptt-85 -139.93 127.95 22.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.681 0.792 . . . . 0.0 110.375 -173.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 483' ' ' ILE . . . . . 0.435 ' HB ' ' HH2' ' A' ' 534' ' ' TRP . 10.3 mt -91.23 105.86 16.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.551 ' HE3' HG21 ' A' ' 545' ' ' VAL . 97.8 mttt -76.71 134.2 39.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.661 0.384 . . . . 0.0 110.385 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -118.85 91.4 3.55 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -97.11 102.05 13.75 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.077 0.951 . . . . 0.0 109.052 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 488' ' ' LEU . 5.8 t -101.39 147.55 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.098 0.559 . . . . 0.0 110.786 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.477 HD23 HG12 ' A' ' 487' ' ' VAL . 2.3 pt? -60.78 -24.73 66.0 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.544 0.738 . . . . 0.0 111.996 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.91 -27.56 68.9 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.346 1.058 . . . . 0.0 111.898 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 124.18 -26.4 5.83 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.677 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.74 100.29 2.32 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.977 0.894 . . . . 0.0 110.295 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -113.43 97.22 6.33 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.887 -1.052 . . . . 0.0 108.321 175.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 25.4 pt -108.71 178.91 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.547 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -156.3 118.45 4.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.32 0.648 . . . . 0.0 109.473 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -86.72 107.72 18.36 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -85.02 146.72 27.04 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.707 0.765 . . . . 0.0 110.195 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -80.18 173.35 12.68 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.955 1.302 . . . . 0.0 109.917 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 71.8 p -89.42 136.96 29.28 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.406 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 74.6 Cg_exo -52.57 -26.94 30.77 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.175 2.583 . . . . 0.0 114.435 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -79.31 -24.47 42.82 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.731 0.813 . . . . 0.0 112.227 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -66.9 127.78 33.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.232 0.613 . . . . 0.0 109.967 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 45.2 mt -129.81 134.08 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.812 0.845 . . . . 0.0 108.94 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 470' ' ' ASN . 0.8 OUTLIER -108.26 130.9 55.15 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -77.75 155.4 31.22 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.751 0.82 . . . . 0.0 111.553 -170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.97 120.73 13.14 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.723 0.809 . . . . 0.0 110.793 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 88.08 -2.26 85.32 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.575 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -95.98 176.02 6.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.05 0.54 . . . . 0.0 110.173 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -148.01 136.75 21.79 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.756 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 3.4 p -101.78 114.66 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.406 0.682 . . . . 0.0 109.781 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.99 94.95 10.0 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 89.6 t -82.64 104.6 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 512' ' ' TRP . . . . . 0.543 ' HB2' HG22 ' A' ' 527' ' ' VAL . 37.7 m95 -93.61 176.83 6.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.065 0.946 . . . . 0.0 112.107 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -98.66 142.07 30.69 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.02 171.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 514' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -66.86 -32.7 74.14 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.191 0.596 . . . . 0.0 111.152 176.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -67.57 -19.59 71.12 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.002 -0.545 . . . . 0.0 113.817 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -66.31 -18.45 65.36 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.153 0.581 . . . . 0.0 110.79 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.17 27.56 72.73 Favored Glycine 0 C--N 1.352 1.454 0 C-N-CA 122.711 0.196 . . . . 0.0 112.878 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.58 149.26 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.436 1.095 . . . . 0.0 110.942 -174.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -68.74 119.55 13.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.279 0.632 . . . . 0.0 110.999 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 520' ' ' HIS . . . . . 0.451 ' NE2' HD12 ' A' ' 526' ' ' LEU . 15.6 t-160 -76.44 124.69 27.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.439 0.695 . . . . 0.0 110.065 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 58.5 m -152.41 79.35 6.09 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.876 0.87 . . . . 0.0 110.464 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.49 161.05 37.88 Favored 'Trans proline' 0 CA--C 1.565 2.037 0 C-N-CA 122.909 2.406 . . . . 0.0 111.844 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.37 -9.17 43.44 Favored 'Cis proline' 0 C--N 1.382 2.314 0 CA-C-N 120.355 1.162 . . . . 0.0 113.904 1.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.1 m -66.33 -37.15 84.7 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.798 0.839 . . . . 0.0 111.753 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 97.0 m -139.46 89.81 2.36 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.775 0.83 . . . . 0.0 108.946 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 30.5 tp -91.83 138.98 31.11 Favored 'General case' 0 C--O 1.209 -1.078 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 512' ' ' TRP . 96.6 t -125.66 122.7 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.03 0.832 . . . . 0.0 109.15 -175.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -70.17 94.55 0.91 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 529' ' ' LYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 23.0 tptm -71.32 117.62 13.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.428 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 121.44 -36.85 3.14 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.23 127.05 34.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.913 0.485 . . . . 0.0 110.684 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 58.4 p -99.42 -36.23 9.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.852 0.861 . . . . 0.0 110.978 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.456 ' OG ' HG22 ' A' ' 536' ' ' THR . 28.9 t -87.54 -35.51 18.11 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.653 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 51.48 34.51 12.34 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.833 0.853 . . . . 0.0 110.423 -174.463 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 64.88 64.21 3.69 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.195 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.456 HG22 ' OG ' ' A' ' 533' ' ' SER . 12.4 t -104.7 168.38 9.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.927 0.491 . . . . 0.0 110.673 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 168.0 -162.51 36.29 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.225 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -69.21 -34.64 75.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.208 0.603 . . . . 0.0 111.253 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.7 m -158.59 137.27 11.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.208 1.003 . . . . 0.0 109.021 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.459 ' HB3' HG22 ' A' ' 487' ' ' VAL . 4.7 p90 -149.98 125.38 10.19 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.83 0.824 . . . . 0.0 112.117 -177.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 72.7 ttt-85 -77.92 102.04 7.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.722 174.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 542' ' ' THR . . . . . 0.59 ' HB ' HD13 ' A' ' 459' ' ' ILE . 16.3 m -95.86 124.52 39.9 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 46.7 t -125.33 134.92 65.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 C-N-CA 123.696 0.798 . . . . 0.0 109.937 -172.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 26.7 tp -97.69 115.96 28.98 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 166.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.551 HG21 ' HE3' ' A' ' 484' ' ' LYS . 92.3 t -110.06 159.17 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.014 1.326 . . . . 0.0 108.702 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -124.56 -170.35 2.14 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.732 0.413 . . . . 0.0 111.783 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.69 73.97 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.378 1.071 . . . . 0.0 112.948 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.33 -36.64 84.79 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.65 0.78 . . . . 0.0 111.07 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.26 -18.57 27.98 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.646 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.68 160.42 32.25 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.506 0.67 . . . . 0.0 110.59 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -92.71 108.0 19.65 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.186 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.17 -23.73 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.932 0.493 . . . . 0.0 111.494 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -151.63 131.66 13.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.814 0.845 . . . . 0.0 109.065 174.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 12.3 ttm -122.83 108.83 13.44 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -126.76 105.17 8.49 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 66.6 m -84.52 136.62 33.73 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.07 138.91 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.07 137.58 51.99 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.25 1.02 . . . . 0.0 108.695 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 559' ' ' LYS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 461' ' ' LEU . 55.8 tttm . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 124.477 1.111 . . . . 0.0 109.962 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' SER . . . . . 0.418 ' HB2' ' HH2' ' A' ' 481' ' ' TRP . 23.1 m . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.48 0.181 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 25.9 t -125.41 134.99 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.06 0.944 . . . . 0.0 108.616 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 20.8 m -115.5 173.05 6.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.129 0.972 . . . . 0.0 110.668 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 52.9 mt -94.7 111.9 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 469' ' ' LYS . 9.5 tp10 -82.63 -63.6 1.34 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.743 0.417 . . . . 0.0 110.968 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 28.9 mt-10 -121.29 151.68 39.78 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 58.9 mt -133.32 130.51 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -78.62 129.18 34.47 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.81 0.694 . . . . 0.0 109.882 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.442 HD13 ' HE3' ' A' ' 559' ' ' LYS . 2.2 pp -76.27 -23.72 54.44 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.247 0.342 . . . . 0.0 111.301 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -68.85 -29.4 67.71 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 167.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 83.8 25.3 46.36 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.498 -0.774 . . . . 0.0 114.032 172.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -82.28 -27.4 32.38 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.377 0.589 . . . . 0.0 111.12 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -146.52 160.03 42.66 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-O 121.458 0.647 . . . . 0.0 112.424 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 95.3 t -130.6 119.72 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 125.177 1.391 . . . . 0.0 107.417 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 4.1 tp-100 -89.19 122.31 32.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.832 0.853 . . . . 0.0 109.771 178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 75.5 mt -102.15 162.23 13.07 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.771 0.829 . . . . 0.0 109.629 171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 1.2 tmtp? -146.75 131.05 17.51 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -86.8 111.26 20.57 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.81 -17.5 47.29 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.032 0.933 . . . . 0.0 112.291 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 81.0 p -70.13 158.15 36.28 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.072 0.463 . . . . 0.0 111.669 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.64 0.67 29.26 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.178 0.991 . . . . 0.0 112.326 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.29 175.62 10.38 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.837 0.855 . . . . 0.0 109.281 -174.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.93 125.98 28.58 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.043 0.537 . . . . 0.0 109.593 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -100.36 131.65 46.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.178 0.991 . . . . 0.0 110.493 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 26.4 p -66.89 124.03 21.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.324 0.65 . . . . 0.0 109.714 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 9.5 tp -119.36 152.77 36.22 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.42 -52.53 0.58 Allowed Glycine 0 N--CA 1.475 1.234 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.837 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -69.75 -14.39 62.76 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.646 0.779 . . . . 0.0 110.639 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.418 ' HH2' ' HB2' ' A' ' 453' ' ' SER . 12.4 m95 -82.85 158.72 22.6 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 125.126 1.371 . . . . 0.0 109.95 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -161.27 131.75 5.12 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.838 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 32.5 mt -87.63 118.76 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.811 0.844 . . . . 0.0 109.742 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.673 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 64.8 mttm -84.81 148.7 26.17 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 166.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 485' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 492' ' ' GLU . 34.9 ttm180 -132.77 96.66 3.85 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 163.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -85.5 102.38 13.44 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.551 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 27.3 t -72.2 168.95 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.04 0.936 . . . . 0.0 110.277 -176.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 539' ' ' SER . 3.4 pp -55.55 -25.92 40.5 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.643 1.177 . . . . 0.0 113.609 177.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -85.2 4.15 35.95 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.517 0.675 . . . . 0.0 110.812 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 86.21 -7.41 78.38 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.636 0.636 . . . . 0.0 113.349 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.49 102.63 3.26 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.689 0.796 . . . . 0.0 110.295 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 485' ' ' ARG . 8.7 pt-20 -96.39 111.89 23.83 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.583 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 28.4 pt -91.44 147.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.297 173.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -121.39 108.9 14.23 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.349 0.66 . . . . 0.0 110.707 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -83.07 107.74 15.86 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 166.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -91.58 147.67 22.84 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -93.72 170.46 9.55 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.414 0.686 . . . . 0.0 110.714 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 82.7 p -93.5 130.23 36.03 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.024 0.93 . . . . 0.0 108.985 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.498 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 17.7 Cg_endo -58.72 -18.88 43.23 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.257 2.638 . . . . 0.0 114.884 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -75.9 -24.02 55.58 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.951 0.501 . . . . 0.0 111.189 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -75.5 142.72 42.81 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.361 0.664 . . . . 0.0 110.528 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 61.9 mt -133.39 136.58 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.081 0.952 . . . . 0.0 108.713 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.39 116.72 33.43 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -73.27 162.26 29.57 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.197 0.599 . . . . 0.0 112.108 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -60.63 124.4 20.29 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.234 1.014 . . . . 0.0 112.302 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 74.43 -6.42 23.46 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.58 0.55 . . . . 0.0 114.297 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -81.02 155.1 26.53 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.456 0.702 . . . . 0.0 109.857 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 55.4 mtm -120.42 126.52 50.65 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.248 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.7 112.65 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 2.1 m -92.7 101.94 14.34 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.521 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.479 HG12 ' HE1' ' A' ' 534' ' ' TRP . 59.0 t -88.74 98.25 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.015 0.436 . . . . 0.0 109.981 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 512' ' ' TRP . . . . . 0.403 ' HE3' ' HB1' ' A' ' 516' ' ' ALA . 49.1 m95 -86.05 176.64 7.91 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.397 1.079 . . . . 0.0 111.509 174.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -95.05 164.06 13.04 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.092 0.957 . . . . 0.0 110.726 174.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 514' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -64.79 -45.48 86.09 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.429 0.692 . . . . 0.0 111.302 174.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -82.91 5.97 73.0 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.683 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.403 ' HB1' ' HE3' ' A' ' 512' ' ' TRP . . . -75.6 -1.05 22.7 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.502 0.721 . . . . 0.0 111.842 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 68.41 31.25 73.82 Favored Glycine 0 C--N 1.356 1.683 0 C-N-CA 123.125 0.393 . . . . 0.0 113.699 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 6.4 p -123.74 135.86 62.06 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 C-N-CA 124.42 1.088 . . . . 0.0 109.968 -172.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -76.95 134.1 39.01 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.292 0.637 . . . . 0.0 110.4 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -64.51 110.89 2.46 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.356 0.663 . . . . 0.0 110.228 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.5 m -126.42 74.22 73.65 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.605 0.762 . . . . 0.0 110.129 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.33 150.91 76.53 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 122.27 1.98 . . . . 0.0 111.435 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -93.23 11.47 53.01 Favored 'Cis proline' 0 C--N 1.376 1.981 0 CA-C-N 119.971 1.025 . . . . 0.0 113.72 -1.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.3 m -82.8 -28.85 29.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.391 0.676 . . . . 0.0 111.833 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 76.7 m -143.58 104.42 4.21 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.727 0.811 . . . . 0.0 109.968 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 66.5 mt -91.35 144.07 25.97 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 169.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 50.3 t -120.85 120.95 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.635 0.774 . . . . 0.0 108.975 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -75.2 96.42 3.3 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 529' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.9 tptt -66.7 136.39 55.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.792 0.837 . . . . 0.0 110.335 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 88.67 -4.97 85.07 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 123.479 0.487 . . . . 0.0 113.325 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -112.99 114.06 26.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 34.2 p -73.56 -56.69 4.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.085 0.554 . . . . 0.0 111.942 -172.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.642 ' HB2' HG23 ' A' ' 536' ' ' THR . 86.6 p -114.45 9.72 16.83 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.267 0.627 . . . . 0.0 112.215 -169.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.479 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 59.44 23.87 12.47 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 124.422 1.089 . . . . 0.0 110.545 -174.24 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.87 71.12 0.9 Allowed Glycine 0 C--N 1.35 1.34 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.642 HG23 ' HB2' ' A' ' 533' ' ' SER . 17.3 p -59.67 129.93 44.33 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.449 0.7 . . . . 0.0 111.949 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -137.0 154.93 22.47 Favored Glycine 0 C--O 1.238 0.371 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 170.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.14 -60.58 2.17 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.492 ' H ' HD23 ' A' ' 488' ' ' LEU . 7.3 m -107.16 125.1 50.65 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.086 0.954 . . . . 0.0 109.026 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.551 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 5.6 p90 -151.28 145.1 25.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.649 0.738 . . . . 0.0 111.883 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 4.3 tmm_? -96.91 102.08 13.78 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.763 1.225 . . . . 0.0 108.468 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 47.7 m -86.44 140.21 30.19 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.452 0.701 . . . . 0.0 109.202 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.673 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 40.0 t -133.8 146.2 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.484 1.114 . . . . 0.0 109.619 -175.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 38.6 tp -113.61 133.09 55.48 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 163.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.588 HG21 ' HE2' ' A' ' 484' ' ' LYS . 85.4 t -124.26 156.24 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.605 1.162 . . . . 0.0 108.369 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -119.58 -170.23 1.9 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.398 0.679 . . . . 0.0 111.814 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.61 64.09 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.156 1.382 . . . . 0.0 113.755 -174.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 548' ' ' ASP . . . . . 0.59 ' HB3' ' HG2' ' A' ' 550' ' ' GLU . 16.8 t70 -67.31 -37.81 83.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.403 0.681 . . . . 0.0 112.1 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.76 -15.97 28.73 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.078 -173.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 550' ' ' GLU . . . . . 0.59 ' HG2' ' HB3' ' A' ' 548' ' ' ASP . 9.9 pt-20 -62.64 137.68 58.32 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.633 0.773 . . . . 0.0 110.325 172.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -81.47 87.72 6.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.807 0.843 . . . . 0.0 109.543 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.02 -35.8 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.694 -170.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -133.37 150.75 51.81 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.518 0.727 . . . . 0.0 109.054 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 51.6 ttm -161.56 121.68 2.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.466 0.706 . . . . 0.0 109.629 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.71 118.74 13.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.29 0.636 . . . . 0.0 109.315 175.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 28.2 m -86.21 140.43 30.15 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.976 0.911 . . . . 0.0 109.276 174.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.42 131.18 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.66 0.784 . . . . 0.0 109.124 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 558' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 0.0 OUTLIER -122.15 125.52 46.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.651 0.78 . . . . 0.0 109.034 175.213 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 559' ' ' LYS . . . . . 0.442 ' HE3' HD13 ' A' ' 461' ' ' LEU . 86.9 tttt . . . . . 0 C--O 1.242 0.695 0 C-N-CA 124.786 1.234 . . . . 0.0 110.052 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 47.2 m . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 110.926 -0.028 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 15.8 t -92.63 103.19 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.6 m -97.92 143.87 28.06 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.963 0.905 . . . . 0.0 110.647 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 28.7 mt -78.16 96.33 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -78.4 -69.66 0.54 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -120.48 154.11 35.7 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.553 ' HB ' HG21 ' A' ' 557' ' ' VAL . 70.4 mt -146.73 143.13 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 168.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' ASP . . . . . 0.404 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 31.1 t70 -60.63 151.87 27.9 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.47 0.708 . . . . 0.0 110.801 174.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.2 pp -55.54 -29.82 59.62 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.789 1.236 . . . . 0.0 113.771 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -118.58 10.37 12.53 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.388 1.075 . . . . 0.0 111.252 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.19 42.7 90.98 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.901 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -78.69 -7.12 57.39 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 36.1 p90 -157.85 147.07 19.66 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 124.419 1.088 . . . . 0.0 109.956 170.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 76.1 t -120.36 122.96 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.436 ' OE1' ' HB3' ' A' ' 508' ' ' MET . 0.1 OUTLIER -103.92 114.13 28.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.122 1.369 . . . . 0.0 108.603 -174.575 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 65.4 mt -107.68 161.73 14.61 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.08 1.352 . . . . 0.0 109.91 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -150.13 132.51 15.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.961 0.504 . . . . 0.0 109.754 -176.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -85.35 131.92 34.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.281 0.632 . . . . 0.0 110.686 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -112.25 -0.14 15.58 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.016 1.327 . . . . 0.0 110.775 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 49.1 m -63.9 147.61 51.5 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.794 0.438 . . . . 0.0 110.654 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -69.62 -11.15 60.61 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.033 0.933 . . . . 0.0 111.778 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.2 OUTLIER -134.69 176.23 8.83 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 125.272 1.429 . . . . 0.0 108.82 -177.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.69 114.8 5.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.526 0.73 . . . . 0.0 109.508 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -74.87 108.34 7.54 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.657 0.783 . . . . 0.0 110.0 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.439 ' HA ' HG12 ' A' ' 502' ' ' ILE . 29.1 p -63.78 104.88 0.73 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 7.6 tp -93.81 -176.59 4.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.89 0.876 . . . . 0.0 109.208 -173.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 134.3 -66.5 0.57 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 112.549 -0.221 . . . . 0.0 112.549 172.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.92 -11.63 59.13 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.372 0.669 . . . . 0.0 111.679 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -67.59 141.79 56.68 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.971 0.908 . . . . 0.0 109.387 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -143.31 131.59 22.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.102 0.561 . . . . 0.0 110.701 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 45.0 mt -88.13 110.33 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.024 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.49 ' HE2' HG21 ' A' ' 545' ' ' VAL . 64.7 mttm -82.67 150.42 26.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.442 0.697 . . . . 0.0 109.202 166.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -144.59 104.87 4.09 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -99.16 108.57 21.21 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.451 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 30.0 t -83.61 160.42 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 124.316 1.046 . . . . 0.0 110.796 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 539' ' ' SER . 4.6 pp -51.3 -26.91 8.19 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.947 1.299 . . . . 0.0 113.614 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -77.65 -10.42 59.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.981 0.913 . . . . 0.0 111.42 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 90.78 1.91 72.99 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -79.92 148.18 31.35 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.077 0.951 . . . . 0.0 109.303 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.87 157.01 47.3 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.036 0.446 . . . . 0.0 110.111 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 30.4 pt -136.75 163.82 32.08 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 C-N-CA 124.493 1.117 . . . . 0.0 108.384 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -136.47 105.67 6.01 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.313 0.645 . . . . 0.0 109.673 172.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -81.62 142.38 32.82 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -131.43 144.41 51.16 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.187 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -84.38 163.14 19.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.739 0.815 . . . . 0.0 110.802 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 59.5 p -79.68 132.4 61.52 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.886 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.533 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 35.2 Cg_endo -61.1 -16.96 49.3 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.172 2.581 . . . . 0.0 113.533 -175.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -86.57 -20.52 27.82 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.75 0.82 . . . . 0.0 111.855 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -66.04 136.9 56.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.132 0.573 . . . . 0.0 110.153 -177.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 502' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 477' ' ' SER . 52.0 mt -131.18 121.86 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.836 0.854 . . . . 0.0 108.976 174.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.71 130.91 34.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -81.32 155.14 26.15 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.159 0.583 . . . . 0.0 110.898 -175.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -61.64 117.65 6.06 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.853 0.861 . . . . 0.0 111.177 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 88.51 -22.38 20.8 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.368 0.417 . . . . 0.0 113.612 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -75.79 173.72 10.77 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.402 0.681 . . . . 0.0 111.242 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 508' ' ' MET . . . . . 0.436 ' HB3' ' OE1' ' A' ' 467' ' ' GLN . 37.2 mtm -124.62 172.46 9.23 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.482 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.18 127.09 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 5.2 m -121.73 113.84 20.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.045 0.538 . . . . 0.0 109.58 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.85 99.11 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.271 0.628 . . . . 0.0 109.974 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -79.85 176.65 9.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.65 1.18 . . . . 0.0 111.754 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -99.16 156.46 16.95 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.23 1.012 . . . . 0.0 110.633 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -62.26 -36.59 82.51 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.541 0.736 . . . . 0.0 111.207 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 515' ' ' GLY . . . . . 0.429 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -88.48 10.16 72.79 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.515 -177.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -80.91 -17.07 51.81 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.294 0.637 . . . . 0.0 110.729 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 71.48 18.87 77.34 Favored Glycine 0 C--N 1.357 1.737 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.511 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.92 149.58 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.461 1.105 . . . . 0.0 110.458 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -77.63 130.46 36.89 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.604 0.762 . . . . 0.0 110.618 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -67.45 113.08 5.01 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 10.9 m -125.41 69.68 61.94 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 123.492 0.717 . . . . 0.0 109.827 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.79 150.72 68.39 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.217 1.945 . . . . 0.0 111.628 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.42 -8.01 49.85 Favored 'Cis proline' 0 C--N 1.371 1.749 0 N-CA-C 114.507 0.926 . . . . 0.0 114.507 3.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.2 m -67.14 -60.53 2.53 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.475 0.71 . . . . 0.0 111.466 -173.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 90.6 m -105.19 93.58 4.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.93 0.892 . . . . 0.0 109.198 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 73.0 mt -81.71 143.69 31.68 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 82.1 t -126.04 131.16 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -74.93 95.06 2.91 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -65.2 124.48 22.29 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.793 0.837 . . . . 0.0 110.698 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 94.41 -27.27 14.18 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.799 0.687 . . . . 0.0 114.129 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.54 99.28 9.09 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 532' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 29.3 p -85.15 -34.07 22.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.126 0.97 . . . . 0.0 113.165 -167.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' ' 536' ' ' THR . 87.1 p -75.47 -28.39 59.22 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.635 0.374 . . . . 0.0 111.3 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 58.77 32.23 22.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.896 1.279 . . . . 0.0 108.917 -169.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 70.36 76.81 0.51 Allowed Glycine 0 C--N 1.358 1.798 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -172.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 533' ' ' SER . 9.6 t -52.23 143.03 15.38 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.408 1.083 . . . . 0.0 113.431 -167.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 158.61 131.74 1.31 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -84.21 -15.78 45.71 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.1 0.56 . . . . 0.0 111.216 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.536 ' HB2' HD23 ' A' ' 488' ' ' LEU . 17.9 m -137.71 132.48 32.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.237 0.615 . . . . 0.0 109.772 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.451 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 30.8 p90 -168.19 176.7 5.85 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.699 1.2 . . . . 0.0 110.308 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 0.0 OUTLIER -128.91 114.59 16.67 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.191 0.997 . . . . 0.0 108.82 169.024 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 83.6 m -86.61 125.42 33.81 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.075 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.527 HG22 ' HG3' ' A' ' 554' ' ' MET . 43.8 t -115.44 117.83 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.14 0.976 . . . . 0.0 108.679 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 24.9 tp -88.63 132.28 34.62 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.49 HG21 ' HE2' ' A' ' 484' ' ' LYS . 50.9 t -115.51 142.99 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 124.838 1.255 . . . . 0.0 108.122 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -96.99 -167.24 1.51 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.877 0.471 . . . . 0.0 111.338 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.04 -37.03 83.4 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -75.4 -0.98 21.8 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.31 15.85 80.39 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 123.258 0.348 . . . . 0.0 113.67 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -97.45 149.75 21.81 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.281 0.632 . . . . 0.0 109.298 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.78 90.21 3.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.165 0.986 . . . . 0.0 109.296 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.15 -32.99 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.431 -173.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -142.66 157.63 44.49 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.459 0.703 . . . . 0.0 110.245 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.527 ' HG3' HG22 ' A' ' 543' ' ' VAL . 26.1 ttt -157.44 146.4 19.77 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.98 0.912 . . . . 0.0 109.334 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -159.83 117.88 2.69 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.701 0.401 . . . . 0.0 110.956 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 87.4 m -88.73 116.51 27.05 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.611 0.764 . . . . 0.0 110.359 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.553 HG21 ' HB ' ' A' ' 459' ' ' ILE . 81.1 t -102.37 131.91 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.523 1.129 . . . . 0.0 109.628 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 558' ' ' LYS . . . . . 0.425 ' HD2' ' HB3' ' A' ' 539' ' ' SER . 13.3 mmmm -131.28 117.84 19.54 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.015 1.326 . . . . 0.0 107.868 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt . . . . . 0 N--CA 1.482 1.144 0 CA-C-N 118.55 0.613 . . . . 0.0 109.423 176.896 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 53.5 m . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.655 0.264 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 454' ' ' VAL . . . . . 0.507 HG21 HD21 ' A' ' 478' ' ' LEU . 17.9 t -93.24 107.77 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 165.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 80.6 p -88.54 160.59 17.39 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.336 0.654 . . . . 0.0 110.006 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' ILE . . . . . 0.45 HG13 ' HB1' ' A' ' 553' ' ' ALA . 48.5 mt -81.53 96.3 3.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 170.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.629 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 14.6 tp10 -68.41 -55.91 10.3 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.494 -171.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.629 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.0 mt-10 -142.0 154.03 44.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.904 0.882 . . . . 0.0 108.896 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.563 ' HB ' HG21 ' A' ' 557' ' ' VAL . 56.2 mt -136.0 135.28 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.62 141.4 57.82 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 123.358 0.411 . . . . 0.0 110.131 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.82 -39.41 94.23 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.665 0.603 . . . . 0.0 110.895 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 559' ' ' LYS . 27.9 mt-10 -74.71 -33.47 62.42 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.33 33.35 6.89 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.064 -0.971 . . . . 0.0 113.109 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -84.19 -15.52 46.69 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.173 0.589 . . . . 0.0 110.46 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -157.89 161.05 38.24 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 123.236 0.614 . . . . 0.0 110.773 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' VAL . . . . . 0.419 HG21 ' HD2' ' A' ' 485' ' ' ARG . 89.2 t -133.6 121.28 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.674 1.19 . . . . 0.0 108.356 174.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 23.0 tp60 -92.37 119.76 32.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.087 0.955 . . . . 0.0 109.718 174.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 69.1 mt -108.85 153.18 23.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.146 0.979 . . . . 0.0 108.716 169.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -147.5 144.52 28.61 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.843 0.457 . . . . 0.0 111.115 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.624 ' HB2' HD12 ' A' ' 503' ' ' LEU . 52.7 t30 -89.53 126.9 35.78 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 174.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -99.01 -17.72 18.14 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.912 0.885 . . . . 0.0 110.097 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' SER . . . . . 0.555 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 28.8 m -79.29 155.96 28.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.968 0.907 . . . . 0.0 112.49 -173.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.1 -37.42 66.73 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.755 0.822 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.555 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.1 OUTLIER -78.7 148.37 33.11 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.098 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.81 140.72 56.63 Favored 'General case' 0 C--O 1.244 0.767 0 O-C-N 123.776 0.673 . . . . 0.0 109.392 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.424 ' HG3' HG23 ' A' ' 454' ' ' VAL . 0.0 OUTLIER -112.18 111.44 22.33 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 39.9 m -75.98 122.98 24.99 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.613 0.765 . . . . 0.0 110.624 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 454' ' ' VAL . 95.6 mt -98.02 167.03 11.15 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.495 0.718 . . . . 0.0 109.932 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 143.48 -53.27 0.6 Allowed Glycine 0 N--CA 1.466 0.691 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -81.32 -12.19 59.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.324 1.049 . . . . 0.0 110.239 175.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -83.84 139.83 32.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.663 0.785 . . . . 0.0 109.762 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -130.5 145.53 51.87 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.603 0.761 . . . . 0.0 110.576 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 34.8 mt -106.7 95.19 3.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -78.66 129.65 34.97 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 124.052 0.941 . . . . 0.0 109.172 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 485' ' ' ARG . . . . . 0.419 ' HD2' HG21 ' A' ' 466' ' ' VAL . 74.4 mtp85 -135.04 93.35 2.99 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -94.09 102.73 14.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.944 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.503 HG12 HD23 ' A' ' 488' ' ' LEU . 39.2 t -76.34 151.58 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.032 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.503 HD23 HG12 ' A' ' 487' ' ' VAL . 2.5 pt? -59.5 -20.42 55.23 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.424 0.69 . . . . 0.0 112.743 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -73.17 -11.49 60.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.616 1.167 . . . . 0.0 112.69 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 109.31 -16.83 31.96 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-N 116.352 -0.385 . . . . 0.0 112.916 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.57 103.07 0.79 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.753 0.821 . . . . 0.0 111.448 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -107.17 119.94 40.75 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.425 HG21 ' NE2' ' A' ' 531' ' ' GLN . 31.6 pt -130.92 146.4 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.743 0.817 . . . . 0.0 109.601 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -129.35 109.01 10.75 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.89 0.476 . . . . 0.0 110.066 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -79.83 103.18 9.55 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -85.05 134.11 34.22 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.161 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -72.73 164.44 26.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.196 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.3 p -80.19 135.68 54.2 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.406 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 54.1 Cg_endo -66.81 -9.69 25.59 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.668 2.246 . . . . 0.0 113.799 -174.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -92.44 -9.66 40.75 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.404 0.681 . . . . 0.0 111.629 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -87.92 119.11 27.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.778 0.431 . . . . 0.0 109.895 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 40.3 mt -108.02 129.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 470' ' ' ASN . 0.9 OUTLIER -84.87 117.06 23.67 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.195 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -76.03 148.79 37.77 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.309 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.75 118.24 9.33 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.385 0.674 . . . . 0.0 110.685 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 103.35 -23.34 33.43 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.287 0.367 . . . . 0.0 112.552 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -88.02 -178.76 6.06 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.637 0.775 . . . . 0.0 111.368 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -157.57 146.28 19.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.808 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 509' ' ' VAL . . . . . 0.423 HG23 HD13 ' A' ' 526' ' ' LEU . 7.2 p -109.6 127.89 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.848 0.859 . . . . 0.0 109.342 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 2.7 m -111.47 105.88 14.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 47.7 t -93.19 112.26 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 512' ' ' TRP . . . . . 0.498 ' HB2' HG22 ' A' ' 527' ' ' VAL . 46.9 m95 -98.41 173.46 6.95 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.041 0.936 . . . . 0.0 111.522 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 516' ' ' ALA . . . -84.07 148.5 26.8 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.452 172.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.7 86.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.486 0.66 . . . . 0.0 110.316 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -88.56 14.3 60.13 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.879 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . . . -84.78 -11.46 55.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.449 0.7 . . . . 0.0 111.47 176.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.69 23.23 77.96 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.109 0.403 . . . . 0.0 114.109 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 11.5 p -98.45 149.82 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.3 1.04 . . . . 0.0 109.98 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.23 122.21 26.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.09 0.556 . . . . 0.0 110.41 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -65.31 110.12 2.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.067 0.547 . . . . 0.0 109.778 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 17.3 m -132.99 78.01 66.68 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.363 0.665 . . . . 0.0 110.626 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.46 154.9 50.38 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.749 2.299 . . . . 0.0 112.834 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -92.06 4.19 63.3 Favored 'Cis proline' 0 C--N 1.376 2.021 0 CA-C-N 119.841 0.979 . . . . 0.0 113.517 3.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.0 m -84.96 -58.17 2.8 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.781 0.432 . . . . 0.0 110.497 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 38.9 m -97.53 89.56 4.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.062 0.545 . . . . 0.0 109.872 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 10.8 mp -86.17 138.64 31.75 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 512' ' ' TRP . 86.9 t -125.54 128.56 72.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -72.96 88.97 1.39 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -64.04 112.41 2.96 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.508 -1.223 . . . . 0.0 108.702 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 122.89 -38.29 2.56 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 123.458 0.474 . . . . 0.0 112.411 -173.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.425 ' NE2' HG21 ' A' ' 493' ' ' ILE . 28.5 tp60 -86.49 96.61 10.11 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 13.8 p -63.53 -52.53 60.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.198 0.999 . . . . 0.0 112.199 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 536' ' ' THR . 96.0 p -88.78 -30.66 18.85 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 122.839 0.456 . . . . 0.0 111.927 -176.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 513' ' ' ALA . 6.3 t-105 56.57 34.94 25.28 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.402 1.096 . . . . 0.0 110.3 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 69.53 51.6 25.25 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.996 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 533' ' ' SER . 15.9 p -74.65 123.44 24.87 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 170.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -156.35 179.95 31.83 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.485 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -77.14 -38.71 51.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.407 0.622 . . . . 0.0 109.508 176.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.408 ' H ' HD22 ' A' ' 488' ' ' LEU . 19.3 m -147.92 125.85 12.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.562 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -146.29 144.78 30.06 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.777 0.831 . . . . 0.0 109.855 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 41.2 ttm180 -107.37 116.78 32.54 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.79 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 59.0 m -94.04 121.93 36.03 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' A' ' 554' ' ' MET . 59.9 t -124.53 117.93 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.332 1.053 . . . . 0.0 108.837 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 40.3 tp -89.52 111.59 22.54 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 51.6 t -102.02 149.78 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.207 1.003 . . . . 0.0 109.114 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.589 ' ND2' ' H ' ' A' ' 548' ' ' ASP . 1.5 p-10 -111.75 -172.59 2.07 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.969 0.507 . . . . 0.0 111.737 -172.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.6 73.01 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.884 1.274 . . . . 0.0 113.15 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 548' ' ' ASP . . . . . 0.589 ' H ' ' ND2' ' A' ' 546' ' ' ASN . 12.5 t70 -59.8 -40.61 88.91 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.583 0.753 . . . . 0.0 111.127 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.24 -17.76 26.27 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.436 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.16 148.21 50.25 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.101 0.477 . . . . 0.0 110.665 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.99 99.97 9.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.077 0.951 . . . . 0.0 108.775 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 27.1 m -85.11 -19.86 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.054 0.542 . . . . 0.0 112.284 -172.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.616 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -147.65 139.76 24.29 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.55 ' HG3' HG22 ' A' ' 543' ' ' VAL . 44.5 ttm -151.12 132.36 14.49 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.628 0.771 . . . . 0.0 109.252 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -157.78 117.62 3.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.264 0.626 . . . . 0.0 109.627 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 8.8 m -103.47 112.34 25.2 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.74 0.816 . . . . 0.0 109.435 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.563 HG21 ' HB ' ' A' ' 459' ' ' ILE . 58.1 t -105.64 122.12 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.503 0.721 . . . . 0.0 110.65 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.97 117.75 35.29 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 559' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 462' ' ' GLU . 25.8 ttpp . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 124.132 0.973 . . . . 0.0 110.565 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 120.785 0.326 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.77 145.05 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.452 1.101 . . . . 0.0 108.208 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 43.9 t -130.55 150.35 51.8 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.378 1.071 . . . . 0.0 109.988 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 459' ' ' ILE . 38.3 mt -84.71 108.86 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -80.71 -72.16 0.43 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.807 0.337 . . . . 0.0 110.824 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -119.25 149.86 41.06 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.993 0.517 . . . . 0.0 109.688 -169.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.47 ' HB ' HG21 ' A' ' 557' ' ' VAL . 80.6 mt -144.56 138.13 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 170.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 460' ' ' ASP . . . . . 0.424 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 20.1 t70 -59.91 142.04 54.39 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 123.488 0.493 . . . . 0.0 110.74 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.574 HD12 ' HG3' ' A' ' 462' ' ' GLU . 2.3 pp -66.71 -35.16 79.48 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.074 0.859 . . . . 0.0 111.432 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.574 ' HG3' HD12 ' A' ' 461' ' ' LEU . 29.0 mt-10 -75.37 -33.22 61.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.31 0.576 . . . . 0.0 109.687 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.84 52.0 1.86 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.422 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -96.19 -18.43 20.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.254 0.622 . . . . 0.0 111.194 175.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 32.0 p90 -150.85 161.1 43.33 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.067 0.461 . . . . 0.0 112.007 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 49.6 t -126.85 141.24 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.314 1.445 . . . . 0.0 107.493 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.72 104.61 9.72 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.456 HD22 HD22 ' A' ' 544' ' ' LEU . 57.8 mt -94.82 162.02 13.93 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.815 1.246 . . . . 0.0 110.204 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -144.28 130.14 19.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.524 ' HB2' HD12 ' A' ' 503' ' ' LEU . 46.9 t30 -78.29 107.58 11.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.118 0.567 . . . . 0.0 109.951 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -81.29 -5.71 58.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.646 0.779 . . . . 0.0 112.332 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 15.0 m -74.7 137.43 42.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.116 0.566 . . . . 0.0 110.715 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.61 -13.6 61.82 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.23 1.012 . . . . 0.0 110.998 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.0 OUTLIER -110.39 170.57 8.0 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.856 1.262 . . . . 0.0 108.457 172.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.9 145.03 50.43 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -107.88 118.24 36.22 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 41.2 p -71.6 118.27 14.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 171.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.3 mt -98.78 169.58 9.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 128.78 -56.51 0.74 Allowed Glycine 0 CA--C 1.492 -1.406 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -74.14 -13.16 60.78 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.886 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -82.16 149.49 27.92 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.566 1.147 . . . . 0.0 110.288 170.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -149.56 145.45 26.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.62 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 10.2 mt -107.25 106.19 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.732 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 62.1 mttm -75.87 159.79 30.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.112 0.565 . . . . 0.0 109.832 175.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 485' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 542' ' ' THR . 42.8 ttm180 -152.92 100.2 2.48 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -88.58 102.45 14.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.098 0.959 . . . . 0.0 108.575 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 489' ' ' GLU . 22.0 t -88.21 127.8 40.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.5 pp -65.79 -16.39 63.76 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.539 0.736 . . . . 0.0 112.468 -176.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 489' ' ' GLU . . . . . 0.424 ' H ' HG12 ' A' ' 487' ' ' VAL . 47.8 mt-10 -73.59 -0.45 15.32 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.866 0.867 . . . . 0.0 111.761 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 106.15 27.45 5.61 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 166.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -132.06 101.12 5.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.168 0.587 . . . . 0.0 110.207 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -106.34 121.96 45.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.89 179.57 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.149 0.98 . . . . 0.0 110.18 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -161.32 118.06 2.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.8 0.84 . . . . 0.0 110.064 172.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -79.18 117.48 20.24 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.548 0.739 . . . . 0.0 109.324 172.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.01 141.71 31.88 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -84.63 169.13 14.66 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 166.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.6 p -91.7 130.2 39.76 Favored Pre-proline 0 CA--C 1.556 1.186 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.475 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 32.4 Cg_exo -60.3 -20.42 62.55 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.249 2.633 . . . . 0.0 114.023 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -72.61 -22.35 60.98 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.66 0.784 . . . . 0.0 111.855 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -83.81 123.78 30.25 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.717 0.807 . . . . 0.0 110.447 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 54.1 mt -116.41 132.92 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 168.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 503' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 470' ' ' ASN . 2.4 tm? -93.96 138.32 32.2 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.55 161.88 29.32 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -57.99 120.07 7.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.925 1.29 . . . . 0.0 112.428 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 66.87 14.74 63.64 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -97.16 -163.56 1.06 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.236 0.614 . . . . 0.0 109.851 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 19.3 ptp -146.06 164.08 33.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.783 0.833 . . . . 0.0 110.835 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.0 p -143.93 124.68 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.099 0.96 . . . . 0.0 109.152 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 4.0 m -114.51 110.05 19.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.827 0.851 . . . . 0.0 109.591 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.415 HG12 ' HE1' ' A' ' 534' ' ' TRP . 41.0 t -96.71 102.07 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.266 0.626 . . . . 0.0 109.861 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -83.69 175.25 9.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.622 1.169 . . . . 0.0 111.457 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -97.05 158.48 15.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.985 0.914 . . . . 0.0 110.195 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -65.05 -25.23 67.74 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.211 0.604 . . . . 0.0 111.865 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 515' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -111.45 21.12 22.17 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.755 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -79.97 -1.0 37.59 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.25 0.62 . . . . 0.0 110.814 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 74.4 38.22 45.72 Favored Glycine 0 C--N 1.358 1.8 0 O-C-N 123.285 0.366 . . . . 0.0 112.379 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.78 148.48 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.135 0.974 . . . . 0.0 110.149 -171.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -91.66 160.45 15.36 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.606 0.762 . . . . 0.0 110.139 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -79.99 122.86 27.25 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 39.0 m -133.18 80.68 58.56 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.692 0.797 . . . . 0.0 109.111 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.94 154.37 58.16 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.739 2.293 . . . . 0.0 112.48 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.54 -18.38 24.04 Favored 'Cis proline' 0 C--N 1.378 2.119 0 C-N-CA 124.787 -0.922 . . . . 0.0 113.741 1.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.2 m -64.98 -52.36 56.65 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.573 0.749 . . . . 0.0 111.708 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 32.6 m -104.01 91.09 3.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 55.6 mt -83.15 148.31 27.55 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.4 127.81 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.417 0.687 . . . . 0.0 109.23 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -70.76 88.07 0.71 Allowed 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -71.93 131.47 43.01 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.714 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 107.51 -36.49 4.35 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.281 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -113.17 112.05 23.12 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.275 0.559 . . . . 0.0 110.703 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 532' ' ' SER . . . . . 0.446 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 22.6 p -85.39 -21.61 28.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.677 1.191 . . . . 0.0 112.702 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.5 t -87.48 -32.95 19.19 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -170.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.415 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 53.35 22.84 2.97 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 124.056 0.942 . . . . 0.0 110.932 -168.012 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.79 60.98 6.61 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -171.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 15.1 t -64.76 149.79 48.61 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.568 0.747 . . . . 0.0 110.25 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -163.12 162.15 34.51 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 116.405 -0.361 . . . . 0.0 112.22 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -76.13 -34.96 59.45 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.975 0.91 . . . . 0.0 109.167 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.431 ' HB2' HD21 ' A' ' 488' ' ' LEU . 50.5 m -150.04 142.26 24.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.674 1.19 . . . . 0.0 108.71 170.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -164.22 -179.8 6.36 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.482 1.113 . . . . 0.0 109.631 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -140.0 125.71 19.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.497 0.665 . . . . 0.0 110.078 170.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 485' ' ' ARG . 24.1 m -101.87 120.86 41.05 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.765 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.732 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 57.4 t -103.62 148.39 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.32 1.048 . . . . 0.0 109.365 -177.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 43.7 tp -110.42 136.19 49.96 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.34 150.02 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.735 1.214 . . . . 0.0 108.348 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.99 -170.94 1.93 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.864 0.866 . . . . 0.0 112.134 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -61.3 -26.34 67.72 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.072 0.949 . . . . 0.0 112.91 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.67 -37.49 84.89 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.086 0.554 . . . . 0.0 110.842 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 100.07 5.03 55.14 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.189 -172.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -88.06 149.54 23.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.309 0.643 . . . . 0.0 110.012 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.03 95.32 6.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.596 0.758 . . . . 0.0 108.96 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.75 -28.91 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.771 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -149.99 160.9 43.26 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.618 0.367 . . . . 0.0 110.639 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 50.6 ttp -158.67 143.44 16.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.792 0.837 . . . . 0.0 109.272 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -142.21 108.66 5.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.029 0.931 . . . . 0.0 109.172 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 42.2 m -82.34 109.48 16.63 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.488 0.715 . . . . 0.0 109.489 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 459' ' ' ILE . 57.3 t -109.22 132.31 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.222 1.009 . . . . 0.0 110.161 -175.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 558' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 558' ' ' LYS . 0.0 OUTLIER -132.67 118.4 19.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.603 1.161 . . . . 0.0 108.627 -177.38 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 559' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 461' ' ' LEU . 33.3 tttm . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 124.861 1.264 . . . . 0.0 109.883 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.43 0.157 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 43.0 t -99.61 121.56 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 16.9 m -108.78 143.66 37.63 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.306 1.042 . . . . 0.0 109.581 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 459' ' ' ILE . 55.5 mt -77.43 130.32 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' A' ' 469' ' ' LYS . 36.1 mm-40 -81.01 -74.19 0.34 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.65 0.262 . . . . 0.0 110.649 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -128.25 155.32 44.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.753 0.821 . . . . 0.0 109.916 -171.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.463 ' HB ' HG11 ' A' ' 557' ' ' VAL . 48.4 mm -131.12 141.57 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.635 0.774 . . . . 0.0 109.0 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.66 153.86 31.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.246 1.018 . . . . 0.0 111.398 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 461' ' ' LEU . 2.2 pt? -109.31 0.31 19.48 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.156 0.582 . . . . 0.0 110.251 166.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -120.83 0.82 10.4 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.137 0.975 . . . . 0.0 112.544 -171.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 73.58 45.87 27.28 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 123.073 0.233 . . . . 0.0 113.597 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -108.31 -50.49 3.03 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.39 0.676 . . . . 0.0 111.295 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -164.59 152.08 11.68 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' VAL . . . . . 0.417 HG11 HD13 ' A' ' 483' ' ' ILE . 71.1 t -112.15 112.0 38.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.673 1.189 . . . . 0.0 108.692 173.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.447 ' HG3' ' HB2' ' A' ' 457' ' ' GLU . 57.4 tp60 -87.32 102.19 14.27 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.542 HD22 HD22 ' A' ' 544' ' ' LEU . 81.9 mt -94.95 165.11 12.61 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.432 1.093 . . . . 0.0 110.106 172.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 469' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 508' ' ' MET . 50.9 tttm -149.91 137.7 20.12 Favored 'General case' 0 C--O 1.219 -0.522 0 C-N-CA 123.215 0.606 . . . . 0.0 110.207 172.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -88.36 136.61 32.9 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -130.61 9.4 5.05 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.167 0.987 . . . . 0.0 110.133 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 46.5 t -77.87 145.8 36.03 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 123.374 0.669 . . . . 0.0 109.732 170.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -70.2 -25.1 63.26 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.249 1.02 . . . . 0.0 111.648 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 474' ' ' LYS . 32.6 pttt -112.95 166.07 11.75 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.016 0.927 . . . . 0.0 110.834 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -70.53 120.44 16.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.422 0.689 . . . . 0.0 109.963 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -87.62 118.85 27.39 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.645 0.778 . . . . 0.0 109.767 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 54.5 p -70.68 101.83 2.15 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.639 0.776 . . . . 0.0 110.375 176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 17.9 tp -91.16 152.69 20.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.712 0.805 . . . . 0.0 109.62 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.08 -58.62 0.51 Allowed Glycine 0 N--CA 1.472 1.049 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.703 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.36 -11.9 61.2 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.288 0.635 . . . . 0.0 111.075 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' TRP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 546' ' ' ASN . 14.1 m95 -75.14 166.03 24.28 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 124.452 1.101 . . . . 0.0 110.927 170.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -160.7 145.81 14.41 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.975 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 49.7 mt -101.42 107.54 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.158 0.583 . . . . 0.0 109.535 176.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.739 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 60.7 mttm -78.13 159.35 28.68 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 170.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 485' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 534' ' ' TRP . 36.8 ttm180 -158.08 100.37 1.71 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.05 111.56 23.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.284 0.633 . . . . 0.0 109.712 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.459 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 53.1 t -68.87 157.52 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.0 0.92 . . . . 0.0 109.797 174.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.0 pp -52.15 -28.12 16.86 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.232 1.013 . . . . 0.0 112.256 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -69.39 -33.33 72.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.493 1.117 . . . . 0.0 111.383 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 131.61 -21.24 4.52 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.792 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.32 109.59 2.32 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.36 1.064 . . . . 0.0 111.461 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -107.77 117.3 33.75 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.402 0.62 . . . . 0.0 110.804 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 40.2 pt -105.85 142.46 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.923 0.889 . . . . 0.0 109.367 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -125.25 116.36 21.85 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.903 0.481 . . . . 0.0 110.931 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -78.98 106.35 10.96 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -81.48 121.63 26.52 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -73.26 169.16 17.67 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 120.819 0.342 . . . . 0.0 110.794 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 68.9 p -93.27 120.78 66.43 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 123.054 0.542 . . . . 0.0 110.32 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.503 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 34.6 Cg_exo -60.37 -15.56 36.17 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.934 3.089 . . . . 0.0 115.199 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -72.48 -23.51 61.05 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.542 0.737 . . . . 0.0 111.64 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -89.02 142.79 27.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.495 1.118 . . . . 0.0 110.884 -171.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 62.2 mt -129.43 132.96 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.391 0.676 . . . . 0.0 109.213 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 503' ' ' LEU . . . . . 0.648 HD21 ' HB ' ' A' ' 509' ' ' VAL . 0.3 OUTLIER -93.85 134.69 35.95 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.026 0.93 . . . . 0.0 109.025 177.482 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -78.16 156.49 29.85 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.131 0.491 . . . . 0.0 111.682 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.04 126.93 29.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.256 1.022 . . . . 0.0 112.031 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 77.97 -12.34 18.06 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.62 0.575 . . . . 0.0 114.395 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -86.71 159.48 19.15 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.661 0.784 . . . . 0.0 110.232 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 508' ' ' MET . . . . . 0.552 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 23.5 ptt? -108.57 169.69 8.5 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.613 0.765 . . . . 0.0 111.517 -175.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 509' ' ' VAL . . . . . 0.648 ' HB ' HD21 ' A' ' 503' ' ' LEU . 7.4 p -145.95 148.89 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 4.2 m -131.09 105.46 7.72 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 71.5 t -86.02 98.63 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.055 0.455 . . . . 0.0 110.224 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -82.34 176.41 9.47 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.905 0.882 . . . . 0.0 111.3 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -103.64 152.14 22.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.826 0.851 . . . . 0.0 110.128 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 514' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.84 -20.06 65.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.874 0.87 . . . . 0.0 112.021 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -103.76 16.63 51.05 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.692 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -90.76 -3.61 57.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.328 0.651 . . . . 0.0 110.713 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.33 33.92 68.71 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 113.995 0.358 . . . . 0.0 113.995 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 12.9 p -130.79 144.25 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 123.412 0.685 . . . . 0.0 110.341 -175.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -81.81 142.9 32.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.57 0.748 . . . . 0.0 111.42 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -61.85 109.33 1.21 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.418 0.687 . . . . 0.0 109.827 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 17.8 m -132.74 80.49 61.35 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.019 0.928 . . . . 0.0 109.556 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.72 160.85 44.46 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.916 2.41 . . . . 0.0 112.175 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -90.31 16.77 43.79 Favored 'Cis proline' 0 C--N 1.381 2.265 0 CA-C-N 119.652 0.911 . . . . 0.0 113.385 3.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.2 m -97.99 -70.88 0.71 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.739 0.815 . . . . 0.0 109.836 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 20.2 m -85.65 86.28 7.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.182 0.593 . . . . 0.0 110.372 -173.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 11.1 mp -91.66 105.19 17.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 171.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 90.3 t -89.46 117.98 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -69.27 91.74 0.54 Allowed 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 529' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 27.7 tptp -75.07 131.03 40.27 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.399 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 104.31 -5.08 44.71 Favored Glycine 0 N--CA 1.472 1.094 0 O-C-N 123.606 0.566 . . . . 0.0 111.988 -172.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -121.95 109.82 15.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.854 0.862 . . . . 0.0 109.179 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 37.2 p -71.72 -61.72 1.68 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.992 0.517 . . . . 0.0 111.21 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 23.7 m -121.16 25.26 9.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.815 0.446 . . . . 0.0 112.108 -167.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.428 ' HB3' ' NH1' ' A' ' 485' ' ' ARG . 0.0 OUTLIER 51.89 30.93 7.69 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.384 1.074 . . . . 0.0 112.541 171.453 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.88 68.7 1.56 Allowed Glycine 0 C--N 1.352 1.43 0 N-CA-C 112.371 -0.291 . . . . 0.0 112.371 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 2.7 p -64.4 142.57 58.37 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.504 0.722 . . . . 0.0 112.66 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -162.86 169.57 38.1 Favored Glycine 0 C--O 1.242 0.599 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.244 172.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -70.48 -26.78 63.77 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.336 0.568 . . . . 0.0 110.105 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 80.8 p -155.13 142.52 19.55 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.841 0.857 . . . . 0.0 109.35 172.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.459 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 8.0 p90 -155.5 136.67 13.85 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.684 0.794 . . . . 0.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.618 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 34.6 ptt180 -87.93 111.25 21.25 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 23.1 m -94.03 110.73 22.41 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.739 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 21.9 t -102.86 144.93 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.828 1.251 . . . . 0.0 109.606 -174.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.542 HD22 HD22 ' A' ' 468' ' ' LEU . 34.7 tp -112.17 125.47 54.17 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 551' ' ' GLU . 22.0 t -124.33 160.14 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.135 1.374 . . . . 0.0 108.485 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.591 HD21 ' HG2' ' A' ' 550' ' ' GLU . 2.9 p30 -126.35 -174.83 3.21 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.017 0.371 . . . . 0.0 111.577 175.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -50.08 -34.47 21.88 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.432 1.493 . . . . 0.0 113.189 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.64 -33.68 76.5 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.262 1.025 . . . . 0.0 111.929 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 102.97 -12.12 56.02 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.049 -174.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 550' ' ' GLU . . . . . 0.591 ' HG2' HD21 ' A' ' 546' ' ' ASN . 13.2 pt-20 -72.79 139.36 47.01 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.21 0.604 . . . . 0.0 109.384 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.483 ' HG2' HG22 ' A' ' 545' ' ' VAL . 38.5 mt-10 -92.0 93.3 8.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.116 0.966 . . . . 0.0 108.994 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 18.0 m -71.67 -16.64 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -167.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -159.36 156.28 28.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.067 0.547 . . . . 0.0 110.482 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.59 ' SD ' ' HD2' ' A' ' 541' ' ' ARG . 67.0 ttp -154.94 109.93 3.04 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.25 0.62 . . . . 0.0 110.097 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -104.14 104.19 14.09 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 30.4 m -85.19 99.04 10.83 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.463 HG11 ' HB ' ' A' ' 459' ' ' ILE . 35.1 m -98.96 147.29 7.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 121.621 0.724 . . . . 0.0 110.383 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.48 168.88 9.77 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.08 175.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 559' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 461' ' ' LEU . 38.7 ttpt . . . . . 0 C--O 1.238 0.478 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 454' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 544' ' ' LEU . 4.1 t -95.55 163.74 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.357 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 21.1 t -155.69 150.66 26.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.566 0.746 . . . . 0.0 109.671 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' ILE . . . . . 0.413 ' HA ' HD12 ' A' ' 468' ' ' LEU . 31.7 mt -77.7 102.41 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.286 0.634 . . . . 0.0 109.863 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.486 ' HG2' ' HG3' ' A' ' 458' ' ' GLU . 42.0 tt0 -81.18 -57.49 3.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.353 0.261 . . . . 0.0 111.602 -170.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.486 ' HG3' ' HG2' ' A' ' 457' ' ' GLU . 29.4 mt-10 -137.88 153.36 49.57 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.256 0.622 . . . . 0.0 109.394 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.0 mt -151.84 138.18 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.61 148.84 38.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.453 HD12 ' HG3' ' A' ' 462' ' ' GLU . 3.5 pp -74.38 -16.51 60.89 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -169.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.453 ' HG3' HD12 ' A' ' 461' ' ' LEU . 2.7 mt-10 -82.02 -31.91 30.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.199 0.6 . . . . 0.0 110.427 174.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 86.97 51.63 3.33 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.986 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -97.1 -19.48 18.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.54 0.736 . . . . 0.0 110.867 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -154.35 163.52 40.03 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.935 0.494 . . . . 0.0 111.872 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' VAL . . . . . 0.402 HG11 HG21 ' A' ' 483' ' ' ILE . 79.2 t -126.37 117.65 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.017 1.327 . . . . 0.0 108.164 170.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.7 tp60 -88.06 113.35 23.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.989 0.916 . . . . 0.0 109.039 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.55 HD22 HD11 ' A' ' 483' ' ' ILE . 22.6 tp -120.21 116.69 26.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.137 0.975 . . . . 0.0 109.495 -172.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 469' ' ' LYS . . . . . 0.411 ' HG2' ' HB3' ' A' ' 508' ' ' MET . 1.8 tmmm? -114.03 130.52 56.55 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.992 0.36 . . . . 0.0 110.368 -169.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -82.62 115.32 21.52 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.436 0.694 . . . . 0.0 109.84 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -85.49 -15.76 41.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.911 0.884 . . . . 0.0 112.033 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' SER . . . . . 0.545 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 69.8 m -65.57 156.45 32.64 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.57 2.36 33.53 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.832 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.545 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.1 OUTLIER -135.38 168.49 19.1 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.24 1.016 . . . . 0.0 108.822 173.352 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 475' ' ' ASP . . . . . 0.402 ' HB3' HG22 ' A' ' 502' ' ' ILE . 24.1 m-20 -73.59 122.05 21.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.428 0.691 . . . . 0.0 109.475 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -83.36 123.02 29.23 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.497 0.719 . . . . 0.0 110.204 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 30.2 p -71.01 106.67 3.76 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.1 mp -91.09 -179.81 5.54 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 0.0 109.97 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 133.28 -67.23 0.56 Allowed Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.64 -11.5 60.2 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.499 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 33.1 m95 -69.84 145.4 52.11 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -149.47 136.27 19.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.882 0.473 . . . . 0.0 111.123 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 483' ' ' ILE . . . . . 0.55 HD11 HD22 ' A' ' 468' ' ' LEU . 57.8 mt -97.41 107.28 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.619 0.768 . . . . 0.0 109.472 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 545' ' ' VAL . 68.0 mttm -78.86 148.17 32.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.363 0.665 . . . . 0.0 110.531 172.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 485' ' ' ARG . . . . . 0.432 ' NH2' ' HB3' ' A' ' 534' ' ' TRP . 20.6 mtm180 -140.49 123.3 16.38 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 486' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 491' ' ' GLU . 51.2 tt0 -116.98 114.06 23.27 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.417 0.687 . . . . 0.0 109.83 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.453 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 13.4 t -84.72 159.31 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.792 1.237 . . . . 0.0 110.645 -177.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.2 -22.87 61.69 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.959 0.904 . . . . 0.0 111.98 173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.57 -22.14 66.13 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.585 1.154 . . . . 0.0 112.407 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 99.86 1.96 56.19 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.339 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 491' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 486' ' ' GLN . 42.1 mt-10 -72.95 122.05 21.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.596 0.758 . . . . 0.0 110.073 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.81 112.56 13.71 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 22.0 pt -132.17 170.09 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.236 1.014 . . . . 0.0 109.629 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -150.22 127.32 11.23 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.893 0.477 . . . . 0.0 110.681 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -80.29 108.98 14.34 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 169.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -84.73 128.3 34.54 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -70.45 169.14 14.67 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.645 0.736 . . . . 0.0 111.327 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 65.9 p -87.36 132.34 41.45 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.871 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.481 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 26.8 Cg_endo -58.78 -21.41 56.58 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.094 2.529 . . . . 0.0 113.302 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -72.31 -25.42 61.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.193 0.597 . . . . 0.0 111.903 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -75.78 126.19 30.52 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 122.825 0.45 . . . . 0.0 110.189 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 502' ' ' ILE . . . . . 0.402 HG22 ' HB3' ' A' ' 475' ' ' ASP . 41.5 mt -122.55 113.9 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.25 120.14 21.88 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -69.75 160.89 30.85 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.9 119.08 10.67 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.166 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.6 6.09 65.55 Favored Glycine 0 C--N 1.343 0.925 0 O-C-N 123.585 0.553 . . . . 0.0 113.666 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -101.59 177.97 4.77 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.642 0.777 . . . . 0.0 109.677 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 508' ' ' MET . . . . . 0.411 ' HB3' ' HG2' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -139.92 162.53 34.96 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.537 0.684 . . . . 0.0 112.039 -175.158 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 509' ' ' VAL . . . . . 0.518 HG23 HD13 ' A' ' 526' ' ' LEU . 6.3 p -123.79 117.49 51.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 125.201 1.401 . . . . 0.0 107.926 176.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 7.8 m -96.48 95.02 7.73 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.89 97.42 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.927 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -79.71 171.74 14.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.635 0.774 . . . . 0.0 110.819 171.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -91.91 165.0 13.45 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.676 0.791 . . . . 0.0 110.109 173.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 514' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -63.51 -34.2 77.26 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.102 0.477 . . . . 0.0 110.379 171.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 515' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -89.41 20.65 33.0 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.305 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -85.07 -24.43 28.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.315 0.646 . . . . 0.0 110.554 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 71.05 35.76 64.47 Favored Glycine 0 C--N 1.35 1.322 0 O-C-N 123.872 0.733 . . . . 0.0 112.917 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 8.6 p -114.44 143.77 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.014 0.926 . . . . 0.0 110.276 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -72.79 123.23 22.94 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.284 0.634 . . . . 0.0 110.227 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -63.92 110.69 2.19 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.425 0.69 . . . . 0.0 110.473 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.8 m -132.24 72.26 78.84 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.063 0.545 . . . . 0.0 110.909 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.93 159.4 53.09 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.739 2.292 . . . . 0.0 112.352 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.23 0.94 50.48 Favored 'Cis proline' 0 C--N 1.382 2.32 0 CA-C-N 120.141 1.086 . . . . 0.0 114.077 -0.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 32.9 t -74.78 -63.22 1.3 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.415 0.686 . . . . 0.0 111.08 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 27.5 m -104.19 98.58 8.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.108 0.963 . . . . 0.0 110.265 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.518 HD13 HG23 ' A' ' 509' ' ' VAL . 11.2 mp -93.64 146.86 23.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 81.9 t -129.82 117.27 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -73.47 89.34 1.65 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 529' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 27.3 tptp -75.77 123.27 25.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.386 177.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 120.75 -24.26 7.59 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -173.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -121.5 109.61 15.04 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 532' ' ' SER . . . . . 0.446 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 32.9 p -82.53 -34.94 27.69 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.853 0.461 . . . . 0.0 111.634 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 536' ' ' THR . 23.6 m -90.28 -29.74 17.95 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.189 0.596 . . . . 0.0 112.167 -174.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.674 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 59.74 22.26 11.08 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 123.224 0.61 . . . . 0.0 109.401 -173.535 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.99 69.08 1.46 Allowed Glycine 0 C--N 1.345 1.037 0 O-C-N 121.653 -0.654 . . . . 0.0 111.949 -171.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 533' ' ' SER . 8.1 p -71.82 159.92 33.47 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.612 0.765 . . . . 0.0 110.231 172.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 172.72 176.43 41.35 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.404 -0.362 . . . . 0.0 113.038 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -84.07 -26.96 28.62 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.756 0.422 . . . . 0.0 110.073 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 66.9 m -152.24 128.23 10.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.531 1.132 . . . . 0.0 108.743 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.453 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 6.8 p90 -154.48 122.47 5.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.96 0.904 . . . . 0.0 110.091 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.621 ' HD3' ' H ' ' A' ' 541' ' ' ARG . 0.0 OUTLIER -86.27 123.39 31.47 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.423 0.63 . . . . 0.0 109.727 -178.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 542' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 485' ' ' ARG . 39.3 m -94.31 140.17 30.13 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.252 1.021 . . . . 0.0 109.506 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 99.9 t -132.93 130.9 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.482 1.113 . . . . 0.0 109.279 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.603 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 53.1 tp -93.96 129.48 40.41 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.459 HG21 ' HE2' ' A' ' 484' ' ' LYS . 81.4 t -118.13 143.73 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.754 1.222 . . . . 0.0 108.226 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.546 HD21 ' HG2' ' A' ' 550' ' ' GLU . 2.0 p30 -103.0 -173.54 2.34 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.514 0.326 . . . . 0.0 111.155 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -64.17 -22.97 67.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.803 0.841 . . . . 0.0 113.234 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -65.24 -39.46 92.72 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.162 0.506 . . . . 0.0 110.453 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.37 -11.26 33.44 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.398 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 550' ' ' GLU . . . . . 0.546 ' HG2' HD21 ' A' ' 546' ' ' ASN . 16.3 pt-20 -80.39 153.87 28.05 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 117.259 0.53 . . . . 0.0 110.549 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -88.65 104.6 17.01 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.673 1.189 . . . . 0.0 110.171 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.74 -29.47 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.566 0.746 . . . . 0.0 112.813 -170.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -139.12 161.11 38.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.072 0.549 . . . . 0.0 110.137 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.431 ' HG3' HG22 ' A' ' 543' ' ' VAL . 40.7 ttp -159.27 108.25 1.86 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.33 0.652 . . . . 0.0 109.795 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -119.46 123.63 44.52 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.755 0.822 . . . . 0.0 109.207 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 26.7 m -79.12 134.0 36.73 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.54 139.9 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -161.53 146.34 13.33 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 122.916 0.486 . . . . 0.0 111.074 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 559' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 461' ' ' LEU . 86.2 tttt . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.19 0.996 . . . . 0.0 110.23 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 121.059 0.457 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 454' ' ' VAL . . . . . 0.457 HG23 ' HG2' ' A' ' 476' ' ' GLN . 21.2 t -85.61 129.82 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 171.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 44.0 t -110.51 145.7 37.27 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.129 1.372 . . . . 0.0 109.497 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 50.8 mt -81.93 95.11 2.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.85 -65.14 1.04 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.652 0.381 . . . . 0.0 110.404 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 20.5 mt-10 -116.49 153.13 32.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.1 0.56 . . . . 0.0 110.368 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.493 HG23 HG22 ' A' ' 466' ' ' VAL . 47.8 mt -140.06 142.53 31.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 170.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.76 145.87 51.9 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.307 0.38 . . . . 0.0 110.474 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.587 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.4 pt? -58.93 -41.16 86.68 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.134 0.974 . . . . 0.0 111.886 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.587 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 43.7 mt-10 -91.45 -22.03 20.63 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.159 0.984 . . . . 0.0 110.066 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 83.92 50.82 4.23 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.053 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -87.71 -16.76 33.41 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.06 163.35 40.01 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.031 0.532 . . . . 0.0 111.166 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' VAL . . . . . 0.493 HG22 HG23 ' A' ' 459' ' ' ILE . 97.2 t -134.9 122.76 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.669 1.188 . . . . 0.0 108.088 168.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.602 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 10.2 tt0 -89.8 111.48 22.51 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.287 0.565 . . . . 0.0 110.103 170.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.85 159.95 18.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.21 165.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 508' ' ' MET . 1.6 tmtp? -152.58 129.01 10.63 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.527 ' HB3' HD12 ' A' ' 503' ' ' LEU . 50.6 t30 -99.07 100.35 11.48 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -76.75 -11.63 59.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.254 0.622 . . . . 0.0 111.511 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 44.9 t -63.73 152.54 38.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.338 1.055 . . . . 0.0 112.847 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -73.11 -12.01 60.75 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.095 1.358 . . . . 0.0 111.296 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -99.01 143.69 29.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.763 0.825 . . . . 0.0 110.893 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.46 102.5 2.68 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.457 ' HG2' HG23 ' A' ' 454' ' ' VAL . 57.2 tp60 -70.29 115.48 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.3 0.64 . . . . 0.0 111.87 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.4 m -64.28 99.71 0.3 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.3 tp -96.49 159.53 14.89 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -175.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 143.83 -65.88 0.46 Allowed Glycine 0 N--CA 1.47 0.95 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.64 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.27 -11.66 59.76 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.698 0.799 . . . . 0.0 111.078 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -75.89 135.0 40.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.832 0.853 . . . . 0.0 108.887 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -128.19 145.61 50.98 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 49.6 mt -106.3 103.93 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.627 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 59.3 mttm -78.89 96.19 5.62 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 19.5 tpp85 -79.53 96.82 6.22 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 168.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -102.05 100.92 11.22 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 15.7 t -94.06 141.9 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.2 pp -65.91 -14.88 62.33 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.52 -8.42 33.68 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.238 0.615 . . . . 0.0 110.847 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 105.95 28.27 5.36 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.504 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -121.38 103.83 9.24 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.178 0.591 . . . . 0.0 110.571 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -107.87 80.96 1.44 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.436 1.112 . . . . 0.0 109.226 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 34.9 pt -95.07 134.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.012 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -108.21 110.71 22.4 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.875 0.47 . . . . 0.0 110.067 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.96 104.38 9.55 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 496' ' ' LYS . 0.2 OUTLIER -91.0 129.66 36.98 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -76.79 170.06 17.16 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.995 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.0 p -88.55 124.66 65.45 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.461 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 19.8 Cg_endo -60.16 -10.0 11.75 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.985 2.456 . . . . 0.0 114.871 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -75.17 -24.66 57.93 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.888 0.475 . . . . 0.0 111.273 172.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -82.08 128.06 33.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.599 0.759 . . . . 0.0 110.198 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 59.8 mt -122.46 123.81 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 503' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 470' ' ' ASN . 1.0 OUTLIER -90.2 123.79 34.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 507' ' ' GLN . 1.2 mpt_? -74.49 169.32 17.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.89 0.876 . . . . 0.0 112.109 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -70.43 121.43 17.73 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.402 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 76.59 12.46 84.38 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.812 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' GLN . . . . . 0.414 ' HG3' ' HB2' ' A' ' 504' ' ' ARG . 32.7 mm-40 -104.09 -176.4 3.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.201 0.6 . . . . 0.0 110.773 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 508' ' ' MET . . . . . 0.496 ' HB3' ' HG2' ' A' ' 469' ' ' LYS . 1.5 ppp? -141.63 164.64 29.66 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.976 0.91 . . . . 0.0 111.196 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.67 135.03 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.402 1.081 . . . . 0.0 108.295 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 7.2 m -116.69 115.55 25.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 526' ' ' LEU . 16.0 m -101.54 98.61 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.171 0.988 . . . . 0.0 110.436 -176.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -87.55 172.91 9.4 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.165 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.697 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -92.3 156.47 17.24 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.949 0.9 . . . . 0.0 110.43 175.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -59.9 -28.06 67.26 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.286 0.635 . . . . 0.0 112.125 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 515' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -111.45 23.86 17.03 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.291 -0.413 . . . . 0.0 113.479 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -89.17 11.27 19.12 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 69.66 36.95 76.53 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-O 121.343 0.413 . . . . 0.0 112.71 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.56 147.92 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.908 0.883 . . . . 0.0 111.319 -167.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -99.13 130.51 45.45 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.915 0.886 . . . . 0.0 109.588 171.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -65.25 112.6 3.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.4 m -131.5 71.18 81.47 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.355 0.662 . . . . 0.0 109.613 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.81 153.34 78.29 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.868 2.379 . . . . 0.0 112.247 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -80.51 -19.87 21.27 Favored 'Cis proline' 0 C--N 1.38 2.19 0 CA-C-N 119.957 1.02 . . . . 0.0 113.608 0.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.2 m -63.14 -35.91 81.86 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.306 1.043 . . . . 0.0 112.588 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 25.8 m -127.83 91.21 3.24 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.47 0.708 . . . . 0.0 109.415 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.57 ' HB2' HG12 ' A' ' 511' ' ' VAL . 66.7 mt -84.75 148.37 26.39 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 54.5 t -132.06 127.9 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -68.57 87.77 0.33 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -70.14 128.5 36.49 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.769 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 98.09 -21.46 45.94 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.729 -0.669 . . . . 0.0 113.188 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.83 103.85 10.38 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 532' ' ' SER . . . . . 0.403 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 42.5 p -85.37 -17.56 36.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.372 1.069 . . . . 0.0 113.822 -166.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 46.5 m -96.45 -29.39 13.95 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.697 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 58.44 21.8 8.85 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.187 0.995 . . . . 0.0 110.76 -168.215 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 66.74 70.65 1.07 Allowed Glycine 0 C--N 1.349 1.29 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 -172.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 14.6 p -63.3 162.07 12.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.614 0.766 . . . . 0.0 112.455 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -176.53 149.58 9.84 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.82 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.66 -21.09 38.35 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.515 ' HB2' HD21 ' A' ' 488' ' ' LEU . 19.4 m -148.25 132.83 17.75 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.727 0.811 . . . . 0.0 109.672 167.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -160.38 -176.41 5.59 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.028 0.931 . . . . 0.0 110.395 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 541' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 11.0 ptp180 -136.7 155.48 49.81 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.786 170.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 542' ' ' THR . . . . . 0.485 ' HB ' HD13 ' A' ' 459' ' ' ILE . 86.4 m -130.97 118.81 21.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.627 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 19.6 t -112.63 151.42 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.442 1.097 . . . . 0.0 108.698 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 39.8 tp -123.94 106.83 10.74 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 551' ' ' GLU . 6.2 p -96.59 147.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.682 1.193 . . . . 0.0 109.215 175.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.441 ' ND2' ' H ' ' A' ' 548' ' ' ASP . 0.7 OUTLIER -107.44 -171.96 1.98 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.697 0.399 . . . . 0.0 110.334 -178.15 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.41 66.78 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 548' ' ' ASP . . . . . 0.573 ' HB2' ' HG2' ' A' ' 550' ' ' GLU . 68.4 m-20 -71.75 -23.74 61.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.085 0.554 . . . . 0.0 111.981 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 93.95 -2.73 69.59 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 550' ' ' GLU . . . . . 0.573 ' HG2' ' HB2' ' A' ' 548' ' ' ASP . 11.7 pt-20 -89.53 141.37 28.64 Favored 'General case' 0 C--O 1.247 0.966 0 C-N-CA 123.189 0.596 . . . . 0.0 109.696 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 545' ' ' VAL . 53.3 mt-10 -81.76 111.05 17.65 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.588 0.755 . . . . 0.0 109.214 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.05 -22.71 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.595 0.758 . . . . 0.0 112.549 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -146.55 157.34 43.72 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.867 0.867 . . . . 0.0 109.361 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.431 ' HG3' HG22 ' A' ' 543' ' ' VAL . 28.5 ttt -168.51 140.51 2.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.427 0.691 . . . . 0.0 110.37 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -152.03 123.66 7.89 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.14 0.976 . . . . 0.0 109.427 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 36.3 m -86.34 124.63 32.91 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.778 0.831 . . . . 0.0 109.853 175.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 459' ' ' ILE . 35.2 t -135.04 142.71 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.929 0.892 . . . . 0.0 109.507 -177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 152.99 41.66 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.754 -177.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 559' ' ' LYS . . . . . 0.564 ' HD2' ' HG2' ' A' ' 462' ' ' GLU . 88.7 tttt . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 121.717 0.77 . . . . 0.0 109.153 170.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 44.1 t . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 19.0 t -114.94 142.18 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.032 0.933 . . . . 0.0 108.616 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 56.3 p -122.57 164.94 17.25 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.287 0.635 . . . . 0.0 110.628 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 43.7 mt -84.66 98.81 6.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.61 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 9.5 tp10 -69.27 -59.77 2.79 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.399 -174.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.61 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 36.0 mt-10 -137.25 160.32 39.38 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.045 0.938 . . . . 0.0 108.86 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.431 ' HB ' HG21 ' A' ' 557' ' ' VAL . 64.8 mt -139.57 141.39 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 172.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' ASP . . . . . 0.433 ' HB2' ' CD1' ' A' ' 465' ' ' PHE . 26.0 t70 -66.23 148.39 51.91 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.706 0.628 . . . . 0.0 111.312 175.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -36.16 83.02 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.203 1.001 . . . . 0.0 112.079 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.35 -31.26 24.88 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 167.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 95.9 36.42 5.27 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.142 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -72.29 -20.5 61.5 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.321 0.648 . . . . 0.0 110.487 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 460' ' ' ASP . 33.2 p90 -151.6 161.79 42.09 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.526 0.679 . . . . 0.0 111.542 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.33 112.9 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.351 1.46 . . . . 0.0 107.542 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.402 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.5 tp-100 -86.98 118.74 26.56 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 468' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 544' ' ' LEU . 85.8 mt -113.65 134.0 54.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.046 0.938 . . . . 0.0 108.713 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 469' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 4.4 tmmm? -116.8 131.12 57.03 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.451 ' HB2' HD13 ' A' ' 503' ' ' LEU . 58.9 t30 -79.79 124.56 28.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.374 0.669 . . . . 0.0 110.709 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -102.65 15.42 29.33 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.228 1.011 . . . . 0.0 110.703 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' SER . . . . . 0.472 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 49.0 m -86.55 149.42 24.96 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.954 0.501 . . . . 0.0 111.353 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.06 -13.8 59.9 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.009 0.924 . . . . 0.0 110.406 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.0 OUTLIER -129.7 175.73 8.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.597 1.159 . . . . 0.0 109.127 178.448 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.66 115.96 6.38 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.393 0.677 . . . . 0.0 109.757 172.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -82.18 113.82 20.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.046 0.538 . . . . 0.0 110.417 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.507 ' HA ' HG12 ' A' ' 502' ' ' ILE . 35.0 p -66.89 110.27 3.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.175 0.59 . . . . 0.0 110.113 173.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.7 tp -103.03 171.88 7.13 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.654 1.182 . . . . 0.0 109.08 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 145.69 -62.99 0.46 Allowed Glycine 0 N--CA 1.472 1.052 0 CA-C-O 121.399 0.444 . . . . 0.0 112.923 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -70.6 -12.3 61.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.267 0.627 . . . . 0.0 110.975 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -69.57 146.52 51.72 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.112 0.965 . . . . 0.0 109.57 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -148.56 125.26 11.13 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.317 0.647 . . . . 0.0 111.002 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 19.4 mt -87.16 117.27 30.98 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 C-N-CA 123.638 0.775 . . . . 0.0 109.219 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.606 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 98.7 mttt -84.33 152.01 24.38 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.002 0.521 . . . . 0.0 109.817 168.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -150.47 104.73 3.25 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -116.48 103.59 10.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.88 0.872 . . . . 0.0 109.608 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.28 154.35 3.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.346 0.659 . . . . 0.0 109.91 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 45.4 tp -53.04 -43.15 66.4 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.989 1.316 . . . . 0.0 111.312 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.36 -24.18 67.21 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.713 0.805 . . . . 0.0 111.96 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 133.97 -22.95 3.77 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-O 118.561 -1.133 . . . . 0.0 115.505 173.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -59.96 100.15 0.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.433 1.117 . . . . 0.0 111.129 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.46 80.78 1.41 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.494 1.14 . . . . 0.0 108.316 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 18.0 pt -113.2 169.72 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.747 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -152.86 116.02 4.63 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.31 0.644 . . . . 0.0 110.42 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -99.36 115.28 28.85 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.556 0.742 . . . . 0.0 109.866 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -90.81 148.02 22.8 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -77.72 169.58 18.05 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.774 0.83 . . . . 0.0 110.845 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 52.0 p -82.55 133.23 50.1 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.66 -26.29 29.18 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.69 2.926 . . . . 0.0 114.346 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.29 -21.49 28.97 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.251 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -63.83 136.74 57.65 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.261 0.624 . . . . 0.0 110.376 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 502' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 477' ' ' SER . 40.9 mt -132.14 125.91 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 503' ' ' LEU . . . . . 0.451 HD13 ' HB2' ' A' ' 470' ' ' ASN . 0.5 OUTLIER -90.04 117.79 29.1 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.307 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -72.97 160.82 31.51 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.007 0.523 . . . . 0.0 111.691 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.32 119.74 10.88 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.666 0.786 . . . . 0.0 112.202 -173.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 80.07 -3.48 70.99 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.498 0.498 . . . . 0.0 114.073 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -83.03 -176.0 6.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.358 0.663 . . . . 0.0 110.082 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -149.52 137.25 20.25 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.137 0.575 . . . . 0.0 110.823 -176.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.95 111.86 32.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.1 m -90.58 96.28 10.57 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 65.1 t -83.91 106.99 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 512' ' ' TRP . . . . . 0.51 ' HB2' HG22 ' A' ' 527' ' ' VAL . 51.5 m95 -99.02 172.36 7.45 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.286 0.634 . . . . 0.0 112.221 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -90.32 148.12 23.06 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.92 170.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.03 92.9 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.866 0.466 . . . . 0.0 110.678 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 515' ' ' GLY . . . . . 0.491 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -79.32 -1.22 85.63 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.697 -0.683 . . . . 0.0 114.329 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -69.38 -26.48 64.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.304 0.642 . . . . 0.0 110.925 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 80.88 38.12 17.04 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.753 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.95 150.63 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.483 1.113 . . . . 0.0 110.308 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -78.54 124.08 27.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.588 0.755 . . . . 0.0 110.694 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 520' ' ' HIS . . . . . 0.404 ' NE2' HD12 ' A' ' 526' ' ' LEU . 3.5 t-160 -72.91 110.8 7.49 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.0 m -128.71 84.5 62.94 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.366 0.666 . . . . 0.0 110.217 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.88 148.04 93.92 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.594 2.196 . . . . 0.0 112.347 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -85.64 -17.94 24.06 Favored 'Cis proline' 0 C--N 1.375 1.973 0 C-N-CA 124.62 -0.992 . . . . 0.0 113.769 -2.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 17.0 m -73.95 -15.12 61.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.85 0.86 . . . . 0.0 113.239 -166.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 66.1 m -135.27 96.94 3.58 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 30.0 tp -105.3 104.48 14.22 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 512' ' ' TRP . 76.2 t -93.36 120.45 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.009 0.524 . . . . 0.0 110.056 -173.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -68.57 97.81 0.82 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -68.41 126.86 30.93 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.493 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 112.46 -25.18 12.56 Favored Glycine 0 C--N 1.342 0.864 0 O-C-N 123.239 0.337 . . . . 0.0 112.912 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.15 114.22 27.95 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 532' ' ' SER . . . . . 0.491 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 66.3 p -79.14 -32.23 44.32 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.675 0.79 . . . . 0.0 111.369 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 536' ' ' THR . 49.8 m -98.08 -33.44 11.16 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 53.51 32.82 14.87 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.459 0.647 . . . . 0.0 109.84 -171.01 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 66.99 55.77 15.27 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.606 -0.724 . . . . 0.0 113.008 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 533' ' ' SER . 4.6 p -73.35 153.78 40.35 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.038 0.447 . . . . 0.0 110.285 170.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 165.28 -161.63 35.01 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.074 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -79.15 -61.8 1.9 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.415 0.686 . . . . 0.0 110.341 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 539' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 558' ' ' LYS . 15.8 p -132.66 127.96 35.99 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.232 1.013 . . . . 0.0 109.531 -170.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.99 133.92 14.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.176 0.59 . . . . 0.0 111.893 -170.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.09 99.52 6.97 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.822 1.249 . . . . 0.0 108.498 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 26.9 m -92.03 113.09 25.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 39.8 t -119.67 141.28 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 123.949 0.9 . . . . 0.0 109.787 -174.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.0 tp -109.25 128.74 55.31 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 171.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.53 HG21 ' HE3' ' A' ' 484' ' ' LYS . 78.9 t -117.93 149.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.152 1.381 . . . . 0.0 108.684 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -103.49 -171.93 2.02 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.018 0.527 . . . . 0.0 111.199 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -61.1 -32.81 72.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.996 0.918 . . . . 0.0 113.394 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.87 -36.29 83.02 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.633 0.773 . . . . 0.0 111.65 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.0 -8.01 29.3 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.714 -0.492 . . . . 0.0 113.423 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.88 151.76 25.86 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 117.385 0.592 . . . . 0.0 110.76 172.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -80.21 113.38 18.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.024 0.93 . . . . 0.0 109.299 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 17.7 m -89.23 -25.81 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.978 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -144.93 148.89 34.36 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.527 0.731 . . . . 0.0 109.736 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 554' ' ' MET . . . . . 0.511 ' HG3' HG22 ' A' ' 543' ' ' VAL . 25.9 ttt -151.97 136.32 16.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.589 0.756 . . . . 0.0 109.552 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -155.38 110.84 3.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.54 0.736 . . . . 0.0 109.118 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 91.6 m -95.95 117.28 30.32 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.509 0.724 . . . . 0.0 110.405 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 557' ' ' VAL . . . . . 0.431 HG21 ' HB ' ' A' ' 459' ' ' ILE . 85.5 t -107.05 128.19 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.551 0.74 . . . . 0.0 109.415 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 558' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 0.0 OUTLIER -117.95 157.71 26.24 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.313 1.045 . . . . 0.0 109.547 175.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? . . . . . 0 N--CA 1.477 0.89 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.716 -173.536 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.46 144.8 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 168.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 60.7 m -134.27 169.99 16.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.334 0.654 . . . . 0.0 110.542 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 51.0 mt -91.74 113.09 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.374 0.67 . . . . 0.0 110.144 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 11.6 tp10 -81.37 -58.19 3.15 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.132 0.973 . . . . 0.0 110.265 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.4 mt-10 -135.01 162.67 31.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.564 0.746 . . . . 0.0 109.992 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.4 mt -144.26 135.53 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.68 142.07 51.57 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.861 0.464 . . . . 0.0 110.101 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.56 HD12 ' HG3' ' A' ' 462' ' ' GLU . 3.2 pp -66.25 -39.55 89.58 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.894 0.478 . . . . 0.0 111.645 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.56 ' HG3' HD12 ' A' ' 461' ' ' LEU . 43.3 mt-10 -72.66 -25.21 61.19 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.199 0.523 . . . . 0.0 110.144 174.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 92.59 31.17 9.0 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.548 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -77.44 -19.85 55.39 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.825 0.85 . . . . 0.0 110.971 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -160.18 163.2 33.84 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 121.779 0.8 . . . . 0.0 112.789 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' VAL . . . . . 0.422 HG11 HG21 ' A' ' 542' ' ' THR . 93.7 t -126.93 130.65 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.006 1.722 . . . . 0.0 107.395 169.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 467' ' ' GLN . . . . . 0.4 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.8 tp-100 -98.49 133.96 42.12 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 171.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.2 mt -117.89 161.71 19.31 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.178 0.991 . . . . 0.0 108.84 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -146.89 131.82 18.12 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.63 ' HB2' ' HG ' ' A' ' 503' ' ' LEU . 65.2 t30 -81.89 117.4 22.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.229 0.612 . . . . 0.0 110.396 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -78.31 -23.74 46.97 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.269 0.628 . . . . 0.0 111.071 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 19.3 m -62.09 145.22 53.9 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.748 0.819 . . . . 0.0 111.266 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -86.75 17.88 3.74 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.88 0.872 . . . . 0.0 110.991 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.5 176.61 12.19 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.142 0.977 . . . . 0.0 110.05 -174.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.38 107.83 0.72 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.268 1.027 . . . . 0.0 111.082 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -88.69 111.31 21.81 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 170.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.6 p -63.53 113.4 3.28 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.012 0.525 . . . . 0.0 109.903 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.6 tp -104.27 155.97 18.3 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -175.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 479' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.37 -55.96 0.54 Allowed Glycine 0 N--CA 1.473 1.125 0 CA-C-O 121.694 0.608 . . . . 0.0 112.141 -176.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -72.72 -11.36 60.59 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.976 0.91 . . . . 0.0 111.399 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -79.48 140.68 37.23 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.637 0.775 . . . . 0.0 109.042 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -133.4 130.42 38.7 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.956 0.502 . . . . 0.0 110.804 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.67 109.75 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.635 0.774 . . . . 0.0 110.03 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 484' ' ' LYS . . . . . 0.538 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 62.7 mttm -79.15 100.44 7.44 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 167.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 485' ' ' ARG . . . . . 0.559 ' HB3' ' HA3' ' A' ' 535' ' ' GLY . 6.3 mmt85 -82.0 90.3 6.48 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 165.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 486' ' ' GLN . . . . . 0.481 ' HG2' ' HB3' ' A' ' 492' ' ' GLU . 21.3 tm0? -99.12 104.97 17.01 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.227 -173.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.46 126.28 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.6 -12.18 50.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.08 -6.62 40.58 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.337 1.055 . . . . 0.0 112.046 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 115.58 28.25 2.81 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 114.427 0.531 . . . . 0.0 114.427 167.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -135.48 141.44 45.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 116.998 0.399 . . . . 0.0 110.078 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.481 ' HB3' ' HG2' ' A' ' 486' ' ' GLN . 10.0 pt-20 -150.35 114.58 5.13 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.24 0.543 . . . . 0.0 109.727 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 28.5 pt -107.69 144.93 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -118.75 108.52 14.98 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.496 0.718 . . . . 0.0 109.637 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -89.23 104.89 17.4 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -84.22 134.81 34.54 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -69.5 164.9 22.12 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.851 0.86 . . . . 0.0 111.746 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.4 p -75.78 126.04 87.64 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' PRO . . . . . 0.465 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 60.2 Cg_endo -68.16 -12.46 35.15 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.647 2.231 . . . . 0.0 113.565 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -74.19 -23.53 59.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.738 0.815 . . . . 0.0 111.504 173.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -79.65 136.25 36.76 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-O 120.975 0.417 . . . . 0.0 109.91 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.71 130.01 74.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 503' ' ' LEU . . . . . 0.63 ' HG ' ' HB2' ' A' ' 470' ' ' ASN . 23.3 tp -95.54 113.4 25.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -76.55 164.0 26.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.214 1.005 . . . . 0.0 112.054 -172.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -55.59 120.3 7.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.372 1.069 . . . . 0.0 112.566 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.73 -5.24 17.92 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 114.338 0.495 . . . . 0.0 114.338 176.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -84.92 154.72 22.03 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.147 0.579 . . . . 0.0 109.883 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 59.7 mtt -113.94 145.15 41.93 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.76 0.824 . . . . 0.0 110.585 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.2 p -125.48 119.18 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.591 0.756 . . . . 0.0 109.225 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.81 107.01 19.41 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 16.8 t -87.0 98.88 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.571 0.749 . . . . 0.0 110.002 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 512' ' ' TRP . . . . . 0.522 ' HB2' HG22 ' A' ' 527' ' ' VAL . 39.5 m95 -90.14 174.19 7.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.603 0.761 . . . . 0.0 111.336 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 513' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.51 152.42 20.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.025 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.03 75.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.038 0.535 . . . . 0.0 110.528 173.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -72.62 -8.63 72.41 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.571 -0.74 . . . . 0.0 114.429 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.52 60.15 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.978 0.511 . . . . 0.0 111.28 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 75.77 38.44 36.69 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-O 121.139 0.299 . . . . 0.0 112.503 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.11 140.04 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 124.107 0.963 . . . . 0.0 110.146 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.53 138.42 36.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.928 0.891 . . . . 0.0 110.751 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -64.36 110.7 2.34 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.246 0.618 . . . . 0.0 109.525 173.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.4 m -129.29 78.52 75.77 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.598 0.759 . . . . 0.0 110.02 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.28 156.39 64.74 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.443 2.095 . . . . 0.0 111.811 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -83.57 -14.28 35.64 Favored 'Cis proline' 0 C--N 1.377 2.039 0 CA-C-N 119.698 0.928 . . . . 0.0 113.968 -1.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.9 m -66.43 -31.72 72.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.962 0.905 . . . . 0.0 112.736 -171.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 94.2 m -136.59 102.1 4.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.295 0.638 . . . . 0.0 110.636 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 67.1 mt -92.24 132.85 36.34 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 167.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 512' ' ' TRP . 99.4 t -118.92 126.44 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -70.54 100.95 1.9 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 172.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.59 133.13 49.67 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.151 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 89.57 -28.56 6.87 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 123.644 0.59 . . . . 0.0 113.591 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 531' ' ' GLN . . . . . 0.425 ' HG3' ' H ' ' A' ' 534' ' ' TRP . 45.7 tp60 -82.99 118.12 23.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.723 0.409 . . . . 0.0 109.987 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 33.4 m -96.28 -39.51 9.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.88 0.472 . . . . 0.0 111.248 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 533' ' ' SER . . . . . 0.485 ' HB2' HG22 ' A' ' 536' ' ' THR . 67.0 p -79.04 -35.7 42.22 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.464 0.477 . . . . 0.0 111.848 -171.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 534' ' ' TRP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.39 31.19 9.19 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.119 0.967 . . . . 0.0 111.366 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 535' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 485' ' ' ARG . . . 70.4 59.17 5.48 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -174.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 536' ' ' THR . . . . . 0.485 HG22 ' HB2' ' A' ' 533' ' ' SER . 10.4 t -79.2 145.31 33.71 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.219 1.008 . . . . 0.0 110.151 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -169.56 165.25 38.68 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.132 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -75.69 -30.94 59.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.8 m -146.29 118.42 8.3 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -142.37 -178.95 5.99 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.565 0.746 . . . . 0.0 110.802 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -147.98 128.33 13.92 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.39 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' THR . . . . . 0.422 HG21 HG11 ' A' ' 466' ' ' VAL . 87.3 m -86.69 128.07 34.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 543' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 65.5 t -124.38 117.5 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 544' ' ' LEU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.6 tp -90.84 107.95 19.52 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 545' ' ' VAL . . . . . 0.43 HG22 ' HG2' ' A' ' 551' ' ' GLU . 83.3 t -96.03 149.56 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.644 1.178 . . . . 0.0 108.585 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 546' ' ' ASN . . . . . 0.421 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.5 p30 -108.29 -172.84 2.14 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.475 0.31 . . . . 0.0 110.965 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -52.16 -39.63 60.3 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.856 1.263 . . . . 0.0 113.27 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.34 -37.56 87.76 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.711 0.804 . . . . 0.0 112.424 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.21 -13.41 28.57 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.041 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 550' ' ' GLU . . . . . 0.421 ' HG2' HD21 ' A' ' 546' ' ' ASN . 11.1 pt-20 -75.1 148.89 39.32 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.278 0.539 . . . . 0.0 110.567 173.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.43 ' HG2' HG22 ' A' ' 545' ' ' VAL . 30.0 mt-10 -87.57 98.27 11.31 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.942 0.897 . . . . 0.0 109.027 -177.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 26.0 m -79.65 -19.06 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.05 -173.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 553' ' ' ALA . . . . . 0.65 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -145.71 145.66 30.96 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.275 0.63 . . . . 0.0 109.425 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 16.9 ttt -151.64 110.55 3.86 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -125.52 106.87 10.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.917 0.887 . . . . 0.0 108.917 -173.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 53.2 m -86.24 140.02 30.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.14 0.576 . . . . 0.0 110.578 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.3 p -144.97 111.02 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 124.43 1.092 . . . . 0.0 109.585 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -92.76 116.57 29.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 172.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 124.339 1.055 . . . . 0.0 110.492 -178.733 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -76.77 77.85 3.39 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.507 0.723 . . . . 0.0 110.477 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 19.5 m -81.85 88.54 6.32 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.808 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.89 29.3 35.14 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.019 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 51.1 p -65.96 -56.81 9.76 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 172.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 470' ' ' ASN . 18.6 t -89.07 146.46 6.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 165.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 84.6 p -134.62 172.07 13.46 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.029 0.931 . . . . 0.0 108.949 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 42.1 mm -74.19 122.2 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 14.6 tp10 -93.97 -68.05 0.82 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 36.0 mt-10 -135.12 160.09 39.45 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.961 0.904 . . . . 0.0 108.83 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.548 HG23 ' NH2' ' A' ' 485' ' ' ARG . 97.0 mt -146.57 142.61 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.87 147.93 48.33 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.02 0.528 . . . . 0.0 110.808 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.64 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.0 pt? -59.37 -35.79 74.56 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.021 0.928 . . . . 0.0 111.786 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.64 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 50.2 mt-10 -103.07 -4.97 23.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.443 1.097 . . . . 0.0 111.298 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 75.49 40.5 32.54 Favored Glycine 0 C--N 1.342 0.911 0 O-C-N 123.469 0.48 . . . . 0.0 113.3 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -78.9 -18.81 53.26 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.241 0.617 . . . . 0.0 110.691 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -155.55 157.33 36.66 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.013 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' VAL . . . . . 0.566 HG22 ' NH2' ' A' ' 485' ' ' ARG . 15.7 t -111.77 148.29 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 165.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 21.0 tp60 -126.54 121.08 31.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.456 HD22 HD22 ' A' ' 544' ' ' LEU . 87.3 mt -110.01 159.62 17.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.91 0.884 . . . . 0.0 109.804 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -144.84 128.93 17.6 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.554 0.742 . . . . 0.0 109.721 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.555 ' HB2' HD12 ' A' ' 503' ' ' LEU . 64.2 t30 -91.35 109.4 20.67 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -86.93 -1.46 57.86 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.287 1.035 . . . . 0.0 111.139 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 27.0 t -74.95 158.47 33.24 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.51 0.724 . . . . 0.0 111.53 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.33 0.4 56.21 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.403 1.081 . . . . 0.0 112.22 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.53 166.18 23.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.969 0.508 . . . . 0.0 110.821 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -66.18 115.58 6.33 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.909 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.439 ' HG2' HG23 ' A' ' 454' ' ' VAL . 61.5 tp60 -80.02 111.08 16.02 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.851 0.719 . . . . 0.0 110.46 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.5 p -64.0 114.34 4.07 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.0 tp -107.99 151.88 25.23 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -170.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 146.87 -65.65 0.42 Allowed Glycine 0 N--CA 1.473 1.111 0 C-N-CA 121.419 -0.42 . . . . 0.0 112.921 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -69.35 -12.75 61.93 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.489 0.716 . . . . 0.0 110.98 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.437 ' CD2' ' HA ' ' A' ' 546' ' ' ASN . 26.3 m95 -67.65 150.86 48.2 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.853 0.861 . . . . 0.0 110.056 169.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 495' ' ' TYR . 30.1 ptt-85 -153.09 139.76 18.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.789 0.436 . . . . 0.0 111.364 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 483' ' ' ILE . . . . . 0.495 HG21 HG21 ' A' ' 466' ' ' VAL . 47.7 mt -101.41 104.6 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.304 0.642 . . . . 0.0 109.552 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.461 ' HE3' HG21 ' A' ' 545' ' ' VAL . 92.0 mttt -86.87 96.91 10.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.74 0.416 . . . . 0.0 109.995 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 485' ' ' ARG . . . . . 0.566 ' NH2' HG22 ' A' ' 466' ' ' VAL . 39.8 ttm180 -94.7 100.0 12.0 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 172.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -104.14 111.81 24.56 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.445 1.098 . . . . 0.0 110.439 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.474 HG12 ' H ' ' A' ' 489' ' ' GLU . 14.1 t -95.15 135.77 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.19 0.996 . . . . 0.0 109.272 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.4 pp -64.96 -22.89 67.07 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.342 0.657 . . . . 0.0 112.207 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' GLU . . . . . 0.474 ' H ' HG12 ' A' ' 487' ' ' VAL . 47.7 mt-10 -69.93 -10.83 59.96 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.058 0.943 . . . . 0.0 111.906 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 130.15 -28.31 3.89 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-O 119.387 -0.674 . . . . 0.0 114.232 166.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.24 116.17 22.28 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.834 0.817 . . . . 0.0 110.313 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.39 125.0 28.17 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 13.5 pt -140.82 148.76 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.8 0.84 . . . . 0.0 110.224 -170.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -121.3 112.51 18.69 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.484 0.714 . . . . 0.0 109.533 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 482' ' ' ARG . 50.4 t80 -79.94 105.18 11.04 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -80.74 132.56 35.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -77.17 170.25 16.87 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.457 0.646 . . . . 0.0 111.312 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' THR . . . . . 0.438 ' HB ' ' HG2' ' A' ' 500' ' ' LYS . 52.3 p -87.99 120.09 70.63 Favored Pre-proline 0 CA--C 1.553 1.079 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.465 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.19 -5.21 7.57 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.241 2.627 . . . . 0.0 114.753 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' LYS . . . . . 0.438 ' HG2' ' HB ' ' A' ' 498' ' ' THR . 63.0 pttt -74.55 -25.94 59.64 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.539 0.335 . . . . 0.0 110.425 170.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -92.33 135.57 33.91 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.639 0.776 . . . . 0.0 110.608 -169.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 52.3 mt -126.96 128.58 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 470' ' ' ASN . 2.3 tm? -95.1 141.5 28.65 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.515 HH22 ' HG2' ' A' ' 523' ' ' PRO . 0.2 OUTLIER -87.43 164.66 16.07 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.019 0.527 . . . . 0.0 111.637 -166.33 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.76 123.32 19.04 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.366 0.667 . . . . 0.0 110.815 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.01 14.53 76.14 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 123.569 0.543 . . . . 0.0 113.938 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -104.92 175.27 5.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.288 0.635 . . . . 0.0 110.673 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 11.5 ptm -146.34 149.0 32.97 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.468 1.107 . . . . 0.0 110.106 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.89 131.32 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.3 0.64 . . . . 0.0 109.803 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.27 112.73 25.87 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.27 0.628 . . . . 0.0 109.499 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.418 HG12 ' HE1' ' A' ' 534' ' ' TRP . 46.9 t -99.38 99.76 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.185 0.594 . . . . 0.0 109.824 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 512' ' ' TRP . . . . . 0.541 ' HB2' HG22 ' A' ' 527' ' ' VAL . 43.4 m95 -87.16 172.99 9.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.736 0.814 . . . . 0.0 111.479 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -91.14 152.94 20.38 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.809 0.844 . . . . 0.0 110.108 172.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 514' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.14 -38.57 85.74 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.337 0.589 . . . . 0.0 110.141 172.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -81.2 13.05 34.76 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.662 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -84.69 -6.98 59.38 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.175 0.59 . . . . 0.0 110.712 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 68.52 16.46 69.63 Favored Glycine 0 C--N 1.359 1.833 0 O-C-N 123.357 0.411 . . . . 0.0 113.44 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.2 p -88.89 150.13 3.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.29 1.036 . . . . 0.0 110.358 -173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.61 118.16 21.94 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.533 0.733 . . . . 0.0 109.72 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -66.94 110.75 3.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.4 m -124.17 81.19 57.96 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.365 0.666 . . . . 0.0 109.888 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -70.55 154.48 64.59 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.67 2.247 . . . . 0.0 111.79 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 523' ' ' PRO . . . . . 0.515 ' HG2' HH22 ' A' ' 504' ' ' ARG . 97.1 Cg_endo -97.94 13.57 32.5 Favored 'Cis proline' 0 C--N 1.37 1.691 0 CA-C-N 119.723 0.937 . . . . 0.0 113.48 -2.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.8 m -78.57 -45.7 21.16 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.457 0.646 . . . . 0.0 110.594 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 93.6 m -121.01 96.38 5.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.802 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 10.7 mp -84.11 147.07 27.55 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 512' ' ' TRP . 57.6 t -128.73 123.06 58.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -67.53 91.06 0.27 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' LYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 55.2 tptt -72.64 122.56 21.62 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.431 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 106.31 -1.86 37.44 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.759 0.662 . . . . 0.0 112.993 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 534' ' ' TRP . 44.7 tp60 -119.48 123.0 42.96 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 42.8 p -90.21 -47.04 8.04 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.034 0.534 . . . . 0.0 111.931 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 536' ' ' THR . 69.0 p -87.44 -34.72 18.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.972 -170.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.734 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.73 39.24 28.24 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.533 0.733 . . . . 0.0 109.973 -173.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 74.95 61.2 3.13 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 462' ' ' GLU . 7.9 p -72.93 142.04 47.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.85 0.46 . . . . 0.0 111.01 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 179.09 168.03 37.53 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.821 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.82 -16.57 40.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.063 0.545 . . . . 0.0 110.322 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.425 ' HB2' HD21 ' A' ' 488' ' ' LEU . 16.6 m -155.82 131.13 9.49 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.758 0.823 . . . . 0.0 108.945 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.469 ' HB3' HG22 ' A' ' 487' ' ' VAL . 23.0 p90 -157.82 145.46 18.54 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.225 0.61 . . . . 0.0 111.13 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 76.0 mtm-85 -97.88 106.15 18.41 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.85 0.86 . . . . 0.0 108.902 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 21.5 m -93.61 105.65 17.68 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.447 HG22 ' SD ' ' A' ' 554' ' ' MET . 12.0 t -103.04 134.47 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.342 1.057 . . . . 0.0 109.706 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.8 tp -103.76 124.11 48.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.461 HG21 ' HE3' ' A' ' 484' ' ' LYS . 84.1 t -118.28 141.55 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.462 1.105 . . . . 0.0 108.872 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.437 ' HA ' ' CD2' ' A' ' 481' ' ' TRP . 1.7 p30 -94.41 -177.17 4.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.652 0.381 . . . . 0.0 111.576 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.08 71.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.666 0.786 . . . . 0.0 112.902 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.21 -29.75 71.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.642 0.777 . . . . 0.0 111.786 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 95.28 25.28 14.38 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.795 -173.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.39 137.87 41.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.242 1.017 . . . . 0.0 108.597 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -75.29 96.89 3.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.791 0.836 . . . . 0.0 109.155 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 35.6 m -85.16 -23.8 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -148.46 162.92 38.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.402 0.681 . . . . 0.0 109.812 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 543' ' ' VAL . 59.2 ttp -170.52 139.22 1.59 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.963 0.905 . . . . 0.0 109.49 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -139.25 124.27 18.84 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.267 0.627 . . . . 0.0 110.101 170.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 28.2 m -81.73 99.76 9.12 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 459' ' ' ILE . 74.5 t -102.85 142.39 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.501 0.667 . . . . 0.0 109.754 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -126.15 158.44 35.54 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.006 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.464 ' HG3' HD12 ' A' ' 461' ' ' LEU . 64.8 tttp -77.51 82.91 3.93 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.514 0.674 . . . . 0.0 109.43 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 17.0 m -124.39 15.39 8.96 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.701 1.2 . . . . 0.0 109.77 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 561' ' ' SER . . . . . 0.617 ' HA ' HD13 ' A' ' 461' ' ' LEU . 16.5 m 61.15 90.7 0.06 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.962 1.305 . . . . 0.0 110.556 -170.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 23.3 m -90.37 -31.0 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.202 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 70.8 mtm -86.38 107.34 17.97 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -90.1 146.55 24.22 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.765 0.826 . . . . 0.0 110.373 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 64.37 30.71 13.14 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.722 1.209 . . . . 0.0 110.766 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -83.96 10.98 8.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.946 0.898 . . . . 0.0 110.954 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.15 -8.36 7.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.775 1.63 . . . . 0.0 114.013 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -116.6 101.29 8.48 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.222 0.609 . . . . 0.0 109.491 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 CA-C-O 119.162 -0.799 . . . . 0.0 113.251 177.902 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.402 ' HB1' ' OG ' ' A' ' 453' ' ' SER . . . -70.64 83.66 0.62 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.976 0.91 . . . . 0.0 111.653 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 23.7 p -87.84 99.48 12.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.078 0.951 . . . . 0.0 110.613 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' GLY . . . . . 0.52 ' H ' ' HB ' ' A' ' 552' ' ' VAL . . . 98.48 4.63 57.16 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.909 175.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 472' ' ' SER . 67.7 m -60.55 -32.92 71.96 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.378 0.671 . . . . 0.0 111.635 176.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 454' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 478' ' ' LEU . 13.5 t -123.71 137.1 58.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 162.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 28.7 t -130.22 170.88 13.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.986 0.914 . . . . 0.0 109.239 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 459' ' ' ILE . 61.8 mt -87.42 117.49 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 122.965 0.506 . . . . 0.0 109.88 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 8.3 tp10 -84.37 -62.07 1.65 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.358 0.663 . . . . 0.0 110.499 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 24.6 mt-10 -140.48 158.31 44.19 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.83 0.852 . . . . 0.0 109.669 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.51 ' HB ' HG21 ' A' ' 557' ' ' VAL . 48.1 mt -141.9 140.42 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -77.29 148.94 35.44 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.321 0.648 . . . . 0.0 111.568 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 559' ' ' LYS . 1.6 pp -76.31 -26.19 55.58 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.886 0.875 . . . . 0.0 112.766 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -86.52 -14.38 43.21 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.239 0.616 . . . . 0.0 110.027 168.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 78.12 28.67 55.75 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.741 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -73.03 -18.26 61.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.139 0.576 . . . . 0.0 111.063 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -158.22 155.8 29.63 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 122.958 0.503 . . . . 0.0 111.348 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.6 111.44 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 457' ' ' GLU . 15.6 tt0 -88.0 128.33 35.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.58 0.752 . . . . 0.0 110.223 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 483' ' ' ILE . 71.5 mt -114.0 162.66 16.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.448 1.099 . . . . 0.0 109.599 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 469' ' ' LYS . 4.7 tmmm? -147.4 132.12 17.92 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.012 0.925 . . . . 0.0 108.764 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' A' ' 505' ' ' ALA . 23.6 t-20 -76.76 127.29 32.48 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.968 1.307 . . . . 0.0 111.035 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -111.43 12.17 21.47 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.975 0.91 . . . . 0.0 111.183 172.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 453' ' ' SER . 24.1 t -79.05 148.24 32.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.847 0.859 . . . . 0.0 110.322 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -88.15 -7.78 56.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.381 0.672 . . . . 0.0 110.956 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.4 OUTLIER -135.68 172.55 12.84 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.986 0.914 . . . . 0.0 109.447 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.87 143.39 57.48 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -124.52 113.68 18.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.477 0.711 . . . . 0.0 110.26 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 40.6 p -70.79 119.27 14.69 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.4 0.68 . . . . 0.0 110.682 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.413 HD11 HG21 ' A' ' 454' ' ' VAL . 6.2 mp -100.2 165.18 11.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.117 0.967 . . . . 0.0 109.455 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 144.1 -58.09 0.53 Allowed Glycine 0 N--CA 1.465 0.624 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 547' ' ' ALA . 5.6 m-20 -81.03 -13.76 58.51 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 114.299 -0.95 . . . . 0.0 111.014 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.431 ' CZ3' HG21 ' A' ' 552' ' ' VAL . 27.8 m95 -72.23 140.12 48.51 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -146.66 135.85 22.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.056 0.542 . . . . 0.0 111.538 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' ILE . . . . . 0.477 HG12 HD13 ' A' ' 544' ' ' LEU . 45.4 mt -99.99 105.99 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.908 0.883 . . . . 0.0 109.13 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -92.83 102.23 14.61 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.56 1.144 . . . . 0.0 110.42 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' ARG . . . . . 0.511 ' HE ' ' HE3' ' A' ' 534' ' ' TRP . 51.1 ttm-85 -87.22 96.35 10.3 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.44 100.88 13.07 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 46.6 t -93.62 121.59 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.42 -28.11 68.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.447 0.699 . . . . 0.0 112.629 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -64.53 -15.73 61.4 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.534 1.133 . . . . 0.0 112.574 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 125.27 27.38 1.21 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 114.471 0.548 . . . . 0.0 114.471 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -129.22 99.17 5.13 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.696 0.748 . . . . 0.0 109.971 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.36 96.86 6.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 174.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.3 pt -107.32 168.4 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.15 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -156.44 132.18 9.61 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.728 0.811 . . . . 0.0 109.67 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -125.53 116.19 21.39 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.442 0.697 . . . . 0.0 109.49 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -79.19 157.81 27.79 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -81.4 171.44 14.75 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.665 0.786 . . . . 0.0 110.872 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 74.7 p -81.93 128.83 67.05 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.05 -29.06 63.36 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.445 2.763 . . . . 0.0 113.785 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -68.73 -21.06 64.41 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.28 0.632 . . . . 0.0 112.49 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -78.95 129.53 34.58 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.364 0.666 . . . . 0.0 109.996 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 49.4 mt -126.3 119.85 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' LEU . . . . . 0.406 HD23 HG22 ' A' ' 454' ' ' VAL . 38.8 tp -83.85 138.6 33.12 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.487 0.715 . . . . 0.0 109.439 178.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -90.63 154.78 19.33 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.222 0.609 . . . . 0.0 110.549 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' ALA . . . . . 0.457 ' HA ' ' OD1' ' A' ' 470' ' ' ASN . . . -72.8 130.39 40.35 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.455 0.702 . . . . 0.0 111.681 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 75.51 20.13 78.78 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.064 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -115.19 -162.46 0.83 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.163 0.985 . . . . 0.0 110.2 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 19.6 ptp -154.4 166.37 33.44 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.361 0.665 . . . . 0.0 110.992 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.68 126.13 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.091 0.957 . . . . 0.0 109.228 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 25.6 m -116.32 111.53 20.24 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.107 0.563 . . . . 0.0 109.719 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 526' ' ' LEU . 35.5 m -88.67 137.31 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -122.01 174.47 6.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.379 1.072 . . . . 0.0 109.862 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -90.53 147.17 23.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.047 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -58.73 -42.24 88.31 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.503 0.721 . . . . 0.0 110.88 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 515' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -88.63 24.16 13.48 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.731 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -88.28 -13.23 41.4 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.262 0.625 . . . . 0.0 110.404 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.45 31.35 68.38 Favored Glycine 0 C--N 1.356 1.648 0 O-C-N 123.512 0.508 . . . . 0.0 112.323 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.67 144.95 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.371 1.068 . . . . 0.0 110.982 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.34 126.12 30.76 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 172.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -73.62 117.44 15.4 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 31.4 m -138.04 73.15 45.86 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.139 0.576 . . . . 0.0 110.335 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.48 148.38 83.76 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.719 2.279 . . . . 0.0 111.589 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.52 -13.54 37.38 Favored 'Cis proline' 0 C--N 1.379 2.173 0 CA-C-N 120.275 1.134 . . . . 0.0 114.424 4.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.6 m -67.6 -32.38 73.06 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.94 0.896 . . . . 0.0 112.431 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 59.8 m -135.48 98.2 3.88 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.623 0.769 . . . . 0.0 110.051 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.502 ' HB2' HG12 ' A' ' 511' ' ' VAL . 82.5 mt -90.87 149.73 21.81 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.33 120.9 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.204 0.602 . . . . 0.0 109.725 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -75.76 109.32 9.26 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 56.4 tptt -72.58 135.97 45.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.966 0.906 . . . . 0.0 110.514 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 99.32 -39.22 2.81 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.921 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -81.55 109.39 15.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.945 0.498 . . . . 0.0 110.482 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 532' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 85.9 p -83.4 -37.34 23.38 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.35 0.66 . . . . 0.0 110.292 174.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.739 ' HB2' HG23 ' A' ' 536' ' ' THR . 55.6 p -94.05 -29.39 15.22 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.794 -173.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.511 ' HE3' ' HE ' ' A' ' 485' ' ' ARG . 0.0 OUTLIER 59.98 34.51 21.5 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.14 0.976 . . . . 0.0 109.258 -171.163 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 79.41 81.08 0.75 Allowed Glycine 0 C--N 1.364 2.12 0 CA-C-O 119.574 -0.57 . . . . 0.0 113.032 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.739 HG23 ' HB2' ' A' ' 533' ' ' SER . 14.5 p -55.41 148.84 14.32 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.824 0.821 . . . . 0.0 112.51 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 164.8 136.15 1.95 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.585 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.71 -37.55 24.58 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 31.9 m -125.84 124.23 40.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.517 0.727 . . . . 0.0 109.186 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -158.74 161.46 37.04 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.642 0.777 . . . . 0.0 111.091 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 35.0 ptt180 -119.72 111.75 18.41 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.935 0.894 . . . . 0.0 108.689 168.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 61.3 m -89.92 133.14 34.94 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.532 HG22 ' HG3' ' A' ' 554' ' ' MET . 19.3 t -124.13 117.94 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.368 1.067 . . . . 0.0 108.723 -174.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 42.9 tp -87.99 132.35 34.29 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.59 157.58 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.176 1.39 . . . . 0.0 108.113 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.507 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.2 p30 -117.77 -170.68 1.91 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.814 0.445 . . . . 0.0 111.234 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 547' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 480' ' ' ASN . . . -51.85 -37.4 51.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.396 1.478 . . . . 0.0 113.839 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.28 -34.47 77.47 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.595 0.758 . . . . 0.0 112.009 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 104.45 -12.95 51.28 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.559 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' GLU . . . . . 0.507 ' HG2' HD21 ' A' ' 546' ' ' ASN . 16.3 pt-20 -67.42 148.21 51.87 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 122.784 0.434 . . . . 0.0 110.139 175.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -80.93 101.24 9.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.52 ' HB ' ' H ' ' A' ' 452' ' ' GLY . 22.1 m -79.27 -21.0 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.566 0.347 . . . . 0.0 111.641 -175.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -158.9 151.71 22.03 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.228 1.011 . . . . 0.0 109.189 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.532 ' HG3' HG22 ' A' ' 543' ' ' VAL . 54.8 ttp -164.21 116.2 1.33 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.661 0.784 . . . . 0.0 109.668 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -133.22 130.59 39.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.549 0.74 . . . . 0.0 110.292 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 79.8 m -90.57 123.1 33.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.363 1.065 . . . . 0.0 109.572 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.51 HG21 ' HB ' ' A' ' 459' ' ' ILE . 86.2 t -123.75 128.87 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.795 0.838 . . . . 0.0 109.72 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 151.46 38.44 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.63 1.172 . . . . 0.0 108.52 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.489 ' HG3' ' HB2' ' A' ' 461' ' ' LEU . 88.0 tttt -75.49 83.34 2.56 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.549 0.69 . . . . 0.0 109.319 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 35.9 t -131.23 94.89 3.66 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.996 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 50.0 m -146.86 129.85 16.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.776 0.83 . . . . 0.0 109.251 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 562' ' ' VAL . . . . . 0.4 HG13 ' HG3' ' A' ' 563' ' ' MET . 5.0 p -137.68 -43.68 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.844 0.858 . . . . 0.0 108.991 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.4 ' HG3' HG13 ' A' ' 562' ' ' VAL . 60.7 mtt -111.55 177.52 4.63 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.3 1.04 . . . . 0.0 109.242 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 69.9 111.36 0.05 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.026 1.33 . . . . 0.0 109.548 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -97.34 88.39 4.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.96 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -106.78 39.96 1.74 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.53 1.132 . . . . 0.0 109.433 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -62.14 -49.84 74.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.785 1.234 . . . . 0.0 112.324 -167.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -81.99 117.65 22.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.256 0 CA-C-O 118.359 -1.245 . . . . 0.0 111.959 179.371 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.792 0.329 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -99.01 93.08 5.81 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 78.5 p -76.23 80.06 3.02 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.594 0.712 . . . . 0.0 110.784 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 76.39 -49.31 2.64 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.62 1.105 . . . . 0.0 112.806 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.9 m -176.98 -62.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.418 1.887 . . . . 0.0 108.241 174.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 13.8 t -91.77 130.95 40.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.374 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 16.6 m -109.64 155.71 21.13 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.341 1.056 . . . . 0.0 109.407 174.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 39.9 mt -79.23 106.54 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.463 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 11.7 tp10 -73.69 -69.47 0.43 Allowed 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.733 0.646 . . . . 0.0 109.68 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.42 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 21.8 mt-10 -133.19 163.73 28.63 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.6 0.76 . . . . 0.0 109.829 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.503 ' HB ' HG21 ' A' ' 557' ' ' VAL . 61.2 mt -142.5 144.34 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 171.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.39 148.62 51.6 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.354 0.662 . . . . 0.0 110.716 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.46 -41.62 98.89 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.065 0.546 . . . . 0.0 111.289 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -80.57 -29.52 37.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.55 0.74 . . . . 0.0 109.362 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' GLY . . . . . 0.453 ' HA3' ' NH2' ' A' ' 485' ' ' ARG . . . 92.1 39.52 5.42 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.408 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -71.26 -20.19 62.26 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.375 0.67 . . . . 0.0 109.915 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -153.5 161.85 41.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.294 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 81.3 t -130.63 111.8 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.463 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.7 tp-100 -86.81 123.06 31.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.148 0.979 . . . . 0.0 109.955 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 483' ' ' ILE . 62.4 mt -112.49 157.86 20.6 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 471' ' ' ASN . 2.1 tmmm? -148.19 129.98 15.15 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -91.72 130.78 37.45 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.234 0.614 . . . . 0.0 110.252 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.516 ' HB3' ' HE3' ' A' ' 469' ' ' LYS . 16.2 p-10 -136.38 84.73 2.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.268 1.027 . . . . 0.0 109.261 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 66.0 m -146.43 -163.32 1.72 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.056 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' ASP . . . . . 0.534 ' HB2' ' HD3' ' A' ' 474' ' ' LYS . 2.2 m-20 -79.16 -48.78 13.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.308 0.643 . . . . 0.0 111.186 -173.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.534 ' HD3' ' HB2' ' A' ' 473' ' ' ASP . 0.0 OUTLIER -133.93 178.45 6.94 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.587 -172.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 475' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 504' ' ' ARG . 8.5 p-10 -53.16 112.46 0.87 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.72 1.208 . . . . 0.0 111.639 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -74.27 113.66 11.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.774 0.83 . . . . 0.0 110.557 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.494 ' HA ' HG12 ' A' ' 502' ' ' ILE . 32.6 t -64.37 100.84 0.38 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.098 0.559 . . . . 0.0 109.508 172.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.8 tp -90.65 165.68 13.58 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 143.22 -65.52 0.47 Allowed Glycine 0 N--CA 1.466 0.684 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.135 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.68 -13.04 58.42 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.153 0.981 . . . . 0.0 112.028 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -74.3 148.53 41.31 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.402 1.081 . . . . 0.0 109.599 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ARG . . . . . 0.4 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 19.1 ptt-85 -148.58 134.11 18.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.047 0.539 . . . . 0.0 111.181 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 483' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 468' ' ' LEU . 49.2 mt -91.58 114.95 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.314 1.046 . . . . 0.0 109.729 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.569 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 67.1 mttm -79.63 144.11 34.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 164.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 485' ' ' ARG . . . . . 0.453 ' NH2' ' HA3' ' A' ' 463' ' ' GLY . 66.9 ttt180 -143.59 98.71 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.594 0.711 . . . . 0.0 109.282 172.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -96.15 103.6 15.51 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.01 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.547 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 24.3 t -67.58 149.44 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.495 HD23 HG12 ' A' ' 487' ' ' VAL . 2.7 pt? -52.42 -33.11 42.42 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -168.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.93 -34.08 75.92 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.288 0.635 . . . . 0.0 111.248 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 130.57 -2.3 5.7 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.728 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -73.05 114.21 10.96 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.168 0.484 . . . . 0.0 110.384 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.12 143.49 38.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.58 0.752 . . . . 0.0 110.556 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 22.5 pt -127.19 146.16 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.19 0.996 . . . . 0.0 108.679 169.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -125.59 109.81 13.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.557 0.743 . . . . 0.0 109.764 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -97.38 106.03 18.28 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.571 0.748 . . . . 0.0 109.658 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -87.07 153.21 21.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -89.25 170.4 10.62 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.216 0.607 . . . . 0.0 110.936 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.1 p -91.07 131.74 36.21 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.044 0.938 . . . . 0.0 109.649 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.25 -17.06 49.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.783 2.322 . . . . 0.0 113.453 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -72.9 -20.39 61.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.549 0.739 . . . . 0.0 111.662 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -84.2 128.3 34.48 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.408 0.683 . . . . 0.0 109.614 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 477' ' ' SER . 49.2 mt -126.46 133.41 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -114.18 124.55 52.33 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 475' ' ' ASP . 8.1 mpt_? -71.13 155.95 40.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.855 0.862 . . . . 0.0 112.152 -170.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.52 129.23 39.0 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.488 0.715 . . . . 0.0 110.753 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 86.18 -6.45 81.56 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.556 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -92.73 -175.59 3.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.835 0.854 . . . . 0.0 110.62 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 21.9 ptt? -145.03 160.96 40.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.922 0.889 . . . . 0.0 110.61 -176.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 509' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 468' ' ' LEU . 2.5 p -137.81 118.64 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.376 1.07 . . . . 0.0 108.367 175.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.7 m -105.07 110.82 23.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 54.2 t -89.18 99.73 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.152 0.581 . . . . 0.0 109.491 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -87.09 170.07 11.85 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.258 1.023 . . . . 0.0 111.518 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -84.28 148.89 26.44 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.114 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -67.04 -31.77 72.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.347 0.659 . . . . 0.0 111.163 174.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -75.42 -12.68 83.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.91 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -71.18 -14.2 62.18 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.391 0.677 . . . . 0.0 111.735 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 66.58 25.86 72.82 Favored Glycine 0 C--N 1.356 1.675 0 CA-C-O 121.124 0.291 . . . . 0.0 113.207 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 5.7 p -84.03 144.46 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.603 1.161 . . . . 0.0 111.066 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -69.29 107.69 3.37 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.81 0.844 . . . . 0.0 110.046 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -62.74 109.88 1.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.1 m -131.83 76.36 74.31 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.473 0.709 . . . . 0.0 110.413 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.0 145.05 87.58 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.757 2.305 . . . . 0.0 112.33 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.59 -23.76 12.27 Favored 'Cis proline' 0 C--N 1.373 1.838 0 CA-C-N 120.008 1.039 . . . . 0.0 113.923 -1.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.1 m -62.83 -29.82 71.02 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 21.9 m -130.44 95.47 3.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.352 0.661 . . . . 0.0 109.411 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 48.5 mt -91.29 147.14 23.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 168.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.57 118.9 44.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -75.12 94.2 2.89 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -66.72 134.75 52.85 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.96 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 104.78 -35.82 4.81 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -98.05 88.44 4.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.048 0.539 . . . . 0.0 110.256 172.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 60.3 p -68.3 -35.47 77.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.446 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 13.9 m -86.41 -32.58 20.81 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.007 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.56 23.03 5.64 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.028 0.931 . . . . 0.0 110.978 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.18 52.06 52.34 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 122.303 -0.248 . . . . 0.0 113.378 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 3.8 p -76.67 110.6 11.38 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.461 0.704 . . . . 0.0 110.458 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -122.01 169.77 14.85 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 173.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 559' ' ' LYS . 14.2 pt-20 -80.22 -12.02 59.67 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.915 0.358 . . . . 0.0 110.888 176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.472 ' HB2' HD13 ' A' ' 488' ' ' LEU . 20.3 m -152.9 137.72 17.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.417 1.087 . . . . 0.0 108.118 172.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.547 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 13.8 p90 -166.26 172.0 11.58 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.531 0.681 . . . . 0.0 111.564 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 541' ' ' ARG . 1.4 mpt_? -118.42 157.24 27.56 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.205 1.402 . . . . 0.0 107.532 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 95.3 m -144.2 119.81 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 41.1 t -113.34 146.63 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.074 0.949 . . . . 0.0 109.404 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 26.8 tp -113.24 125.15 53.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.507 HG21 ' HE2' ' A' ' 484' ' ' LYS . 61.2 t -111.85 154.8 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.132 1.373 . . . . 0.0 107.839 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.415 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.6 p30 -114.51 -174.54 2.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.509 0.324 . . . . 0.0 111.068 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.95 69.23 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.601 1.16 . . . . 0.0 113.217 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.4 -39.34 86.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.886 0.874 . . . . 0.0 111.98 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 107.42 0.47 35.05 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.144 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 550' ' ' GLU . . . . . 0.415 ' HG2' HD21 ' A' ' 546' ' ' ASN . 8.4 pt-20 -87.08 151.7 23.0 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.438 0.619 . . . . 0.0 110.537 172.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 545' ' ' VAL . 39.8 mt-10 -85.89 99.27 11.29 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.903 0.881 . . . . 0.0 109.459 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.23 -38.57 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.042 -171.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -136.55 157.02 47.75 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.167 0.587 . . . . 0.0 110.051 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.437 ' HG3' HG22 ' A' ' 543' ' ' VAL . 28.1 ttt -159.02 141.9 14.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.845 0.458 . . . . 0.0 110.973 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -132.8 164.19 27.39 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.146 1.378 . . . . 0.0 108.665 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 74.3 m -139.98 121.96 15.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.503 HG21 ' HB ' ' A' ' 459' ' ' ILE . 55.0 t -124.58 133.94 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.452 0.701 . . . . 0.0 110.686 -174.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -114.46 124.96 53.23 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.698 0.799 . . . . 0.0 109.679 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 538' ' ' GLU . 60.4 tttp -69.83 100.43 1.54 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 166.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 51.1 m -98.89 -44.05 6.5 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.24 0.616 . . . . 0.0 109.398 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 28.3 m 61.74 105.76 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.87 1.268 . . . . 0.0 111.315 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.19 -5.31 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 124.066 0.946 . . . . 0.0 111.865 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.2 mtm -103.51 154.26 19.66 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.979 0.912 . . . . 0.0 110.469 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 179.57 5.39 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 66.05 104.1 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.646 1.178 . . . . 0.0 111.434 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -113.66 56.08 0.71 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.016 0.926 . . . . 0.0 109.268 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.09 -52.1 63.98 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.133 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -94.88 114.68 26.56 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.96 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -177.057 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 455' ' ' SER . 50.1 m . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -77.16 79.6 3.68 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.731 0.412 . . . . 0.0 110.277 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' SER . . . . . 0.406 ' HB3' ' HB ' ' A' ' 552' ' ' VAL . 68.0 m -73.84 84.41 1.69 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.705 0.802 . . . . 0.0 109.921 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.32 -46.71 3.06 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.905 -169.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 58.0 m -167.89 -57.68 0.02 OUTLIER 'General case' 0 C--N 1.354 0.78 0 C-N-CA 125.756 1.622 . . . . 0.0 108.66 172.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 470' ' ' ASN . 9.3 t -95.95 157.74 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.315 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 455' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 449' ' ' SER . 35.6 t -145.15 165.42 28.36 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.427 0.691 . . . . 0.0 110.148 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 459' ' ' ILE . 24.9 mt -81.62 94.6 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.009 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.89 -50.65 19.22 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.015 0.526 . . . . 0.0 111.722 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -140.6 156.33 46.31 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 456' ' ' ILE . 22.1 mt -141.24 145.45 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.75 152.11 44.14 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.447 0.699 . . . . 0.0 111.339 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 462' ' ' GLU . 2.4 pp -62.21 -37.85 86.92 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.704 0.802 . . . . 0.0 112.379 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.686 ' HG2' ' HE3' ' A' ' 559' ' ' LYS . 27.8 mt-10 -83.4 -23.92 32.16 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.216 0.531 . . . . 0.0 109.786 169.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 85.57 21.01 55.31 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.327 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -70.62 -5.67 31.14 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.109 0.455 . . . . 0.0 110.323 -175.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -149.12 159.07 44.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.695 0.798 . . . . 0.0 110.285 166.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.22 124.03 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.766 1.226 . . . . 0.0 108.049 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -96.74 120.52 37.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.177 0.591 . . . . 0.0 109.731 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 483' ' ' ILE . 79.1 mt -118.27 119.44 34.68 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.825 0.85 . . . . 0.0 109.09 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -113.43 131.32 56.06 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 454' ' ' VAL . 49.8 t30 -81.46 109.51 15.99 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.496 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -86.1 -3.68 59.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.929 0.892 . . . . 0.0 111.877 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.6 m -77.42 155.3 31.9 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.335 0.588 . . . . 0.0 112.406 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.95 -24.96 52.35 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.391 174.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.3 OUTLIER -100.97 161.41 13.61 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.791 0.836 . . . . 0.0 109.8 178.618 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -85.16 121.78 28.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.237 1.015 . . . . 0.0 109.267 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.31 115.28 21.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.36 0.664 . . . . 0.0 110.552 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 24.0 p -70.2 99.5 1.52 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.6 tp -85.39 172.04 11.36 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.584 0.753 . . . . 0.0 109.883 -172.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 136.66 -55.76 0.7 Allowed Glycine 0 N--CA 1.471 0.983 0 CA-C-O 121.365 0.425 . . . . 0.0 112.226 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -70.93 -14.56 62.42 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.593 -0.803 . . . . 0.0 110.736 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -79.62 152.67 29.9 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.259 1.024 . . . . 0.0 109.424 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 -156.2 140.37 16.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.129 0.571 . . . . 0.0 110.627 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 12.7 mt -96.64 107.41 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.64 0.776 . . . . 0.0 109.627 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.647 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 67.9 mttm -76.3 161.09 29.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.178 0.513 . . . . 0.0 109.641 169.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -156.06 96.82 1.75 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -91.21 102.48 15.21 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.522 0.677 . . . . 0.0 109.49 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 489' ' ' GLU . 11.4 t -80.11 138.98 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.492 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 538' ' ' GLU . 4.6 pp -63.11 -17.88 62.81 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.918 0.487 . . . . 0.0 112.075 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' GLU . . . . . 0.41 ' H ' HG12 ' A' ' 487' ' ' VAL . 43.8 tt0 -60.93 -22.54 64.49 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.688 0.795 . . . . 0.0 111.163 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 116.68 28.26 2.56 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.79 -0.641 . . . . 0.0 114.361 170.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.67 165.54 26.67 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.473 0.636 . . . . 0.0 111.106 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -141.0 129.54 22.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.799 0.44 . . . . 0.0 110.23 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 29.4 pt -103.72 148.47 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -133.68 107.62 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.778 0.431 . . . . 0.0 110.153 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -83.71 106.31 15.32 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -81.47 152.46 27.35 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.94 0.4 . . . . 0.0 109.965 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.52 169.74 9.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.148 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 68.8 p -88.96 136.25 30.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 92.8 Cg_endo -73.12 -4.76 16.0 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.896 2.397 . . . . 0.0 113.472 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -90.68 -17.32 27.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.841 0.856 . . . . 0.0 110.837 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -75.53 133.63 40.96 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.776 0.83 . . . . 0.0 109.814 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 67.5 mt -119.89 124.32 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.73 112.1 23.28 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.444 ' H ' ' HD2' ' A' ' 504' ' ' ARG . 2.3 mpt_? -75.18 163.41 27.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.039 0.447 . . . . 0.0 111.067 -172.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.15 118.07 8.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.765 0.826 . . . . 0.0 111.088 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 85.9 -9.13 70.05 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 123.152 0.283 . . . . 0.0 113.784 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -75.98 171.29 14.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.169 0.588 . . . . 0.0 110.428 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -147.97 129.23 14.71 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.581 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.25 104.4 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 121.953 0.883 . . . . 0.0 109.202 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.9 m -87.43 94.24 9.64 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.407 HG12 ' HE1' ' A' ' 534' ' ' TRP . 48.2 t -86.96 99.25 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.33 0.652 . . . . 0.0 110.959 -177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 512' ' ' TRP . . . . . 0.57 ' HB2' HG22 ' A' ' 527' ' ' VAL . 55.2 m95 -84.96 174.89 9.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.162 0.985 . . . . 0.0 111.889 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -97.35 143.34 28.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.056 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -59.85 -37.75 80.16 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.501 0.72 . . . . 0.0 111.489 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -76.4 -0.57 67.29 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.769 -0.65 . . . . 0.0 114.621 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -78.35 -8.69 58.73 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.879 0.471 . . . . 0.0 111.305 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 69.07 23.23 76.15 Favored Glycine 0 C--N 1.361 1.918 0 C-N-CA 123.221 0.439 . . . . 0.0 113.65 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.17 146.26 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.47 1.108 . . . . 0.0 110.403 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -75.59 114.68 14.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.586 0.755 . . . . 0.0 110.164 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 520' ' ' HIS . . . . . 0.445 ' NE2' HD12 ' A' ' 526' ' ' LEU . 20.5 t-160 -69.06 117.03 10.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.84 0.456 . . . . 0.0 109.825 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.6 m -134.74 78.47 55.2 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 123.426 0.691 . . . . 0.0 110.001 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.63 151.46 82.71 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.176 1.917 . . . . 0.0 111.061 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.37 -29.64 4.34 Favored 'Cis proline' 0 CA--C 1.559 1.766 0 CA-C-N 120.48 1.207 . . . . 0.0 114.768 4.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 10.0 m -73.38 -26.12 60.86 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.514 0.726 . . . . 0.0 112.619 -164.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 44.6 m -124.32 83.53 2.16 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.445 HD12 ' NE2' ' A' ' 520' ' ' HIS . 20.7 tp -86.77 150.01 24.45 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.404 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 512' ' ' TRP . 67.6 t -134.91 126.05 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.47 -0.769 . . . . 0.0 109.275 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -69.21 95.17 0.74 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 171.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 529' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 56.2 tptt -67.46 135.24 52.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.95 0.9 . . . . 0.0 110.052 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 89.57 -15.55 58.52 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.381 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.49 120.64 30.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.042 0.537 . . . . 0.0 109.614 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 14.3 p -78.65 -60.37 2.41 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.194 0.598 . . . . 0.0 112.145 -176.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 17.2 t -116.13 -1.46 12.43 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -166.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.407 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 62.72 23.49 13.99 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.212 1.005 . . . . 0.0 110.761 -174.201 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.43 67.06 2.25 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 112.396 -0.282 . . . . 0.0 112.396 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 13.8 t -72.22 163.57 27.71 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.875 0.47 . . . . 0.0 110.936 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -177.64 165.77 35.68 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' GLU . . . . . 0.536 ' HG3' HD21 ' A' ' 488' ' ' LEU . 8.8 pt-20 -59.61 -27.94 66.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.011 0.924 . . . . 0.0 111.902 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.53 ' HB3' HD23 ' A' ' 488' ' ' LEU . 41.1 t -164.3 143.83 7.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.96 0.904 . . . . 0.0 110.167 169.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -156.69 143.92 18.9 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.476 1.11 . . . . 0.0 109.0 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 14.6 ptt-85 -97.29 105.3 17.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.283 0.563 . . . . 0.0 109.776 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 86.0 m -85.16 122.65 29.66 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 71.1 t -121.41 138.35 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.657 1.183 . . . . 0.0 109.857 -171.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 29.4 tp -99.88 122.25 42.54 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 171.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.13 154.0 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.182 1.393 . . . . 0.0 108.435 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.43 HD21 ' HG2' ' A' ' 550' ' ' GLU . 2.5 p30 -117.12 -168.15 1.43 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.93 0.492 . . . . 0.0 111.531 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.2 76.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.787 1.235 . . . . 0.0 113.435 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.25 -38.48 80.17 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.363 0.665 . . . . 0.0 111.403 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 103.24 2.05 47.94 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.378 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 550' ' ' GLU . . . . . 0.43 ' HG2' HD21 ' A' ' 546' ' ' ASN . 10.3 pt-20 -86.64 152.3 22.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.174 0.512 . . . . 0.0 110.541 171.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -80.12 106.51 12.2 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.016 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 451' ' ' SER . 15.8 m -82.04 -35.69 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 122.32 0.248 . . . . 0.0 111.338 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -137.17 149.27 47.14 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.561 0.744 . . . . 0.0 109.562 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.429 ' HG3' HG22 ' A' ' 543' ' ' VAL . 19.2 ttt -150.94 135.24 16.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.138 0.975 . . . . 0.0 109.524 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -145.96 134.22 21.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.984 0.913 . . . . 0.0 109.919 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 36.7 m -97.87 135.86 39.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.437 0.695 . . . . 0.0 109.665 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 459' ' ' ILE . 41.1 t -111.11 129.28 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.789 1.236 . . . . 0.0 108.792 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.27 110.2 22.09 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.686 ' HE3' ' HG2' ' A' ' 462' ' ' GLU . 83.0 tttt -66.32 133.89 51.46 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 11.3 m -64.87 -56.44 13.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.658 0.783 . . . . 0.0 110.466 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 34.8 p -175.44 179.31 1.49 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.074 1.35 . . . . 0.0 109.123 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.06 12.56 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.792 0.837 . . . . 0.0 109.614 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 61.3 mtt -68.7 102.18 1.46 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 123.673 0.789 . . . . 0.0 110.316 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -101.17 149.95 23.45 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.923 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -76.8 111.77 12.67 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.558 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -112.82 6.28 17.92 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.474 0.71 . . . . 0.0 111.177 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.19 -20.08 63.99 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.856 0.863 . . . . 0.0 112.498 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -147.94 21.88 1.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.398 1.079 . . . . 0.0 109.267 173.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.22 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.715 -178.221 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.57 90.97 0.57 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.482 0.713 . . . . 0.0 110.079 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 18.4 m -104.99 105.06 14.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.691 0.797 . . . . 0.0 110.114 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 97.06 4.79 58.55 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.971 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 43.9 m -63.53 -38.16 90.06 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.342 0.657 . . . . 0.0 110.562 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.49 147.6 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.0 m -142.25 148.28 37.84 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.836 0.854 . . . . 0.0 109.185 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.46 ' HA ' HD12 ' A' ' 468' ' ' LEU . 53.2 mt -69.59 132.53 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.699 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 10.5 tp10 -94.83 -66.28 0.92 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.045 0.538 . . . . 0.0 110.249 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.699 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 34.0 mt-10 -133.81 157.18 46.57 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.497 0.719 . . . . 0.0 109.155 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.535 HD13 ' HB ' ' A' ' 542' ' ' THR . 77.8 mt -141.91 139.6 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.64 143.64 51.37 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 123.666 0.604 . . . . 0.0 110.187 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.566 HD12 ' HG3' ' A' ' 462' ' ' GLU . 2.9 pp -71.05 -29.91 65.94 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.482 0.713 . . . . 0.0 112.009 -175.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.566 ' HG3' HD12 ' A' ' 461' ' ' LEU . 36.7 mt-10 -82.25 -31.63 30.06 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 170.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 97.58 41.25 3.43 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 114.904 -1.043 . . . . 0.0 112.633 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -76.21 -27.02 56.67 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.817 0.847 . . . . 0.0 110.798 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -159.23 163.3 36.0 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.367 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 42.6 t -122.65 114.9 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.9 tp-100 -85.51 107.17 17.33 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 171.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.55 HD22 HD11 ' A' ' 483' ' ' ILE . 29.6 tp -105.35 132.08 51.99 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 123.943 0.897 . . . . 0.0 108.83 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 469' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 54.3 tttm -113.7 142.07 46.47 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.355 0.525 . . . . 0.0 111.101 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -89.06 128.77 35.75 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -117.23 12.5 14.4 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.012 0.925 . . . . 0.0 110.979 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 33.8 t -75.88 160.32 30.05 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.723 0.809 . . . . 0.0 110.342 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -87.54 0.25 55.86 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.435 0.694 . . . . 0.0 111.769 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 179.23 7.89 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.611 1.164 . . . . 0.0 109.314 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -53.39 104.49 0.1 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.328 0.651 . . . . 0.0 109.984 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -78.94 112.11 15.79 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 28.8 t -68.84 98.36 0.92 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.776 0.672 . . . . 0.0 109.585 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.1 tp -86.03 174.31 9.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.927 0.891 . . . . 0.0 108.816 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 134.83 -56.53 0.71 Allowed Glycine 0 N--CA 1.468 0.832 0 O-C-N 122.032 -0.417 . . . . 0.0 112.66 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.9 -13.47 62.26 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.788 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -81.47 162.73 23.15 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.147 0.979 . . . . 0.0 110.177 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ARG . . . . . 0.575 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 11.9 ptt180 -157.34 127.8 6.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.61 0.764 . . . . 0.0 110.66 -174.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 483' ' ' ILE . . . . . 0.55 HD11 HD22 ' A' ' 468' ' ' LEU . 50.3 mt -93.49 109.86 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.11 0.564 . . . . 0.0 109.601 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.714 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 97.8 mttt -81.9 167.41 18.99 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.242 0.617 . . . . 0.0 110.827 171.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 485' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 534' ' ' TRP . 42.5 ttm180 -151.69 118.38 5.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 166.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 486' ' ' GLN . . . . . 0.461 ' OE1' ' HB3' ' A' ' 492' ' ' GLU . 23.4 mm-40 -97.84 102.33 14.06 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.024 1.33 . . . . 0.0 108.568 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 40.0 t -75.04 156.78 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.21 0.604 . . . . 0.0 109.807 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 539' ' ' SER . 4.2 pp -54.9 -25.82 31.71 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.411 1.085 . . . . 0.0 113.757 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 489' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 491' ' ' GLU . 13.1 pt-20 -86.51 -21.15 27.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.082 0.553 . . . . 0.0 111.249 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 117.45 14.07 7.14 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.516 -0.602 . . . . 0.0 114.188 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 491' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 489' ' ' GLU . 50.8 mt-10 -76.49 109.78 10.5 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 117.945 0.873 . . . . 0.0 110.305 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.461 ' HB3' ' OE1' ' A' ' 486' ' ' GLN . 7.0 pt-20 -101.11 98.61 9.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.149 0.98 . . . . 0.0 109.815 178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.48 139.37 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.43 ' HB2' ' HG2' ' A' ' 484' ' ' LYS . . . -135.49 112.74 10.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.856 0.462 . . . . 0.0 111.09 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -82.9 112.87 20.09 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.71 0.804 . . . . 0.0 110.281 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -84.81 145.41 27.88 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.52 169.57 10.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.415 0.686 . . . . 0.0 109.923 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 82.5 p -89.42 132.55 36.93 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.324 0.65 . . . . 0.0 109.25 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.44 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 52.0 Cg_exo -58.39 -15.98 26.86 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.422 2.748 . . . . 0.0 114.808 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -79.38 -24.05 42.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.243 0.617 . . . . 0.0 111.284 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -74.29 130.68 40.17 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.466 0.706 . . . . 0.0 110.23 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 46.7 mt -134.71 124.41 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.468 0.707 . . . . 0.0 109.23 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.74 135.16 43.76 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -77.12 154.24 33.45 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.602 0.761 . . . . 0.0 112.156 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -59.78 131.28 50.43 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.053 0.941 . . . . 0.0 110.371 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 89.49 -42.4 3.0 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.47 0.481 . . . . 0.0 112.57 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -66.25 178.35 1.21 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.367 1.067 . . . . 0.0 112.257 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 15.9 ptp -153.13 150.24 28.88 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.391 -174.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 2.8 p -112.04 118.62 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.256 1.422 . . . . 0.0 108.84 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.6 m -95.33 99.75 11.63 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.27 97.58 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.126 0.57 . . . . 0.0 109.994 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -83.56 172.35 12.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.423 1.089 . . . . 0.0 111.616 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -89.85 154.05 20.18 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.041 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.56 68.07 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.066 0.46 . . . . 0.0 110.416 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -75.21 -8.48 83.45 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.615 -0.72 . . . . 0.0 113.986 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -74.56 -19.24 60.4 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.261 0.625 . . . . 0.0 110.772 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.06 22.65 77.3 Favored Glycine 0 C--N 1.357 1.744 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.313 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.16 142.27 13.46 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.252 1.021 . . . . 0.0 109.969 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -69.5 127.52 33.28 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.574 0.75 . . . . 0.0 110.367 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -65.79 110.06 2.69 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.2 m -135.59 80.17 45.29 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.364 0.666 . . . . 0.0 109.953 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.61 154.08 44.9 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.918 2.412 . . . . 0.0 112.685 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -84.82 -17.61 25.96 Favored 'Cis proline' 0 C--N 1.374 1.882 0 CA-C-N 119.898 0.999 . . . . 0.0 114.005 -0.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 21.3 m -71.46 -38.96 71.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.311 0.644 . . . . 0.0 112.427 -169.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 74.0 m -121.35 97.49 5.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.022 0.529 . . . . 0.0 110.615 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 9.4 mp -93.04 145.26 24.51 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 166.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 91.9 t -127.97 126.69 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -73.09 96.99 2.27 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.24 130.29 42.81 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.15 0.98 . . . . 0.0 110.545 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 94.85 -45.86 2.11 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.511 0.507 . . . . 0.0 112.907 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -75.24 100.72 4.42 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 55.4 m -76.1 -43.61 42.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.058 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 536' ' ' THR . 16.8 m -85.55 -29.23 24.35 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -165.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.64 27.05 4.81 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 124.001 0.92 . . . . 0.0 110.611 -174.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.04 58.65 11.02 Favored Glycine 0 C--N 1.345 1.028 0 O-C-N 122.474 -0.141 . . . . 0.0 113.08 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 533' ' ' SER . 2.4 p -64.51 121.73 15.1 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.194 0.598 . . . . 0.0 110.523 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -154.67 155.1 25.98 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.703 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -78.82 -11.02 59.97 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.1 0.476 . . . . 0.0 110.503 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 558' ' ' LYS . 20.9 m -151.61 130.66 12.62 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.192 0.997 . . . . 0.0 108.728 173.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.474 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 8.5 p90 -161.24 171.77 17.83 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.098 0.959 . . . . 0.0 110.287 172.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.615 ' HD3' ' SD ' ' A' ' 554' ' ' MET . 7.0 ptp180 -129.4 109.36 11.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 542' ' ' THR . . . . . 0.535 ' HB ' HD13 ' A' ' 459' ' ' ILE . 21.6 m -87.43 122.27 30.95 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.714 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 41.0 t -108.69 143.86 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.134 0.973 . . . . 0.0 110.075 -170.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 67.1 tp -108.39 123.11 48.34 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.017 0.927 . . . . 0.0 108.539 168.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.575 ' HB ' ' HG3' ' A' ' 482' ' ' ARG . 75.7 t -116.25 144.77 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.389 1.076 . . . . 0.0 108.651 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.557 HD22 ' HG3' ' A' ' 550' ' ' GLU . 8.9 p30 -102.42 -172.89 2.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.809 0.843 . . . . 0.0 111.479 177.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.93 80.99 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.836 1.254 . . . . 0.0 113.723 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -55.87 -39.67 71.86 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.847 0.859 . . . . 0.0 111.899 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.39 -7.71 28.51 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.532 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 550' ' ' GLU . . . . . 0.557 ' HG3' HD22 ' A' ' 546' ' ' ASN . 9.4 pt-20 -73.39 141.26 46.99 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.14 0.47 . . . . 0.0 110.293 174.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -84.35 82.47 8.37 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.41 -39.85 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.267 -171.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -131.53 154.73 48.49 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.325 0.65 . . . . 0.0 110.027 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.615 ' SD ' ' HD3' ' A' ' 541' ' ' ARG . 60.0 ttp -161.33 135.67 7.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.731 0.812 . . . . 0.0 109.524 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -128.18 114.09 16.54 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.037 0.935 . . . . 0.0 109.138 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 29.7 m -81.3 113.55 19.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.201 0.6 . . . . 0.0 109.389 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.509 HG21 ' HB ' ' A' ' 459' ' ' ILE . 82.1 t -114.53 112.27 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.019 0.928 . . . . 0.0 110.063 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 558' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 2.6 mppt? -98.79 137.61 37.13 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 165.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -56.76 97.15 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.764 0.825 . . . . 0.0 110.648 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 23.6 m -119.37 110.69 17.25 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.438 1.095 . . . . 0.0 108.236 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 34.8 m -65.2 99.95 0.42 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.633 0.773 . . . . 0.0 110.686 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.5 p -122.6 -13.31 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.814 0.846 . . . . 0.0 111.176 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.56 125.54 27.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -118.37 -162.19 0.88 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.56 81.81 2.58 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 121.165 0.507 . . . . 0.0 109.838 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -171.31 78.17 0.07 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.702 1.201 . . . . 0.0 108.247 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -73.66 -49.86 23.81 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -156.82 110.62 2.66 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.687 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.255 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 177.636 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.759 0.314 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -143.42 100.59 3.64 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.69 0.796 . . . . 0.0 109.91 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 50.9 m -85.64 79.77 9.24 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.27 -42.44 2.89 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 114.901 -1.045 . . . . 0.0 114.061 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 43.4 m 70.76 -0.72 2.87 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.536 1.535 . . . . 0.0 113.167 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 27.9 t -104.13 117.75 50.2 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 25.1 t -113.05 155.01 25.62 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.088 0.555 . . . . 0.0 110.419 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.47 111.96 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -84.36 -69.47 0.64 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.163 0.585 . . . . 0.0 110.414 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 27.6 mt-10 -117.47 150.28 39.18 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.033 -171.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 50.6 mt -139.58 143.69 30.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.02 148.87 48.31 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -15.72 57.61 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.46 1.104 . . . . 0.0 113.605 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -111.44 -30.79 7.26 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.855 1.262 . . . . 0.0 109.167 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 105.27 31.14 4.45 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.339 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 516' ' ' ALA . 1.9 mppt? -73.71 -8.62 56.72 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.703 0.751 . . . . 0.0 110.915 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -156.83 157.26 34.63 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.289 0.636 . . . . 0.0 111.021 172.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 77.3 t -134.27 113.69 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.868 1.267 . . . . 0.0 107.862 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.7 tp-100 -86.03 107.9 18.0 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.876 0.87 . . . . 0.0 109.497 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.482 HD22 HD22 ' A' ' 544' ' ' LEU . 50.4 mt -92.82 160.62 14.85 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 170.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -145.13 127.34 15.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -89.92 97.92 11.47 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -74.46 -10.98 60.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.255 1.022 . . . . 0.0 111.706 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.5 t -63.56 145.69 55.18 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.697 0.799 . . . . 0.0 111.677 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.26 -0.12 48.12 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.176 0.99 . . . . 0.0 111.412 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.13 164.91 27.32 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 124.36 1.064 . . . . 0.0 108.644 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.92 161.39 10.6 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.751 0.821 . . . . 0.0 111.802 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 13.4 tm0? -136.51 112.43 9.59 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.423 ' HA ' HG12 ' A' ' 502' ' ' ILE . 23.4 p -65.24 103.16 0.74 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.312 0.645 . . . . 0.0 109.896 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.67 161.71 16.71 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -172.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 147.94 -66.39 0.4 Allowed Glycine 0 N--CA 1.473 1.162 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.738 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -69.07 -12.61 61.84 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.295 0.638 . . . . 0.0 111.134 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -67.1 145.08 55.68 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.554 1.142 . . . . 0.0 110.387 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ARG . . . . . 0.5 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 4.3 ptt85 -148.76 123.86 10.1 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.293 -171.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 483' ' ' ILE . . . . . 0.4 HD11 HD11 ' A' ' 468' ' ' LEU . 45.3 mt -90.51 109.26 20.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 123.916 0.886 . . . . 0.0 109.307 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.613 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.0 mttt -77.9 123.95 27.39 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 174.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 49.8 mmm-85 -119.95 92.35 3.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -111.98 116.73 31.06 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 489' ' ' GLU . 13.0 t -103.65 147.78 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.72 -24.45 65.38 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 120.949 0.404 . . . . 0.0 111.392 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' GLU . . . . . 0.54 ' H ' HG12 ' A' ' 487' ' ' VAL . 22.5 mm-40 -61.53 -23.88 66.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.318 1.047 . . . . 0.0 110.603 171.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 126.0 -21.64 6.16 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-O 119.613 -0.549 . . . . 0.0 113.27 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.15 102.62 0.85 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.185 0.594 . . . . 0.0 111.358 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -126.71 116.25 20.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.612 0.765 . . . . 0.0 110.209 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.4 HD12 ' CZ3' ' A' ' 528' ' ' TRP . 20.2 pt -136.55 176.14 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.812 1.245 . . . . 0.0 109.57 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -149.26 108.54 3.94 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -80.56 105.04 11.51 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.25 149.27 31.91 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -91.88 171.74 8.93 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.665 0.786 . . . . 0.0 110.177 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.4 p -90.65 133.19 33.08 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.491 0.716 . . . . 0.0 109.489 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.14 8.5 3.18 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.021 2.481 . . . . 0.0 113.321 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -101.74 -22.84 14.31 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.802 1.241 . . . . 0.0 110.46 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -84.96 123.69 30.81 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 477' ' ' SER . 54.2 mt -104.61 129.99 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.8 127.87 33.42 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 174.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -88.12 158.87 18.44 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.23 127.02 29.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.667 1.187 . . . . 0.0 112.543 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 65.92 14.71 61.45 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.6 0.562 . . . . 0.0 113.747 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -105.52 -164.05 0.99 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.894 0.878 . . . . 0.0 110.282 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -152.7 163.28 39.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.037 0.935 . . . . 0.0 110.448 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.22 116.65 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.19 101.71 13.39 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 59.3 t -87.32 106.03 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 122.75 0.42 . . . . 0.0 110.347 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 512' ' ' TRP . . . . . 0.529 ' HB2' HG22 ' A' ' 527' ' ' VAL . 36.3 m95 -94.72 179.46 5.24 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.686 0.795 . . . . 0.0 111.312 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.687 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -107.3 155.44 19.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.288 1.035 . . . . 0.0 110.067 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 514' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -65.76 -33.39 75.76 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.19 0.596 . . . . 0.0 110.532 172.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 515' ' ' GLY . . . . . 0.451 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -78.47 -3.91 86.76 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.939 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . . . -76.58 -8.48 57.31 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.009 0.524 . . . . 0.0 110.562 169.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 73.96 21.11 79.57 Favored Glycine 0 C--N 1.36 1.871 0 C-N-CA 123.517 0.579 . . . . 0.0 113.21 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.38 143.71 16.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.332 1.053 . . . . 0.0 110.391 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -87.15 141.51 28.6 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.525 0.73 . . . . 0.0 110.398 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -61.78 119.17 8.23 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.85 0.86 . . . . 0.0 109.679 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 39.6 m -129.97 75.44 79.49 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.594 0.757 . . . . 0.0 109.881 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.66 161.23 39.96 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.735 2.29 . . . . 0.0 112.05 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.49 17.78 41.41 Favored 'Cis proline' 0 C--N 1.379 2.17 0 CA-C-N 119.771 0.954 . . . . 0.0 113.673 0.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.4 m -90.42 -68.3 0.79 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.185 0.594 . . . . 0.0 110.052 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 525' ' ' THR . . . . . 0.443 HG23 ' CD1' ' A' ' 512' ' ' TRP . 72.0 m -90.36 95.05 10.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.115 0.966 . . . . 0.0 110.298 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 10.9 mp -92.47 104.93 17.2 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 173.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 512' ' ' TRP . 96.8 t -91.48 123.64 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 528' ' ' TRP . . . . . 0.4 ' CZ3' HD12 ' A' ' 493' ' ' ILE . 7.0 t90 -71.53 89.3 0.96 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 173.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 529' ' ' LYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 25.2 tptp -76.28 117.96 18.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.953 -175.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 123.28 -40.42 1.99 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.0 116.18 28.59 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 532' ' ' SER . . . . . 0.451 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 63.1 p -88.29 -41.65 12.76 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.12 0.568 . . . . 0.0 111.506 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.4 p -79.94 -31.22 40.04 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.687 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 54.49 23.81 4.84 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 123.699 0.799 . . . . 0.0 110.602 -175.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 72.82 67.53 1.79 Allowed Glycine 0 C--N 1.353 1.483 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 -171.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 5.1 p -63.31 140.1 58.84 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.066 0.546 . . . . 0.0 110.733 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -167.59 143.93 8.58 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.628 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.62 -25.55 53.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.287 0.635 . . . . 0.0 110.088 171.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 14.8 m -148.92 120.58 8.04 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.218 1.007 . . . . 0.0 108.484 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -150.64 169.62 21.15 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.989 0.915 . . . . 0.0 110.978 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -117.85 116.99 28.09 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.002 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 40.3 m -96.58 117.34 30.75 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 45.0 t -117.85 139.19 45.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.359 1.064 . . . . 0.0 108.526 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 31.5 tp -110.11 115.87 30.53 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.523 HG21 ' HE3' ' A' ' 484' ' ' LYS . 63.8 t -108.47 151.73 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.494 1.118 . . . . 0.0 108.778 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.446 HD21 ' HG2' ' A' ' 550' ' ' GLU . 0.5 OUTLIER -110.16 -173.09 2.17 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.949 0.5 . . . . 0.0 111.119 -176.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -60.92 -35.67 77.3 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.377 1.071 . . . . 0.0 113.069 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.02 -40.74 98.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.079 0.552 . . . . 0.0 110.524 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 112.48 -11.3 26.0 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.595 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' GLU . . . . . 0.446 ' HG2' HD21 ' A' ' 546' ' ' ASN . 10.6 pt-20 -69.66 146.47 51.61 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 117.78 0.79 . . . . 0.0 110.009 172.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.442 ' HG2' HG22 ' A' ' 545' ' ' VAL . 38.4 mt-10 -84.71 99.1 10.62 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 33.3 m -78.02 -25.85 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.146 -170.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -144.27 156.13 44.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.678 0.791 . . . . 0.0 109.554 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.518 ' HG3' HG22 ' A' ' 543' ' ' VAL . 56.9 ttp -160.2 146.93 15.89 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.343 0.657 . . . . 0.0 109.715 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.68 117.08 4.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.902 0.481 . . . . 0.0 110.402 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 62.1 m -87.93 103.72 15.95 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.724 0.81 . . . . 0.0 108.874 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.0 p -114.93 129.56 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.153 0.981 . . . . 0.0 110.432 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.94 163.32 32.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.134 0.973 . . . . 0.0 109.948 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -85.14 100.32 11.65 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.843 0.857 . . . . 0.0 109.597 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 48.9 m -105.44 -8.39 18.15 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.935 0.894 . . . . 0.0 110.638 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 43.4 m -114.98 115.3 26.65 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.968 0.907 . . . . 0.0 110.021 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.28 -8.39 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.945 0.898 . . . . 0.0 111.125 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -65.52 145.82 55.62 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.745 0.818 . . . . 0.0 111.557 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 -177.92 3.5 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 62.24 57.81 1.91 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.478 1.111 . . . . 0.0 110.742 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -158.87 105.83 1.81 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.052 170.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -96.42 -6.58 37.09 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.548 0.739 . . . . 0.0 112.094 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.18 101.16 5.89 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.402 0.681 . . . . 0.0 111.007 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 119.166 -0.796 . . . . 0.0 112.231 179.412 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 471' ' ' ASN . . . -152.02 89.26 1.44 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.888 0.875 . . . . 0.0 109.425 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' SER . . . . . 0.446 ' HB2' ' HB ' ' A' ' 552' ' ' VAL . 17.9 p -78.65 94.87 5.13 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 88.27 -44.52 3.2 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.077 -173.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 19.8 p 177.26 -42.55 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.407 1.483 . . . . 0.0 109.3 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 12.3 t -98.53 162.74 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.433 1.093 . . . . 0.0 109.954 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 35.7 t -145.82 152.0 38.82 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.876 1.27 . . . . 0.0 109.366 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.0 mt -86.08 107.67 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -86.68 -53.08 5.15 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -171.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 30.0 mt-10 -136.79 163.02 31.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.637 HG23 HH21 ' A' ' 485' ' ' ARG . 89.0 mt -147.67 143.69 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.098 1.359 . . . . 0.0 107.749 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.462 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 37.2 t70 -66.98 148.33 52.1 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.74 0.416 . . . . 0.0 111.138 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 559' ' ' LYS . 0.4 OUTLIER -64.34 -27.42 69.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.968 0.907 . . . . 0.0 112.634 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.01 -32.01 11.86 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.28 0.632 . . . . 0.0 109.571 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 103.35 44.04 1.77 Allowed Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.545 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -91.04 -9.55 45.45 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.542 0.737 . . . . 0.0 111.15 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 29.5 p90 -154.71 161.09 41.69 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.33 0.586 . . . . 0.0 112.373 173.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 42.3 t -127.11 117.62 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.473 1.509 . . . . 0.0 107.335 169.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.3 tp-100 -86.03 112.41 21.21 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.499 HD22 HD11 ' A' ' 483' ' ' ILE . 16.5 tp -112.15 121.34 44.66 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.994 0.917 . . . . 0.0 108.736 -176.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -113.41 139.09 49.19 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.024 0.53 . . . . 0.0 111.698 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.488 ' HB2' HD12 ' A' ' 503' ' ' LEU . 52.9 t30 -92.71 137.23 32.54 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 450' ' ' ALA . 30.5 m-80 -127.62 16.4 6.98 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.48 0.712 . . . . 0.0 109.92 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 41.9 t -73.79 152.85 40.2 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.759 0.824 . . . . 0.0 109.459 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.86 -21.35 62.44 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.376 0.67 . . . . 0.0 111.014 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.442 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.0 OUTLIER -122.97 174.89 6.9 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.469 0.708 . . . . 0.0 109.687 176.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 475' ' ' ASP . . . . . 0.492 ' HB2' HG22 ' A' ' 502' ' ' ILE . 5.1 p-10 -65.13 111.65 3.03 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.037 0.935 . . . . 0.0 109.963 172.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -78.03 122.41 25.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.08 0.952 . . . . 0.0 110.426 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 18.2 p -66.2 98.01 0.43 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.687 0.756 . . . . 0.0 109.626 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.6 tp -89.46 162.6 15.65 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 135.13 -51.16 0.84 Allowed Glycine 0 N--CA 1.471 0.998 0 O-C-N 121.451 -0.78 . . . . 0.0 112.334 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -68.66 -13.5 62.4 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.203 -0.999 . . . . 0.0 111.0 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -91.9 162.63 14.34 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 124.713 1.205 . . . . 0.0 110.294 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -153.43 143.75 22.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.97 0.908 . . . . 0.0 110.337 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' ILE . . . . . 0.499 HD11 HD22 ' A' ' 468' ' ' LEU . 61.5 mt -102.51 107.73 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.438 0.695 . . . . 0.0 109.618 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.668 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.5 mttt -78.67 162.24 26.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.321 0.649 . . . . 0.0 111.626 172.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 485' ' ' ARG . . . . . 0.637 HH21 HG23 ' A' ' 459' ' ' ILE . 71.2 mtt180 -153.03 102.46 2.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.201 1.4 . . . . 0.0 108.377 170.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 486' ' ' GLN . . . . . 0.491 ' HG3' ' HD3' ' A' ' 541' ' ' ARG . 8.4 pt20 -101.8 109.33 21.07 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.727 0.811 . . . . 0.0 109.712 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.475 HG12 HD23 ' A' ' 488' ' ' LEU . 6.6 t -89.44 156.58 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.919 0.888 . . . . 0.0 109.19 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 487' ' ' VAL . 2.7 pt? -66.41 -18.15 65.19 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.028 0.442 . . . . 0.0 111.458 173.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' GLU . . . . . 0.405 ' H ' HG12 ' A' ' 487' ' ' VAL . 37.4 mt-10 -83.08 4.73 25.07 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.49 1.116 . . . . 0.0 111.779 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 102.16 -26.1 25.46 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.145 -0.808 . . . . 0.0 114.469 168.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.53 104.53 0.81 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.677 0.739 . . . . 0.0 111.001 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.53 79.84 1.35 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.4 1.08 . . . . 0.0 108.961 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 35.6 pt -97.54 170.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.741 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -155.49 116.39 3.89 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.735 0.414 . . . . 0.0 110.162 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -80.17 108.49 13.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.966 0.506 . . . . 0.0 109.769 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -76.35 150.3 36.88 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.72 167.76 11.08 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 76.2 p -95.82 132.76 26.56 Favored Pre-proline 0 N--CA 1.477 0.897 0 CA-C-O 118.441 -0.79 . . . . 0.0 108.994 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.486 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 54.3 Cg_exo -55.27 -25.7 48.33 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 123.206 2.604 . . . . 0.0 115.066 -175.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -68.33 -24.67 64.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.038 0.535 . . . . 0.0 111.457 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -73.39 127.34 32.41 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.2 1.0 . . . . 0.0 109.478 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 475' ' ' ASP . 43.4 mt -129.66 118.69 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 503' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 470' ' ' ASN . 1.4 tm? -93.36 125.82 38.16 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -67.54 163.34 21.37 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.326 1.05 . . . . 0.0 113.227 -168.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.2 116.69 5.66 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.352 1.061 . . . . 0.0 111.851 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 80.94 -14.93 23.96 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 123.485 0.49 . . . . 0.0 113.926 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -79.29 -172.94 3.42 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.122 0.969 . . . . 0.0 111.068 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -154.42 147.49 24.66 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.33 0.586 . . . . 0.0 112.268 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.76 127.88 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.814 1.245 . . . . 0.0 109.135 172.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.89 99.99 11.12 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.55 97.92 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 122.856 0.462 . . . . 0.0 110.044 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' TRP . . . . . 0.523 ' HH2' ' HA ' ' A' ' 567' ' ' GLU . 39.3 m95 -86.61 178.24 7.12 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.044 0.938 . . . . 0.0 111.506 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.612 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.26 158.49 16.0 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.814 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.74 -28.18 67.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.386 0.675 . . . . 0.0 110.591 172.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -76.16 -16.99 80.3 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.466 -0.788 . . . . 0.0 114.066 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -68.32 -29.3 68.02 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.168 0.587 . . . . 0.0 110.729 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.72 26.47 73.99 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 116.321 -0.399 . . . . 0.0 113.635 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 13.4 p -81.09 159.03 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.827 1.251 . . . . 0.0 111.117 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -73.8 113.9 11.48 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.128 0.571 . . . . 0.0 110.139 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -64.85 110.87 2.57 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.093 0.557 . . . . 0.0 109.625 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.9 m -127.39 69.35 74.73 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.16 0.584 . . . . 0.0 110.254 -175.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.88 149.69 60.2 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.35 2.033 . . . . 0.0 111.87 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.42 -13.87 34.77 Favored 'Cis proline' 0 C--N 1.376 2.012 0 N-CA-C 114.442 0.901 . . . . 0.0 114.442 -2.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.3 m -60.12 -28.55 67.95 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.868 0.867 . . . . 0.0 113.048 -172.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 97.1 m -140.75 101.21 4.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.07 0.948 . . . . 0.0 108.878 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.86 138.94 31.21 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 83.4 t -113.67 117.73 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -70.45 92.34 0.81 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' LYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.7 tptt -68.45 135.07 51.11 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.121 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 91.54 -14.77 63.06 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.17 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -100.91 110.89 23.0 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 66.1 p -82.34 -50.79 8.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.327 0.584 . . . . 0.0 111.219 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.597 ' HB3' HG22 ' A' ' 536' ' ' THR . 20.3 m -90.11 -28.51 18.93 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.939 -167.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 56.56 38.09 29.33 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.05 0.94 . . . . 0.0 110.142 -176.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.47 52.91 45.69 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.597 HG22 ' HB3' ' A' ' 533' ' ' SER . 14.3 t -72.21 156.01 39.61 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.51 0.724 . . . . 0.0 110.274 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 179.97 167.87 37.79 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.8 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -71.84 -25.29 61.91 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 18.2 m -154.42 121.69 5.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.856 0.862 . . . . 0.0 109.71 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.45 ' HB3' HG22 ' A' ' 487' ' ' VAL . 31.5 p90 -143.65 150.7 39.13 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.431 0.692 . . . . 0.0 111.06 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.491 ' HD3' ' HG3' ' A' ' 486' ' ' GLN . 5.4 mpt_? -101.92 106.21 17.12 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 33.5 m -84.99 106.34 16.41 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.668 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 28.3 t -105.64 133.48 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.058 0.943 . . . . 0.0 110.127 -170.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.2 tp -98.08 119.67 37.13 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.466 HG22 ' HG2' ' A' ' 551' ' ' GLU . 40.2 t -115.86 143.66 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.428 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.6 p30 -105.38 -172.89 2.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.499 0.32 . . . . 0.0 110.919 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -52.72 -40.23 62.83 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.844 1.258 . . . . 0.0 113.745 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.01 -36.9 82.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.613 0.765 . . . . 0.0 111.87 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.3 -19.48 29.34 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.035 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' GLU . . . . . 0.428 ' HG2' HD21 ' A' ' 546' ' ' ASN . 11.3 pt-20 -66.95 134.81 52.75 Favored 'General case' 0 C--O 1.248 1.019 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.466 ' HG2' HG22 ' A' ' 545' ' ' VAL . 44.7 mt-10 -79.33 102.27 8.54 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 451' ' ' SER . 28.0 m -74.29 -37.39 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.651 -172.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -133.78 159.95 39.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.59 0.756 . . . . 0.0 109.32 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.52 ' HG3' HG22 ' A' ' 543' ' ' VAL . 27.4 ttt -157.41 125.28 5.4 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -137.32 105.86 5.82 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -172.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 49.8 m -83.63 110.32 18.16 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.243 0.617 . . . . 0.0 109.682 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.9 116.62 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -87.6 147.97 25.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.664 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.53 ' HE2' HG13 ' A' ' 562' ' ' VAL . 20.6 tttm -59.8 98.96 0.06 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.835 0.854 . . . . 0.0 110.254 176.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 36.7 p -71.75 -44.04 64.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.812 0.845 . . . . 0.0 110.365 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 23.1 t -162.57 175.61 11.25 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.235 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 562' ' ' VAL . . . . . 0.53 HG13 ' HE2' ' A' ' 559' ' ' LYS . 17.2 m -117.84 -14.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.666 1.186 . . . . 0.0 109.78 170.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.9 mtt -91.34 147.69 22.86 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.659 1.184 . . . . 0.0 110.134 -171.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 67.73 128.76 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.402 1.481 . . . . 0.0 110.683 -168.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -111.65 132.32 54.67 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.798 0.839 . . . . 0.0 110.34 -173.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -100.1 10.92 40.52 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 567' ' ' GLU . . . . . 0.523 ' HA ' ' HH2' ' A' ' 512' ' ' TRP . 37.3 tt0 -82.3 -46.71 13.29 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.617 1.167 . . . . 0.0 111.058 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 59.48 85.1 0.1 Allowed 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.138 0.899 . . . . 0.0 110.68 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.087 0 CA-C-O 119.009 -0.884 . . . . 0.0 111.532 -179.43 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 37.2 m . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -75.99 90.55 3.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.815 0.446 . . . . 0.0 109.839 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 51.3 p -127.91 117.43 21.76 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.78 0.832 . . . . 0.0 109.583 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 93.19 5.31 63.92 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.726 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' SER . . . . . 0.405 ' HB3' ' OG ' ' A' ' 472' ' ' SER . 16.6 m -63.62 -38.33 90.7 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.26 1.024 . . . . 0.0 111.688 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.07 150.8 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.964 1.306 . . . . 0.0 107.646 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 22.7 t -137.12 153.21 50.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.866 0.866 . . . . 0.0 109.629 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 64.8 mt -76.64 107.19 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 14.0 tp10 -78.54 -68.68 0.62 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 28.9 mt-10 -130.44 167.45 18.58 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.864 0.866 . . . . 0.0 109.16 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 23.4 mt -141.43 147.43 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 20.8 t70 -66.65 145.92 55.05 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.249 0.62 . . . . 0.0 111.245 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 462' ' ' GLU . 0.4 OUTLIER -63.94 -33.6 76.09 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.403 1.081 . . . . 0.0 112.74 -178.05 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.417 ' H ' HD12 ' A' ' 461' ' ' LEU . 44.8 mt-10 -93.38 -23.75 18.33 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.895 0.878 . . . . 0.0 110.285 173.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.67 32.46 7.24 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.001 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -79.26 -15.66 57.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.545 0.738 . . . . 0.0 111.215 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 20.5 p90 -155.15 162.17 41.05 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.277 0.56 . . . . 0.0 111.621 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.46 119.59 59.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 125.296 1.438 . . . . 0.0 107.813 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.413 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 29.3 tp60 -88.48 109.74 20.28 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.56 ' HB2' HG13 ' A' ' 509' ' ' VAL . 87.0 mt -100.13 155.72 17.58 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 469' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 508' ' ' MET . 0.0 OUTLIER -140.47 129.8 23.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 175.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.72 111.2 17.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.947 0.899 . . . . 0.0 110.163 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.73 -10.84 59.7 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.146 0.979 . . . . 0.0 111.939 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 453' ' ' SER . 50.4 m -59.9 148.58 34.44 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.72 -15.81 63.22 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.653 1.181 . . . . 0.0 111.408 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.17 176.34 8.84 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.317 1.047 . . . . 0.0 110.447 -171.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.11 108.7 0.72 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.143 0.977 . . . . 0.0 110.675 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -79.92 117.34 20.68 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.405 0.682 . . . . 0.0 110.423 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.539 ' HA ' HG12 ' A' ' 502' ' ' ILE . 8.9 p -73.3 105.79 4.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.756 0.822 . . . . 0.0 109.906 175.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.5 tp -98.02 163.5 12.74 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 145.63 -64.59 0.45 Allowed Glycine 0 N--CA 1.47 0.915 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -67.91 -12.07 59.97 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.595 0.758 . . . . 0.0 111.465 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -74.19 151.26 40.03 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.886 0.875 . . . . 0.0 109.926 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -153.42 136.49 15.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.074 0.55 . . . . 0.0 111.184 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 62.4 mt -91.71 140.3 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.052 0.941 . . . . 0.0 109.739 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.73 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 55.2 mttm -115.67 107.44 15.1 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.995 0.918 . . . . 0.0 110.149 175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -92.78 93.77 8.61 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 171.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 492' ' ' GLU . 43.3 mt-30 -93.46 104.7 16.82 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.474 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 489' ' ' GLU . 9.7 t -98.63 139.83 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.473 0.709 . . . . 0.0 109.306 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 539' ' ' SER . 4.7 pp -65.5 -21.34 66.62 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.024 0.53 . . . . 0.0 111.403 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 489' ' ' GLU . . . . . 0.556 ' H ' HG12 ' A' ' 487' ' ' VAL . 28.2 tt0 -71.25 -2.98 17.93 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.925 1.29 . . . . 0.0 110.895 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 110.13 11.96 19.03 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 115.509 0.964 . . . . 0.0 115.509 162.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -118.14 106.55 12.97 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.258 1.029 . . . . 0.0 110.771 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 486' ' ' GLN . 8.9 pt-20 -105.01 80.97 1.68 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 122.364 1.078 . . . . 0.0 109.006 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 38.3 pt -85.67 155.6 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.602 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -128.48 139.2 52.45 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.179 0.592 . . . . 0.0 110.16 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -123.02 105.92 10.38 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.072 0.949 . . . . 0.0 108.614 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 152.33 26.71 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -89.93 163.22 15.06 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.248 0.619 . . . . 0.0 110.512 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 75.7 p -80.24 130.02 67.41 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.79 -17.83 56.94 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.795 2.33 . . . . 0.0 113.333 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -72.55 -16.36 61.76 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.9 0.88 . . . . 0.0 111.623 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -89.37 134.76 33.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.746 0.819 . . . . 0.0 110.914 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 477' ' ' SER . 58.3 mt -137.67 141.2 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.89 140.27 52.05 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -73.84 166.2 23.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.082 0.953 . . . . 0.0 113.062 -168.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.72 124.76 22.28 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.234 1.014 . . . . 0.0 112.349 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 74.08 0.65 57.3 Favored Glycine 0 C--N 1.343 0.942 0 O-C-N 123.664 0.602 . . . . 0.0 114.42 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -88.89 -174.9 4.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.35 0.66 . . . . 0.0 109.451 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' MET . . . . . 0.49 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -133.42 161.01 35.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.404 0.682 . . . . 0.0 110.99 -177.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 509' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 468' ' ' LEU . 2.4 p -134.64 105.83 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.554 1.142 . . . . 0.0 109.113 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 3.3 m -89.07 104.09 16.66 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.979 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 34.9 t -91.92 103.5 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -87.47 175.55 7.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.114 0.965 . . . . 0.0 111.694 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -96.73 156.5 16.32 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.616 171.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 514' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -62.98 -36.2 82.72 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.221 0.609 . . . . 0.0 110.652 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -80.06 4.06 68.23 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.401 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -77.09 -28.28 54.45 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.002 0.521 . . . . 0.0 110.715 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 85.61 9.0 79.42 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.556 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.7 148.57 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.087 0.955 . . . . 0.0 110.642 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -78.64 124.28 28.01 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.294 0.638 . . . . 0.0 109.621 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -63.98 111.32 2.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.814 0.446 . . . . 0.0 109.804 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.4 m -128.38 76.34 78.33 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.414 0.686 . . . . 0.0 109.632 -176.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.12 158.95 55.82 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.716 2.277 . . . . 0.0 111.631 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.69 -38.5 1.66 Allowed 'Cis proline' 0 C--N 1.379 2.15 0 CA-C-N 120.228 1.117 . . . . 0.0 114.757 6.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 60.3 m -63.85 -52.34 60.53 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.006 0.523 . . . . 0.0 112.35 -170.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 40.0 m -87.91 86.43 7.14 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.459 0.647 . . . . 0.0 109.893 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.97 149.82 24.92 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 96.1 t -133.43 121.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -72.66 94.64 1.76 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 529' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.4 tptt -70.54 136.18 49.12 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.928 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 96.06 -9.74 67.85 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.527 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -116.07 111.24 20.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.243 0.617 . . . . 0.0 109.587 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 49.3 m -81.82 -44.49 16.85 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.953 0.501 . . . . 0.0 111.846 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.627 ' HB3' HG22 ' A' ' 536' ' ' THR . 34.6 m -87.43 -28.42 22.13 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -168.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 60.3 26.58 16.09 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.285 1.034 . . . . 0.0 110.896 -175.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.66 75.68 0.5 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 533' ' ' SER . 13.1 t -109.36 167.27 10.25 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 123.872 0.869 . . . . 0.0 110.628 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 169.83 -164.97 38.38 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.815 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.43 -54.38 33.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.989 0.916 . . . . 0.0 110.012 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.418 ' HB2' HD23 ' A' ' 488' ' ' LEU . 26.8 m -143.44 132.74 23.26 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -154.01 146.02 23.61 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.776 0.83 . . . . 0.0 109.826 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 13.6 ptp180 -109.67 141.59 42.02 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.313 0.578 . . . . 0.0 110.519 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 47.7 m -95.66 138.36 33.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 169.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.73 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 42.0 t -124.46 150.5 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 41.8 tp -124.54 113.06 17.59 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.464 HG22 ' HG2' ' A' ' 551' ' ' GLU . 54.0 t -100.49 154.02 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.882 1.273 . . . . 0.0 108.779 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.9 -171.67 1.89 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.845 0.458 . . . . 0.0 111.747 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.5 88.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.341 1.056 . . . . 0.0 112.863 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.37 -38.84 92.44 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.645 0.778 . . . . 0.0 110.97 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 112.57 -5.91 26.29 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.852 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -72.81 146.89 45.98 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 118.793 1.297 . . . . 0.0 110.295 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 545' ' ' VAL . 47.3 mt-10 -81.37 94.5 6.79 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.641 0.776 . . . . 0.0 108.982 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 18.8 m -79.0 -19.65 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -168.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -149.11 155.06 40.13 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.059 0.544 . . . . 0.0 109.671 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 50.0 ttp -163.74 131.77 3.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.571 0.748 . . . . 0.0 109.624 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -145.38 126.31 14.49 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.024 0.93 . . . . 0.0 108.848 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 13.4 m -92.91 147.21 23.03 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.009 0.523 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.74 121.19 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.388 1.075 . . . . 0.0 109.307 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.54 118.05 35.57 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -76.91 86.27 3.46 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 45.1 m -73.7 -14.81 61.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.641 0.776 . . . . 0.0 109.552 171.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 561' ' ' SER . . . . . 0.607 ' HB2' ' HG2' ' A' ' 563' ' ' MET . 16.5 m 70.22 -174.66 0.18 Allowed 'General case' 0 C--N 1.365 1.248 0 C-N-CA 125.676 1.59 . . . . 0.0 110.858 176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.07 -1.14 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 CA-C-O 121.295 0.569 . . . . 0.0 110.77 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.607 ' HG2' ' HB2' ' A' ' 561' ' ' SER . 26.5 ptt? -92.89 168.42 11.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.225 1.01 . . . . 0.0 110.557 176.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 13.4 ttt85 -86.65 146.12 26.44 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.789 0.836 . . . . 0.0 109.537 169.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.74 133.09 35.31 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.423 0.689 . . . . 0.0 110.095 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -86.64 71.66 10.34 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.78 -67.22 0.48 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.081 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -98.38 77.21 2.34 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.818 -0.99 . . . . 0.0 112.489 178.16 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 548' ' ' ASP . 41.3 m . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 120.567 0.222 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -93.79 67.91 3.87 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 171.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 14.5 m -79.97 112.17 17.0 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.016 -170.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 66.37 30.56 76.84 Favored Glycine 0 C--N 1.345 1.037 0 O-C-N 123.717 0.636 . . . . 0.0 113.659 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 24.8 m -76.33 -45.37 32.54 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.414 0.685 . . . . 0.0 110.297 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.28 143.16 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 19.5 m -130.14 150.34 51.45 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.216 1.006 . . . . 0.0 109.577 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 53.4 mt -76.3 106.13 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.449 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 11.3 tp10 -78.02 -55.66 5.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.751 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 43.9 mt-10 -140.57 165.7 26.75 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.824 0.85 . . . . 0.0 109.9 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.62 ' HB ' HG21 ' A' ' 557' ' ' VAL . 79.6 mt -143.18 151.39 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.83 149.92 48.4 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.455 0.702 . . . . 0.0 111.002 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.483 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.4 pt? -64.02 -39.99 95.35 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.714 0.806 . . . . 0.0 112.004 -177.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.483 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 18.3 mt-10 -89.18 -27.24 20.81 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.309 1.044 . . . . 0.0 109.199 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 98.32 40.64 3.41 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.789 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 516' ' ' ALA . 1.5 mppt? -83.9 -10.67 57.81 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.765 0.426 . . . . 0.0 111.387 176.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -156.02 162.14 40.36 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.91 0.386 . . . . 0.0 111.635 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' VAL . . . . . 0.41 HG13 HG12 ' A' ' 459' ' ' ILE . 59.0 t -133.07 112.37 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.367 1.467 . . . . 0.0 107.914 174.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.449 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 14.3 tp60 -86.43 111.58 20.67 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.168 0.987 . . . . 0.0 110.094 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 7.0 mp -92.29 160.55 15.08 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.424 1.09 . . . . 0.0 109.453 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' LYS . . . . . 0.717 ' HE3' ' HB3' ' A' ' 471' ' ' ASN . 3.3 tmmm? -147.0 128.24 14.78 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -88.44 107.84 19.07 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.216 0.606 . . . . 0.0 109.802 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.717 ' HB3' ' HE3' ' A' ' 469' ' ' LYS . 12.0 p-10 -95.77 19.07 11.86 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.611 0.764 . . . . 0.0 112.046 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 45.0 m -76.55 151.94 36.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.674 0.39 . . . . 0.0 110.971 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -78.75 -22.75 46.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.885 0.874 . . . . 0.0 110.612 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -116.69 168.05 10.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.123 0.969 . . . . 0.0 111.247 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.33 111.0 4.35 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.72 0.808 . . . . 0.0 110.342 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.59 109.61 17.56 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 54.6 p -68.95 114.31 7.13 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.083 0.553 . . . . 0.0 110.359 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 7.6 tp -90.78 169.79 10.66 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.033 0.933 . . . . 0.0 109.027 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 143.15 -66.65 0.46 Allowed Glycine 0 N--CA 1.473 1.117 0 O-C-N 121.996 -0.44 . . . . 0.0 112.467 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -71.99 -9.9 59.03 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.37 0.668 . . . . 0.0 111.009 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -70.39 143.69 51.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.836 0.854 . . . . 0.0 109.796 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 22.9 ptt-85 -140.87 137.79 33.47 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.741 0.416 . . . . 0.0 110.747 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 45.6 mt -96.75 106.92 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.2 mttt -75.3 147.23 40.37 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.77 91.89 2.29 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -99.55 104.46 16.26 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.487 -170.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 31.7 t -66.44 154.91 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 539' ' ' SER . 4.3 pp -51.79 -32.1 29.85 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -173.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.35 -11.35 58.64 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.377 0.671 . . . . 0.0 112.063 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 125.17 -26.68 5.5 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.979 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.81 111.57 1.93 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.48 0.712 . . . . 0.0 111.633 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.98 145.09 43.87 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.24 0.543 . . . . 0.0 111.385 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.71 153.89 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.89 1.276 . . . . 0.0 108.108 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -133.01 108.45 8.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.407 0.283 . . . . 0.0 110.356 -177.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -85.06 103.7 14.31 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -91.44 143.65 26.39 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.39 0.614 . . . . 0.0 109.489 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -83.93 170.79 13.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.482 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 2.6 t -94.06 140.23 22.83 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.151 0.58 . . . . 0.0 109.715 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.78 -26.1 78.79 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.877 3.052 . . . . 0.0 114.128 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -68.39 -19.41 64.62 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.4 0.68 . . . . 0.0 111.771 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -82.65 136.86 34.66 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.518 0.727 . . . . 0.0 110.617 -174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 66.7 mt -131.03 150.81 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' LEU . . . . . 0.497 HD21 ' HB ' ' A' ' 509' ' ' VAL . 0.3 OUTLIER -123.99 135.34 53.56 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -81.25 156.76 25.44 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.704 0.801 . . . . 0.0 111.674 -168.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.33 132.76 52.62 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.958 0.903 . . . . 0.0 112.372 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 64.29 15.83 59.46 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.921 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -107.69 -166.53 1.15 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.653 0.781 . . . . 0.0 109.908 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 171.89 16.14 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.19 0.519 . . . . 0.0 111.731 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 509' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 503' ' ' LEU . 7.4 p -146.49 142.1 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.872 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 5.2 m -118.86 109.08 15.6 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 45.7 t -90.27 100.33 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -82.21 175.93 9.89 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.674 1.19 . . . . 0.0 111.508 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.36 153.45 19.65 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.337 173.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 514' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -64.39 -32.11 73.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.115 0.566 . . . . 0.0 110.9 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -71.4 -16.02 75.34 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.992 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . . . -70.79 -23.7 62.43 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.3 0.64 . . . . 0.0 111.473 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 78.46 36.64 29.63 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 123.235 0.334 . . . . 0.0 113.618 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.79 147.18 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.183 0.993 . . . . 0.0 110.386 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -74.72 123.31 24.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.487 0.715 . . . . 0.0 110.961 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -67.46 111.15 3.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.4 0.68 . . . . 0.0 109.681 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.7 m -134.84 80.3 49.65 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.117 0.567 . . . . 0.0 110.091 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.37 156.2 61.46 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.857 2.371 . . . . 0.0 112.164 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -99.9 30.7 11.62 Favored 'Cis proline' 0 C--N 1.38 2.186 0 CA-C-N 119.684 0.923 . . . . 0.0 113.591 -0.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 39.5 m -112.44 -38.61 4.61 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.989 0.516 . . . . 0.0 111.149 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 60.3 m -118.3 96.34 5.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.49 0.716 . . . . 0.0 109.718 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 58.1 mt -87.63 149.91 23.99 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 65.1 t -137.29 116.74 15.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -72.55 98.25 2.27 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 529' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 0.4 OUTLIER -66.14 134.11 52.09 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.88 0.872 . . . . 0.0 110.16 -177.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 92.28 -24.79 20.63 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.958 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -87.23 103.61 15.6 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 55.4 p -77.97 -45.27 24.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.815 0.446 . . . . 0.0 111.076 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 536' ' ' THR . 15.2 m -93.37 -30.26 15.2 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -166.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 55.7 32.73 19.94 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 123.644 0.777 . . . . 0.0 110.352 -174.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 72.28 59.92 4.35 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.214 -0.448 . . . . 0.0 113.027 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 533' ' ' SER . 12.2 p -65.28 147.7 52.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.985 0.514 . . . . 0.0 111.761 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 175.97 159.85 22.43 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.87 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -73.11 -9.55 58.84 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.06 0.544 . . . . 0.0 110.818 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 488' ' ' LEU . 29.6 t -157.55 139.43 14.15 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 124.589 1.156 . . . . 0.0 108.252 172.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.97 122.13 5.07 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.021 0.528 . . . . 0.0 111.282 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.603 ' HD2' ' SD ' ' A' ' 554' ' ' MET . 52.9 ttp180 -84.5 105.43 15.31 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 32.2 m -94.25 128.57 40.8 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 22.8 t -120.33 145.94 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.845 0.858 . . . . 0.0 109.427 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 34.2 tp -114.88 119.42 36.51 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.5 HG22 ' HG2' ' A' ' 551' ' ' GLU . 60.9 t -106.49 154.65 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.009 1.324 . . . . 0.0 108.632 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 550' ' ' GLU . 1.2 p30 -115.52 -173.64 2.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.536 0.335 . . . . 0.0 111.675 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.24 -36.56 71.07 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.753 1.221 . . . . 0.0 112.611 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 548' ' ' ASP . . . . . 0.521 ' HB2' ' HA ' ' A' ' 449' ' ' SER . 20.1 t70 -60.65 -38.98 86.65 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.755 0.822 . . . . 0.0 111.635 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.15 -12.44 31.45 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.542 -174.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' GLU . . . . . 0.518 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 0.7 OUTLIER -74.82 149.65 39.56 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.193 0.497 . . . . 0.0 110.072 177.096 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.5 ' HG2' HG22 ' A' ' 545' ' ' VAL . 34.5 mt-10 -88.54 92.71 9.29 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.562 0.745 . . . . 0.0 109.31 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.53 -34.57 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -168.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.574 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -135.17 165.81 24.55 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.124 0.57 . . . . 0.0 109.86 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.603 ' SD ' ' HD2' ' A' ' 541' ' ' ARG . 50.1 ttm -169.57 115.97 0.57 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.306 0.642 . . . . 0.0 109.519 -176.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 53.0 ttm-85 -124.35 115.42 20.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.483 0.713 . . . . 0.0 109.825 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 17.4 m -92.11 126.31 37.14 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.73 0.812 . . . . 0.0 109.622 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.62 HG21 ' HB ' ' A' ' 459' ' ' ILE . 78.2 t -123.72 123.71 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.623 0.769 . . . . 0.0 109.701 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 138.13 49.81 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.14 0.976 . . . . 0.0 109.718 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -72.27 91.9 1.35 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.103 0.961 . . . . 0.0 111.383 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 23.5 t -106.58 2.46 26.07 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.807 164.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 30.3 m -107.48 135.49 48.86 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.86 0.864 . . . . 0.0 110.835 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 34.9 m -96.01 19.49 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.075 0.95 . . . . 0.0 110.139 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 79.6 mtp -53.85 117.35 3.11 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.547 1.139 . . . . 0.0 110.956 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -82.3 133.56 35.24 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.02 0.528 . . . . 0.0 109.921 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -160.44 110.28 1.77 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -153.55 142.88 21.56 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.352 0.661 . . . . 0.0 109.833 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -162.77 -44.86 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -69.63 106.48 3.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.776 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 119.18 -0.789 . . . . 0.0 111.362 -177.01 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -147.79 67.97 1.11 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.706 0.765 . . . . 0.0 109.654 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' SER . . . . . 0.494 ' HA ' HG12 ' A' ' 552' ' ' VAL . 27.0 p -81.26 94.99 6.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.851 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' GLY . . . . . 0.47 ' H ' ' HB ' ' A' ' 552' ' ' VAL . . . 92.5 34.27 7.1 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.968 171.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.6 m -71.08 -51.4 25.4 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.763 0.792 . . . . 0.0 108.945 170.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 5.0 t -110.53 146.54 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 23.2 t -124.34 177.85 5.67 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.603 1.161 . . . . 0.0 109.587 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.7 mt -98.4 123.27 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.504 ' HG3' ' HG2' ' A' ' 458' ' ' GLU . 6.6 tp10 -87.68 -76.11 0.39 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 457' ' ' GLU . 55.0 mm-40 -122.91 160.94 25.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.393 1.077 . . . . 0.0 109.383 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.447 HG12 HG13 ' A' ' 466' ' ' VAL . 66.2 mt -140.68 148.14 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.26 147.99 51.43 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.42 HD12 ' HG3' ' A' ' 462' ' ' GLU . 3.3 pp -67.0 -36.34 81.94 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.541 0.736 . . . . 0.0 111.456 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.42 ' HG3' HD12 ' A' ' 461' ' ' LEU . 40.2 mt-10 -81.34 -31.88 33.23 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 170.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' GLY . . . . . 0.547 ' HA3' HH22 ' A' ' 485' ' ' ARG . . . 92.7 51.47 2.31 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.177 -175.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -81.97 -18.97 41.61 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.361 0.665 . . . . 0.0 110.505 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -156.42 158.63 37.64 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.889 0.476 . . . . 0.0 111.554 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' VAL . . . . . 0.447 HG13 HG12 ' A' ' 459' ' ' ILE . 61.1 t -127.3 107.12 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.889 1.275 . . . . 0.0 108.19 174.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 19.6 tp60 -85.76 114.61 22.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 109.27 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 70.4 mt -100.96 151.84 21.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.695 1.198 . . . . 0.0 109.334 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 4.6 tmmm? -138.94 136.8 35.84 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.751 0.821 . . . . 0.0 109.568 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.455 ' OD1' ' HA ' ' A' ' 505' ' ' ALA . 25.9 t-20 -90.97 133.24 35.44 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.106 0.963 . . . . 0.0 111.335 -176.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -110.91 7.26 21.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.71 0.804 . . . . 0.0 111.95 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 48.8 m -80.53 155.5 26.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.274 0.63 . . . . 0.0 111.718 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -85.4 -19.4 31.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.61 0.764 . . . . 0.0 110.053 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.492 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.1 OUTLIER -123.24 150.91 42.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.487 1.115 . . . . 0.0 109.108 -178.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -69.01 135.76 51.39 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.296 0.638 . . . . 0.0 111.397 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -89.65 118.33 29.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.517 0.727 . . . . 0.0 109.923 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 15.4 p -65.12 109.82 2.31 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 503' ' ' LEU . 4.8 tp -102.14 175.66 5.46 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -171.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 122.05 -50.57 0.83 Allowed Glycine 0 N--CA 1.469 0.857 0 CA-C-O 121.993 0.774 . . . . 0.0 111.179 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 480' ' ' ASN . . . . . 0.595 ' HB3' ' HB2' ' A' ' 547' ' ' ALA . 9.0 m120 -65.46 -24.28 67.13 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 113.368 -1.416 . . . . 0.0 110.543 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.475 ' CZ3' HG21 ' A' ' 552' ' ' VAL . 13.6 m0 -77.12 164.23 25.88 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.061 0.945 . . . . 0.0 111.289 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -156.21 138.67 14.9 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.523 -170.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.06 113.57 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.421 1.088 . . . . 0.0 108.61 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -79.61 140.92 36.96 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' ARG . . . . . 0.547 HH22 ' HA3' ' A' ' 463' ' ' GLY . 74.4 ttt180 -143.8 96.38 2.89 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 173.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 486' ' ' GLN . . . . . 0.519 ' HG3' ' HB2' ' A' ' 541' ' ' ARG . 5.6 pt20 -98.36 103.87 15.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.864 1.265 . . . . 0.0 109.434 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.71 153.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.602 0.761 . . . . 0.0 109.178 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.419 HD23 ' HB2' ' A' ' 539' ' ' SER . 2.4 pp -66.23 -14.37 61.81 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.391 0.541 . . . . 0.0 111.679 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -62.01 -23.37 66.4 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.613 0.765 . . . . 0.0 110.939 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 104.37 -8.53 48.41 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.704 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -78.33 105.47 9.6 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 123.44 0.696 . . . . 0.0 110.496 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.08 133.24 51.11 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.514 173.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 24.2 pt -128.58 156.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.16 0.984 . . . . 0.0 108.661 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -131.11 108.01 9.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -87.91 103.56 15.79 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -87.08 146.54 26.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 170.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -83.43 170.24 14.7 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.08 0.552 . . . . 0.0 110.935 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.9 p -84.79 129.92 54.87 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.213 0.605 . . . . 0.0 109.372 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.526 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 36.3 Cg_endo -62.31 -14.32 37.84 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.893 2.395 . . . . 0.0 113.465 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.88 1.81 41.52 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.971 0.908 . . . . 0.0 111.977 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -103.26 136.92 42.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.606 0.762 . . . . 0.0 111.002 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 69.5 mt -118.12 136.59 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' LEU . . . . . 0.479 ' HB2' HD22 ' A' ' 478' ' ' LEU . 3.1 tm? -100.54 121.25 41.27 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -79.94 161.95 25.22 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.305 0.642 . . . . 0.0 112.655 -171.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' ALA . . . . . 0.455 ' HA ' ' OD1' ' A' ' 470' ' ' ASN . . . -73.95 133.96 43.1 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.083 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 70.15 1.26 33.19 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.509 0.505 . . . . 0.0 113.817 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -101.97 174.72 5.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.956 0.902 . . . . 0.0 110.35 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -140.68 144.02 35.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.013 0.525 . . . . 0.0 111.432 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.53 128.97 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.835 0.854 . . . . 0.0 108.907 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.3 m -103.79 103.31 13.17 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 56.7 t -87.4 97.85 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 122.803 0.441 . . . . 0.0 110.167 -176.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 512' ' ' TRP . . . . . 0.543 ' HB2' HG22 ' A' ' 527' ' ' VAL . 43.9 m95 -90.94 175.47 6.96 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.849 0.859 . . . . 0.0 112.007 -175.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -104.04 152.85 21.56 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.357 1.063 . . . . 0.0 110.308 174.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 514' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -63.54 -38.96 93.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.422 0.689 . . . . 0.0 111.879 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -82.7 -0.63 90.23 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.34 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -83.25 7.0 17.6 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.404 0.681 . . . . 0.0 111.632 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 76.83 38.56 30.89 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 113.572 0.189 . . . . 0.0 113.572 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 4.6 p -146.5 137.33 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.703 0.801 . . . . 0.0 110.617 -170.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -91.09 151.49 20.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.101 0.961 . . . . 0.0 111.139 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -67.05 112.27 4.3 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.5 m -131.78 79.34 68.39 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.672 0.789 . . . . 0.0 109.889 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.95 156.25 56.53 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.716 2.278 . . . . 0.0 111.845 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -93.4 4.42 57.66 Favored 'Cis proline' 0 C--N 1.381 2.244 0 CA-C-N 119.815 0.97 . . . . 0.0 113.491 2.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.0 m -82.81 -30.09 29.04 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.605 0.762 . . . . 0.0 111.595 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 84.0 m -140.75 102.84 4.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.367 0.667 . . . . 0.0 110.658 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 9.7 mp -97.49 103.77 15.73 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 512' ' ' TRP . 72.0 t -89.29 122.19 40.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -71.07 87.1 0.75 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' LYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 22.1 tptp -68.01 116.54 8.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.701 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 120.84 -45.36 1.24 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -172.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.11 105.85 12.65 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 532' ' ' SER . . . . . 0.455 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 34.2 p -72.18 -47.16 52.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.483 0.713 . . . . 0.0 111.243 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 536' ' ' THR . 48.7 m -99.23 -14.34 19.33 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.489 0.715 . . . . 0.0 112.271 -173.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 61.72 23.76 14.01 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.04 0.936 . . . . 0.0 109.582 -171.02 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.92 65.2 2.71 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-N 116.54 -0.3 . . . . 0.0 112.717 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 533' ' ' SER . 10.8 p -59.55 166.11 2.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.167 0.987 . . . . 0.0 113.624 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 177.72 160.21 23.92 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.034 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -78.4 -27.12 46.68 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.852 0.326 . . . . 0.0 110.399 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.419 ' HB2' HD23 ' A' ' 488' ' ' LEU . 2.7 m -145.71 129.5 17.22 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 168.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.87 137.79 20.24 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.843 0.857 . . . . 0.0 110.887 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.519 ' HB2' ' HG3' ' A' ' 486' ' ' GLN . 1.3 mpt_? -91.68 116.14 28.63 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 78.8 m -108.12 119.34 39.2 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 543' ' ' VAL . . . . . . . . . . . . . 20.4 t -115.67 123.25 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.024 0.93 . . . . 0.0 109.744 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 42.2 tp -81.25 124.43 29.31 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 546' ' ' ASN . 53.5 t -126.45 144.37 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.824 0.85 . . . . 0.0 109.556 -173.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.471 ' O ' HG12 ' A' ' 545' ' ' VAL . 11.3 t-20 -84.03 162.69 20.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.907 0.883 . . . . 0.0 109.935 170.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 547' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 480' ' ' ASN . . . -45.51 -41.49 9.7 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.439 1.495 . . . . 0.0 114.48 -175.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.26 -32.44 68.37 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.557 1.143 . . . . 0.0 112.897 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.85 -6.29 31.07 Favored Glycine 0 N--CA 1.464 0.551 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -168.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.81 117.63 9.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.568 0.747 . . . . 0.0 109.642 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.42 116.81 15.52 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 451' ' ' SER . 16.1 m -95.33 -28.86 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 122.719 0.408 . . . . 0.0 111.546 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -156.89 147.33 21.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.167 0.987 . . . . 0.0 109.251 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 554' ' ' MET . 0.0 OUTLIER -147.26 147.67 30.65 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.119 0.568 . . . . 0.0 109.694 -178.215 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 555' ' ' ARG . . . . . 0.435 ' NH1' HG22 ' A' ' 557' ' ' VAL . 2.1 tmt_? -160.86 108.51 1.54 Allowed 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 63.2 m -81.55 138.13 35.46 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.619 0.768 . . . . 0.0 109.573 174.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.435 HG22 ' NH1' ' A' ' 555' ' ' ARG . 36.2 t -115.9 146.63 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.686 1.194 . . . . 0.0 109.133 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 113.1 6.18 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.005 0.922 . . . . 0.0 108.823 166.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -54.02 105.77 0.16 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.948 1.699 . . . . 0.0 111.384 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 36.4 p -160.65 -41.64 0.05 OUTLIER 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.642 1.177 . . . . 0.0 108.886 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 17.3 m -62.74 143.68 57.21 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.557 0.743 . . . . 0.0 110.573 172.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.3 86.36 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.392 1.091 . . . . 0.0 109.719 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 62.0 mtt -119.12 179.39 4.18 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.289 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -74.03 148.95 41.51 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.862 0.465 . . . . 0.0 110.173 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.78 133.98 48.05 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.008 0.923 . . . . 0.0 112.01 -171.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -93.88 73.93 4.19 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 567' ' ' GLU . . . . . 0.492 ' HA ' ' HZ2' ' A' ' 512' ' ' TRP . 11.2 pt-20 -71.49 -27.88 63.53 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.759 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 57.0 t30 59.51 83.86 0.12 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.72 1.208 . . . . 0.0 112.158 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.317 0 CA-C-O 118.761 -1.022 . . . . 0.0 112.487 178.596 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 120.534 0.207 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -73.82 138.5 44.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.566 0.746 . . . . 0.0 109.422 170.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 15.7 m -74.86 84.97 2.21 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.409 0.683 . . . . 0.0 111.849 -171.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.0 -37.74 2.53 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 115.349 0.899 . . . . 0.0 115.349 170.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 8.2 t 70.1 1.36 3.49 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 125.665 1.586 . . . . 0.0 112.139 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.39 128.51 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 171.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 28.6 t -117.18 174.2 6.25 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.17 0.588 . . . . 0.0 109.785 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 36.8 mt -93.03 116.23 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 469' ' ' LYS . 7.2 tp10 -70.33 -71.38 0.25 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.738 0.815 . . . . 0.0 109.92 -177.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.0 mt-10 -126.56 159.38 33.64 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.183 0.993 . . . . 0.0 108.705 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.59 HD13 ' HB ' ' A' ' 542' ' ' THR . 15.9 mt -137.09 131.3 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.67 127.0 31.16 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.655 ' HB2' ' HA ' ' A' ' 559' ' ' LYS . 0.9 OUTLIER -80.31 -17.83 50.96 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.534 0.521 . . . . 0.0 111.491 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -12.71 60.11 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 165.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 79.09 21.5 67.68 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.107 -0.951 . . . . 0.0 115.144 164.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -91.21 -13.16 33.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.058 0.429 . . . . 0.0 111.109 -176.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -155.29 158.7 39.19 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.5 116.81 46.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.114 1.366 . . . . 0.0 107.693 168.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.416 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.4 tp-100 -89.58 113.64 25.1 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.02 140.48 34.19 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' LYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 21.3 tptm -113.96 129.28 56.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.425 ' HB2' HD12 ' A' ' 503' ' ' LEU . 48.2 t30 -88.1 100.08 12.68 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -90.94 6.92 42.69 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.14 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.9 t -76.11 161.41 28.87 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.596 0.758 . . . . 0.0 111.066 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.75 -9.55 58.09 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.233 0.613 . . . . 0.0 111.616 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.403 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.3 OUTLIER -130.08 168.41 16.8 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.161 0.584 . . . . 0.0 110.038 177.732 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.19 118.42 10.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.484 0.714 . . . . 0.0 109.327 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -94.39 118.78 32.15 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.446 0.698 . . . . 0.0 110.391 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 67.6 p -71.94 116.97 12.97 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.397 0.679 . . . . 0.0 110.273 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.53 177.82 6.0 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 146.05 -67.42 0.41 Allowed Glycine 0 N--CA 1.474 1.2 0 CA-C-O 121.494 0.496 . . . . 0.0 112.743 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -73.23 -9.79 59.08 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.702 -0.749 . . . . 0.0 109.692 167.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -72.05 131.08 42.39 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.97 0.908 . . . . 0.0 109.148 171.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 21.5 ptt-85 -139.93 127.95 22.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.681 0.792 . . . . 0.0 110.375 -173.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' ILE . . . . . 0.435 ' HB ' ' HH2' ' A' ' 534' ' ' TRP . 10.3 mt -91.23 105.86 16.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.551 ' HE3' HG21 ' A' ' 545' ' ' VAL . 97.8 mttt -76.71 134.2 39.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.661 0.384 . . . . 0.0 110.385 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -118.85 91.4 3.55 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -97.11 102.05 13.75 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.077 0.951 . . . . 0.0 109.052 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 488' ' ' LEU . 5.8 t -101.39 147.55 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.098 0.559 . . . . 0.0 110.786 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.477 HD23 HG12 ' A' ' 487' ' ' VAL . 2.3 pt? -60.78 -24.73 66.0 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.544 0.738 . . . . 0.0 111.996 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.91 -27.56 68.9 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.346 1.058 . . . . 0.0 111.898 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 124.18 -26.4 5.83 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.677 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.74 100.29 2.32 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.977 0.894 . . . . 0.0 110.295 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -113.43 97.22 6.33 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.887 -1.052 . . . . 0.0 108.321 175.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 25.4 pt -108.71 178.91 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.547 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -156.3 118.45 4.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.32 0.648 . . . . 0.0 109.473 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -86.72 107.72 18.36 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -85.02 146.72 27.04 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.707 0.765 . . . . 0.0 110.195 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -80.18 173.35 12.68 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.955 1.302 . . . . 0.0 109.917 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 71.8 p -89.42 136.96 29.28 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.406 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 74.6 Cg_exo -52.57 -26.94 30.77 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.175 2.583 . . . . 0.0 114.435 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -79.31 -24.47 42.82 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.731 0.813 . . . . 0.0 112.227 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -66.9 127.78 33.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.232 0.613 . . . . 0.0 109.967 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 45.2 mt -129.81 134.08 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.812 0.845 . . . . 0.0 108.94 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 470' ' ' ASN . 0.8 OUTLIER -108.26 130.9 55.15 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -77.75 155.4 31.22 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.751 0.82 . . . . 0.0 111.553 -170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.97 120.73 13.14 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.723 0.809 . . . . 0.0 110.793 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 88.08 -2.26 85.32 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.575 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -95.98 176.02 6.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.05 0.54 . . . . 0.0 110.173 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -148.01 136.75 21.79 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.756 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 3.4 p -101.78 114.66 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.406 0.682 . . . . 0.0 109.781 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.99 94.95 10.0 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 89.6 t -82.64 104.6 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 512' ' ' TRP . . . . . 0.543 ' HB2' HG22 ' A' ' 527' ' ' VAL . 37.7 m95 -93.61 176.83 6.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.065 0.946 . . . . 0.0 112.107 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -98.66 142.07 30.69 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.02 171.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 514' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -66.86 -32.7 74.14 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.191 0.596 . . . . 0.0 111.152 176.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -67.57 -19.59 71.12 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.002 -0.545 . . . . 0.0 113.817 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -66.31 -18.45 65.36 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.153 0.581 . . . . 0.0 110.79 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.17 27.56 72.73 Favored Glycine 0 C--N 1.352 1.454 0 C-N-CA 122.711 0.196 . . . . 0.0 112.878 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.58 149.26 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.436 1.095 . . . . 0.0 110.942 -174.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -68.74 119.55 13.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.279 0.632 . . . . 0.0 110.999 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 520' ' ' HIS . . . . . 0.451 ' NE2' HD12 ' A' ' 526' ' ' LEU . 15.6 t-160 -76.44 124.69 27.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.439 0.695 . . . . 0.0 110.065 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 58.5 m -152.41 79.35 6.09 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.876 0.87 . . . . 0.0 110.464 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.49 161.05 37.88 Favored 'Trans proline' 0 CA--C 1.565 2.037 0 C-N-CA 122.909 2.406 . . . . 0.0 111.844 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.37 -9.17 43.44 Favored 'Cis proline' 0 C--N 1.382 2.314 0 CA-C-N 120.355 1.162 . . . . 0.0 113.904 1.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.1 m -66.33 -37.15 84.7 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.798 0.839 . . . . 0.0 111.753 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 97.0 m -139.46 89.81 2.36 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.775 0.83 . . . . 0.0 108.946 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 30.5 tp -91.83 138.98 31.11 Favored 'General case' 0 C--O 1.209 -1.078 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 512' ' ' TRP . 96.6 t -125.66 122.7 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.03 0.832 . . . . 0.0 109.15 -175.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -70.17 94.55 0.91 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 529' ' ' LYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 23.0 tptm -71.32 117.62 13.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.428 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 121.44 -36.85 3.14 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.23 127.05 34.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.913 0.485 . . . . 0.0 110.684 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 58.4 p -99.42 -36.23 9.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.852 0.861 . . . . 0.0 110.978 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.456 ' OG ' HG22 ' A' ' 536' ' ' THR . 28.9 t -87.54 -35.51 18.11 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.653 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 51.48 34.51 12.34 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.833 0.853 . . . . 0.0 110.423 -174.463 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 64.88 64.21 3.69 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.195 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.456 HG22 ' OG ' ' A' ' 533' ' ' SER . 12.4 t -104.7 168.38 9.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.927 0.491 . . . . 0.0 110.673 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 168.0 -162.51 36.29 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.225 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -69.21 -34.64 75.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.208 0.603 . . . . 0.0 111.253 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.7 m -158.59 137.27 11.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.208 1.003 . . . . 0.0 109.021 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.459 ' HB3' HG22 ' A' ' 487' ' ' VAL . 4.7 p90 -149.98 125.38 10.19 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.83 0.824 . . . . 0.0 112.117 -177.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 72.7 ttt-85 -77.92 102.04 7.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.722 174.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 542' ' ' THR . . . . . 0.59 ' HB ' HD13 ' A' ' 459' ' ' ILE . 16.3 m -95.86 124.52 39.9 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 46.7 t -125.33 134.92 65.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 C-N-CA 123.696 0.798 . . . . 0.0 109.937 -172.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 26.7 tp -97.69 115.96 28.98 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 166.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.551 HG21 ' HE3' ' A' ' 484' ' ' LYS . 92.3 t -110.06 159.17 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.014 1.326 . . . . 0.0 108.702 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -124.56 -170.35 2.14 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.732 0.413 . . . . 0.0 111.783 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.69 73.97 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.378 1.071 . . . . 0.0 112.948 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.33 -36.64 84.79 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.65 0.78 . . . . 0.0 111.07 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.26 -18.57 27.98 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.646 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.68 160.42 32.25 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.506 0.67 . . . . 0.0 110.59 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -92.71 108.0 19.65 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.186 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.17 -23.73 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.932 0.493 . . . . 0.0 111.494 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -151.63 131.66 13.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.814 0.845 . . . . 0.0 109.065 174.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 12.3 ttm -122.83 108.83 13.44 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -126.76 105.17 8.49 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 66.6 m -84.52 136.62 33.73 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.07 138.91 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.07 137.58 51.99 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.25 1.02 . . . . 0.0 108.695 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 461' ' ' LEU . 55.8 tttm -75.99 77.28 2.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.477 1.111 . . . . 0.0 109.962 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 17.7 m -101.96 -13.52 17.55 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.294 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 47.2 t -86.84 165.63 15.82 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.324 0.649 . . . . 0.0 110.802 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.18 2.78 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 C-N-CA 123.968 0.907 . . . . 0.0 110.693 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 74.2 mtm -66.06 152.0 45.64 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.381 0.673 . . . . 0.0 111.596 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.13 170.87 7.83 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.608 0.763 . . . . 0.0 111.564 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.68 136.76 57.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.758 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 74.34 -29.39 0.19 Allowed 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.303 1.441 . . . . 0.0 112.717 -178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -58.2 -26.58 62.97 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.185 0.994 . . . . 0.0 111.25 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 5.1 t30 74.01 -75.39 0.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.608 1.163 . . . . 0.0 111.624 165.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.468 0 CA-C-O 118.566 -1.13 . . . . 0.0 111.042 -177.965 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -59.44 93.44 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.856 0.862 . . . . 0.0 111.548 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' SER . . . . . 0.476 ' HA ' HG23 ' A' ' 552' ' ' VAL . 27.6 p -106.31 121.28 43.89 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.3 1.04 . . . . 0.0 109.821 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 83.34 14.0 75.15 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-N 115.915 -0.584 . . . . 0.0 114.096 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' SER . . . . . 0.418 ' HB2' ' HH2' ' A' ' 481' ' ' TRP . 23.1 m -70.39 -51.65 28.13 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 117.236 0.518 . . . . 0.0 110.572 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 25.9 t -125.41 134.99 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.06 0.944 . . . . 0.0 108.616 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 20.8 m -115.5 173.05 6.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.129 0.972 . . . . 0.0 110.668 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 52.9 mt -94.7 111.9 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 469' ' ' LYS . 9.5 tp10 -82.63 -63.6 1.34 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.743 0.417 . . . . 0.0 110.968 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 28.9 mt-10 -121.29 151.68 39.78 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 58.9 mt -133.32 130.51 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -78.62 129.18 34.47 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.81 0.694 . . . . 0.0 109.882 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.442 HD13 ' HE3' ' A' ' 559' ' ' LYS . 2.2 pp -76.27 -23.72 54.44 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.247 0.342 . . . . 0.0 111.301 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -68.85 -29.4 67.71 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 167.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 83.8 25.3 46.36 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.498 -0.774 . . . . 0.0 114.032 172.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -82.28 -27.4 32.38 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.377 0.589 . . . . 0.0 111.12 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -146.52 160.03 42.66 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-O 121.458 0.647 . . . . 0.0 112.424 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 95.3 t -130.6 119.72 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 125.177 1.391 . . . . 0.0 107.417 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 4.1 tp-100 -89.19 122.31 32.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.832 0.853 . . . . 0.0 109.771 178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 75.5 mt -102.15 162.23 13.07 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.771 0.829 . . . . 0.0 109.629 171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 1.2 tmtp? -146.75 131.05 17.51 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -86.8 111.26 20.57 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.81 -17.5 47.29 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.032 0.933 . . . . 0.0 112.291 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 81.0 p -70.13 158.15 36.28 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.072 0.463 . . . . 0.0 111.669 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.64 0.67 29.26 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.178 0.991 . . . . 0.0 112.326 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.29 175.62 10.38 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.837 0.855 . . . . 0.0 109.281 -174.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.93 125.98 28.58 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.043 0.537 . . . . 0.0 109.593 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -100.36 131.65 46.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.178 0.991 . . . . 0.0 110.493 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 26.4 p -66.89 124.03 21.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.324 0.65 . . . . 0.0 109.714 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 9.5 tp -119.36 152.77 36.22 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.42 -52.53 0.58 Allowed Glycine 0 N--CA 1.475 1.234 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.837 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -69.75 -14.39 62.76 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.646 0.779 . . . . 0.0 110.639 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.418 ' HH2' ' HB2' ' A' ' 453' ' ' SER . 12.4 m95 -82.85 158.72 22.6 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 125.126 1.371 . . . . 0.0 109.95 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -161.27 131.75 5.12 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.838 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 32.5 mt -87.63 118.76 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.811 0.844 . . . . 0.0 109.742 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.673 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 64.8 mttm -84.81 148.7 26.17 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 166.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 485' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 492' ' ' GLU . 34.9 ttm180 -132.77 96.66 3.85 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 163.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -85.5 102.38 13.44 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.551 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 27.3 t -72.2 168.95 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.04 0.936 . . . . 0.0 110.277 -176.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 539' ' ' SER . 3.4 pp -55.55 -25.92 40.5 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.643 1.177 . . . . 0.0 113.609 177.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -85.2 4.15 35.95 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.517 0.675 . . . . 0.0 110.812 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 86.21 -7.41 78.38 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.636 0.636 . . . . 0.0 113.349 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.49 102.63 3.26 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.689 0.796 . . . . 0.0 110.295 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 485' ' ' ARG . 8.7 pt-20 -96.39 111.89 23.83 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.583 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 28.4 pt -91.44 147.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.297 173.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -121.39 108.9 14.23 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.349 0.66 . . . . 0.0 110.707 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -83.07 107.74 15.86 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 166.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -91.58 147.67 22.84 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -93.72 170.46 9.55 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.414 0.686 . . . . 0.0 110.714 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 82.7 p -93.5 130.23 36.03 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.024 0.93 . . . . 0.0 108.985 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.498 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 17.7 Cg_endo -58.72 -18.88 43.23 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.257 2.638 . . . . 0.0 114.884 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -75.9 -24.02 55.58 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.951 0.501 . . . . 0.0 111.189 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -75.5 142.72 42.81 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.361 0.664 . . . . 0.0 110.528 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 61.9 mt -133.39 136.58 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.081 0.952 . . . . 0.0 108.713 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.39 116.72 33.43 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -73.27 162.26 29.57 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.197 0.599 . . . . 0.0 112.108 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -60.63 124.4 20.29 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.234 1.014 . . . . 0.0 112.302 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 74.43 -6.42 23.46 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.58 0.55 . . . . 0.0 114.297 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -81.02 155.1 26.53 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.456 0.702 . . . . 0.0 109.857 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 55.4 mtm -120.42 126.52 50.65 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.248 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.7 112.65 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 2.1 m -92.7 101.94 14.34 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.521 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.479 HG12 ' HE1' ' A' ' 534' ' ' TRP . 59.0 t -88.74 98.25 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.015 0.436 . . . . 0.0 109.981 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 512' ' ' TRP . . . . . 0.403 ' HE3' ' HB1' ' A' ' 516' ' ' ALA . 49.1 m95 -86.05 176.64 7.91 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.397 1.079 . . . . 0.0 111.509 174.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -95.05 164.06 13.04 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.092 0.957 . . . . 0.0 110.726 174.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -64.79 -45.48 86.09 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.429 0.692 . . . . 0.0 111.302 174.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -82.91 5.97 73.0 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.683 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.403 ' HB1' ' HE3' ' A' ' 512' ' ' TRP . . . -75.6 -1.05 22.7 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.502 0.721 . . . . 0.0 111.842 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 68.41 31.25 73.82 Favored Glycine 0 C--N 1.356 1.683 0 C-N-CA 123.125 0.393 . . . . 0.0 113.699 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 6.4 p -123.74 135.86 62.06 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 C-N-CA 124.42 1.088 . . . . 0.0 109.968 -172.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -76.95 134.1 39.01 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.292 0.637 . . . . 0.0 110.4 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -64.51 110.89 2.46 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.356 0.663 . . . . 0.0 110.228 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.5 m -126.42 74.22 73.65 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.605 0.762 . . . . 0.0 110.129 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.33 150.91 76.53 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 122.27 1.98 . . . . 0.0 111.435 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -93.23 11.47 53.01 Favored 'Cis proline' 0 C--N 1.376 1.981 0 CA-C-N 119.971 1.025 . . . . 0.0 113.72 -1.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.3 m -82.8 -28.85 29.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.391 0.676 . . . . 0.0 111.833 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 76.7 m -143.58 104.42 4.21 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.727 0.811 . . . . 0.0 109.968 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 66.5 mt -91.35 144.07 25.97 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 169.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 50.3 t -120.85 120.95 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.635 0.774 . . . . 0.0 108.975 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -75.2 96.42 3.3 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 529' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.9 tptt -66.7 136.39 55.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.792 0.837 . . . . 0.0 110.335 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 88.67 -4.97 85.07 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 123.479 0.487 . . . . 0.0 113.325 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -112.99 114.06 26.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 34.2 p -73.56 -56.69 4.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.085 0.554 . . . . 0.0 111.942 -172.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.642 ' HB2' HG23 ' A' ' 536' ' ' THR . 86.6 p -114.45 9.72 16.83 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.267 0.627 . . . . 0.0 112.215 -169.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.479 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 59.44 23.87 12.47 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 124.422 1.089 . . . . 0.0 110.545 -174.24 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.87 71.12 0.9 Allowed Glycine 0 C--N 1.35 1.34 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.642 HG23 ' HB2' ' A' ' 533' ' ' SER . 17.3 p -59.67 129.93 44.33 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.449 0.7 . . . . 0.0 111.949 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -137.0 154.93 22.47 Favored Glycine 0 C--O 1.238 0.371 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 170.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.14 -60.58 2.17 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.492 ' H ' HD23 ' A' ' 488' ' ' LEU . 7.3 m -107.16 125.1 50.65 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.086 0.954 . . . . 0.0 109.026 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.551 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 5.6 p90 -151.28 145.1 25.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.649 0.738 . . . . 0.0 111.883 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 4.3 tmm_? -96.91 102.08 13.78 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.763 1.225 . . . . 0.0 108.468 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 47.7 m -86.44 140.21 30.19 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.452 0.701 . . . . 0.0 109.202 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.673 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 40.0 t -133.8 146.2 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.484 1.114 . . . . 0.0 109.619 -175.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 38.6 tp -113.61 133.09 55.48 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 163.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.588 HG21 ' HE2' ' A' ' 484' ' ' LYS . 85.4 t -124.26 156.24 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.605 1.162 . . . . 0.0 108.369 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -119.58 -170.23 1.9 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.398 0.679 . . . . 0.0 111.814 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.61 64.09 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.156 1.382 . . . . 0.0 113.755 -174.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 548' ' ' ASP . . . . . 0.59 ' HB3' ' HG2' ' A' ' 550' ' ' GLU . 16.8 t70 -67.31 -37.81 83.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.403 0.681 . . . . 0.0 112.1 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.76 -15.97 28.73 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.078 -173.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 550' ' ' GLU . . . . . 0.59 ' HG2' ' HB3' ' A' ' 548' ' ' ASP . 9.9 pt-20 -62.64 137.68 58.32 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.633 0.773 . . . . 0.0 110.325 172.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -81.47 87.72 6.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.807 0.843 . . . . 0.0 109.543 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 451' ' ' SER . 7.6 p -64.02 -35.8 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.694 -170.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -133.37 150.75 51.81 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.518 0.727 . . . . 0.0 109.054 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 51.6 ttm -161.56 121.68 2.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.466 0.706 . . . . 0.0 109.629 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.71 118.74 13.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.29 0.636 . . . . 0.0 109.315 175.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 28.2 m -86.21 140.43 30.15 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.976 0.911 . . . . 0.0 109.276 174.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.42 131.18 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.66 0.784 . . . . 0.0 109.124 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 558' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 0.0 OUTLIER -122.15 125.52 46.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.651 0.78 . . . . 0.0 109.034 175.213 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.442 ' HE3' HD13 ' A' ' 461' ' ' LEU . 86.9 tttt -73.91 104.64 4.85 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.786 1.234 . . . . 0.0 110.052 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 36.0 t -69.75 -42.85 73.37 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.307 0.643 . . . . 0.0 109.391 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 32.3 t -161.65 175.27 12.21 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.836 0.854 . . . . 0.0 110.152 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.77 69.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 122.997 1.38 . . . . 0.0 109.463 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 12.9 ptp -157.82 112.5 2.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.366 -1.743 . . . . 0.0 108.593 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -76.01 134.89 40.01 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.207 0.527 . . . . 0.0 110.402 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.24 161.14 13.94 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.117 172.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -62.82 -39.81 95.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.52 0.328 . . . . 0.0 111.075 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 56.73 -80.16 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.676 1.59 . . . . 0.0 111.921 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -121.64 123.32 41.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.615 1.166 . . . . 0.0 108.042 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.354 179.229 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -63.11 86.59 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.424 0.69 . . . . 0.0 110.302 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 36.3 p -80.27 123.06 27.64 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.831 0.852 . . . . 0.0 110.611 -176.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 100.39 -8.09 58.52 Favored Glycine 0 N--CA 1.468 0.821 0 O-C-N 123.456 0.472 . . . . 0.0 112.696 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 47.2 m -66.57 -69.69 0.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.714 0.806 . . . . 0.0 110.926 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 15.8 t -92.63 103.19 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.6 m -97.92 143.87 28.06 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.963 0.905 . . . . 0.0 110.647 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 28.7 mt -78.16 96.33 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -78.4 -69.66 0.54 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -120.48 154.11 35.7 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.553 ' HB ' HG21 ' A' ' 557' ' ' VAL . 70.4 mt -146.73 143.13 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 168.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.404 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 31.1 t70 -60.63 151.87 27.9 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.47 0.708 . . . . 0.0 110.801 174.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.2 pp -55.54 -29.82 59.62 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.789 1.236 . . . . 0.0 113.771 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -118.58 10.37 12.53 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.388 1.075 . . . . 0.0 111.252 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.19 42.7 90.98 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.901 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -78.69 -7.12 57.39 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 36.1 p90 -157.85 147.07 19.66 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 124.419 1.088 . . . . 0.0 109.956 170.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 76.1 t -120.36 122.96 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.436 ' OE1' ' HB3' ' A' ' 508' ' ' MET . 0.1 OUTLIER -103.92 114.13 28.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.122 1.369 . . . . 0.0 108.603 -174.575 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 65.4 mt -107.68 161.73 14.61 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.08 1.352 . . . . 0.0 109.91 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -150.13 132.51 15.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.961 0.504 . . . . 0.0 109.754 -176.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -85.35 131.92 34.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.281 0.632 . . . . 0.0 110.686 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -112.25 -0.14 15.58 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.016 1.327 . . . . 0.0 110.775 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 49.1 m -63.9 147.61 51.5 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.794 0.438 . . . . 0.0 110.654 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -69.62 -11.15 60.61 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.033 0.933 . . . . 0.0 111.778 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.2 OUTLIER -134.69 176.23 8.83 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 125.272 1.429 . . . . 0.0 108.82 -177.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.69 114.8 5.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.526 0.73 . . . . 0.0 109.508 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -74.87 108.34 7.54 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.657 0.783 . . . . 0.0 110.0 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.439 ' HA ' HG12 ' A' ' 502' ' ' ILE . 29.1 p -63.78 104.88 0.73 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 7.6 tp -93.81 -176.59 4.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.89 0.876 . . . . 0.0 109.208 -173.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 134.3 -66.5 0.57 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 112.549 -0.221 . . . . 0.0 112.549 172.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.92 -11.63 59.13 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.372 0.669 . . . . 0.0 111.679 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -67.59 141.79 56.68 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.971 0.908 . . . . 0.0 109.387 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -143.31 131.59 22.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.102 0.561 . . . . 0.0 110.701 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 45.0 mt -88.13 110.33 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.024 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.49 ' HE2' HG21 ' A' ' 545' ' ' VAL . 64.7 mttm -82.67 150.42 26.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.442 0.697 . . . . 0.0 109.202 166.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -144.59 104.87 4.09 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -99.16 108.57 21.21 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.451 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 30.0 t -83.61 160.42 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 124.316 1.046 . . . . 0.0 110.796 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 539' ' ' SER . 4.6 pp -51.3 -26.91 8.19 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.947 1.299 . . . . 0.0 113.614 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -77.65 -10.42 59.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.981 0.913 . . . . 0.0 111.42 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 90.78 1.91 72.99 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -79.92 148.18 31.35 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.077 0.951 . . . . 0.0 109.303 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.87 157.01 47.3 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.036 0.446 . . . . 0.0 110.111 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 30.4 pt -136.75 163.82 32.08 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 C-N-CA 124.493 1.117 . . . . 0.0 108.384 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -136.47 105.67 6.01 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.313 0.645 . . . . 0.0 109.673 172.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -81.62 142.38 32.82 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -131.43 144.41 51.16 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.187 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -84.38 163.14 19.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.739 0.815 . . . . 0.0 110.802 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 59.5 p -79.68 132.4 61.52 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.886 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.533 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 35.2 Cg_endo -61.1 -16.96 49.3 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.172 2.581 . . . . 0.0 113.533 -175.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -86.57 -20.52 27.82 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.75 0.82 . . . . 0.0 111.855 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -66.04 136.9 56.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.132 0.573 . . . . 0.0 110.153 -177.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 477' ' ' SER . 52.0 mt -131.18 121.86 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.836 0.854 . . . . 0.0 108.976 174.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.71 130.91 34.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -81.32 155.14 26.15 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.159 0.583 . . . . 0.0 110.898 -175.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -61.64 117.65 6.06 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.853 0.861 . . . . 0.0 111.177 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 88.51 -22.38 20.8 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.368 0.417 . . . . 0.0 113.612 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -75.79 173.72 10.77 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.402 0.681 . . . . 0.0 111.242 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' MET . . . . . 0.436 ' HB3' ' OE1' ' A' ' 467' ' ' GLN . 37.2 mtm -124.62 172.46 9.23 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.482 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.18 127.09 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 5.2 m -121.73 113.84 20.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.045 0.538 . . . . 0.0 109.58 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.85 99.11 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.271 0.628 . . . . 0.0 109.974 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -79.85 176.65 9.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.65 1.18 . . . . 0.0 111.754 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -99.16 156.46 16.95 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.23 1.012 . . . . 0.0 110.633 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -62.26 -36.59 82.51 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.541 0.736 . . . . 0.0 111.207 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' GLY . . . . . 0.429 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -88.48 10.16 72.79 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.515 -177.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -80.91 -17.07 51.81 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.294 0.637 . . . . 0.0 110.729 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 71.48 18.87 77.34 Favored Glycine 0 C--N 1.357 1.737 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.511 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.92 149.58 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.461 1.105 . . . . 0.0 110.458 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -77.63 130.46 36.89 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.604 0.762 . . . . 0.0 110.618 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -67.45 113.08 5.01 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 10.9 m -125.41 69.68 61.94 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 123.492 0.717 . . . . 0.0 109.827 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.79 150.72 68.39 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.217 1.945 . . . . 0.0 111.628 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.42 -8.01 49.85 Favored 'Cis proline' 0 C--N 1.371 1.749 0 N-CA-C 114.507 0.926 . . . . 0.0 114.507 3.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.2 m -67.14 -60.53 2.53 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.475 0.71 . . . . 0.0 111.466 -173.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 90.6 m -105.19 93.58 4.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.93 0.892 . . . . 0.0 109.198 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 73.0 mt -81.71 143.69 31.68 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 82.1 t -126.04 131.16 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -74.93 95.06 2.91 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -65.2 124.48 22.29 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.793 0.837 . . . . 0.0 110.698 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 94.41 -27.27 14.18 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.799 0.687 . . . . 0.0 114.129 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.54 99.28 9.09 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 532' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 29.3 p -85.15 -34.07 22.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.126 0.97 . . . . 0.0 113.165 -167.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' ' 536' ' ' THR . 87.1 p -75.47 -28.39 59.22 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.635 0.374 . . . . 0.0 111.3 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 58.77 32.23 22.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.896 1.279 . . . . 0.0 108.917 -169.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 70.36 76.81 0.51 Allowed Glycine 0 C--N 1.358 1.798 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -172.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 533' ' ' SER . 9.6 t -52.23 143.03 15.38 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.408 1.083 . . . . 0.0 113.431 -167.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 158.61 131.74 1.31 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -84.21 -15.78 45.71 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.1 0.56 . . . . 0.0 111.216 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.536 ' HB2' HD23 ' A' ' 488' ' ' LEU . 17.9 m -137.71 132.48 32.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.237 0.615 . . . . 0.0 109.772 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.451 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 30.8 p90 -168.19 176.7 5.85 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.699 1.2 . . . . 0.0 110.308 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 0.0 OUTLIER -128.91 114.59 16.67 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.191 0.997 . . . . 0.0 108.82 169.024 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 83.6 m -86.61 125.42 33.81 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.075 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.527 HG22 ' HG3' ' A' ' 554' ' ' MET . 43.8 t -115.44 117.83 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.14 0.976 . . . . 0.0 108.679 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 24.9 tp -88.63 132.28 34.62 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.49 HG21 ' HE2' ' A' ' 484' ' ' LYS . 50.9 t -115.51 142.99 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 124.838 1.255 . . . . 0.0 108.122 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -96.99 -167.24 1.51 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.877 0.471 . . . . 0.0 111.338 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.04 -37.03 83.4 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -75.4 -0.98 21.8 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.31 15.85 80.39 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 123.258 0.348 . . . . 0.0 113.67 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -97.45 149.75 21.81 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.281 0.632 . . . . 0.0 109.298 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.78 90.21 3.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.165 0.986 . . . . 0.0 109.296 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.15 -32.99 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.431 -173.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -142.66 157.63 44.49 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.459 0.703 . . . . 0.0 110.245 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.527 ' HG3' HG22 ' A' ' 543' ' ' VAL . 26.1 ttt -157.44 146.4 19.77 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.98 0.912 . . . . 0.0 109.334 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -159.83 117.88 2.69 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.701 0.401 . . . . 0.0 110.956 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 87.4 m -88.73 116.51 27.05 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.611 0.764 . . . . 0.0 110.359 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.553 HG21 ' HB ' ' A' ' 459' ' ' ILE . 81.1 t -102.37 131.91 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.523 1.129 . . . . 0.0 109.628 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 558' ' ' LYS . . . . . 0.425 ' HD2' ' HB3' ' A' ' 539' ' ' SER . 13.3 mmmm -131.28 117.84 19.54 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.015 1.326 . . . . 0.0 107.868 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -67.36 96.42 0.5 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.55 0.613 . . . . 0.0 109.423 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 19.1 m -114.55 86.47 2.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 51.8 p -147.31 124.04 11.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.319 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 10.4 p -78.68 -8.89 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.362 0.665 . . . . 0.0 110.311 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 65.7 mtt -52.33 126.24 18.49 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 124.184 0.994 . . . . 0.0 110.635 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -67.27 159.24 29.62 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 124.053 0.845 . . . . 0.0 110.368 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.11 97.45 0.09 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.413 0.625 . . . . 0.0 112.12 -174.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -121.89 75.33 1.2 Allowed 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -47.16 -57.23 5.35 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.664 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 56.37 83.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.471 1.108 . . . . 0.0 110.742 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.962 0 CA-C-O 119.091 -0.838 . . . . 0.0 111.914 -179.408 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 N--CA 1.476 0.844 0 CA-C-O 120.528 0.204 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -65.08 89.33 0.08 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.83 0.852 . . . . 0.0 110.462 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 44.5 m -78.23 81.0 4.62 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.266 1.027 . . . . 0.0 111.265 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' GLY . . . . . 0.496 ' H ' ' HB ' ' A' ' 552' ' ' VAL . . . 73.4 27.68 67.35 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.712 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 53.5 m -56.75 -48.61 77.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.425 0.69 . . . . 0.0 110.581 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' VAL . . . . . 0.507 HG21 HD21 ' A' ' 478' ' ' LEU . 17.9 t -93.24 107.77 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 165.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 80.6 p -88.54 160.59 17.39 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.336 0.654 . . . . 0.0 110.006 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.45 HG13 ' HB1' ' A' ' 553' ' ' ALA . 48.5 mt -81.53 96.3 3.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 170.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.629 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 14.6 tp10 -68.41 -55.91 10.3 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.494 -171.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.629 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.0 mt-10 -142.0 154.03 44.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.904 0.882 . . . . 0.0 108.896 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.563 ' HB ' HG21 ' A' ' 557' ' ' VAL . 56.2 mt -136.0 135.28 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.62 141.4 57.82 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 123.358 0.411 . . . . 0.0 110.131 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.82 -39.41 94.23 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.665 0.603 . . . . 0.0 110.895 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 559' ' ' LYS . 27.9 mt-10 -74.71 -33.47 62.42 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.33 33.35 6.89 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.064 -0.971 . . . . 0.0 113.109 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -84.19 -15.52 46.69 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.173 0.589 . . . . 0.0 110.46 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -157.89 161.05 38.24 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 123.236 0.614 . . . . 0.0 110.773 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' VAL . . . . . 0.419 HG21 ' HD2' ' A' ' 485' ' ' ARG . 89.2 t -133.6 121.28 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.674 1.19 . . . . 0.0 108.356 174.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 23.0 tp60 -92.37 119.76 32.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.087 0.955 . . . . 0.0 109.718 174.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 69.1 mt -108.85 153.18 23.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.146 0.979 . . . . 0.0 108.716 169.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -147.5 144.52 28.61 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.843 0.457 . . . . 0.0 111.115 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.624 ' HB2' HD12 ' A' ' 503' ' ' LEU . 52.7 t30 -89.53 126.9 35.78 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 174.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -99.01 -17.72 18.14 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.912 0.885 . . . . 0.0 110.097 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' SER . . . . . 0.555 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 28.8 m -79.29 155.96 28.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.968 0.907 . . . . 0.0 112.49 -173.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.1 -37.42 66.73 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.755 0.822 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.555 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.1 OUTLIER -78.7 148.37 33.11 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.098 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.81 140.72 56.63 Favored 'General case' 0 C--O 1.244 0.767 0 O-C-N 123.776 0.673 . . . . 0.0 109.392 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.424 ' HG3' HG23 ' A' ' 454' ' ' VAL . 0.0 OUTLIER -112.18 111.44 22.33 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 39.9 m -75.98 122.98 24.99 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.613 0.765 . . . . 0.0 110.624 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 454' ' ' VAL . 95.6 mt -98.02 167.03 11.15 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.495 0.718 . . . . 0.0 109.932 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 143.48 -53.27 0.6 Allowed Glycine 0 N--CA 1.466 0.691 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -81.32 -12.19 59.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.324 1.049 . . . . 0.0 110.239 175.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -83.84 139.83 32.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.663 0.785 . . . . 0.0 109.762 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -130.5 145.53 51.87 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.603 0.761 . . . . 0.0 110.576 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 34.8 mt -106.7 95.19 3.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -78.66 129.65 34.97 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 124.052 0.941 . . . . 0.0 109.172 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' ARG . . . . . 0.419 ' HD2' HG21 ' A' ' 466' ' ' VAL . 74.4 mtp85 -135.04 93.35 2.99 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -94.09 102.73 14.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.944 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.503 HG12 HD23 ' A' ' 488' ' ' LEU . 39.2 t -76.34 151.58 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.032 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.503 HD23 HG12 ' A' ' 487' ' ' VAL . 2.5 pt? -59.5 -20.42 55.23 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.424 0.69 . . . . 0.0 112.743 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -73.17 -11.49 60.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.616 1.167 . . . . 0.0 112.69 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 109.31 -16.83 31.96 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-N 116.352 -0.385 . . . . 0.0 112.916 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.57 103.07 0.79 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.753 0.821 . . . . 0.0 111.448 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -107.17 119.94 40.75 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.425 HG21 ' NE2' ' A' ' 531' ' ' GLN . 31.6 pt -130.92 146.4 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.743 0.817 . . . . 0.0 109.601 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -129.35 109.01 10.75 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.89 0.476 . . . . 0.0 110.066 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -79.83 103.18 9.55 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -85.05 134.11 34.22 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.161 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -72.73 164.44 26.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.196 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.3 p -80.19 135.68 54.2 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.406 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 54.1 Cg_endo -66.81 -9.69 25.59 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.668 2.246 . . . . 0.0 113.799 -174.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -92.44 -9.66 40.75 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.404 0.681 . . . . 0.0 111.629 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -87.92 119.11 27.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.778 0.431 . . . . 0.0 109.895 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 40.3 mt -108.02 129.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 470' ' ' ASN . 0.9 OUTLIER -84.87 117.06 23.67 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.195 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -76.03 148.79 37.77 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.309 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.75 118.24 9.33 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.385 0.674 . . . . 0.0 110.685 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 103.35 -23.34 33.43 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.287 0.367 . . . . 0.0 112.552 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -88.02 -178.76 6.06 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.637 0.775 . . . . 0.0 111.368 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -157.57 146.28 19.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.808 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' VAL . . . . . 0.423 HG23 HD13 ' A' ' 526' ' ' LEU . 7.2 p -109.6 127.89 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.848 0.859 . . . . 0.0 109.342 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 2.7 m -111.47 105.88 14.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 47.7 t -93.19 112.26 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 512' ' ' TRP . . . . . 0.498 ' HB2' HG22 ' A' ' 527' ' ' VAL . 46.9 m95 -98.41 173.46 6.95 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.041 0.936 . . . . 0.0 111.522 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 516' ' ' ALA . . . -84.07 148.5 26.8 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.452 172.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.7 86.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.486 0.66 . . . . 0.0 110.316 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -88.56 14.3 60.13 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.879 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . . . -84.78 -11.46 55.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.449 0.7 . . . . 0.0 111.47 176.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.69 23.23 77.96 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.109 0.403 . . . . 0.0 114.109 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 11.5 p -98.45 149.82 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.3 1.04 . . . . 0.0 109.98 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.23 122.21 26.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.09 0.556 . . . . 0.0 110.41 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -65.31 110.12 2.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.067 0.547 . . . . 0.0 109.778 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 17.3 m -132.99 78.01 66.68 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.363 0.665 . . . . 0.0 110.626 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.46 154.9 50.38 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.749 2.299 . . . . 0.0 112.834 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -92.06 4.19 63.3 Favored 'Cis proline' 0 C--N 1.376 2.021 0 CA-C-N 119.841 0.979 . . . . 0.0 113.517 3.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.0 m -84.96 -58.17 2.8 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.781 0.432 . . . . 0.0 110.497 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 38.9 m -97.53 89.56 4.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.062 0.545 . . . . 0.0 109.872 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 10.8 mp -86.17 138.64 31.75 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 512' ' ' TRP . 86.9 t -125.54 128.56 72.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -72.96 88.97 1.39 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -64.04 112.41 2.96 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.508 -1.223 . . . . 0.0 108.702 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 122.89 -38.29 2.56 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 123.458 0.474 . . . . 0.0 112.411 -173.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.425 ' NE2' HG21 ' A' ' 493' ' ' ILE . 28.5 tp60 -86.49 96.61 10.11 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 13.8 p -63.53 -52.53 60.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.198 0.999 . . . . 0.0 112.199 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 536' ' ' THR . 96.0 p -88.78 -30.66 18.85 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 122.839 0.456 . . . . 0.0 111.927 -176.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 513' ' ' ALA . 6.3 t-105 56.57 34.94 25.28 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.402 1.096 . . . . 0.0 110.3 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 69.53 51.6 25.25 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.996 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 533' ' ' SER . 15.9 p -74.65 123.44 24.87 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 170.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -156.35 179.95 31.83 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.485 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -77.14 -38.71 51.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.407 0.622 . . . . 0.0 109.508 176.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.408 ' H ' HD22 ' A' ' 488' ' ' LEU . 19.3 m -147.92 125.85 12.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.562 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -146.29 144.78 30.06 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.777 0.831 . . . . 0.0 109.855 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 41.2 ttm180 -107.37 116.78 32.54 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.79 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 59.0 m -94.04 121.93 36.03 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' A' ' 554' ' ' MET . 59.9 t -124.53 117.93 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.332 1.053 . . . . 0.0 108.837 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 40.3 tp -89.52 111.59 22.54 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 51.6 t -102.02 149.78 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.207 1.003 . . . . 0.0 109.114 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.589 ' ND2' ' H ' ' A' ' 548' ' ' ASP . 1.5 p-10 -111.75 -172.59 2.07 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.969 0.507 . . . . 0.0 111.737 -172.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.6 73.01 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.884 1.274 . . . . 0.0 113.15 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 548' ' ' ASP . . . . . 0.589 ' H ' ' ND2' ' A' ' 546' ' ' ASN . 12.5 t70 -59.8 -40.61 88.91 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.583 0.753 . . . . 0.0 111.127 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.24 -17.76 26.27 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.436 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.16 148.21 50.25 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.101 0.477 . . . . 0.0 110.665 175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.99 99.97 9.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.077 0.951 . . . . 0.0 108.775 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.496 ' HB ' ' H ' ' A' ' 452' ' ' GLY . 27.1 m -85.11 -19.86 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.054 0.542 . . . . 0.0 112.284 -172.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.616 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -147.65 139.76 24.29 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.55 ' HG3' HG22 ' A' ' 543' ' ' VAL . 44.5 ttm -151.12 132.36 14.49 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.628 0.771 . . . . 0.0 109.252 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -157.78 117.62 3.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.264 0.626 . . . . 0.0 109.627 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 8.8 m -103.47 112.34 25.2 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.74 0.816 . . . . 0.0 109.435 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.563 HG21 ' HB ' ' A' ' 459' ' ' ILE . 58.1 t -105.64 122.12 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.503 0.721 . . . . 0.0 110.65 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.97 117.75 35.29 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 462' ' ' GLU . 25.8 ttpp -60.68 94.05 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.132 0.973 . . . . 0.0 110.565 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 42.7 t -84.57 -72.45 0.47 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.513 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 21.0 p -163.84 172.87 13.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.5 0.72 . . . . 0.0 111.042 -170.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.61 24.77 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.091 0.956 . . . . 0.0 110.97 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 63.3 mtm -64.2 -22.77 67.07 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.52 0.728 . . . . 0.0 112.085 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -118.02 159.7 22.75 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.858 0.863 . . . . 0.0 109.493 174.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 69.74 65.95 0.24 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.954 1.301 . . . . 0.0 111.229 168.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -70.4 96.39 1.14 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.351 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.47 -9.51 27.06 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.312 0.645 . . . . 0.0 112.107 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.72 -34.21 30.67 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.935 0.494 . . . . 0.0 110.149 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.147 0 CA-C-O 119.042 -0.865 . . . . 0.0 111.887 176.594 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -141.84 78.01 1.61 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.491 0.716 . . . . 0.0 109.24 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 26.9 p -81.14 84.94 6.41 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.531 -175.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.36 29.4 12.41 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.056 -0.974 . . . . 0.0 113.631 172.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 28.1 m -68.58 -38.76 80.94 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.785 0.326 . . . . 0.0 110.182 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.77 145.05 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.452 1.101 . . . . 0.0 108.208 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 43.9 t -130.55 150.35 51.8 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.378 1.071 . . . . 0.0 109.988 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 459' ' ' ILE . 38.3 mt -84.71 108.86 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -80.71 -72.16 0.43 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.807 0.337 . . . . 0.0 110.824 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -119.25 149.86 41.06 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.993 0.517 . . . . 0.0 109.688 -169.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.47 ' HB ' HG21 ' A' ' 557' ' ' VAL . 80.6 mt -144.56 138.13 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 170.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.424 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 20.1 t70 -59.91 142.04 54.39 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 123.488 0.493 . . . . 0.0 110.74 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.574 HD12 ' HG3' ' A' ' 462' ' ' GLU . 2.3 pp -66.71 -35.16 79.48 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.074 0.859 . . . . 0.0 111.432 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.574 ' HG3' HD12 ' A' ' 461' ' ' LEU . 29.0 mt-10 -75.37 -33.22 61.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.31 0.576 . . . . 0.0 109.687 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.84 52.0 1.86 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.422 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -96.19 -18.43 20.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.254 0.622 . . . . 0.0 111.194 175.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 32.0 p90 -150.85 161.1 43.33 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.067 0.461 . . . . 0.0 112.007 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 49.6 t -126.85 141.24 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.314 1.445 . . . . 0.0 107.493 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.72 104.61 9.72 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.456 HD22 HD22 ' A' ' 544' ' ' LEU . 57.8 mt -94.82 162.02 13.93 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.815 1.246 . . . . 0.0 110.204 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -144.28 130.14 19.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.524 ' HB2' HD12 ' A' ' 503' ' ' LEU . 46.9 t30 -78.29 107.58 11.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.118 0.567 . . . . 0.0 109.951 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -81.29 -5.71 58.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.646 0.779 . . . . 0.0 112.332 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 15.0 m -74.7 137.43 42.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.116 0.566 . . . . 0.0 110.715 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.61 -13.6 61.82 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.23 1.012 . . . . 0.0 110.998 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.0 OUTLIER -110.39 170.57 8.0 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.856 1.262 . . . . 0.0 108.457 172.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.9 145.03 50.43 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -107.88 118.24 36.22 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 41.2 p -71.6 118.27 14.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 171.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.3 mt -98.78 169.58 9.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 128.78 -56.51 0.74 Allowed Glycine 0 CA--C 1.492 -1.406 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -74.14 -13.16 60.78 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.886 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -82.16 149.49 27.92 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.566 1.147 . . . . 0.0 110.288 170.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -149.56 145.45 26.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.62 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 10.2 mt -107.25 106.19 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.732 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 62.1 mttm -75.87 159.79 30.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.112 0.565 . . . . 0.0 109.832 175.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 485' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 542' ' ' THR . 42.8 ttm180 -152.92 100.2 2.48 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -88.58 102.45 14.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.098 0.959 . . . . 0.0 108.575 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 489' ' ' GLU . 22.0 t -88.21 127.8 40.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.5 pp -65.79 -16.39 63.76 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.539 0.736 . . . . 0.0 112.468 -176.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 489' ' ' GLU . . . . . 0.424 ' H ' HG12 ' A' ' 487' ' ' VAL . 47.8 mt-10 -73.59 -0.45 15.32 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.866 0.867 . . . . 0.0 111.761 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 106.15 27.45 5.61 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 166.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -132.06 101.12 5.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.168 0.587 . . . . 0.0 110.207 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -106.34 121.96 45.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.89 179.57 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.149 0.98 . . . . 0.0 110.18 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -161.32 118.06 2.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.8 0.84 . . . . 0.0 110.064 172.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -79.18 117.48 20.24 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.548 0.739 . . . . 0.0 109.324 172.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.01 141.71 31.88 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -84.63 169.13 14.66 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 166.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.6 p -91.7 130.2 39.76 Favored Pre-proline 0 CA--C 1.556 1.186 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.475 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 32.4 Cg_exo -60.3 -20.42 62.55 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.249 2.633 . . . . 0.0 114.023 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -72.61 -22.35 60.98 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.66 0.784 . . . . 0.0 111.855 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -83.81 123.78 30.25 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.717 0.807 . . . . 0.0 110.447 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 54.1 mt -116.41 132.92 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 168.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 470' ' ' ASN . 2.4 tm? -93.96 138.32 32.2 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.55 161.88 29.32 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -57.99 120.07 7.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.925 1.29 . . . . 0.0 112.428 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 66.87 14.74 63.64 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -97.16 -163.56 1.06 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.236 0.614 . . . . 0.0 109.851 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 19.3 ptp -146.06 164.08 33.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.783 0.833 . . . . 0.0 110.835 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.0 p -143.93 124.68 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.099 0.96 . . . . 0.0 109.152 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 4.0 m -114.51 110.05 19.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.827 0.851 . . . . 0.0 109.591 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.415 HG12 ' HE1' ' A' ' 534' ' ' TRP . 41.0 t -96.71 102.07 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.266 0.626 . . . . 0.0 109.861 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -83.69 175.25 9.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.622 1.169 . . . . 0.0 111.457 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -97.05 158.48 15.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.985 0.914 . . . . 0.0 110.195 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -65.05 -25.23 67.74 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.211 0.604 . . . . 0.0 111.865 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -111.45 21.12 22.17 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.755 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -79.97 -1.0 37.59 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.25 0.62 . . . . 0.0 110.814 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 74.4 38.22 45.72 Favored Glycine 0 C--N 1.358 1.8 0 O-C-N 123.285 0.366 . . . . 0.0 112.379 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.78 148.48 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.135 0.974 . . . . 0.0 110.149 -171.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -91.66 160.45 15.36 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.606 0.762 . . . . 0.0 110.139 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -79.99 122.86 27.25 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 39.0 m -133.18 80.68 58.56 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.692 0.797 . . . . 0.0 109.111 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.94 154.37 58.16 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.739 2.293 . . . . 0.0 112.48 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.54 -18.38 24.04 Favored 'Cis proline' 0 C--N 1.378 2.119 0 C-N-CA 124.787 -0.922 . . . . 0.0 113.741 1.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.2 m -64.98 -52.36 56.65 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.573 0.749 . . . . 0.0 111.708 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 32.6 m -104.01 91.09 3.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 55.6 mt -83.15 148.31 27.55 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.4 127.81 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.417 0.687 . . . . 0.0 109.23 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -70.76 88.07 0.71 Allowed 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -71.93 131.47 43.01 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.714 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 107.51 -36.49 4.35 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.281 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -113.17 112.05 23.12 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.275 0.559 . . . . 0.0 110.703 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 532' ' ' SER . . . . . 0.446 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 22.6 p -85.39 -21.61 28.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.677 1.191 . . . . 0.0 112.702 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.5 t -87.48 -32.95 19.19 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -170.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.415 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 53.35 22.84 2.97 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 124.056 0.942 . . . . 0.0 110.932 -168.012 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.79 60.98 6.61 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -171.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 15.1 t -64.76 149.79 48.61 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.568 0.747 . . . . 0.0 110.25 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -163.12 162.15 34.51 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 116.405 -0.361 . . . . 0.0 112.22 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -76.13 -34.96 59.45 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.975 0.91 . . . . 0.0 109.167 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.431 ' HB2' HD21 ' A' ' 488' ' ' LEU . 50.5 m -150.04 142.26 24.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.674 1.19 . . . . 0.0 108.71 170.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -164.22 -179.8 6.36 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.482 1.113 . . . . 0.0 109.631 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -140.0 125.71 19.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.497 0.665 . . . . 0.0 110.078 170.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 485' ' ' ARG . 24.1 m -101.87 120.86 41.05 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.765 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.732 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 57.4 t -103.62 148.39 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.32 1.048 . . . . 0.0 109.365 -177.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 43.7 tp -110.42 136.19 49.96 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.34 150.02 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.735 1.214 . . . . 0.0 108.348 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.99 -170.94 1.93 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.864 0.866 . . . . 0.0 112.134 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -61.3 -26.34 67.72 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.072 0.949 . . . . 0.0 112.91 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.67 -37.49 84.89 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.086 0.554 . . . . 0.0 110.842 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 100.07 5.03 55.14 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.189 -172.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -88.06 149.54 23.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.309 0.643 . . . . 0.0 110.012 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.03 95.32 6.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.596 0.758 . . . . 0.0 108.96 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.75 -28.91 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.771 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -149.99 160.9 43.26 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.618 0.367 . . . . 0.0 110.639 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 50.6 ttp -158.67 143.44 16.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.792 0.837 . . . . 0.0 109.272 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -142.21 108.66 5.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.029 0.931 . . . . 0.0 109.172 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 42.2 m -82.34 109.48 16.63 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.488 0.715 . . . . 0.0 109.489 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 459' ' ' ILE . 57.3 t -109.22 132.31 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.222 1.009 . . . . 0.0 110.161 -175.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 558' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 558' ' ' LYS . 0.0 OUTLIER -132.67 118.4 19.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.603 1.161 . . . . 0.0 108.627 -177.38 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 461' ' ' LEU . 33.3 tttm -69.56 90.53 0.56 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.861 1.264 . . . . 0.0 109.883 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 29.4 m -111.54 -40.86 4.23 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.963 0.905 . . . . 0.0 109.598 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 40.9 m 63.91 107.11 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.805 1.242 . . . . 0.0 113.333 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.59 -24.5 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.687 0.795 . . . . 0.0 110.804 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -66.87 136.84 56.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.512 0.725 . . . . 0.0 110.436 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -94.23 172.22 8.35 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.258 0.623 . . . . 0.0 110.702 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -79.02 100.11 7.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.841 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -156.38 31.46 0.33 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.01 0.924 . . . . 0.0 109.888 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -81.74 -35.3 29.84 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.808 0.843 . . . . 0.0 111.567 -175.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 63.35 95.23 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.814 1.246 . . . . 0.0 111.199 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.281 0 CA-C-O 118.995 -0.891 . . . . 0.0 112.263 177.937 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -161.66 90.53 0.79 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 26.1 t -75.16 85.89 2.39 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.868 0.867 . . . . 0.0 111.299 -172.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' A' ' 552' ' ' VAL . . . 74.05 26.51 68.57 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.41 -0.813 . . . . 0.0 114.226 175.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 41.5 m -57.03 -52.58 64.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.125 0.57 . . . . 0.0 110.922 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 43.0 t -99.61 121.56 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 16.9 m -108.78 143.66 37.63 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.306 1.042 . . . . 0.0 109.581 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 459' ' ' ILE . 55.5 mt -77.43 130.32 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' A' ' 469' ' ' LYS . 36.1 mm-40 -81.01 -74.19 0.34 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.65 0.262 . . . . 0.0 110.649 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -128.25 155.32 44.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.753 0.821 . . . . 0.0 109.916 -171.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.463 ' HB ' HG11 ' A' ' 557' ' ' VAL . 48.4 mm -131.12 141.57 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.635 0.774 . . . . 0.0 109.0 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.66 153.86 31.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.246 1.018 . . . . 0.0 111.398 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 461' ' ' LEU . 2.2 pt? -109.31 0.31 19.48 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.156 0.582 . . . . 0.0 110.251 166.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -120.83 0.82 10.4 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.137 0.975 . . . . 0.0 112.544 -171.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 73.58 45.87 27.28 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 123.073 0.233 . . . . 0.0 113.597 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -108.31 -50.49 3.03 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.39 0.676 . . . . 0.0 111.295 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -164.59 152.08 11.68 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' VAL . . . . . 0.417 HG11 HD13 ' A' ' 483' ' ' ILE . 71.1 t -112.15 112.0 38.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.673 1.189 . . . . 0.0 108.692 173.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.447 ' HG3' ' HB2' ' A' ' 457' ' ' GLU . 57.4 tp60 -87.32 102.19 14.27 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.542 HD22 HD22 ' A' ' 544' ' ' LEU . 81.9 mt -94.95 165.11 12.61 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.432 1.093 . . . . 0.0 110.106 172.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 469' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 508' ' ' MET . 50.9 tttm -149.91 137.7 20.12 Favored 'General case' 0 C--O 1.219 -0.522 0 C-N-CA 123.215 0.606 . . . . 0.0 110.207 172.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -88.36 136.61 32.9 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -130.61 9.4 5.05 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.167 0.987 . . . . 0.0 110.133 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 46.5 t -77.87 145.8 36.03 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 123.374 0.669 . . . . 0.0 109.732 170.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -70.2 -25.1 63.26 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.249 1.02 . . . . 0.0 111.648 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 474' ' ' LYS . 32.6 pttt -112.95 166.07 11.75 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.016 0.927 . . . . 0.0 110.834 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -70.53 120.44 16.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.422 0.689 . . . . 0.0 109.963 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -87.62 118.85 27.39 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.645 0.778 . . . . 0.0 109.767 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 54.5 p -70.68 101.83 2.15 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.639 0.776 . . . . 0.0 110.375 176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 17.9 tp -91.16 152.69 20.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.712 0.805 . . . . 0.0 109.62 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.08 -58.62 0.51 Allowed Glycine 0 N--CA 1.472 1.049 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.703 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.36 -11.9 61.2 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.288 0.635 . . . . 0.0 111.075 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' TRP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 546' ' ' ASN . 14.1 m95 -75.14 166.03 24.28 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 124.452 1.101 . . . . 0.0 110.927 170.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -160.7 145.81 14.41 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.975 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 49.7 mt -101.42 107.54 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.158 0.583 . . . . 0.0 109.535 176.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.739 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 60.7 mttm -78.13 159.35 28.68 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 170.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 485' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 534' ' ' TRP . 36.8 ttm180 -158.08 100.37 1.71 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.05 111.56 23.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.284 0.633 . . . . 0.0 109.712 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.459 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 53.1 t -68.87 157.52 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.0 0.92 . . . . 0.0 109.797 174.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.0 pp -52.15 -28.12 16.86 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.232 1.013 . . . . 0.0 112.256 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -69.39 -33.33 72.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.493 1.117 . . . . 0.0 111.383 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 131.61 -21.24 4.52 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.792 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.32 109.59 2.32 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.36 1.064 . . . . 0.0 111.461 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -107.77 117.3 33.75 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.402 0.62 . . . . 0.0 110.804 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 40.2 pt -105.85 142.46 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.923 0.889 . . . . 0.0 109.367 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -125.25 116.36 21.85 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.903 0.481 . . . . 0.0 110.931 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -78.98 106.35 10.96 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -81.48 121.63 26.52 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -73.26 169.16 17.67 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 120.819 0.342 . . . . 0.0 110.794 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 68.9 p -93.27 120.78 66.43 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 123.054 0.542 . . . . 0.0 110.32 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.503 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 34.6 Cg_exo -60.37 -15.56 36.17 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.934 3.089 . . . . 0.0 115.199 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -72.48 -23.51 61.05 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.542 0.737 . . . . 0.0 111.64 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -89.02 142.79 27.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.495 1.118 . . . . 0.0 110.884 -171.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 62.2 mt -129.43 132.96 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.391 0.676 . . . . 0.0 109.213 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' LEU . . . . . 0.648 HD21 ' HB ' ' A' ' 509' ' ' VAL . 0.3 OUTLIER -93.85 134.69 35.95 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.026 0.93 . . . . 0.0 109.025 177.482 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -78.16 156.49 29.85 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.131 0.491 . . . . 0.0 111.682 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.04 126.93 29.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.256 1.022 . . . . 0.0 112.031 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 77.97 -12.34 18.06 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.62 0.575 . . . . 0.0 114.395 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -86.71 159.48 19.15 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.661 0.784 . . . . 0.0 110.232 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' MET . . . . . 0.552 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 23.5 ptt? -108.57 169.69 8.5 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.613 0.765 . . . . 0.0 111.517 -175.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 509' ' ' VAL . . . . . 0.648 ' HB ' HD21 ' A' ' 503' ' ' LEU . 7.4 p -145.95 148.89 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 4.2 m -131.09 105.46 7.72 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 71.5 t -86.02 98.63 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.055 0.455 . . . . 0.0 110.224 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -82.34 176.41 9.47 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.905 0.882 . . . . 0.0 111.3 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -103.64 152.14 22.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.826 0.851 . . . . 0.0 110.128 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.84 -20.06 65.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.874 0.87 . . . . 0.0 112.021 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -103.76 16.63 51.05 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.692 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -90.76 -3.61 57.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.328 0.651 . . . . 0.0 110.713 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.33 33.92 68.71 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 113.995 0.358 . . . . 0.0 113.995 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 12.9 p -130.79 144.25 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 123.412 0.685 . . . . 0.0 110.341 -175.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -81.81 142.9 32.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.57 0.748 . . . . 0.0 111.42 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -61.85 109.33 1.21 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.418 0.687 . . . . 0.0 109.827 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 17.8 m -132.74 80.49 61.35 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.019 0.928 . . . . 0.0 109.556 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.72 160.85 44.46 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.916 2.41 . . . . 0.0 112.175 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -90.31 16.77 43.79 Favored 'Cis proline' 0 C--N 1.381 2.265 0 CA-C-N 119.652 0.911 . . . . 0.0 113.385 3.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.2 m -97.99 -70.88 0.71 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.739 0.815 . . . . 0.0 109.836 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 20.2 m -85.65 86.28 7.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.182 0.593 . . . . 0.0 110.372 -173.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 11.1 mp -91.66 105.19 17.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 171.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 90.3 t -89.46 117.98 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -69.27 91.74 0.54 Allowed 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 529' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 27.7 tptp -75.07 131.03 40.27 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.399 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 104.31 -5.08 44.71 Favored Glycine 0 N--CA 1.472 1.094 0 O-C-N 123.606 0.566 . . . . 0.0 111.988 -172.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -121.95 109.82 15.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.854 0.862 . . . . 0.0 109.179 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 37.2 p -71.72 -61.72 1.68 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.992 0.517 . . . . 0.0 111.21 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 23.7 m -121.16 25.26 9.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.815 0.446 . . . . 0.0 112.108 -167.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.428 ' HB3' ' NH1' ' A' ' 485' ' ' ARG . 0.0 OUTLIER 51.89 30.93 7.69 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.384 1.074 . . . . 0.0 112.541 171.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.88 68.7 1.56 Allowed Glycine 0 C--N 1.352 1.43 0 N-CA-C 112.371 -0.291 . . . . 0.0 112.371 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 2.7 p -64.4 142.57 58.37 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.504 0.722 . . . . 0.0 112.66 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -162.86 169.57 38.1 Favored Glycine 0 C--O 1.242 0.599 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.244 172.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -70.48 -26.78 63.77 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.336 0.568 . . . . 0.0 110.105 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 80.8 p -155.13 142.52 19.55 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.841 0.857 . . . . 0.0 109.35 172.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.459 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 8.0 p90 -155.5 136.67 13.85 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.684 0.794 . . . . 0.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.618 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 34.6 ptt180 -87.93 111.25 21.25 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 23.1 m -94.03 110.73 22.41 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.739 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 21.9 t -102.86 144.93 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.828 1.251 . . . . 0.0 109.606 -174.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.542 HD22 HD22 ' A' ' 468' ' ' LEU . 34.7 tp -112.17 125.47 54.17 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 551' ' ' GLU . 22.0 t -124.33 160.14 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.135 1.374 . . . . 0.0 108.485 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.591 HD21 ' HG2' ' A' ' 550' ' ' GLU . 2.9 p30 -126.35 -174.83 3.21 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.017 0.371 . . . . 0.0 111.577 175.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -50.08 -34.47 21.88 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.432 1.493 . . . . 0.0 113.189 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.64 -33.68 76.5 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.262 1.025 . . . . 0.0 111.929 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 102.97 -12.12 56.02 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.049 -174.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 550' ' ' GLU . . . . . 0.591 ' HG2' HD21 ' A' ' 546' ' ' ASN . 13.2 pt-20 -72.79 139.36 47.01 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.21 0.604 . . . . 0.0 109.384 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.483 ' HG2' HG22 ' A' ' 545' ' ' VAL . 38.5 mt-10 -92.0 93.3 8.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.116 0.966 . . . . 0.0 108.994 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 552' ' ' VAL . . . . . 0.482 ' HB ' ' HA2' ' A' ' 452' ' ' GLY . 18.0 m -71.67 -16.64 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -167.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -159.36 156.28 28.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.067 0.547 . . . . 0.0 110.482 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.59 ' SD ' ' HD2' ' A' ' 541' ' ' ARG . 67.0 ttp -154.94 109.93 3.04 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.25 0.62 . . . . 0.0 110.097 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -104.14 104.19 14.09 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 30.4 m -85.19 99.04 10.83 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.463 HG11 ' HB ' ' A' ' 459' ' ' ILE . 35.1 m -98.96 147.29 7.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 121.621 0.724 . . . . 0.0 110.383 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.48 168.88 9.77 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.08 175.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 461' ' ' LEU . 38.7 ttpt -75.73 86.2 2.75 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 32.1 t -91.61 -8.38 47.44 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.088 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 43.9 m 60.19 98.92 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.483 1.513 . . . . 0.0 110.963 -172.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.04 74.33 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 122.452 1.12 . . . . 0.0 109.568 -174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.02 121.53 23.65 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.382 168.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.47 -167.04 0.22 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.992 0.917 . . . . 0.0 108.957 -168.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 73.37 -59.17 0.57 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.601 1.161 . . . . 0.0 112.657 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -62.83 102.4 0.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.421 0.688 . . . . 0.0 110.041 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.64 -78.43 0.09 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 20.5 t30 62.43 142.11 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.025 1.33 . . . . 0.0 113.085 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.604 -1.109 . . . . 0.0 111.675 178.088 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -75.23 101.72 4.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.285 0.634 . . . . 0.0 110.82 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 18.8 m -81.72 80.66 7.99 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.654 0.74 . . . . 0.0 109.208 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 85.96 -44.62 3.37 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.424 -170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 32.0 p -174.68 -52.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.73 1.212 . . . . 0.0 108.939 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 544' ' ' LEU . 4.1 t -95.55 163.74 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.357 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 21.1 t -155.69 150.66 26.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.566 0.746 . . . . 0.0 109.671 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' ILE . . . . . 0.413 ' HA ' HD12 ' A' ' 468' ' ' LEU . 31.7 mt -77.7 102.41 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.286 0.634 . . . . 0.0 109.863 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.486 ' HG2' ' HG3' ' A' ' 458' ' ' GLU . 42.0 tt0 -81.18 -57.49 3.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.353 0.261 . . . . 0.0 111.602 -170.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.486 ' HG3' ' HG2' ' A' ' 457' ' ' GLU . 29.4 mt-10 -137.88 153.36 49.57 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.256 0.622 . . . . 0.0 109.394 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.0 mt -151.84 138.18 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.61 148.84 38.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.453 HD12 ' HG3' ' A' ' 462' ' ' GLU . 3.5 pp -74.38 -16.51 60.89 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -169.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.453 ' HG3' HD12 ' A' ' 461' ' ' LEU . 2.7 mt-10 -82.02 -31.91 30.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.199 0.6 . . . . 0.0 110.427 174.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 86.97 51.63 3.33 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.986 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -97.1 -19.48 18.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.54 0.736 . . . . 0.0 110.867 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -154.35 163.52 40.03 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.935 0.494 . . . . 0.0 111.872 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' VAL . . . . . 0.402 HG11 HG21 ' A' ' 483' ' ' ILE . 79.2 t -126.37 117.65 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.017 1.327 . . . . 0.0 108.164 170.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.7 tp60 -88.06 113.35 23.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.989 0.916 . . . . 0.0 109.039 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.55 HD22 HD11 ' A' ' 483' ' ' ILE . 22.6 tp -120.21 116.69 26.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.137 0.975 . . . . 0.0 109.495 -172.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 469' ' ' LYS . . . . . 0.411 ' HG2' ' HB3' ' A' ' 508' ' ' MET . 1.8 tmmm? -114.03 130.52 56.55 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.992 0.36 . . . . 0.0 110.368 -169.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -82.62 115.32 21.52 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.436 0.694 . . . . 0.0 109.84 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -85.49 -15.76 41.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.911 0.884 . . . . 0.0 112.033 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' SER . . . . . 0.545 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 69.8 m -65.57 156.45 32.64 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.57 2.36 33.53 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.832 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.545 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.1 OUTLIER -135.38 168.49 19.1 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.24 1.016 . . . . 0.0 108.822 173.352 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 475' ' ' ASP . . . . . 0.402 ' HB3' HG22 ' A' ' 502' ' ' ILE . 24.1 m-20 -73.59 122.05 21.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.428 0.691 . . . . 0.0 109.475 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -83.36 123.02 29.23 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.497 0.719 . . . . 0.0 110.204 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 30.2 p -71.01 106.67 3.76 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.1 mp -91.09 -179.81 5.54 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 0.0 109.97 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 133.28 -67.23 0.56 Allowed Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.64 -11.5 60.2 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.499 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 33.1 m95 -69.84 145.4 52.11 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -149.47 136.27 19.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.882 0.473 . . . . 0.0 111.123 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' ILE . . . . . 0.55 HD11 HD22 ' A' ' 468' ' ' LEU . 57.8 mt -97.41 107.28 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.619 0.768 . . . . 0.0 109.472 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 545' ' ' VAL . 68.0 mttm -78.86 148.17 32.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.363 0.665 . . . . 0.0 110.531 172.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 485' ' ' ARG . . . . . 0.432 ' NH2' ' HB3' ' A' ' 534' ' ' TRP . 20.6 mtm180 -140.49 123.3 16.38 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 486' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 491' ' ' GLU . 51.2 tt0 -116.98 114.06 23.27 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.417 0.687 . . . . 0.0 109.83 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.453 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 13.4 t -84.72 159.31 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.792 1.237 . . . . 0.0 110.645 -177.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.2 -22.87 61.69 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.959 0.904 . . . . 0.0 111.98 173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.57 -22.14 66.13 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.585 1.154 . . . . 0.0 112.407 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 99.86 1.96 56.19 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.339 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 486' ' ' GLN . 42.1 mt-10 -72.95 122.05 21.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.596 0.758 . . . . 0.0 110.073 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.81 112.56 13.71 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 22.0 pt -132.17 170.09 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.236 1.014 . . . . 0.0 109.629 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -150.22 127.32 11.23 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.893 0.477 . . . . 0.0 110.681 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -80.29 108.98 14.34 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 169.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -84.73 128.3 34.54 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -70.45 169.14 14.67 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.645 0.736 . . . . 0.0 111.327 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 65.9 p -87.36 132.34 41.45 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.871 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.481 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 26.8 Cg_endo -58.78 -21.41 56.58 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.094 2.529 . . . . 0.0 113.302 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -72.31 -25.42 61.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.193 0.597 . . . . 0.0 111.903 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -75.78 126.19 30.52 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 122.825 0.45 . . . . 0.0 110.189 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' ILE . . . . . 0.402 HG22 ' HB3' ' A' ' 475' ' ' ASP . 41.5 mt -122.55 113.9 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.25 120.14 21.88 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -69.75 160.89 30.85 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.9 119.08 10.67 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.166 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.6 6.09 65.55 Favored Glycine 0 C--N 1.343 0.925 0 O-C-N 123.585 0.553 . . . . 0.0 113.666 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -101.59 177.97 4.77 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.642 0.777 . . . . 0.0 109.677 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' MET . . . . . 0.411 ' HB3' ' HG2' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -139.92 162.53 34.96 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.537 0.684 . . . . 0.0 112.039 -175.158 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 509' ' ' VAL . . . . . 0.518 HG23 HD13 ' A' ' 526' ' ' LEU . 6.3 p -123.79 117.49 51.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 125.201 1.401 . . . . 0.0 107.926 176.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 7.8 m -96.48 95.02 7.73 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.89 97.42 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.927 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -79.71 171.74 14.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.635 0.774 . . . . 0.0 110.819 171.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -91.91 165.0 13.45 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.676 0.791 . . . . 0.0 110.109 173.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 514' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -63.51 -34.2 77.26 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.102 0.477 . . . . 0.0 110.379 171.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 515' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -89.41 20.65 33.0 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.305 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -85.07 -24.43 28.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.315 0.646 . . . . 0.0 110.554 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 71.05 35.76 64.47 Favored Glycine 0 C--N 1.35 1.322 0 O-C-N 123.872 0.733 . . . . 0.0 112.917 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 8.6 p -114.44 143.77 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.014 0.926 . . . . 0.0 110.276 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -72.79 123.23 22.94 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.284 0.634 . . . . 0.0 110.227 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -63.92 110.69 2.19 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.425 0.69 . . . . 0.0 110.473 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.8 m -132.24 72.26 78.84 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.063 0.545 . . . . 0.0 110.909 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.93 159.4 53.09 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.739 2.292 . . . . 0.0 112.352 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.23 0.94 50.48 Favored 'Cis proline' 0 C--N 1.382 2.32 0 CA-C-N 120.141 1.086 . . . . 0.0 114.077 -0.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 32.9 t -74.78 -63.22 1.3 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.415 0.686 . . . . 0.0 111.08 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 27.5 m -104.19 98.58 8.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.108 0.963 . . . . 0.0 110.265 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.518 HD13 HG23 ' A' ' 509' ' ' VAL . 11.2 mp -93.64 146.86 23.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 81.9 t -129.82 117.27 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -73.47 89.34 1.65 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 529' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 27.3 tptp -75.77 123.27 25.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.386 177.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 120.75 -24.26 7.59 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -173.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -121.5 109.61 15.04 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 532' ' ' SER . . . . . 0.446 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 32.9 p -82.53 -34.94 27.69 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.853 0.461 . . . . 0.0 111.634 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 536' ' ' THR . 23.6 m -90.28 -29.74 17.95 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.189 0.596 . . . . 0.0 112.167 -174.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.674 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 59.74 22.26 11.08 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 123.224 0.61 . . . . 0.0 109.401 -173.535 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.99 69.08 1.46 Allowed Glycine 0 C--N 1.345 1.037 0 O-C-N 121.653 -0.654 . . . . 0.0 111.949 -171.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 533' ' ' SER . 8.1 p -71.82 159.92 33.47 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.612 0.765 . . . . 0.0 110.231 172.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 172.72 176.43 41.35 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.404 -0.362 . . . . 0.0 113.038 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -84.07 -26.96 28.62 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.756 0.422 . . . . 0.0 110.073 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 66.9 m -152.24 128.23 10.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.531 1.132 . . . . 0.0 108.743 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.453 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 6.8 p90 -154.48 122.47 5.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.96 0.904 . . . . 0.0 110.091 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.621 ' HD3' ' H ' ' A' ' 541' ' ' ARG . 0.0 OUTLIER -86.27 123.39 31.47 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.423 0.63 . . . . 0.0 109.727 -178.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 542' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 485' ' ' ARG . 39.3 m -94.31 140.17 30.13 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.252 1.021 . . . . 0.0 109.506 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 99.9 t -132.93 130.9 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.482 1.113 . . . . 0.0 109.279 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.603 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 53.1 tp -93.96 129.48 40.41 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.459 HG21 ' HE2' ' A' ' 484' ' ' LYS . 81.4 t -118.13 143.73 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.754 1.222 . . . . 0.0 108.226 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.546 HD21 ' HG2' ' A' ' 550' ' ' GLU . 2.0 p30 -103.0 -173.54 2.34 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.514 0.326 . . . . 0.0 111.155 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -64.17 -22.97 67.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.803 0.841 . . . . 0.0 113.234 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -65.24 -39.46 92.72 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.162 0.506 . . . . 0.0 110.453 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.37 -11.26 33.44 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.398 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 550' ' ' GLU . . . . . 0.546 ' HG2' HD21 ' A' ' 546' ' ' ASN . 16.3 pt-20 -80.39 153.87 28.05 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 117.259 0.53 . . . . 0.0 110.549 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -88.65 104.6 17.01 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.673 1.189 . . . . 0.0 110.171 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.74 -29.47 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.566 0.746 . . . . 0.0 112.813 -170.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -139.12 161.11 38.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.072 0.549 . . . . 0.0 110.137 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.431 ' HG3' HG22 ' A' ' 543' ' ' VAL . 40.7 ttp -159.27 108.25 1.86 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.33 0.652 . . . . 0.0 109.795 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -119.46 123.63 44.52 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.755 0.822 . . . . 0.0 109.207 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 26.7 m -79.12 134.0 36.73 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.54 139.9 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -161.53 146.34 13.33 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 122.916 0.486 . . . . 0.0 111.074 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.577 ' HG3' ' SD ' ' A' ' 563' ' ' MET . 86.2 tttt -53.84 113.28 1.15 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.19 0.996 . . . . 0.0 110.23 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 61.1 m -144.07 67.75 1.27 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.463 0.705 . . . . 0.0 109.488 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 38.3 m 65.23 -175.59 0.18 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.84 1.256 . . . . 0.0 111.399 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 13.0 t 52.31 56.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 124.189 0.995 . . . . 0.0 111.087 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.577 ' SD ' ' HG3' ' A' ' 559' ' ' LYS . 92.4 mmm -79.81 125.89 30.27 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.235 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -78.72 125.26 29.13 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -79.58 79.22 6.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.321 0.582 . . . . 0.0 110.085 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -77.62 -3.04 38.88 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.052 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -56.23 -31.26 63.35 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.341 1.056 . . . . 0.0 112.518 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -140.71 158.59 43.76 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.943 0.897 . . . . 0.0 109.342 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.039 178.629 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -68.97 130.85 43.96 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.443 0.697 . . . . 0.0 111.296 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 49.2 m -122.51 106.61 11.17 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.209 0.604 . . . . 0.0 111.306 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.02 8.86 68.47 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.471 174.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 20.0 m -63.11 -55.22 27.21 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.398 0.679 . . . . 0.0 110.837 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' VAL . . . . . 0.457 HG23 ' HG2' ' A' ' 476' ' ' GLN . 21.2 t -85.61 129.82 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 171.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 44.0 t -110.51 145.7 37.27 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.129 1.372 . . . . 0.0 109.497 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 50.8 mt -81.93 95.11 2.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.85 -65.14 1.04 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.652 0.381 . . . . 0.0 110.404 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 20.5 mt-10 -116.49 153.13 32.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.1 0.56 . . . . 0.0 110.368 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.493 HG23 HG22 ' A' ' 466' ' ' VAL . 47.8 mt -140.06 142.53 31.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 170.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.76 145.87 51.9 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.307 0.38 . . . . 0.0 110.474 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.587 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.4 pt? -58.93 -41.16 86.68 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.134 0.974 . . . . 0.0 111.886 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.587 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 43.7 mt-10 -91.45 -22.03 20.63 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.159 0.984 . . . . 0.0 110.066 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 83.92 50.82 4.23 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.053 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -87.71 -16.76 33.41 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.06 163.35 40.01 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.031 0.532 . . . . 0.0 111.166 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' VAL . . . . . 0.493 HG22 HG23 ' A' ' 459' ' ' ILE . 97.2 t -134.9 122.76 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.669 1.188 . . . . 0.0 108.088 168.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.602 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 10.2 tt0 -89.8 111.48 22.51 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.287 0.565 . . . . 0.0 110.103 170.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.85 159.95 18.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.21 165.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 508' ' ' MET . 1.6 tmtp? -152.58 129.01 10.63 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.527 ' HB3' HD12 ' A' ' 503' ' ' LEU . 50.6 t30 -99.07 100.35 11.48 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -76.75 -11.63 59.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.254 0.622 . . . . 0.0 111.511 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 44.9 t -63.73 152.54 38.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.338 1.055 . . . . 0.0 112.847 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -73.11 -12.01 60.75 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.095 1.358 . . . . 0.0 111.296 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -99.01 143.69 29.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.763 0.825 . . . . 0.0 110.893 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.46 102.5 2.68 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.457 ' HG2' HG23 ' A' ' 454' ' ' VAL . 57.2 tp60 -70.29 115.48 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.3 0.64 . . . . 0.0 111.87 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.4 m -64.28 99.71 0.3 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.3 tp -96.49 159.53 14.89 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -175.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 143.83 -65.88 0.46 Allowed Glycine 0 N--CA 1.47 0.95 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.64 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.27 -11.66 59.76 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.698 0.799 . . . . 0.0 111.078 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -75.89 135.0 40.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.832 0.853 . . . . 0.0 108.887 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -128.19 145.61 50.98 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 49.6 mt -106.3 103.93 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.627 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 59.3 mttm -78.89 96.19 5.62 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 19.5 tpp85 -79.53 96.82 6.22 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 168.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -102.05 100.92 11.22 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 15.7 t -94.06 141.9 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.2 pp -65.91 -14.88 62.33 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.52 -8.42 33.68 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.238 0.615 . . . . 0.0 110.847 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 105.95 28.27 5.36 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.504 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -121.38 103.83 9.24 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.178 0.591 . . . . 0.0 110.571 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -107.87 80.96 1.44 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.436 1.112 . . . . 0.0 109.226 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 34.9 pt -95.07 134.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.012 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -108.21 110.71 22.4 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.875 0.47 . . . . 0.0 110.067 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.96 104.38 9.55 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 496' ' ' LYS . 0.2 OUTLIER -91.0 129.66 36.98 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -76.79 170.06 17.16 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.995 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.0 p -88.55 124.66 65.45 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.461 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 19.8 Cg_endo -60.16 -10.0 11.75 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.985 2.456 . . . . 0.0 114.871 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -75.17 -24.66 57.93 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.888 0.475 . . . . 0.0 111.273 172.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -82.08 128.06 33.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.599 0.759 . . . . 0.0 110.198 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 59.8 mt -122.46 123.81 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 503' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 470' ' ' ASN . 1.0 OUTLIER -90.2 123.79 34.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 507' ' ' GLN . 1.2 mpt_? -74.49 169.32 17.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.89 0.876 . . . . 0.0 112.109 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -70.43 121.43 17.73 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.402 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 76.59 12.46 84.38 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.812 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' GLN . . . . . 0.414 ' HG3' ' HB2' ' A' ' 504' ' ' ARG . 32.7 mm-40 -104.09 -176.4 3.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.201 0.6 . . . . 0.0 110.773 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 508' ' ' MET . . . . . 0.496 ' HB3' ' HG2' ' A' ' 469' ' ' LYS . 1.5 ppp? -141.63 164.64 29.66 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.976 0.91 . . . . 0.0 111.196 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.67 135.03 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.402 1.081 . . . . 0.0 108.295 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 7.2 m -116.69 115.55 25.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 526' ' ' LEU . 16.0 m -101.54 98.61 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.171 0.988 . . . . 0.0 110.436 -176.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -87.55 172.91 9.4 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.165 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.697 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -92.3 156.47 17.24 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.949 0.9 . . . . 0.0 110.43 175.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -59.9 -28.06 67.26 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.286 0.635 . . . . 0.0 112.125 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 515' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -111.45 23.86 17.03 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.291 -0.413 . . . . 0.0 113.479 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -89.17 11.27 19.12 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 69.66 36.95 76.53 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-O 121.343 0.413 . . . . 0.0 112.71 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.56 147.92 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.908 0.883 . . . . 0.0 111.319 -167.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -99.13 130.51 45.45 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.915 0.886 . . . . 0.0 109.588 171.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -65.25 112.6 3.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.4 m -131.5 71.18 81.47 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.355 0.662 . . . . 0.0 109.613 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.81 153.34 78.29 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.868 2.379 . . . . 0.0 112.247 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -80.51 -19.87 21.27 Favored 'Cis proline' 0 C--N 1.38 2.19 0 CA-C-N 119.957 1.02 . . . . 0.0 113.608 0.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.2 m -63.14 -35.91 81.86 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.306 1.043 . . . . 0.0 112.588 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 25.8 m -127.83 91.21 3.24 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.47 0.708 . . . . 0.0 109.415 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.57 ' HB2' HG12 ' A' ' 511' ' ' VAL . 66.7 mt -84.75 148.37 26.39 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 54.5 t -132.06 127.9 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -68.57 87.77 0.33 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -70.14 128.5 36.49 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.769 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 98.09 -21.46 45.94 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.729 -0.669 . . . . 0.0 113.188 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.83 103.85 10.38 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 532' ' ' SER . . . . . 0.403 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 42.5 p -85.37 -17.56 36.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.372 1.069 . . . . 0.0 113.822 -166.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 46.5 m -96.45 -29.39 13.95 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.697 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 58.44 21.8 8.85 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.187 0.995 . . . . 0.0 110.76 -168.215 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 66.74 70.65 1.07 Allowed Glycine 0 C--N 1.349 1.29 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 -172.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 14.6 p -63.3 162.07 12.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.614 0.766 . . . . 0.0 112.455 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -176.53 149.58 9.84 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.82 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.66 -21.09 38.35 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.515 ' HB2' HD21 ' A' ' 488' ' ' LEU . 19.4 m -148.25 132.83 17.75 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.727 0.811 . . . . 0.0 109.672 167.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -160.38 -176.41 5.59 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.028 0.931 . . . . 0.0 110.395 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 541' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 11.0 ptp180 -136.7 155.48 49.81 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.786 170.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 542' ' ' THR . . . . . 0.485 ' HB ' HD13 ' A' ' 459' ' ' ILE . 86.4 m -130.97 118.81 21.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.627 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 19.6 t -112.63 151.42 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.442 1.097 . . . . 0.0 108.698 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 39.8 tp -123.94 106.83 10.74 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 551' ' ' GLU . 6.2 p -96.59 147.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.682 1.193 . . . . 0.0 109.215 175.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -107.44 -171.96 1.98 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.697 0.399 . . . . 0.0 110.334 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.41 66.78 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 548' ' ' ASP . . . . . 0.573 ' HB2' ' HG2' ' A' ' 550' ' ' GLU . 68.4 m-20 -71.75 -23.74 61.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.085 0.554 . . . . 0.0 111.981 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 93.95 -2.73 69.59 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 550' ' ' GLU . . . . . 0.573 ' HG2' ' HB2' ' A' ' 548' ' ' ASP . 11.7 pt-20 -89.53 141.37 28.64 Favored 'General case' 0 C--O 1.247 0.966 0 C-N-CA 123.189 0.596 . . . . 0.0 109.696 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 545' ' ' VAL . 53.3 mt-10 -81.76 111.05 17.65 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.588 0.755 . . . . 0.0 109.214 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.05 -22.71 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.595 0.758 . . . . 0.0 112.549 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -146.55 157.34 43.72 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.867 0.867 . . . . 0.0 109.361 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.431 ' HG3' HG22 ' A' ' 543' ' ' VAL . 28.5 ttt -168.51 140.51 2.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.427 0.691 . . . . 0.0 110.37 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -152.03 123.66 7.89 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.14 0.976 . . . . 0.0 109.427 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 36.3 m -86.34 124.63 32.91 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.778 0.831 . . . . 0.0 109.853 175.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 459' ' ' ILE . 35.2 t -135.04 142.71 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.929 0.892 . . . . 0.0 109.507 -177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 152.99 41.66 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.754 -177.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.564 ' HD2' ' HG2' ' A' ' 462' ' ' GLU . 88.7 tttt -75.15 81.21 2.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.717 0.77 . . . . 0.0 109.153 170.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 25.4 t -98.04 -46.43 5.89 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 20.2 m -76.14 123.07 25.25 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 164.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 13.8 p -69.4 -25.7 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.131 0.491 . . . . 0.0 110.31 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.3 mtt -84.94 158.39 20.55 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.414 1.085 . . . . 0.0 110.764 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -63.36 113.87 3.5 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.39 135.26 55.96 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.597 0.759 . . . . 0.0 111.694 -172.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -86.15 106.33 17.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.044 0.938 . . . . 0.0 110.323 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -135.62 -87.57 0.35 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 7.0 t30 21.42 76.8 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 126.652 1.981 . . . . 0.0 114.257 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.176 0 CA-C-O 118.869 -0.962 . . . . 0.0 112.066 -175.67 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -61.21 94.15 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.452 0.701 . . . . 0.0 111.214 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 22.0 m -118.39 79.93 1.45 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.106 0.962 . . . . 0.0 109.027 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.86 -45.86 3.02 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.649 0.643 . . . . 0.0 112.76 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 44.1 t -179.96 -46.79 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.454 1.502 . . . . 0.0 108.707 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 19.0 t -114.94 142.18 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.032 0.933 . . . . 0.0 108.616 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 56.3 p -122.57 164.94 17.25 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.287 0.635 . . . . 0.0 110.628 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 43.7 mt -84.66 98.81 6.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.61 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 9.5 tp10 -69.27 -59.77 2.79 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.399 -174.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.61 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 36.0 mt-10 -137.25 160.32 39.38 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.045 0.938 . . . . 0.0 108.86 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.431 ' HB ' HG21 ' A' ' 557' ' ' VAL . 64.8 mt -139.57 141.39 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 172.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.433 ' HB2' ' CD1' ' A' ' 465' ' ' PHE . 26.0 t70 -66.23 148.39 51.91 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.706 0.628 . . . . 0.0 111.312 175.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -36.16 83.02 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.203 1.001 . . . . 0.0 112.079 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.35 -31.26 24.88 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 167.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 95.9 36.42 5.27 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.142 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -72.29 -20.5 61.5 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.321 0.648 . . . . 0.0 110.487 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 460' ' ' ASP . 33.2 p90 -151.6 161.79 42.09 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.526 0.679 . . . . 0.0 111.542 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.33 112.9 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.351 1.46 . . . . 0.0 107.542 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.402 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.5 tp-100 -86.98 118.74 26.56 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 544' ' ' LEU . 85.8 mt -113.65 134.0 54.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.046 0.938 . . . . 0.0 108.713 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 469' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 4.4 tmmm? -116.8 131.12 57.03 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.451 ' HB2' HD13 ' A' ' 503' ' ' LEU . 58.9 t30 -79.79 124.56 28.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.374 0.669 . . . . 0.0 110.709 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -102.65 15.42 29.33 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.228 1.011 . . . . 0.0 110.703 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' SER . . . . . 0.472 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 49.0 m -86.55 149.42 24.96 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.954 0.501 . . . . 0.0 111.353 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.06 -13.8 59.9 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.009 0.924 . . . . 0.0 110.406 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.0 OUTLIER -129.7 175.73 8.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.597 1.159 . . . . 0.0 109.127 178.448 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.66 115.96 6.38 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.393 0.677 . . . . 0.0 109.757 172.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -82.18 113.82 20.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.046 0.538 . . . . 0.0 110.417 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.507 ' HA ' HG12 ' A' ' 502' ' ' ILE . 35.0 p -66.89 110.27 3.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.175 0.59 . . . . 0.0 110.113 173.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.7 tp -103.03 171.88 7.13 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.654 1.182 . . . . 0.0 109.08 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 145.69 -62.99 0.46 Allowed Glycine 0 N--CA 1.472 1.052 0 CA-C-O 121.399 0.444 . . . . 0.0 112.923 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -70.6 -12.3 61.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.267 0.627 . . . . 0.0 110.975 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -69.57 146.52 51.72 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.112 0.965 . . . . 0.0 109.57 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -148.56 125.26 11.13 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.317 0.647 . . . . 0.0 111.002 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 19.4 mt -87.16 117.27 30.98 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 C-N-CA 123.638 0.775 . . . . 0.0 109.219 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.606 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 98.7 mttt -84.33 152.01 24.38 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.002 0.521 . . . . 0.0 109.817 168.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -150.47 104.73 3.25 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -116.48 103.59 10.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.88 0.872 . . . . 0.0 109.608 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.28 154.35 3.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.346 0.659 . . . . 0.0 109.91 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 45.4 tp -53.04 -43.15 66.4 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.989 1.316 . . . . 0.0 111.312 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.36 -24.18 67.21 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.713 0.805 . . . . 0.0 111.96 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 133.97 -22.95 3.77 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-O 118.561 -1.133 . . . . 0.0 115.505 173.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -59.96 100.15 0.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.433 1.117 . . . . 0.0 111.129 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.46 80.78 1.41 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.494 1.14 . . . . 0.0 108.316 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 18.0 pt -113.2 169.72 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.747 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -152.86 116.02 4.63 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.31 0.644 . . . . 0.0 110.42 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -99.36 115.28 28.85 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.556 0.742 . . . . 0.0 109.866 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -90.81 148.02 22.8 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -77.72 169.58 18.05 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.774 0.83 . . . . 0.0 110.845 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 52.0 p -82.55 133.23 50.1 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.66 -26.29 29.18 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.69 2.926 . . . . 0.0 114.346 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.29 -21.49 28.97 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.251 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -63.83 136.74 57.65 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.261 0.624 . . . . 0.0 110.376 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 502' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 477' ' ' SER . 40.9 mt -132.14 125.91 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 503' ' ' LEU . . . . . 0.451 HD13 ' HB2' ' A' ' 470' ' ' ASN . 0.5 OUTLIER -90.04 117.79 29.1 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.307 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -72.97 160.82 31.51 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.007 0.523 . . . . 0.0 111.691 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.32 119.74 10.88 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.666 0.786 . . . . 0.0 112.202 -173.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 80.07 -3.48 70.99 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.498 0.498 . . . . 0.0 114.073 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -83.03 -176.0 6.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.358 0.663 . . . . 0.0 110.082 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -149.52 137.25 20.25 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.137 0.575 . . . . 0.0 110.823 -176.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.95 111.86 32.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.1 m -90.58 96.28 10.57 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 65.1 t -83.91 106.99 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 512' ' ' TRP . . . . . 0.51 ' HB2' HG22 ' A' ' 527' ' ' VAL . 51.5 m95 -99.02 172.36 7.45 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.286 0.634 . . . . 0.0 112.221 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -90.32 148.12 23.06 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.92 170.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.03 92.9 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.866 0.466 . . . . 0.0 110.678 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 515' ' ' GLY . . . . . 0.491 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -79.32 -1.22 85.63 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.697 -0.683 . . . . 0.0 114.329 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -69.38 -26.48 64.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.304 0.642 . . . . 0.0 110.925 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 80.88 38.12 17.04 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.753 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.95 150.63 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.483 1.113 . . . . 0.0 110.308 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -78.54 124.08 27.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.588 0.755 . . . . 0.0 110.694 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 520' ' ' HIS . . . . . 0.404 ' NE2' HD12 ' A' ' 526' ' ' LEU . 3.5 t-160 -72.91 110.8 7.49 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.0 m -128.71 84.5 62.94 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.366 0.666 . . . . 0.0 110.217 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.88 148.04 93.92 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.594 2.196 . . . . 0.0 112.347 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -85.64 -17.94 24.06 Favored 'Cis proline' 0 C--N 1.375 1.973 0 C-N-CA 124.62 -0.992 . . . . 0.0 113.769 -2.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 17.0 m -73.95 -15.12 61.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.85 0.86 . . . . 0.0 113.239 -166.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 66.1 m -135.27 96.94 3.58 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 30.0 tp -105.3 104.48 14.22 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 512' ' ' TRP . 76.2 t -93.36 120.45 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.009 0.524 . . . . 0.0 110.056 -173.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -68.57 97.81 0.82 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -68.41 126.86 30.93 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.493 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 112.46 -25.18 12.56 Favored Glycine 0 C--N 1.342 0.864 0 O-C-N 123.239 0.337 . . . . 0.0 112.912 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.15 114.22 27.95 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 532' ' ' SER . . . . . 0.491 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 66.3 p -79.14 -32.23 44.32 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.675 0.79 . . . . 0.0 111.369 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 536' ' ' THR . 49.8 m -98.08 -33.44 11.16 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 53.51 32.82 14.87 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.459 0.647 . . . . 0.0 109.84 -171.01 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 66.99 55.77 15.27 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.606 -0.724 . . . . 0.0 113.008 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 533' ' ' SER . 4.6 p -73.35 153.78 40.35 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.038 0.447 . . . . 0.0 110.285 170.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 165.28 -161.63 35.01 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.074 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -79.15 -61.8 1.9 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.415 0.686 . . . . 0.0 110.341 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 558' ' ' LYS . 15.8 p -132.66 127.96 35.99 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.232 1.013 . . . . 0.0 109.531 -170.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.99 133.92 14.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.176 0.59 . . . . 0.0 111.893 -170.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.09 99.52 6.97 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.822 1.249 . . . . 0.0 108.498 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 26.9 m -92.03 113.09 25.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 39.8 t -119.67 141.28 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 123.949 0.9 . . . . 0.0 109.787 -174.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.0 tp -109.25 128.74 55.31 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 171.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.53 HG21 ' HE3' ' A' ' 484' ' ' LYS . 78.9 t -117.93 149.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.152 1.381 . . . . 0.0 108.684 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -103.49 -171.93 2.02 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.018 0.527 . . . . 0.0 111.199 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -61.1 -32.81 72.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.996 0.918 . . . . 0.0 113.394 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.87 -36.29 83.02 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.633 0.773 . . . . 0.0 111.65 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.0 -8.01 29.3 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.714 -0.492 . . . . 0.0 113.423 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.88 151.76 25.86 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 117.385 0.592 . . . . 0.0 110.76 172.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -80.21 113.38 18.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.024 0.93 . . . . 0.0 109.299 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 17.7 m -89.23 -25.81 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.978 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -144.93 148.89 34.36 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.527 0.731 . . . . 0.0 109.736 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 554' ' ' MET . . . . . 0.511 ' HG3' HG22 ' A' ' 543' ' ' VAL . 25.9 ttt -151.97 136.32 16.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.589 0.756 . . . . 0.0 109.552 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -155.38 110.84 3.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.54 0.736 . . . . 0.0 109.118 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 91.6 m -95.95 117.28 30.32 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.509 0.724 . . . . 0.0 110.405 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 557' ' ' VAL . . . . . 0.431 HG21 ' HB ' ' A' ' 459' ' ' ILE . 85.5 t -107.05 128.19 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.551 0.74 . . . . 0.0 109.415 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 558' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 0.0 OUTLIER -117.95 157.71 26.24 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.313 1.045 . . . . 0.0 109.547 175.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.42 99.72 0.15 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.716 -173.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 16.9 p -169.17 84.88 0.14 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 125.265 1.426 . . . . 0.0 107.398 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 44.3 p -64.33 112.59 3.14 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.454 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 32.9 m -74.61 -21.41 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.372 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 45.5 mtm 73.31 124.39 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.222 1.409 . . . . 0.0 111.162 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 32.1 mmm180 -74.75 105.66 5.92 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.722 0.809 . . . . 0.0 109.256 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -101.63 171.2 7.7 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.513 0.725 . . . . 0.0 111.322 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.08 40.47 1.12 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 171.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.6 -42.65 99.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.181 0.993 . . . . 0.0 109.576 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -78.52 121.7 24.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.442 -1.254 . . . . 0.0 107.686 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.44 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.506 -176.511 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.414 0.15 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -74.07 81.51 1.75 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.072 0.549 . . . . 0.0 110.35 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 18.8 p -76.79 96.67 4.32 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.281 1.033 . . . . 0.0 111.7 -174.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 64.8 24.62 69.99 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.66 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 20.0 m -60.96 -34.42 74.73 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.845 0.858 . . . . 0.0 112.126 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.46 144.8 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 168.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 60.7 m -134.27 169.99 16.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.334 0.654 . . . . 0.0 110.542 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 51.0 mt -91.74 113.09 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.374 0.67 . . . . 0.0 110.144 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 11.6 tp10 -81.37 -58.19 3.15 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.132 0.973 . . . . 0.0 110.265 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.4 mt-10 -135.01 162.67 31.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.564 0.746 . . . . 0.0 109.992 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.4 mt -144.26 135.53 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.68 142.07 51.57 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.861 0.464 . . . . 0.0 110.101 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.783 HD11 ' HG3' ' A' ' 563' ' ' MET . 3.2 pp -66.25 -39.55 89.58 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.894 0.478 . . . . 0.0 111.645 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.56 ' HG3' HD12 ' A' ' 461' ' ' LEU . 43.3 mt-10 -72.66 -25.21 61.19 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.199 0.523 . . . . 0.0 110.144 174.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 92.59 31.17 9.0 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.548 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -77.44 -19.85 55.39 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.825 0.85 . . . . 0.0 110.971 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -160.18 163.2 33.84 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 121.779 0.8 . . . . 0.0 112.789 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' VAL . . . . . 0.422 HG11 HG21 ' A' ' 542' ' ' THR . 93.7 t -126.93 130.65 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.006 1.722 . . . . 0.0 107.395 169.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLN . . . . . 0.4 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.8 tp-100 -98.49 133.96 42.12 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 171.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.2 mt -117.89 161.71 19.31 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.178 0.991 . . . . 0.0 108.84 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -146.89 131.82 18.12 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.63 ' HB2' ' HG ' ' A' ' 503' ' ' LEU . 65.2 t30 -81.89 117.4 22.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.229 0.612 . . . . 0.0 110.396 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -78.31 -23.74 46.97 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.269 0.628 . . . . 0.0 111.071 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 19.3 m -62.09 145.22 53.9 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.748 0.819 . . . . 0.0 111.266 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -86.75 17.88 3.74 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.88 0.872 . . . . 0.0 110.991 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.5 176.61 12.19 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.142 0.977 . . . . 0.0 110.05 -174.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.38 107.83 0.72 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.268 1.027 . . . . 0.0 111.082 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -88.69 111.31 21.81 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 170.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.6 p -63.53 113.4 3.28 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.012 0.525 . . . . 0.0 109.903 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.6 tp -104.27 155.97 18.3 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -175.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.37 -55.96 0.54 Allowed Glycine 0 N--CA 1.473 1.125 0 CA-C-O 121.694 0.608 . . . . 0.0 112.141 -176.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -72.72 -11.36 60.59 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.976 0.91 . . . . 0.0 111.399 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -79.48 140.68 37.23 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.637 0.775 . . . . 0.0 109.042 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -133.4 130.42 38.7 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.956 0.502 . . . . 0.0 110.804 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.67 109.75 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.635 0.774 . . . . 0.0 110.03 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.538 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 62.7 mttm -79.15 100.44 7.44 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 167.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 485' ' ' ARG . . . . . 0.559 ' HB3' ' HA3' ' A' ' 535' ' ' GLY . 6.3 mmt85 -82.0 90.3 6.48 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 165.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 486' ' ' GLN . . . . . 0.481 ' HG2' ' HB3' ' A' ' 492' ' ' GLU . 21.3 tm0? -99.12 104.97 17.01 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.227 -173.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.46 126.28 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.6 -12.18 50.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.08 -6.62 40.58 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.337 1.055 . . . . 0.0 112.046 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 115.58 28.25 2.81 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 114.427 0.531 . . . . 0.0 114.427 167.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -135.48 141.44 45.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 116.998 0.399 . . . . 0.0 110.078 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.481 ' HB3' ' HG2' ' A' ' 486' ' ' GLN . 10.0 pt-20 -150.35 114.58 5.13 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.24 0.543 . . . . 0.0 109.727 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 28.5 pt -107.69 144.93 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -118.75 108.52 14.98 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.496 0.718 . . . . 0.0 109.637 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -89.23 104.89 17.4 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -84.22 134.81 34.54 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -69.5 164.9 22.12 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.851 0.86 . . . . 0.0 111.746 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.4 p -75.78 126.04 87.64 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' PRO . . . . . 0.465 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 60.2 Cg_endo -68.16 -12.46 35.15 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.647 2.231 . . . . 0.0 113.565 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -74.19 -23.53 59.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.738 0.815 . . . . 0.0 111.504 173.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -79.65 136.25 36.76 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-O 120.975 0.417 . . . . 0.0 109.91 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.71 130.01 74.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 503' ' ' LEU . . . . . 0.63 ' HG ' ' HB2' ' A' ' 470' ' ' ASN . 23.3 tp -95.54 113.4 25.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -76.55 164.0 26.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.214 1.005 . . . . 0.0 112.054 -172.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -55.59 120.3 7.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.372 1.069 . . . . 0.0 112.566 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.73 -5.24 17.92 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 114.338 0.495 . . . . 0.0 114.338 176.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -84.92 154.72 22.03 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.147 0.579 . . . . 0.0 109.883 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 59.7 mtt -113.94 145.15 41.93 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.76 0.824 . . . . 0.0 110.585 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.2 p -125.48 119.18 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.591 0.756 . . . . 0.0 109.225 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.81 107.01 19.41 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 16.8 t -87.0 98.88 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.571 0.749 . . . . 0.0 110.002 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 512' ' ' TRP . . . . . 0.522 ' HB2' HG22 ' A' ' 527' ' ' VAL . 39.5 m95 -90.14 174.19 7.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.603 0.761 . . . . 0.0 111.336 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 513' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.51 152.42 20.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.025 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.03 75.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.038 0.535 . . . . 0.0 110.528 173.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -72.62 -8.63 72.41 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.571 -0.74 . . . . 0.0 114.429 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.52 60.15 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.978 0.511 . . . . 0.0 111.28 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 75.77 38.44 36.69 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-O 121.139 0.299 . . . . 0.0 112.503 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.11 140.04 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 124.107 0.963 . . . . 0.0 110.146 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.53 138.42 36.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.928 0.891 . . . . 0.0 110.751 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -64.36 110.7 2.34 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.246 0.618 . . . . 0.0 109.525 173.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.4 m -129.29 78.52 75.77 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.598 0.759 . . . . 0.0 110.02 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.28 156.39 64.74 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.443 2.095 . . . . 0.0 111.811 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -83.57 -14.28 35.64 Favored 'Cis proline' 0 C--N 1.377 2.039 0 CA-C-N 119.698 0.928 . . . . 0.0 113.968 -1.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.9 m -66.43 -31.72 72.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.962 0.905 . . . . 0.0 112.736 -171.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 94.2 m -136.59 102.1 4.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.295 0.638 . . . . 0.0 110.636 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 67.1 mt -92.24 132.85 36.34 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 167.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 512' ' ' TRP . 99.4 t -118.92 126.44 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -70.54 100.95 1.9 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 172.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.59 133.13 49.67 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.151 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 89.57 -28.56 6.87 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 123.644 0.59 . . . . 0.0 113.591 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' GLN . . . . . 0.425 ' HG3' ' H ' ' A' ' 534' ' ' TRP . 45.7 tp60 -82.99 118.12 23.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.723 0.409 . . . . 0.0 109.987 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 33.4 m -96.28 -39.51 9.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.88 0.472 . . . . 0.0 111.248 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' SER . . . . . 0.485 ' HB2' HG22 ' A' ' 536' ' ' THR . 67.0 p -79.04 -35.7 42.22 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.464 0.477 . . . . 0.0 111.848 -171.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 534' ' ' TRP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.39 31.19 9.19 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.119 0.967 . . . . 0.0 111.366 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 535' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 485' ' ' ARG . . . 70.4 59.17 5.48 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -174.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 536' ' ' THR . . . . . 0.485 HG22 ' HB2' ' A' ' 533' ' ' SER . 10.4 t -79.2 145.31 33.71 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.219 1.008 . . . . 0.0 110.151 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -169.56 165.25 38.68 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.132 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -75.69 -30.94 59.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.8 m -146.29 118.42 8.3 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -142.37 -178.95 5.99 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.565 0.746 . . . . 0.0 110.802 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -147.98 128.33 13.92 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.39 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' THR . . . . . 0.422 HG21 HG11 ' A' ' 466' ' ' VAL . 87.3 m -86.69 128.07 34.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 543' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 65.5 t -124.38 117.5 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 544' ' ' LEU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.6 tp -90.84 107.95 19.52 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 545' ' ' VAL . . . . . 0.43 HG22 ' HG2' ' A' ' 551' ' ' GLU . 83.3 t -96.03 149.56 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.644 1.178 . . . . 0.0 108.585 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 546' ' ' ASN . . . . . 0.421 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.5 p30 -108.29 -172.84 2.14 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.475 0.31 . . . . 0.0 110.965 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -52.16 -39.63 60.3 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.856 1.263 . . . . 0.0 113.27 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.34 -37.56 87.76 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.711 0.804 . . . . 0.0 112.424 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.21 -13.41 28.57 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.041 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 550' ' ' GLU . . . . . 0.421 ' HG2' HD21 ' A' ' 546' ' ' ASN . 11.1 pt-20 -75.1 148.89 39.32 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.278 0.539 . . . . 0.0 110.567 173.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.43 ' HG2' HG22 ' A' ' 545' ' ' VAL . 30.0 mt-10 -87.57 98.27 11.31 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.942 0.897 . . . . 0.0 109.027 -177.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 26.0 m -79.65 -19.06 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.05 -173.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.65 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -145.71 145.66 30.96 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.275 0.63 . . . . 0.0 109.425 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 16.9 ttt -151.64 110.55 3.86 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -125.52 106.87 10.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.917 0.887 . . . . 0.0 108.917 -173.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 53.2 m -86.24 140.02 30.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.14 0.576 . . . . 0.0 110.578 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.3 p -144.97 111.02 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 124.43 1.092 . . . . 0.0 109.585 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -92.76 116.57 29.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 172.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 559' ' ' LYS . . . . . 0.596 ' HE2' HG12 ' A' ' 562' ' ' VAL . 86.7 tttt -66.38 100.63 0.66 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.339 1.055 . . . . 0.0 110.492 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 47.8 p -97.82 -7.03 31.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.125 0.97 . . . . 0.0 111.619 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 561' ' ' SER . . . . . 0.491 ' HB3' HD22 ' A' ' 461' ' ' LEU . 44.7 t -138.59 149.59 45.41 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.82 0.848 . . . . 0.0 109.691 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 562' ' ' VAL . . . . . 0.596 HG12 ' HE2' ' A' ' 559' ' ' LYS . 35.0 m -110.17 9.11 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.115 0.966 . . . . 0.0 109.924 172.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.783 ' HG3' HD11 ' A' ' 461' ' ' LEU . 66.7 mtt 63.22 -170.06 0.18 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.898 1.279 . . . . 0.0 110.571 -168.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -99.54 171.68 7.78 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.529 0.681 . . . . 0.0 111.067 173.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.23 25.76 0.96 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.993 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -72.77 80.18 1.13 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.373 0.669 . . . . 0.0 109.275 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -97.2 -38.43 9.7 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.633 1.173 . . . . 0.0 109.485 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -169.05 123.41 0.84 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.548 1.139 . . . . 0.0 107.987 -176.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 CA-C-O 118.832 -0.982 . . . . 0.0 111.313 -178.981 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 51.1 p . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 470' ' ' ASN . 18.6 t -89.07 146.46 6.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 165.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 84.6 p -134.62 172.07 13.46 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.029 0.931 . . . . 0.0 108.949 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 42.1 mm -74.19 122.2 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 14.6 tp10 -93.97 -68.05 0.82 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 36.0 mt-10 -135.12 160.09 39.45 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.961 0.904 . . . . 0.0 108.83 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.548 HG23 ' NH2' ' A' ' 485' ' ' ARG . 97.0 mt -146.57 142.61 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.87 147.93 48.33 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.02 0.528 . . . . 0.0 110.808 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.64 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.0 pt? -59.37 -35.79 74.56 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.021 0.928 . . . . 0.0 111.786 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.64 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 50.2 mt-10 -103.07 -4.97 23.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.443 1.097 . . . . 0.0 111.298 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 75.49 40.5 32.54 Favored Glycine 0 C--N 1.342 0.911 0 O-C-N 123.469 0.48 . . . . 0.0 113.3 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -78.9 -18.81 53.26 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.241 0.617 . . . . 0.0 110.691 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -155.55 157.33 36.66 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.013 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . 0.566 HG22 ' NH2' ' A' ' 485' ' ' ARG . 15.7 t -111.77 148.29 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 165.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.5 tp-100 -126.54 121.08 31.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.456 HD22 HD22 ' A' ' 544' ' ' LEU . 87.3 mt -110.01 159.62 17.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.91 0.884 . . . . 0.0 109.804 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -144.84 128.93 17.6 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.554 0.742 . . . . 0.0 109.721 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.555 ' HB2' HD12 ' A' ' 503' ' ' LEU . 64.2 t30 -91.35 109.4 20.67 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -86.93 -1.46 57.86 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.287 1.035 . . . . 0.0 111.139 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 27.0 t -74.95 158.47 33.24 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.51 0.724 . . . . 0.0 111.53 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.33 0.4 56.21 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.403 1.081 . . . . 0.0 112.22 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.53 166.18 23.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.969 0.508 . . . . 0.0 110.821 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -66.18 115.58 6.33 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.909 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.439 ' HG2' HG23 ' A' ' 454' ' ' VAL . 61.5 tp60 -80.02 111.08 16.02 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.851 0.719 . . . . 0.0 110.46 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.5 p -64.0 114.34 4.07 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.0 tp -107.99 151.88 25.23 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -170.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 146.87 -65.65 0.42 Allowed Glycine 0 N--CA 1.473 1.111 0 C-N-CA 121.419 -0.42 . . . . 0.0 112.921 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -69.35 -12.75 61.93 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.489 0.716 . . . . 0.0 110.98 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.437 ' CD2' ' HA ' ' A' ' 546' ' ' ASN . 26.3 m95 -67.65 150.86 48.2 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.853 0.861 . . . . 0.0 110.056 169.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 495' ' ' TYR . 30.1 ptt-85 -153.09 139.76 18.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.789 0.436 . . . . 0.0 111.364 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . 0.495 HG21 HG21 ' A' ' 466' ' ' VAL . 47.7 mt -101.41 104.6 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.304 0.642 . . . . 0.0 109.552 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.461 ' HE3' HG21 ' A' ' 545' ' ' VAL . 92.0 mttt -86.87 96.91 10.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.74 0.416 . . . . 0.0 109.995 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . 0.566 ' NH2' HG22 ' A' ' 466' ' ' VAL . 39.8 ttm180 -94.7 100.0 12.0 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 172.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -104.14 111.81 24.56 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.445 1.098 . . . . 0.0 110.439 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.474 HG12 ' H ' ' A' ' 489' ' ' GLU . 14.1 t -95.15 135.77 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.19 0.996 . . . . 0.0 109.272 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.4 pp -64.96 -22.89 67.07 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.342 0.657 . . . . 0.0 112.207 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . 0.474 ' H ' HG12 ' A' ' 487' ' ' VAL . 47.7 mt-10 -69.93 -10.83 59.96 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.058 0.943 . . . . 0.0 111.906 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 130.15 -28.31 3.89 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-O 119.387 -0.674 . . . . 0.0 114.232 166.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.24 116.17 22.28 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.834 0.817 . . . . 0.0 110.313 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.39 125.0 28.17 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 13.5 pt -140.82 148.76 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.8 0.84 . . . . 0.0 110.224 -170.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -121.3 112.51 18.69 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.484 0.714 . . . . 0.0 109.533 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 482' ' ' ARG . 50.4 t80 -79.94 105.18 11.04 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -80.74 132.56 35.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -77.17 170.25 16.87 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.457 0.646 . . . . 0.0 111.312 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . 0.438 ' HB ' ' HG2' ' A' ' 500' ' ' LYS . 52.3 p -87.99 120.09 70.63 Favored Pre-proline 0 CA--C 1.553 1.079 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.465 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.19 -5.21 7.57 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.241 2.627 . . . . 0.0 114.753 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . 0.438 ' HG2' ' HB ' ' A' ' 498' ' ' THR . 63.0 pttt -74.55 -25.94 59.64 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.539 0.335 . . . . 0.0 110.425 170.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -92.33 135.57 33.91 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.639 0.776 . . . . 0.0 110.608 -169.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 52.3 mt -126.96 128.58 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 470' ' ' ASN . 2.3 tm? -95.1 141.5 28.65 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.515 HH22 ' HG2' ' A' ' 523' ' ' PRO . 0.2 OUTLIER -87.43 164.66 16.07 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.019 0.527 . . . . 0.0 111.637 -166.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.76 123.32 19.04 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.366 0.667 . . . . 0.0 110.815 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.01 14.53 76.14 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 123.569 0.543 . . . . 0.0 113.938 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -104.92 175.27 5.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.288 0.635 . . . . 0.0 110.673 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 11.5 ptm -146.34 149.0 32.97 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.468 1.107 . . . . 0.0 110.106 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.89 131.32 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.3 0.64 . . . . 0.0 109.803 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.27 112.73 25.87 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.27 0.628 . . . . 0.0 109.499 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.418 HG12 ' HE1' ' A' ' 534' ' ' TRP . 46.9 t -99.38 99.76 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.185 0.594 . . . . 0.0 109.824 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . 0.541 ' HB2' HG22 ' A' ' 527' ' ' VAL . 43.4 m95 -87.16 172.99 9.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.736 0.814 . . . . 0.0 111.479 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -91.14 152.94 20.38 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.809 0.844 . . . . 0.0 110.108 172.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.14 -38.57 85.74 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.337 0.589 . . . . 0.0 110.141 172.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -81.2 13.05 34.76 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.662 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -84.69 -6.98 59.38 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.175 0.59 . . . . 0.0 110.712 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 68.52 16.46 69.63 Favored Glycine 0 C--N 1.359 1.833 0 O-C-N 123.357 0.411 . . . . 0.0 113.44 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.2 p -88.89 150.13 3.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.29 1.036 . . . . 0.0 110.358 -173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.61 118.16 21.94 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.533 0.733 . . . . 0.0 109.72 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -66.94 110.75 3.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.4 m -124.17 81.19 57.96 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.365 0.666 . . . . 0.0 109.888 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -70.55 154.48 64.59 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.67 2.247 . . . . 0.0 111.79 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . 0.515 ' HG2' HH22 ' A' ' 504' ' ' ARG . 97.1 Cg_endo -97.94 13.57 32.5 Favored 'Cis proline' 0 C--N 1.37 1.691 0 CA-C-N 119.723 0.937 . . . . 0.0 113.48 -2.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.8 m -78.57 -45.7 21.16 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.457 0.646 . . . . 0.0 110.594 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 93.6 m -121.01 96.38 5.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.802 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 10.7 mp -84.11 147.07 27.55 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 512' ' ' TRP . 57.6 t -128.73 123.06 58.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -67.53 91.06 0.27 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 55.2 tptt -72.64 122.56 21.62 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.431 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 106.31 -1.86 37.44 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.759 0.662 . . . . 0.0 112.993 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 534' ' ' TRP . 44.7 tp60 -119.48 123.0 42.96 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 42.8 p -90.21 -47.04 8.04 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.034 0.534 . . . . 0.0 111.931 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 536' ' ' THR . 69.0 p -87.44 -34.72 18.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.972 -170.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.734 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.73 39.24 28.24 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.533 0.733 . . . . 0.0 109.973 -173.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 74.95 61.2 3.13 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 462' ' ' GLU . 7.9 p -72.93 142.04 47.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.85 0.46 . . . . 0.0 111.01 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 179.09 168.03 37.53 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.821 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.82 -16.57 40.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.063 0.545 . . . . 0.0 110.322 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.425 ' HB2' HD21 ' A' ' 488' ' ' LEU . 16.6 m -155.82 131.13 9.49 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.758 0.823 . . . . 0.0 108.945 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.469 ' HB3' HG22 ' A' ' 487' ' ' VAL . 23.0 p90 -157.82 145.46 18.54 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.225 0.61 . . . . 0.0 111.13 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 76.0 mtm-85 -97.88 106.15 18.41 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.85 0.86 . . . . 0.0 108.902 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 21.5 m -93.61 105.65 17.68 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.447 HG22 ' SD ' ' A' ' 554' ' ' MET . 12.0 t -103.04 134.47 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.342 1.057 . . . . 0.0 109.706 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.8 tp -103.76 124.11 48.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.461 HG21 ' HE3' ' A' ' 484' ' ' LYS . 84.1 t -118.28 141.55 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.462 1.105 . . . . 0.0 108.872 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.437 ' HA ' ' CD2' ' A' ' 481' ' ' TRP . 1.7 p30 -94.41 -177.17 4.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.652 0.381 . . . . 0.0 111.576 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.08 71.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.666 0.786 . . . . 0.0 112.902 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.21 -29.75 71.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.642 0.777 . . . . 0.0 111.786 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 95.28 25.28 14.38 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.795 -173.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.39 137.87 41.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.242 1.017 . . . . 0.0 108.597 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -75.29 96.89 3.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.791 0.836 . . . . 0.0 109.155 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 35.6 m -85.16 -23.8 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -148.46 162.92 38.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.402 0.681 . . . . 0.0 109.812 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 543' ' ' VAL . 59.2 ttp -170.52 139.22 1.59 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.963 0.905 . . . . 0.0 109.49 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -139.25 124.27 18.84 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.267 0.627 . . . . 0.0 110.101 170.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 28.2 m -81.73 99.76 9.12 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 459' ' ' ILE . 74.5 t -102.85 142.39 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.501 0.667 . . . . 0.0 109.754 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -126.15 158.44 35.54 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.006 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . 0.464 ' HG3' HD12 ' A' ' 461' ' ' LEU . 64.8 tttp . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 121.514 0.674 . . . . 0.0 109.43 175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 472' ' ' SER . 67.7 m . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.861 0.362 . . . . 0.0 111.635 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 478' ' ' LEU . 13.5 t -123.71 137.1 58.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 162.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 28.7 t -130.22 170.88 13.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.986 0.914 . . . . 0.0 109.239 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 459' ' ' ILE . 61.8 mt -87.42 117.49 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 122.965 0.506 . . . . 0.0 109.88 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 8.3 tp10 -84.37 -62.07 1.65 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.358 0.663 . . . . 0.0 110.499 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 24.6 mt-10 -140.48 158.31 44.19 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.83 0.852 . . . . 0.0 109.669 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.51 ' HB ' HG21 ' A' ' 557' ' ' VAL . 48.1 mt -141.9 140.42 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -77.29 148.94 35.44 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.321 0.648 . . . . 0.0 111.568 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 559' ' ' LYS . 1.6 pp -76.31 -26.19 55.58 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.886 0.875 . . . . 0.0 112.766 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -86.52 -14.38 43.21 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.239 0.616 . . . . 0.0 110.027 168.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 78.12 28.67 55.75 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.741 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -73.03 -18.26 61.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.139 0.576 . . . . 0.0 111.063 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -158.22 155.8 29.63 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 122.958 0.503 . . . . 0.0 111.348 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.6 111.44 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 457' ' ' GLU . 15.6 tt0 -88.0 128.33 35.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.58 0.752 . . . . 0.0 110.223 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 483' ' ' ILE . 71.5 mt -114.0 162.66 16.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.448 1.099 . . . . 0.0 109.599 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 469' ' ' LYS . 4.7 tmmm? -147.4 132.12 17.92 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.012 0.925 . . . . 0.0 108.764 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' A' ' 505' ' ' ALA . 23.6 t-20 -76.76 127.29 32.48 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.968 1.307 . . . . 0.0 111.035 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -111.43 12.17 21.47 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.975 0.91 . . . . 0.0 111.183 172.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 453' ' ' SER . 24.1 t -79.05 148.24 32.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.847 0.859 . . . . 0.0 110.322 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -88.15 -7.78 56.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.381 0.672 . . . . 0.0 110.956 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.4 OUTLIER -135.68 172.55 12.84 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.986 0.914 . . . . 0.0 109.447 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.87 143.39 57.48 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -124.52 113.68 18.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.477 0.711 . . . . 0.0 110.26 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 40.6 p -70.79 119.27 14.69 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.4 0.68 . . . . 0.0 110.682 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.413 HD11 HG21 ' A' ' 454' ' ' VAL . 6.2 mp -100.2 165.18 11.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.117 0.967 . . . . 0.0 109.455 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 144.1 -58.09 0.53 Allowed Glycine 0 N--CA 1.465 0.624 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 547' ' ' ALA . 0.9 OUTLIER -81.03 -13.76 58.51 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 114.299 -0.95 . . . . 0.0 111.014 174.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.431 ' CZ3' HG21 ' A' ' 552' ' ' VAL . 27.8 m95 -72.23 140.12 48.51 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -146.66 135.85 22.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.056 0.542 . . . . 0.0 111.538 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . 0.477 HG12 HD13 ' A' ' 544' ' ' LEU . 45.4 mt -99.99 105.99 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.908 0.883 . . . . 0.0 109.13 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -92.83 102.23 14.61 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.56 1.144 . . . . 0.0 110.42 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . 0.511 ' HE ' ' HE3' ' A' ' 534' ' ' TRP . 51.1 ttm-85 -87.22 96.35 10.3 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.44 100.88 13.07 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 46.6 t -93.62 121.59 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.42 -28.11 68.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.447 0.699 . . . . 0.0 112.629 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -64.53 -15.73 61.4 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.534 1.133 . . . . 0.0 112.574 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 125.27 27.38 1.21 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 114.471 0.548 . . . . 0.0 114.471 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -129.22 99.17 5.13 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.696 0.748 . . . . 0.0 109.971 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.36 96.86 6.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 174.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.3 pt -107.32 168.4 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.15 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -156.44 132.18 9.61 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.728 0.811 . . . . 0.0 109.67 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -125.53 116.19 21.39 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.442 0.697 . . . . 0.0 109.49 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -79.19 157.81 27.79 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -81.4 171.44 14.75 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.665 0.786 . . . . 0.0 110.872 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 74.7 p -81.93 128.83 67.05 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.05 -29.06 63.36 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.445 2.763 . . . . 0.0 113.785 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -68.73 -21.06 64.41 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.28 0.632 . . . . 0.0 112.49 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -78.95 129.53 34.58 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.364 0.666 . . . . 0.0 109.996 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 49.4 mt -126.3 119.85 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . 0.406 HD23 HG22 ' A' ' 454' ' ' VAL . 38.8 tp -83.85 138.6 33.12 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.487 0.715 . . . . 0.0 109.439 178.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -90.63 154.78 19.33 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.222 0.609 . . . . 0.0 110.549 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . 0.457 ' HA ' ' OD1' ' A' ' 470' ' ' ASN . . . -72.8 130.39 40.35 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.455 0.702 . . . . 0.0 111.681 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 75.51 20.13 78.78 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.064 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -115.19 -162.46 0.83 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.163 0.985 . . . . 0.0 110.2 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 19.6 ptp -154.4 166.37 33.44 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.361 0.665 . . . . 0.0 110.992 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.68 126.13 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.091 0.957 . . . . 0.0 109.228 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 25.6 m -116.32 111.53 20.24 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.107 0.563 . . . . 0.0 109.719 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 526' ' ' LEU . 35.5 m -88.67 137.31 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -122.01 174.47 6.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.379 1.072 . . . . 0.0 109.862 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -90.53 147.17 23.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.047 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -58.73 -42.24 88.31 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.503 0.721 . . . . 0.0 110.88 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -88.63 24.16 13.48 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.731 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -88.28 -13.23 41.4 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.262 0.625 . . . . 0.0 110.404 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.45 31.35 68.38 Favored Glycine 0 C--N 1.356 1.648 0 O-C-N 123.512 0.508 . . . . 0.0 112.323 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.67 144.95 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.371 1.068 . . . . 0.0 110.982 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.34 126.12 30.76 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 172.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -73.62 117.44 15.4 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 31.4 m -138.04 73.15 45.86 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.139 0.576 . . . . 0.0 110.335 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.48 148.38 83.76 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.719 2.279 . . . . 0.0 111.589 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.52 -13.54 37.38 Favored 'Cis proline' 0 C--N 1.379 2.173 0 CA-C-N 120.275 1.134 . . . . 0.0 114.424 4.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.6 m -67.6 -32.38 73.06 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.94 0.896 . . . . 0.0 112.431 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 59.8 m -135.48 98.2 3.88 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.623 0.769 . . . . 0.0 110.051 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.502 ' HB2' HG12 ' A' ' 511' ' ' VAL . 82.5 mt -90.87 149.73 21.81 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.33 120.9 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.204 0.602 . . . . 0.0 109.725 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -75.76 109.32 9.26 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 56.4 tptt -72.58 135.97 45.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.966 0.906 . . . . 0.0 110.514 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 99.32 -39.22 2.81 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.921 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -81.55 109.39 15.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.945 0.498 . . . . 0.0 110.482 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 85.9 p -83.4 -37.34 23.38 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.35 0.66 . . . . 0.0 110.292 174.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.739 ' HB2' HG23 ' A' ' 536' ' ' THR . 55.6 p -94.05 -29.39 15.22 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.794 -173.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.511 ' HE3' ' HE ' ' A' ' 485' ' ' ARG . 0.0 OUTLIER 59.98 34.51 21.5 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.14 0.976 . . . . 0.0 109.258 -171.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 79.41 81.08 0.75 Allowed Glycine 0 C--N 1.364 2.12 0 CA-C-O 119.574 -0.57 . . . . 0.0 113.032 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.739 HG23 ' HB2' ' A' ' 533' ' ' SER . 14.5 p -55.41 148.84 14.32 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.824 0.821 . . . . 0.0 112.51 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 164.8 136.15 1.95 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.585 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.71 -37.55 24.58 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 31.9 m -125.84 124.23 40.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.517 0.727 . . . . 0.0 109.186 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -158.74 161.46 37.04 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.642 0.777 . . . . 0.0 111.091 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 35.0 ptt180 -119.72 111.75 18.41 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.935 0.894 . . . . 0.0 108.689 168.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 61.3 m -89.92 133.14 34.94 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.532 HG22 ' HG3' ' A' ' 554' ' ' MET . 19.3 t -124.13 117.94 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.368 1.067 . . . . 0.0 108.723 -174.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 42.9 tp -87.99 132.35 34.29 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.59 157.58 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.176 1.39 . . . . 0.0 108.113 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.507 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.2 p30 -117.77 -170.68 1.91 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.814 0.445 . . . . 0.0 111.234 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 480' ' ' ASN . . . -51.85 -37.4 51.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.396 1.478 . . . . 0.0 113.839 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.28 -34.47 77.47 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.595 0.758 . . . . 0.0 112.009 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 104.45 -12.95 51.28 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.559 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.507 ' HG2' HD21 ' A' ' 546' ' ' ASN . 16.3 pt-20 -67.42 148.21 51.87 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 122.784 0.434 . . . . 0.0 110.139 175.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -80.93 101.24 9.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.431 HG21 ' CZ3' ' A' ' 481' ' ' TRP . 22.1 m -79.27 -21.0 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.566 0.347 . . . . 0.0 111.641 -175.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -158.9 151.71 22.03 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.228 1.011 . . . . 0.0 109.189 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.532 ' HG3' HG22 ' A' ' 543' ' ' VAL . 54.8 ttp -164.21 116.2 1.33 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.661 0.784 . . . . 0.0 109.668 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -133.22 130.59 39.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.549 0.74 . . . . 0.0 110.292 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 79.8 m -90.57 123.1 33.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.363 1.065 . . . . 0.0 109.572 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.51 HG21 ' HB ' ' A' ' 459' ' ' ILE . 86.2 t -123.75 128.87 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.795 0.838 . . . . 0.0 109.72 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 151.46 38.44 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.63 1.172 . . . . 0.0 108.52 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . 0.489 ' HG3' ' HB2' ' A' ' 461' ' ' LEU . 88.0 tttt . . . . . 0 CA--C 1.54 0.569 0 CA-C-O 121.549 0.69 . . . . 0.0 109.319 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 13.8 t -91.77 130.95 40.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.374 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 16.6 m -109.64 155.71 21.13 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.341 1.056 . . . . 0.0 109.407 174.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 39.9 mt -79.23 106.54 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.463 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 11.7 tp10 -73.69 -69.47 0.43 Allowed 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.733 0.646 . . . . 0.0 109.68 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.42 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 21.8 mt-10 -133.19 163.73 28.63 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.6 0.76 . . . . 0.0 109.829 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.503 ' HB ' HG21 ' A' ' 557' ' ' VAL . 61.2 mt -142.5 144.34 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 171.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.39 148.62 51.6 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.354 0.662 . . . . 0.0 110.716 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.46 -41.62 98.89 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.065 0.546 . . . . 0.0 111.289 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -80.57 -29.52 37.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.55 0.74 . . . . 0.0 109.362 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . 0.453 ' HA3' ' NH2' ' A' ' 485' ' ' ARG . . . 92.1 39.52 5.42 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.408 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -71.26 -20.19 62.26 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.375 0.67 . . . . 0.0 109.915 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -153.5 161.85 41.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.294 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 81.3 t -130.63 111.8 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.463 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.7 tp-100 -86.81 123.06 31.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.148 0.979 . . . . 0.0 109.955 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 483' ' ' ILE . 62.4 mt -112.49 157.86 20.6 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 471' ' ' ASN . 2.1 tmmm? -148.19 129.98 15.15 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -91.72 130.78 37.45 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.234 0.614 . . . . 0.0 110.252 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.516 ' HB3' ' HE3' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -136.38 84.73 2.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.268 1.027 . . . . 0.0 109.261 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 66.0 m -146.43 -163.32 1.72 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.056 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . 0.534 ' HB2' ' HD3' ' A' ' 474' ' ' LYS . 2.2 m-20 -79.16 -48.78 13.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.308 0.643 . . . . 0.0 111.186 -173.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.534 ' HD3' ' HB2' ' A' ' 473' ' ' ASP . 0.0 OUTLIER -133.93 178.45 6.94 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.587 -172.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 504' ' ' ARG . 8.5 p-10 -53.16 112.46 0.87 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.72 1.208 . . . . 0.0 111.639 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -74.27 113.66 11.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.774 0.83 . . . . 0.0 110.557 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.494 ' HA ' HG12 ' A' ' 502' ' ' ILE . 32.6 t -64.37 100.84 0.38 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.098 0.559 . . . . 0.0 109.508 172.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.8 tp -90.65 165.68 13.58 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 143.22 -65.52 0.47 Allowed Glycine 0 N--CA 1.466 0.684 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.135 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.68 -13.04 58.42 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.153 0.981 . . . . 0.0 112.028 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -74.3 148.53 41.31 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.402 1.081 . . . . 0.0 109.599 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . 0.4 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 19.1 ptt-85 -148.58 134.11 18.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.047 0.539 . . . . 0.0 111.181 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 468' ' ' LEU . 49.2 mt -91.58 114.95 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.314 1.046 . . . . 0.0 109.729 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.569 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 67.1 mttm -79.63 144.11 34.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 164.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . 0.453 ' NH2' ' HA3' ' A' ' 463' ' ' GLY . 66.9 ttt180 -143.59 98.71 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.594 0.711 . . . . 0.0 109.282 172.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -96.15 103.6 15.51 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.01 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.547 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 24.3 t -67.58 149.44 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.495 HD23 HG12 ' A' ' 487' ' ' VAL . 2.7 pt? -52.42 -33.11 42.42 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -168.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.93 -34.08 75.92 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.288 0.635 . . . . 0.0 111.248 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 130.57 -2.3 5.7 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.728 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -73.05 114.21 10.96 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.168 0.484 . . . . 0.0 110.384 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.12 143.49 38.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.58 0.752 . . . . 0.0 110.556 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 22.5 pt -127.19 146.16 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.19 0.996 . . . . 0.0 108.679 169.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -125.59 109.81 13.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.557 0.743 . . . . 0.0 109.764 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -97.38 106.03 18.28 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.571 0.748 . . . . 0.0 109.658 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -87.07 153.21 21.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -89.25 170.4 10.62 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.216 0.607 . . . . 0.0 110.936 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.1 p -91.07 131.74 36.21 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.044 0.938 . . . . 0.0 109.649 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.25 -17.06 49.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.783 2.322 . . . . 0.0 113.453 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -72.9 -20.39 61.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.549 0.739 . . . . 0.0 111.662 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -84.2 128.3 34.48 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.408 0.683 . . . . 0.0 109.614 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 477' ' ' SER . 49.2 mt -126.46 133.41 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -114.18 124.55 52.33 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 475' ' ' ASP . 8.1 mpt_? -71.13 155.95 40.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.855 0.862 . . . . 0.0 112.152 -170.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.52 129.23 39.0 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.488 0.715 . . . . 0.0 110.753 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 86.18 -6.45 81.56 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.556 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -92.73 -175.59 3.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.835 0.854 . . . . 0.0 110.62 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 21.9 ptt? -145.03 160.96 40.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.922 0.889 . . . . 0.0 110.61 -176.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 468' ' ' LEU . 2.5 p -137.81 118.64 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.376 1.07 . . . . 0.0 108.367 175.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.7 m -105.07 110.82 23.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 54.2 t -89.18 99.73 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.152 0.581 . . . . 0.0 109.491 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -87.09 170.07 11.85 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.258 1.023 . . . . 0.0 111.518 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -84.28 148.89 26.44 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.114 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -67.04 -31.77 72.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.347 0.659 . . . . 0.0 111.163 174.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -75.42 -12.68 83.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.91 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -71.18 -14.2 62.18 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.391 0.677 . . . . 0.0 111.735 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 66.58 25.86 72.82 Favored Glycine 0 C--N 1.356 1.675 0 CA-C-O 121.124 0.291 . . . . 0.0 113.207 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 5.7 p -84.03 144.46 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.603 1.161 . . . . 0.0 111.066 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -69.29 107.69 3.37 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.81 0.844 . . . . 0.0 110.046 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -62.74 109.88 1.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.1 m -131.83 76.36 74.31 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.473 0.709 . . . . 0.0 110.413 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.0 145.05 87.58 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.757 2.305 . . . . 0.0 112.33 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.59 -23.76 12.27 Favored 'Cis proline' 0 C--N 1.373 1.838 0 CA-C-N 120.008 1.039 . . . . 0.0 113.923 -1.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.1 m -62.83 -29.82 71.02 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 21.9 m -130.44 95.47 3.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.352 0.661 . . . . 0.0 109.411 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 48.5 mt -91.29 147.14 23.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 168.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.57 118.9 44.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -75.12 94.2 2.89 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -66.72 134.75 52.85 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.96 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 104.78 -35.82 4.81 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -98.05 88.44 4.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.048 0.539 . . . . 0.0 110.256 172.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 60.3 p -68.3 -35.47 77.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.446 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 13.9 m -86.41 -32.58 20.81 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.007 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.56 23.03 5.64 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.028 0.931 . . . . 0.0 110.978 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.18 52.06 52.34 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 122.303 -0.248 . . . . 0.0 113.378 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 3.8 p -76.67 110.6 11.38 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.461 0.704 . . . . 0.0 110.458 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -122.01 169.77 14.85 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 173.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 559' ' ' LYS . 14.2 pt-20 -80.22 -12.02 59.67 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.915 0.358 . . . . 0.0 110.888 176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.472 ' HB2' HD13 ' A' ' 488' ' ' LEU . 20.3 m -152.9 137.72 17.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.417 1.087 . . . . 0.0 108.118 172.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.547 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 13.8 p90 -166.26 172.0 11.58 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.531 0.681 . . . . 0.0 111.564 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 541' ' ' ARG . 1.4 mpt_? -118.42 157.24 27.56 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.205 1.402 . . . . 0.0 107.532 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 95.3 m -144.2 119.81 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 41.1 t -113.34 146.63 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.074 0.949 . . . . 0.0 109.404 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 26.8 tp -113.24 125.15 53.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.507 HG21 ' HE2' ' A' ' 484' ' ' LYS . 61.2 t -111.85 154.8 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.132 1.373 . . . . 0.0 107.839 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.415 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.6 p30 -114.51 -174.54 2.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.509 0.324 . . . . 0.0 111.068 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.95 69.23 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.601 1.16 . . . . 0.0 113.217 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.4 -39.34 86.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.886 0.874 . . . . 0.0 111.98 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 107.42 0.47 35.05 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.144 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.415 ' HG2' HD21 ' A' ' 546' ' ' ASN . 8.4 pt-20 -87.08 151.7 23.0 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.438 0.619 . . . . 0.0 110.537 172.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 545' ' ' VAL . 39.8 mt-10 -85.89 99.27 11.29 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.903 0.881 . . . . 0.0 109.459 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.23 -38.57 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.042 -171.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -136.55 157.02 47.75 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.167 0.587 . . . . 0.0 110.051 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.437 ' HG3' HG22 ' A' ' 543' ' ' VAL . 28.1 ttt -159.02 141.9 14.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.845 0.458 . . . . 0.0 110.973 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -132.8 164.19 27.39 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.146 1.378 . . . . 0.0 108.665 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 74.3 m -139.98 121.96 15.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.503 HG21 ' HB ' ' A' ' 459' ' ' ILE . 55.0 t -124.58 133.94 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.452 0.701 . . . . 0.0 110.686 -174.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -114.46 124.96 53.23 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.698 0.799 . . . . 0.0 109.679 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 538' ' ' GLU . 60.4 tttp . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 166.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 470' ' ' ASN . 9.3 t -95.95 157.74 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.315 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 35.6 t -145.15 165.42 28.36 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.427 0.691 . . . . 0.0 110.148 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 459' ' ' ILE . 24.9 mt -81.62 94.6 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.009 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.89 -50.65 19.22 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.015 0.526 . . . . 0.0 111.722 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -140.6 156.33 46.31 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 456' ' ' ILE . 22.1 mt -141.24 145.45 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.75 152.11 44.14 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.447 0.699 . . . . 0.0 111.339 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 462' ' ' GLU . 2.4 pp -62.21 -37.85 86.92 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.704 0.802 . . . . 0.0 112.379 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.686 ' HG2' ' HE3' ' A' ' 559' ' ' LYS . 27.8 mt-10 -83.4 -23.92 32.16 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.216 0.531 . . . . 0.0 109.786 169.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 85.57 21.01 55.31 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.327 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -70.62 -5.67 31.14 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.109 0.455 . . . . 0.0 110.323 -175.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -149.12 159.07 44.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.695 0.798 . . . . 0.0 110.285 166.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.22 124.03 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.766 1.226 . . . . 0.0 108.049 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -96.74 120.52 37.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.177 0.591 . . . . 0.0 109.731 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 483' ' ' ILE . 79.1 mt -118.27 119.44 34.68 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.825 0.85 . . . . 0.0 109.09 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -113.43 131.32 56.06 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 454' ' ' VAL . 49.8 t30 -81.46 109.51 15.99 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.496 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -86.1 -3.68 59.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.929 0.892 . . . . 0.0 111.877 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.6 m -77.42 155.3 31.9 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.335 0.588 . . . . 0.0 112.406 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.95 -24.96 52.35 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.391 174.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.3 OUTLIER -100.97 161.41 13.61 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.791 0.836 . . . . 0.0 109.8 178.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -85.16 121.78 28.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.237 1.015 . . . . 0.0 109.267 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -82.31 115.28 21.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.36 0.664 . . . . 0.0 110.552 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 24.0 p -70.2 99.5 1.52 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.6 tp -85.39 172.04 11.36 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.584 0.753 . . . . 0.0 109.883 -172.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 136.66 -55.76 0.7 Allowed Glycine 0 N--CA 1.471 0.983 0 CA-C-O 121.365 0.425 . . . . 0.0 112.226 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -70.93 -14.56 62.42 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.593 -0.803 . . . . 0.0 110.736 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -79.62 152.67 29.9 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.259 1.024 . . . . 0.0 109.424 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 -156.2 140.37 16.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.129 0.571 . . . . 0.0 110.627 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 12.7 mt -96.64 107.41 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.64 0.776 . . . . 0.0 109.627 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.647 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 67.9 mttm -76.3 161.09 29.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.178 0.513 . . . . 0.0 109.641 169.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -156.06 96.82 1.75 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -91.21 102.48 15.21 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.522 0.677 . . . . 0.0 109.49 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 489' ' ' GLU . 11.4 t -80.11 138.98 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.492 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 538' ' ' GLU . 4.6 pp -63.11 -17.88 62.81 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.918 0.487 . . . . 0.0 112.075 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . 0.41 ' H ' HG12 ' A' ' 487' ' ' VAL . 43.8 tt0 -60.93 -22.54 64.49 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.688 0.795 . . . . 0.0 111.163 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 116.68 28.26 2.56 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.79 -0.641 . . . . 0.0 114.361 170.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.67 165.54 26.67 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.473 0.636 . . . . 0.0 111.106 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -141.0 129.54 22.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.799 0.44 . . . . 0.0 110.23 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 29.4 pt -103.72 148.47 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -133.68 107.62 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.778 0.431 . . . . 0.0 110.153 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -83.71 106.31 15.32 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -81.47 152.46 27.35 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.94 0.4 . . . . 0.0 109.965 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.52 169.74 9.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.148 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 68.8 p -88.96 136.25 30.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 92.8 Cg_endo -73.12 -4.76 16.0 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.896 2.397 . . . . 0.0 113.472 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -90.68 -17.32 27.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.841 0.856 . . . . 0.0 110.837 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -75.53 133.63 40.96 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.776 0.83 . . . . 0.0 109.814 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 67.5 mt -119.89 124.32 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.73 112.1 23.28 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.444 ' HD2' ' H ' ' A' ' 504' ' ' ARG . 2.3 mpt_? -75.18 163.41 27.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.039 0.447 . . . . 0.0 111.067 -172.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.15 118.07 8.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.765 0.826 . . . . 0.0 111.088 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 85.9 -9.13 70.05 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 123.152 0.283 . . . . 0.0 113.784 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -75.98 171.29 14.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.169 0.588 . . . . 0.0 110.428 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -147.97 129.23 14.71 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.581 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.25 104.4 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 121.953 0.883 . . . . 0.0 109.202 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.9 m -87.43 94.24 9.64 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.407 HG12 ' HE1' ' A' ' 534' ' ' TRP . 48.2 t -86.96 99.25 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.33 0.652 . . . . 0.0 110.959 -177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . 0.57 ' HB2' HG22 ' A' ' 527' ' ' VAL . 55.2 m95 -84.96 174.89 9.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.162 0.985 . . . . 0.0 111.889 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -97.35 143.34 28.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.056 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -59.85 -37.75 80.16 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.501 0.72 . . . . 0.0 111.489 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -76.4 -0.57 67.29 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.769 -0.65 . . . . 0.0 114.621 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -78.35 -8.69 58.73 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.879 0.471 . . . . 0.0 111.305 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 69.07 23.23 76.15 Favored Glycine 0 C--N 1.361 1.918 0 C-N-CA 123.221 0.439 . . . . 0.0 113.65 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.17 146.26 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.47 1.108 . . . . 0.0 110.403 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -75.59 114.68 14.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.586 0.755 . . . . 0.0 110.164 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . 0.445 ' NE2' HD12 ' A' ' 526' ' ' LEU . 20.5 t-160 -69.06 117.03 10.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.84 0.456 . . . . 0.0 109.825 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.6 m -134.74 78.47 55.2 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 123.426 0.691 . . . . 0.0 110.001 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.63 151.46 82.71 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.176 1.917 . . . . 0.0 111.061 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.37 -29.64 4.34 Favored 'Cis proline' 0 CA--C 1.559 1.766 0 CA-C-N 120.48 1.207 . . . . 0.0 114.768 4.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 10.0 m -73.38 -26.12 60.86 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.514 0.726 . . . . 0.0 112.619 -164.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 44.6 m -124.32 83.53 2.16 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.445 HD12 ' NE2' ' A' ' 520' ' ' HIS . 20.7 tp -86.77 150.01 24.45 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.404 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 512' ' ' TRP . 67.6 t -134.91 126.05 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.47 -0.769 . . . . 0.0 109.275 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -69.21 95.17 0.74 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 171.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 56.2 tptt -67.46 135.24 52.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.95 0.9 . . . . 0.0 110.052 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 89.57 -15.55 58.52 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.381 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.49 120.64 30.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.042 0.537 . . . . 0.0 109.614 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 14.3 p -78.65 -60.37 2.41 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.194 0.598 . . . . 0.0 112.145 -176.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 17.2 t -116.13 -1.46 12.43 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -166.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.407 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 62.72 23.49 13.99 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.212 1.005 . . . . 0.0 110.761 -174.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.43 67.06 2.25 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 112.396 -0.282 . . . . 0.0 112.396 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 13.8 t -72.22 163.57 27.71 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.875 0.47 . . . . 0.0 110.936 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -177.64 165.77 35.68 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . 0.536 ' HG3' HD21 ' A' ' 488' ' ' LEU . 8.8 pt-20 -59.61 -27.94 66.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.011 0.924 . . . . 0.0 111.902 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.53 ' HB3' HD23 ' A' ' 488' ' ' LEU . 41.1 t -164.3 143.83 7.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.96 0.904 . . . . 0.0 110.167 169.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -156.69 143.92 18.9 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.476 1.11 . . . . 0.0 109.0 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 14.6 ptt-85 -97.29 105.3 17.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.283 0.563 . . . . 0.0 109.776 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 86.0 m -85.16 122.65 29.66 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 71.1 t -121.41 138.35 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.657 1.183 . . . . 0.0 109.857 -171.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 29.4 tp -99.88 122.25 42.54 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 171.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.13 154.0 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.182 1.393 . . . . 0.0 108.435 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.43 HD21 ' HG2' ' A' ' 550' ' ' GLU . 2.5 p30 -117.12 -168.15 1.43 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.93 0.492 . . . . 0.0 111.531 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.2 76.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.787 1.235 . . . . 0.0 113.435 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.25 -38.48 80.17 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.363 0.665 . . . . 0.0 111.403 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 103.24 2.05 47.94 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.378 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.43 ' HG2' HD21 ' A' ' 546' ' ' ASN . 10.3 pt-20 -86.64 152.3 22.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.174 0.512 . . . . 0.0 110.541 171.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -80.12 106.51 12.2 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.016 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 15.8 m -82.04 -35.69 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 122.32 0.248 . . . . 0.0 111.338 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -137.17 149.27 47.14 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.561 0.744 . . . . 0.0 109.562 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.429 ' HG3' HG22 ' A' ' 543' ' ' VAL . 19.2 ttt -150.94 135.24 16.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.138 0.975 . . . . 0.0 109.524 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -145.96 134.22 21.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.984 0.913 . . . . 0.0 109.919 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 36.7 m -97.87 135.86 39.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.437 0.695 . . . . 0.0 109.665 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 459' ' ' ILE . 41.1 t -111.11 129.28 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.789 1.236 . . . . 0.0 108.792 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.27 110.2 22.09 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . 0.686 ' HE3' ' HG2' ' A' ' 462' ' ' GLU . 83.0 tttt . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 43.9 m . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 121.316 0.579 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.49 147.6 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.0 m -142.25 148.28 37.84 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.836 0.854 . . . . 0.0 109.185 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . 0.46 ' HA ' HD12 ' A' ' 468' ' ' LEU . 53.2 mt -69.59 132.53 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.699 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 10.5 tp10 -94.83 -66.28 0.92 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.045 0.538 . . . . 0.0 110.249 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.699 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 34.0 mt-10 -133.81 157.18 46.57 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.497 0.719 . . . . 0.0 109.155 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.535 HD13 ' HB ' ' A' ' 542' ' ' THR . 77.8 mt -141.91 139.6 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.64 143.64 51.37 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 123.666 0.604 . . . . 0.0 110.187 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.566 HD12 ' HG3' ' A' ' 462' ' ' GLU . 2.9 pp -71.05 -29.91 65.94 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.482 0.713 . . . . 0.0 112.009 -175.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.566 ' HG3' HD12 ' A' ' 461' ' ' LEU . 36.7 mt-10 -82.25 -31.63 30.06 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 170.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 97.58 41.25 3.43 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 114.904 -1.043 . . . . 0.0 112.633 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -76.21 -27.02 56.67 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.817 0.847 . . . . 0.0 110.798 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -159.23 163.3 36.0 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.367 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 42.6 t -122.65 114.9 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.9 tp-100 -85.51 107.17 17.33 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 171.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.55 HD22 HD11 ' A' ' 483' ' ' ILE . 29.6 tp -105.35 132.08 51.99 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 123.943 0.897 . . . . 0.0 108.83 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 54.3 tttm -113.7 142.07 46.47 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.355 0.525 . . . . 0.0 111.101 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -89.06 128.77 35.75 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -117.23 12.5 14.4 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.012 0.925 . . . . 0.0 110.979 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 33.8 t -75.88 160.32 30.05 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.723 0.809 . . . . 0.0 110.342 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -87.54 0.25 55.86 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.435 0.694 . . . . 0.0 111.769 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 179.23 7.89 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.611 1.164 . . . . 0.0 109.314 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -53.39 104.49 0.1 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.328 0.651 . . . . 0.0 109.984 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -78.94 112.11 15.79 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 28.8 t -68.84 98.36 0.92 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.776 0.672 . . . . 0.0 109.585 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.1 tp -86.03 174.31 9.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.927 0.891 . . . . 0.0 108.816 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 134.83 -56.53 0.71 Allowed Glycine 0 N--CA 1.468 0.832 0 O-C-N 122.032 -0.417 . . . . 0.0 112.66 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.9 -13.47 62.26 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.788 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -81.47 162.73 23.15 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.147 0.979 . . . . 0.0 110.177 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . 0.575 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 11.9 ptt180 -157.34 127.8 6.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.61 0.764 . . . . 0.0 110.66 -174.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . 0.55 HD11 HD22 ' A' ' 468' ' ' LEU . 50.3 mt -93.49 109.86 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.11 0.564 . . . . 0.0 109.601 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.714 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 97.8 mttt -81.9 167.41 18.99 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.242 0.617 . . . . 0.0 110.827 171.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 534' ' ' TRP . 42.5 ttm180 -151.69 118.38 5.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 166.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . 0.461 ' OE1' ' HB3' ' A' ' 492' ' ' GLU . 23.4 mm-40 -97.84 102.33 14.06 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.024 1.33 . . . . 0.0 108.568 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 40.0 t -75.04 156.78 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.21 0.604 . . . . 0.0 109.807 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 539' ' ' SER . 4.2 pp -54.9 -25.82 31.71 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.411 1.085 . . . . 0.0 113.757 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 491' ' ' GLU . 13.1 pt-20 -86.51 -21.15 27.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.082 0.553 . . . . 0.0 111.249 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 117.45 14.07 7.14 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.516 -0.602 . . . . 0.0 114.188 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 489' ' ' GLU . 50.8 mt-10 -76.49 109.78 10.5 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 117.945 0.873 . . . . 0.0 110.305 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.461 ' HB3' ' OE1' ' A' ' 486' ' ' GLN . 7.0 pt-20 -101.11 98.61 9.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.149 0.98 . . . . 0.0 109.815 178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.48 139.37 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.43 ' HB2' ' HG2' ' A' ' 484' ' ' LYS . . . -135.49 112.74 10.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.856 0.462 . . . . 0.0 111.09 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -82.9 112.87 20.09 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.71 0.804 . . . . 0.0 110.281 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -84.81 145.41 27.88 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.52 169.57 10.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.415 0.686 . . . . 0.0 109.923 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 82.5 p -89.42 132.55 36.93 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.324 0.65 . . . . 0.0 109.25 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.44 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 52.0 Cg_exo -58.39 -15.98 26.86 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.422 2.748 . . . . 0.0 114.808 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -79.38 -24.05 42.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.243 0.617 . . . . 0.0 111.284 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -74.29 130.68 40.17 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.466 0.706 . . . . 0.0 110.23 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 46.7 mt -134.71 124.41 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.468 0.707 . . . . 0.0 109.23 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.74 135.16 43.76 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -77.12 154.24 33.45 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.602 0.761 . . . . 0.0 112.156 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -59.78 131.28 50.43 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.053 0.941 . . . . 0.0 110.371 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 89.49 -42.4 3.0 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.47 0.481 . . . . 0.0 112.57 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -66.25 178.35 1.21 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.367 1.067 . . . . 0.0 112.257 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 15.9 ptp -153.13 150.24 28.88 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.391 -174.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 2.8 p -112.04 118.62 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.256 1.422 . . . . 0.0 108.84 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.6 m -95.33 99.75 11.63 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.27 97.58 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.126 0.57 . . . . 0.0 109.994 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -83.56 172.35 12.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.423 1.089 . . . . 0.0 111.616 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -89.85 154.05 20.18 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.041 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.56 68.07 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.066 0.46 . . . . 0.0 110.416 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -75.21 -8.48 83.45 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.615 -0.72 . . . . 0.0 113.986 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -74.56 -19.24 60.4 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.261 0.625 . . . . 0.0 110.772 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.06 22.65 77.3 Favored Glycine 0 C--N 1.357 1.744 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.313 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.16 142.27 13.46 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.252 1.021 . . . . 0.0 109.969 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -69.5 127.52 33.28 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.574 0.75 . . . . 0.0 110.367 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -65.79 110.06 2.69 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.2 m -135.59 80.17 45.29 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.364 0.666 . . . . 0.0 109.953 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.61 154.08 44.9 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.918 2.412 . . . . 0.0 112.685 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -84.82 -17.61 25.96 Favored 'Cis proline' 0 C--N 1.374 1.882 0 CA-C-N 119.898 0.999 . . . . 0.0 114.005 -0.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 21.3 m -71.46 -38.96 71.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.311 0.644 . . . . 0.0 112.427 -169.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 74.0 m -121.35 97.49 5.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.022 0.529 . . . . 0.0 110.615 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 9.4 mp -93.04 145.26 24.51 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 166.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 91.9 t -127.97 126.69 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -73.09 96.99 2.27 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.24 130.29 42.81 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.15 0.98 . . . . 0.0 110.545 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 94.85 -45.86 2.11 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.511 0.507 . . . . 0.0 112.907 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -75.24 100.72 4.42 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 55.4 m -76.1 -43.61 42.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.058 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 536' ' ' THR . 16.8 m -85.55 -29.23 24.35 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -165.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.64 27.05 4.81 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 124.001 0.92 . . . . 0.0 110.611 -174.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.04 58.65 11.02 Favored Glycine 0 C--N 1.345 1.028 0 O-C-N 122.474 -0.141 . . . . 0.0 113.08 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 533' ' ' SER . 2.4 p -64.51 121.73 15.1 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.194 0.598 . . . . 0.0 110.523 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -154.67 155.1 25.98 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.703 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -78.82 -11.02 59.97 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.1 0.476 . . . . 0.0 110.503 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 558' ' ' LYS . 20.9 m -151.61 130.66 12.62 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.192 0.997 . . . . 0.0 108.728 173.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.474 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 8.5 p90 -161.24 171.77 17.83 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.098 0.959 . . . . 0.0 110.287 172.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.615 ' HD3' ' SD ' ' A' ' 554' ' ' MET . 7.0 ptp180 -129.4 109.36 11.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . 0.535 ' HB ' HD13 ' A' ' 459' ' ' ILE . 21.6 m -87.43 122.27 30.95 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.714 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 41.0 t -108.69 143.86 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.134 0.973 . . . . 0.0 110.075 -170.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 67.1 tp -108.39 123.11 48.34 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.017 0.927 . . . . 0.0 108.539 168.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.575 ' HB ' ' HG3' ' A' ' 482' ' ' ARG . 75.7 t -116.25 144.77 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.389 1.076 . . . . 0.0 108.651 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.57 HD21 ' HG2' ' A' ' 550' ' ' GLU . 0.8 OUTLIER -102.42 -172.89 2.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.809 0.843 . . . . 0.0 111.479 177.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.93 80.99 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.836 1.254 . . . . 0.0 113.723 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . 0.486 ' HB3' ' ND2' ' A' ' 546' ' ' ASN . 9.5 t70 -55.87 -39.67 71.86 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.847 0.859 . . . . 0.0 111.899 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.39 -7.71 28.51 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.532 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.57 ' HG2' HD21 ' A' ' 546' ' ' ASN . 9.4 pt-20 -73.39 141.26 46.99 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.14 0.47 . . . . 0.0 110.293 174.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -84.35 82.47 8.37 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.41 -39.85 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.267 -171.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -131.53 154.73 48.49 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.325 0.65 . . . . 0.0 110.027 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.615 ' SD ' ' HD3' ' A' ' 541' ' ' ARG . 60.0 ttp -161.33 135.67 7.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.731 0.812 . . . . 0.0 109.524 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -128.18 114.09 16.54 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.037 0.935 . . . . 0.0 109.138 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 29.7 m -81.3 113.55 19.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.201 0.6 . . . . 0.0 109.389 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.509 HG21 ' HB ' ' A' ' 459' ' ' ILE . 82.1 t -114.53 112.27 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.019 0.928 . . . . 0.0 110.063 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 2.6 mppt? -98.79 137.61 37.13 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 165.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 82.7 tttt . . . . . 0 CA--C 1.545 0.758 0 C-N-CA 123.764 0.825 . . . . 0.0 110.648 -179.229 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 27.9 t -104.13 117.75 50.2 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 25.1 t -113.05 155.01 25.62 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.088 0.555 . . . . 0.0 110.419 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.47 111.96 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -84.36 -69.47 0.64 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.163 0.585 . . . . 0.0 110.414 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 27.6 mt-10 -117.47 150.28 39.18 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.033 -171.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 50.6 mt -139.58 143.69 30.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.02 148.87 48.31 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -15.72 57.61 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.46 1.104 . . . . 0.0 113.605 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -111.44 -30.79 7.26 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.855 1.262 . . . . 0.0 109.167 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 105.27 31.14 4.45 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.339 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 516' ' ' ALA . 1.9 mppt? -73.71 -8.62 56.72 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.703 0.751 . . . . 0.0 110.915 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -156.83 157.26 34.63 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.289 0.636 . . . . 0.0 111.021 172.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 77.3 t -134.27 113.69 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.868 1.267 . . . . 0.0 107.862 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.7 tp-100 -86.03 107.9 18.0 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.876 0.87 . . . . 0.0 109.497 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.482 HD22 HD22 ' A' ' 544' ' ' LEU . 50.4 mt -92.82 160.62 14.85 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 170.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -145.13 127.34 15.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -89.92 97.92 11.47 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -74.46 -10.98 60.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.255 1.022 . . . . 0.0 111.706 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.5 t -63.56 145.69 55.18 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.697 0.799 . . . . 0.0 111.677 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.26 -0.12 48.12 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.176 0.99 . . . . 0.0 111.412 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.13 164.91 27.32 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 124.36 1.064 . . . . 0.0 108.644 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.92 161.39 10.6 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.751 0.821 . . . . 0.0 111.802 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 13.4 tm0? -136.51 112.43 9.59 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.423 ' HA ' HG12 ' A' ' 502' ' ' ILE . 23.4 p -65.24 103.16 0.74 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.312 0.645 . . . . 0.0 109.896 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.67 161.71 16.71 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -172.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 147.94 -66.39 0.4 Allowed Glycine 0 N--CA 1.473 1.162 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.738 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -69.07 -12.61 61.84 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.295 0.638 . . . . 0.0 111.134 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -67.1 145.08 55.68 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.554 1.142 . . . . 0.0 110.387 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . 0.5 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 4.3 ptt85 -148.76 123.86 10.1 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.293 -171.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . 0.4 HD11 HD11 ' A' ' 468' ' ' LEU . 45.3 mt -90.51 109.26 20.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 123.916 0.886 . . . . 0.0 109.307 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.613 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.0 mttt -77.9 123.95 27.39 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 174.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 49.8 mmm-85 -119.95 92.35 3.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -111.98 116.73 31.06 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 489' ' ' GLU . 13.0 t -103.65 147.78 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.72 -24.45 65.38 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 120.949 0.404 . . . . 0.0 111.392 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . 0.54 ' H ' HG12 ' A' ' 487' ' ' VAL . 22.5 mm-40 -61.53 -23.88 66.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.318 1.047 . . . . 0.0 110.603 171.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 126.0 -21.64 6.16 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-O 119.613 -0.549 . . . . 0.0 113.27 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.15 102.62 0.85 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.185 0.594 . . . . 0.0 111.358 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -126.71 116.25 20.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.612 0.765 . . . . 0.0 110.209 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.4 HD12 ' CZ3' ' A' ' 528' ' ' TRP . 20.2 pt -136.55 176.14 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.812 1.245 . . . . 0.0 109.57 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -149.26 108.54 3.94 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -80.56 105.04 11.51 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.25 149.27 31.91 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -91.88 171.74 8.93 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.665 0.786 . . . . 0.0 110.177 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.4 p -90.65 133.19 33.08 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.491 0.716 . . . . 0.0 109.489 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.14 8.5 3.18 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.021 2.481 . . . . 0.0 113.321 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -101.74 -22.84 14.31 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.802 1.241 . . . . 0.0 110.46 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -84.96 123.69 30.81 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 477' ' ' SER . 54.2 mt -104.61 129.99 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.8 127.87 33.42 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 174.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -88.12 158.87 18.44 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.23 127.02 29.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.667 1.187 . . . . 0.0 112.543 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 65.92 14.71 61.45 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.6 0.562 . . . . 0.0 113.747 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -105.52 -164.05 0.99 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.894 0.878 . . . . 0.0 110.282 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -152.7 163.28 39.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.037 0.935 . . . . 0.0 110.448 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.22 116.65 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.19 101.71 13.39 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 59.3 t -87.32 106.03 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 122.75 0.42 . . . . 0.0 110.347 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . 0.529 ' HB2' HG22 ' A' ' 527' ' ' VAL . 36.3 m95 -94.72 179.46 5.24 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.686 0.795 . . . . 0.0 111.312 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.687 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -107.3 155.44 19.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.288 1.035 . . . . 0.0 110.067 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -65.76 -33.39 75.76 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.19 0.596 . . . . 0.0 110.532 172.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . 0.451 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -78.47 -3.91 86.76 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.939 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . . . -76.58 -8.48 57.31 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.009 0.524 . . . . 0.0 110.562 169.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 73.96 21.11 79.57 Favored Glycine 0 C--N 1.36 1.871 0 C-N-CA 123.517 0.579 . . . . 0.0 113.21 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.38 143.71 16.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.332 1.053 . . . . 0.0 110.391 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -87.15 141.51 28.6 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.525 0.73 . . . . 0.0 110.398 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -61.78 119.17 8.23 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.85 0.86 . . . . 0.0 109.679 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 39.6 m -129.97 75.44 79.49 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.594 0.757 . . . . 0.0 109.881 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.66 161.23 39.96 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.735 2.29 . . . . 0.0 112.05 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.49 17.78 41.41 Favored 'Cis proline' 0 C--N 1.379 2.17 0 CA-C-N 119.771 0.954 . . . . 0.0 113.673 0.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.4 m -90.42 -68.3 0.79 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.185 0.594 . . . . 0.0 110.052 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . 0.443 HG23 ' CD1' ' A' ' 512' ' ' TRP . 72.0 m -90.36 95.05 10.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.115 0.966 . . . . 0.0 110.298 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 10.9 mp -92.47 104.93 17.2 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 173.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 512' ' ' TRP . 96.8 t -91.48 123.64 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . 0.4 ' CZ3' HD12 ' A' ' 493' ' ' ILE . 7.0 t90 -71.53 89.3 0.96 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 173.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 25.2 tptp -76.28 117.96 18.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.953 -175.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 123.28 -40.42 1.99 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.0 116.18 28.59 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . 0.451 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 63.1 p -88.29 -41.65 12.76 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.12 0.568 . . . . 0.0 111.506 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.4 p -79.94 -31.22 40.04 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.687 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 54.49 23.81 4.84 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 123.699 0.799 . . . . 0.0 110.602 -175.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 72.82 67.53 1.79 Allowed Glycine 0 C--N 1.353 1.483 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 -171.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 5.1 p -63.31 140.1 58.84 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.066 0.546 . . . . 0.0 110.733 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -167.59 143.93 8.58 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.628 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.62 -25.55 53.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.287 0.635 . . . . 0.0 110.088 171.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 14.8 m -148.92 120.58 8.04 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.218 1.007 . . . . 0.0 108.484 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -150.64 169.62 21.15 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.989 0.915 . . . . 0.0 110.978 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -117.85 116.99 28.09 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.002 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 40.3 m -96.58 117.34 30.75 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 45.0 t -117.85 139.19 45.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.359 1.064 . . . . 0.0 108.526 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 31.5 tp -110.11 115.87 30.53 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.523 HG21 ' HE3' ' A' ' 484' ' ' LYS . 63.8 t -108.47 151.73 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.494 1.118 . . . . 0.0 108.778 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.446 HD21 ' HG2' ' A' ' 550' ' ' GLU . 0.5 OUTLIER -110.16 -173.09 2.17 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.949 0.5 . . . . 0.0 111.119 -176.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -60.92 -35.67 77.3 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.377 1.071 . . . . 0.0 113.069 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.02 -40.74 98.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.079 0.552 . . . . 0.0 110.524 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 112.48 -11.3 26.0 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.595 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.446 ' HG2' HD21 ' A' ' 546' ' ' ASN . 10.6 pt-20 -69.66 146.47 51.61 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 117.78 0.79 . . . . 0.0 110.009 172.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.442 ' HG2' HG22 ' A' ' 545' ' ' VAL . 38.4 mt-10 -84.71 99.1 10.62 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 33.3 m -78.02 -25.85 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.146 -170.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -144.27 156.13 44.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.678 0.791 . . . . 0.0 109.554 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.518 ' HG3' HG22 ' A' ' 543' ' ' VAL . 56.9 ttp -160.2 146.93 15.89 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.343 0.657 . . . . 0.0 109.715 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.68 117.08 4.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.902 0.481 . . . . 0.0 110.402 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 62.1 m -87.93 103.72 15.95 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.724 0.81 . . . . 0.0 108.874 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.0 p -114.93 129.56 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.153 0.981 . . . . 0.0 110.432 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.94 163.32 32.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.134 0.973 . . . . 0.0 109.948 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm . . . . . 0 CA--C 1.537 0.468 0 C-N-CA 123.843 0.857 . . . . 0.0 109.597 -175.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 12.3 t -98.53 162.74 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.433 1.093 . . . . 0.0 109.954 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 35.7 t -145.82 152.0 38.82 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.876 1.27 . . . . 0.0 109.366 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.0 mt -86.08 107.67 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -86.68 -53.08 5.15 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -171.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 30.0 mt-10 -136.79 163.02 31.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.637 HG23 HH21 ' A' ' 485' ' ' ARG . 89.0 mt -147.67 143.69 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.098 1.359 . . . . 0.0 107.749 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . 0.462 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 37.2 t70 -66.98 148.33 52.1 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.74 0.416 . . . . 0.0 111.138 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 559' ' ' LYS . 0.4 OUTLIER -64.34 -27.42 69.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.968 0.907 . . . . 0.0 112.634 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.01 -32.01 11.86 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.28 0.632 . . . . 0.0 109.571 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 103.35 44.04 1.77 Allowed Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.545 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -91.04 -9.55 45.45 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.542 0.737 . . . . 0.0 111.15 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 29.5 p90 -154.71 161.09 41.69 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.33 0.586 . . . . 0.0 112.373 173.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 42.3 t -127.11 117.62 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.473 1.509 . . . . 0.0 107.335 169.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.3 tp-100 -86.03 112.41 21.21 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.499 HD22 HD11 ' A' ' 483' ' ' ILE . 16.5 tp -112.15 121.34 44.66 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.994 0.917 . . . . 0.0 108.736 -176.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -113.41 139.09 49.19 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.024 0.53 . . . . 0.0 111.698 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.488 ' HB2' HD12 ' A' ' 503' ' ' LEU . 52.9 t30 -92.71 137.23 32.54 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -127.62 16.4 6.98 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.48 0.712 . . . . 0.0 109.92 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 41.9 t -73.79 152.85 40.2 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.759 0.824 . . . . 0.0 109.459 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.86 -21.35 62.44 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.376 0.67 . . . . 0.0 111.014 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.442 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.0 OUTLIER -122.97 174.89 6.9 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.469 0.708 . . . . 0.0 109.687 176.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . 0.492 ' HB2' HG22 ' A' ' 502' ' ' ILE . 5.1 p-10 -65.13 111.65 3.03 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.037 0.935 . . . . 0.0 109.963 172.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -78.03 122.41 25.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.08 0.952 . . . . 0.0 110.426 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 18.2 p -66.2 98.01 0.43 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.687 0.756 . . . . 0.0 109.626 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.6 tp -89.46 162.6 15.65 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 135.13 -51.16 0.84 Allowed Glycine 0 N--CA 1.471 0.998 0 O-C-N 121.451 -0.78 . . . . 0.0 112.334 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -68.66 -13.5 62.4 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.203 -0.999 . . . . 0.0 111.0 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -91.9 162.63 14.34 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 124.713 1.205 . . . . 0.0 110.294 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -153.43 143.75 22.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.97 0.908 . . . . 0.0 110.337 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . 0.499 HD11 HD22 ' A' ' 468' ' ' LEU . 61.5 mt -102.51 107.73 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.438 0.695 . . . . 0.0 109.618 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.668 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.5 mttt -78.67 162.24 26.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.321 0.649 . . . . 0.0 111.626 172.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . 0.637 HH21 HG23 ' A' ' 459' ' ' ILE . 71.2 mtt180 -153.03 102.46 2.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.201 1.4 . . . . 0.0 108.377 170.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . 0.491 ' HG3' ' HD3' ' A' ' 541' ' ' ARG . 8.4 pt20 -101.8 109.33 21.07 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.727 0.811 . . . . 0.0 109.712 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.475 HG12 HD23 ' A' ' 488' ' ' LEU . 6.6 t -89.44 156.58 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.919 0.888 . . . . 0.0 109.19 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 487' ' ' VAL . 2.7 pt? -66.41 -18.15 65.19 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.028 0.442 . . . . 0.0 111.458 173.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . 0.405 ' H ' HG12 ' A' ' 487' ' ' VAL . 37.4 mt-10 -83.08 4.73 25.07 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.49 1.116 . . . . 0.0 111.779 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 102.16 -26.1 25.46 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.145 -0.808 . . . . 0.0 114.469 168.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.53 104.53 0.81 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.677 0.739 . . . . 0.0 111.001 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.53 79.84 1.35 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.4 1.08 . . . . 0.0 108.961 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 35.6 pt -97.54 170.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.741 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -155.49 116.39 3.89 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.735 0.414 . . . . 0.0 110.162 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -80.17 108.49 13.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.966 0.506 . . . . 0.0 109.769 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -76.35 150.3 36.88 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.72 167.76 11.08 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 76.2 p -95.82 132.76 26.56 Favored Pre-proline 0 N--CA 1.477 0.897 0 CA-C-O 118.441 -0.79 . . . . 0.0 108.994 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.486 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 54.3 Cg_exo -55.27 -25.7 48.33 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 123.206 2.604 . . . . 0.0 115.066 -175.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -68.33 -24.67 64.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.038 0.535 . . . . 0.0 111.457 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -73.39 127.34 32.41 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.2 1.0 . . . . 0.0 109.478 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 475' ' ' ASP . 43.4 mt -129.66 118.69 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 470' ' ' ASN . 1.4 tm? -93.36 125.82 38.16 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -67.54 163.34 21.37 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.326 1.05 . . . . 0.0 113.227 -168.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.2 116.69 5.66 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.352 1.061 . . . . 0.0 111.851 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 80.94 -14.93 23.96 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 123.485 0.49 . . . . 0.0 113.926 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -79.29 -172.94 3.42 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.122 0.969 . . . . 0.0 111.068 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -154.42 147.49 24.66 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.33 0.586 . . . . 0.0 112.268 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.76 127.88 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.814 1.245 . . . . 0.0 109.135 172.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.89 99.99 11.12 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.55 97.92 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 122.856 0.462 . . . . 0.0 110.044 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -86.61 178.24 7.12 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.044 0.938 . . . . 0.0 111.506 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.612 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.26 158.49 16.0 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.814 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.74 -28.18 67.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.386 0.675 . . . . 0.0 110.591 172.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -76.16 -16.99 80.3 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.466 -0.788 . . . . 0.0 114.066 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -68.32 -29.3 68.02 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.168 0.587 . . . . 0.0 110.729 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.72 26.47 73.99 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 116.321 -0.399 . . . . 0.0 113.635 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 13.4 p -81.09 159.03 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.827 1.251 . . . . 0.0 111.117 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -73.8 113.9 11.48 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.128 0.571 . . . . 0.0 110.139 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -64.85 110.87 2.57 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.093 0.557 . . . . 0.0 109.625 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.9 m -127.39 69.35 74.73 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.16 0.584 . . . . 0.0 110.254 -175.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.88 149.69 60.2 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.35 2.033 . . . . 0.0 111.87 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.42 -13.87 34.77 Favored 'Cis proline' 0 C--N 1.376 2.012 0 N-CA-C 114.442 0.901 . . . . 0.0 114.442 -2.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.3 m -60.12 -28.55 67.95 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.868 0.867 . . . . 0.0 113.048 -172.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 97.1 m -140.75 101.21 4.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.07 0.948 . . . . 0.0 108.878 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.86 138.94 31.21 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 83.4 t -113.67 117.73 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -70.45 92.34 0.81 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.7 tptt -68.45 135.07 51.11 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.121 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 91.54 -14.77 63.06 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.17 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -100.91 110.89 23.0 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 66.1 p -82.34 -50.79 8.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.327 0.584 . . . . 0.0 111.219 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.597 ' HB3' HG22 ' A' ' 536' ' ' THR . 20.3 m -90.11 -28.51 18.93 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.939 -167.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 56.56 38.09 29.33 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.05 0.94 . . . . 0.0 110.142 -176.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.47 52.91 45.69 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.597 HG22 ' HB3' ' A' ' 533' ' ' SER . 14.3 t -72.21 156.01 39.61 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.51 0.724 . . . . 0.0 110.274 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 179.97 167.87 37.79 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.8 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -71.84 -25.29 61.91 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 18.2 m -154.42 121.69 5.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.856 0.862 . . . . 0.0 109.71 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.45 ' HB3' HG22 ' A' ' 487' ' ' VAL . 31.5 p90 -143.65 150.7 39.13 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.431 0.692 . . . . 0.0 111.06 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.491 ' HD3' ' HG3' ' A' ' 486' ' ' GLN . 5.4 mpt_? -101.92 106.21 17.12 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 33.5 m -84.99 106.34 16.41 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.668 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 28.3 t -105.64 133.48 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.058 0.943 . . . . 0.0 110.127 -170.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.2 tp -98.08 119.67 37.13 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.466 HG22 ' HG2' ' A' ' 551' ' ' GLU . 40.2 t -115.86 143.66 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.428 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.6 p30 -105.38 -172.89 2.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.499 0.32 . . . . 0.0 110.919 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -52.72 -40.23 62.83 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.844 1.258 . . . . 0.0 113.745 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.01 -36.9 82.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.613 0.765 . . . . 0.0 111.87 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.3 -19.48 29.34 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.035 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.428 ' HG2' HD21 ' A' ' 546' ' ' ASN . 11.3 pt-20 -66.95 134.81 52.75 Favored 'General case' 0 C--O 1.248 1.019 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.466 ' HG2' HG22 ' A' ' 545' ' ' VAL . 44.7 mt-10 -79.33 102.27 8.54 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 28.0 m -74.29 -37.39 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.651 -172.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -133.78 159.95 39.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.59 0.756 . . . . 0.0 109.32 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.52 ' HG3' HG22 ' A' ' 543' ' ' VAL . 27.4 ttt -157.41 125.28 5.4 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -137.32 105.86 5.82 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -172.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 49.8 m -83.63 110.32 18.16 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.243 0.617 . . . . 0.0 109.682 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.9 116.62 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -87.6 147.97 25.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.664 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 461' ' ' LEU . 20.6 tttm . . . . . 0 CA--C 1.544 0.733 0 C-N-CA 123.835 0.854 . . . . 0.0 110.254 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . 0.405 ' HB3' ' OG ' ' A' ' 472' ' ' SER . 16.6 m . . . . . 0 CA--C 1.545 0.765 0 CA-C-O 120.999 0.428 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.07 150.8 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.964 1.306 . . . . 0.0 107.646 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 22.7 t -137.12 153.21 50.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.866 0.866 . . . . 0.0 109.629 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 64.8 mt -76.64 107.19 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 14.0 tp10 -78.54 -68.68 0.62 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 28.9 mt-10 -130.44 167.45 18.58 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.864 0.866 . . . . 0.0 109.16 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 23.4 mt -141.43 147.43 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 20.8 t70 -66.65 145.92 55.05 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.249 0.62 . . . . 0.0 111.245 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 462' ' ' GLU . 0.4 OUTLIER -63.94 -33.6 76.09 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.403 1.081 . . . . 0.0 112.74 -178.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.417 ' H ' HD12 ' A' ' 461' ' ' LEU . 44.8 mt-10 -93.38 -23.75 18.33 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.895 0.878 . . . . 0.0 110.285 173.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.67 32.46 7.24 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.001 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -79.26 -15.66 57.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.545 0.738 . . . . 0.0 111.215 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 20.5 p90 -155.15 162.17 41.05 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.277 0.56 . . . . 0.0 111.621 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.46 119.59 59.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 125.296 1.438 . . . . 0.0 107.813 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.413 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 6.2 tp-100 -88.48 109.74 20.28 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.56 ' HB2' HG13 ' A' ' 509' ' ' VAL . 87.0 mt -100.13 155.72 17.58 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 508' ' ' MET . 0.0 OUTLIER -140.47 129.8 23.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 175.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.72 111.2 17.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.947 0.899 . . . . 0.0 110.163 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.73 -10.84 59.7 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.146 0.979 . . . . 0.0 111.939 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 453' ' ' SER . 50.4 m -59.9 148.58 34.44 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.72 -15.81 63.22 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.653 1.181 . . . . 0.0 111.408 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.17 176.34 8.84 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.317 1.047 . . . . 0.0 110.447 -171.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.11 108.7 0.72 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.143 0.977 . . . . 0.0 110.675 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -79.92 117.34 20.68 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.405 0.682 . . . . 0.0 110.423 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.539 ' HA ' HG12 ' A' ' 502' ' ' ILE . 8.9 p -73.3 105.79 4.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.756 0.822 . . . . 0.0 109.906 175.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.5 tp -98.02 163.5 12.74 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 145.63 -64.59 0.45 Allowed Glycine 0 N--CA 1.47 0.915 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -67.91 -12.07 59.97 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.595 0.758 . . . . 0.0 111.465 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -74.19 151.26 40.03 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.886 0.875 . . . . 0.0 109.926 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -153.42 136.49 15.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.074 0.55 . . . . 0.0 111.184 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 62.4 mt -91.71 140.3 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.052 0.941 . . . . 0.0 109.739 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.73 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 55.2 mttm -115.67 107.44 15.1 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.995 0.918 . . . . 0.0 110.149 175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -92.78 93.77 8.61 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 171.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 492' ' ' GLU . 43.3 mt-30 -93.46 104.7 16.82 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.474 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 489' ' ' GLU . 9.7 t -98.63 139.83 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.473 0.709 . . . . 0.0 109.306 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 539' ' ' SER . 4.7 pp -65.5 -21.34 66.62 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.024 0.53 . . . . 0.0 111.403 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . 0.556 ' H ' HG12 ' A' ' 487' ' ' VAL . 28.2 tt0 -71.25 -2.98 17.93 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.925 1.29 . . . . 0.0 110.895 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 110.13 11.96 19.03 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 115.509 0.964 . . . . 0.0 115.509 162.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -118.14 106.55 12.97 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.258 1.029 . . . . 0.0 110.771 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 486' ' ' GLN . 8.9 pt-20 -105.01 80.97 1.68 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 122.364 1.078 . . . . 0.0 109.006 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 38.3 pt -85.67 155.6 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.602 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -128.48 139.2 52.45 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.179 0.592 . . . . 0.0 110.16 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -123.02 105.92 10.38 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.072 0.949 . . . . 0.0 108.614 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 152.33 26.71 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -89.93 163.22 15.06 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.248 0.619 . . . . 0.0 110.512 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 75.7 p -80.24 130.02 67.41 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.79 -17.83 56.94 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.795 2.33 . . . . 0.0 113.333 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -72.55 -16.36 61.76 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.9 0.88 . . . . 0.0 111.623 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -89.37 134.76 33.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.746 0.819 . . . . 0.0 110.914 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 477' ' ' SER . 58.3 mt -137.67 141.2 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.89 140.27 52.05 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -73.84 166.2 23.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.082 0.953 . . . . 0.0 113.062 -168.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.72 124.76 22.28 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.234 1.014 . . . . 0.0 112.349 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 74.08 0.65 57.3 Favored Glycine 0 C--N 1.343 0.942 0 O-C-N 123.664 0.602 . . . . 0.0 114.42 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -88.89 -174.9 4.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.35 0.66 . . . . 0.0 109.451 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . 0.49 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -133.42 161.01 35.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.404 0.682 . . . . 0.0 110.99 -177.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 468' ' ' LEU . 2.4 p -134.64 105.83 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.554 1.142 . . . . 0.0 109.113 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 3.3 m -89.07 104.09 16.66 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.979 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 34.9 t -91.92 103.5 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -87.47 175.55 7.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.114 0.965 . . . . 0.0 111.694 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -96.73 156.5 16.32 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.616 171.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -62.98 -36.2 82.72 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.221 0.609 . . . . 0.0 110.652 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -80.06 4.06 68.23 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.401 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -77.09 -28.28 54.45 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.002 0.521 . . . . 0.0 110.715 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 85.61 9.0 79.42 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.556 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.7 148.57 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.087 0.955 . . . . 0.0 110.642 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -78.64 124.28 28.01 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.294 0.638 . . . . 0.0 109.621 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -63.98 111.32 2.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.814 0.446 . . . . 0.0 109.804 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.4 m -128.38 76.34 78.33 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.414 0.686 . . . . 0.0 109.632 -176.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.12 158.95 55.82 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.716 2.277 . . . . 0.0 111.631 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.69 -38.5 1.66 Allowed 'Cis proline' 0 C--N 1.379 2.15 0 CA-C-N 120.228 1.117 . . . . 0.0 114.757 6.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 60.3 m -63.85 -52.34 60.53 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.006 0.523 . . . . 0.0 112.35 -170.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 40.0 m -87.91 86.43 7.14 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.459 0.647 . . . . 0.0 109.893 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.97 149.82 24.92 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 96.1 t -133.43 121.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -72.66 94.64 1.76 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.4 tptt -70.54 136.18 49.12 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.928 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 96.06 -9.74 67.85 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.527 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -116.07 111.24 20.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.243 0.617 . . . . 0.0 109.587 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 49.3 m -81.82 -44.49 16.85 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.953 0.501 . . . . 0.0 111.846 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.627 ' HB3' HG22 ' A' ' 536' ' ' THR . 34.6 m -87.43 -28.42 22.13 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -168.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 60.3 26.58 16.09 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.285 1.034 . . . . 0.0 110.896 -175.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.66 75.68 0.5 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 533' ' ' SER . 13.1 t -109.36 167.27 10.25 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 123.872 0.869 . . . . 0.0 110.628 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 169.83 -164.97 38.38 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.815 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.43 -54.38 33.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.989 0.916 . . . . 0.0 110.012 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.418 ' HB2' HD23 ' A' ' 488' ' ' LEU . 26.8 m -143.44 132.74 23.26 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -154.01 146.02 23.61 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.776 0.83 . . . . 0.0 109.826 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 13.6 ptp180 -109.67 141.59 42.02 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.313 0.578 . . . . 0.0 110.519 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 47.7 m -95.66 138.36 33.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 169.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.73 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 42.0 t -124.46 150.5 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 41.8 tp -124.54 113.06 17.59 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.464 HG22 ' HG2' ' A' ' 551' ' ' GLU . 54.0 t -100.49 154.02 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.882 1.273 . . . . 0.0 108.779 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.9 -171.67 1.89 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.845 0.458 . . . . 0.0 111.747 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.5 88.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.341 1.056 . . . . 0.0 112.863 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.37 -38.84 92.44 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.645 0.778 . . . . 0.0 110.97 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 112.57 -5.91 26.29 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.852 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -72.81 146.89 45.98 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 118.793 1.297 . . . . 0.0 110.295 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 545' ' ' VAL . 47.3 mt-10 -81.37 94.5 6.79 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.641 0.776 . . . . 0.0 108.982 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 18.8 m -79.0 -19.65 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -168.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -149.11 155.06 40.13 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.059 0.544 . . . . 0.0 109.671 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 50.0 ttp -163.74 131.77 3.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.571 0.748 . . . . 0.0 109.624 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -145.38 126.31 14.49 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.024 0.93 . . . . 0.0 108.848 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 13.4 m -92.91 147.21 23.03 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.009 0.523 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.74 121.19 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.388 1.075 . . . . 0.0 109.307 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.54 118.05 35.57 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? . . . . . 0 C--O 1.24 0.603 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.779 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 CA--C 1.546 0.801 0 CA-C-O 120.712 0.291 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.28 143.16 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 19.5 m -130.14 150.34 51.45 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.216 1.006 . . . . 0.0 109.577 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 53.4 mt -76.3 106.13 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.449 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 11.3 tp10 -78.02 -55.66 5.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.751 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 43.9 mt-10 -140.57 165.7 26.75 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.824 0.85 . . . . 0.0 109.9 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.62 ' HB ' HG21 ' A' ' 557' ' ' VAL . 79.6 mt -143.18 151.39 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.83 149.92 48.4 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.455 0.702 . . . . 0.0 111.002 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.483 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.4 pt? -64.02 -39.99 95.35 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.714 0.806 . . . . 0.0 112.004 -177.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.483 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 18.3 mt-10 -89.18 -27.24 20.81 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.309 1.044 . . . . 0.0 109.199 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 98.32 40.64 3.41 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.789 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 516' ' ' ALA . 1.5 mppt? -83.9 -10.67 57.81 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.765 0.426 . . . . 0.0 111.387 176.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -156.02 162.14 40.36 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.91 0.386 . . . . 0.0 111.635 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . 0.41 HG13 HG12 ' A' ' 459' ' ' ILE . 59.0 t -133.07 112.37 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.367 1.467 . . . . 0.0 107.914 174.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.449 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 14.3 tp60 -86.43 111.58 20.67 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.168 0.987 . . . . 0.0 110.094 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 7.0 mp -92.29 160.55 15.08 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.424 1.09 . . . . 0.0 109.453 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . 0.717 ' HE3' ' HB3' ' A' ' 471' ' ' ASN . 3.3 tmmm? -147.0 128.24 14.78 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -88.44 107.84 19.07 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.216 0.606 . . . . 0.0 109.802 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.717 ' HB3' ' HE3' ' A' ' 469' ' ' LYS . 12.0 p-10 -95.77 19.07 11.86 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.611 0.764 . . . . 0.0 112.046 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 45.0 m -76.55 151.94 36.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.674 0.39 . . . . 0.0 110.971 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -78.75 -22.75 46.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.885 0.874 . . . . 0.0 110.612 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -116.69 168.05 10.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.123 0.969 . . . . 0.0 111.247 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.33 111.0 4.35 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.72 0.808 . . . . 0.0 110.342 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.59 109.61 17.56 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 54.6 p -68.95 114.31 7.13 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.083 0.553 . . . . 0.0 110.359 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 7.6 tp -90.78 169.79 10.66 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.033 0.933 . . . . 0.0 109.027 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 143.15 -66.65 0.46 Allowed Glycine 0 N--CA 1.473 1.117 0 O-C-N 121.996 -0.44 . . . . 0.0 112.467 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . 0.456 HD22 ' N ' ' A' ' 480' ' ' ASN . 0.8 OUTLIER -71.99 -9.9 59.03 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.37 0.668 . . . . 0.0 111.009 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -70.39 143.69 51.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.836 0.854 . . . . 0.0 109.796 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 22.9 ptt-85 -140.87 137.79 33.47 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.741 0.416 . . . . 0.0 110.747 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 45.6 mt -96.75 106.92 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.2 mttt -75.3 147.23 40.37 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.77 91.89 2.29 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -99.55 104.46 16.26 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.487 -170.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 31.7 t -66.44 154.91 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 539' ' ' SER . 4.3 pp -51.79 -32.1 29.85 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -173.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.35 -11.35 58.64 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.377 0.671 . . . . 0.0 112.063 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 125.17 -26.68 5.5 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.979 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.81 111.57 1.93 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.48 0.712 . . . . 0.0 111.633 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.98 145.09 43.87 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.24 0.543 . . . . 0.0 111.385 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.71 153.89 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.89 1.276 . . . . 0.0 108.108 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -133.01 108.45 8.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.407 0.283 . . . . 0.0 110.356 -177.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -85.06 103.7 14.31 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -91.44 143.65 26.39 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.39 0.614 . . . . 0.0 109.489 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -83.93 170.79 13.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.482 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 2.6 t -94.06 140.23 22.83 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.151 0.58 . . . . 0.0 109.715 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.78 -26.1 78.79 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.877 3.052 . . . . 0.0 114.128 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -68.39 -19.41 64.62 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.4 0.68 . . . . 0.0 111.771 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -82.65 136.86 34.66 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.518 0.727 . . . . 0.0 110.617 -174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 66.7 mt -131.03 150.81 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . 0.497 HD21 ' HB ' ' A' ' 509' ' ' VAL . 0.3 OUTLIER -123.99 135.34 53.56 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -81.25 156.76 25.44 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.704 0.801 . . . . 0.0 111.674 -168.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.33 132.76 52.62 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.958 0.903 . . . . 0.0 112.372 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 64.29 15.83 59.46 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.921 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -107.69 -166.53 1.15 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.653 0.781 . . . . 0.0 109.908 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 171.89 16.14 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.19 0.519 . . . . 0.0 111.731 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 503' ' ' LEU . 7.4 p -146.49 142.1 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.872 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 5.2 m -118.86 109.08 15.6 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 45.7 t -90.27 100.33 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -82.21 175.93 9.89 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.674 1.19 . . . . 0.0 111.508 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.36 153.45 19.65 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.337 173.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -64.39 -32.11 73.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.115 0.566 . . . . 0.0 110.9 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -71.4 -16.02 75.34 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.992 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . . . -70.79 -23.7 62.43 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.3 0.64 . . . . 0.0 111.473 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 78.46 36.64 29.63 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 123.235 0.334 . . . . 0.0 113.618 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.79 147.18 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.183 0.993 . . . . 0.0 110.386 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -74.72 123.31 24.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.487 0.715 . . . . 0.0 110.961 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -67.46 111.15 3.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.4 0.68 . . . . 0.0 109.681 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.7 m -134.84 80.3 49.65 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.117 0.567 . . . . 0.0 110.091 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.37 156.2 61.46 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.857 2.371 . . . . 0.0 112.164 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -99.9 30.7 11.62 Favored 'Cis proline' 0 C--N 1.38 2.186 0 CA-C-N 119.684 0.923 . . . . 0.0 113.591 -0.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 39.5 m -112.44 -38.61 4.61 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.989 0.516 . . . . 0.0 111.149 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 60.3 m -118.3 96.34 5.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.49 0.716 . . . . 0.0 109.718 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 58.1 mt -87.63 149.91 23.99 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 65.1 t -137.29 116.74 15.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -72.55 98.25 2.27 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 0.4 OUTLIER -66.14 134.11 52.09 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.88 0.872 . . . . 0.0 110.16 -177.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 92.28 -24.79 20.63 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.958 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -87.23 103.61 15.6 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 55.4 p -77.97 -45.27 24.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.815 0.446 . . . . 0.0 111.076 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 536' ' ' THR . 15.2 m -93.37 -30.26 15.2 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -166.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 55.7 32.73 19.94 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 123.644 0.777 . . . . 0.0 110.352 -174.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 72.28 59.92 4.35 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.214 -0.448 . . . . 0.0 113.027 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 533' ' ' SER . 12.2 p -65.28 147.7 52.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.985 0.514 . . . . 0.0 111.761 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 175.97 159.85 22.43 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.87 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -73.11 -9.55 58.84 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.06 0.544 . . . . 0.0 110.818 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 488' ' ' LEU . 29.6 t -157.55 139.43 14.15 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 124.589 1.156 . . . . 0.0 108.252 172.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.97 122.13 5.07 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.021 0.528 . . . . 0.0 111.282 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.603 ' HD2' ' SD ' ' A' ' 554' ' ' MET . 52.9 ttp180 -84.5 105.43 15.31 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 32.2 m -94.25 128.57 40.8 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 22.8 t -120.33 145.94 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.845 0.858 . . . . 0.0 109.427 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 34.2 tp -114.88 119.42 36.51 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.5 HG22 ' HG2' ' A' ' 551' ' ' GLU . 60.9 t -106.49 154.65 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.009 1.324 . . . . 0.0 108.632 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 550' ' ' GLU . 1.2 p30 -115.52 -173.64 2.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.536 0.335 . . . . 0.0 111.675 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.24 -36.56 71.07 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.753 1.221 . . . . 0.0 112.611 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . 0.424 ' HB3' HD21 ' A' ' 546' ' ' ASN . 20.1 t70 -60.65 -38.98 86.65 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.755 0.822 . . . . 0.0 111.635 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.15 -12.44 31.45 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.542 -174.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.518 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 0.7 OUTLIER -74.82 149.65 39.56 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.193 0.497 . . . . 0.0 110.072 177.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.5 ' HG2' HG22 ' A' ' 545' ' ' VAL . 34.5 mt-10 -88.54 92.71 9.29 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.562 0.745 . . . . 0.0 109.31 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.53 -34.57 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -168.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.574 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -135.17 165.81 24.55 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.124 0.57 . . . . 0.0 109.86 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.603 ' SD ' ' HD2' ' A' ' 541' ' ' ARG . 50.1 ttm -169.57 115.97 0.57 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.306 0.642 . . . . 0.0 109.519 -176.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 53.0 ttm-85 -124.35 115.42 20.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.483 0.713 . . . . 0.0 109.825 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 17.4 m -92.11 126.31 37.14 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.73 0.812 . . . . 0.0 109.622 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.62 HG21 ' HB ' ' A' ' 459' ' ' ILE . 78.2 t -123.72 123.71 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.623 0.769 . . . . 0.0 109.701 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 138.13 49.81 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.14 0.976 . . . . 0.0 109.718 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 63.0 tttp . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 124.103 0.961 . . . . 0.0 111.383 -179.076 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 121.763 0.792 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 5.0 t -110.53 146.54 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 23.2 t -124.34 177.85 5.67 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.603 1.161 . . . . 0.0 109.587 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.7 mt -98.4 123.27 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.504 ' HG3' ' HG2' ' A' ' 458' ' ' GLU . 6.6 tp10 -87.68 -76.11 0.39 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 457' ' ' GLU . 55.0 mm-40 -122.91 160.94 25.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.393 1.077 . . . . 0.0 109.383 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.447 HG12 HG13 ' A' ' 466' ' ' VAL . 66.2 mt -140.68 148.14 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.26 147.99 51.43 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.42 HD12 ' HG3' ' A' ' 462' ' ' GLU . 3.3 pp -67.0 -36.34 81.94 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.541 0.736 . . . . 0.0 111.456 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.42 ' HG3' HD12 ' A' ' 461' ' ' LEU . 40.2 mt-10 -81.34 -31.88 33.23 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 170.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . 0.547 ' HA3' HH22 ' A' ' 485' ' ' ARG . . . 92.7 51.47 2.31 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.177 -175.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -81.97 -18.97 41.61 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.361 0.665 . . . . 0.0 110.505 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -156.42 158.63 37.64 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.889 0.476 . . . . 0.0 111.554 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . 0.447 HG13 HG12 ' A' ' 459' ' ' ILE . 61.1 t -127.3 107.12 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.889 1.275 . . . . 0.0 108.19 174.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 4.7 tp-100 -85.76 114.61 22.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 109.27 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 70.4 mt -100.96 151.84 21.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.695 1.198 . . . . 0.0 109.334 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 4.6 tmmm? -138.94 136.8 35.84 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.751 0.821 . . . . 0.0 109.568 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.455 ' OD1' ' HA ' ' A' ' 505' ' ' ALA . 25.9 t-20 -90.97 133.24 35.44 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.106 0.963 . . . . 0.0 111.335 -176.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.403 HD21 ' HE3' ' A' ' 469' ' ' LYS . 20.8 m120 -110.91 7.26 21.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.71 0.804 . . . . 0.0 111.95 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 48.8 m -80.53 155.5 26.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.274 0.63 . . . . 0.0 111.718 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -85.4 -19.4 31.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.61 0.764 . . . . 0.0 110.053 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.492 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.1 OUTLIER -123.24 150.91 42.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.487 1.115 . . . . 0.0 109.108 -178.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -69.01 135.76 51.39 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.296 0.638 . . . . 0.0 111.397 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -89.65 118.33 29.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.517 0.727 . . . . 0.0 109.923 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 15.4 p -65.12 109.82 2.31 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 503' ' ' LEU . 4.8 tp -102.14 175.66 5.46 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -171.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 122.05 -50.57 0.83 Allowed Glycine 0 N--CA 1.469 0.857 0 CA-C-O 121.993 0.774 . . . . 0.0 111.179 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . 0.595 ' HB3' ' HB2' ' A' ' 547' ' ' ALA . 9.0 m120 -65.46 -24.28 67.13 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 113.368 -1.416 . . . . 0.0 110.543 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.475 ' CZ3' HG21 ' A' ' 552' ' ' VAL . 13.6 m0 -77.12 164.23 25.88 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.061 0.945 . . . . 0.0 111.289 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -156.21 138.67 14.9 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.523 -170.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.06 113.57 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.421 1.088 . . . . 0.0 108.61 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -79.61 140.92 36.96 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . 0.547 HH22 ' HA3' ' A' ' 463' ' ' GLY . 74.4 ttt180 -143.8 96.38 2.89 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 173.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . 0.519 ' HG3' ' HB2' ' A' ' 541' ' ' ARG . 5.6 pt20 -98.36 103.87 15.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.864 1.265 . . . . 0.0 109.434 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.71 153.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.602 0.761 . . . . 0.0 109.178 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.419 HD23 ' HB2' ' A' ' 539' ' ' SER . 2.4 pp -66.23 -14.37 61.81 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.391 0.541 . . . . 0.0 111.679 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -62.01 -23.37 66.4 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.613 0.765 . . . . 0.0 110.939 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 104.37 -8.53 48.41 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.704 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -78.33 105.47 9.6 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 123.44 0.696 . . . . 0.0 110.496 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.08 133.24 51.11 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.514 173.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 24.2 pt -128.58 156.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.16 0.984 . . . . 0.0 108.661 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -131.11 108.01 9.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -87.91 103.56 15.79 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -87.08 146.54 26.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 170.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -83.43 170.24 14.7 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.08 0.552 . . . . 0.0 110.935 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.9 p -84.79 129.92 54.87 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.213 0.605 . . . . 0.0 109.372 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.526 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 36.3 Cg_endo -62.31 -14.32 37.84 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.893 2.395 . . . . 0.0 113.465 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.88 1.81 41.52 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.971 0.908 . . . . 0.0 111.977 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -103.26 136.92 42.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.606 0.762 . . . . 0.0 111.002 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 69.5 mt -118.12 136.59 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . 0.479 ' HB2' HD22 ' A' ' 478' ' ' LEU . 3.1 tm? -100.54 121.25 41.27 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -79.94 161.95 25.22 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.305 0.642 . . . . 0.0 112.655 -171.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . 0.455 ' HA ' ' OD1' ' A' ' 470' ' ' ASN . . . -73.95 133.96 43.1 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.083 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 70.15 1.26 33.19 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.509 0.505 . . . . 0.0 113.817 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -101.97 174.72 5.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.956 0.902 . . . . 0.0 110.35 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -140.68 144.02 35.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.013 0.525 . . . . 0.0 111.432 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.53 128.97 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.835 0.854 . . . . 0.0 108.907 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.3 m -103.79 103.31 13.17 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 56.7 t -87.4 97.85 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 122.803 0.441 . . . . 0.0 110.167 -176.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . 0.543 ' HB2' HG22 ' A' ' 527' ' ' VAL . 43.9 m95 -90.94 175.47 6.96 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.849 0.859 . . . . 0.0 112.007 -175.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -104.04 152.85 21.56 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.357 1.063 . . . . 0.0 110.308 174.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -63.54 -38.96 93.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.422 0.689 . . . . 0.0 111.879 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -82.7 -0.63 90.23 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.34 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -83.25 7.0 17.6 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.404 0.681 . . . . 0.0 111.632 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 76.83 38.56 30.89 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 113.572 0.189 . . . . 0.0 113.572 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 4.6 p -146.5 137.33 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.703 0.801 . . . . 0.0 110.617 -170.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -91.09 151.49 20.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.101 0.961 . . . . 0.0 111.139 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -67.05 112.27 4.3 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.5 m -131.78 79.34 68.39 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.672 0.789 . . . . 0.0 109.889 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.95 156.25 56.53 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.716 2.278 . . . . 0.0 111.845 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -93.4 4.42 57.66 Favored 'Cis proline' 0 C--N 1.381 2.244 0 CA-C-N 119.815 0.97 . . . . 0.0 113.491 2.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.0 m -82.81 -30.09 29.04 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.605 0.762 . . . . 0.0 111.595 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 84.0 m -140.75 102.84 4.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.367 0.667 . . . . 0.0 110.658 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 9.7 mp -97.49 103.77 15.73 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 512' ' ' TRP . 72.0 t -89.29 122.19 40.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -71.07 87.1 0.75 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 22.1 tptp -68.01 116.54 8.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.701 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 120.84 -45.36 1.24 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -172.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.11 105.85 12.65 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . 0.455 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 34.2 p -72.18 -47.16 52.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.483 0.713 . . . . 0.0 111.243 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 536' ' ' THR . 48.7 m -99.23 -14.34 19.33 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.489 0.715 . . . . 0.0 112.271 -173.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 61.72 23.76 14.01 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.04 0.936 . . . . 0.0 109.582 -171.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.92 65.2 2.71 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-N 116.54 -0.3 . . . . 0.0 112.717 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 533' ' ' SER . 10.8 p -59.55 166.11 2.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.167 0.987 . . . . 0.0 113.624 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 177.72 160.21 23.92 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.034 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -78.4 -27.12 46.68 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.852 0.326 . . . . 0.0 110.399 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.419 ' HB2' HD23 ' A' ' 488' ' ' LEU . 2.7 m -145.71 129.5 17.22 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 168.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.87 137.79 20.24 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.843 0.857 . . . . 0.0 110.887 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.519 ' HB2' ' HG3' ' A' ' 486' ' ' GLN . 1.3 mpt_? -91.68 116.14 28.63 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 78.8 m -108.12 119.34 39.2 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . . . . . . . . . 20.4 t -115.67 123.25 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.024 0.93 . . . . 0.0 109.744 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 42.2 tp -81.25 124.43 29.31 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 546' ' ' ASN . 53.5 t -126.45 144.37 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.824 0.85 . . . . 0.0 109.556 -173.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.471 ' O ' HG12 ' A' ' 545' ' ' VAL . 4.1 t30 -84.03 162.69 20.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.907 0.883 . . . . 0.0 109.935 170.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 480' ' ' ASN . . . -45.51 -41.49 9.7 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.439 1.495 . . . . 0.0 114.48 -175.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.26 -32.44 68.37 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.557 1.143 . . . . 0.0 112.897 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.85 -6.29 31.07 Favored Glycine 0 N--CA 1.464 0.551 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -168.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.435 ' HG2' HD22 ' A' ' 546' ' ' ASN . 13.8 pt-20 -67.81 117.63 9.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.568 0.747 . . . . 0.0 109.642 174.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.42 116.81 15.52 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.475 HG21 ' CZ3' ' A' ' 481' ' ' TRP . 16.1 m -95.33 -28.86 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 122.719 0.408 . . . . 0.0 111.546 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -156.89 147.33 21.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.167 0.987 . . . . 0.0 109.251 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 554' ' ' MET . 0.0 OUTLIER -147.26 147.67 30.65 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.119 0.568 . . . . 0.0 109.694 -178.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . 0.435 ' NH1' HG22 ' A' ' 557' ' ' VAL . 2.1 tmt_? -160.86 108.51 1.54 Allowed 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 63.2 m -81.55 138.13 35.46 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.619 0.768 . . . . 0.0 109.573 174.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.435 HG22 ' NH1' ' A' ' 555' ' ' ARG . 36.2 t -115.9 146.63 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.686 1.194 . . . . 0.0 109.133 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 113.1 6.18 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.005 0.922 . . . . 0.0 108.823 166.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 57.8 tttm . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 125.948 1.699 . . . . 0.0 111.384 176.755 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.559 1.321 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.39 128.51 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 171.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 28.6 t -117.18 174.2 6.25 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.17 0.588 . . . . 0.0 109.785 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 36.8 mt -93.03 116.23 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 469' ' ' LYS . 7.2 tp10 -70.33 -71.38 0.25 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.738 0.815 . . . . 0.0 109.92 -177.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.0 mt-10 -126.56 159.38 33.64 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.183 0.993 . . . . 0.0 108.705 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.59 HD13 ' HB ' ' A' ' 542' ' ' THR . 15.9 mt -137.09 131.3 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.67 127.0 31.16 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.655 ' HB2' ' HA ' ' A' ' 559' ' ' LYS . 0.9 OUTLIER -80.31 -17.83 50.96 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.534 0.521 . . . . 0.0 111.491 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -12.71 60.11 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 165.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 79.09 21.5 67.68 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.107 -0.951 . . . . 0.0 115.144 164.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -91.21 -13.16 33.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.058 0.429 . . . . 0.0 111.109 -176.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -155.29 158.7 39.19 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.5 116.81 46.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.114 1.366 . . . . 0.0 107.693 168.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.416 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.4 tp-100 -89.58 113.64 25.1 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.02 140.48 34.19 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 21.3 tptm -113.96 129.28 56.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.425 ' HB2' HD12 ' A' ' 503' ' ' LEU . 48.2 t30 -88.1 100.08 12.68 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -90.94 6.92 42.69 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.14 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.9 t -76.11 161.41 28.87 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.596 0.758 . . . . 0.0 111.066 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.75 -9.55 58.09 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.233 0.613 . . . . 0.0 111.616 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.403 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.3 OUTLIER -130.08 168.41 16.8 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.161 0.584 . . . . 0.0 110.038 177.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.19 118.42 10.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.484 0.714 . . . . 0.0 109.327 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -94.39 118.78 32.15 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.446 0.698 . . . . 0.0 110.391 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 67.6 p -71.94 116.97 12.97 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.397 0.679 . . . . 0.0 110.273 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.53 177.82 6.0 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 146.05 -67.42 0.41 Allowed Glycine 0 N--CA 1.474 1.2 0 CA-C-O 121.494 0.496 . . . . 0.0 112.743 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -73.23 -9.79 59.08 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.702 -0.749 . . . . 0.0 109.692 167.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -72.05 131.08 42.39 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.97 0.908 . . . . 0.0 109.148 171.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 21.5 ptt-85 -139.93 127.95 22.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.681 0.792 . . . . 0.0 110.375 -173.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . 0.435 ' HB ' ' HH2' ' A' ' 534' ' ' TRP . 10.3 mt -91.23 105.86 16.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.551 ' HE3' HG21 ' A' ' 545' ' ' VAL . 97.8 mttt -76.71 134.2 39.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.661 0.384 . . . . 0.0 110.385 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -118.85 91.4 3.55 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -97.11 102.05 13.75 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.077 0.951 . . . . 0.0 109.052 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 488' ' ' LEU . 5.8 t -101.39 147.55 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.098 0.559 . . . . 0.0 110.786 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.477 HD23 HG12 ' A' ' 487' ' ' VAL . 2.3 pt? -60.78 -24.73 66.0 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.544 0.738 . . . . 0.0 111.996 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.91 -27.56 68.9 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.346 1.058 . . . . 0.0 111.898 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 124.18 -26.4 5.83 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.677 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.74 100.29 2.32 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.977 0.894 . . . . 0.0 110.295 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -113.43 97.22 6.33 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.887 -1.052 . . . . 0.0 108.321 175.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 25.4 pt -108.71 178.91 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.547 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -156.3 118.45 4.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.32 0.648 . . . . 0.0 109.473 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -86.72 107.72 18.36 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -85.02 146.72 27.04 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.707 0.765 . . . . 0.0 110.195 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -80.18 173.35 12.68 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.955 1.302 . . . . 0.0 109.917 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 71.8 p -89.42 136.96 29.28 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.406 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 74.6 Cg_exo -52.57 -26.94 30.77 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.175 2.583 . . . . 0.0 114.435 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -79.31 -24.47 42.82 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.731 0.813 . . . . 0.0 112.227 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -66.9 127.78 33.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.232 0.613 . . . . 0.0 109.967 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 45.2 mt -129.81 134.08 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.812 0.845 . . . . 0.0 108.94 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 470' ' ' ASN . 0.8 OUTLIER -108.26 130.9 55.15 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -77.75 155.4 31.22 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.751 0.82 . . . . 0.0 111.553 -170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.97 120.73 13.14 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.723 0.809 . . . . 0.0 110.793 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 88.08 -2.26 85.32 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.575 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -95.98 176.02 6.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.05 0.54 . . . . 0.0 110.173 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -148.01 136.75 21.79 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.756 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 3.4 p -101.78 114.66 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.406 0.682 . . . . 0.0 109.781 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.99 94.95 10.0 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 89.6 t -82.64 104.6 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . 0.543 ' HB2' HG22 ' A' ' 527' ' ' VAL . 37.7 m95 -93.61 176.83 6.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.065 0.946 . . . . 0.0 112.107 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -98.66 142.07 30.69 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.02 171.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -66.86 -32.7 74.14 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.191 0.596 . . . . 0.0 111.152 176.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -67.57 -19.59 71.12 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.002 -0.545 . . . . 0.0 113.817 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -66.31 -18.45 65.36 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.153 0.581 . . . . 0.0 110.79 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.17 27.56 72.73 Favored Glycine 0 C--N 1.352 1.454 0 C-N-CA 122.711 0.196 . . . . 0.0 112.878 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.58 149.26 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.436 1.095 . . . . 0.0 110.942 -174.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -68.74 119.55 13.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.279 0.632 . . . . 0.0 110.999 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . 0.451 ' NE2' HD12 ' A' ' 526' ' ' LEU . 15.6 t-160 -76.44 124.69 27.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.439 0.695 . . . . 0.0 110.065 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 58.5 m -152.41 79.35 6.09 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.876 0.87 . . . . 0.0 110.464 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.49 161.05 37.88 Favored 'Trans proline' 0 CA--C 1.565 2.037 0 C-N-CA 122.909 2.406 . . . . 0.0 111.844 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.37 -9.17 43.44 Favored 'Cis proline' 0 C--N 1.382 2.314 0 CA-C-N 120.355 1.162 . . . . 0.0 113.904 1.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.1 m -66.33 -37.15 84.7 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.798 0.839 . . . . 0.0 111.753 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 97.0 m -139.46 89.81 2.36 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.775 0.83 . . . . 0.0 108.946 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 30.5 tp -91.83 138.98 31.11 Favored 'General case' 0 C--O 1.209 -1.078 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 512' ' ' TRP . 96.6 t -125.66 122.7 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.03 0.832 . . . . 0.0 109.15 -175.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -70.17 94.55 0.91 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 23.0 tptm -71.32 117.62 13.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.428 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 121.44 -36.85 3.14 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.23 127.05 34.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.913 0.485 . . . . 0.0 110.684 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 58.4 p -99.42 -36.23 9.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.852 0.861 . . . . 0.0 110.978 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.456 ' OG ' HG22 ' A' ' 536' ' ' THR . 28.9 t -87.54 -35.51 18.11 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.653 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 51.48 34.51 12.34 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.833 0.853 . . . . 0.0 110.423 -174.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 64.88 64.21 3.69 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.195 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.456 HG22 ' OG ' ' A' ' 533' ' ' SER . 12.4 t -104.7 168.38 9.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.927 0.491 . . . . 0.0 110.673 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 168.0 -162.51 36.29 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.225 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -69.21 -34.64 75.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.208 0.603 . . . . 0.0 111.253 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.7 m -158.59 137.27 11.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.208 1.003 . . . . 0.0 109.021 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.459 ' HB3' HG22 ' A' ' 487' ' ' VAL . 4.7 p90 -149.98 125.38 10.19 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.83 0.824 . . . . 0.0 112.117 -177.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 72.7 ttt-85 -77.92 102.04 7.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.722 174.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . 0.59 ' HB ' HD13 ' A' ' 459' ' ' ILE . 16.3 m -95.86 124.52 39.9 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 46.7 t -125.33 134.92 65.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 C-N-CA 123.696 0.798 . . . . 0.0 109.937 -172.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 26.7 tp -97.69 115.96 28.98 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 166.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.551 HG21 ' HE3' ' A' ' 484' ' ' LYS . 92.3 t -110.06 159.17 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.014 1.326 . . . . 0.0 108.702 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -124.56 -170.35 2.14 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.732 0.413 . . . . 0.0 111.783 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.69 73.97 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.378 1.071 . . . . 0.0 112.948 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.33 -36.64 84.79 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.65 0.78 . . . . 0.0 111.07 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.26 -18.57 27.98 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.646 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.68 160.42 32.25 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.506 0.67 . . . . 0.0 110.59 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -92.71 108.0 19.65 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.186 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.17 -23.73 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.932 0.493 . . . . 0.0 111.494 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -151.63 131.66 13.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.814 0.845 . . . . 0.0 109.065 174.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 12.3 ttm -122.83 108.83 13.44 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -126.76 105.17 8.49 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 66.6 m -84.52 136.62 33.73 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.07 138.91 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.07 137.58 51.99 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.25 1.02 . . . . 0.0 108.695 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 461' ' ' LEU . 55.8 tttm . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 124.477 1.111 . . . . 0.0 109.962 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . 0.418 ' HB2' ' HH2' ' A' ' 481' ' ' TRP . 23.1 m . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.48 0.181 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 25.9 t -125.41 134.99 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.06 0.944 . . . . 0.0 108.616 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 20.8 m -115.5 173.05 6.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.129 0.972 . . . . 0.0 110.668 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 52.9 mt -94.7 111.9 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 469' ' ' LYS . 9.5 tp10 -82.63 -63.6 1.34 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.743 0.417 . . . . 0.0 110.968 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 28.9 mt-10 -121.29 151.68 39.78 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 58.9 mt -133.32 130.51 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -78.62 129.18 34.47 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.81 0.694 . . . . 0.0 109.882 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.442 HD13 ' HE3' ' A' ' 559' ' ' LYS . 2.2 pp -76.27 -23.72 54.44 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.247 0.342 . . . . 0.0 111.301 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -68.85 -29.4 67.71 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 167.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 83.8 25.3 46.36 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.498 -0.774 . . . . 0.0 114.032 172.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -82.28 -27.4 32.38 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.377 0.589 . . . . 0.0 111.12 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -146.52 160.03 42.66 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-O 121.458 0.647 . . . . 0.0 112.424 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 95.3 t -130.6 119.72 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 125.177 1.391 . . . . 0.0 107.417 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 4.1 tp-100 -89.19 122.31 32.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.832 0.853 . . . . 0.0 109.771 178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 75.5 mt -102.15 162.23 13.07 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.771 0.829 . . . . 0.0 109.629 171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 1.2 tmtp? -146.75 131.05 17.51 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -86.8 111.26 20.57 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.81 -17.5 47.29 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.032 0.933 . . . . 0.0 112.291 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 81.0 p -70.13 158.15 36.28 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.072 0.463 . . . . 0.0 111.669 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.64 0.67 29.26 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.178 0.991 . . . . 0.0 112.326 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.29 175.62 10.38 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.837 0.855 . . . . 0.0 109.281 -174.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.93 125.98 28.58 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.043 0.537 . . . . 0.0 109.593 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -100.36 131.65 46.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.178 0.991 . . . . 0.0 110.493 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 26.4 p -66.89 124.03 21.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.324 0.65 . . . . 0.0 109.714 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 9.5 tp -119.36 152.77 36.22 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.42 -52.53 0.58 Allowed Glycine 0 N--CA 1.475 1.234 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.837 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -69.75 -14.39 62.76 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.646 0.779 . . . . 0.0 110.639 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.418 ' HH2' ' HB2' ' A' ' 453' ' ' SER . 12.4 m95 -82.85 158.72 22.6 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 125.126 1.371 . . . . 0.0 109.95 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -161.27 131.75 5.12 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.838 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 32.5 mt -87.63 118.76 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.811 0.844 . . . . 0.0 109.742 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.673 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 64.8 mttm -84.81 148.7 26.17 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 166.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 492' ' ' GLU . 34.9 ttm180 -132.77 96.66 3.85 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 163.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -85.5 102.38 13.44 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.551 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 27.3 t -72.2 168.95 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.04 0.936 . . . . 0.0 110.277 -176.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 539' ' ' SER . 3.4 pp -55.55 -25.92 40.5 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.643 1.177 . . . . 0.0 113.609 177.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -85.2 4.15 35.95 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.517 0.675 . . . . 0.0 110.812 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 86.21 -7.41 78.38 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.636 0.636 . . . . 0.0 113.349 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.49 102.63 3.26 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.689 0.796 . . . . 0.0 110.295 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 485' ' ' ARG . 8.7 pt-20 -96.39 111.89 23.83 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.583 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 28.4 pt -91.44 147.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.297 173.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -121.39 108.9 14.23 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.349 0.66 . . . . 0.0 110.707 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -83.07 107.74 15.86 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 166.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -91.58 147.67 22.84 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -93.72 170.46 9.55 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.414 0.686 . . . . 0.0 110.714 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 82.7 p -93.5 130.23 36.03 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.024 0.93 . . . . 0.0 108.985 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.498 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 17.7 Cg_endo -58.72 -18.88 43.23 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.257 2.638 . . . . 0.0 114.884 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -75.9 -24.02 55.58 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.951 0.501 . . . . 0.0 111.189 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -75.5 142.72 42.81 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.361 0.664 . . . . 0.0 110.528 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 61.9 mt -133.39 136.58 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.081 0.952 . . . . 0.0 108.713 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.39 116.72 33.43 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -73.27 162.26 29.57 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.197 0.599 . . . . 0.0 112.108 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -60.63 124.4 20.29 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.234 1.014 . . . . 0.0 112.302 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 74.43 -6.42 23.46 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.58 0.55 . . . . 0.0 114.297 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -81.02 155.1 26.53 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.456 0.702 . . . . 0.0 109.857 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 55.4 mtm -120.42 126.52 50.65 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.248 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.7 112.65 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 2.1 m -92.7 101.94 14.34 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.521 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.479 HG12 ' HE1' ' A' ' 534' ' ' TRP . 59.0 t -88.74 98.25 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.015 0.436 . . . . 0.0 109.981 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . 0.403 ' HE3' ' HB1' ' A' ' 516' ' ' ALA . 49.1 m95 -86.05 176.64 7.91 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.397 1.079 . . . . 0.0 111.509 174.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -95.05 164.06 13.04 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.092 0.957 . . . . 0.0 110.726 174.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -64.79 -45.48 86.09 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.429 0.692 . . . . 0.0 111.302 174.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -82.91 5.97 73.0 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.683 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.403 ' HB1' ' HE3' ' A' ' 512' ' ' TRP . . . -75.6 -1.05 22.7 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.502 0.721 . . . . 0.0 111.842 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 68.41 31.25 73.82 Favored Glycine 0 C--N 1.356 1.683 0 C-N-CA 123.125 0.393 . . . . 0.0 113.699 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 6.4 p -123.74 135.86 62.06 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 C-N-CA 124.42 1.088 . . . . 0.0 109.968 -172.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -76.95 134.1 39.01 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.292 0.637 . . . . 0.0 110.4 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -64.51 110.89 2.46 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.356 0.663 . . . . 0.0 110.228 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.5 m -126.42 74.22 73.65 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.605 0.762 . . . . 0.0 110.129 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.33 150.91 76.53 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 122.27 1.98 . . . . 0.0 111.435 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -93.23 11.47 53.01 Favored 'Cis proline' 0 C--N 1.376 1.981 0 CA-C-N 119.971 1.025 . . . . 0.0 113.72 -1.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.3 m -82.8 -28.85 29.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.391 0.676 . . . . 0.0 111.833 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 76.7 m -143.58 104.42 4.21 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.727 0.811 . . . . 0.0 109.968 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 66.5 mt -91.35 144.07 25.97 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 169.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 50.3 t -120.85 120.95 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.635 0.774 . . . . 0.0 108.975 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -75.2 96.42 3.3 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.9 tptt -66.7 136.39 55.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.792 0.837 . . . . 0.0 110.335 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 88.67 -4.97 85.07 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 123.479 0.487 . . . . 0.0 113.325 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -112.99 114.06 26.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 34.2 p -73.56 -56.69 4.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.085 0.554 . . . . 0.0 111.942 -172.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.642 ' HB2' HG23 ' A' ' 536' ' ' THR . 86.6 p -114.45 9.72 16.83 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.267 0.627 . . . . 0.0 112.215 -169.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.479 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 59.44 23.87 12.47 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 124.422 1.089 . . . . 0.0 110.545 -174.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.87 71.12 0.9 Allowed Glycine 0 C--N 1.35 1.34 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.642 HG23 ' HB2' ' A' ' 533' ' ' SER . 17.3 p -59.67 129.93 44.33 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.449 0.7 . . . . 0.0 111.949 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -137.0 154.93 22.47 Favored Glycine 0 C--O 1.238 0.371 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 170.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.14 -60.58 2.17 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.492 ' H ' HD23 ' A' ' 488' ' ' LEU . 7.3 m -107.16 125.1 50.65 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.086 0.954 . . . . 0.0 109.026 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.551 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 5.6 p90 -151.28 145.1 25.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.649 0.738 . . . . 0.0 111.883 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 4.3 tmm_? -96.91 102.08 13.78 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.763 1.225 . . . . 0.0 108.468 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 47.7 m -86.44 140.21 30.19 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.452 0.701 . . . . 0.0 109.202 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.673 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 40.0 t -133.8 146.2 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.484 1.114 . . . . 0.0 109.619 -175.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 38.6 tp -113.61 133.09 55.48 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 163.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.588 HG21 ' HE2' ' A' ' 484' ' ' LYS . 85.4 t -124.26 156.24 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.605 1.162 . . . . 0.0 108.369 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.69 HD21 ' HG3' ' A' ' 550' ' ' GLU . 6.4 p30 -119.58 -170.23 1.9 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.398 0.679 . . . . 0.0 111.814 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.61 64.09 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.156 1.382 . . . . 0.0 113.755 -174.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . 0.59 ' HB3' ' HG2' ' A' ' 550' ' ' GLU . 16.8 t70 -67.31 -37.81 83.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.403 0.681 . . . . 0.0 112.1 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.76 -15.97 28.73 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.078 -173.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.69 ' HG3' HD21 ' A' ' 546' ' ' ASN . 9.9 pt-20 -62.64 137.68 58.32 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.633 0.773 . . . . 0.0 110.325 172.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -81.47 87.72 6.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.807 0.843 . . . . 0.0 109.543 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . 0.455 ' HB ' ' ND2' ' A' ' 546' ' ' ASN . 7.6 p -64.02 -35.8 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.694 -170.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -133.37 150.75 51.81 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.518 0.727 . . . . 0.0 109.054 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 51.6 ttm -161.56 121.68 2.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.466 0.706 . . . . 0.0 109.629 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.71 118.74 13.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.29 0.636 . . . . 0.0 109.315 175.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 28.2 m -86.21 140.43 30.15 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.976 0.911 . . . . 0.0 109.276 174.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.42 131.18 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.66 0.784 . . . . 0.0 109.124 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 0.0 OUTLIER -122.15 125.52 46.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.651 0.78 . . . . 0.0 109.034 175.213 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . 0.442 ' HE3' HD13 ' A' ' 461' ' ' LEU . 86.9 tttt . . . . . 0 C--O 1.242 0.695 0 C-N-CA 124.786 1.234 . . . . 0.0 110.052 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 47.2 m . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 110.926 -0.028 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 15.8 t -92.63 103.19 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.6 m -97.92 143.87 28.06 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.963 0.905 . . . . 0.0 110.647 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 28.7 mt -78.16 96.33 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -78.4 -69.66 0.54 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -120.48 154.11 35.7 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.553 ' HB ' HG21 ' A' ' 557' ' ' VAL . 70.4 mt -146.73 143.13 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 168.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . 0.404 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 31.1 t70 -60.63 151.87 27.9 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.47 0.708 . . . . 0.0 110.801 174.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.2 pp -55.54 -29.82 59.62 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.789 1.236 . . . . 0.0 113.771 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -118.58 10.37 12.53 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.388 1.075 . . . . 0.0 111.252 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.19 42.7 90.98 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.901 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -78.69 -7.12 57.39 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 36.1 p90 -157.85 147.07 19.66 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 124.419 1.088 . . . . 0.0 109.956 170.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 76.1 t -120.36 122.96 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.436 ' OE1' ' HB3' ' A' ' 508' ' ' MET . 0.1 OUTLIER -103.92 114.13 28.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.122 1.369 . . . . 0.0 108.603 -174.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 65.4 mt -107.68 161.73 14.61 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.08 1.352 . . . . 0.0 109.91 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -150.13 132.51 15.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.961 0.504 . . . . 0.0 109.754 -176.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -85.35 131.92 34.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.281 0.632 . . . . 0.0 110.686 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -112.25 -0.14 15.58 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.016 1.327 . . . . 0.0 110.775 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 49.1 m -63.9 147.61 51.5 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.794 0.438 . . . . 0.0 110.654 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -69.62 -11.15 60.61 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.033 0.933 . . . . 0.0 111.778 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.51 ' H ' ' HD3' ' A' ' 474' ' ' LYS . 0.2 OUTLIER -134.69 176.23 8.83 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 125.272 1.429 . . . . 0.0 108.82 -177.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.69 114.8 5.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.526 0.73 . . . . 0.0 109.508 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -74.87 108.34 7.54 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.657 0.783 . . . . 0.0 110.0 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.439 ' HA ' HG12 ' A' ' 502' ' ' ILE . 29.1 p -63.78 104.88 0.73 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 7.6 tp -93.81 -176.59 4.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.89 0.876 . . . . 0.0 109.208 -173.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 134.3 -66.5 0.57 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 112.549 -0.221 . . . . 0.0 112.549 172.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . 0.457 ' N ' HD22 ' A' ' 480' ' ' ASN . 0.8 OUTLIER -67.92 -11.63 59.13 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.372 0.669 . . . . 0.0 111.679 -179.308 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -67.59 141.79 56.68 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.971 0.908 . . . . 0.0 109.387 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -143.31 131.59 22.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.102 0.561 . . . . 0.0 110.701 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 45.0 mt -88.13 110.33 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.024 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.49 ' HE2' HG21 ' A' ' 545' ' ' VAL . 64.7 mttm -82.67 150.42 26.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.442 0.697 . . . . 0.0 109.202 166.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -144.59 104.87 4.09 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -99.16 108.57 21.21 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.451 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 30.0 t -83.61 160.42 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 124.316 1.046 . . . . 0.0 110.796 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 539' ' ' SER . 4.6 pp -51.3 -26.91 8.19 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.947 1.299 . . . . 0.0 113.614 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -77.65 -10.42 59.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.981 0.913 . . . . 0.0 111.42 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 90.78 1.91 72.99 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -79.92 148.18 31.35 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.077 0.951 . . . . 0.0 109.303 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.87 157.01 47.3 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.036 0.446 . . . . 0.0 110.111 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 30.4 pt -136.75 163.82 32.08 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 C-N-CA 124.493 1.117 . . . . 0.0 108.384 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -136.47 105.67 6.01 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.313 0.645 . . . . 0.0 109.673 172.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -81.62 142.38 32.82 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -131.43 144.41 51.16 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -84.38 163.14 19.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.739 0.815 . . . . 0.0 110.802 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 59.5 p -79.68 132.4 61.52 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.886 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.533 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 35.2 Cg_endo -61.1 -16.96 49.3 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.172 2.581 . . . . 0.0 113.533 -175.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -86.57 -20.52 27.82 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.75 0.82 . . . . 0.0 111.855 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -66.04 136.9 56.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.132 0.573 . . . . 0.0 110.153 -177.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 477' ' ' SER . 52.0 mt -131.18 121.86 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.836 0.854 . . . . 0.0 108.976 174.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.71 130.91 34.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -81.32 155.14 26.15 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.159 0.583 . . . . 0.0 110.898 -175.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -61.64 117.65 6.06 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.853 0.861 . . . . 0.0 111.177 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 88.51 -22.38 20.8 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.368 0.417 . . . . 0.0 113.612 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -75.79 173.72 10.77 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.402 0.681 . . . . 0.0 111.242 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . 0.436 ' HB3' ' OE1' ' A' ' 467' ' ' GLN . 37.2 mtm -124.62 172.46 9.23 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.482 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.18 127.09 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 5.2 m -121.73 113.84 20.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.045 0.538 . . . . 0.0 109.58 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.85 99.11 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.271 0.628 . . . . 0.0 109.974 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -79.85 176.65 9.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.65 1.18 . . . . 0.0 111.754 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -99.16 156.46 16.95 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.23 1.012 . . . . 0.0 110.633 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -62.26 -36.59 82.51 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.541 0.736 . . . . 0.0 111.207 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . 0.429 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -88.48 10.16 72.79 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.515 -177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -80.91 -17.07 51.81 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.294 0.637 . . . . 0.0 110.729 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 71.48 18.87 77.34 Favored Glycine 0 C--N 1.357 1.737 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.511 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.92 149.58 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.461 1.105 . . . . 0.0 110.458 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -77.63 130.46 36.89 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.604 0.762 . . . . 0.0 110.618 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -67.45 113.08 5.01 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 10.9 m -125.41 69.68 61.94 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 123.492 0.717 . . . . 0.0 109.827 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.79 150.72 68.39 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.217 1.945 . . . . 0.0 111.628 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.42 -8.01 49.85 Favored 'Cis proline' 0 C--N 1.371 1.749 0 N-CA-C 114.507 0.926 . . . . 0.0 114.507 3.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.2 m -67.14 -60.53 2.53 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.475 0.71 . . . . 0.0 111.466 -173.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 90.6 m -105.19 93.58 4.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.93 0.892 . . . . 0.0 109.198 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 73.0 mt -81.71 143.69 31.68 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 82.1 t -126.04 131.16 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -74.93 95.06 2.91 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -65.2 124.48 22.29 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.793 0.837 . . . . 0.0 110.698 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 94.41 -27.27 14.18 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.799 0.687 . . . . 0.0 114.129 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.54 99.28 9.09 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 29.3 p -85.15 -34.07 22.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.126 0.97 . . . . 0.0 113.165 -167.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' ' 536' ' ' THR . 87.1 p -75.47 -28.39 59.22 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.635 0.374 . . . . 0.0 111.3 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 58.77 32.23 22.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.896 1.279 . . . . 0.0 108.917 -169.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 70.36 76.81 0.51 Allowed Glycine 0 C--N 1.358 1.798 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -172.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 533' ' ' SER . 9.6 t -52.23 143.03 15.38 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.408 1.083 . . . . 0.0 113.431 -167.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 158.61 131.74 1.31 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -84.21 -15.78 45.71 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.1 0.56 . . . . 0.0 111.216 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.536 ' HB2' HD23 ' A' ' 488' ' ' LEU . 17.9 m -137.71 132.48 32.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.237 0.615 . . . . 0.0 109.772 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.451 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 30.8 p90 -168.19 176.7 5.85 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.699 1.2 . . . . 0.0 110.308 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 0.0 OUTLIER -128.91 114.59 16.67 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.191 0.997 . . . . 0.0 108.82 169.024 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 83.6 m -86.61 125.42 33.81 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.075 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.527 HG22 ' HG3' ' A' ' 554' ' ' MET . 43.8 t -115.44 117.83 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.14 0.976 . . . . 0.0 108.679 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 24.9 tp -88.63 132.28 34.62 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.49 HG21 ' HE2' ' A' ' 484' ' ' LYS . 50.9 t -115.51 142.99 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 124.838 1.255 . . . . 0.0 108.122 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.469 ' ND2' ' HG2' ' A' ' 550' ' ' GLU . 0.2 OUTLIER -96.99 -167.24 1.51 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.877 0.471 . . . . 0.0 111.338 -179.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.04 -37.03 83.4 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -75.4 -0.98 21.8 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.31 15.85 80.39 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 123.258 0.348 . . . . 0.0 113.67 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.469 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 5.7 pt-20 -97.45 149.75 21.81 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.281 0.632 . . . . 0.0 109.298 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.78 90.21 3.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.165 0.986 . . . . 0.0 109.296 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.15 -32.99 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.431 -173.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -142.66 157.63 44.49 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.459 0.703 . . . . 0.0 110.245 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.527 ' HG3' HG22 ' A' ' 543' ' ' VAL . 26.1 ttt -157.44 146.4 19.77 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.98 0.912 . . . . 0.0 109.334 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -159.83 117.88 2.69 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.701 0.401 . . . . 0.0 110.956 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 87.4 m -88.73 116.51 27.05 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.611 0.764 . . . . 0.0 110.359 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.553 HG21 ' HB ' ' A' ' 459' ' ' ILE . 81.1 t -102.37 131.91 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.523 1.129 . . . . 0.0 109.628 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . 0.425 ' HD2' ' HB3' ' A' ' 539' ' ' SER . 13.3 mmmm -131.28 117.84 19.54 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.015 1.326 . . . . 0.0 107.868 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt . . . . . 0 N--CA 1.482 1.144 0 CA-C-N 118.55 0.613 . . . . 0.0 109.423 176.896 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 53.5 m . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.655 0.264 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . 0.507 HG21 HD21 ' A' ' 478' ' ' LEU . 17.9 t -93.24 107.77 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 165.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 80.6 p -88.54 160.59 17.39 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.336 0.654 . . . . 0.0 110.006 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . 0.45 HG13 ' HB1' ' A' ' 553' ' ' ALA . 48.5 mt -81.53 96.3 3.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 170.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.629 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 14.6 tp10 -68.41 -55.91 10.3 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.494 -171.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.629 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.0 mt-10 -142.0 154.03 44.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.904 0.882 . . . . 0.0 108.896 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.563 ' HB ' HG21 ' A' ' 557' ' ' VAL . 56.2 mt -136.0 135.28 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.62 141.4 57.82 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 123.358 0.411 . . . . 0.0 110.131 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.82 -39.41 94.23 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.665 0.603 . . . . 0.0 110.895 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 559' ' ' LYS . 27.9 mt-10 -74.71 -33.47 62.42 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.33 33.35 6.89 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.064 -0.971 . . . . 0.0 113.109 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -84.19 -15.52 46.69 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.173 0.589 . . . . 0.0 110.46 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -157.89 161.05 38.24 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 123.236 0.614 . . . . 0.0 110.773 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . 0.419 HG21 ' HD2' ' A' ' 485' ' ' ARG . 89.2 t -133.6 121.28 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.674 1.19 . . . . 0.0 108.356 174.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 23.0 tp60 -92.37 119.76 32.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.087 0.955 . . . . 0.0 109.718 174.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 69.1 mt -108.85 153.18 23.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.146 0.979 . . . . 0.0 108.716 169.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -147.5 144.52 28.61 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.843 0.457 . . . . 0.0 111.115 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.624 ' HB2' HD12 ' A' ' 503' ' ' LEU . 52.7 t30 -89.53 126.9 35.78 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 174.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 471' ' ' ASN . 0.7 OUTLIER -99.01 -17.72 18.14 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.912 0.885 . . . . 0.0 110.097 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . 0.555 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 28.8 m -79.29 155.96 28.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.968 0.907 . . . . 0.0 112.49 -173.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.1 -37.42 66.73 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.755 0.822 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.555 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.1 OUTLIER -78.7 148.37 33.11 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.098 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.81 140.72 56.63 Favored 'General case' 0 C--O 1.244 0.767 0 O-C-N 123.776 0.673 . . . . 0.0 109.392 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.424 ' HG3' HG23 ' A' ' 454' ' ' VAL . 0.0 OUTLIER -112.18 111.44 22.33 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 39.9 m -75.98 122.98 24.99 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.613 0.765 . . . . 0.0 110.624 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 454' ' ' VAL . 95.6 mt -98.02 167.03 11.15 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.495 0.718 . . . . 0.0 109.932 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 143.48 -53.27 0.6 Allowed Glycine 0 N--CA 1.466 0.691 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . 0.477 HD22 ' N ' ' A' ' 480' ' ' ASN . 0.7 OUTLIER -81.32 -12.19 59.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.324 1.049 . . . . 0.0 110.239 175.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -83.84 139.83 32.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.663 0.785 . . . . 0.0 109.762 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -130.5 145.53 51.87 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.603 0.761 . . . . 0.0 110.576 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 34.8 mt -106.7 95.19 3.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -78.66 129.65 34.97 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 124.052 0.941 . . . . 0.0 109.172 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . 0.419 ' HD2' HG21 ' A' ' 466' ' ' VAL . 74.4 mtp85 -135.04 93.35 2.99 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -94.09 102.73 14.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.944 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.503 HG12 HD23 ' A' ' 488' ' ' LEU . 39.2 t -76.34 151.58 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.032 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.503 HD23 HG12 ' A' ' 487' ' ' VAL . 2.5 pt? -59.5 -20.42 55.23 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.424 0.69 . . . . 0.0 112.743 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -73.17 -11.49 60.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.616 1.167 . . . . 0.0 112.69 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 109.31 -16.83 31.96 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-N 116.352 -0.385 . . . . 0.0 112.916 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.57 103.07 0.79 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.753 0.821 . . . . 0.0 111.448 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -107.17 119.94 40.75 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.425 HG21 ' NE2' ' A' ' 531' ' ' GLN . 31.6 pt -130.92 146.4 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.743 0.817 . . . . 0.0 109.601 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -129.35 109.01 10.75 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.89 0.476 . . . . 0.0 110.066 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -79.83 103.18 9.55 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -85.05 134.11 34.22 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.161 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -72.73 164.44 26.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.196 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.3 p -80.19 135.68 54.2 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.406 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 54.1 Cg_endo -66.81 -9.69 25.59 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.668 2.246 . . . . 0.0 113.799 -174.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -92.44 -9.66 40.75 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.404 0.681 . . . . 0.0 111.629 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -87.92 119.11 27.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.778 0.431 . . . . 0.0 109.895 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 40.3 mt -108.02 129.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 470' ' ' ASN . 0.9 OUTLIER -84.87 117.06 23.67 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -76.03 148.79 37.77 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.309 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.75 118.24 9.33 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.385 0.674 . . . . 0.0 110.685 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 103.35 -23.34 33.43 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.287 0.367 . . . . 0.0 112.552 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -88.02 -178.76 6.06 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.637 0.775 . . . . 0.0 111.368 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -157.57 146.28 19.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.808 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . 0.423 HG23 HD13 ' A' ' 526' ' ' LEU . 7.2 p -109.6 127.89 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.848 0.859 . . . . 0.0 109.342 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 2.7 m -111.47 105.88 14.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 47.7 t -93.19 112.26 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . 0.498 ' HB2' HG22 ' A' ' 527' ' ' VAL . 46.9 m95 -98.41 173.46 6.95 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.041 0.936 . . . . 0.0 111.522 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 516' ' ' ALA . . . -84.07 148.5 26.8 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.452 172.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.7 86.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.486 0.66 . . . . 0.0 110.316 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -88.56 14.3 60.13 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.879 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . . . -84.78 -11.46 55.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.449 0.7 . . . . 0.0 111.47 176.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.69 23.23 77.96 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.109 0.403 . . . . 0.0 114.109 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 11.5 p -98.45 149.82 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.3 1.04 . . . . 0.0 109.98 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.23 122.21 26.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.09 0.556 . . . . 0.0 110.41 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -65.31 110.12 2.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.067 0.547 . . . . 0.0 109.778 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 17.3 m -132.99 78.01 66.68 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.363 0.665 . . . . 0.0 110.626 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.46 154.9 50.38 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.749 2.299 . . . . 0.0 112.834 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -92.06 4.19 63.3 Favored 'Cis proline' 0 C--N 1.376 2.021 0 CA-C-N 119.841 0.979 . . . . 0.0 113.517 3.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.0 m -84.96 -58.17 2.8 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.781 0.432 . . . . 0.0 110.497 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 38.9 m -97.53 89.56 4.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.062 0.545 . . . . 0.0 109.872 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 10.8 mp -86.17 138.64 31.75 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 512' ' ' TRP . 86.9 t -125.54 128.56 72.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -72.96 88.97 1.39 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -64.04 112.41 2.96 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.508 -1.223 . . . . 0.0 108.702 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 122.89 -38.29 2.56 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 123.458 0.474 . . . . 0.0 112.411 -173.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.425 ' NE2' HG21 ' A' ' 493' ' ' ILE . 28.5 tp60 -86.49 96.61 10.11 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 13.8 p -63.53 -52.53 60.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.198 0.999 . . . . 0.0 112.199 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 536' ' ' THR . 96.0 p -88.78 -30.66 18.85 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 122.839 0.456 . . . . 0.0 111.927 -176.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 513' ' ' ALA . 6.3 t-105 56.57 34.94 25.28 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.402 1.096 . . . . 0.0 110.3 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 69.53 51.6 25.25 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.996 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 533' ' ' SER . 15.9 p -74.65 123.44 24.87 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 170.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -156.35 179.95 31.83 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.485 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -77.14 -38.71 51.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.407 0.622 . . . . 0.0 109.508 176.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.408 ' H ' HD22 ' A' ' 488' ' ' LEU . 19.3 m -147.92 125.85 12.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.562 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -146.29 144.78 30.06 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.777 0.831 . . . . 0.0 109.855 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 41.2 ttm180 -107.37 116.78 32.54 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.79 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 59.0 m -94.04 121.93 36.03 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' A' ' 554' ' ' MET . 59.9 t -124.53 117.93 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.332 1.053 . . . . 0.0 108.837 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 40.3 tp -89.52 111.59 22.54 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 51.6 t -102.02 149.78 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.207 1.003 . . . . 0.0 109.114 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.558 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.1 p30 -111.75 -172.59 2.07 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.969 0.507 . . . . 0.0 111.737 -172.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.6 73.01 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.884 1.274 . . . . 0.0 113.15 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . 0.48 ' HB3' HD21 ' A' ' 546' ' ' ASN . 12.5 t70 -59.8 -40.61 88.91 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.583 0.753 . . . . 0.0 111.127 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.24 -17.76 26.27 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.436 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.558 ' HG2' HD21 ' A' ' 546' ' ' ASN . 14.0 pt-20 -69.16 148.21 50.25 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.101 0.477 . . . . 0.0 110.665 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.99 99.97 9.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.077 0.951 . . . . 0.0 108.775 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 27.1 m -85.11 -19.86 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.054 0.542 . . . . 0.0 112.284 -172.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.616 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -147.65 139.76 24.29 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.55 ' HG3' HG22 ' A' ' 543' ' ' VAL . 44.5 ttm -151.12 132.36 14.49 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.628 0.771 . . . . 0.0 109.252 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -157.78 117.62 3.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.264 0.626 . . . . 0.0 109.627 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 8.8 m -103.47 112.34 25.2 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.74 0.816 . . . . 0.0 109.435 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.563 HG21 ' HB ' ' A' ' 459' ' ' ILE . 58.1 t -105.64 122.12 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.503 0.721 . . . . 0.0 110.65 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.97 117.75 35.29 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 462' ' ' GLU . 25.8 ttpp . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 124.132 0.973 . . . . 0.0 110.565 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 120.785 0.326 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.77 145.05 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.452 1.101 . . . . 0.0 108.208 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 43.9 t -130.55 150.35 51.8 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.378 1.071 . . . . 0.0 109.988 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 459' ' ' ILE . 38.3 mt -84.71 108.86 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -80.71 -72.16 0.43 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.807 0.337 . . . . 0.0 110.824 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -119.25 149.86 41.06 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.993 0.517 . . . . 0.0 109.688 -169.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.47 ' HB ' HG21 ' A' ' 557' ' ' VAL . 80.6 mt -144.56 138.13 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 170.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . 0.424 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 20.1 t70 -59.91 142.04 54.39 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 123.488 0.493 . . . . 0.0 110.74 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.574 HD12 ' HG3' ' A' ' 462' ' ' GLU . 2.3 pp -66.71 -35.16 79.48 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.074 0.859 . . . . 0.0 111.432 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.574 ' HG3' HD12 ' A' ' 461' ' ' LEU . 29.0 mt-10 -75.37 -33.22 61.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.31 0.576 . . . . 0.0 109.687 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.84 52.0 1.86 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.422 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -96.19 -18.43 20.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.254 0.622 . . . . 0.0 111.194 175.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 32.0 p90 -150.85 161.1 43.33 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.067 0.461 . . . . 0.0 112.007 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 49.6 t -126.85 141.24 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.314 1.445 . . . . 0.0 107.493 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.72 104.61 9.72 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.456 HD22 HD22 ' A' ' 544' ' ' LEU . 57.8 mt -94.82 162.02 13.93 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.815 1.246 . . . . 0.0 110.204 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -144.28 130.14 19.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.524 ' HB2' HD12 ' A' ' 503' ' ' LEU . 46.9 t30 -78.29 107.58 11.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.118 0.567 . . . . 0.0 109.951 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -81.29 -5.71 58.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.646 0.779 . . . . 0.0 112.332 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 15.0 m -74.7 137.43 42.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.116 0.566 . . . . 0.0 110.715 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.61 -13.6 61.82 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.23 1.012 . . . . 0.0 110.998 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.493 ' H ' ' HD3' ' A' ' 474' ' ' LYS . 0.0 OUTLIER -110.39 170.57 8.0 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.856 1.262 . . . . 0.0 108.457 172.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.9 145.03 50.43 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -107.88 118.24 36.22 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 41.2 p -71.6 118.27 14.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 171.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.3 mt -98.78 169.58 9.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 128.78 -56.51 0.74 Allowed Glycine 0 CA--C 1.492 -1.406 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -74.14 -13.16 60.78 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.886 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -82.16 149.49 27.92 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.566 1.147 . . . . 0.0 110.288 170.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -149.56 145.45 26.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.62 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 10.2 mt -107.25 106.19 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.732 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 62.1 mttm -75.87 159.79 30.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.112 0.565 . . . . 0.0 109.832 175.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 542' ' ' THR . 42.8 ttm180 -152.92 100.2 2.48 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -88.58 102.45 14.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.098 0.959 . . . . 0.0 108.575 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 489' ' ' GLU . 22.0 t -88.21 127.8 40.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.5 pp -65.79 -16.39 63.76 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.539 0.736 . . . . 0.0 112.468 -176.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . 0.424 ' H ' HG12 ' A' ' 487' ' ' VAL . 47.8 mt-10 -73.59 -0.45 15.32 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.866 0.867 . . . . 0.0 111.761 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 106.15 27.45 5.61 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 166.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -132.06 101.12 5.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.168 0.587 . . . . 0.0 110.207 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -106.34 121.96 45.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.89 179.57 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.149 0.98 . . . . 0.0 110.18 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -161.32 118.06 2.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.8 0.84 . . . . 0.0 110.064 172.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -79.18 117.48 20.24 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.548 0.739 . . . . 0.0 109.324 172.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.01 141.71 31.88 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -84.63 169.13 14.66 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 166.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.6 p -91.7 130.2 39.76 Favored Pre-proline 0 CA--C 1.556 1.186 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.475 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 32.4 Cg_exo -60.3 -20.42 62.55 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.249 2.633 . . . . 0.0 114.023 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -72.61 -22.35 60.98 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.66 0.784 . . . . 0.0 111.855 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -83.81 123.78 30.25 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.717 0.807 . . . . 0.0 110.447 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 54.1 mt -116.41 132.92 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 168.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 470' ' ' ASN . 2.4 tm? -93.96 138.32 32.2 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.55 161.88 29.32 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -57.99 120.07 7.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.925 1.29 . . . . 0.0 112.428 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 66.87 14.74 63.64 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -97.16 -163.56 1.06 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.236 0.614 . . . . 0.0 109.851 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 19.3 ptp -146.06 164.08 33.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.783 0.833 . . . . 0.0 110.835 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.0 p -143.93 124.68 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.099 0.96 . . . . 0.0 109.152 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 4.0 m -114.51 110.05 19.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.827 0.851 . . . . 0.0 109.591 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.415 HG12 ' HE1' ' A' ' 534' ' ' TRP . 41.0 t -96.71 102.07 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.266 0.626 . . . . 0.0 109.861 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -83.69 175.25 9.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.622 1.169 . . . . 0.0 111.457 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -97.05 158.48 15.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.985 0.914 . . . . 0.0 110.195 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -65.05 -25.23 67.74 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.211 0.604 . . . . 0.0 111.865 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -111.45 21.12 22.17 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.755 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -79.97 -1.0 37.59 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.25 0.62 . . . . 0.0 110.814 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 74.4 38.22 45.72 Favored Glycine 0 C--N 1.358 1.8 0 O-C-N 123.285 0.366 . . . . 0.0 112.379 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.78 148.48 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.135 0.974 . . . . 0.0 110.149 -171.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -91.66 160.45 15.36 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.606 0.762 . . . . 0.0 110.139 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -79.99 122.86 27.25 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 39.0 m -133.18 80.68 58.56 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.692 0.797 . . . . 0.0 109.111 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.94 154.37 58.16 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.739 2.293 . . . . 0.0 112.48 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.54 -18.38 24.04 Favored 'Cis proline' 0 C--N 1.378 2.119 0 C-N-CA 124.787 -0.922 . . . . 0.0 113.741 1.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.2 m -64.98 -52.36 56.65 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.573 0.749 . . . . 0.0 111.708 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 32.6 m -104.01 91.09 3.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 55.6 mt -83.15 148.31 27.55 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.4 127.81 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.417 0.687 . . . . 0.0 109.23 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -70.76 88.07 0.71 Allowed 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -71.93 131.47 43.01 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.714 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 107.51 -36.49 4.35 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.281 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.17 112.05 23.12 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.275 0.559 . . . . 0.0 110.703 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . 0.446 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 22.6 p -85.39 -21.61 28.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.677 1.191 . . . . 0.0 112.702 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.5 t -87.48 -32.95 19.19 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -170.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.415 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 53.35 22.84 2.97 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 124.056 0.942 . . . . 0.0 110.932 -168.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.79 60.98 6.61 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -171.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 15.1 t -64.76 149.79 48.61 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.568 0.747 . . . . 0.0 110.25 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -163.12 162.15 34.51 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 116.405 -0.361 . . . . 0.0 112.22 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -76.13 -34.96 59.45 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.975 0.91 . . . . 0.0 109.167 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.431 ' HB2' HD21 ' A' ' 488' ' ' LEU . 50.5 m -150.04 142.26 24.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.674 1.19 . . . . 0.0 108.71 170.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -164.22 -179.8 6.36 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.482 1.113 . . . . 0.0 109.631 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -140.0 125.71 19.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.497 0.665 . . . . 0.0 110.078 170.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 485' ' ' ARG . 24.1 m -101.87 120.86 41.05 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.765 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.732 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 57.4 t -103.62 148.39 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.32 1.048 . . . . 0.0 109.365 -177.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 43.7 tp -110.42 136.19 49.96 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.34 150.02 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.735 1.214 . . . . 0.0 108.348 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.472 HD21 ' HG3' ' A' ' 550' ' ' GLU . 4.3 p30 -116.99 -170.94 1.93 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.864 0.866 . . . . 0.0 112.134 -173.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -61.3 -26.34 67.72 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.072 0.949 . . . . 0.0 112.91 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.67 -37.49 84.89 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.086 0.554 . . . . 0.0 110.842 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 100.07 5.03 55.14 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.189 -172.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.472 ' HG3' HD21 ' A' ' 546' ' ' ASN . 17.7 pt-20 -88.06 149.54 23.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.309 0.643 . . . . 0.0 110.012 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.03 95.32 6.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.596 0.758 . . . . 0.0 108.96 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.75 -28.91 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.771 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -149.99 160.9 43.26 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.618 0.367 . . . . 0.0 110.639 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 50.6 ttp -158.67 143.44 16.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.792 0.837 . . . . 0.0 109.272 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -142.21 108.66 5.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.029 0.931 . . . . 0.0 109.172 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 42.2 m -82.34 109.48 16.63 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.488 0.715 . . . . 0.0 109.489 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 459' ' ' ILE . 57.3 t -109.22 132.31 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.222 1.009 . . . . 0.0 110.161 -175.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 558' ' ' LYS . 0.0 OUTLIER -132.67 118.4 19.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.603 1.161 . . . . 0.0 108.627 -177.38 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 461' ' ' LEU . 33.3 tttm . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 124.861 1.264 . . . . 0.0 109.883 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.43 0.157 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 43.0 t -99.61 121.56 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 16.9 m -108.78 143.66 37.63 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.306 1.042 . . . . 0.0 109.581 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 459' ' ' ILE . 55.5 mt -77.43 130.32 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' A' ' 469' ' ' LYS . 36.1 mm-40 -81.01 -74.19 0.34 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.65 0.262 . . . . 0.0 110.649 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -128.25 155.32 44.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.753 0.821 . . . . 0.0 109.916 -171.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.463 ' HB ' HG11 ' A' ' 557' ' ' VAL . 48.4 mm -131.12 141.57 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.635 0.774 . . . . 0.0 109.0 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.66 153.86 31.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.246 1.018 . . . . 0.0 111.398 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 461' ' ' LEU . 2.2 pt? -109.31 0.31 19.48 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.156 0.582 . . . . 0.0 110.251 166.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -120.83 0.82 10.4 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.137 0.975 . . . . 0.0 112.544 -171.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 73.58 45.87 27.28 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 123.073 0.233 . . . . 0.0 113.597 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -108.31 -50.49 3.03 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.39 0.676 . . . . 0.0 111.295 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -164.59 152.08 11.68 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . 0.417 HG11 HD13 ' A' ' 483' ' ' ILE . 71.1 t -112.15 112.0 38.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.673 1.189 . . . . 0.0 108.692 173.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.447 ' HG3' ' HB2' ' A' ' 457' ' ' GLU . 57.4 tp60 -87.32 102.19 14.27 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.542 HD22 HD22 ' A' ' 544' ' ' LEU . 81.9 mt -94.95 165.11 12.61 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.432 1.093 . . . . 0.0 110.106 172.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 508' ' ' MET . 50.9 tttm -149.91 137.7 20.12 Favored 'General case' 0 C--O 1.219 -0.522 0 C-N-CA 123.215 0.606 . . . . 0.0 110.207 172.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -88.36 136.61 32.9 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -130.61 9.4 5.05 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.167 0.987 . . . . 0.0 110.133 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 46.5 t -77.87 145.8 36.03 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 123.374 0.669 . . . . 0.0 109.732 170.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -70.2 -25.1 63.26 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.249 1.02 . . . . 0.0 111.648 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 474' ' ' LYS . 32.6 pttt -112.95 166.07 11.75 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.016 0.927 . . . . 0.0 110.834 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -70.53 120.44 16.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.422 0.689 . . . . 0.0 109.963 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -87.62 118.85 27.39 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.645 0.778 . . . . 0.0 109.767 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 54.5 p -70.68 101.83 2.15 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.639 0.776 . . . . 0.0 110.375 176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 17.9 tp -91.16 152.69 20.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.712 0.805 . . . . 0.0 109.62 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.08 -58.62 0.51 Allowed Glycine 0 N--CA 1.472 1.049 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.703 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.36 -11.9 61.2 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.288 0.635 . . . . 0.0 111.075 177.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 546' ' ' ASN . 14.1 m95 -75.14 166.03 24.28 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 124.452 1.101 . . . . 0.0 110.927 170.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -160.7 145.81 14.41 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.975 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 49.7 mt -101.42 107.54 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.158 0.583 . . . . 0.0 109.535 176.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.739 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 60.7 mttm -78.13 159.35 28.68 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 170.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 534' ' ' TRP . 36.8 ttm180 -158.08 100.37 1.71 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.05 111.56 23.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.284 0.633 . . . . 0.0 109.712 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.459 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 53.1 t -68.87 157.52 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.0 0.92 . . . . 0.0 109.797 174.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.0 pp -52.15 -28.12 16.86 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.232 1.013 . . . . 0.0 112.256 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -69.39 -33.33 72.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.493 1.117 . . . . 0.0 111.383 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 131.61 -21.24 4.52 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.792 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.32 109.59 2.32 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.36 1.064 . . . . 0.0 111.461 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -107.77 117.3 33.75 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.402 0.62 . . . . 0.0 110.804 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 40.2 pt -105.85 142.46 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.923 0.889 . . . . 0.0 109.367 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -125.25 116.36 21.85 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.903 0.481 . . . . 0.0 110.931 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -78.98 106.35 10.96 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -81.48 121.63 26.52 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -73.26 169.16 17.67 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 120.819 0.342 . . . . 0.0 110.794 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 68.9 p -93.27 120.78 66.43 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 123.054 0.542 . . . . 0.0 110.32 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.503 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 34.6 Cg_exo -60.37 -15.56 36.17 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.934 3.089 . . . . 0.0 115.199 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -72.48 -23.51 61.05 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.542 0.737 . . . . 0.0 111.64 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -89.02 142.79 27.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.495 1.118 . . . . 0.0 110.884 -171.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 62.2 mt -129.43 132.96 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.391 0.676 . . . . 0.0 109.213 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . 0.648 HD21 ' HB ' ' A' ' 509' ' ' VAL . 0.3 OUTLIER -93.85 134.69 35.95 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.026 0.93 . . . . 0.0 109.025 177.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -78.16 156.49 29.85 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.131 0.491 . . . . 0.0 111.682 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.04 126.93 29.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.256 1.022 . . . . 0.0 112.031 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 77.97 -12.34 18.06 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.62 0.575 . . . . 0.0 114.395 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -86.71 159.48 19.15 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.661 0.784 . . . . 0.0 110.232 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . 0.552 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 23.5 ptt? -108.57 169.69 8.5 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.613 0.765 . . . . 0.0 111.517 -175.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . 0.648 ' HB ' HD21 ' A' ' 503' ' ' LEU . 7.4 p -145.95 148.89 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 4.2 m -131.09 105.46 7.72 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 71.5 t -86.02 98.63 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.055 0.455 . . . . 0.0 110.224 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -82.34 176.41 9.47 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.905 0.882 . . . . 0.0 111.3 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -103.64 152.14 22.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.826 0.851 . . . . 0.0 110.128 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.84 -20.06 65.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.874 0.87 . . . . 0.0 112.021 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -103.76 16.63 51.05 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.692 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -90.76 -3.61 57.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.328 0.651 . . . . 0.0 110.713 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.33 33.92 68.71 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 113.995 0.358 . . . . 0.0 113.995 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 12.9 p -130.79 144.25 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 123.412 0.685 . . . . 0.0 110.341 -175.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -81.81 142.9 32.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.57 0.748 . . . . 0.0 111.42 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . 0.444 ' HD2' ' HA ' ' A' ' 526' ' ' LEU . 17.3 t-80 -61.85 109.33 1.21 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.418 0.687 . . . . 0.0 109.827 172.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 17.8 m -132.74 80.49 61.35 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.019 0.928 . . . . 0.0 109.556 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.72 160.85 44.46 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.916 2.41 . . . . 0.0 112.175 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -90.31 16.77 43.79 Favored 'Cis proline' 0 C--N 1.381 2.265 0 CA-C-N 119.652 0.911 . . . . 0.0 113.385 3.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.2 m -97.99 -70.88 0.71 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.739 0.815 . . . . 0.0 109.836 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 20.2 m -85.65 86.28 7.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.182 0.593 . . . . 0.0 110.372 -173.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 11.1 mp -91.66 105.19 17.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 171.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 90.3 t -89.46 117.98 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -69.27 91.74 0.54 Allowed 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 27.7 tptp -75.07 131.03 40.27 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.399 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 104.31 -5.08 44.71 Favored Glycine 0 N--CA 1.472 1.094 0 O-C-N 123.606 0.566 . . . . 0.0 111.988 -172.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -121.95 109.82 15.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.854 0.862 . . . . 0.0 109.179 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 37.2 p -71.72 -61.72 1.68 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.992 0.517 . . . . 0.0 111.21 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 23.7 m -121.16 25.26 9.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.815 0.446 . . . . 0.0 112.108 -167.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.428 ' HB3' ' NH1' ' A' ' 485' ' ' ARG . 0.0 OUTLIER 51.89 30.93 7.69 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.384 1.074 . . . . 0.0 112.541 171.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.88 68.7 1.56 Allowed Glycine 0 C--N 1.352 1.43 0 N-CA-C 112.371 -0.291 . . . . 0.0 112.371 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 2.7 p -64.4 142.57 58.37 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.504 0.722 . . . . 0.0 112.66 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -162.86 169.57 38.1 Favored Glycine 0 C--O 1.242 0.599 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.244 172.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -70.48 -26.78 63.77 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.336 0.568 . . . . 0.0 110.105 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 80.8 p -155.13 142.52 19.55 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.841 0.857 . . . . 0.0 109.35 172.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.459 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 8.0 p90 -155.5 136.67 13.85 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.684 0.794 . . . . 0.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.618 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 34.6 ptt180 -87.93 111.25 21.25 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 23.1 m -94.03 110.73 22.41 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.739 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 21.9 t -102.86 144.93 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.828 1.251 . . . . 0.0 109.606 -174.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.542 HD22 HD22 ' A' ' 468' ' ' LEU . 34.7 tp -112.17 125.47 54.17 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 551' ' ' GLU . 22.0 t -124.33 160.14 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.135 1.374 . . . . 0.0 108.485 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.591 HD21 ' HG2' ' A' ' 550' ' ' GLU . 2.9 p30 -126.35 -174.83 3.21 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.017 0.371 . . . . 0.0 111.577 175.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -50.08 -34.47 21.88 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.432 1.493 . . . . 0.0 113.189 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.64 -33.68 76.5 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.262 1.025 . . . . 0.0 111.929 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 102.97 -12.12 56.02 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.049 -174.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.591 ' HG2' HD21 ' A' ' 546' ' ' ASN . 13.2 pt-20 -72.79 139.36 47.01 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.21 0.604 . . . . 0.0 109.384 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.483 ' HG2' HG22 ' A' ' 545' ' ' VAL . 38.5 mt-10 -92.0 93.3 8.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.116 0.966 . . . . 0.0 108.994 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 18.0 m -71.67 -16.64 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -167.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -159.36 156.28 28.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.067 0.547 . . . . 0.0 110.482 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.59 ' SD ' ' HD2' ' A' ' 541' ' ' ARG . 67.0 ttp -154.94 109.93 3.04 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.25 0.62 . . . . 0.0 110.097 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -104.14 104.19 14.09 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 30.4 m -85.19 99.04 10.83 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.463 HG11 ' HB ' ' A' ' 459' ' ' ILE . 35.1 m -98.96 147.29 7.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 121.621 0.724 . . . . 0.0 110.383 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.48 168.88 9.77 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.08 175.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 461' ' ' LEU . 38.7 ttpt . . . . . 0 C--O 1.238 0.478 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 544' ' ' LEU . 4.1 t -95.55 163.74 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.357 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 21.1 t -155.69 150.66 26.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.566 0.746 . . . . 0.0 109.671 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . 0.413 ' HA ' HD12 ' A' ' 468' ' ' LEU . 31.7 mt -77.7 102.41 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.286 0.634 . . . . 0.0 109.863 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.486 ' HG2' ' HG3' ' A' ' 458' ' ' GLU . 42.0 tt0 -81.18 -57.49 3.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.353 0.261 . . . . 0.0 111.602 -170.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.486 ' HG3' ' HG2' ' A' ' 457' ' ' GLU . 29.4 mt-10 -137.88 153.36 49.57 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.256 0.622 . . . . 0.0 109.394 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.0 mt -151.84 138.18 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.61 148.84 38.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.453 HD12 ' HG3' ' A' ' 462' ' ' GLU . 3.5 pp -74.38 -16.51 60.89 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -169.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.453 ' HG3' HD12 ' A' ' 461' ' ' LEU . 2.7 mt-10 -82.02 -31.91 30.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.199 0.6 . . . . 0.0 110.427 174.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 86.97 51.63 3.33 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.986 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -97.1 -19.48 18.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.54 0.736 . . . . 0.0 110.867 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -154.35 163.52 40.03 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.935 0.494 . . . . 0.0 111.872 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . 0.402 HG11 HG21 ' A' ' 483' ' ' ILE . 79.2 t -126.37 117.65 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.017 1.327 . . . . 0.0 108.164 170.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.7 tp60 -88.06 113.35 23.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.989 0.916 . . . . 0.0 109.039 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.55 HD22 HD11 ' A' ' 483' ' ' ILE . 22.6 tp -120.21 116.69 26.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.137 0.975 . . . . 0.0 109.495 -172.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . 0.411 ' HG2' ' HB3' ' A' ' 508' ' ' MET . 1.8 tmmm? -114.03 130.52 56.55 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.992 0.36 . . . . 0.0 110.368 -169.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -82.62 115.32 21.52 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.436 0.694 . . . . 0.0 109.84 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -85.49 -15.76 41.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.911 0.884 . . . . 0.0 112.033 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . 0.545 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 69.8 m -65.57 156.45 32.64 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.57 2.36 33.53 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.832 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.545 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.1 OUTLIER -135.38 168.49 19.1 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.24 1.016 . . . . 0.0 108.822 173.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . 0.402 ' HB3' HG22 ' A' ' 502' ' ' ILE . 24.1 m-20 -73.59 122.05 21.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.428 0.691 . . . . 0.0 109.475 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -83.36 123.02 29.23 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.497 0.719 . . . . 0.0 110.204 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 30.2 p -71.01 106.67 3.76 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.1 mp -91.09 -179.81 5.54 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 0.0 109.97 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 133.28 -67.23 0.56 Allowed Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 480' ' ' ASN . 0.8 OUTLIER -74.64 -11.5 60.2 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.499 177.302 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 33.1 m95 -69.84 145.4 52.11 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -149.47 136.27 19.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.882 0.473 . . . . 0.0 111.123 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . 0.55 HD11 HD22 ' A' ' 468' ' ' LEU . 57.8 mt -97.41 107.28 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.619 0.768 . . . . 0.0 109.472 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 545' ' ' VAL . 68.0 mttm -78.86 148.17 32.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.363 0.665 . . . . 0.0 110.531 172.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . 0.432 ' NH2' ' HB3' ' A' ' 534' ' ' TRP . 20.6 mtm180 -140.49 123.3 16.38 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 491' ' ' GLU . 51.2 tt0 -116.98 114.06 23.27 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.417 0.687 . . . . 0.0 109.83 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.453 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 13.4 t -84.72 159.31 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.792 1.237 . . . . 0.0 110.645 -177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.2 -22.87 61.69 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.959 0.904 . . . . 0.0 111.98 173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.57 -22.14 66.13 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.585 1.154 . . . . 0.0 112.407 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 99.86 1.96 56.19 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.339 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 486' ' ' GLN . 42.1 mt-10 -72.95 122.05 21.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.596 0.758 . . . . 0.0 110.073 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.81 112.56 13.71 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 22.0 pt -132.17 170.09 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.236 1.014 . . . . 0.0 109.629 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -150.22 127.32 11.23 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.893 0.477 . . . . 0.0 110.681 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -80.29 108.98 14.34 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 169.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -84.73 128.3 34.54 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -70.45 169.14 14.67 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.645 0.736 . . . . 0.0 111.327 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 65.9 p -87.36 132.34 41.45 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.871 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.481 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 26.8 Cg_endo -58.78 -21.41 56.58 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.094 2.529 . . . . 0.0 113.302 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -72.31 -25.42 61.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.193 0.597 . . . . 0.0 111.903 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -75.78 126.19 30.52 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 122.825 0.45 . . . . 0.0 110.189 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . 0.402 HG22 ' HB3' ' A' ' 475' ' ' ASP . 41.5 mt -122.55 113.9 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.25 120.14 21.88 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -69.75 160.89 30.85 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.9 119.08 10.67 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.166 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.6 6.09 65.55 Favored Glycine 0 C--N 1.343 0.925 0 O-C-N 123.585 0.553 . . . . 0.0 113.666 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -101.59 177.97 4.77 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.642 0.777 . . . . 0.0 109.677 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . 0.411 ' HB3' ' HG2' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -139.92 162.53 34.96 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.537 0.684 . . . . 0.0 112.039 -175.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . 0.518 HG23 HD13 ' A' ' 526' ' ' LEU . 6.3 p -123.79 117.49 51.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 125.201 1.401 . . . . 0.0 107.926 176.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 7.8 m -96.48 95.02 7.73 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.89 97.42 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.927 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -79.71 171.74 14.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.635 0.774 . . . . 0.0 110.819 171.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -91.91 165.0 13.45 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.676 0.791 . . . . 0.0 110.109 173.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -63.51 -34.2 77.26 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.102 0.477 . . . . 0.0 110.379 171.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -89.41 20.65 33.0 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.305 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -85.07 -24.43 28.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.315 0.646 . . . . 0.0 110.554 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 71.05 35.76 64.47 Favored Glycine 0 C--N 1.35 1.322 0 O-C-N 123.872 0.733 . . . . 0.0 112.917 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 8.6 p -114.44 143.77 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.014 0.926 . . . . 0.0 110.276 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -72.79 123.23 22.94 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.284 0.634 . . . . 0.0 110.227 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -63.92 110.69 2.19 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.425 0.69 . . . . 0.0 110.473 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.8 m -132.24 72.26 78.84 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.063 0.545 . . . . 0.0 110.909 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.93 159.4 53.09 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.739 2.292 . . . . 0.0 112.352 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.23 0.94 50.48 Favored 'Cis proline' 0 C--N 1.382 2.32 0 CA-C-N 120.141 1.086 . . . . 0.0 114.077 -0.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 32.9 t -74.78 -63.22 1.3 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.415 0.686 . . . . 0.0 111.08 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 27.5 m -104.19 98.58 8.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.108 0.963 . . . . 0.0 110.265 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.518 HD13 HG23 ' A' ' 509' ' ' VAL . 11.2 mp -93.64 146.86 23.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 81.9 t -129.82 117.27 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -73.47 89.34 1.65 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 27.3 tptp -75.77 123.27 25.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.386 177.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 120.75 -24.26 7.59 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -173.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -121.5 109.61 15.04 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . 0.446 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 32.9 p -82.53 -34.94 27.69 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.853 0.461 . . . . 0.0 111.634 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 536' ' ' THR . 23.6 m -90.28 -29.74 17.95 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.189 0.596 . . . . 0.0 112.167 -174.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.674 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 59.74 22.26 11.08 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 123.224 0.61 . . . . 0.0 109.401 -173.535 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.99 69.08 1.46 Allowed Glycine 0 C--N 1.345 1.037 0 O-C-N 121.653 -0.654 . . . . 0.0 111.949 -171.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 533' ' ' SER . 8.1 p -71.82 159.92 33.47 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.612 0.765 . . . . 0.0 110.231 172.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 172.72 176.43 41.35 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.404 -0.362 . . . . 0.0 113.038 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -84.07 -26.96 28.62 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.756 0.422 . . . . 0.0 110.073 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 66.9 m -152.24 128.23 10.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.531 1.132 . . . . 0.0 108.743 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.453 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 6.8 p90 -154.48 122.47 5.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.96 0.904 . . . . 0.0 110.091 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.621 ' HD3' ' H ' ' A' ' 541' ' ' ARG . 0.0 OUTLIER -86.27 123.39 31.47 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.423 0.63 . . . . 0.0 109.727 -178.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 485' ' ' ARG . 39.3 m -94.31 140.17 30.13 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.252 1.021 . . . . 0.0 109.506 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 99.9 t -132.93 130.9 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.482 1.113 . . . . 0.0 109.279 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.603 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 53.1 tp -93.96 129.48 40.41 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.459 HG21 ' HE2' ' A' ' 484' ' ' LYS . 81.4 t -118.13 143.73 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.754 1.222 . . . . 0.0 108.226 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.546 HD21 ' HG2' ' A' ' 550' ' ' GLU . 2.0 p30 -103.0 -173.54 2.34 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.514 0.326 . . . . 0.0 111.155 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -64.17 -22.97 67.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.803 0.841 . . . . 0.0 113.234 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -65.24 -39.46 92.72 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.162 0.506 . . . . 0.0 110.453 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.37 -11.26 33.44 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.398 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.546 ' HG2' HD21 ' A' ' 546' ' ' ASN . 16.3 pt-20 -80.39 153.87 28.05 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 117.259 0.53 . . . . 0.0 110.549 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -88.65 104.6 17.01 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.673 1.189 . . . . 0.0 110.171 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.74 -29.47 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.566 0.746 . . . . 0.0 112.813 -170.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -139.12 161.11 38.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.072 0.549 . . . . 0.0 110.137 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.431 ' HG3' HG22 ' A' ' 543' ' ' VAL . 40.7 ttp -159.27 108.25 1.86 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.33 0.652 . . . . 0.0 109.795 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -119.46 123.63 44.52 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.755 0.822 . . . . 0.0 109.207 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 26.7 m -79.12 134.0 36.73 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.54 139.9 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -161.53 146.34 13.33 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 122.916 0.486 . . . . 0.0 111.074 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 461' ' ' LEU . 86.2 tttt . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.19 0.996 . . . . 0.0 110.23 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 121.059 0.457 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . 0.457 HG23 ' HG2' ' A' ' 476' ' ' GLN . 21.2 t -85.61 129.82 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 171.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 44.0 t -110.51 145.7 37.27 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.129 1.372 . . . . 0.0 109.497 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 50.8 mt -81.93 95.11 2.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.85 -65.14 1.04 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.652 0.381 . . . . 0.0 110.404 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 20.5 mt-10 -116.49 153.13 32.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.1 0.56 . . . . 0.0 110.368 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.493 HG23 HG22 ' A' ' 466' ' ' VAL . 47.8 mt -140.06 142.53 31.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 170.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.76 145.87 51.9 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.307 0.38 . . . . 0.0 110.474 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.587 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.4 pt? -58.93 -41.16 86.68 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.134 0.974 . . . . 0.0 111.886 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.587 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 43.7 mt-10 -91.45 -22.03 20.63 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.159 0.984 . . . . 0.0 110.066 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 83.92 50.82 4.23 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.053 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -87.71 -16.76 33.41 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.06 163.35 40.01 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.031 0.532 . . . . 0.0 111.166 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . 0.493 HG22 HG23 ' A' ' 459' ' ' ILE . 97.2 t -134.9 122.76 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.669 1.188 . . . . 0.0 108.088 168.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.602 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 13.5 tt0 -89.8 111.48 22.51 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.287 0.565 . . . . 0.0 110.103 170.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.85 159.95 18.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.21 165.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 508' ' ' MET . 1.6 tmtp? -152.58 129.01 10.63 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.527 ' HB3' HD12 ' A' ' 503' ' ' LEU . 50.6 t30 -99.07 100.35 11.48 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -76.75 -11.63 59.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.254 0.622 . . . . 0.0 111.511 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 44.9 t -63.73 152.54 38.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.338 1.055 . . . . 0.0 112.847 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -73.11 -12.01 60.75 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.095 1.358 . . . . 0.0 111.296 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -99.01 143.69 29.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.763 0.825 . . . . 0.0 110.893 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.46 102.5 2.68 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.457 ' HG2' HG23 ' A' ' 454' ' ' VAL . 57.2 tp60 -70.29 115.48 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.3 0.64 . . . . 0.0 111.87 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.4 m -64.28 99.71 0.3 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.3 tp -96.49 159.53 14.89 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -175.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 143.83 -65.88 0.46 Allowed Glycine 0 N--CA 1.47 0.95 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.64 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.27 -11.66 59.76 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.698 0.799 . . . . 0.0 111.078 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -75.89 135.0 40.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.832 0.853 . . . . 0.0 108.887 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -128.19 145.61 50.98 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 49.6 mt -106.3 103.93 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.627 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 59.3 mttm -78.89 96.19 5.62 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 19.5 tpp85 -79.53 96.82 6.22 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 168.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -102.05 100.92 11.22 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 15.7 t -94.06 141.9 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.2 pp -65.91 -14.88 62.33 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.52 -8.42 33.68 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.238 0.615 . . . . 0.0 110.847 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 105.95 28.27 5.36 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.504 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -121.38 103.83 9.24 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.178 0.591 . . . . 0.0 110.571 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -107.87 80.96 1.44 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.436 1.112 . . . . 0.0 109.226 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 34.9 pt -95.07 134.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.012 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -108.21 110.71 22.4 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.875 0.47 . . . . 0.0 110.067 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.96 104.38 9.55 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 496' ' ' LYS . 0.2 OUTLIER -91.0 129.66 36.98 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -76.79 170.06 17.16 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.995 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.0 p -88.55 124.66 65.45 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.461 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 19.8 Cg_endo -60.16 -10.0 11.75 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.985 2.456 . . . . 0.0 114.871 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -75.17 -24.66 57.93 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.888 0.475 . . . . 0.0 111.273 172.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -82.08 128.06 33.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.599 0.759 . . . . 0.0 110.198 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 59.8 mt -122.46 123.81 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 470' ' ' ASN . 1.0 OUTLIER -90.2 123.79 34.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 507' ' ' GLN . 1.2 mpt_? -74.49 169.32 17.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.89 0.876 . . . . 0.0 112.109 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -70.43 121.43 17.73 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.402 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 76.59 12.46 84.38 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.812 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . 0.414 ' HG3' ' HB2' ' A' ' 504' ' ' ARG . 32.7 mm-40 -104.09 -176.4 3.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.201 0.6 . . . . 0.0 110.773 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . 0.496 ' HB3' ' HG2' ' A' ' 469' ' ' LYS . 1.5 ppp? -141.63 164.64 29.66 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.976 0.91 . . . . 0.0 111.196 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.67 135.03 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.402 1.081 . . . . 0.0 108.295 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 7.2 m -116.69 115.55 25.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 526' ' ' LEU . 16.0 m -101.54 98.61 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.171 0.988 . . . . 0.0 110.436 -176.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -87.55 172.91 9.4 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.165 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.697 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -92.3 156.47 17.24 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.949 0.9 . . . . 0.0 110.43 175.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -59.9 -28.06 67.26 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.286 0.635 . . . . 0.0 112.125 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -111.45 23.86 17.03 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.291 -0.413 . . . . 0.0 113.479 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -89.17 11.27 19.12 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 69.66 36.95 76.53 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-O 121.343 0.413 . . . . 0.0 112.71 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.56 147.92 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.908 0.883 . . . . 0.0 111.319 -167.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -99.13 130.51 45.45 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.915 0.886 . . . . 0.0 109.588 171.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -65.25 112.6 3.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.4 m -131.5 71.18 81.47 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.355 0.662 . . . . 0.0 109.613 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.81 153.34 78.29 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.868 2.379 . . . . 0.0 112.247 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -80.51 -19.87 21.27 Favored 'Cis proline' 0 C--N 1.38 2.19 0 CA-C-N 119.957 1.02 . . . . 0.0 113.608 0.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.2 m -63.14 -35.91 81.86 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.306 1.043 . . . . 0.0 112.588 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 25.8 m -127.83 91.21 3.24 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.47 0.708 . . . . 0.0 109.415 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.57 ' HB2' HG12 ' A' ' 511' ' ' VAL . 66.7 mt -84.75 148.37 26.39 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 54.5 t -132.06 127.9 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -68.57 87.77 0.33 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -70.14 128.5 36.49 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.769 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 98.09 -21.46 45.94 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.729 -0.669 . . . . 0.0 113.188 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.83 103.85 10.38 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . 0.403 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 42.5 p -85.37 -17.56 36.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.372 1.069 . . . . 0.0 113.822 -166.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 46.5 m -96.45 -29.39 13.95 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.697 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 58.44 21.8 8.85 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.187 0.995 . . . . 0.0 110.76 -168.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 66.74 70.65 1.07 Allowed Glycine 0 C--N 1.349 1.29 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 -172.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 14.6 p -63.3 162.07 12.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.614 0.766 . . . . 0.0 112.455 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -176.53 149.58 9.84 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.82 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.66 -21.09 38.35 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.515 ' HB2' HD21 ' A' ' 488' ' ' LEU . 19.4 m -148.25 132.83 17.75 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.727 0.811 . . . . 0.0 109.672 167.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -160.38 -176.41 5.59 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.028 0.931 . . . . 0.0 110.395 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 11.0 ptp180 -136.7 155.48 49.81 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.786 170.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . 0.485 ' HB ' HD13 ' A' ' 459' ' ' ILE . 86.4 m -130.97 118.81 21.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.627 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 19.6 t -112.63 151.42 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.442 1.097 . . . . 0.0 108.698 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 39.8 tp -123.94 106.83 10.74 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 551' ' ' GLU . 6.2 p -96.59 147.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.682 1.193 . . . . 0.0 109.215 175.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -107.44 -171.96 1.98 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.697 0.399 . . . . 0.0 110.334 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.41 66.78 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . 0.573 ' HB2' ' HG2' ' A' ' 550' ' ' GLU . 68.4 m-20 -71.75 -23.74 61.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.085 0.554 . . . . 0.0 111.981 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 93.95 -2.73 69.59 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.573 ' HG2' ' HB2' ' A' ' 548' ' ' ASP . 11.7 pt-20 -89.53 141.37 28.64 Favored 'General case' 0 C--O 1.247 0.966 0 C-N-CA 123.189 0.596 . . . . 0.0 109.696 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 545' ' ' VAL . 53.3 mt-10 -81.76 111.05 17.65 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.588 0.755 . . . . 0.0 109.214 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.05 -22.71 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.595 0.758 . . . . 0.0 112.549 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -146.55 157.34 43.72 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.867 0.867 . . . . 0.0 109.361 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.431 ' HG3' HG22 ' A' ' 543' ' ' VAL . 28.5 ttt -168.51 140.51 2.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.427 0.691 . . . . 0.0 110.37 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -152.03 123.66 7.89 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.14 0.976 . . . . 0.0 109.427 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 36.3 m -86.34 124.63 32.91 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.778 0.831 . . . . 0.0 109.853 175.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 459' ' ' ILE . 35.2 t -135.04 142.71 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.929 0.892 . . . . 0.0 109.507 -177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 152.99 41.66 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.754 -177.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . 0.564 ' HD2' ' HG2' ' A' ' 462' ' ' GLU . 88.7 tttt . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 121.717 0.77 . . . . 0.0 109.153 170.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 44.1 t . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 19.0 t -114.94 142.18 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.032 0.933 . . . . 0.0 108.616 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 56.3 p -122.57 164.94 17.25 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.287 0.635 . . . . 0.0 110.628 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 43.7 mt -84.66 98.81 6.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.61 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 9.5 tp10 -69.27 -59.77 2.79 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.399 -174.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.61 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 36.0 mt-10 -137.25 160.32 39.38 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.045 0.938 . . . . 0.0 108.86 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.431 ' HB ' HG21 ' A' ' 557' ' ' VAL . 64.8 mt -139.57 141.39 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 172.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . 0.433 ' HB2' ' CD1' ' A' ' 465' ' ' PHE . 26.0 t70 -66.23 148.39 51.91 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.706 0.628 . . . . 0.0 111.312 175.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -36.16 83.02 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.203 1.001 . . . . 0.0 112.079 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.35 -31.26 24.88 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 167.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 95.9 36.42 5.27 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.142 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -72.29 -20.5 61.5 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.321 0.648 . . . . 0.0 110.487 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 460' ' ' ASP . 33.2 p90 -151.6 161.79 42.09 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.526 0.679 . . . . 0.0 111.542 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.33 112.9 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.351 1.46 . . . . 0.0 107.542 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.402 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.5 tp-100 -86.98 118.74 26.56 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 544' ' ' LEU . 85.8 mt -113.65 134.0 54.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.046 0.938 . . . . 0.0 108.713 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 4.4 tmmm? -116.8 131.12 57.03 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.451 ' HB2' HD13 ' A' ' 503' ' ' LEU . 58.9 t30 -79.79 124.56 28.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.374 0.669 . . . . 0.0 110.709 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -102.65 15.42 29.33 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.228 1.011 . . . . 0.0 110.703 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . 0.472 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 49.0 m -86.55 149.42 24.96 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.954 0.501 . . . . 0.0 111.353 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.06 -13.8 59.9 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.009 0.924 . . . . 0.0 110.406 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.0 OUTLIER -129.7 175.73 8.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.597 1.159 . . . . 0.0 109.127 178.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.66 115.96 6.38 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.393 0.677 . . . . 0.0 109.757 172.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -82.18 113.82 20.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.046 0.538 . . . . 0.0 110.417 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.507 ' HA ' HG12 ' A' ' 502' ' ' ILE . 35.0 p -66.89 110.27 3.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.175 0.59 . . . . 0.0 110.113 173.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.7 tp -103.03 171.88 7.13 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.654 1.182 . . . . 0.0 109.08 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 145.69 -62.99 0.46 Allowed Glycine 0 N--CA 1.472 1.052 0 CA-C-O 121.399 0.444 . . . . 0.0 112.923 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . 0.474 HD22 ' N ' ' A' ' 480' ' ' ASN . 0.8 OUTLIER -70.6 -12.3 61.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.267 0.627 . . . . 0.0 110.975 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -69.57 146.52 51.72 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.112 0.965 . . . . 0.0 109.57 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -148.56 125.26 11.13 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.317 0.647 . . . . 0.0 111.002 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 19.4 mt -87.16 117.27 30.98 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 C-N-CA 123.638 0.775 . . . . 0.0 109.219 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.606 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 98.7 mttt -84.33 152.01 24.38 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.002 0.521 . . . . 0.0 109.817 168.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -150.47 104.73 3.25 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -116.48 103.59 10.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.88 0.872 . . . . 0.0 109.608 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.28 154.35 3.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.346 0.659 . . . . 0.0 109.91 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 45.4 tp -53.04 -43.15 66.4 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.989 1.316 . . . . 0.0 111.312 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.36 -24.18 67.21 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.713 0.805 . . . . 0.0 111.96 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 133.97 -22.95 3.77 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-O 118.561 -1.133 . . . . 0.0 115.505 173.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -59.96 100.15 0.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.433 1.117 . . . . 0.0 111.129 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.46 80.78 1.41 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.494 1.14 . . . . 0.0 108.316 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 18.0 pt -113.2 169.72 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.747 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -152.86 116.02 4.63 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.31 0.644 . . . . 0.0 110.42 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -99.36 115.28 28.85 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.556 0.742 . . . . 0.0 109.866 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -90.81 148.02 22.8 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -77.72 169.58 18.05 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.774 0.83 . . . . 0.0 110.845 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 52.0 p -82.55 133.23 50.1 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.66 -26.29 29.18 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.69 2.926 . . . . 0.0 114.346 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.29 -21.49 28.97 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.251 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -63.83 136.74 57.65 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.261 0.624 . . . . 0.0 110.376 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 477' ' ' SER . 40.9 mt -132.14 125.91 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . 0.451 HD13 ' HB2' ' A' ' 470' ' ' ASN . 0.5 OUTLIER -90.04 117.79 29.1 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -72.97 160.82 31.51 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.007 0.523 . . . . 0.0 111.691 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.32 119.74 10.88 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.666 0.786 . . . . 0.0 112.202 -173.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 80.07 -3.48 70.99 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.498 0.498 . . . . 0.0 114.073 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -83.03 -176.0 6.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.358 0.663 . . . . 0.0 110.082 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -149.52 137.25 20.25 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.137 0.575 . . . . 0.0 110.823 -176.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.95 111.86 32.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.1 m -90.58 96.28 10.57 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 65.1 t -83.91 106.99 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . 0.51 ' HB2' HG22 ' A' ' 527' ' ' VAL . 51.5 m95 -99.02 172.36 7.45 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.286 0.634 . . . . 0.0 112.221 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -90.32 148.12 23.06 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.92 170.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.03 92.9 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.866 0.466 . . . . 0.0 110.678 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . 0.491 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -79.32 -1.22 85.63 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.697 -0.683 . . . . 0.0 114.329 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -69.38 -26.48 64.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.304 0.642 . . . . 0.0 110.925 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 80.88 38.12 17.04 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.753 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.95 150.63 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.483 1.113 . . . . 0.0 110.308 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -78.54 124.08 27.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.588 0.755 . . . . 0.0 110.694 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . 0.404 ' NE2' HD12 ' A' ' 526' ' ' LEU . 3.5 t-160 -72.91 110.8 7.49 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.0 m -128.71 84.5 62.94 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.366 0.666 . . . . 0.0 110.217 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.88 148.04 93.92 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.594 2.196 . . . . 0.0 112.347 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -85.64 -17.94 24.06 Favored 'Cis proline' 0 C--N 1.375 1.973 0 C-N-CA 124.62 -0.992 . . . . 0.0 113.769 -2.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 17.0 m -73.95 -15.12 61.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.85 0.86 . . . . 0.0 113.239 -166.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 66.1 m -135.27 96.94 3.58 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 30.0 tp -105.3 104.48 14.22 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 512' ' ' TRP . 76.2 t -93.36 120.45 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.009 0.524 . . . . 0.0 110.056 -173.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -68.57 97.81 0.82 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -68.41 126.86 30.93 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.493 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 112.46 -25.18 12.56 Favored Glycine 0 C--N 1.342 0.864 0 O-C-N 123.239 0.337 . . . . 0.0 112.912 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.15 114.22 27.95 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . 0.491 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 66.3 p -79.14 -32.23 44.32 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.675 0.79 . . . . 0.0 111.369 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 536' ' ' THR . 49.8 m -98.08 -33.44 11.16 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 53.51 32.82 14.87 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.459 0.647 . . . . 0.0 109.84 -171.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 66.99 55.77 15.27 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.606 -0.724 . . . . 0.0 113.008 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 533' ' ' SER . 4.6 p -73.35 153.78 40.35 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.038 0.447 . . . . 0.0 110.285 170.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 165.28 -161.63 35.01 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.074 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -79.15 -61.8 1.9 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.415 0.686 . . . . 0.0 110.341 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 558' ' ' LYS . 15.8 p -132.66 127.96 35.99 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.232 1.013 . . . . 0.0 109.531 -170.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.99 133.92 14.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.176 0.59 . . . . 0.0 111.893 -170.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.09 99.52 6.97 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.822 1.249 . . . . 0.0 108.498 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 26.9 m -92.03 113.09 25.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 39.8 t -119.67 141.28 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 123.949 0.9 . . . . 0.0 109.787 -174.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.0 tp -109.25 128.74 55.31 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 171.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.53 HG21 ' HE3' ' A' ' 484' ' ' LYS . 78.9 t -117.93 149.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.152 1.381 . . . . 0.0 108.684 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -103.49 -171.93 2.02 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.018 0.527 . . . . 0.0 111.199 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -61.1 -32.81 72.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.996 0.918 . . . . 0.0 113.394 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.87 -36.29 83.02 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.633 0.773 . . . . 0.0 111.65 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.0 -8.01 29.3 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.714 -0.492 . . . . 0.0 113.423 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.88 151.76 25.86 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 117.385 0.592 . . . . 0.0 110.76 172.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -80.21 113.38 18.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.024 0.93 . . . . 0.0 109.299 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 17.7 m -89.23 -25.81 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.978 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -144.93 148.89 34.36 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.527 0.731 . . . . 0.0 109.736 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . 0.511 ' HG3' HG22 ' A' ' 543' ' ' VAL . 25.9 ttt -151.97 136.32 16.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.589 0.756 . . . . 0.0 109.552 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -155.38 110.84 3.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.54 0.736 . . . . 0.0 109.118 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 91.6 m -95.95 117.28 30.32 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.509 0.724 . . . . 0.0 110.405 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . 0.431 HG21 ' HB ' ' A' ' 459' ' ' ILE . 85.5 t -107.05 128.19 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.551 0.74 . . . . 0.0 109.415 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 0.0 OUTLIER -117.95 157.71 26.24 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.313 1.045 . . . . 0.0 109.547 175.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? . . . . . 0 N--CA 1.477 0.89 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.716 -173.536 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.46 144.8 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 168.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 60.7 m -134.27 169.99 16.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.334 0.654 . . . . 0.0 110.542 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 51.0 mt -91.74 113.09 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.374 0.67 . . . . 0.0 110.144 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 11.6 tp10 -81.37 -58.19 3.15 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.132 0.973 . . . . 0.0 110.265 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.4 mt-10 -135.01 162.67 31.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.564 0.746 . . . . 0.0 109.992 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.4 mt -144.26 135.53 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.68 142.07 51.57 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.861 0.464 . . . . 0.0 110.101 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.56 HD12 ' HG3' ' A' ' 462' ' ' GLU . 3.2 pp -66.25 -39.55 89.58 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.894 0.478 . . . . 0.0 111.645 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.56 ' HG3' HD12 ' A' ' 461' ' ' LEU . 43.3 mt-10 -72.66 -25.21 61.19 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.199 0.523 . . . . 0.0 110.144 174.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 92.59 31.17 9.0 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.548 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -77.44 -19.85 55.39 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.825 0.85 . . . . 0.0 110.971 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -160.18 163.2 33.84 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 121.779 0.8 . . . . 0.0 112.789 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . 0.422 HG11 HG21 ' A' ' 542' ' ' THR . 93.7 t -126.93 130.65 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.006 1.722 . . . . 0.0 107.395 169.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' GLN . . . . . 0.4 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.8 tp-100 -98.49 133.96 42.12 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 171.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.2 mt -117.89 161.71 19.31 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.178 0.991 . . . . 0.0 108.84 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -146.89 131.82 18.12 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.63 ' HB2' ' HG ' ' A' ' 503' ' ' LEU . 65.2 t30 -81.89 117.4 22.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.229 0.612 . . . . 0.0 110.396 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -78.31 -23.74 46.97 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.269 0.628 . . . . 0.0 111.071 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 19.3 m -62.09 145.22 53.9 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.748 0.819 . . . . 0.0 111.266 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -86.75 17.88 3.74 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.88 0.872 . . . . 0.0 110.991 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.5 176.61 12.19 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.142 0.977 . . . . 0.0 110.05 -174.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.38 107.83 0.72 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.268 1.027 . . . . 0.0 111.082 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -88.69 111.31 21.81 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 170.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.6 p -63.53 113.4 3.28 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.012 0.525 . . . . 0.0 109.903 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.6 tp -104.27 155.97 18.3 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -175.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.37 -55.96 0.54 Allowed Glycine 0 N--CA 1.473 1.125 0 CA-C-O 121.694 0.608 . . . . 0.0 112.141 -176.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -72.72 -11.36 60.59 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.976 0.91 . . . . 0.0 111.399 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -79.48 140.68 37.23 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.637 0.775 . . . . 0.0 109.042 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -133.4 130.42 38.7 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.956 0.502 . . . . 0.0 110.804 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.67 109.75 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.635 0.774 . . . . 0.0 110.03 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' LYS . . . . . 0.538 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 62.7 mttm -79.15 100.44 7.44 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 167.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' ARG . . . . . 0.559 ' HB3' ' HA3' ' A' ' 535' ' ' GLY . 6.3 mmt85 -82.0 90.3 6.48 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 165.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' GLN . . . . . 0.481 ' HG2' ' HB3' ' A' ' 492' ' ' GLU . 21.3 tm0? -99.12 104.97 17.01 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.227 -173.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.46 126.28 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.6 -12.18 50.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.08 -6.62 40.58 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.337 1.055 . . . . 0.0 112.046 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 115.58 28.25 2.81 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 114.427 0.531 . . . . 0.0 114.427 167.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -135.48 141.44 45.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 116.998 0.399 . . . . 0.0 110.078 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.481 ' HB3' ' HG2' ' A' ' 486' ' ' GLN . 10.0 pt-20 -150.35 114.58 5.13 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.24 0.543 . . . . 0.0 109.727 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 28.5 pt -107.69 144.93 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -118.75 108.52 14.98 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.496 0.718 . . . . 0.0 109.637 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -89.23 104.89 17.4 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -84.22 134.81 34.54 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -69.5 164.9 22.12 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.851 0.86 . . . . 0.0 111.746 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.4 p -75.78 126.04 87.64 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' PRO . . . . . 0.465 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 60.2 Cg_endo -68.16 -12.46 35.15 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.647 2.231 . . . . 0.0 113.565 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -74.19 -23.53 59.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.738 0.815 . . . . 0.0 111.504 173.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -79.65 136.25 36.76 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-O 120.975 0.417 . . . . 0.0 109.91 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.71 130.01 74.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' LEU . . . . . 0.63 ' HG ' ' HB2' ' A' ' 470' ' ' ASN . 23.3 tp -95.54 113.4 25.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -76.55 164.0 26.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.214 1.005 . . . . 0.0 112.054 -172.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -55.59 120.3 7.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.372 1.069 . . . . 0.0 112.566 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.73 -5.24 17.92 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 114.338 0.495 . . . . 0.0 114.338 176.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -84.92 154.72 22.03 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.147 0.579 . . . . 0.0 109.883 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 59.7 mtt -113.94 145.15 41.93 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.76 0.824 . . . . 0.0 110.585 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.2 p -125.48 119.18 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.591 0.756 . . . . 0.0 109.225 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.81 107.01 19.41 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 16.8 t -87.0 98.88 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.571 0.749 . . . . 0.0 110.002 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' TRP . . . . . 0.522 ' HB2' HG22 ' A' ' 527' ' ' VAL . 39.5 m95 -90.14 174.19 7.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.603 0.761 . . . . 0.0 111.336 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.51 152.42 20.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.025 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.03 75.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.038 0.535 . . . . 0.0 110.528 173.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -72.62 -8.63 72.41 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.571 -0.74 . . . . 0.0 114.429 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.52 60.15 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.978 0.511 . . . . 0.0 111.28 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 75.77 38.44 36.69 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-O 121.139 0.299 . . . . 0.0 112.503 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.11 140.04 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 124.107 0.963 . . . . 0.0 110.146 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.53 138.42 36.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.928 0.891 . . . . 0.0 110.751 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -64.36 110.7 2.34 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.246 0.618 . . . . 0.0 109.525 173.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.4 m -129.29 78.52 75.77 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.598 0.759 . . . . 0.0 110.02 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.28 156.39 64.74 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.443 2.095 . . . . 0.0 111.811 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -83.57 -14.28 35.64 Favored 'Cis proline' 0 C--N 1.377 2.039 0 CA-C-N 119.698 0.928 . . . . 0.0 113.968 -1.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.9 m -66.43 -31.72 72.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.962 0.905 . . . . 0.0 112.736 -171.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 94.2 m -136.59 102.1 4.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.295 0.638 . . . . 0.0 110.636 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 67.1 mt -92.24 132.85 36.34 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 167.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 512' ' ' TRP . 99.4 t -118.92 126.44 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -70.54 100.95 1.9 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 172.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.59 133.13 49.67 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.151 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 89.57 -28.56 6.87 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 123.644 0.59 . . . . 0.0 113.591 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' GLN . . . . . 0.425 ' HG3' ' H ' ' A' ' 534' ' ' TRP . 45.7 tp60 -82.99 118.12 23.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.723 0.409 . . . . 0.0 109.987 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 33.4 m -96.28 -39.51 9.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.88 0.472 . . . . 0.0 111.248 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . 0.485 ' HB2' HG22 ' A' ' 536' ' ' THR . 67.0 p -79.04 -35.7 42.22 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.464 0.477 . . . . 0.0 111.848 -171.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' TRP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.39 31.19 9.19 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.119 0.967 . . . . 0.0 111.366 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 485' ' ' ARG . . . 70.4 59.17 5.48 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -174.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' THR . . . . . 0.485 HG22 ' HB2' ' A' ' 533' ' ' SER . 10.4 t -79.2 145.31 33.71 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.219 1.008 . . . . 0.0 110.151 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -169.56 165.25 38.68 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.132 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -75.69 -30.94 59.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.8 m -146.29 118.42 8.3 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -142.37 -178.95 5.99 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.565 0.746 . . . . 0.0 110.802 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -147.98 128.33 13.92 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.39 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' THR . . . . . 0.422 HG21 HG11 ' A' ' 466' ' ' VAL . 87.3 m -86.69 128.07 34.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 65.5 t -124.38 117.5 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' LEU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.6 tp -90.84 107.95 19.52 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . 0.43 HG22 ' HG2' ' A' ' 551' ' ' GLU . 83.3 t -96.03 149.56 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.644 1.178 . . . . 0.0 108.585 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' ASN . . . . . 0.421 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.5 p30 -108.29 -172.84 2.14 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.475 0.31 . . . . 0.0 110.965 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -52.16 -39.63 60.3 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.856 1.263 . . . . 0.0 113.27 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.34 -37.56 87.76 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.711 0.804 . . . . 0.0 112.424 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.21 -13.41 28.57 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.041 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' GLU . . . . . 0.421 ' HG2' HD21 ' A' ' 546' ' ' ASN . 11.1 pt-20 -75.1 148.89 39.32 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.278 0.539 . . . . 0.0 110.567 173.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.43 ' HG2' HG22 ' A' ' 545' ' ' VAL . 30.0 mt-10 -87.57 98.27 11.31 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.942 0.897 . . . . 0.0 109.027 -177.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 26.0 m -79.65 -19.06 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.05 -173.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' ALA . . . . . 0.65 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -145.71 145.66 30.96 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.275 0.63 . . . . 0.0 109.425 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 16.9 ttt -151.64 110.55 3.86 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -125.52 106.87 10.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.917 0.887 . . . . 0.0 108.917 -173.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 53.2 m -86.24 140.02 30.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.14 0.576 . . . . 0.0 110.578 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.3 p -144.97 111.02 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 124.43 1.092 . . . . 0.0 109.585 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -92.76 116.57 29.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 172.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 124.339 1.055 . . . . 0.0 110.492 -178.733 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -76.77 77.85 3.39 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.507 0.723 . . . . 0.0 110.477 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 19.5 m -81.85 88.54 6.32 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.808 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.89 29.3 35.14 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.019 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 51.1 p -65.96 -56.81 9.76 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 172.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 470' ' ' ASN . 18.6 t -89.07 146.46 6.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 165.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 84.6 p -134.62 172.07 13.46 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.029 0.931 . . . . 0.0 108.949 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 42.1 mm -74.19 122.2 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 14.6 tp10 -93.97 -68.05 0.82 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.502 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 36.0 mt-10 -135.12 160.09 39.45 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.961 0.904 . . . . 0.0 108.83 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.548 HG23 ' NH2' ' A' ' 485' ' ' ARG . 97.0 mt -146.57 142.61 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.87 147.93 48.33 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.02 0.528 . . . . 0.0 110.808 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.64 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.0 pt? -59.37 -35.79 74.56 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.021 0.928 . . . . 0.0 111.786 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.64 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 50.2 mt-10 -103.07 -4.97 23.81 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.443 1.097 . . . . 0.0 111.298 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 75.49 40.5 32.54 Favored Glycine 0 C--N 1.342 0.911 0 O-C-N 123.469 0.48 . . . . 0.0 113.3 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -78.9 -18.81 53.26 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.241 0.617 . . . . 0.0 110.691 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -155.55 157.33 36.66 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.013 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . 0.566 HG22 ' NH2' ' A' ' 485' ' ' ARG . 15.7 t -111.77 148.29 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 165.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.5 tp-100 -126.54 121.08 31.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.456 HD22 HD22 ' A' ' 544' ' ' LEU . 87.3 mt -110.01 159.62 17.13 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.91 0.884 . . . . 0.0 109.804 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -144.84 128.93 17.6 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.554 0.742 . . . . 0.0 109.721 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.555 ' HB2' HD12 ' A' ' 503' ' ' LEU . 64.2 t30 -91.35 109.4 20.67 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -86.93 -1.46 57.86 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.287 1.035 . . . . 0.0 111.139 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 27.0 t -74.95 158.47 33.24 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.51 0.724 . . . . 0.0 111.53 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.33 0.4 56.21 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.403 1.081 . . . . 0.0 112.22 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.53 166.18 23.79 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.969 0.508 . . . . 0.0 110.821 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -66.18 115.58 6.33 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.909 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.439 ' HG2' HG23 ' A' ' 454' ' ' VAL . 61.5 tp60 -80.02 111.08 16.02 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.851 0.719 . . . . 0.0 110.46 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.5 p -64.0 114.34 4.07 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.0 tp -107.99 151.88 25.23 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -170.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 146.87 -65.65 0.42 Allowed Glycine 0 N--CA 1.473 1.111 0 C-N-CA 121.419 -0.42 . . . . 0.0 112.921 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -69.35 -12.75 61.93 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.489 0.716 . . . . 0.0 110.98 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.437 ' CD2' ' HA ' ' A' ' 546' ' ' ASN . 26.3 m95 -67.65 150.86 48.2 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.853 0.861 . . . . 0.0 110.056 169.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 495' ' ' TYR . 30.1 ptt-85 -153.09 139.76 18.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.789 0.436 . . . . 0.0 111.364 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . 0.495 HG21 HG21 ' A' ' 466' ' ' VAL . 47.7 mt -101.41 104.6 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.304 0.642 . . . . 0.0 109.552 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.461 ' HE3' HG21 ' A' ' 545' ' ' VAL . 92.0 mttt -86.87 96.91 10.38 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.74 0.416 . . . . 0.0 109.995 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . 0.566 ' NH2' HG22 ' A' ' 466' ' ' VAL . 39.8 ttm180 -94.7 100.0 12.0 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 172.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -104.14 111.81 24.56 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.445 1.098 . . . . 0.0 110.439 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.474 HG12 ' H ' ' A' ' 489' ' ' GLU . 14.1 t -95.15 135.77 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.19 0.996 . . . . 0.0 109.272 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.4 pp -64.96 -22.89 67.07 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.342 0.657 . . . . 0.0 112.207 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . 0.474 ' H ' HG12 ' A' ' 487' ' ' VAL . 47.7 mt-10 -69.93 -10.83 59.96 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.058 0.943 . . . . 0.0 111.906 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 130.15 -28.31 3.89 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-O 119.387 -0.674 . . . . 0.0 114.232 166.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -83.24 116.17 22.28 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.834 0.817 . . . . 0.0 110.313 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.39 125.0 28.17 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 13.5 pt -140.82 148.76 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.8 0.84 . . . . 0.0 110.224 -170.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -121.3 112.51 18.69 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.484 0.714 . . . . 0.0 109.533 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 482' ' ' ARG . 50.4 t80 -79.94 105.18 11.04 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -80.74 132.56 35.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -77.17 170.25 16.87 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.457 0.646 . . . . 0.0 111.312 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . 0.438 ' HB ' ' HG2' ' A' ' 500' ' ' LYS . 52.3 p -87.99 120.09 70.63 Favored Pre-proline 0 CA--C 1.553 1.079 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.465 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.19 -5.21 7.57 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.241 2.627 . . . . 0.0 114.753 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . 0.438 ' HG2' ' HB ' ' A' ' 498' ' ' THR . 63.0 pttt -74.55 -25.94 59.64 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.539 0.335 . . . . 0.0 110.425 170.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -92.33 135.57 33.91 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.639 0.776 . . . . 0.0 110.608 -169.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 52.3 mt -126.96 128.58 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 470' ' ' ASN . 2.3 tm? -95.1 141.5 28.65 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.515 HH22 ' HG2' ' A' ' 523' ' ' PRO . 0.2 OUTLIER -87.43 164.66 16.07 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.019 0.527 . . . . 0.0 111.637 -166.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.76 123.32 19.04 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.366 0.667 . . . . 0.0 110.815 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.01 14.53 76.14 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 123.569 0.543 . . . . 0.0 113.938 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -104.92 175.27 5.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.288 0.635 . . . . 0.0 110.673 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 11.5 ptm -146.34 149.0 32.97 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.468 1.107 . . . . 0.0 110.106 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.89 131.32 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.3 0.64 . . . . 0.0 109.803 -176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.27 112.73 25.87 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.27 0.628 . . . . 0.0 109.499 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.418 HG12 ' HE1' ' A' ' 534' ' ' TRP . 46.9 t -99.38 99.76 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.185 0.594 . . . . 0.0 109.824 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . 0.541 ' HB2' HG22 ' A' ' 527' ' ' VAL . 43.4 m95 -87.16 172.99 9.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.736 0.814 . . . . 0.0 111.479 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -91.14 152.94 20.38 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.809 0.844 . . . . 0.0 110.108 172.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.14 -38.57 85.74 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.337 0.589 . . . . 0.0 110.141 172.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -81.2 13.05 34.76 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.662 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -84.69 -6.98 59.38 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.175 0.59 . . . . 0.0 110.712 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 68.52 16.46 69.63 Favored Glycine 0 C--N 1.359 1.833 0 O-C-N 123.357 0.411 . . . . 0.0 113.44 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.2 p -88.89 150.13 3.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.29 1.036 . . . . 0.0 110.358 -173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.61 118.16 21.94 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.533 0.733 . . . . 0.0 109.72 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -66.94 110.75 3.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.4 m -124.17 81.19 57.96 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.365 0.666 . . . . 0.0 109.888 -175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -70.55 154.48 64.59 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.67 2.247 . . . . 0.0 111.79 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . 0.515 ' HG2' HH22 ' A' ' 504' ' ' ARG . 97.1 Cg_endo -97.94 13.57 32.5 Favored 'Cis proline' 0 C--N 1.37 1.691 0 CA-C-N 119.723 0.937 . . . . 0.0 113.48 -2.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.8 m -78.57 -45.7 21.16 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.457 0.646 . . . . 0.0 110.594 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 93.6 m -121.01 96.38 5.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.802 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 10.7 mp -84.11 147.07 27.55 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.541 HG22 ' HB2' ' A' ' 512' ' ' TRP . 57.6 t -128.73 123.06 58.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -67.53 91.06 0.27 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 55.2 tptt -72.64 122.56 21.62 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.431 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 106.31 -1.86 37.44 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.759 0.662 . . . . 0.0 112.993 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 534' ' ' TRP . 44.7 tp60 -119.48 123.0 42.96 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 42.8 p -90.21 -47.04 8.04 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.034 0.534 . . . . 0.0 111.931 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 536' ' ' THR . 69.0 p -87.44 -34.72 18.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.972 -170.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.734 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.73 39.24 28.24 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.533 0.733 . . . . 0.0 109.973 -173.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 74.95 61.2 3.13 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 462' ' ' GLU . 7.9 p -72.93 142.04 47.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.85 0.46 . . . . 0.0 111.01 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 179.09 168.03 37.53 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.821 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.82 -16.57 40.96 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.063 0.545 . . . . 0.0 110.322 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.425 ' HB2' HD21 ' A' ' 488' ' ' LEU . 16.6 m -155.82 131.13 9.49 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.758 0.823 . . . . 0.0 108.945 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.469 ' HB3' HG22 ' A' ' 487' ' ' VAL . 23.0 p90 -157.82 145.46 18.54 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.225 0.61 . . . . 0.0 111.13 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 76.0 mtm-85 -97.88 106.15 18.41 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.85 0.86 . . . . 0.0 108.902 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 21.5 m -93.61 105.65 17.68 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.447 HG22 ' SD ' ' A' ' 554' ' ' MET . 12.0 t -103.04 134.47 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.342 1.057 . . . . 0.0 109.706 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.8 tp -103.76 124.11 48.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.461 HG21 ' HE3' ' A' ' 484' ' ' LYS . 84.1 t -118.28 141.55 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.462 1.105 . . . . 0.0 108.872 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.437 ' HA ' ' CD2' ' A' ' 481' ' ' TRP . 1.7 p30 -94.41 -177.17 4.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.652 0.381 . . . . 0.0 111.576 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.08 71.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.666 0.786 . . . . 0.0 112.902 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.21 -29.75 71.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.642 0.777 . . . . 0.0 111.786 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 95.28 25.28 14.38 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.795 -173.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.39 137.87 41.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.242 1.017 . . . . 0.0 108.597 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -75.29 96.89 3.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.791 0.836 . . . . 0.0 109.155 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 35.6 m -85.16 -23.8 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -148.46 162.92 38.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.402 0.681 . . . . 0.0 109.812 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 543' ' ' VAL . 59.2 ttp -170.52 139.22 1.59 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.963 0.905 . . . . 0.0 109.49 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -139.25 124.27 18.84 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.267 0.627 . . . . 0.0 110.101 170.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 28.2 m -81.73 99.76 9.12 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 459' ' ' ILE . 74.5 t -102.85 142.39 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.501 0.667 . . . . 0.0 109.754 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -126.15 158.44 35.54 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.006 -174.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.464 ' HG3' HD12 ' A' ' 461' ' ' LEU . 64.8 tttp -77.51 82.91 3.93 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.514 0.674 . . . . 0.0 109.43 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 17.0 m -124.39 15.39 8.96 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.701 1.2 . . . . 0.0 109.77 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . 0.617 ' HA ' HD13 ' A' ' 461' ' ' LEU . 16.5 m 61.15 90.7 0.06 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.962 1.305 . . . . 0.0 110.556 -170.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 23.3 m -90.37 -31.0 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.202 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 70.8 mtm -86.38 107.34 17.97 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -90.1 146.55 24.22 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.765 0.826 . . . . 0.0 110.373 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 64.37 30.71 13.14 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.722 1.209 . . . . 0.0 110.766 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -83.96 10.98 8.52 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.946 0.898 . . . . 0.0 110.954 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.15 -8.36 7.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.775 1.63 . . . . 0.0 114.013 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -116.6 101.29 8.48 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.222 0.609 . . . . 0.0 109.491 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 CA-C-O 119.162 -0.799 . . . . 0.0 113.251 177.902 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.402 ' HB1' ' OG ' ' A' ' 453' ' ' SER . . . -70.64 83.66 0.62 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.976 0.91 . . . . 0.0 111.653 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 23.7 p -87.84 99.48 12.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.078 0.951 . . . . 0.0 110.613 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . 0.52 ' H ' ' HB ' ' A' ' 552' ' ' VAL . . . 98.48 4.63 57.16 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.909 175.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 472' ' ' SER . 67.7 m -60.55 -32.92 71.96 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.378 0.671 . . . . 0.0 111.635 176.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 478' ' ' LEU . 13.5 t -123.71 137.1 58.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 162.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 28.7 t -130.22 170.88 13.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.986 0.914 . . . . 0.0 109.239 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 459' ' ' ILE . 61.8 mt -87.42 117.49 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 122.965 0.506 . . . . 0.0 109.88 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 8.3 tp10 -84.37 -62.07 1.65 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.358 0.663 . . . . 0.0 110.499 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 24.6 mt-10 -140.48 158.31 44.19 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.83 0.852 . . . . 0.0 109.669 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.51 ' HB ' HG21 ' A' ' 557' ' ' VAL . 48.1 mt -141.9 140.42 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -77.29 148.94 35.44 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.321 0.648 . . . . 0.0 111.568 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 559' ' ' LYS . 1.6 pp -76.31 -26.19 55.58 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.886 0.875 . . . . 0.0 112.766 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -86.52 -14.38 43.21 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.239 0.616 . . . . 0.0 110.027 168.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 78.12 28.67 55.75 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.741 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -73.03 -18.26 61.35 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.139 0.576 . . . . 0.0 111.063 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -158.22 155.8 29.63 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 122.958 0.503 . . . . 0.0 111.348 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.6 111.44 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 457' ' ' GLU . 15.6 tt0 -88.0 128.33 35.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.58 0.752 . . . . 0.0 110.223 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 483' ' ' ILE . 71.5 mt -114.0 162.66 16.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.448 1.099 . . . . 0.0 109.599 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 469' ' ' LYS . 4.7 tmmm? -147.4 132.12 17.92 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.012 0.925 . . . . 0.0 108.764 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' A' ' 505' ' ' ALA . 23.6 t-20 -76.76 127.29 32.48 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.968 1.307 . . . . 0.0 111.035 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -111.43 12.17 21.47 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.975 0.91 . . . . 0.0 111.183 172.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 453' ' ' SER . 24.1 t -79.05 148.24 32.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.847 0.859 . . . . 0.0 110.322 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -88.15 -7.78 56.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.381 0.672 . . . . 0.0 110.956 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.4 OUTLIER -135.68 172.55 12.84 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.986 0.914 . . . . 0.0 109.447 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.87 143.39 57.48 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -124.52 113.68 18.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.477 0.711 . . . . 0.0 110.26 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 40.6 p -70.79 119.27 14.69 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.4 0.68 . . . . 0.0 110.682 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.413 HD11 HG21 ' A' ' 454' ' ' VAL . 6.2 mp -100.2 165.18 11.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.117 0.967 . . . . 0.0 109.455 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 144.1 -58.09 0.53 Allowed Glycine 0 N--CA 1.465 0.624 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 547' ' ' ALA . 0.9 OUTLIER -81.03 -13.76 58.51 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 114.299 -0.95 . . . . 0.0 111.014 174.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.431 ' CZ3' HG21 ' A' ' 552' ' ' VAL . 27.8 m95 -72.23 140.12 48.51 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -146.66 135.85 22.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.056 0.542 . . . . 0.0 111.538 -171.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . 0.477 HG12 HD13 ' A' ' 544' ' ' LEU . 45.4 mt -99.99 105.99 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.908 0.883 . . . . 0.0 109.13 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -92.83 102.23 14.61 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.56 1.144 . . . . 0.0 110.42 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . 0.511 ' HE ' ' HE3' ' A' ' 534' ' ' TRP . 51.1 ttm-85 -87.22 96.35 10.3 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.44 100.88 13.07 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 46.6 t -93.62 121.59 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.42 -28.11 68.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.447 0.699 . . . . 0.0 112.629 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -64.53 -15.73 61.4 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.534 1.133 . . . . 0.0 112.574 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 125.27 27.38 1.21 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 114.471 0.548 . . . . 0.0 114.471 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -129.22 99.17 5.13 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.696 0.748 . . . . 0.0 109.971 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.36 96.86 6.71 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 174.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.3 pt -107.32 168.4 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.15 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -156.44 132.18 9.61 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.728 0.811 . . . . 0.0 109.67 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -125.53 116.19 21.39 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.442 0.697 . . . . 0.0 109.49 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -79.19 157.81 27.79 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -81.4 171.44 14.75 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.665 0.786 . . . . 0.0 110.872 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 74.7 p -81.93 128.83 67.05 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -55.05 -29.06 63.36 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.445 2.763 . . . . 0.0 113.785 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -68.73 -21.06 64.41 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.28 0.632 . . . . 0.0 112.49 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -78.95 129.53 34.58 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.364 0.666 . . . . 0.0 109.996 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 49.4 mt -126.3 119.85 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . 0.406 HD23 HG22 ' A' ' 454' ' ' VAL . 38.8 tp -83.85 138.6 33.12 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.487 0.715 . . . . 0.0 109.439 178.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -90.63 154.78 19.33 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.222 0.609 . . . . 0.0 110.549 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . 0.457 ' HA ' ' OD1' ' A' ' 470' ' ' ASN . . . -72.8 130.39 40.35 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.455 0.702 . . . . 0.0 111.681 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 75.51 20.13 78.78 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.064 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -115.19 -162.46 0.83 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.163 0.985 . . . . 0.0 110.2 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 19.6 ptp -154.4 166.37 33.44 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.361 0.665 . . . . 0.0 110.992 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.68 126.13 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.091 0.957 . . . . 0.0 109.228 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 25.6 m -116.32 111.53 20.24 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.107 0.563 . . . . 0.0 109.719 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 526' ' ' LEU . 35.5 m -88.67 137.31 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 175.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -122.01 174.47 6.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.379 1.072 . . . . 0.0 109.862 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -90.53 147.17 23.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.047 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -58.73 -42.24 88.31 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.503 0.721 . . . . 0.0 110.88 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -88.63 24.16 13.48 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.13 -0.941 . . . . 0.0 113.731 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -88.28 -13.23 41.4 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.262 0.625 . . . . 0.0 110.404 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.45 31.35 68.38 Favored Glycine 0 C--N 1.356 1.648 0 O-C-N 123.512 0.508 . . . . 0.0 112.323 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.67 144.95 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.371 1.068 . . . . 0.0 110.982 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.34 126.12 30.76 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 172.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -73.62 117.44 15.4 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 31.4 m -138.04 73.15 45.86 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.139 0.576 . . . . 0.0 110.335 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.48 148.38 83.76 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.719 2.279 . . . . 0.0 111.589 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.52 -13.54 37.38 Favored 'Cis proline' 0 C--N 1.379 2.173 0 CA-C-N 120.275 1.134 . . . . 0.0 114.424 4.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.6 m -67.6 -32.38 73.06 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.94 0.896 . . . . 0.0 112.431 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 59.8 m -135.48 98.2 3.88 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.623 0.769 . . . . 0.0 110.051 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.502 ' HB2' HG12 ' A' ' 511' ' ' VAL . 82.5 mt -90.87 149.73 21.81 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.33 120.9 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.204 0.602 . . . . 0.0 109.725 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -75.76 109.32 9.26 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 56.4 tptt -72.58 135.97 45.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.966 0.906 . . . . 0.0 110.514 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 99.32 -39.22 2.81 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.921 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -81.55 109.39 15.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.945 0.498 . . . . 0.0 110.482 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 85.9 p -83.4 -37.34 23.38 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.35 0.66 . . . . 0.0 110.292 174.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.739 ' HB2' HG23 ' A' ' 536' ' ' THR . 55.6 p -94.05 -29.39 15.22 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.794 -173.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.511 ' HE3' ' HE ' ' A' ' 485' ' ' ARG . 0.0 OUTLIER 59.98 34.51 21.5 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.14 0.976 . . . . 0.0 109.258 -171.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 79.41 81.08 0.75 Allowed Glycine 0 C--N 1.364 2.12 0 CA-C-O 119.574 -0.57 . . . . 0.0 113.032 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.739 HG23 ' HB2' ' A' ' 533' ' ' SER . 14.5 p -55.41 148.84 14.32 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.824 0.821 . . . . 0.0 112.51 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 164.8 136.15 1.95 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.585 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.71 -37.55 24.58 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 31.9 m -125.84 124.23 40.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.517 0.727 . . . . 0.0 109.186 -176.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -158.74 161.46 37.04 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.642 0.777 . . . . 0.0 111.091 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 35.0 ptt180 -119.72 111.75 18.41 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.935 0.894 . . . . 0.0 108.689 168.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 61.3 m -89.92 133.14 34.94 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.532 HG22 ' HG3' ' A' ' 554' ' ' MET . 19.3 t -124.13 117.94 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.368 1.067 . . . . 0.0 108.723 -174.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 42.9 tp -87.99 132.35 34.29 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.59 157.58 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.176 1.39 . . . . 0.0 108.113 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.507 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.2 p30 -117.77 -170.68 1.91 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.814 0.445 . . . . 0.0 111.234 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 480' ' ' ASN . . . -51.85 -37.4 51.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.396 1.478 . . . . 0.0 113.839 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.28 -34.47 77.47 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.595 0.758 . . . . 0.0 112.009 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 104.45 -12.95 51.28 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.559 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.507 ' HG2' HD21 ' A' ' 546' ' ' ASN . 16.3 pt-20 -67.42 148.21 51.87 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 122.784 0.434 . . . . 0.0 110.139 175.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -80.93 101.24 9.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.52 ' HB ' ' H ' ' A' ' 452' ' ' GLY . 22.1 m -79.27 -21.0 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.566 0.347 . . . . 0.0 111.641 -175.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -158.9 151.71 22.03 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.228 1.011 . . . . 0.0 109.189 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.532 ' HG3' HG22 ' A' ' 543' ' ' VAL . 54.8 ttp -164.21 116.2 1.33 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.661 0.784 . . . . 0.0 109.668 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -133.22 130.59 39.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.549 0.74 . . . . 0.0 110.292 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 79.8 m -90.57 123.1 33.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.363 1.065 . . . . 0.0 109.572 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.51 HG21 ' HB ' ' A' ' 459' ' ' ILE . 86.2 t -123.75 128.87 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.795 0.838 . . . . 0.0 109.72 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 151.46 38.44 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.63 1.172 . . . . 0.0 108.52 173.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.489 ' HG3' ' HB2' ' A' ' 461' ' ' LEU . 88.0 tttt -75.49 83.34 2.56 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.549 0.69 . . . . 0.0 109.319 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 35.9 t -131.23 94.89 3.66 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.996 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 50.0 m -146.86 129.85 16.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.776 0.83 . . . . 0.0 109.251 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . 0.4 HG13 ' HG3' ' A' ' 563' ' ' MET . 5.0 p -137.68 -43.68 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.844 0.858 . . . . 0.0 108.991 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.4 ' HG3' HG13 ' A' ' 562' ' ' VAL . 60.7 mtt -111.55 177.52 4.63 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.3 1.04 . . . . 0.0 109.242 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 69.9 111.36 0.05 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.026 1.33 . . . . 0.0 109.548 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -97.34 88.39 4.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.96 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -106.78 39.96 1.74 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.53 1.132 . . . . 0.0 109.433 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -62.14 -49.84 74.24 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.785 1.234 . . . . 0.0 112.324 -167.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -81.99 117.65 22.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.256 0 CA-C-O 118.359 -1.245 . . . . 0.0 111.959 179.371 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.792 0.329 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -99.01 93.08 5.81 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 78.5 p -76.23 80.06 3.02 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.594 0.712 . . . . 0.0 110.784 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 76.39 -49.31 2.64 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.62 1.105 . . . . 0.0 112.806 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.9 m -176.98 -62.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.418 1.887 . . . . 0.0 108.241 174.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 13.8 t -91.77 130.95 40.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.374 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 16.6 m -109.64 155.71 21.13 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.341 1.056 . . . . 0.0 109.407 174.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 39.9 mt -79.23 106.54 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.463 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 11.7 tp10 -73.69 -69.47 0.43 Allowed 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.733 0.646 . . . . 0.0 109.68 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.42 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 21.8 mt-10 -133.19 163.73 28.63 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.6 0.76 . . . . 0.0 109.829 -178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.503 ' HB ' HG21 ' A' ' 557' ' ' VAL . 61.2 mt -142.5 144.34 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 171.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.39 148.62 51.6 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.354 0.662 . . . . 0.0 110.716 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.46 -41.62 98.89 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.065 0.546 . . . . 0.0 111.289 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -80.57 -29.52 37.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.55 0.74 . . . . 0.0 109.362 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . 0.453 ' HA3' ' NH2' ' A' ' 485' ' ' ARG . . . 92.1 39.52 5.42 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.408 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -71.26 -20.19 62.26 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.375 0.67 . . . . 0.0 109.915 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -153.5 161.85 41.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.294 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 81.3 t -130.63 111.8 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.463 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.7 tp-100 -86.81 123.06 31.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.148 0.979 . . . . 0.0 109.955 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 483' ' ' ILE . 62.4 mt -112.49 157.86 20.6 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 471' ' ' ASN . 2.1 tmmm? -148.19 129.98 15.15 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -91.72 130.78 37.45 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.234 0.614 . . . . 0.0 110.252 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.516 ' HB3' ' HE3' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -136.38 84.73 2.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.268 1.027 . . . . 0.0 109.261 179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 66.0 m -146.43 -163.32 1.72 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.056 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . 0.534 ' HB2' ' HD3' ' A' ' 474' ' ' LYS . 2.2 m-20 -79.16 -48.78 13.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.308 0.643 . . . . 0.0 111.186 -173.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.534 ' HD3' ' HB2' ' A' ' 473' ' ' ASP . 0.0 OUTLIER -133.93 178.45 6.94 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.587 -172.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 504' ' ' ARG . 8.5 p-10 -53.16 112.46 0.87 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.72 1.208 . . . . 0.0 111.639 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -74.27 113.66 11.74 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.774 0.83 . . . . 0.0 110.557 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.494 ' HA ' HG12 ' A' ' 502' ' ' ILE . 32.6 t -64.37 100.84 0.38 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.098 0.559 . . . . 0.0 109.508 172.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 12.8 tp -90.65 165.68 13.58 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 143.22 -65.52 0.47 Allowed Glycine 0 N--CA 1.466 0.684 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.135 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.68 -13.04 58.42 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.153 0.981 . . . . 0.0 112.028 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -74.3 148.53 41.31 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.402 1.081 . . . . 0.0 109.599 174.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . 0.4 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 19.1 ptt-85 -148.58 134.11 18.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.047 0.539 . . . . 0.0 111.181 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . 0.443 HD11 HD11 ' A' ' 468' ' ' LEU . 49.2 mt -91.58 114.95 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.314 1.046 . . . . 0.0 109.729 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.569 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 67.1 mttm -79.63 144.11 34.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 164.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . 0.453 ' NH2' ' HA3' ' A' ' 463' ' ' GLY . 66.9 ttt180 -143.59 98.71 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.594 0.711 . . . . 0.0 109.282 172.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -96.15 103.6 15.51 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.01 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.547 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 24.3 t -67.58 149.44 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.495 HD23 HG12 ' A' ' 487' ' ' VAL . 2.7 pt? -52.42 -33.11 42.42 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -168.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.93 -34.08 75.92 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.288 0.635 . . . . 0.0 111.248 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 130.57 -2.3 5.7 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.728 174.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -73.05 114.21 10.96 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.168 0.484 . . . . 0.0 110.384 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -109.12 143.49 38.41 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.58 0.752 . . . . 0.0 110.556 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 22.5 pt -127.19 146.16 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.19 0.996 . . . . 0.0 108.679 169.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -125.59 109.81 13.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.557 0.743 . . . . 0.0 109.764 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -97.38 106.03 18.28 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.571 0.748 . . . . 0.0 109.658 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -87.07 153.21 21.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -89.25 170.4 10.62 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.216 0.607 . . . . 0.0 110.936 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.1 p -91.07 131.74 36.21 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 124.044 0.938 . . . . 0.0 109.649 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.25 -17.06 49.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.783 2.322 . . . . 0.0 113.453 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -72.9 -20.39 61.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.549 0.739 . . . . 0.0 111.662 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -84.2 128.3 34.48 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.408 0.683 . . . . 0.0 109.614 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 477' ' ' SER . 49.2 mt -126.46 133.41 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -114.18 124.55 52.33 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 475' ' ' ASP . 8.1 mpt_? -71.13 155.95 40.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.855 0.862 . . . . 0.0 112.152 -170.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.52 129.23 39.0 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.488 0.715 . . . . 0.0 110.753 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 86.18 -6.45 81.56 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.556 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -92.73 -175.59 3.98 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.835 0.854 . . . . 0.0 110.62 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 21.9 ptt? -145.03 160.96 40.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.922 0.889 . . . . 0.0 110.61 -176.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 468' ' ' LEU . 2.5 p -137.81 118.64 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.376 1.07 . . . . 0.0 108.367 175.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.7 m -105.07 110.82 23.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 54.2 t -89.18 99.73 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.152 0.581 . . . . 0.0 109.491 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -87.09 170.07 11.85 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.258 1.023 . . . . 0.0 111.518 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -84.28 148.89 26.44 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.114 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -67.04 -31.77 72.52 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.347 0.659 . . . . 0.0 111.163 174.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -75.42 -12.68 83.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.91 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -71.18 -14.2 62.18 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.391 0.677 . . . . 0.0 111.735 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 66.58 25.86 72.82 Favored Glycine 0 C--N 1.356 1.675 0 CA-C-O 121.124 0.291 . . . . 0.0 113.207 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 5.7 p -84.03 144.46 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.603 1.161 . . . . 0.0 111.066 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -69.29 107.69 3.37 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.81 0.844 . . . . 0.0 110.046 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -62.74 109.88 1.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.1 m -131.83 76.36 74.31 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.473 0.709 . . . . 0.0 110.413 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.0 145.05 87.58 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.757 2.305 . . . . 0.0 112.33 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.59 -23.76 12.27 Favored 'Cis proline' 0 C--N 1.373 1.838 0 CA-C-N 120.008 1.039 . . . . 0.0 113.923 -1.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.1 m -62.83 -29.82 71.02 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 21.9 m -130.44 95.47 3.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.352 0.661 . . . . 0.0 109.411 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 48.5 mt -91.29 147.14 23.25 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 168.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.57 118.9 44.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -75.12 94.2 2.89 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -66.72 134.75 52.85 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.96 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 104.78 -35.82 4.81 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -98.05 88.44 4.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.048 0.539 . . . . 0.0 110.256 172.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 60.3 p -68.3 -35.47 77.88 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.446 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 13.9 m -86.41 -32.58 20.81 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.007 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 55.56 23.03 5.64 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.028 0.931 . . . . 0.0 110.978 -177.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.18 52.06 52.34 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 122.303 -0.248 . . . . 0.0 113.378 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 3.8 p -76.67 110.6 11.38 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.461 0.704 . . . . 0.0 110.458 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -122.01 169.77 14.85 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 173.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 559' ' ' LYS . 14.2 pt-20 -80.22 -12.02 59.67 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.915 0.358 . . . . 0.0 110.888 176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.472 ' HB2' HD13 ' A' ' 488' ' ' LEU . 20.3 m -152.9 137.72 17.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.417 1.087 . . . . 0.0 108.118 172.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.547 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 13.8 p90 -166.26 172.0 11.58 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.531 0.681 . . . . 0.0 111.564 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 541' ' ' ARG . 1.4 mpt_? -118.42 157.24 27.56 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.205 1.402 . . . . 0.0 107.532 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 95.3 m -144.2 119.81 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 41.1 t -113.34 146.63 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.074 0.949 . . . . 0.0 109.404 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 26.8 tp -113.24 125.15 53.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.507 HG21 ' HE2' ' A' ' 484' ' ' LYS . 61.2 t -111.85 154.8 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.132 1.373 . . . . 0.0 107.839 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.415 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.6 p30 -114.51 -174.54 2.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.509 0.324 . . . . 0.0 111.068 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.95 69.23 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.601 1.16 . . . . 0.0 113.217 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.4 -39.34 86.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.886 0.874 . . . . 0.0 111.98 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 107.42 0.47 35.05 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.144 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.415 ' HG2' HD21 ' A' ' 546' ' ' ASN . 8.4 pt-20 -87.08 151.7 23.0 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.438 0.619 . . . . 0.0 110.537 172.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 545' ' ' VAL . 39.8 mt-10 -85.89 99.27 11.29 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.903 0.881 . . . . 0.0 109.459 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.23 -38.57 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.042 -171.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -136.55 157.02 47.75 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.167 0.587 . . . . 0.0 110.051 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.437 ' HG3' HG22 ' A' ' 543' ' ' VAL . 28.1 ttt -159.02 141.9 14.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.845 0.458 . . . . 0.0 110.973 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -132.8 164.19 27.39 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.146 1.378 . . . . 0.0 108.665 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 74.3 m -139.98 121.96 15.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 172.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.503 HG21 ' HB ' ' A' ' 459' ' ' ILE . 55.0 t -124.58 133.94 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.452 0.701 . . . . 0.0 110.686 -174.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -114.46 124.96 53.23 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.698 0.799 . . . . 0.0 109.679 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 538' ' ' GLU . 60.4 tttp -69.83 100.43 1.54 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 166.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 51.1 m -98.89 -44.05 6.5 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.24 0.616 . . . . 0.0 109.398 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 28.3 m 61.74 105.76 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.87 1.268 . . . . 0.0 111.315 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.19 -5.31 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 124.066 0.946 . . . . 0.0 111.865 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 58.2 mtm -103.51 154.26 19.66 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.979 0.912 . . . . 0.0 110.469 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 179.57 5.39 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 66.05 104.1 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.646 1.178 . . . . 0.0 111.434 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -113.66 56.08 0.71 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.016 0.926 . . . . 0.0 109.268 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.09 -52.1 63.98 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.133 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -94.88 114.68 26.56 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.96 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -177.057 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 455' ' ' SER . 50.1 m . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -77.16 79.6 3.68 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.731 0.412 . . . . 0.0 110.277 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . 0.406 ' HB3' ' HB ' ' A' ' 552' ' ' VAL . 68.0 m -73.84 84.41 1.69 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.705 0.802 . . . . 0.0 109.921 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.32 -46.71 3.06 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.905 -169.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 58.0 m -167.89 -57.68 0.02 OUTLIER 'General case' 0 C--N 1.354 0.78 0 C-N-CA 125.756 1.622 . . . . 0.0 108.66 172.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 470' ' ' ASN . 9.3 t -95.95 157.74 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.315 -174.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 449' ' ' SER . 35.6 t -145.15 165.42 28.36 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.427 0.691 . . . . 0.0 110.148 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 459' ' ' ILE . 24.9 mt -81.62 94.6 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.009 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.89 -50.65 19.22 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.015 0.526 . . . . 0.0 111.722 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -140.6 156.33 46.31 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.475 HD11 HG21 ' A' ' 456' ' ' ILE . 22.1 mt -141.24 145.45 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.75 152.11 44.14 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.447 0.699 . . . . 0.0 111.339 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 462' ' ' GLU . 2.4 pp -62.21 -37.85 86.92 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.704 0.802 . . . . 0.0 112.379 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.686 ' HG2' ' HE3' ' A' ' 559' ' ' LYS . 27.8 mt-10 -83.4 -23.92 32.16 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.216 0.531 . . . . 0.0 109.786 169.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 85.57 21.01 55.31 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.327 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -70.62 -5.67 31.14 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.109 0.455 . . . . 0.0 110.323 -175.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -149.12 159.07 44.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.695 0.798 . . . . 0.0 110.285 166.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.22 124.03 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.766 1.226 . . . . 0.0 108.049 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -96.74 120.52 37.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.177 0.591 . . . . 0.0 109.731 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 483' ' ' ILE . 79.1 mt -118.27 119.44 34.68 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.825 0.85 . . . . 0.0 109.09 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -113.43 131.32 56.06 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 454' ' ' VAL . 49.8 t30 -81.46 109.51 15.99 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.496 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -86.1 -3.68 59.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.929 0.892 . . . . 0.0 111.877 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 71.6 m -77.42 155.3 31.9 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.335 0.588 . . . . 0.0 112.406 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -76.95 -24.96 52.35 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.391 174.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.3 OUTLIER -100.97 161.41 13.61 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.791 0.836 . . . . 0.0 109.8 178.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -85.16 121.78 28.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.237 1.015 . . . . 0.0 109.267 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -82.31 115.28 21.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.36 0.664 . . . . 0.0 110.552 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 24.0 p -70.2 99.5 1.52 Allowed 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.6 tp -85.39 172.04 11.36 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.584 0.753 . . . . 0.0 109.883 -172.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 136.66 -55.76 0.7 Allowed Glycine 0 N--CA 1.471 0.983 0 CA-C-O 121.365 0.425 . . . . 0.0 112.226 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -70.93 -14.56 62.42 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.593 -0.803 . . . . 0.0 110.736 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -79.62 152.67 29.9 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.259 1.024 . . . . 0.0 109.424 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 -156.2 140.37 16.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.129 0.571 . . . . 0.0 110.627 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 12.7 mt -96.64 107.41 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.64 0.776 . . . . 0.0 109.627 -177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.647 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 67.9 mttm -76.3 161.09 29.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.178 0.513 . . . . 0.0 109.641 169.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -156.06 96.82 1.75 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -91.21 102.48 15.21 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.522 0.677 . . . . 0.0 109.49 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 489' ' ' GLU . 11.4 t -80.11 138.98 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.492 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 538' ' ' GLU . 4.6 pp -63.11 -17.88 62.81 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.918 0.487 . . . . 0.0 112.075 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . 0.41 ' H ' HG12 ' A' ' 487' ' ' VAL . 43.8 tt0 -60.93 -22.54 64.49 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.688 0.795 . . . . 0.0 111.163 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 116.68 28.26 2.56 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.79 -0.641 . . . . 0.0 114.361 170.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.67 165.54 26.67 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.473 0.636 . . . . 0.0 111.106 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -141.0 129.54 22.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.799 0.44 . . . . 0.0 110.23 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 29.4 pt -103.72 148.47 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -133.68 107.62 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.778 0.431 . . . . 0.0 110.153 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -83.71 106.31 15.32 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -81.47 152.46 27.35 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.94 0.4 . . . . 0.0 109.965 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.52 169.74 9.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.148 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 68.8 p -88.96 136.25 30.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 92.8 Cg_endo -73.12 -4.76 16.0 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.896 2.397 . . . . 0.0 113.472 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -90.68 -17.32 27.0 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.841 0.856 . . . . 0.0 110.837 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -75.53 133.63 40.96 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.776 0.83 . . . . 0.0 109.814 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 67.5 mt -119.89 124.32 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.73 112.1 23.28 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.444 ' HD2' ' H ' ' A' ' 504' ' ' ARG . 2.3 mpt_? -75.18 163.41 27.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.039 0.447 . . . . 0.0 111.067 -172.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.15 118.07 8.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.765 0.826 . . . . 0.0 111.088 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 85.9 -9.13 70.05 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 123.152 0.283 . . . . 0.0 113.784 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -75.98 171.29 14.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.169 0.588 . . . . 0.0 110.428 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -147.97 129.23 14.71 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.581 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.25 104.4 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 121.953 0.883 . . . . 0.0 109.202 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.9 m -87.43 94.24 9.64 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.407 HG12 ' HE1' ' A' ' 534' ' ' TRP . 48.2 t -86.96 99.25 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.33 0.652 . . . . 0.0 110.959 -177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . 0.57 ' HB2' HG22 ' A' ' 527' ' ' VAL . 55.2 m95 -84.96 174.89 9.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.162 0.985 . . . . 0.0 111.889 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -97.35 143.34 28.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.056 170.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -59.85 -37.75 80.16 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.501 0.72 . . . . 0.0 111.489 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -76.4 -0.57 67.29 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.769 -0.65 . . . . 0.0 114.621 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -78.35 -8.69 58.73 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.879 0.471 . . . . 0.0 111.305 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 69.07 23.23 76.15 Favored Glycine 0 C--N 1.361 1.918 0 C-N-CA 123.221 0.439 . . . . 0.0 113.65 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.17 146.26 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.47 1.108 . . . . 0.0 110.403 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -75.59 114.68 14.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.586 0.755 . . . . 0.0 110.164 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . 0.445 ' NE2' HD12 ' A' ' 526' ' ' LEU . 20.5 t-160 -69.06 117.03 10.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.84 0.456 . . . . 0.0 109.825 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.6 m -134.74 78.47 55.2 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 123.426 0.691 . . . . 0.0 110.001 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.63 151.46 82.71 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.176 1.917 . . . . 0.0 111.061 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.37 -29.64 4.34 Favored 'Cis proline' 0 CA--C 1.559 1.766 0 CA-C-N 120.48 1.207 . . . . 0.0 114.768 4.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 10.0 m -73.38 -26.12 60.86 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.514 0.726 . . . . 0.0 112.619 -164.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 44.6 m -124.32 83.53 2.16 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.445 HD12 ' NE2' ' A' ' 520' ' ' HIS . 20.7 tp -86.77 150.01 24.45 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.404 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 512' ' ' TRP . 67.6 t -134.91 126.05 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.47 -0.769 . . . . 0.0 109.275 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -69.21 95.17 0.74 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 171.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 56.2 tptt -67.46 135.24 52.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.95 0.9 . . . . 0.0 110.052 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 89.57 -15.55 58.52 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.381 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -88.49 120.64 30.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.042 0.537 . . . . 0.0 109.614 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 14.3 p -78.65 -60.37 2.41 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.194 0.598 . . . . 0.0 112.145 -176.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 17.2 t -116.13 -1.46 12.43 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -166.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.407 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 62.72 23.49 13.99 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.212 1.005 . . . . 0.0 110.761 -174.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.43 67.06 2.25 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 112.396 -0.282 . . . . 0.0 112.396 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 13.8 t -72.22 163.57 27.71 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.875 0.47 . . . . 0.0 110.936 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -177.64 165.77 35.68 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . 0.536 ' HG3' HD21 ' A' ' 488' ' ' LEU . 8.8 pt-20 -59.61 -27.94 66.75 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.011 0.924 . . . . 0.0 111.902 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.53 ' HB3' HD23 ' A' ' 488' ' ' LEU . 41.1 t -164.3 143.83 7.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.96 0.904 . . . . 0.0 110.167 169.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -156.69 143.92 18.9 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.476 1.11 . . . . 0.0 109.0 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 14.6 ptt-85 -97.29 105.3 17.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.283 0.563 . . . . 0.0 109.776 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 86.0 m -85.16 122.65 29.66 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 71.1 t -121.41 138.35 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.657 1.183 . . . . 0.0 109.857 -171.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 29.4 tp -99.88 122.25 42.54 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 171.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.13 154.0 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.182 1.393 . . . . 0.0 108.435 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.43 HD21 ' HG2' ' A' ' 550' ' ' GLU . 2.5 p30 -117.12 -168.15 1.43 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.93 0.492 . . . . 0.0 111.531 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.2 76.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.787 1.235 . . . . 0.0 113.435 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.25 -38.48 80.17 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.363 0.665 . . . . 0.0 111.403 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 103.24 2.05 47.94 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.378 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.43 ' HG2' HD21 ' A' ' 546' ' ' ASN . 10.3 pt-20 -86.64 152.3 22.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.174 0.512 . . . . 0.0 110.541 171.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -80.12 106.51 12.2 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.016 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 451' ' ' SER . 15.8 m -82.04 -35.69 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 122.32 0.248 . . . . 0.0 111.338 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -137.17 149.27 47.14 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.561 0.744 . . . . 0.0 109.562 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.429 ' HG3' HG22 ' A' ' 543' ' ' VAL . 19.2 ttt -150.94 135.24 16.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.138 0.975 . . . . 0.0 109.524 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -145.96 134.22 21.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.984 0.913 . . . . 0.0 109.919 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 36.7 m -97.87 135.86 39.0 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.437 0.695 . . . . 0.0 109.665 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 459' ' ' ILE . 41.1 t -111.11 129.28 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.789 1.236 . . . . 0.0 108.792 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -103.27 110.2 22.09 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.686 ' HE3' ' HG2' ' A' ' 462' ' ' GLU . 83.0 tttt -66.32 133.89 51.46 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 11.3 m -64.87 -56.44 13.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.658 0.783 . . . . 0.0 110.466 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 34.8 p -175.44 179.31 1.49 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.074 1.35 . . . . 0.0 109.123 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.06 12.56 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 123.792 0.837 . . . . 0.0 109.614 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 61.3 mtt -68.7 102.18 1.46 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 123.673 0.789 . . . . 0.0 110.316 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -101.17 149.95 23.45 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.923 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -76.8 111.77 12.67 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.558 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -112.82 6.28 17.92 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.474 0.71 . . . . 0.0 111.177 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.19 -20.08 63.99 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.856 0.863 . . . . 0.0 112.498 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -147.94 21.88 1.11 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.398 1.079 . . . . 0.0 109.267 173.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.22 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.715 -178.221 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -69.57 90.97 0.57 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.482 0.713 . . . . 0.0 110.079 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 18.4 m -104.99 105.06 14.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.691 0.797 . . . . 0.0 110.114 -175.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 97.06 4.79 58.55 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.971 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 43.9 m -63.53 -38.16 90.06 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.342 0.657 . . . . 0.0 110.562 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.49 147.6 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.0 m -142.25 148.28 37.84 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.836 0.854 . . . . 0.0 109.185 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.46 ' HA ' HD12 ' A' ' 468' ' ' LEU . 53.2 mt -69.59 132.53 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.699 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 10.5 tp10 -94.83 -66.28 0.92 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.045 0.538 . . . . 0.0 110.249 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.699 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 34.0 mt-10 -133.81 157.18 46.57 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.497 0.719 . . . . 0.0 109.155 -177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.535 HD13 ' HB ' ' A' ' 542' ' ' THR . 77.8 mt -141.91 139.6 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 171.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.64 143.64 51.37 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 123.666 0.604 . . . . 0.0 110.187 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.566 HD12 ' HG3' ' A' ' 462' ' ' GLU . 2.9 pp -71.05 -29.91 65.94 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.482 0.713 . . . . 0.0 112.009 -175.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.566 ' HG3' HD12 ' A' ' 461' ' ' LEU . 36.7 mt-10 -82.25 -31.63 30.06 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 170.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 97.58 41.25 3.43 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 114.904 -1.043 . . . . 0.0 112.633 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -76.21 -27.02 56.67 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.817 0.847 . . . . 0.0 110.798 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -159.23 163.3 36.0 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.367 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 42.6 t -122.65 114.9 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.9 tp-100 -85.51 107.17 17.33 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 171.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.55 HD22 HD11 ' A' ' 483' ' ' ILE . 29.6 tp -105.35 132.08 51.99 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 123.943 0.897 . . . . 0.0 108.83 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 54.3 tttm -113.7 142.07 46.47 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.355 0.525 . . . . 0.0 111.101 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -89.06 128.77 35.75 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -117.23 12.5 14.4 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.012 0.925 . . . . 0.0 110.979 -175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 33.8 t -75.88 160.32 30.05 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.723 0.809 . . . . 0.0 110.342 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -87.54 0.25 55.86 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.435 0.694 . . . . 0.0 111.769 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 179.23 7.89 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.611 1.164 . . . . 0.0 109.314 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -53.39 104.49 0.1 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.328 0.651 . . . . 0.0 109.984 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -78.94 112.11 15.79 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 28.8 t -68.84 98.36 0.92 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.776 0.672 . . . . 0.0 109.585 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.1 tp -86.03 174.31 9.29 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.927 0.891 . . . . 0.0 108.816 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 134.83 -56.53 0.71 Allowed Glycine 0 N--CA 1.468 0.832 0 O-C-N 122.032 -0.417 . . . . 0.0 112.66 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.9 -13.47 62.26 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.788 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 21.7 m95 -81.47 162.73 23.15 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.147 0.979 . . . . 0.0 110.177 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . 0.575 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 11.9 ptt180 -157.34 127.8 6.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.61 0.764 . . . . 0.0 110.66 -174.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . 0.55 HD11 HD22 ' A' ' 468' ' ' LEU . 50.3 mt -93.49 109.86 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.11 0.564 . . . . 0.0 109.601 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.714 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 97.8 mttt -81.9 167.41 18.99 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.242 0.617 . . . . 0.0 110.827 171.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 534' ' ' TRP . 42.5 ttm180 -151.69 118.38 5.75 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 166.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . 0.461 ' OE1' ' HB3' ' A' ' 492' ' ' GLU . 23.4 mm-40 -97.84 102.33 14.06 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.024 1.33 . . . . 0.0 108.568 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 40.0 t -75.04 156.78 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.21 0.604 . . . . 0.0 109.807 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 539' ' ' SER . 4.2 pp -54.9 -25.82 31.71 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.411 1.085 . . . . 0.0 113.757 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 491' ' ' GLU . 13.1 pt-20 -86.51 -21.15 27.13 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.082 0.553 . . . . 0.0 111.249 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 117.45 14.07 7.14 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.516 -0.602 . . . . 0.0 114.188 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 489' ' ' GLU . 50.8 mt-10 -76.49 109.78 10.5 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 117.945 0.873 . . . . 0.0 110.305 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.461 ' HB3' ' OE1' ' A' ' 486' ' ' GLN . 7.0 pt-20 -101.11 98.61 9.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.149 0.98 . . . . 0.0 109.815 178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.48 139.37 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.43 ' HB2' ' HG2' ' A' ' 484' ' ' LYS . . . -135.49 112.74 10.51 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.856 0.462 . . . . 0.0 111.09 -174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -82.9 112.87 20.09 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.71 0.804 . . . . 0.0 110.281 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -84.81 145.41 27.88 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.52 169.57 10.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.415 0.686 . . . . 0.0 109.923 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 82.5 p -89.42 132.55 36.93 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.324 0.65 . . . . 0.0 109.25 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.44 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 52.0 Cg_exo -58.39 -15.98 26.86 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.422 2.748 . . . . 0.0 114.808 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -79.38 -24.05 42.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.243 0.617 . . . . 0.0 111.284 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -74.29 130.68 40.17 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.466 0.706 . . . . 0.0 110.23 -174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 46.7 mt -134.71 124.41 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.468 0.707 . . . . 0.0 109.23 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.74 135.16 43.76 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -77.12 154.24 33.45 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.602 0.761 . . . . 0.0 112.156 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -59.78 131.28 50.43 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.053 0.941 . . . . 0.0 110.371 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 89.49 -42.4 3.0 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.47 0.481 . . . . 0.0 112.57 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -66.25 178.35 1.21 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.367 1.067 . . . . 0.0 112.257 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 15.9 ptp -153.13 150.24 28.88 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.391 -174.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 2.8 p -112.04 118.62 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.256 1.422 . . . . 0.0 108.84 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.6 m -95.33 99.75 11.63 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.27 97.58 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.126 0.57 . . . . 0.0 109.994 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -83.56 172.35 12.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.423 1.089 . . . . 0.0 111.616 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -89.85 154.05 20.18 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.041 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -67.34 -28.56 68.07 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.066 0.46 . . . . 0.0 110.416 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -75.21 -8.48 83.45 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.615 -0.72 . . . . 0.0 113.986 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -74.56 -19.24 60.4 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.261 0.625 . . . . 0.0 110.772 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.06 22.65 77.3 Favored Glycine 0 C--N 1.357 1.744 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.313 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.16 142.27 13.46 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.252 1.021 . . . . 0.0 109.969 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -69.5 127.52 33.28 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.574 0.75 . . . . 0.0 110.367 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -65.79 110.06 2.69 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.2 m -135.59 80.17 45.29 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.364 0.666 . . . . 0.0 109.953 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.61 154.08 44.9 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.918 2.412 . . . . 0.0 112.685 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -84.82 -17.61 25.96 Favored 'Cis proline' 0 C--N 1.374 1.882 0 CA-C-N 119.898 0.999 . . . . 0.0 114.005 -0.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 21.3 m -71.46 -38.96 71.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.311 0.644 . . . . 0.0 112.427 -169.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 74.0 m -121.35 97.49 5.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.022 0.529 . . . . 0.0 110.615 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 9.4 mp -93.04 145.26 24.51 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 166.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 91.9 t -127.97 126.69 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -73.09 96.99 2.27 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.24 130.29 42.81 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.15 0.98 . . . . 0.0 110.545 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 94.85 -45.86 2.11 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.511 0.507 . . . . 0.0 112.907 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -75.24 100.72 4.42 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 55.4 m -76.1 -43.61 42.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.058 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 536' ' ' THR . 16.8 m -85.55 -29.23 24.35 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -165.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.64 27.05 4.81 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 124.001 0.92 . . . . 0.0 110.611 -174.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.04 58.65 11.02 Favored Glycine 0 C--N 1.345 1.028 0 O-C-N 122.474 -0.141 . . . . 0.0 113.08 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 533' ' ' SER . 2.4 p -64.51 121.73 15.1 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.194 0.598 . . . . 0.0 110.523 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -154.67 155.1 25.98 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.703 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -78.82 -11.02 59.97 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.1 0.476 . . . . 0.0 110.503 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 558' ' ' LYS . 20.9 m -151.61 130.66 12.62 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.192 0.997 . . . . 0.0 108.728 173.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.474 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 8.5 p90 -161.24 171.77 17.83 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.098 0.959 . . . . 0.0 110.287 172.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.615 ' HD3' ' SD ' ' A' ' 554' ' ' MET . 7.0 ptp180 -129.4 109.36 11.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . 0.535 ' HB ' HD13 ' A' ' 459' ' ' ILE . 21.6 m -87.43 122.27 30.95 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.714 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 41.0 t -108.69 143.86 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.134 0.973 . . . . 0.0 110.075 -170.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 67.1 tp -108.39 123.11 48.34 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.017 0.927 . . . . 0.0 108.539 168.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.575 ' HB ' ' HG3' ' A' ' 482' ' ' ARG . 75.7 t -116.25 144.77 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.389 1.076 . . . . 0.0 108.651 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.57 HD21 ' HG2' ' A' ' 550' ' ' GLU . 0.8 OUTLIER -102.42 -172.89 2.21 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.809 0.843 . . . . 0.0 111.479 177.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.93 80.99 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.836 1.254 . . . . 0.0 113.723 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . 0.486 ' HB3' ' ND2' ' A' ' 546' ' ' ASN . 9.5 t70 -55.87 -39.67 71.86 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.847 0.859 . . . . 0.0 111.899 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.39 -7.71 28.51 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.532 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.57 ' HG2' HD21 ' A' ' 546' ' ' ASN . 9.4 pt-20 -73.39 141.26 46.99 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.14 0.47 . . . . 0.0 110.293 174.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -84.35 82.47 8.37 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.41 -39.85 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.267 -171.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.584 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -131.53 154.73 48.49 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.325 0.65 . . . . 0.0 110.027 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.615 ' SD ' ' HD3' ' A' ' 541' ' ' ARG . 60.0 ttp -161.33 135.67 7.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.731 0.812 . . . . 0.0 109.524 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -128.18 114.09 16.54 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.037 0.935 . . . . 0.0 109.138 174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 29.7 m -81.3 113.55 19.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.201 0.6 . . . . 0.0 109.389 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.509 HG21 ' HB ' ' A' ' 459' ' ' ILE . 82.1 t -114.53 112.27 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.019 0.928 . . . . 0.0 110.063 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 2.6 mppt? -98.79 137.61 37.13 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 165.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -56.76 97.15 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.764 0.825 . . . . 0.0 110.648 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 23.6 m -119.37 110.69 17.25 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.438 1.095 . . . . 0.0 108.236 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 34.8 m -65.2 99.95 0.42 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.633 0.773 . . . . 0.0 110.686 -175.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.5 p -122.6 -13.31 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.814 0.846 . . . . 0.0 111.176 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.56 125.54 27.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -118.37 -162.19 0.88 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.56 81.81 2.58 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 121.165 0.507 . . . . 0.0 109.838 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -171.31 78.17 0.07 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.702 1.201 . . . . 0.0 108.247 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -73.66 -49.86 23.81 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -156.82 110.62 2.66 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.687 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.255 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 177.636 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.759 0.314 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -143.42 100.59 3.64 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.69 0.796 . . . . 0.0 109.91 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 50.9 m -85.64 79.77 9.24 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.27 -42.44 2.89 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 114.901 -1.045 . . . . 0.0 114.061 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 43.4 m 70.76 -0.72 2.87 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.536 1.535 . . . . 0.0 113.167 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 27.9 t -104.13 117.75 50.2 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 25.1 t -113.05 155.01 25.62 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.088 0.555 . . . . 0.0 110.419 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.47 111.96 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -84.36 -69.47 0.64 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.163 0.585 . . . . 0.0 110.414 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 27.6 mt-10 -117.47 150.28 39.18 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.033 -171.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 50.6 mt -139.58 143.69 30.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.02 148.87 48.31 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -15.72 57.61 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.46 1.104 . . . . 0.0 113.605 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -111.44 -30.79 7.26 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.855 1.262 . . . . 0.0 109.167 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 105.27 31.14 4.45 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.339 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 516' ' ' ALA . 1.9 mppt? -73.71 -8.62 56.72 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 117.703 0.751 . . . . 0.0 110.915 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -156.83 157.26 34.63 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.289 0.636 . . . . 0.0 111.021 172.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 77.3 t -134.27 113.69 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.868 1.267 . . . . 0.0 107.862 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.7 tp-100 -86.03 107.9 18.0 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.876 0.87 . . . . 0.0 109.497 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.482 HD22 HD22 ' A' ' 544' ' ' LEU . 50.4 mt -92.82 160.62 14.85 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 170.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -145.13 127.34 15.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -89.92 97.92 11.47 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -74.46 -10.98 60.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.255 1.022 . . . . 0.0 111.706 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.5 t -63.56 145.69 55.18 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.697 0.799 . . . . 0.0 111.677 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.26 -0.12 48.12 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.176 0.99 . . . . 0.0 111.412 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.13 164.91 27.32 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 124.36 1.064 . . . . 0.0 108.644 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -61.92 161.39 10.6 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.751 0.821 . . . . 0.0 111.802 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 13.4 tm0? -136.51 112.43 9.59 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.423 ' HA ' HG12 ' A' ' 502' ' ' ILE . 23.4 p -65.24 103.16 0.74 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.312 0.645 . . . . 0.0 109.896 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 10.9 tp -88.67 161.71 16.71 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -172.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 147.94 -66.39 0.4 Allowed Glycine 0 N--CA 1.473 1.162 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.738 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -69.07 -12.61 61.84 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.295 0.638 . . . . 0.0 111.134 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -67.1 145.08 55.68 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.554 1.142 . . . . 0.0 110.387 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . 0.5 ' HG3' ' HB ' ' A' ' 545' ' ' VAL . 4.3 ptt85 -148.76 123.86 10.1 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.293 -171.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . 0.4 HD11 HD11 ' A' ' 468' ' ' LEU . 45.3 mt -90.51 109.26 20.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 123.916 0.886 . . . . 0.0 109.307 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.613 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.0 mttt -77.9 123.95 27.39 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 174.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 49.8 mmm-85 -119.95 92.35 3.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -111.98 116.73 31.06 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 489' ' ' GLU . 13.0 t -103.65 147.78 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.6 pp -67.72 -24.45 65.38 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 120.949 0.404 . . . . 0.0 111.392 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . 0.54 ' H ' HG12 ' A' ' 487' ' ' VAL . 22.5 mm-40 -61.53 -23.88 66.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.318 1.047 . . . . 0.0 110.603 171.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 126.0 -21.64 6.16 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-O 119.613 -0.549 . . . . 0.0 113.27 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.15 102.62 0.85 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.185 0.594 . . . . 0.0 111.358 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -126.71 116.25 20.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.612 0.765 . . . . 0.0 110.209 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.4 HD12 ' CZ3' ' A' ' 528' ' ' TRP . 20.2 pt -136.55 176.14 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.812 1.245 . . . . 0.0 109.57 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -149.26 108.54 3.94 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -80.56 105.04 11.51 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.25 149.27 31.91 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -91.88 171.74 8.93 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.665 0.786 . . . . 0.0 110.177 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.4 p -90.65 133.19 33.08 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.491 0.716 . . . . 0.0 109.489 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.14 8.5 3.18 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.021 2.481 . . . . 0.0 113.321 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -101.74 -22.84 14.31 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.802 1.241 . . . . 0.0 110.46 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -84.96 123.69 30.81 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 477' ' ' SER . 54.2 mt -104.61 129.99 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.8 127.87 33.42 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 174.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -88.12 158.87 18.44 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.23 127.02 29.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.667 1.187 . . . . 0.0 112.543 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 65.92 14.71 61.45 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.6 0.562 . . . . 0.0 113.747 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -105.52 -164.05 0.99 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.894 0.878 . . . . 0.0 110.282 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -152.7 163.28 39.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.037 0.935 . . . . 0.0 110.448 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.22 116.65 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.19 101.71 13.39 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 59.3 t -87.32 106.03 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 122.75 0.42 . . . . 0.0 110.347 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . 0.529 ' HB2' HG22 ' A' ' 527' ' ' VAL . 36.3 m95 -94.72 179.46 5.24 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.686 0.795 . . . . 0.0 111.312 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.687 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -107.3 155.44 19.96 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.288 1.035 . . . . 0.0 110.067 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -65.76 -33.39 75.76 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.19 0.596 . . . . 0.0 110.532 172.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . 0.451 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -78.47 -3.91 86.76 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.939 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . . . -76.58 -8.48 57.31 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.009 0.524 . . . . 0.0 110.562 169.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 73.96 21.11 79.57 Favored Glycine 0 C--N 1.36 1.871 0 C-N-CA 123.517 0.579 . . . . 0.0 113.21 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.38 143.71 16.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.332 1.053 . . . . 0.0 110.391 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -87.15 141.51 28.6 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.525 0.73 . . . . 0.0 110.398 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -61.78 119.17 8.23 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.85 0.86 . . . . 0.0 109.679 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 39.6 m -129.97 75.44 79.49 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.594 0.757 . . . . 0.0 109.881 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.66 161.23 39.96 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.735 2.29 . . . . 0.0 112.05 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.49 17.78 41.41 Favored 'Cis proline' 0 C--N 1.379 2.17 0 CA-C-N 119.771 0.954 . . . . 0.0 113.673 0.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.4 m -90.42 -68.3 0.79 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.185 0.594 . . . . 0.0 110.052 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . 0.443 HG23 ' CD1' ' A' ' 512' ' ' TRP . 72.0 m -90.36 95.05 10.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.115 0.966 . . . . 0.0 110.298 -176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 10.9 mp -92.47 104.93 17.2 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 173.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 512' ' ' TRP . 96.8 t -91.48 123.64 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . 0.4 ' CZ3' HD12 ' A' ' 493' ' ' ILE . 7.0 t90 -71.53 89.3 0.96 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 173.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 25.2 tptp -76.28 117.96 18.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.953 -175.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 123.28 -40.42 1.99 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.0 116.18 28.59 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . 0.451 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 63.1 p -88.29 -41.65 12.76 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.12 0.568 . . . . 0.0 111.506 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 78.4 p -79.94 -31.22 40.04 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.687 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 54.49 23.81 4.84 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 123.699 0.799 . . . . 0.0 110.602 -175.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 72.82 67.53 1.79 Allowed Glycine 0 C--N 1.353 1.483 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 -171.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 5.1 p -63.31 140.1 58.84 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.066 0.546 . . . . 0.0 110.733 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -167.59 143.93 8.58 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.628 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -76.62 -25.55 53.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.287 0.635 . . . . 0.0 110.088 171.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 14.8 m -148.92 120.58 8.04 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.218 1.007 . . . . 0.0 108.484 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -150.64 169.62 21.15 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.989 0.915 . . . . 0.0 110.978 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -117.85 116.99 28.09 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.002 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 40.3 m -96.58 117.34 30.75 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 45.0 t -117.85 139.19 45.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.359 1.064 . . . . 0.0 108.526 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 31.5 tp -110.11 115.87 30.53 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.523 HG21 ' HE3' ' A' ' 484' ' ' LYS . 63.8 t -108.47 151.73 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.494 1.118 . . . . 0.0 108.778 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.446 HD21 ' HG2' ' A' ' 550' ' ' GLU . 0.5 OUTLIER -110.16 -173.09 2.17 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.949 0.5 . . . . 0.0 111.119 -176.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -60.92 -35.67 77.3 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.377 1.071 . . . . 0.0 113.069 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.02 -40.74 98.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.079 0.552 . . . . 0.0 110.524 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 112.48 -11.3 26.0 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.595 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.446 ' HG2' HD21 ' A' ' 546' ' ' ASN . 10.6 pt-20 -69.66 146.47 51.61 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 117.78 0.79 . . . . 0.0 110.009 172.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.442 ' HG2' HG22 ' A' ' 545' ' ' VAL . 38.4 mt-10 -84.71 99.1 10.62 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 33.3 m -78.02 -25.85 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.146 -170.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -144.27 156.13 44.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.678 0.791 . . . . 0.0 109.554 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.518 ' HG3' HG22 ' A' ' 543' ' ' VAL . 56.9 ttp -160.2 146.93 15.89 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.343 0.657 . . . . 0.0 109.715 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.68 117.08 4.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.902 0.481 . . . . 0.0 110.402 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 62.1 m -87.93 103.72 15.95 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.724 0.81 . . . . 0.0 108.874 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.0 p -114.93 129.56 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.153 0.981 . . . . 0.0 110.432 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.94 163.32 32.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.134 0.973 . . . . 0.0 109.948 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -85.14 100.32 11.65 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.843 0.857 . . . . 0.0 109.597 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 48.9 m -105.44 -8.39 18.15 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.935 0.894 . . . . 0.0 110.638 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 43.4 m -114.98 115.3 26.65 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.968 0.907 . . . . 0.0 110.021 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.28 -8.39 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.945 0.898 . . . . 0.0 111.125 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -65.52 145.82 55.62 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.745 0.818 . . . . 0.0 111.557 -177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 -177.92 3.5 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 62.24 57.81 1.91 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.478 1.111 . . . . 0.0 110.742 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -158.87 105.83 1.81 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.052 170.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -96.42 -6.58 37.09 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.548 0.739 . . . . 0.0 112.094 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.18 101.16 5.89 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.402 0.681 . . . . 0.0 111.007 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 119.166 -0.796 . . . . 0.0 112.231 179.412 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 471' ' ' ASN . . . -152.02 89.26 1.44 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.888 0.875 . . . . 0.0 109.425 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . 0.446 ' HB2' ' HB ' ' A' ' 552' ' ' VAL . 17.9 p -78.65 94.87 5.13 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 88.27 -44.52 3.2 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.077 -173.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 19.8 p 177.26 -42.55 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.407 1.483 . . . . 0.0 109.3 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 12.3 t -98.53 162.74 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.433 1.093 . . . . 0.0 109.954 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 35.7 t -145.82 152.0 38.82 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.876 1.27 . . . . 0.0 109.366 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.0 mt -86.08 107.67 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -86.68 -53.08 5.15 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -171.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 30.0 mt-10 -136.79 163.02 31.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.637 HG23 HH21 ' A' ' 485' ' ' ARG . 89.0 mt -147.67 143.69 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.098 1.359 . . . . 0.0 107.749 177.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.462 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 37.2 t70 -66.98 148.33 52.1 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.74 0.416 . . . . 0.0 111.138 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 559' ' ' LYS . 0.4 OUTLIER -64.34 -27.42 69.01 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.968 0.907 . . . . 0.0 112.634 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.01 -32.01 11.86 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.28 0.632 . . . . 0.0 109.571 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 103.35 44.04 1.77 Allowed Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.545 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -91.04 -9.55 45.45 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.542 0.737 . . . . 0.0 111.15 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 29.5 p90 -154.71 161.09 41.69 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.33 0.586 . . . . 0.0 112.373 173.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 42.3 t -127.11 117.62 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.473 1.509 . . . . 0.0 107.335 169.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.3 tp-100 -86.03 112.41 21.21 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.499 HD22 HD11 ' A' ' 483' ' ' ILE . 16.5 tp -112.15 121.34 44.66 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.994 0.917 . . . . 0.0 108.736 -176.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -113.41 139.09 49.19 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.024 0.53 . . . . 0.0 111.698 -172.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.488 ' HB2' HD12 ' A' ' 503' ' ' LEU . 52.9 t30 -92.71 137.23 32.54 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 450' ' ' ALA . 30.5 m-80 -127.62 16.4 6.98 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.48 0.712 . . . . 0.0 109.92 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 41.9 t -73.79 152.85 40.2 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.759 0.824 . . . . 0.0 109.459 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.86 -21.35 62.44 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.376 0.67 . . . . 0.0 111.014 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.442 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.0 OUTLIER -122.97 174.89 6.9 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.469 0.708 . . . . 0.0 109.687 176.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . 0.492 ' HB2' HG22 ' A' ' 502' ' ' ILE . 5.1 p-10 -65.13 111.65 3.03 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.037 0.935 . . . . 0.0 109.963 172.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -78.03 122.41 25.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.08 0.952 . . . . 0.0 110.426 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 18.2 p -66.2 98.01 0.43 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.687 0.756 . . . . 0.0 109.626 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.6 tp -89.46 162.6 15.65 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 135.13 -51.16 0.84 Allowed Glycine 0 N--CA 1.471 0.998 0 O-C-N 121.451 -0.78 . . . . 0.0 112.334 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -68.66 -13.5 62.4 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.203 -0.999 . . . . 0.0 111.0 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -91.9 162.63 14.34 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 124.713 1.205 . . . . 0.0 110.294 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -153.43 143.75 22.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.97 0.908 . . . . 0.0 110.337 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . 0.499 HD11 HD22 ' A' ' 468' ' ' LEU . 61.5 mt -102.51 107.73 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.438 0.695 . . . . 0.0 109.618 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.668 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.5 mttt -78.67 162.24 26.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.321 0.649 . . . . 0.0 111.626 172.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . 0.637 HH21 HG23 ' A' ' 459' ' ' ILE . 71.2 mtt180 -153.03 102.46 2.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.201 1.4 . . . . 0.0 108.377 170.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . 0.491 ' HG3' ' HD3' ' A' ' 541' ' ' ARG . 8.4 pt20 -101.8 109.33 21.07 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.727 0.811 . . . . 0.0 109.712 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.475 HG12 HD23 ' A' ' 488' ' ' LEU . 6.6 t -89.44 156.58 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.919 0.888 . . . . 0.0 109.19 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 487' ' ' VAL . 2.7 pt? -66.41 -18.15 65.19 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.028 0.442 . . . . 0.0 111.458 173.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . 0.405 ' H ' HG12 ' A' ' 487' ' ' VAL . 37.4 mt-10 -83.08 4.73 25.07 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.49 1.116 . . . . 0.0 111.779 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 102.16 -26.1 25.46 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.145 -0.808 . . . . 0.0 114.469 168.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -64.53 104.53 0.81 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.677 0.739 . . . . 0.0 111.001 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.53 79.84 1.35 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.4 1.08 . . . . 0.0 108.961 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 35.6 pt -97.54 170.94 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.741 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -155.49 116.39 3.89 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.735 0.414 . . . . 0.0 110.162 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -80.17 108.49 13.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.966 0.506 . . . . 0.0 109.769 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -76.35 150.3 36.88 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.72 167.76 11.08 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 170.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 76.2 p -95.82 132.76 26.56 Favored Pre-proline 0 N--CA 1.477 0.897 0 CA-C-O 118.441 -0.79 . . . . 0.0 108.994 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.486 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 54.3 Cg_exo -55.27 -25.7 48.33 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 123.206 2.604 . . . . 0.0 115.066 -175.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -68.33 -24.67 64.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.038 0.535 . . . . 0.0 111.457 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -73.39 127.34 32.41 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.2 1.0 . . . . 0.0 109.478 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 475' ' ' ASP . 43.4 mt -129.66 118.69 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 470' ' ' ASN . 1.4 tm? -93.36 125.82 38.16 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -175.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -67.54 163.34 21.37 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.326 1.05 . . . . 0.0 113.227 -168.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.2 116.69 5.66 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.352 1.061 . . . . 0.0 111.851 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 80.94 -14.93 23.96 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 123.485 0.49 . . . . 0.0 113.926 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -79.29 -172.94 3.42 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.122 0.969 . . . . 0.0 111.068 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -154.42 147.49 24.66 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.33 0.586 . . . . 0.0 112.268 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.76 127.88 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.814 1.245 . . . . 0.0 109.135 172.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.89 99.99 11.12 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.7 t -85.55 97.92 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 122.856 0.462 . . . . 0.0 110.044 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . 0.523 ' HH2' ' HA ' ' A' ' 567' ' ' GLU . 39.3 m95 -86.61 178.24 7.12 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.044 0.938 . . . . 0.0 111.506 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.612 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.26 158.49 16.0 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.814 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.74 -28.18 67.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.386 0.675 . . . . 0.0 110.591 172.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -76.16 -16.99 80.3 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.466 -0.788 . . . . 0.0 114.066 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -68.32 -29.3 68.02 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.168 0.587 . . . . 0.0 110.729 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.72 26.47 73.99 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 116.321 -0.399 . . . . 0.0 113.635 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 13.4 p -81.09 159.03 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.827 1.251 . . . . 0.0 111.117 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -73.8 113.9 11.48 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.128 0.571 . . . . 0.0 110.139 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -64.85 110.87 2.57 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.093 0.557 . . . . 0.0 109.625 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.9 m -127.39 69.35 74.73 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.16 0.584 . . . . 0.0 110.254 -175.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.88 149.69 60.2 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.35 2.033 . . . . 0.0 111.87 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.42 -13.87 34.77 Favored 'Cis proline' 0 C--N 1.376 2.012 0 N-CA-C 114.442 0.901 . . . . 0.0 114.442 -2.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.3 m -60.12 -28.55 67.95 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.868 0.867 . . . . 0.0 113.048 -172.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 97.1 m -140.75 101.21 4.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.07 0.948 . . . . 0.0 108.878 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 63.6 mt -90.86 138.94 31.21 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 83.4 t -113.67 117.73 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -70.45 92.34 0.81 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.7 tptt -68.45 135.07 51.11 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.121 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 91.54 -14.77 63.06 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.17 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -100.91 110.89 23.0 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 66.1 p -82.34 -50.79 8.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.327 0.584 . . . . 0.0 111.219 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.597 ' HB3' HG22 ' A' ' 536' ' ' THR . 20.3 m -90.11 -28.51 18.93 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.939 -167.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 56.56 38.09 29.33 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.05 0.94 . . . . 0.0 110.142 -176.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 62.47 52.91 45.69 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.597 HG22 ' HB3' ' A' ' 533' ' ' SER . 14.3 t -72.21 156.01 39.61 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.51 0.724 . . . . 0.0 110.274 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 179.97 167.87 37.79 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.8 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -71.84 -25.29 61.91 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 18.2 m -154.42 121.69 5.69 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.856 0.862 . . . . 0.0 109.71 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.45 ' HB3' HG22 ' A' ' 487' ' ' VAL . 31.5 p90 -143.65 150.7 39.13 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.431 0.692 . . . . 0.0 111.06 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.491 ' HD3' ' HG3' ' A' ' 486' ' ' GLN . 5.4 mpt_? -101.92 106.21 17.12 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 33.5 m -84.99 106.34 16.41 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.668 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 28.3 t -105.64 133.48 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.058 0.943 . . . . 0.0 110.127 -170.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.2 tp -98.08 119.67 37.13 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.466 HG22 ' HG2' ' A' ' 551' ' ' GLU . 40.2 t -115.86 143.66 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.428 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.6 p30 -105.38 -172.89 2.18 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.499 0.32 . . . . 0.0 110.919 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -52.72 -40.23 62.83 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.844 1.258 . . . . 0.0 113.745 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.01 -36.9 82.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.613 0.765 . . . . 0.0 111.87 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.3 -19.48 29.34 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.035 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.428 ' HG2' HD21 ' A' ' 546' ' ' ASN . 11.3 pt-20 -66.95 134.81 52.75 Favored 'General case' 0 C--O 1.248 1.019 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.466 ' HG2' HG22 ' A' ' 545' ' ' VAL . 44.7 mt-10 -79.33 102.27 8.54 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 451' ' ' SER . 28.0 m -74.29 -37.39 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.651 -172.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -133.78 159.95 39.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.59 0.756 . . . . 0.0 109.32 177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.52 ' HG3' HG22 ' A' ' 543' ' ' VAL . 27.4 ttt -157.41 125.28 5.4 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -137.32 105.86 5.82 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -172.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 49.8 m -83.63 110.32 18.16 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.243 0.617 . . . . 0.0 109.682 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 53.0 t -108.9 116.62 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -87.6 147.97 25.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.664 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.53 ' HE2' HG13 ' A' ' 562' ' ' VAL . 20.6 tttm -59.8 98.96 0.06 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.835 0.854 . . . . 0.0 110.254 176.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 36.7 p -71.75 -44.04 64.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.812 0.845 . . . . 0.0 110.365 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 23.1 t -162.57 175.61 11.25 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.235 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . 0.53 HG13 ' HE2' ' A' ' 559' ' ' LYS . 17.2 m -117.84 -14.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.666 1.186 . . . . 0.0 109.78 170.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.9 mtt -91.34 147.69 22.86 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.659 1.184 . . . . 0.0 110.134 -171.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 67.73 128.76 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.402 1.481 . . . . 0.0 110.683 -168.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -111.65 132.32 54.67 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.798 0.839 . . . . 0.0 110.34 -173.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -100.1 10.92 40.52 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . 0.523 ' HA ' ' HH2' ' A' ' 512' ' ' TRP . 37.3 tt0 -82.3 -46.71 13.29 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.617 1.167 . . . . 0.0 111.058 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 59.48 85.1 0.1 Allowed 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.138 0.899 . . . . 0.0 110.68 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.087 0 CA-C-O 119.009 -0.884 . . . . 0.0 111.532 -179.43 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 37.2 m . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -75.99 90.55 3.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.815 0.446 . . . . 0.0 109.839 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 51.3 p -127.91 117.43 21.76 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.78 0.832 . . . . 0.0 109.583 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 93.19 5.31 63.92 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.726 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . 0.405 ' HB3' ' OG ' ' A' ' 472' ' ' SER . 16.6 m -63.62 -38.33 90.7 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.26 1.024 . . . . 0.0 111.688 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.07 150.8 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.964 1.306 . . . . 0.0 107.646 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 22.7 t -137.12 153.21 50.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.866 0.866 . . . . 0.0 109.629 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 64.8 mt -76.64 107.19 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 14.0 tp10 -78.54 -68.68 0.62 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 28.9 mt-10 -130.44 167.45 18.58 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.864 0.866 . . . . 0.0 109.16 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 23.4 mt -141.43 147.43 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 20.8 t70 -66.65 145.92 55.05 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.249 0.62 . . . . 0.0 111.245 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 462' ' ' GLU . 0.4 OUTLIER -63.94 -33.6 76.09 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.403 1.081 . . . . 0.0 112.74 -178.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.417 ' H ' HD12 ' A' ' 461' ' ' LEU . 44.8 mt-10 -93.38 -23.75 18.33 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.895 0.878 . . . . 0.0 110.285 173.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.67 32.46 7.24 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.001 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -79.26 -15.66 57.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.545 0.738 . . . . 0.0 111.215 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 20.5 p90 -155.15 162.17 41.05 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.277 0.56 . . . . 0.0 111.621 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 57.5 t -121.46 119.59 59.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 125.296 1.438 . . . . 0.0 107.813 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.413 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 6.2 tp-100 -88.48 109.74 20.28 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.56 ' HB2' HG13 ' A' ' 509' ' ' VAL . 87.0 mt -100.13 155.72 17.58 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 508' ' ' MET . 0.0 OUTLIER -140.47 129.8 23.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 175.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.72 111.2 17.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.947 0.899 . . . . 0.0 110.163 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -80.73 -10.84 59.7 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.146 0.979 . . . . 0.0 111.939 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 453' ' ' SER . 50.4 m -59.9 148.58 34.44 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -175.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.72 -15.81 63.22 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.653 1.181 . . . . 0.0 111.408 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.17 176.34 8.84 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.317 1.047 . . . . 0.0 110.447 -171.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.11 108.7 0.72 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.143 0.977 . . . . 0.0 110.675 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -79.92 117.34 20.68 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.405 0.682 . . . . 0.0 110.423 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.539 ' HA ' HG12 ' A' ' 502' ' ' ILE . 8.9 p -73.3 105.79 4.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.756 0.822 . . . . 0.0 109.906 175.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.5 tp -98.02 163.5 12.74 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 145.63 -64.59 0.45 Allowed Glycine 0 N--CA 1.47 0.915 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -67.91 -12.07 59.97 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.595 0.758 . . . . 0.0 111.465 175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -74.19 151.26 40.03 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.886 0.875 . . . . 0.0 109.926 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -153.42 136.49 15.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.074 0.55 . . . . 0.0 111.184 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 62.4 mt -91.71 140.3 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.052 0.941 . . . . 0.0 109.739 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.73 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 55.2 mttm -115.67 107.44 15.1 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.995 0.918 . . . . 0.0 110.149 175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -92.78 93.77 8.61 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 171.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 492' ' ' GLU . 43.3 mt-30 -93.46 104.7 16.82 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.474 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 489' ' ' GLU . 9.7 t -98.63 139.83 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.473 0.709 . . . . 0.0 109.306 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 539' ' ' SER . 4.7 pp -65.5 -21.34 66.62 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.024 0.53 . . . . 0.0 111.403 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . 0.556 ' H ' HG12 ' A' ' 487' ' ' VAL . 28.2 tt0 -71.25 -2.98 17.93 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.925 1.29 . . . . 0.0 110.895 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 110.13 11.96 19.03 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 115.509 0.964 . . . . 0.0 115.509 162.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -118.14 106.55 12.97 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.258 1.029 . . . . 0.0 110.771 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 486' ' ' GLN . 8.9 pt-20 -105.01 80.97 1.68 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 122.364 1.078 . . . . 0.0 109.006 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 38.3 pt -85.67 155.6 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.602 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -128.48 139.2 52.45 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.179 0.592 . . . . 0.0 110.16 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -123.02 105.92 10.38 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.072 0.949 . . . . 0.0 108.614 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 152.33 26.71 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -89.93 163.22 15.06 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.248 0.619 . . . . 0.0 110.512 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 75.7 p -80.24 130.02 67.41 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -65.79 -17.83 56.94 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.795 2.33 . . . . 0.0 113.333 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -72.55 -16.36 61.76 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.9 0.88 . . . . 0.0 111.623 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -89.37 134.76 33.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.746 0.819 . . . . 0.0 110.914 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 477' ' ' SER . 58.3 mt -137.67 141.2 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.89 140.27 52.05 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -73.84 166.2 23.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.082 0.953 . . . . 0.0 113.062 -168.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.72 124.76 22.28 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.234 1.014 . . . . 0.0 112.349 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 74.08 0.65 57.3 Favored Glycine 0 C--N 1.343 0.942 0 O-C-N 123.664 0.602 . . . . 0.0 114.42 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -88.89 -174.9 4.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.35 0.66 . . . . 0.0 109.451 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . 0.49 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -133.42 161.01 35.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.404 0.682 . . . . 0.0 110.99 -177.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 468' ' ' LEU . 2.4 p -134.64 105.83 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.554 1.142 . . . . 0.0 109.113 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 3.3 m -89.07 104.09 16.66 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.979 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 34.9 t -91.92 103.5 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -87.47 175.55 7.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.114 0.965 . . . . 0.0 111.694 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -96.73 156.5 16.32 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.616 171.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -62.98 -36.2 82.72 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.221 0.609 . . . . 0.0 110.652 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -80.06 4.06 68.23 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.401 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -77.09 -28.28 54.45 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.002 0.521 . . . . 0.0 110.715 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 85.61 9.0 79.42 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.556 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.7 148.57 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.087 0.955 . . . . 0.0 110.642 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -78.64 124.28 28.01 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.294 0.638 . . . . 0.0 109.621 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -63.98 111.32 2.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.814 0.446 . . . . 0.0 109.804 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.4 m -128.38 76.34 78.33 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.414 0.686 . . . . 0.0 109.632 -176.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.12 158.95 55.82 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.716 2.277 . . . . 0.0 111.631 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.69 -38.5 1.66 Allowed 'Cis proline' 0 C--N 1.379 2.15 0 CA-C-N 120.228 1.117 . . . . 0.0 114.757 6.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 60.3 m -63.85 -52.34 60.53 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.006 0.523 . . . . 0.0 112.35 -170.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 40.0 m -87.91 86.43 7.14 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.459 0.647 . . . . 0.0 109.893 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.97 149.82 24.92 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 96.1 t -133.43 121.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -72.66 94.64 1.76 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.4 tptt -70.54 136.18 49.12 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.928 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 96.06 -9.74 67.85 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.527 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -116.07 111.24 20.01 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.243 0.617 . . . . 0.0 109.587 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 49.3 m -81.82 -44.49 16.85 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.953 0.501 . . . . 0.0 111.846 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.627 ' HB3' HG22 ' A' ' 536' ' ' THR . 34.6 m -87.43 -28.42 22.13 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -168.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 60.3 26.58 16.09 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.285 1.034 . . . . 0.0 110.896 -175.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.66 75.68 0.5 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 533' ' ' SER . 13.1 t -109.36 167.27 10.25 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 123.872 0.869 . . . . 0.0 110.628 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 169.83 -164.97 38.38 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.815 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.43 -54.38 33.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.989 0.916 . . . . 0.0 110.012 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.418 ' HB2' HD23 ' A' ' 488' ' ' LEU . 26.8 m -143.44 132.74 23.26 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -154.01 146.02 23.61 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.776 0.83 . . . . 0.0 109.826 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 13.6 ptp180 -109.67 141.59 42.02 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.313 0.578 . . . . 0.0 110.519 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 47.7 m -95.66 138.36 33.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 169.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.73 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 42.0 t -124.46 150.5 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 41.8 tp -124.54 113.06 17.59 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.464 HG22 ' HG2' ' A' ' 551' ' ' GLU . 54.0 t -100.49 154.02 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.882 1.273 . . . . 0.0 108.779 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.9 -171.67 1.89 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.845 0.458 . . . . 0.0 111.747 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.5 88.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.341 1.056 . . . . 0.0 112.863 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -64.37 -38.84 92.44 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.645 0.778 . . . . 0.0 110.97 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 112.57 -5.91 26.29 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-O 118.813 -0.993 . . . . 0.0 113.852 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -72.81 146.89 45.98 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 118.793 1.297 . . . . 0.0 110.295 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 545' ' ' VAL . 47.3 mt-10 -81.37 94.5 6.79 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.641 0.776 . . . . 0.0 108.982 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 18.8 m -79.0 -19.65 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -168.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -149.11 155.06 40.13 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.059 0.544 . . . . 0.0 109.671 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 50.0 ttp -163.74 131.77 3.59 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.571 0.748 . . . . 0.0 109.624 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -145.38 126.31 14.49 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.024 0.93 . . . . 0.0 108.848 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 13.4 m -92.91 147.21 23.03 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.009 0.523 . . . . 0.0 110.401 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.74 121.19 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.388 1.075 . . . . 0.0 109.307 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.54 118.05 35.57 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -76.91 86.27 3.46 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 45.1 m -73.7 -14.81 61.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.641 0.776 . . . . 0.0 109.552 171.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . 0.607 ' HB2' ' HG2' ' A' ' 563' ' ' MET . 16.5 m 70.22 -174.66 0.18 Allowed 'General case' 0 C--N 1.365 1.248 0 C-N-CA 125.676 1.59 . . . . 0.0 110.858 176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.07 -1.14 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 CA-C-O 121.295 0.569 . . . . 0.0 110.77 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.607 ' HG2' ' HB2' ' A' ' 561' ' ' SER . 26.5 ptt? -92.89 168.42 11.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.225 1.01 . . . . 0.0 110.557 176.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 13.4 ttt85 -86.65 146.12 26.44 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.789 0.836 . . . . 0.0 109.537 169.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.74 133.09 35.31 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.423 0.689 . . . . 0.0 110.095 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -86.64 71.66 10.34 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.78 -67.22 0.48 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.081 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -98.38 77.21 2.34 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.818 -0.99 . . . . 0.0 112.489 178.16 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 548' ' ' ASP . 41.3 m . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 120.567 0.222 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -93.79 67.91 3.87 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 171.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 14.5 m -79.97 112.17 17.0 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.016 -170.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 66.37 30.56 76.84 Favored Glycine 0 C--N 1.345 1.037 0 O-C-N 123.717 0.636 . . . . 0.0 113.659 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 24.8 m -76.33 -45.37 32.54 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.414 0.685 . . . . 0.0 110.297 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.28 143.16 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 19.5 m -130.14 150.34 51.45 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.216 1.006 . . . . 0.0 109.577 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 53.4 mt -76.3 106.13 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 174.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.449 ' HB3' ' HG3' ' A' ' 467' ' ' GLN . 11.3 tp10 -78.02 -55.66 5.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.751 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 43.9 mt-10 -140.57 165.7 26.75 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.824 0.85 . . . . 0.0 109.9 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.62 ' HB ' HG21 ' A' ' 557' ' ' VAL . 79.6 mt -143.18 151.39 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.83 149.92 48.4 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.455 0.702 . . . . 0.0 111.002 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.483 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.4 pt? -64.02 -39.99 95.35 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.714 0.806 . . . . 0.0 112.004 -177.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.483 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 18.3 mt-10 -89.18 -27.24 20.81 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.309 1.044 . . . . 0.0 109.199 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 98.32 40.64 3.41 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.789 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 516' ' ' ALA . 1.5 mppt? -83.9 -10.67 57.81 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.765 0.426 . . . . 0.0 111.387 176.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -156.02 162.14 40.36 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 120.91 0.386 . . . . 0.0 111.635 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . 0.41 HG13 HG12 ' A' ' 459' ' ' ILE . 59.0 t -133.07 112.37 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.367 1.467 . . . . 0.0 107.914 174.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.449 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 14.3 tp60 -86.43 111.58 20.67 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.168 0.987 . . . . 0.0 110.094 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 7.0 mp -92.29 160.55 15.08 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.424 1.09 . . . . 0.0 109.453 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . 0.717 ' HE3' ' HB3' ' A' ' 471' ' ' ASN . 3.3 tmmm? -147.0 128.24 14.78 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -88.44 107.84 19.07 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.216 0.606 . . . . 0.0 109.802 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.717 ' HB3' ' HE3' ' A' ' 469' ' ' LYS . 12.0 p-10 -95.77 19.07 11.86 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.611 0.764 . . . . 0.0 112.046 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 45.0 m -76.55 151.94 36.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.674 0.39 . . . . 0.0 110.971 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -78.75 -22.75 46.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.885 0.874 . . . . 0.0 110.612 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -116.69 168.05 10.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.123 0.969 . . . . 0.0 111.247 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.33 111.0 4.35 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.72 0.808 . . . . 0.0 110.342 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.59 109.61 17.56 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -176.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 54.6 p -68.95 114.31 7.13 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.083 0.553 . . . . 0.0 110.359 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 7.6 tp -90.78 169.79 10.66 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.033 0.933 . . . . 0.0 109.027 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 143.15 -66.65 0.46 Allowed Glycine 0 N--CA 1.473 1.117 0 O-C-N 121.996 -0.44 . . . . 0.0 112.467 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . 0.456 HD22 ' N ' ' A' ' 480' ' ' ASN . 0.8 OUTLIER -71.99 -9.9 59.03 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.37 0.668 . . . . 0.0 111.009 179.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -70.39 143.69 51.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.836 0.854 . . . . 0.0 109.796 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 22.9 ptt-85 -140.87 137.79 33.47 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.741 0.416 . . . . 0.0 110.747 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 45.6 mt -96.75 106.92 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 99.2 mttt -75.3 147.23 40.37 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 170.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.77 91.89 2.29 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -99.55 104.46 16.26 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.487 -170.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 31.7 t -66.44 154.91 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 539' ' ' SER . 4.3 pp -51.79 -32.1 29.85 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -173.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.35 -11.35 58.64 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.377 0.671 . . . . 0.0 112.063 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 125.17 -26.68 5.5 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.621 -0.544 . . . . 0.0 112.979 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.81 111.57 1.93 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.48 0.712 . . . . 0.0 111.633 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.98 145.09 43.87 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.24 0.543 . . . . 0.0 111.385 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.71 153.89 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.89 1.276 . . . . 0.0 108.108 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -133.01 108.45 8.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.407 0.283 . . . . 0.0 110.356 -177.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -85.06 103.7 14.31 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -91.44 143.65 26.39 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.39 0.614 . . . . 0.0 109.489 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -83.93 170.79 13.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.482 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 2.6 t -94.06 140.23 22.83 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.151 0.58 . . . . 0.0 109.715 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.78 -26.1 78.79 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.877 3.052 . . . . 0.0 114.128 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -68.39 -19.41 64.62 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.4 0.68 . . . . 0.0 111.771 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -82.65 136.86 34.66 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.518 0.727 . . . . 0.0 110.617 -174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 66.7 mt -131.03 150.81 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . 0.497 HD21 ' HB ' ' A' ' 509' ' ' VAL . 0.3 OUTLIER -123.99 135.34 53.56 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -81.25 156.76 25.44 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.704 0.801 . . . . 0.0 111.674 -168.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -63.33 132.76 52.62 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.958 0.903 . . . . 0.0 112.372 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 64.29 15.83 59.46 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.921 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -107.69 -166.53 1.15 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.653 0.781 . . . . 0.0 109.908 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 171.89 16.14 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.19 0.519 . . . . 0.0 111.731 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 503' ' ' LEU . 7.4 p -146.49 142.1 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.872 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 5.2 m -118.86 109.08 15.6 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 45.7 t -90.27 100.33 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -82.21 175.93 9.89 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.674 1.19 . . . . 0.0 111.508 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.36 153.45 19.65 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.337 173.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -64.39 -32.11 73.59 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.115 0.566 . . . . 0.0 110.9 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -71.4 -16.02 75.34 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.992 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.411 ' HB2' ' HB3' ' A' ' 464' ' ' LYS . . . -70.79 -23.7 62.43 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.3 0.64 . . . . 0.0 111.473 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 78.46 36.64 29.63 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 123.235 0.334 . . . . 0.0 113.618 173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.79 147.18 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.183 0.993 . . . . 0.0 110.386 -175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -74.72 123.31 24.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.487 0.715 . . . . 0.0 110.961 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -67.46 111.15 3.94 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.4 0.68 . . . . 0.0 109.681 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 18.7 m -134.84 80.3 49.65 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.117 0.567 . . . . 0.0 110.091 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.37 156.2 61.46 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.857 2.371 . . . . 0.0 112.164 176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -99.9 30.7 11.62 Favored 'Cis proline' 0 C--N 1.38 2.186 0 CA-C-N 119.684 0.923 . . . . 0.0 113.591 -0.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 39.5 m -112.44 -38.61 4.61 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.989 0.516 . . . . 0.0 111.149 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 60.3 m -118.3 96.34 5.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.49 0.716 . . . . 0.0 109.718 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 58.1 mt -87.63 149.91 23.99 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 65.1 t -137.29 116.74 15.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -72.55 98.25 2.27 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 0.4 OUTLIER -66.14 134.11 52.09 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.88 0.872 . . . . 0.0 110.16 -177.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 92.28 -24.79 20.63 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.958 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -87.23 103.61 15.6 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 55.4 p -77.97 -45.27 24.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.815 0.446 . . . . 0.0 111.076 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 536' ' ' THR . 15.2 m -93.37 -30.26 15.2 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -166.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 55.7 32.73 19.94 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 123.644 0.777 . . . . 0.0 110.352 -174.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 72.28 59.92 4.35 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.214 -0.448 . . . . 0.0 113.027 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 533' ' ' SER . 12.2 p -65.28 147.7 52.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.985 0.514 . . . . 0.0 111.761 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 175.97 159.85 22.43 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.87 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -73.11 -9.55 58.84 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.06 0.544 . . . . 0.0 110.818 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 488' ' ' LEU . 29.6 t -157.55 139.43 14.15 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 124.589 1.156 . . . . 0.0 108.252 172.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.97 122.13 5.07 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.021 0.528 . . . . 0.0 111.282 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.603 ' HD2' ' SD ' ' A' ' 554' ' ' MET . 52.9 ttp180 -84.5 105.43 15.31 Favored 'General case' 0 C--N 1.347 0.497 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 32.2 m -94.25 128.57 40.8 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 22.8 t -120.33 145.94 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.845 0.858 . . . . 0.0 109.427 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 34.2 tp -114.88 119.42 36.51 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.5 HG22 ' HG2' ' A' ' 551' ' ' GLU . 60.9 t -106.49 154.65 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.009 1.324 . . . . 0.0 108.632 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 550' ' ' GLU . 1.2 p30 -115.52 -173.64 2.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.536 0.335 . . . . 0.0 111.675 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.24 -36.56 71.07 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.753 1.221 . . . . 0.0 112.611 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . 0.521 ' HB2' ' HA ' ' A' ' 449' ' ' SER . 20.1 t70 -60.65 -38.98 86.65 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.755 0.822 . . . . 0.0 111.635 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.15 -12.44 31.45 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.542 -174.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.518 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 0.7 OUTLIER -74.82 149.65 39.56 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.193 0.497 . . . . 0.0 110.072 177.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.5 ' HG2' HG22 ' A' ' 545' ' ' VAL . 34.5 mt-10 -88.54 92.71 9.29 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.562 0.745 . . . . 0.0 109.31 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.53 -34.57 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -168.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.574 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -135.17 165.81 24.55 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.124 0.57 . . . . 0.0 109.86 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.603 ' SD ' ' HD2' ' A' ' 541' ' ' ARG . 50.1 ttm -169.57 115.97 0.57 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.306 0.642 . . . . 0.0 109.519 -176.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 53.0 ttm-85 -124.35 115.42 20.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.483 0.713 . . . . 0.0 109.825 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 17.4 m -92.11 126.31 37.14 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.73 0.812 . . . . 0.0 109.622 175.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.62 HG21 ' HB ' ' A' ' 459' ' ' ILE . 78.2 t -123.72 123.71 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.623 0.769 . . . . 0.0 109.701 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 138.13 49.81 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.14 0.976 . . . . 0.0 109.718 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -72.27 91.9 1.35 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.103 0.961 . . . . 0.0 111.383 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 23.5 t -106.58 2.46 26.07 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.807 164.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 30.3 m -107.48 135.49 48.86 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.86 0.864 . . . . 0.0 110.835 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 34.9 m -96.01 19.49 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.075 0.95 . . . . 0.0 110.139 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 79.6 mtp -53.85 117.35 3.11 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.547 1.139 . . . . 0.0 110.956 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -82.3 133.56 35.24 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.02 0.528 . . . . 0.0 109.921 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -160.44 110.28 1.77 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -153.55 142.88 21.56 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.352 0.661 . . . . 0.0 109.833 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -162.77 -44.86 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -69.63 106.48 3.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.776 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 119.18 -0.789 . . . . 0.0 111.362 -177.01 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -147.79 67.97 1.11 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.706 0.765 . . . . 0.0 109.654 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . 0.494 ' HA ' HG12 ' A' ' 552' ' ' VAL . 27.0 p -81.26 94.99 6.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.851 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . 0.47 ' H ' ' HB ' ' A' ' 552' ' ' VAL . . . 92.5 34.27 7.1 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.968 171.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 21.6 m -71.08 -51.4 25.4 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.763 0.792 . . . . 0.0 108.945 170.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 5.0 t -110.53 146.54 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 23.2 t -124.34 177.85 5.67 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.603 1.161 . . . . 0.0 109.587 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 40.7 mt -98.4 123.27 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.504 ' HG3' ' HG2' ' A' ' 458' ' ' GLU . 6.6 tp10 -87.68 -76.11 0.39 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 457' ' ' GLU . 55.0 mm-40 -122.91 160.94 25.09 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.393 1.077 . . . . 0.0 109.383 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.447 HG12 HG13 ' A' ' 466' ' ' VAL . 66.2 mt -140.68 148.14 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.26 147.99 51.43 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 174.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.42 HD12 ' HG3' ' A' ' 462' ' ' GLU . 3.3 pp -67.0 -36.34 81.94 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.541 0.736 . . . . 0.0 111.456 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.42 ' HG3' HD12 ' A' ' 461' ' ' LEU . 40.2 mt-10 -81.34 -31.88 33.23 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 170.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . 0.547 ' HA3' HH22 ' A' ' 485' ' ' ARG . . . 92.7 51.47 2.31 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.177 -175.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -81.97 -18.97 41.61 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.361 0.665 . . . . 0.0 110.505 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -156.42 158.63 37.64 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.889 0.476 . . . . 0.0 111.554 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . 0.447 HG13 HG12 ' A' ' 459' ' ' ILE . 61.1 t -127.3 107.12 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.889 1.275 . . . . 0.0 108.19 174.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 4.7 tp-100 -85.76 114.61 22.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 109.27 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 70.4 mt -100.96 151.84 21.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.695 1.198 . . . . 0.0 109.334 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 4.6 tmmm? -138.94 136.8 35.84 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.751 0.821 . . . . 0.0 109.568 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.455 ' OD1' ' HA ' ' A' ' 505' ' ' ALA . 25.9 t-20 -90.97 133.24 35.44 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.106 0.963 . . . . 0.0 111.335 -176.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.403 HD21 ' HE3' ' A' ' 469' ' ' LYS . 20.8 m120 -110.91 7.26 21.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.71 0.804 . . . . 0.0 111.95 176.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 48.8 m -80.53 155.5 26.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.274 0.63 . . . . 0.0 111.718 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -85.4 -19.4 31.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.61 0.764 . . . . 0.0 110.053 172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.492 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.1 OUTLIER -123.24 150.91 42.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.487 1.115 . . . . 0.0 109.108 -178.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -69.01 135.76 51.39 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.296 0.638 . . . . 0.0 111.397 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -89.65 118.33 29.19 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.517 0.727 . . . . 0.0 109.923 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 15.4 p -65.12 109.82 2.31 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 503' ' ' LEU . 4.8 tp -102.14 175.66 5.46 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -171.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 122.05 -50.57 0.83 Allowed Glycine 0 N--CA 1.469 0.857 0 CA-C-O 121.993 0.774 . . . . 0.0 111.179 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . 0.595 ' HB3' ' HB2' ' A' ' 547' ' ' ALA . 9.0 m120 -65.46 -24.28 67.13 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 113.368 -1.416 . . . . 0.0 110.543 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.475 ' CZ3' HG21 ' A' ' 552' ' ' VAL . 13.6 m0 -77.12 164.23 25.88 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.061 0.945 . . . . 0.0 111.289 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -156.21 138.67 14.9 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.523 -170.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.06 113.57 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.421 1.088 . . . . 0.0 108.61 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -79.61 140.92 36.96 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . 0.547 HH22 ' HA3' ' A' ' 463' ' ' GLY . 74.4 ttt180 -143.8 96.38 2.89 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 173.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . 0.519 ' HG3' ' HB2' ' A' ' 541' ' ' ARG . 5.6 pt20 -98.36 103.87 15.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.864 1.265 . . . . 0.0 109.434 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.71 153.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.602 0.761 . . . . 0.0 109.178 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.419 HD23 ' HB2' ' A' ' 539' ' ' SER . 2.4 pp -66.23 -14.37 61.81 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 118.391 0.541 . . . . 0.0 111.679 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -62.01 -23.37 66.4 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.613 0.765 . . . . 0.0 110.939 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 104.37 -8.53 48.41 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.704 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -78.33 105.47 9.6 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 123.44 0.696 . . . . 0.0 110.496 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.08 133.24 51.11 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.514 173.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 24.2 pt -128.58 156.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.16 0.984 . . . . 0.0 108.661 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -131.11 108.01 9.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -87.91 103.56 15.79 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -87.08 146.54 26.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 170.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -83.43 170.24 14.7 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.08 0.552 . . . . 0.0 110.935 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.9 p -84.79 129.92 54.87 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.213 0.605 . . . . 0.0 109.372 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.526 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 36.3 Cg_endo -62.31 -14.32 37.84 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.893 2.395 . . . . 0.0 113.465 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.88 1.81 41.52 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.971 0.908 . . . . 0.0 111.977 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -103.26 136.92 42.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.606 0.762 . . . . 0.0 111.002 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 69.5 mt -118.12 136.59 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . 0.479 ' HB2' HD22 ' A' ' 478' ' ' LEU . 3.1 tm? -100.54 121.25 41.27 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -79.94 161.95 25.22 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.305 0.642 . . . . 0.0 112.655 -171.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . 0.455 ' HA ' ' OD1' ' A' ' 470' ' ' ASN . . . -73.95 133.96 43.1 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.083 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 70.15 1.26 33.19 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.509 0.505 . . . . 0.0 113.817 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -101.97 174.72 5.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.956 0.902 . . . . 0.0 110.35 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -140.68 144.02 35.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.013 0.525 . . . . 0.0 111.432 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.53 128.97 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.835 0.854 . . . . 0.0 108.907 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.3 m -103.79 103.31 13.17 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 56.7 t -87.4 97.85 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 122.803 0.441 . . . . 0.0 110.167 -176.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . 0.543 ' HB2' HG22 ' A' ' 527' ' ' VAL . 43.9 m95 -90.94 175.47 6.96 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.849 0.859 . . . . 0.0 112.007 -175.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -104.04 152.85 21.56 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.357 1.063 . . . . 0.0 110.308 174.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -63.54 -38.96 93.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.422 0.689 . . . . 0.0 111.879 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -82.7 -0.63 90.23 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.34 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -83.25 7.0 17.6 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.404 0.681 . . . . 0.0 111.632 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 76.83 38.56 30.89 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 113.572 0.189 . . . . 0.0 113.572 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 4.6 p -146.5 137.33 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.703 0.801 . . . . 0.0 110.617 -170.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -91.09 151.49 20.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.101 0.961 . . . . 0.0 111.139 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -67.05 112.27 4.3 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.5 m -131.78 79.34 68.39 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.672 0.789 . . . . 0.0 109.889 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.95 156.25 56.53 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.716 2.278 . . . . 0.0 111.845 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -93.4 4.42 57.66 Favored 'Cis proline' 0 C--N 1.381 2.244 0 CA-C-N 119.815 0.97 . . . . 0.0 113.491 2.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.0 m -82.81 -30.09 29.04 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.605 0.762 . . . . 0.0 111.595 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 84.0 m -140.75 102.84 4.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.367 0.667 . . . . 0.0 110.658 -174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 9.7 mp -97.49 103.77 15.73 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 512' ' ' TRP . 72.0 t -89.29 122.19 40.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -71.07 87.1 0.75 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 22.1 tptp -68.01 116.54 8.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.701 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 120.84 -45.36 1.24 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -172.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.11 105.85 12.65 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . 0.455 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 34.2 p -72.18 -47.16 52.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.483 0.713 . . . . 0.0 111.243 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 536' ' ' THR . 48.7 m -99.23 -14.34 19.33 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.489 0.715 . . . . 0.0 112.271 -173.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 61.72 23.76 14.01 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.04 0.936 . . . . 0.0 109.582 -171.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.92 65.2 2.71 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-N 116.54 -0.3 . . . . 0.0 112.717 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 533' ' ' SER . 10.8 p -59.55 166.11 2.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.167 0.987 . . . . 0.0 113.624 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 177.72 160.21 23.92 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.034 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -78.4 -27.12 46.68 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.852 0.326 . . . . 0.0 110.399 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.419 ' HB2' HD23 ' A' ' 488' ' ' LEU . 2.7 m -145.71 129.5 17.22 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 168.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.87 137.79 20.24 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.843 0.857 . . . . 0.0 110.887 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.519 ' HB2' ' HG3' ' A' ' 486' ' ' GLN . 1.3 mpt_? -91.68 116.14 28.63 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 78.8 m -108.12 119.34 39.2 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . . . . . . . . . 20.4 t -115.67 123.25 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.024 0.93 . . . . 0.0 109.744 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 42.2 tp -81.25 124.43 29.31 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 546' ' ' ASN . 53.5 t -126.45 144.37 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.824 0.85 . . . . 0.0 109.556 -173.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.471 ' O ' HG12 ' A' ' 545' ' ' VAL . 4.1 t30 -84.03 162.69 20.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.907 0.883 . . . . 0.0 109.935 170.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 480' ' ' ASN . . . -45.51 -41.49 9.7 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.439 1.495 . . . . 0.0 114.48 -175.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.26 -32.44 68.37 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.557 1.143 . . . . 0.0 112.897 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.85 -6.29 31.07 Favored Glycine 0 N--CA 1.464 0.551 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -168.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.435 ' HG2' HD22 ' A' ' 546' ' ' ASN . 13.8 pt-20 -67.81 117.63 9.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.568 0.747 . . . . 0.0 109.642 174.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.42 116.81 15.52 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 451' ' ' SER . 16.1 m -95.33 -28.86 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 122.719 0.408 . . . . 0.0 111.546 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -156.89 147.33 21.34 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.167 0.987 . . . . 0.0 109.251 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 554' ' ' MET . 0.0 OUTLIER -147.26 147.67 30.65 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.119 0.568 . . . . 0.0 109.694 -178.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . 0.435 ' NH1' HG22 ' A' ' 557' ' ' VAL . 2.1 tmt_? -160.86 108.51 1.54 Allowed 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 63.2 m -81.55 138.13 35.46 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.619 0.768 . . . . 0.0 109.573 174.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.435 HG22 ' NH1' ' A' ' 555' ' ' ARG . 36.2 t -115.9 146.63 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.686 1.194 . . . . 0.0 109.133 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 113.1 6.18 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.005 0.922 . . . . 0.0 108.823 166.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -54.02 105.77 0.16 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.948 1.699 . . . . 0.0 111.384 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 36.4 p -160.65 -41.64 0.05 OUTLIER 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.642 1.177 . . . . 0.0 108.886 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 17.3 m -62.74 143.68 57.21 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.557 0.743 . . . . 0.0 110.573 172.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 4.4 p -143.3 86.36 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.392 1.091 . . . . 0.0 109.719 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 62.0 mtt -119.12 179.39 4.18 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.289 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -74.03 148.95 41.51 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.862 0.465 . . . . 0.0 110.173 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.78 133.98 48.05 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.008 0.923 . . . . 0.0 112.01 -171.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -93.88 73.93 4.19 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . 0.492 ' HA ' ' HZ2' ' A' ' 512' ' ' TRP . 11.2 pt-20 -71.49 -27.88 63.53 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.759 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 57.0 t30 59.51 83.86 0.12 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.72 1.208 . . . . 0.0 112.158 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.317 0 CA-C-O 118.761 -1.022 . . . . 0.0 112.487 178.596 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 120.534 0.207 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -73.82 138.5 44.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.566 0.746 . . . . 0.0 109.422 170.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 15.7 m -74.86 84.97 2.21 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.409 0.683 . . . . 0.0 111.849 -171.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 82.0 -37.74 2.53 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 115.349 0.899 . . . . 0.0 115.349 170.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 8.2 t 70.1 1.36 3.49 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 125.665 1.586 . . . . 0.0 112.139 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 21.7 t -110.39 128.51 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 171.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 28.6 t -117.18 174.2 6.25 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.17 0.588 . . . . 0.0 109.785 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 36.8 mt -93.03 116.23 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 469' ' ' LYS . 7.2 tp10 -70.33 -71.38 0.25 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.738 0.815 . . . . 0.0 109.92 -177.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.0 mt-10 -126.56 159.38 33.64 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.183 0.993 . . . . 0.0 108.705 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.59 HD13 ' HB ' ' A' ' 542' ' ' THR . 15.9 mt -137.09 131.3 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -70.67 127.0 31.16 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.655 ' HB2' ' HA ' ' A' ' 559' ' ' LYS . 0.9 OUTLIER -80.31 -17.83 50.96 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.534 0.521 . . . . 0.0 111.491 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -12.71 60.11 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 165.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 79.09 21.5 67.68 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.107 -0.951 . . . . 0.0 115.144 164.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -91.21 -13.16 33.34 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.058 0.429 . . . . 0.0 111.109 -176.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -155.29 158.7 39.19 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 174.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.5 116.81 46.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.114 1.366 . . . . 0.0 107.693 168.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.416 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.4 tp-100 -89.58 113.64 25.1 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.02 140.48 34.19 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 21.3 tptm -113.96 129.28 56.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.425 ' HB2' HD12 ' A' ' 503' ' ' LEU . 48.2 t30 -88.1 100.08 12.68 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -90.94 6.92 42.69 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.14 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.9 t -76.11 161.41 28.87 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.596 0.758 . . . . 0.0 111.066 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.75 -9.55 58.09 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.233 0.613 . . . . 0.0 111.616 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.403 ' HD3' ' H ' ' A' ' 474' ' ' LYS . 0.3 OUTLIER -130.08 168.41 16.8 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.161 0.584 . . . . 0.0 110.038 177.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.19 118.42 10.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.484 0.714 . . . . 0.0 109.327 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -94.39 118.78 32.15 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.446 0.698 . . . . 0.0 110.391 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 67.6 p -71.94 116.97 12.97 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.397 0.679 . . . . 0.0 110.273 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.53 177.82 6.0 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 146.05 -67.42 0.41 Allowed Glycine 0 N--CA 1.474 1.2 0 CA-C-O 121.494 0.496 . . . . 0.0 112.743 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -73.23 -9.79 59.08 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.702 -0.749 . . . . 0.0 109.692 167.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 34.9 m95 -72.05 131.08 42.39 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.97 0.908 . . . . 0.0 109.148 171.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 21.5 ptt-85 -139.93 127.95 22.23 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.681 0.792 . . . . 0.0 110.375 -173.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . 0.435 ' HB ' ' HH2' ' A' ' 534' ' ' TRP . 10.3 mt -91.23 105.86 16.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.551 ' HE3' HG21 ' A' ' 545' ' ' VAL . 97.8 mttt -76.71 134.2 39.28 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.661 0.384 . . . . 0.0 110.385 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -118.85 91.4 3.55 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -97.11 102.05 13.75 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.077 0.951 . . . . 0.0 109.052 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 488' ' ' LEU . 5.8 t -101.39 147.55 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.098 0.559 . . . . 0.0 110.786 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.477 HD23 HG12 ' A' ' 487' ' ' VAL . 2.3 pt? -60.78 -24.73 66.0 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.544 0.738 . . . . 0.0 111.996 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.91 -27.56 68.9 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.346 1.058 . . . . 0.0 111.898 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 124.18 -26.4 5.83 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.677 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.74 100.29 2.32 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.977 0.894 . . . . 0.0 110.295 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -113.43 97.22 6.33 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.887 -1.052 . . . . 0.0 108.321 175.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 25.4 pt -108.71 178.91 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.547 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -156.3 118.45 4.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.32 0.648 . . . . 0.0 109.473 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -86.72 107.72 18.36 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -85.02 146.72 27.04 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.707 0.765 . . . . 0.0 110.195 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -80.18 173.35 12.68 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.955 1.302 . . . . 0.0 109.917 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 71.8 p -89.42 136.96 29.28 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.406 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 74.6 Cg_exo -52.57 -26.94 30.77 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.175 2.583 . . . . 0.0 114.435 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -79.31 -24.47 42.82 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.731 0.813 . . . . 0.0 112.227 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -66.9 127.78 33.82 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.232 0.613 . . . . 0.0 109.967 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 45.2 mt -129.81 134.08 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.812 0.845 . . . . 0.0 108.94 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 470' ' ' ASN . 0.8 OUTLIER -108.26 130.9 55.15 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -77.75 155.4 31.22 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.751 0.82 . . . . 0.0 111.553 -170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.97 120.73 13.14 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.723 0.809 . . . . 0.0 110.793 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 88.08 -2.26 85.32 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.575 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -95.98 176.02 6.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.05 0.54 . . . . 0.0 110.173 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -148.01 136.75 21.79 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.756 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 3.4 p -101.78 114.66 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.406 0.682 . . . . 0.0 109.781 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.99 94.95 10.0 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 89.6 t -82.64 104.6 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . 0.543 ' HB2' HG22 ' A' ' 527' ' ' VAL . 37.7 m95 -93.61 176.83 6.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.065 0.946 . . . . 0.0 112.107 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -98.66 142.07 30.69 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.02 171.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -66.86 -32.7 74.14 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.191 0.596 . . . . 0.0 111.152 176.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -67.57 -19.59 71.12 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.002 -0.545 . . . . 0.0 113.817 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -66.31 -18.45 65.36 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.153 0.581 . . . . 0.0 110.79 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.17 27.56 72.73 Favored Glycine 0 C--N 1.352 1.454 0 C-N-CA 122.711 0.196 . . . . 0.0 112.878 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.58 149.26 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.436 1.095 . . . . 0.0 110.942 -174.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -68.74 119.55 13.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.279 0.632 . . . . 0.0 110.999 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . 0.451 ' NE2' HD12 ' A' ' 526' ' ' LEU . 15.6 t-160 -76.44 124.69 27.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.439 0.695 . . . . 0.0 110.065 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 58.5 m -152.41 79.35 6.09 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.876 0.87 . . . . 0.0 110.464 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.49 161.05 37.88 Favored 'Trans proline' 0 CA--C 1.565 2.037 0 C-N-CA 122.909 2.406 . . . . 0.0 111.844 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.37 -9.17 43.44 Favored 'Cis proline' 0 C--N 1.382 2.314 0 CA-C-N 120.355 1.162 . . . . 0.0 113.904 1.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.1 m -66.33 -37.15 84.7 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.798 0.839 . . . . 0.0 111.753 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 97.0 m -139.46 89.81 2.36 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.775 0.83 . . . . 0.0 108.946 -176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 30.5 tp -91.83 138.98 31.11 Favored 'General case' 0 C--O 1.209 -1.078 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 512' ' ' TRP . 96.6 t -125.66 122.7 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.03 0.832 . . . . 0.0 109.15 -175.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -70.17 94.55 0.91 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 23.0 tptm -71.32 117.62 13.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.428 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 121.44 -36.85 3.14 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.23 127.05 34.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.913 0.485 . . . . 0.0 110.684 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 58.4 p -99.42 -36.23 9.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.852 0.861 . . . . 0.0 110.978 177.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.456 ' OG ' HG22 ' A' ' 536' ' ' THR . 28.9 t -87.54 -35.51 18.11 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.653 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 51.48 34.51 12.34 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.833 0.853 . . . . 0.0 110.423 -174.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 64.88 64.21 3.69 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.195 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.456 HG22 ' OG ' ' A' ' 533' ' ' SER . 12.4 t -104.7 168.38 9.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.927 0.491 . . . . 0.0 110.673 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 168.0 -162.51 36.29 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.225 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -69.21 -34.64 75.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.208 0.603 . . . . 0.0 111.253 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.7 m -158.59 137.27 11.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.208 1.003 . . . . 0.0 109.021 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.459 ' HB3' HG22 ' A' ' 487' ' ' VAL . 4.7 p90 -149.98 125.38 10.19 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.83 0.824 . . . . 0.0 112.117 -177.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 72.7 ttt-85 -77.92 102.04 7.13 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.722 174.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . 0.59 ' HB ' HD13 ' A' ' 459' ' ' ILE . 16.3 m -95.86 124.52 39.9 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 46.7 t -125.33 134.92 65.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 C-N-CA 123.696 0.798 . . . . 0.0 109.937 -172.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . . . . . . . . . 26.7 tp -97.69 115.96 28.98 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 166.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.551 HG21 ' HE3' ' A' ' 484' ' ' LYS . 92.3 t -110.06 159.17 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.014 1.326 . . . . 0.0 108.702 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -124.56 -170.35 2.14 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.732 0.413 . . . . 0.0 111.783 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.69 73.97 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.378 1.071 . . . . 0.0 112.948 -178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.33 -36.64 84.79 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.65 0.78 . . . . 0.0 111.07 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.26 -18.57 27.98 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.646 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.68 160.42 32.25 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.506 0.67 . . . . 0.0 110.59 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -92.71 108.0 19.65 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.186 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 15.7 m -75.17 -23.73 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.932 0.493 . . . . 0.0 111.494 -175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -151.63 131.66 13.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.814 0.845 . . . . 0.0 109.065 174.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 12.3 ttm -122.83 108.83 13.44 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -126.76 105.17 8.49 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 66.6 m -84.52 136.62 33.73 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.07 138.91 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.07 137.58 51.99 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.25 1.02 . . . . 0.0 108.695 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 461' ' ' LEU . 55.8 tttm -75.99 77.28 2.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.477 1.111 . . . . 0.0 109.962 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 17.7 m -101.96 -13.52 17.55 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.294 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 47.2 t -86.84 165.63 15.82 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.324 0.649 . . . . 0.0 110.802 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.18 2.78 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 C-N-CA 123.968 0.907 . . . . 0.0 110.693 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 74.2 mtm -66.06 152.0 45.64 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.381 0.673 . . . . 0.0 111.596 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.13 170.87 7.83 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.608 0.763 . . . . 0.0 111.564 -173.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.68 136.76 57.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.758 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 19.1 m120 74.34 -29.39 0.19 Allowed 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.303 1.441 . . . . 0.0 112.717 -178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -58.2 -26.58 62.97 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.185 0.994 . . . . 0.0 111.25 175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 5.1 t30 74.01 -75.39 0.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.608 1.163 . . . . 0.0 111.624 165.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.468 0 CA-C-O 118.566 -1.13 . . . . 0.0 111.042 -177.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -59.44 93.44 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.856 0.862 . . . . 0.0 111.548 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . 0.476 ' HA ' HG23 ' A' ' 552' ' ' VAL . 27.6 p -106.31 121.28 43.89 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.3 1.04 . . . . 0.0 109.821 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 83.34 14.0 75.15 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-N 115.915 -0.584 . . . . 0.0 114.096 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . 0.418 ' HB2' ' HH2' ' A' ' 481' ' ' TRP . 23.1 m -70.39 -51.65 28.13 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 117.236 0.518 . . . . 0.0 110.572 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 25.9 t -125.41 134.99 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.06 0.944 . . . . 0.0 108.616 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 20.8 m -115.5 173.05 6.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.129 0.972 . . . . 0.0 110.668 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 52.9 mt -94.7 111.9 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 469' ' ' LYS . 9.5 tp10 -82.63 -63.6 1.34 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.743 0.417 . . . . 0.0 110.968 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 28.9 mt-10 -121.29 151.68 39.78 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 58.9 mt -133.32 130.51 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 170.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -78.62 129.18 34.47 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.81 0.694 . . . . 0.0 109.882 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.442 HD13 ' HE3' ' A' ' 559' ' ' LYS . 2.2 pp -76.27 -23.72 54.44 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.247 0.342 . . . . 0.0 111.301 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -68.85 -29.4 67.71 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 167.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 83.8 25.3 46.36 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.498 -0.774 . . . . 0.0 114.032 172.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -82.28 -27.4 32.38 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.377 0.589 . . . . 0.0 111.12 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -146.52 160.03 42.66 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-O 121.458 0.647 . . . . 0.0 112.424 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 95.3 t -130.6 119.72 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 125.177 1.391 . . . . 0.0 107.417 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 4.1 tp-100 -89.19 122.31 32.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.832 0.853 . . . . 0.0 109.771 178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 75.5 mt -102.15 162.23 13.07 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.771 0.829 . . . . 0.0 109.629 171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 1.2 tmtp? -146.75 131.05 17.51 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -86.8 111.26 20.57 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.81 -17.5 47.29 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.032 0.933 . . . . 0.0 112.291 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 81.0 p -70.13 158.15 36.28 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.072 0.463 . . . . 0.0 111.669 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.64 0.67 29.26 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.178 0.991 . . . . 0.0 112.326 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.29 175.62 10.38 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.837 0.855 . . . . 0.0 109.281 -174.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -71.93 125.98 28.58 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.043 0.537 . . . . 0.0 109.593 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -100.36 131.65 46.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.178 0.991 . . . . 0.0 110.493 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 26.4 p -66.89 124.03 21.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.324 0.65 . . . . 0.0 109.714 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 9.5 tp -119.36 152.77 36.22 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.42 -52.53 0.58 Allowed Glycine 0 N--CA 1.475 1.234 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.837 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -69.75 -14.39 62.76 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.646 0.779 . . . . 0.0 110.639 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.418 ' HH2' ' HB2' ' A' ' 453' ' ' SER . 12.4 m95 -82.85 158.72 22.6 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 125.126 1.371 . . . . 0.0 109.95 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -161.27 131.75 5.12 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.838 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 32.5 mt -87.63 118.76 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.811 0.844 . . . . 0.0 109.742 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.673 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 64.8 mttm -84.81 148.7 26.17 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 166.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 492' ' ' GLU . 34.9 ttm180 -132.77 96.66 3.85 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 163.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -85.5 102.38 13.44 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.551 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 27.3 t -72.2 168.95 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.04 0.936 . . . . 0.0 110.277 -176.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 539' ' ' SER . 3.4 pp -55.55 -25.92 40.5 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.643 1.177 . . . . 0.0 113.609 177.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -85.2 4.15 35.95 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.517 0.675 . . . . 0.0 110.812 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 86.21 -7.41 78.38 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 123.636 0.636 . . . . 0.0 113.349 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.49 102.63 3.26 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.689 0.796 . . . . 0.0 110.295 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 485' ' ' ARG . 8.7 pt-20 -96.39 111.89 23.83 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.583 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 28.4 pt -91.44 147.36 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.297 173.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -121.39 108.9 14.23 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.349 0.66 . . . . 0.0 110.707 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -83.07 107.74 15.86 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 166.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -91.58 147.67 22.84 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -93.72 170.46 9.55 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.414 0.686 . . . . 0.0 110.714 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 82.7 p -93.5 130.23 36.03 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.024 0.93 . . . . 0.0 108.985 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.498 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 17.7 Cg_endo -58.72 -18.88 43.23 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.257 2.638 . . . . 0.0 114.884 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -75.9 -24.02 55.58 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.951 0.501 . . . . 0.0 111.189 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -75.5 142.72 42.81 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.361 0.664 . . . . 0.0 110.528 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 61.9 mt -133.39 136.58 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.081 0.952 . . . . 0.0 108.713 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.39 116.72 33.43 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -73.27 162.26 29.57 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.197 0.599 . . . . 0.0 112.108 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -60.63 124.4 20.29 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.234 1.014 . . . . 0.0 112.302 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 74.43 -6.42 23.46 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.58 0.55 . . . . 0.0 114.297 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -81.02 155.1 26.53 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.456 0.702 . . . . 0.0 109.857 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 55.4 mtm -120.42 126.52 50.65 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.248 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.7 112.65 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 2.1 m -92.7 101.94 14.34 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.521 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.479 HG12 ' HE1' ' A' ' 534' ' ' TRP . 59.0 t -88.74 98.25 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.015 0.436 . . . . 0.0 109.981 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . 0.403 ' HE3' ' HB1' ' A' ' 516' ' ' ALA . 49.1 m95 -86.05 176.64 7.91 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.397 1.079 . . . . 0.0 111.509 174.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -95.05 164.06 13.04 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.092 0.957 . . . . 0.0 110.726 174.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -64.79 -45.48 86.09 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.429 0.692 . . . . 0.0 111.302 174.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -82.91 5.97 73.0 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.683 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.403 ' HB1' ' HE3' ' A' ' 512' ' ' TRP . . . -75.6 -1.05 22.7 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.502 0.721 . . . . 0.0 111.842 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 68.41 31.25 73.82 Favored Glycine 0 C--N 1.356 1.683 0 C-N-CA 123.125 0.393 . . . . 0.0 113.699 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 6.4 p -123.74 135.86 62.06 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 C-N-CA 124.42 1.088 . . . . 0.0 109.968 -172.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -76.95 134.1 39.01 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.292 0.637 . . . . 0.0 110.4 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -64.51 110.89 2.46 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.356 0.663 . . . . 0.0 110.228 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.5 m -126.42 74.22 73.65 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.605 0.762 . . . . 0.0 110.129 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.33 150.91 76.53 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 C-N-CA 122.27 1.98 . . . . 0.0 111.435 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -93.23 11.47 53.01 Favored 'Cis proline' 0 C--N 1.376 1.981 0 CA-C-N 119.971 1.025 . . . . 0.0 113.72 -1.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.3 m -82.8 -28.85 29.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.391 0.676 . . . . 0.0 111.833 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 76.7 m -143.58 104.42 4.21 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.727 0.811 . . . . 0.0 109.968 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 66.5 mt -91.35 144.07 25.97 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 169.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 50.3 t -120.85 120.95 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.635 0.774 . . . . 0.0 108.975 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -75.2 96.42 3.3 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 53.9 tptt -66.7 136.39 55.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.792 0.837 . . . . 0.0 110.335 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 88.67 -4.97 85.07 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 123.479 0.487 . . . . 0.0 113.325 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -112.99 114.06 26.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 34.2 p -73.56 -56.69 4.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.085 0.554 . . . . 0.0 111.942 -172.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.642 ' HB2' HG23 ' A' ' 536' ' ' THR . 86.6 p -114.45 9.72 16.83 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.267 0.627 . . . . 0.0 112.215 -169.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.479 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 59.44 23.87 12.47 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 124.422 1.089 . . . . 0.0 110.545 -174.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.87 71.12 0.9 Allowed Glycine 0 C--N 1.35 1.34 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.642 HG23 ' HB2' ' A' ' 533' ' ' SER . 17.3 p -59.67 129.93 44.33 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.449 0.7 . . . . 0.0 111.949 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -137.0 154.93 22.47 Favored Glycine 0 C--O 1.238 0.371 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 170.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.14 -60.58 2.17 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.492 ' H ' HD23 ' A' ' 488' ' ' LEU . 7.3 m -107.16 125.1 50.65 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.086 0.954 . . . . 0.0 109.026 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.551 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 5.6 p90 -151.28 145.1 25.11 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.649 0.738 . . . . 0.0 111.883 174.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 4.3 tmm_? -96.91 102.08 13.78 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.763 1.225 . . . . 0.0 108.468 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 47.7 m -86.44 140.21 30.19 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.452 0.701 . . . . 0.0 109.202 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.673 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 40.0 t -133.8 146.2 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.484 1.114 . . . . 0.0 109.619 -175.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 38.6 tp -113.61 133.09 55.48 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 163.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.588 HG21 ' HE2' ' A' ' 484' ' ' LYS . 85.4 t -124.26 156.24 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.605 1.162 . . . . 0.0 108.369 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.69 HD21 ' HG3' ' A' ' 550' ' ' GLU . 6.4 p30 -119.58 -170.23 1.9 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.398 0.679 . . . . 0.0 111.814 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.61 64.09 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.156 1.382 . . . . 0.0 113.755 -174.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . 0.59 ' HB3' ' HG2' ' A' ' 550' ' ' GLU . 16.8 t70 -67.31 -37.81 83.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.403 0.681 . . . . 0.0 112.1 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 110.76 -15.97 28.73 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.078 -173.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.69 ' HG3' HD21 ' A' ' 546' ' ' ASN . 9.9 pt-20 -62.64 137.68 58.32 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.633 0.773 . . . . 0.0 110.325 172.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -81.47 87.72 6.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.807 0.843 . . . . 0.0 109.543 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 451' ' ' SER . 7.6 p -64.02 -35.8 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.694 -170.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -133.37 150.75 51.81 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.518 0.727 . . . . 0.0 109.054 176.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 51.6 ttm -161.56 121.68 2.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.466 0.706 . . . . 0.0 109.629 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.71 118.74 13.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.29 0.636 . . . . 0.0 109.315 175.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 28.2 m -86.21 140.43 30.15 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.976 0.911 . . . . 0.0 109.276 174.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.42 131.18 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.66 0.784 . . . . 0.0 109.124 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 0.0 OUTLIER -122.15 125.52 46.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.651 0.78 . . . . 0.0 109.034 175.213 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.442 ' HE3' HD13 ' A' ' 461' ' ' LEU . 86.9 tttt -73.91 104.64 4.85 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.786 1.234 . . . . 0.0 110.052 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 36.0 t -69.75 -42.85 73.37 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.307 0.643 . . . . 0.0 109.391 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 32.3 t -161.65 175.27 12.21 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.836 0.854 . . . . 0.0 110.152 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.77 69.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 122.997 1.38 . . . . 0.0 109.463 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 12.9 ptp -157.82 112.5 2.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.366 -1.743 . . . . 0.0 108.593 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -76.01 134.89 40.01 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 121.207 0.527 . . . . 0.0 110.402 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.24 161.14 13.94 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.117 172.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -62.82 -39.81 95.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.52 0.328 . . . . 0.0 111.075 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 56.73 -80.16 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.676 1.59 . . . . 0.0 111.921 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -121.64 123.32 41.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.615 1.166 . . . . 0.0 108.042 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.354 179.229 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -63.11 86.59 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.424 0.69 . . . . 0.0 110.302 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 36.3 p -80.27 123.06 27.64 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.831 0.852 . . . . 0.0 110.611 -176.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 100.39 -8.09 58.52 Favored Glycine 0 N--CA 1.468 0.821 0 O-C-N 123.456 0.472 . . . . 0.0 112.696 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 47.2 m -66.57 -69.69 0.29 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.714 0.806 . . . . 0.0 110.926 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 15.8 t -92.63 103.19 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.6 m -97.92 143.87 28.06 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.963 0.905 . . . . 0.0 110.647 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 28.7 mt -78.16 96.33 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -78.4 -69.66 0.54 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -120.48 154.11 35.7 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.553 ' HB ' HG21 ' A' ' 557' ' ' VAL . 70.4 mt -146.73 143.13 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 168.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.404 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 31.1 t70 -60.63 151.87 27.9 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.47 0.708 . . . . 0.0 110.801 174.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.2 pp -55.54 -29.82 59.62 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.789 1.236 . . . . 0.0 113.771 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -118.58 10.37 12.53 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.388 1.075 . . . . 0.0 111.252 173.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 67.19 42.7 90.98 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.901 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -78.69 -7.12 57.39 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 36.1 p90 -157.85 147.07 19.66 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 124.419 1.088 . . . . 0.0 109.956 170.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 76.1 t -120.36 122.96 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.436 ' OE1' ' HB3' ' A' ' 508' ' ' MET . 0.1 OUTLIER -103.92 114.13 28.15 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.122 1.369 . . . . 0.0 108.603 -174.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 65.4 mt -107.68 161.73 14.61 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.08 1.352 . . . . 0.0 109.91 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -150.13 132.51 15.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.961 0.504 . . . . 0.0 109.754 -176.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -85.35 131.92 34.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.281 0.632 . . . . 0.0 110.686 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -112.25 -0.14 15.58 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.016 1.327 . . . . 0.0 110.775 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 49.1 m -63.9 147.61 51.5 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.794 0.438 . . . . 0.0 110.654 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -69.62 -11.15 60.61 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.033 0.933 . . . . 0.0 111.778 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.51 ' H ' ' HD3' ' A' ' 474' ' ' LYS . 0.2 OUTLIER -134.69 176.23 8.83 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 125.272 1.429 . . . . 0.0 108.82 -177.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.69 114.8 5.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.526 0.73 . . . . 0.0 109.508 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -74.87 108.34 7.54 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.657 0.783 . . . . 0.0 110.0 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.439 ' HA ' HG12 ' A' ' 502' ' ' ILE . 29.1 p -63.78 104.88 0.73 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 7.6 tp -93.81 -176.59 4.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.89 0.876 . . . . 0.0 109.208 -173.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 134.3 -66.5 0.57 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 112.549 -0.221 . . . . 0.0 112.549 172.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . 0.457 ' N ' HD22 ' A' ' 480' ' ' ASN . 0.8 OUTLIER -67.92 -11.63 59.13 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.372 0.669 . . . . 0.0 111.679 -179.308 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -67.59 141.79 56.68 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.971 0.908 . . . . 0.0 109.387 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -143.31 131.59 22.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.102 0.561 . . . . 0.0 110.701 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 45.0 mt -88.13 110.33 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.024 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.49 ' HE2' HG21 ' A' ' 545' ' ' VAL . 64.7 mttm -82.67 150.42 26.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.442 0.697 . . . . 0.0 109.202 166.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -144.59 104.87 4.09 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -99.16 108.57 21.21 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.451 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 30.0 t -83.61 160.42 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 124.316 1.046 . . . . 0.0 110.796 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 539' ' ' SER . 4.6 pp -51.3 -26.91 8.19 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.947 1.299 . . . . 0.0 113.614 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -77.65 -10.42 59.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.981 0.913 . . . . 0.0 111.42 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 90.78 1.91 72.99 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -79.92 148.18 31.35 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.077 0.951 . . . . 0.0 109.303 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.87 157.01 47.3 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.036 0.446 . . . . 0.0 110.111 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 30.4 pt -136.75 163.82 32.08 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 C-N-CA 124.493 1.117 . . . . 0.0 108.384 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -136.47 105.67 6.01 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.313 0.645 . . . . 0.0 109.673 172.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -81.62 142.38 32.82 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 166.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -131.43 144.41 51.16 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -84.38 163.14 19.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.739 0.815 . . . . 0.0 110.802 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 59.5 p -79.68 132.4 61.52 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.886 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.533 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 35.2 Cg_endo -61.1 -16.96 49.3 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.172 2.581 . . . . 0.0 113.533 -175.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -86.57 -20.52 27.82 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.75 0.82 . . . . 0.0 111.855 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -66.04 136.9 56.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.132 0.573 . . . . 0.0 110.153 -177.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 477' ' ' SER . 52.0 mt -131.18 121.86 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.836 0.854 . . . . 0.0 108.976 174.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.71 130.91 34.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -81.32 155.14 26.15 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.159 0.583 . . . . 0.0 110.898 -175.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -61.64 117.65 6.06 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.853 0.861 . . . . 0.0 111.177 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 88.51 -22.38 20.8 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.368 0.417 . . . . 0.0 113.612 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -75.79 173.72 10.77 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.402 0.681 . . . . 0.0 111.242 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . 0.436 ' HB3' ' OE1' ' A' ' 467' ' ' GLN . 37.2 mtm -124.62 172.46 9.23 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.482 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.18 127.09 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 5.2 m -121.73 113.84 20.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.045 0.538 . . . . 0.0 109.58 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.85 99.11 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.271 0.628 . . . . 0.0 109.974 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -79.85 176.65 9.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.65 1.18 . . . . 0.0 111.754 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -99.16 156.46 16.95 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.23 1.012 . . . . 0.0 110.633 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -62.26 -36.59 82.51 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.541 0.736 . . . . 0.0 111.207 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . 0.429 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -88.48 10.16 72.79 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.296 -0.866 . . . . 0.0 113.515 -177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -80.91 -17.07 51.81 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.294 0.637 . . . . 0.0 110.729 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 71.48 18.87 77.34 Favored Glycine 0 C--N 1.357 1.737 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.511 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.92 149.58 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.461 1.105 . . . . 0.0 110.458 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -77.63 130.46 36.89 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.604 0.762 . . . . 0.0 110.618 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -67.45 113.08 5.01 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 10.9 m -125.41 69.68 61.94 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 123.492 0.717 . . . . 0.0 109.827 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.79 150.72 68.39 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.217 1.945 . . . . 0.0 111.628 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.42 -8.01 49.85 Favored 'Cis proline' 0 C--N 1.371 1.749 0 N-CA-C 114.507 0.926 . . . . 0.0 114.507 3.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.2 m -67.14 -60.53 2.53 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.475 0.71 . . . . 0.0 111.466 -173.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 90.6 m -105.19 93.58 4.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.93 0.892 . . . . 0.0 109.198 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 73.0 mt -81.71 143.69 31.68 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 82.1 t -126.04 131.16 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -74.93 95.06 2.91 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -65.2 124.48 22.29 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.793 0.837 . . . . 0.0 110.698 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 94.41 -27.27 14.18 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.799 0.687 . . . . 0.0 114.129 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.54 99.28 9.09 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 29.3 p -85.15 -34.07 22.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.126 0.97 . . . . 0.0 113.165 -167.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' ' 536' ' ' THR . 87.1 p -75.47 -28.39 59.22 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.635 0.374 . . . . 0.0 111.3 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 58.77 32.23 22.0 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.896 1.279 . . . . 0.0 108.917 -169.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 70.36 76.81 0.51 Allowed Glycine 0 C--N 1.358 1.798 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -172.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 533' ' ' SER . 9.6 t -52.23 143.03 15.38 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.408 1.083 . . . . 0.0 113.431 -167.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 158.61 131.74 1.31 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -84.21 -15.78 45.71 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.1 0.56 . . . . 0.0 111.216 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.536 ' HB2' HD23 ' A' ' 488' ' ' LEU . 17.9 m -137.71 132.48 32.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.237 0.615 . . . . 0.0 109.772 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.451 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 30.8 p90 -168.19 176.7 5.85 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.699 1.2 . . . . 0.0 110.308 -172.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 0.0 OUTLIER -128.91 114.59 16.67 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.191 0.997 . . . . 0.0 108.82 169.024 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 83.6 m -86.61 125.42 33.81 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.075 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.527 HG22 ' HG3' ' A' ' 554' ' ' MET . 43.8 t -115.44 117.83 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.14 0.976 . . . . 0.0 108.679 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 24.9 tp -88.63 132.28 34.62 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.49 HG21 ' HE2' ' A' ' 484' ' ' LYS . 50.9 t -115.51 142.99 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 124.838 1.255 . . . . 0.0 108.122 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.469 ' ND2' ' HG2' ' A' ' 550' ' ' GLU . 0.2 OUTLIER -96.99 -167.24 1.51 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.877 0.471 . . . . 0.0 111.338 -179.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.04 -37.03 83.4 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -75.4 -0.98 21.8 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.31 15.85 80.39 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 123.258 0.348 . . . . 0.0 113.67 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.469 ' HG2' ' ND2' ' A' ' 546' ' ' ASN . 5.7 pt-20 -97.45 149.75 21.81 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.281 0.632 . . . . 0.0 109.298 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -76.78 90.21 3.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.165 0.986 . . . . 0.0 109.296 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.15 -32.99 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.431 -173.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -142.66 157.63 44.49 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.459 0.703 . . . . 0.0 110.245 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.527 ' HG3' HG22 ' A' ' 543' ' ' VAL . 26.1 ttt -157.44 146.4 19.77 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.98 0.912 . . . . 0.0 109.334 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -159.83 117.88 2.69 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.701 0.401 . . . . 0.0 110.956 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 87.4 m -88.73 116.51 27.05 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.611 0.764 . . . . 0.0 110.359 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.553 HG21 ' HB ' ' A' ' 459' ' ' ILE . 81.1 t -102.37 131.91 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.523 1.129 . . . . 0.0 109.628 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . 0.425 ' HD2' ' HB3' ' A' ' 539' ' ' SER . 13.3 mmmm -131.28 117.84 19.54 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.015 1.326 . . . . 0.0 107.868 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -67.36 96.42 0.5 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.55 0.613 . . . . 0.0 109.423 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 19.1 m -114.55 86.47 2.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 51.8 p -147.31 124.04 11.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.319 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 10.4 p -78.68 -8.89 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.362 0.665 . . . . 0.0 110.311 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 65.7 mtt -52.33 126.24 18.49 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 124.184 0.994 . . . . 0.0 110.635 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -67.27 159.24 29.62 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 124.053 0.845 . . . . 0.0 110.368 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.11 97.45 0.09 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.413 0.625 . . . . 0.0 112.12 -174.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -121.89 75.33 1.2 Allowed 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -47.16 -57.23 5.35 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.664 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 56.37 83.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.471 1.108 . . . . 0.0 110.742 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.962 0 CA-C-O 119.091 -0.838 . . . . 0.0 111.914 -179.408 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 N--CA 1.476 0.844 0 CA-C-O 120.528 0.204 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -65.08 89.33 0.08 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.83 0.852 . . . . 0.0 110.462 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 44.5 m -78.23 81.0 4.62 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.266 1.027 . . . . 0.0 111.265 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . 0.496 ' H ' ' HB ' ' A' ' 552' ' ' VAL . . . 73.4 27.68 67.35 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.712 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 53.5 m -56.75 -48.61 77.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.425 0.69 . . . . 0.0 110.581 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . 0.507 HG21 HD21 ' A' ' 478' ' ' LEU . 17.9 t -93.24 107.77 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 165.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 80.6 p -88.54 160.59 17.39 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.336 0.654 . . . . 0.0 110.006 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.45 HG13 ' HB1' ' A' ' 553' ' ' ALA . 48.5 mt -81.53 96.3 3.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 170.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.629 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 14.6 tp10 -68.41 -55.91 10.3 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.494 -171.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.629 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.0 mt-10 -142.0 154.03 44.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.904 0.882 . . . . 0.0 108.896 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.563 ' HB ' HG21 ' A' ' 557' ' ' VAL . 56.2 mt -136.0 135.28 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.62 141.4 57.82 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 123.358 0.411 . . . . 0.0 110.131 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.82 -39.41 94.23 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.665 0.603 . . . . 0.0 110.895 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 559' ' ' LYS . 27.9 mt-10 -74.71 -33.47 62.42 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.33 33.35 6.89 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.064 -0.971 . . . . 0.0 113.109 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -84.19 -15.52 46.69 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.173 0.589 . . . . 0.0 110.46 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -157.89 161.05 38.24 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 123.236 0.614 . . . . 0.0 110.773 175.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . 0.419 HG21 ' HD2' ' A' ' 485' ' ' ARG . 89.2 t -133.6 121.28 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.674 1.19 . . . . 0.0 108.356 174.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 23.0 tp60 -92.37 119.76 32.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.087 0.955 . . . . 0.0 109.718 174.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 69.1 mt -108.85 153.18 23.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.146 0.979 . . . . 0.0 108.716 169.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -147.5 144.52 28.61 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.843 0.457 . . . . 0.0 111.115 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.624 ' HB2' HD12 ' A' ' 503' ' ' LEU . 52.7 t30 -89.53 126.9 35.78 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 174.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 471' ' ' ASN . 0.7 OUTLIER -99.01 -17.72 18.14 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.912 0.885 . . . . 0.0 110.097 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . 0.555 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 28.8 m -79.29 155.96 28.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.968 0.907 . . . . 0.0 112.49 -173.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.1 -37.42 66.73 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.755 0.822 . . . . 0.0 110.879 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.555 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.1 OUTLIER -78.7 148.37 33.11 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.098 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.81 140.72 56.63 Favored 'General case' 0 C--O 1.244 0.767 0 O-C-N 123.776 0.673 . . . . 0.0 109.392 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.424 ' HG3' HG23 ' A' ' 454' ' ' VAL . 0.0 OUTLIER -112.18 111.44 22.33 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 39.9 m -75.98 122.98 24.99 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.613 0.765 . . . . 0.0 110.624 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 454' ' ' VAL . 95.6 mt -98.02 167.03 11.15 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.495 0.718 . . . . 0.0 109.932 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 143.48 -53.27 0.6 Allowed Glycine 0 N--CA 1.466 0.691 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . 0.477 HD22 ' N ' ' A' ' 480' ' ' ASN . 0.7 OUTLIER -81.32 -12.19 59.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.324 1.049 . . . . 0.0 110.239 175.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -83.84 139.83 32.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.663 0.785 . . . . 0.0 109.762 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -130.5 145.53 51.87 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.603 0.761 . . . . 0.0 110.576 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 34.8 mt -106.7 95.19 3.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -78.66 129.65 34.97 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 124.052 0.941 . . . . 0.0 109.172 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . 0.419 ' HD2' HG21 ' A' ' 466' ' ' VAL . 74.4 mtp85 -135.04 93.35 2.99 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -94.09 102.73 14.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.944 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.503 HG12 HD23 ' A' ' 488' ' ' LEU . 39.2 t -76.34 151.58 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.032 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.503 HD23 HG12 ' A' ' 487' ' ' VAL . 2.5 pt? -59.5 -20.42 55.23 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.424 0.69 . . . . 0.0 112.743 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -73.17 -11.49 60.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.616 1.167 . . . . 0.0 112.69 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 109.31 -16.83 31.96 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-N 116.352 -0.385 . . . . 0.0 112.916 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -65.57 103.07 0.79 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.753 0.821 . . . . 0.0 111.448 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -107.17 119.94 40.75 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.425 HG21 ' NE2' ' A' ' 531' ' ' GLN . 31.6 pt -130.92 146.4 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.743 0.817 . . . . 0.0 109.601 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -129.35 109.01 10.75 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.89 0.476 . . . . 0.0 110.066 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -79.83 103.18 9.55 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 496' ' ' LYS . 0.0 OUTLIER -85.05 134.11 34.22 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.161 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -72.73 164.44 26.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.196 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 70.3 p -80.19 135.68 54.2 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.406 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 54.1 Cg_endo -66.81 -9.69 25.59 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.668 2.246 . . . . 0.0 113.799 -174.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -92.44 -9.66 40.75 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.404 0.681 . . . . 0.0 111.629 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -87.92 119.11 27.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.778 0.431 . . . . 0.0 109.895 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 40.3 mt -108.02 129.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 470' ' ' ASN . 0.9 OUTLIER -84.87 117.06 23.67 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -76.03 148.79 37.77 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.309 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.75 118.24 9.33 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.385 0.674 . . . . 0.0 110.685 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 103.35 -23.34 33.43 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.287 0.367 . . . . 0.0 112.552 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -88.02 -178.76 6.06 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.637 0.775 . . . . 0.0 111.368 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 16.5 ptt? -157.57 146.28 19.49 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.808 -173.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . 0.423 HG23 HD13 ' A' ' 526' ' ' LEU . 7.2 p -109.6 127.89 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.848 0.859 . . . . 0.0 109.342 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 2.7 m -111.47 105.88 14.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 47.7 t -93.19 112.26 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . 0.498 ' HB2' HG22 ' A' ' 527' ' ' VAL . 46.9 m95 -98.41 173.46 6.95 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.041 0.936 . . . . 0.0 111.522 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 516' ' ' ALA . . . -84.07 148.5 26.8 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.452 172.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.7 86.54 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.486 0.66 . . . . 0.0 110.316 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -88.56 14.3 60.13 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.879 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 513' ' ' ALA . . . -84.78 -11.46 55.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.449 0.7 . . . . 0.0 111.47 176.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.69 23.23 77.96 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.109 0.403 . . . . 0.0 114.109 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 11.5 p -98.45 149.82 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.3 1.04 . . . . 0.0 109.98 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.23 122.21 26.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.09 0.556 . . . . 0.0 110.41 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -65.31 110.12 2.5 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.067 0.547 . . . . 0.0 109.778 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 17.3 m -132.99 78.01 66.68 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 123.363 0.665 . . . . 0.0 110.626 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.46 154.9 50.38 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.749 2.299 . . . . 0.0 112.834 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -92.06 4.19 63.3 Favored 'Cis proline' 0 C--N 1.376 2.021 0 CA-C-N 119.841 0.979 . . . . 0.0 113.517 3.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.0 m -84.96 -58.17 2.8 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.781 0.432 . . . . 0.0 110.497 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 38.9 m -97.53 89.56 4.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.062 0.545 . . . . 0.0 109.872 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 10.8 mp -86.17 138.64 31.75 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 512' ' ' TRP . 86.9 t -125.54 128.56 72.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -72.96 88.97 1.39 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -64.04 112.41 2.96 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.508 -1.223 . . . . 0.0 108.702 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 122.89 -38.29 2.56 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 123.458 0.474 . . . . 0.0 112.411 -173.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.425 ' NE2' HG21 ' A' ' 493' ' ' ILE . 28.5 tp60 -86.49 96.61 10.11 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 13.8 p -63.53 -52.53 60.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.198 0.999 . . . . 0.0 112.199 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 536' ' ' THR . 96.0 p -88.78 -30.66 18.85 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 122.839 0.456 . . . . 0.0 111.927 -176.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 513' ' ' ALA . 6.3 t-105 56.57 34.94 25.28 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.402 1.096 . . . . 0.0 110.3 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 69.53 51.6 25.25 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.996 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 533' ' ' SER . 15.9 p -74.65 123.44 24.87 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 170.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -156.35 179.95 31.83 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.485 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -77.14 -38.71 51.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.407 0.622 . . . . 0.0 109.508 176.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.408 ' H ' HD22 ' A' ' 488' ' ' LEU . 19.3 m -147.92 125.85 12.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.562 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -146.29 144.78 30.06 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.777 0.831 . . . . 0.0 109.855 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 41.2 ttm180 -107.37 116.78 32.54 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.79 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 59.0 m -94.04 121.93 36.03 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' A' ' 554' ' ' MET . 59.9 t -124.53 117.93 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.332 1.053 . . . . 0.0 108.837 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 40.3 tp -89.52 111.59 22.54 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 51.6 t -102.02 149.78 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.207 1.003 . . . . 0.0 109.114 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.558 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.1 p30 -111.75 -172.59 2.07 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.969 0.507 . . . . 0.0 111.737 -172.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -57.41 -37.6 73.01 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.884 1.274 . . . . 0.0 113.15 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . 0.48 ' HB3' HD21 ' A' ' 546' ' ' ASN . 12.5 t70 -59.8 -40.61 88.91 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.583 0.753 . . . . 0.0 111.127 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.24 -17.76 26.27 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.436 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.558 ' HG2' HD21 ' A' ' 546' ' ' ASN . 14.0 pt-20 -69.16 148.21 50.25 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.101 0.477 . . . . 0.0 110.665 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.99 99.97 9.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.077 0.951 . . . . 0.0 108.775 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.496 ' HB ' ' H ' ' A' ' 452' ' ' GLY . 27.1 m -85.11 -19.86 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.054 0.542 . . . . 0.0 112.284 -172.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.616 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -147.65 139.76 24.29 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.55 ' HG3' HG22 ' A' ' 543' ' ' VAL . 44.5 ttm -151.12 132.36 14.49 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.628 0.771 . . . . 0.0 109.252 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -157.78 117.62 3.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.264 0.626 . . . . 0.0 109.627 -173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 8.8 m -103.47 112.34 25.2 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.74 0.816 . . . . 0.0 109.435 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.563 HG21 ' HB ' ' A' ' 459' ' ' ILE . 58.1 t -105.64 122.12 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.503 0.721 . . . . 0.0 110.65 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.97 117.75 35.29 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 173.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 462' ' ' GLU . 25.8 ttpp -60.68 94.05 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.132 0.973 . . . . 0.0 110.565 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 42.7 t -84.57 -72.45 0.47 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.513 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 21.0 p -163.84 172.87 13.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.5 0.72 . . . . 0.0 111.042 -170.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.61 24.77 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.091 0.956 . . . . 0.0 110.97 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 63.3 mtm -64.2 -22.77 67.07 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.52 0.728 . . . . 0.0 112.085 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -118.02 159.7 22.75 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.858 0.863 . . . . 0.0 109.493 174.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 69.74 65.95 0.24 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.954 1.301 . . . . 0.0 111.229 168.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -70.4 96.39 1.14 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.351 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.47 -9.51 27.06 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.312 0.645 . . . . 0.0 112.107 -176.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.72 -34.21 30.67 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.935 0.494 . . . . 0.0 110.149 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.147 0 CA-C-O 119.042 -0.865 . . . . 0.0 111.887 176.594 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -141.84 78.01 1.61 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.491 0.716 . . . . 0.0 109.24 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 26.9 p -81.14 84.94 6.41 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.531 -175.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 91.36 29.4 12.41 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.056 -0.974 . . . . 0.0 113.631 172.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 28.1 m -68.58 -38.76 80.94 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.785 0.326 . . . . 0.0 110.182 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.77 145.05 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.452 1.101 . . . . 0.0 108.208 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 43.9 t -130.55 150.35 51.8 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.378 1.071 . . . . 0.0 109.988 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 459' ' ' ILE . 38.3 mt -84.71 108.86 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -80.71 -72.16 0.43 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.807 0.337 . . . . 0.0 110.824 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -119.25 149.86 41.06 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.993 0.517 . . . . 0.0 109.688 -169.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.47 ' HB ' HG21 ' A' ' 557' ' ' VAL . 80.6 mt -144.56 138.13 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 170.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.424 ' HB2' ' CD2' ' A' ' 465' ' ' PHE . 20.1 t70 -59.91 142.04 54.39 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 123.488 0.493 . . . . 0.0 110.74 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.574 HD12 ' HG3' ' A' ' 462' ' ' GLU . 2.3 pp -66.71 -35.16 79.48 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.074 0.859 . . . . 0.0 111.432 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.574 ' HG3' HD12 ' A' ' 461' ' ' LEU . 29.0 mt-10 -75.37 -33.22 61.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.31 0.576 . . . . 0.0 109.687 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 94.84 52.0 1.86 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.422 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -96.19 -18.43 20.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.254 0.622 . . . . 0.0 111.194 175.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 460' ' ' ASP . 32.0 p90 -150.85 161.1 43.33 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.067 0.461 . . . . 0.0 112.007 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 49.6 t -126.85 141.24 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.314 1.445 . . . . 0.0 107.493 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.72 104.61 9.72 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.456 HD22 HD22 ' A' ' 544' ' ' LEU . 57.8 mt -94.82 162.02 13.93 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.815 1.246 . . . . 0.0 110.204 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -144.28 130.14 19.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.524 ' HB2' HD12 ' A' ' 503' ' ' LEU . 46.9 t30 -78.29 107.58 11.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.118 0.567 . . . . 0.0 109.951 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -81.29 -5.71 58.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.646 0.779 . . . . 0.0 112.332 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 15.0 m -74.7 137.43 42.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.116 0.566 . . . . 0.0 110.715 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.61 -13.6 61.82 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.23 1.012 . . . . 0.0 110.998 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.493 ' H ' ' HD3' ' A' ' 474' ' ' LYS . 0.0 OUTLIER -110.39 170.57 8.0 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.856 1.262 . . . . 0.0 108.457 172.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -70.9 145.03 50.43 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -107.88 118.24 36.22 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 41.2 p -71.6 118.27 14.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 171.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.3 mt -98.78 169.58 9.37 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 128.78 -56.51 0.74 Allowed Glycine 0 CA--C 1.492 -1.406 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -74.14 -13.16 60.78 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.886 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -82.16 149.49 27.92 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 124.566 1.147 . . . . 0.0 110.288 170.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 27.7 ptt-85 -149.56 145.45 26.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.62 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 10.2 mt -107.25 106.19 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.732 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 62.1 mttm -75.87 159.79 30.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.112 0.565 . . . . 0.0 109.832 175.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 542' ' ' THR . 42.8 ttm180 -152.92 100.2 2.48 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -88.58 102.45 14.95 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.098 0.959 . . . . 0.0 108.575 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 489' ' ' GLU . 22.0 t -88.21 127.8 40.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.5 pp -65.79 -16.39 63.76 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.539 0.736 . . . . 0.0 112.468 -176.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . 0.424 ' H ' HG12 ' A' ' 487' ' ' VAL . 47.8 mt-10 -73.59 -0.45 15.32 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.866 0.867 . . . . 0.0 111.761 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 106.15 27.45 5.61 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.152 0.421 . . . . 0.0 114.152 166.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -132.06 101.12 5.28 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.168 0.587 . . . . 0.0 110.207 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -106.34 121.96 45.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.89 179.57 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.149 0.98 . . . . 0.0 110.18 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -161.32 118.06 2.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.8 0.84 . . . . 0.0 110.064 172.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -79.18 117.48 20.24 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.548 0.739 . . . . 0.0 109.324 172.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.01 141.71 31.88 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -84.63 169.13 14.66 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 166.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.6 p -91.7 130.2 39.76 Favored Pre-proline 0 CA--C 1.556 1.186 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.475 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 32.4 Cg_exo -60.3 -20.42 62.55 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.249 2.633 . . . . 0.0 114.023 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -72.61 -22.35 60.98 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.66 0.784 . . . . 0.0 111.855 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -83.81 123.78 30.25 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.717 0.807 . . . . 0.0 110.447 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 54.1 mt -116.41 132.92 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 168.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 470' ' ' ASN . 2.4 tm? -93.96 138.32 32.2 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.55 161.88 29.32 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -57.99 120.07 7.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.925 1.29 . . . . 0.0 112.428 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 66.87 14.74 63.64 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 114.923 0.729 . . . . 0.0 114.923 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -97.16 -163.56 1.06 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.236 0.614 . . . . 0.0 109.851 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 19.3 ptp -146.06 164.08 33.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.783 0.833 . . . . 0.0 110.835 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.0 p -143.93 124.68 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.099 0.96 . . . . 0.0 109.152 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 4.0 m -114.51 110.05 19.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.827 0.851 . . . . 0.0 109.591 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.415 HG12 ' HE1' ' A' ' 534' ' ' TRP . 41.0 t -96.71 102.07 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.266 0.626 . . . . 0.0 109.861 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -83.69 175.25 9.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.622 1.169 . . . . 0.0 111.457 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -97.05 158.48 15.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.985 0.914 . . . . 0.0 110.195 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -65.05 -25.23 67.74 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.211 0.604 . . . . 0.0 111.865 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -111.45 21.12 22.17 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.755 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -79.97 -1.0 37.59 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.25 0.62 . . . . 0.0 110.814 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 74.4 38.22 45.72 Favored Glycine 0 C--N 1.358 1.8 0 O-C-N 123.285 0.366 . . . . 0.0 112.379 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.78 148.48 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.135 0.974 . . . . 0.0 110.149 -171.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -91.66 160.45 15.36 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.606 0.762 . . . . 0.0 110.139 174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -79.99 122.86 27.25 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 39.0 m -133.18 80.68 58.56 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.692 0.797 . . . . 0.0 109.111 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.94 154.37 58.16 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.739 2.293 . . . . 0.0 112.48 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.54 -18.38 24.04 Favored 'Cis proline' 0 C--N 1.378 2.119 0 C-N-CA 124.787 -0.922 . . . . 0.0 113.741 1.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.2 m -64.98 -52.36 56.65 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.573 0.749 . . . . 0.0 111.708 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 32.6 m -104.01 91.09 3.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 55.6 mt -83.15 148.31 27.55 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.4 127.81 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.417 0.687 . . . . 0.0 109.23 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -70.76 88.07 0.71 Allowed 'General case' 0 C--N 1.351 0.648 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -71.93 131.47 43.01 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.714 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 107.51 -36.49 4.35 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.281 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.17 112.05 23.12 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.275 0.559 . . . . 0.0 110.703 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . 0.446 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 22.6 p -85.39 -21.61 28.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.677 1.191 . . . . 0.0 112.702 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.5 t -87.48 -32.95 19.19 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -170.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.415 ' HE1' HG12 ' A' ' 511' ' ' VAL . 0.0 OUTLIER 53.35 22.84 2.97 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 124.056 0.942 . . . . 0.0 110.932 -168.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.79 60.98 6.61 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -171.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 15.1 t -64.76 149.79 48.61 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.568 0.747 . . . . 0.0 110.25 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -163.12 162.15 34.51 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 116.405 -0.361 . . . . 0.0 112.22 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -76.13 -34.96 59.45 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.975 0.91 . . . . 0.0 109.167 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.431 ' HB2' HD21 ' A' ' 488' ' ' LEU . 50.5 m -150.04 142.26 24.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.674 1.19 . . . . 0.0 108.71 170.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -164.22 -179.8 6.36 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.482 1.113 . . . . 0.0 109.631 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -140.0 125.71 19.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.497 0.665 . . . . 0.0 110.078 170.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 485' ' ' ARG . 24.1 m -101.87 120.86 41.05 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.765 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.732 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 57.4 t -103.62 148.39 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.32 1.048 . . . . 0.0 109.365 -177.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 43.7 tp -110.42 136.19 49.96 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.34 150.02 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.735 1.214 . . . . 0.0 108.348 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.472 HD21 ' HG3' ' A' ' 550' ' ' GLU . 4.3 p30 -116.99 -170.94 1.93 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.864 0.866 . . . . 0.0 112.134 -173.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -61.3 -26.34 67.72 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.072 0.949 . . . . 0.0 112.91 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.67 -37.49 84.89 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.086 0.554 . . . . 0.0 110.842 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 100.07 5.03 55.14 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.189 -172.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.472 ' HG3' HD21 ' A' ' 546' ' ' ASN . 17.7 pt-20 -88.06 149.54 23.91 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.309 0.643 . . . . 0.0 110.012 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.03 95.32 6.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.596 0.758 . . . . 0.0 108.96 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.75 -28.91 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.771 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -149.99 160.9 43.26 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.618 0.367 . . . . 0.0 110.639 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 50.6 ttp -158.67 143.44 16.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.792 0.837 . . . . 0.0 109.272 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -142.21 108.66 5.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.029 0.931 . . . . 0.0 109.172 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 42.2 m -82.34 109.48 16.63 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.488 0.715 . . . . 0.0 109.489 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 459' ' ' ILE . 57.3 t -109.22 132.31 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.222 1.009 . . . . 0.0 110.161 -175.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 558' ' ' LYS . 0.0 OUTLIER -132.67 118.4 19.07 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.603 1.161 . . . . 0.0 108.627 -177.38 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 461' ' ' LEU . 33.3 tttm -69.56 90.53 0.56 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.861 1.264 . . . . 0.0 109.883 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 29.4 m -111.54 -40.86 4.23 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.963 0.905 . . . . 0.0 109.598 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 40.9 m 63.91 107.11 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.805 1.242 . . . . 0.0 113.333 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.59 -24.5 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.687 0.795 . . . . 0.0 110.804 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -66.87 136.84 56.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.512 0.725 . . . . 0.0 110.436 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -94.23 172.22 8.35 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.258 0.623 . . . . 0.0 110.702 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -79.02 100.11 7.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.841 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -156.38 31.46 0.33 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.01 0.924 . . . . 0.0 109.888 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -81.74 -35.3 29.84 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.808 0.843 . . . . 0.0 111.567 -175.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 63.35 95.23 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.814 1.246 . . . . 0.0 111.199 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.281 0 CA-C-O 118.995 -0.891 . . . . 0.0 112.263 177.937 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -161.66 90.53 0.79 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 26.1 t -75.16 85.89 2.39 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.868 0.867 . . . . 0.0 111.299 -172.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' A' ' 552' ' ' VAL . . . 74.05 26.51 68.57 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.41 -0.813 . . . . 0.0 114.226 175.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 41.5 m -57.03 -52.58 64.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.125 0.57 . . . . 0.0 110.922 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 43.0 t -99.61 121.56 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 16.9 m -108.78 143.66 37.63 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.306 1.042 . . . . 0.0 109.581 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 459' ' ' ILE . 55.5 mt -77.43 130.32 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' A' ' 469' ' ' LYS . 36.1 mm-40 -81.01 -74.19 0.34 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.65 0.262 . . . . 0.0 110.649 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -128.25 155.32 44.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.753 0.821 . . . . 0.0 109.916 -171.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.463 ' HB ' HG11 ' A' ' 557' ' ' VAL . 48.4 mm -131.12 141.57 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.635 0.774 . . . . 0.0 109.0 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.66 153.86 31.06 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.246 1.018 . . . . 0.0 111.398 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 461' ' ' LEU . 2.2 pt? -109.31 0.31 19.48 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.156 0.582 . . . . 0.0 110.251 166.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -120.83 0.82 10.4 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.137 0.975 . . . . 0.0 112.544 -171.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 73.58 45.87 27.28 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 123.073 0.233 . . . . 0.0 113.597 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -108.31 -50.49 3.03 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.39 0.676 . . . . 0.0 111.295 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -164.59 152.08 11.68 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . 0.417 HG11 HD13 ' A' ' 483' ' ' ILE . 71.1 t -112.15 112.0 38.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.673 1.189 . . . . 0.0 108.692 173.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.447 ' HG3' ' HB2' ' A' ' 457' ' ' GLU . 57.4 tp60 -87.32 102.19 14.27 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.542 HD22 HD22 ' A' ' 544' ' ' LEU . 81.9 mt -94.95 165.11 12.61 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.432 1.093 . . . . 0.0 110.106 172.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 508' ' ' MET . 50.9 tttm -149.91 137.7 20.12 Favored 'General case' 0 C--O 1.219 -0.522 0 C-N-CA 123.215 0.606 . . . . 0.0 110.207 172.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -88.36 136.61 32.9 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -130.61 9.4 5.05 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.167 0.987 . . . . 0.0 110.133 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 46.5 t -77.87 145.8 36.03 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 123.374 0.669 . . . . 0.0 109.732 170.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -70.2 -25.1 63.26 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.249 1.02 . . . . 0.0 111.648 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 474' ' ' LYS . 32.6 pttt -112.95 166.07 11.75 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.016 0.927 . . . . 0.0 110.834 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -70.53 120.44 16.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.422 0.689 . . . . 0.0 109.963 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -87.62 118.85 27.39 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.645 0.778 . . . . 0.0 109.767 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 54.5 p -70.68 101.83 2.15 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.639 0.776 . . . . 0.0 110.375 176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 17.9 tp -91.16 152.69 20.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.712 0.805 . . . . 0.0 109.62 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.08 -58.62 0.51 Allowed Glycine 0 N--CA 1.472 1.049 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.703 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.36 -11.9 61.2 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.288 0.635 . . . . 0.0 111.075 177.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 546' ' ' ASN . 14.1 m95 -75.14 166.03 24.28 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 124.452 1.101 . . . . 0.0 110.927 170.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -160.7 145.81 14.41 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.975 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 494' ' ' ALA . 49.7 mt -101.42 107.54 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.158 0.583 . . . . 0.0 109.535 176.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.739 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 60.7 mttm -78.13 159.35 28.68 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 170.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 534' ' ' TRP . 36.8 ttm180 -158.08 100.37 1.71 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.05 111.56 23.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.284 0.633 . . . . 0.0 109.712 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.459 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 53.1 t -68.87 157.52 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.0 0.92 . . . . 0.0 109.797 174.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.0 pp -52.15 -28.12 16.86 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.232 1.013 . . . . 0.0 112.256 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -69.39 -33.33 72.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.493 1.117 . . . . 0.0 111.383 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 131.61 -21.24 4.52 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.792 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.32 109.59 2.32 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.36 1.064 . . . . 0.0 111.461 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -107.77 117.3 33.75 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.402 0.62 . . . . 0.0 110.804 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 40.2 pt -105.85 142.46 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.923 0.889 . . . . 0.0 109.367 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 483' ' ' ILE . . . -125.25 116.36 21.85 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.903 0.481 . . . . 0.0 110.931 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -78.98 106.35 10.96 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 170.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -81.48 121.63 26.52 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -73.26 169.16 17.67 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 120.819 0.342 . . . . 0.0 110.794 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 68.9 p -93.27 120.78 66.43 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 123.054 0.542 . . . . 0.0 110.32 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.503 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 34.6 Cg_exo -60.37 -15.56 36.17 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.934 3.089 . . . . 0.0 115.199 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -72.48 -23.51 61.05 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.542 0.737 . . . . 0.0 111.64 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -89.02 142.79 27.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.495 1.118 . . . . 0.0 110.884 -171.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 62.2 mt -129.43 132.96 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.391 0.676 . . . . 0.0 109.213 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . 0.648 HD21 ' HB ' ' A' ' 509' ' ' VAL . 0.3 OUTLIER -93.85 134.69 35.95 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.026 0.93 . . . . 0.0 109.025 177.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -78.16 156.49 29.85 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.131 0.491 . . . . 0.0 111.682 -178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.04 126.93 29.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.256 1.022 . . . . 0.0 112.031 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 77.97 -12.34 18.06 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.62 0.575 . . . . 0.0 114.395 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -86.71 159.48 19.15 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.661 0.784 . . . . 0.0 110.232 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . 0.552 ' HA ' ' HA ' ' A' ' 469' ' ' LYS . 23.5 ptt? -108.57 169.69 8.5 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.613 0.765 . . . . 0.0 111.517 -175.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . 0.648 ' HB ' HD21 ' A' ' 503' ' ' LEU . 7.4 p -145.95 148.89 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 4.2 m -131.09 105.46 7.72 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 71.5 t -86.02 98.63 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.055 0.455 . . . . 0.0 110.224 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -82.34 176.41 9.47 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.905 0.882 . . . . 0.0 111.3 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . . . . . . . . . . . -103.64 152.14 22.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.826 0.851 . . . . 0.0 110.128 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -67.84 -20.06 65.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.874 0.87 . . . . 0.0 112.021 175.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -103.76 16.63 51.05 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 116.466 -0.334 . . . . 0.0 112.692 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -90.76 -3.61 57.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.328 0.651 . . . . 0.0 110.713 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 70.33 33.92 68.71 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 113.995 0.358 . . . . 0.0 113.995 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 12.9 p -130.79 144.25 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 123.412 0.685 . . . . 0.0 110.341 -175.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -81.81 142.9 32.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.57 0.748 . . . . 0.0 111.42 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . 0.444 ' HD2' ' HA ' ' A' ' 526' ' ' LEU . 17.3 t-80 -61.85 109.33 1.21 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.418 0.687 . . . . 0.0 109.827 172.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 17.8 m -132.74 80.49 61.35 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.019 0.928 . . . . 0.0 109.556 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.72 160.85 44.46 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.916 2.41 . . . . 0.0 112.175 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -90.31 16.77 43.79 Favored 'Cis proline' 0 C--N 1.381 2.265 0 CA-C-N 119.652 0.911 . . . . 0.0 113.385 3.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.2 m -97.99 -70.88 0.71 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.739 0.815 . . . . 0.0 109.836 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 20.2 m -85.65 86.28 7.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.182 0.593 . . . . 0.0 110.372 -173.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 11.1 mp -91.66 105.19 17.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 171.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 90.3 t -89.46 117.98 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -69.27 91.74 0.54 Allowed 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 27.7 tptp -75.07 131.03 40.27 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.399 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 104.31 -5.08 44.71 Favored Glycine 0 N--CA 1.472 1.094 0 O-C-N 123.606 0.566 . . . . 0.0 111.988 -172.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -121.95 109.82 15.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.854 0.862 . . . . 0.0 109.179 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 37.2 p -71.72 -61.72 1.68 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.992 0.517 . . . . 0.0 111.21 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 23.7 m -121.16 25.26 9.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.815 0.446 . . . . 0.0 112.108 -167.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.428 ' HB3' ' NH1' ' A' ' 485' ' ' ARG . 0.0 OUTLIER 51.89 30.93 7.69 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.384 1.074 . . . . 0.0 112.541 171.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 63.88 68.7 1.56 Allowed Glycine 0 C--N 1.352 1.43 0 N-CA-C 112.371 -0.291 . . . . 0.0 112.371 -176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 2.7 p -64.4 142.57 58.37 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.504 0.722 . . . . 0.0 112.66 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -162.86 169.57 38.1 Favored Glycine 0 C--O 1.242 0.599 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.244 172.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -70.48 -26.78 63.77 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.336 0.568 . . . . 0.0 110.105 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 80.8 p -155.13 142.52 19.55 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.841 0.857 . . . . 0.0 109.35 172.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.459 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 8.0 p90 -155.5 136.67 13.85 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.684 0.794 . . . . 0.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.618 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 34.6 ptt180 -87.93 111.25 21.25 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 23.1 m -94.03 110.73 22.41 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.739 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 21.9 t -102.86 144.93 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.828 1.251 . . . . 0.0 109.606 -174.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.542 HD22 HD22 ' A' ' 468' ' ' LEU . 34.7 tp -112.17 125.47 54.17 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 170.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 551' ' ' GLU . 22.0 t -124.33 160.14 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.135 1.374 . . . . 0.0 108.485 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.591 HD21 ' HG2' ' A' ' 550' ' ' GLU . 2.9 p30 -126.35 -174.83 3.21 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.017 0.371 . . . . 0.0 111.577 175.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -50.08 -34.47 21.88 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.432 1.493 . . . . 0.0 113.189 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -64.64 -33.68 76.5 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.262 1.025 . . . . 0.0 111.929 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 102.97 -12.12 56.02 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.049 -174.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.591 ' HG2' HD21 ' A' ' 546' ' ' ASN . 13.2 pt-20 -72.79 139.36 47.01 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.21 0.604 . . . . 0.0 109.384 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.483 ' HG2' HG22 ' A' ' 545' ' ' VAL . 38.5 mt-10 -92.0 93.3 8.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.116 0.966 . . . . 0.0 108.994 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . 0.482 ' HB ' ' HA2' ' A' ' 452' ' ' GLY . 18.0 m -71.67 -16.64 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -167.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . . . . . . . . . . . -159.36 156.28 28.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.067 0.547 . . . . 0.0 110.482 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.59 ' SD ' ' HD2' ' A' ' 541' ' ' ARG . 67.0 ttp -154.94 109.93 3.04 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.25 0.62 . . . . 0.0 110.097 174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -104.14 104.19 14.09 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 30.4 m -85.19 99.04 10.83 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.463 HG11 ' HB ' ' A' ' 459' ' ' ILE . 35.1 m -98.96 147.29 7.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 121.621 0.724 . . . . 0.0 110.383 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.48 168.88 9.77 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.08 175.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 461' ' ' LEU . 38.7 ttpt -75.73 86.2 2.75 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 32.1 t -91.61 -8.38 47.44 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.088 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 43.9 m 60.19 98.92 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.483 1.513 . . . . 0.0 110.963 -172.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.04 74.33 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 122.452 1.12 . . . . 0.0 109.568 -174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.02 121.53 23.65 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 113.819 -1.537 . . . . 0.0 107.382 168.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.47 -167.04 0.22 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.992 0.917 . . . . 0.0 108.957 -168.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 73.37 -59.17 0.57 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.601 1.161 . . . . 0.0 112.657 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -62.83 102.4 0.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.421 0.688 . . . . 0.0 110.041 173.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.64 -78.43 0.09 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 62.43 142.11 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.025 1.33 . . . . 0.0 113.085 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.604 -1.109 . . . . 0.0 111.675 178.088 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -75.23 101.72 4.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.285 0.634 . . . . 0.0 110.82 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 18.8 m -81.72 80.66 7.99 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.654 0.74 . . . . 0.0 109.208 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 85.96 -44.62 3.37 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.424 -170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 32.0 p -174.68 -52.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.73 1.212 . . . . 0.0 108.939 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 544' ' ' LEU . 4.1 t -95.55 163.74 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.357 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 21.1 t -155.69 150.66 26.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.566 0.746 . . . . 0.0 109.671 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . 0.413 ' HA ' HD12 ' A' ' 468' ' ' LEU . 31.7 mt -77.7 102.41 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.286 0.634 . . . . 0.0 109.863 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.486 ' HG2' ' HG3' ' A' ' 458' ' ' GLU . 42.0 tt0 -81.18 -57.49 3.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.353 0.261 . . . . 0.0 111.602 -170.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.486 ' HG3' ' HG2' ' A' ' 457' ' ' GLU . 29.4 mt-10 -137.88 153.36 49.57 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.256 0.622 . . . . 0.0 109.394 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.0 mt -151.84 138.18 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.61 148.84 38.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.453 HD12 ' HG3' ' A' ' 462' ' ' GLU . 3.5 pp -74.38 -16.51 60.89 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -169.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.453 ' HG3' HD12 ' A' ' 461' ' ' LEU . 2.7 mt-10 -82.02 -31.91 30.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.199 0.6 . . . . 0.0 110.427 174.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 86.97 51.63 3.33 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.986 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -97.1 -19.48 18.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.54 0.736 . . . . 0.0 110.867 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -154.35 163.52 40.03 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.935 0.494 . . . . 0.0 111.872 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . 0.402 HG11 HG21 ' A' ' 483' ' ' ILE . 79.2 t -126.37 117.65 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.017 1.327 . . . . 0.0 108.164 170.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 5.7 tp60 -88.06 113.35 23.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.989 0.916 . . . . 0.0 109.039 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.55 HD22 HD11 ' A' ' 483' ' ' ILE . 22.6 tp -120.21 116.69 26.12 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.137 0.975 . . . . 0.0 109.495 -172.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . 0.411 ' HG2' ' HB3' ' A' ' 508' ' ' MET . 1.8 tmmm? -114.03 130.52 56.55 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.992 0.36 . . . . 0.0 110.368 -169.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -82.62 115.32 21.52 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.436 0.694 . . . . 0.0 109.84 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -85.49 -15.76 41.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.911 0.884 . . . . 0.0 112.033 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . 0.545 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 69.8 m -65.57 156.45 32.64 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.57 2.36 33.53 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.832 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.545 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.1 OUTLIER -135.38 168.49 19.1 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.24 1.016 . . . . 0.0 108.822 173.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . 0.402 ' HB3' HG22 ' A' ' 502' ' ' ILE . 24.1 m-20 -73.59 122.05 21.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.428 0.691 . . . . 0.0 109.475 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -83.36 123.02 29.23 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.497 0.719 . . . . 0.0 110.204 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 30.2 p -71.01 106.67 3.76 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.1 mp -91.09 -179.81 5.54 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 0.0 109.97 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 133.28 -67.23 0.56 Allowed Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 480' ' ' ASN . 0.8 OUTLIER -74.64 -11.5 60.2 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.499 177.302 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 33.1 m95 -69.84 145.4 52.11 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -149.47 136.27 19.53 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.882 0.473 . . . . 0.0 111.123 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . 0.55 HD11 HD22 ' A' ' 468' ' ' LEU . 57.8 mt -97.41 107.28 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.619 0.768 . . . . 0.0 109.472 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 545' ' ' VAL . 68.0 mttm -78.86 148.17 32.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.363 0.665 . . . . 0.0 110.531 172.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . 0.432 ' NH2' ' HB3' ' A' ' 534' ' ' TRP . 20.6 mtm180 -140.49 123.3 16.38 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 491' ' ' GLU . 51.2 tt0 -116.98 114.06 23.27 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.417 0.687 . . . . 0.0 109.83 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.453 ' HA ' ' HB3' ' A' ' 540' ' ' PHE . 13.4 t -84.72 159.31 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.792 1.237 . . . . 0.0 110.645 -177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.2 -22.87 61.69 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.959 0.904 . . . . 0.0 111.98 173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.57 -22.14 66.13 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.585 1.154 . . . . 0.0 112.407 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 99.86 1.96 56.19 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.339 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 486' ' ' GLN . 42.1 mt-10 -72.95 122.05 21.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.596 0.758 . . . . 0.0 110.073 176.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.81 112.56 13.71 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 22.0 pt -132.17 170.09 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.236 1.014 . . . . 0.0 109.629 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -150.22 127.32 11.23 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.893 0.477 . . . . 0.0 110.681 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -80.29 108.98 14.34 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 169.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -84.73 128.3 34.54 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -70.45 169.14 14.67 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.645 0.736 . . . . 0.0 111.327 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 65.9 p -87.36 132.34 41.45 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.871 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.481 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 26.8 Cg_endo -58.78 -21.41 56.58 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.094 2.529 . . . . 0.0 113.302 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -72.31 -25.42 61.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.193 0.597 . . . . 0.0 111.903 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -75.78 126.19 30.52 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 122.825 0.45 . . . . 0.0 110.189 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . 0.402 HG22 ' HB3' ' A' ' 475' ' ' ASP . 41.5 mt -122.55 113.9 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.25 120.14 21.88 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -69.75 160.89 30.85 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -65.9 119.08 10.67 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.166 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.6 6.09 65.55 Favored Glycine 0 C--N 1.343 0.925 0 O-C-N 123.585 0.553 . . . . 0.0 113.666 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -101.59 177.97 4.77 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.642 0.777 . . . . 0.0 109.677 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . 0.411 ' HB3' ' HG2' ' A' ' 469' ' ' LYS . 0.0 OUTLIER -139.92 162.53 34.96 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.537 0.684 . . . . 0.0 112.039 -175.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . 0.518 HG23 HD13 ' A' ' 526' ' ' LEU . 6.3 p -123.79 117.49 51.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 125.201 1.401 . . . . 0.0 107.926 176.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 7.8 m -96.48 95.02 7.73 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.89 97.42 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.927 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -79.71 171.74 14.73 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.635 0.774 . . . . 0.0 110.819 171.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -91.91 165.0 13.45 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.676 0.791 . . . . 0.0 110.109 173.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 529' ' ' LYS . . . -63.51 -34.2 77.26 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.102 0.477 . . . . 0.0 110.379 171.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -89.41 20.65 33.0 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.305 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -85.07 -24.43 28.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.315 0.646 . . . . 0.0 110.554 172.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 71.05 35.76 64.47 Favored Glycine 0 C--N 1.35 1.322 0 O-C-N 123.872 0.733 . . . . 0.0 112.917 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 8.6 p -114.44 143.77 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.014 0.926 . . . . 0.0 110.276 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -72.79 123.23 22.94 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.284 0.634 . . . . 0.0 110.227 176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -63.92 110.69 2.19 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.425 0.69 . . . . 0.0 110.473 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 22.8 m -132.24 72.26 78.84 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 123.063 0.545 . . . . 0.0 110.909 -174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.93 159.4 53.09 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.739 2.292 . . . . 0.0 112.352 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.23 0.94 50.48 Favored 'Cis proline' 0 C--N 1.382 2.32 0 CA-C-N 120.141 1.086 . . . . 0.0 114.077 -0.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 32.9 t -74.78 -63.22 1.3 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.415 0.686 . . . . 0.0 111.08 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 27.5 m -104.19 98.58 8.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.108 0.963 . . . . 0.0 110.265 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.518 HD13 HG23 ' A' ' 509' ' ' VAL . 11.2 mp -93.64 146.86 23.52 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 170.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 81.9 t -129.82 117.27 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -73.47 89.34 1.65 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 514' ' ' ALA . 27.3 tptp -75.77 123.27 25.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.386 177.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 120.75 -24.26 7.59 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -173.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -121.5 109.61 15.04 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . 0.446 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 32.9 p -82.53 -34.94 27.69 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.853 0.461 . . . . 0.0 111.634 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 536' ' ' THR . 23.6 m -90.28 -29.74 17.95 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.189 0.596 . . . . 0.0 112.167 -174.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.674 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 59.74 22.26 11.08 Favored 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 123.224 0.61 . . . . 0.0 109.401 -173.535 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 68.99 69.08 1.46 Allowed Glycine 0 C--N 1.345 1.037 0 O-C-N 121.653 -0.654 . . . . 0.0 111.949 -171.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 533' ' ' SER . 8.1 p -71.82 159.92 33.47 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.612 0.765 . . . . 0.0 110.231 172.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 172.72 176.43 41.35 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.404 -0.362 . . . . 0.0 113.038 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -84.07 -26.96 28.62 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.756 0.422 . . . . 0.0 110.073 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 66.9 m -152.24 128.23 10.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.531 1.132 . . . . 0.0 108.743 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.453 ' HB3' ' HA ' ' A' ' 487' ' ' VAL . 6.8 p90 -154.48 122.47 5.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.96 0.904 . . . . 0.0 110.091 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.621 ' HD3' ' H ' ' A' ' 541' ' ' ARG . 0.0 OUTLIER -86.27 123.39 31.47 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.423 0.63 . . . . 0.0 109.727 -178.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 485' ' ' ARG . 39.3 m -94.31 140.17 30.13 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.252 1.021 . . . . 0.0 109.506 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 99.9 t -132.93 130.9 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.482 1.113 . . . . 0.0 109.279 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.603 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 53.1 tp -93.96 129.48 40.41 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.459 HG21 ' HE2' ' A' ' 484' ' ' LYS . 81.4 t -118.13 143.73 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.754 1.222 . . . . 0.0 108.226 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.546 HD21 ' HG2' ' A' ' 550' ' ' GLU . 2.0 p30 -103.0 -173.54 2.34 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.514 0.326 . . . . 0.0 111.155 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -64.17 -22.97 67.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.803 0.841 . . . . 0.0 113.234 -177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -65.24 -39.46 92.72 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.162 0.506 . . . . 0.0 110.453 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 109.37 -11.26 33.44 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.398 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.546 ' HG2' HD21 ' A' ' 546' ' ' ASN . 16.3 pt-20 -80.39 153.87 28.05 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 117.259 0.53 . . . . 0.0 110.549 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -88.65 104.6 17.01 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.673 1.189 . . . . 0.0 110.171 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.74 -29.47 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.566 0.746 . . . . 0.0 112.813 -170.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -139.12 161.11 38.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.072 0.549 . . . . 0.0 110.137 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.431 ' HG3' HG22 ' A' ' 543' ' ' VAL . 40.7 ttp -159.27 108.25 1.86 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.33 0.652 . . . . 0.0 109.795 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -119.46 123.63 44.52 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.755 0.822 . . . . 0.0 109.207 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 26.7 m -79.12 134.0 36.73 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.54 139.9 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -161.53 146.34 13.33 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 122.916 0.486 . . . . 0.0 111.074 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.577 ' HG3' ' SD ' ' A' ' 563' ' ' MET . 86.2 tttt -53.84 113.28 1.15 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.19 0.996 . . . . 0.0 110.23 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 61.1 m -144.07 67.75 1.27 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.463 0.705 . . . . 0.0 109.488 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 38.3 m 65.23 -175.59 0.18 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.84 1.256 . . . . 0.0 111.399 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 13.0 t 52.31 56.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 124.189 0.995 . . . . 0.0 111.087 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.577 ' SD ' ' HG3' ' A' ' 559' ' ' LYS . 92.4 mmm -79.81 125.89 30.27 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.235 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -78.72 125.26 29.13 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -79.58 79.22 6.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.321 0.582 . . . . 0.0 110.085 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -77.62 -3.04 38.88 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.052 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . 0.446 ' HG3' HD22 ' A' ' 568' ' ' ASN . 10.0 pt-20 -56.23 -31.26 63.35 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.341 1.056 . . . . 0.0 112.518 175.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . 0.446 HD22 ' HG3' ' A' ' 567' ' ' GLU . 50.3 m-80 -140.71 158.59 43.76 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.943 0.897 . . . . 0.0 109.342 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.039 178.629 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -68.97 130.85 43.96 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.443 0.697 . . . . 0.0 111.296 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 49.2 m -122.51 106.61 11.17 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.209 0.604 . . . . 0.0 111.306 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 89.02 8.86 68.47 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.471 174.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 20.0 m -63.11 -55.22 27.21 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.398 0.679 . . . . 0.0 110.837 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . 0.457 HG23 ' HG2' ' A' ' 476' ' ' GLN . 21.2 t -85.61 129.82 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 171.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 44.0 t -110.51 145.7 37.27 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.129 1.372 . . . . 0.0 109.497 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 50.8 mt -81.93 95.11 2.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.85 -65.14 1.04 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.652 0.381 . . . . 0.0 110.404 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 467' ' ' GLN . 20.5 mt-10 -116.49 153.13 32.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.1 0.56 . . . . 0.0 110.368 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.493 HG23 HG22 ' A' ' 466' ' ' VAL . 47.8 mt -140.06 142.53 31.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 170.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.76 145.87 51.9 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.307 0.38 . . . . 0.0 110.474 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.587 ' HG ' ' HG3' ' A' ' 462' ' ' GLU . 2.4 pt? -58.93 -41.16 86.68 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.134 0.974 . . . . 0.0 111.886 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.587 ' HG3' ' HG ' ' A' ' 461' ' ' LEU . 43.7 mt-10 -91.45 -22.03 20.63 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.159 0.984 . . . . 0.0 110.066 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 83.92 50.82 4.23 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.285 -0.87 . . . . 0.0 113.053 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -87.71 -16.76 33.41 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.06 163.35 40.01 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.031 0.532 . . . . 0.0 111.166 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . 0.493 HG22 HG23 ' A' ' 459' ' ' ILE . 97.2 t -134.9 122.76 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.669 1.188 . . . . 0.0 108.088 168.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.602 ' HB3' ' HB2' ' A' ' 458' ' ' GLU . 13.5 tt0 -89.8 111.48 22.51 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.287 0.565 . . . . 0.0 110.103 170.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.85 159.95 18.19 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.21 165.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 508' ' ' MET . 1.6 tmtp? -152.58 129.01 10.63 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.527 ' HB3' HD12 ' A' ' 503' ' ' LEU . 50.6 t30 -99.07 100.35 11.48 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -76.75 -11.63 59.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.254 0.622 . . . . 0.0 111.511 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 44.9 t -63.73 152.54 38.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.338 1.055 . . . . 0.0 112.847 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -73.11 -12.01 60.75 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.095 1.358 . . . . 0.0 111.296 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -99.01 143.69 29.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.763 0.825 . . . . 0.0 110.893 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.46 102.5 2.68 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.457 ' HG2' HG23 ' A' ' 454' ' ' VAL . 57.2 tp60 -70.29 115.48 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.3 0.64 . . . . 0.0 111.87 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.4 m -64.28 99.71 0.3 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 14.3 tp -96.49 159.53 14.89 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -175.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 143.83 -65.88 0.46 Allowed Glycine 0 N--CA 1.47 0.95 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.64 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.27 -11.66 59.76 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.698 0.799 . . . . 0.0 111.078 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -75.89 135.0 40.14 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.832 0.853 . . . . 0.0 108.887 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -128.19 145.61 50.98 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 49.6 mt -106.3 103.93 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.627 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 59.3 mttm -78.89 96.19 5.62 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 19.5 tpp85 -79.53 96.82 6.22 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 168.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -102.05 100.92 11.22 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 15.7 t -94.06 141.9 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 539' ' ' SER . 4.2 pp -65.91 -14.88 62.33 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.52 -8.42 33.68 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.238 0.615 . . . . 0.0 110.847 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 105.95 28.27 5.36 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.504 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -121.38 103.83 9.24 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.178 0.591 . . . . 0.0 110.571 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -107.87 80.96 1.44 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.436 1.112 . . . . 0.0 109.226 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 34.9 pt -95.07 134.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.012 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -108.21 110.71 22.4 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.875 0.47 . . . . 0.0 110.067 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.96 104.38 9.55 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 496' ' ' LYS . 0.2 OUTLIER -91.0 129.66 36.98 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -76.79 170.06 17.16 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.995 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.0 p -88.55 124.66 65.45 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.461 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 19.8 Cg_endo -60.16 -10.0 11.75 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.985 2.456 . . . . 0.0 114.871 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -75.17 -24.66 57.93 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.888 0.475 . . . . 0.0 111.273 172.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -82.08 128.06 33.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.599 0.759 . . . . 0.0 110.198 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 59.8 mt -122.46 123.81 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 470' ' ' ASN . 1.0 OUTLIER -90.2 123.79 34.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 507' ' ' GLN . 1.2 mpt_? -74.49 169.32 17.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.89 0.876 . . . . 0.0 112.109 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -70.43 121.43 17.73 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.402 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 76.59 12.46 84.38 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.228 -0.442 . . . . 0.0 113.812 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . 0.414 ' HG3' ' HB2' ' A' ' 504' ' ' ARG . 32.7 mm-40 -104.09 -176.4 3.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.201 0.6 . . . . 0.0 110.773 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . 0.496 ' HB3' ' HG2' ' A' ' 469' ' ' LYS . 1.5 ppp? -141.63 164.64 29.66 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.976 0.91 . . . . 0.0 111.196 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.67 135.03 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.402 1.081 . . . . 0.0 108.295 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 7.2 m -116.69 115.55 25.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 526' ' ' LEU . 16.0 m -101.54 98.61 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.171 0.988 . . . . 0.0 110.436 -176.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -87.55 172.91 9.4 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.165 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.697 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -92.3 156.47 17.24 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.949 0.9 . . . . 0.0 110.43 175.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -59.9 -28.06 67.26 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.286 0.635 . . . . 0.0 112.125 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -111.45 23.86 17.03 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.291 -0.413 . . . . 0.0 113.479 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -89.17 11.27 19.12 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 69.66 36.95 76.53 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-O 121.343 0.413 . . . . 0.0 112.71 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.56 147.92 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.908 0.883 . . . . 0.0 111.319 -167.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -99.13 130.51 45.45 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.915 0.886 . . . . 0.0 109.588 171.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -65.25 112.6 3.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.4 m -131.5 71.18 81.47 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.355 0.662 . . . . 0.0 109.613 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.81 153.34 78.29 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.868 2.379 . . . . 0.0 112.247 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -80.51 -19.87 21.27 Favored 'Cis proline' 0 C--N 1.38 2.19 0 CA-C-N 119.957 1.02 . . . . 0.0 113.608 0.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.2 m -63.14 -35.91 81.86 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.306 1.043 . . . . 0.0 112.588 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 25.8 m -127.83 91.21 3.24 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.47 0.708 . . . . 0.0 109.415 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.57 ' HB2' HG12 ' A' ' 511' ' ' VAL . 66.7 mt -84.75 148.37 26.39 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . . . . . . . . . 54.5 t -132.06 127.9 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -68.57 87.77 0.33 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -70.14 128.5 36.49 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.769 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 98.09 -21.46 45.94 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.729 -0.669 . . . . 0.0 113.188 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.83 103.85 10.38 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . 0.403 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 42.5 p -85.37 -17.56 36.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.372 1.069 . . . . 0.0 113.822 -166.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 46.5 m -96.45 -29.39 13.95 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.697 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 58.44 21.8 8.85 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.187 0.995 . . . . 0.0 110.76 -168.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 66.74 70.65 1.07 Allowed Glycine 0 C--N 1.349 1.29 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 -172.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . . . . . . . . . 14.6 p -63.3 162.07 12.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.614 0.766 . . . . 0.0 112.455 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -176.53 149.58 9.84 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.82 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.66 -21.09 38.35 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.515 ' HB2' HD21 ' A' ' 488' ' ' LEU . 19.4 m -148.25 132.83 17.75 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.727 0.811 . . . . 0.0 109.672 167.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -160.38 -176.41 5.59 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.028 0.931 . . . . 0.0 110.395 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 556' ' ' THR . 11.0 ptp180 -136.7 155.48 49.81 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.786 170.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . 0.485 ' HB ' HD13 ' A' ' 459' ' ' ILE . 86.4 m -130.97 118.81 21.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.627 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 19.6 t -112.63 151.42 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.442 1.097 . . . . 0.0 108.698 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 39.8 tp -123.94 106.83 10.74 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 173.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 551' ' ' GLU . 6.2 p -96.59 147.41 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.682 1.193 . . . . 0.0 109.215 175.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -107.44 -171.96 1.98 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.697 0.399 . . . . 0.0 110.334 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.41 66.78 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . 0.573 ' HB2' ' HG2' ' A' ' 550' ' ' GLU . 68.4 m-20 -71.75 -23.74 61.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.085 0.554 . . . . 0.0 111.981 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 93.95 -2.73 69.59 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.573 ' HG2' ' HB2' ' A' ' 548' ' ' ASP . 11.7 pt-20 -89.53 141.37 28.64 Favored 'General case' 0 C--O 1.247 0.966 0 C-N-CA 123.189 0.596 . . . . 0.0 109.696 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 545' ' ' VAL . 53.3 mt-10 -81.76 111.05 17.65 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.588 0.755 . . . . 0.0 109.214 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.05 -22.71 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.595 0.758 . . . . 0.0 112.549 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -146.55 157.34 43.72 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.867 0.867 . . . . 0.0 109.361 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.431 ' HG3' HG22 ' A' ' 543' ' ' VAL . 28.5 ttt -168.51 140.51 2.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.427 0.691 . . . . 0.0 110.37 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -152.03 123.66 7.89 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.14 0.976 . . . . 0.0 109.427 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 541' ' ' ARG . 36.3 m -86.34 124.63 32.91 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.778 0.831 . . . . 0.0 109.853 175.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 459' ' ' ILE . 35.2 t -135.04 142.71 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.929 0.892 . . . . 0.0 109.507 -177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 152.99 41.66 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.754 -177.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.564 ' HD2' ' HG2' ' A' ' 462' ' ' GLU . 88.7 tttt -75.15 81.21 2.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.717 0.77 . . . . 0.0 109.153 170.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 25.4 t -98.04 -46.43 5.89 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 20.2 m -76.14 123.07 25.25 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 164.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 13.8 p -69.4 -25.7 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.131 0.491 . . . . 0.0 110.31 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.3 mtt -84.94 158.39 20.55 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.414 1.085 . . . . 0.0 110.764 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -63.36 113.87 3.5 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.39 135.26 55.96 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.597 0.759 . . . . 0.0 111.694 -172.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -86.15 106.33 17.19 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.044 0.938 . . . . 0.0 110.323 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -135.62 -87.57 0.35 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 7.0 t30 21.42 76.8 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 126.652 1.981 . . . . 0.0 114.257 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.176 0 CA-C-O 118.869 -0.962 . . . . 0.0 112.066 -175.67 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -61.21 94.15 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.452 0.701 . . . . 0.0 111.214 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 22.0 m -118.39 79.93 1.45 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.106 0.962 . . . . 0.0 109.027 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.86 -45.86 3.02 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.649 0.643 . . . . 0.0 112.76 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 44.1 t -179.96 -46.79 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.454 1.502 . . . . 0.0 108.707 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 19.0 t -114.94 142.18 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.032 0.933 . . . . 0.0 108.616 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 56.3 p -122.57 164.94 17.25 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.287 0.635 . . . . 0.0 110.628 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 43.7 mt -84.66 98.81 6.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.61 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 9.5 tp10 -69.27 -59.77 2.79 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.399 -174.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.61 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 36.0 mt-10 -137.25 160.32 39.38 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.045 0.938 . . . . 0.0 108.86 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.431 ' HB ' HG21 ' A' ' 557' ' ' VAL . 64.8 mt -139.57 141.39 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 172.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.433 ' HB2' ' CD1' ' A' ' 465' ' ' PHE . 26.0 t70 -66.23 148.39 51.91 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.706 0.628 . . . . 0.0 111.312 175.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -36.16 83.02 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.203 1.001 . . . . 0.0 112.079 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.35 -31.26 24.88 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 167.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 95.9 36.42 5.27 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.142 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -72.29 -20.5 61.5 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.321 0.648 . . . . 0.0 110.487 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 460' ' ' ASP . 33.2 p90 -151.6 161.79 42.09 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.526 0.679 . . . . 0.0 111.542 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.33 112.9 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.351 1.46 . . . . 0.0 107.542 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.402 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.5 tp-100 -86.98 118.74 26.56 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 544' ' ' LEU . 85.8 mt -113.65 134.0 54.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.046 0.938 . . . . 0.0 108.713 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 457' ' ' GLU . 4.4 tmmm? -116.8 131.12 57.03 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.451 ' HB2' HD13 ' A' ' 503' ' ' LEU . 58.9 t30 -79.79 124.56 28.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.374 0.669 . . . . 0.0 110.709 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -102.65 15.42 29.33 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.228 1.011 . . . . 0.0 110.703 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . 0.472 ' HB3' ' HD3' ' A' ' 474' ' ' LYS . 49.0 m -86.55 149.42 24.96 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.954 0.501 . . . . 0.0 111.353 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.06 -13.8 59.9 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.009 0.924 . . . . 0.0 110.406 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 472' ' ' SER . 0.0 OUTLIER -129.7 175.73 8.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.597 1.159 . . . . 0.0 109.127 178.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.66 115.96 6.38 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.393 0.677 . . . . 0.0 109.757 172.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -82.18 113.82 20.28 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.046 0.538 . . . . 0.0 110.417 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.507 ' HA ' HG12 ' A' ' 502' ' ' ILE . 35.0 p -66.89 110.27 3.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.175 0.59 . . . . 0.0 110.113 173.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.7 tp -103.03 171.88 7.13 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.654 1.182 . . . . 0.0 109.08 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . . . . . . . . . . . 145.69 -62.99 0.46 Allowed Glycine 0 N--CA 1.472 1.052 0 CA-C-O 121.399 0.444 . . . . 0.0 112.923 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . 0.474 HD22 ' N ' ' A' ' 480' ' ' ASN . 0.8 OUTLIER -70.6 -12.3 61.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.267 0.627 . . . . 0.0 110.975 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 25.5 m95 -69.57 146.52 51.72 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.112 0.965 . . . . 0.0 109.57 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -148.56 125.26 11.13 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.317 0.647 . . . . 0.0 111.002 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 19.4 mt -87.16 117.27 30.98 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 C-N-CA 123.638 0.775 . . . . 0.0 109.219 177.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.606 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 98.7 mttt -84.33 152.01 24.38 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.002 0.521 . . . . 0.0 109.817 168.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . . . . . . . . . 20.6 tpp85 -150.47 104.73 3.25 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -116.48 103.59 10.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.88 0.872 . . . . 0.0 109.608 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.28 154.35 3.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.346 0.659 . . . . 0.0 109.91 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 45.4 tp -53.04 -43.15 66.4 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.989 1.316 . . . . 0.0 111.312 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.36 -24.18 67.21 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.713 0.805 . . . . 0.0 111.96 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 133.97 -22.95 3.77 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-O 118.561 -1.133 . . . . 0.0 115.505 173.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -59.96 100.15 0.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.433 1.117 . . . . 0.0 111.129 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.46 80.78 1.41 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.494 1.14 . . . . 0.0 108.316 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 18.0 pt -113.2 169.72 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.747 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -152.86 116.02 4.63 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.31 0.644 . . . . 0.0 110.42 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -99.36 115.28 28.85 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.556 0.742 . . . . 0.0 109.866 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -90.81 148.02 22.8 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -77.72 169.58 18.05 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.774 0.83 . . . . 0.0 110.845 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 52.0 p -82.55 133.23 50.1 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.66 -26.29 29.18 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.69 2.926 . . . . 0.0 114.346 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.29 -21.49 28.97 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.251 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -63.83 136.74 57.65 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.261 0.624 . . . . 0.0 110.376 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 477' ' ' SER . 40.9 mt -132.14 125.91 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . 0.451 HD13 ' HB2' ' A' ' 470' ' ' ASN . 0.5 OUTLIER -90.04 117.79 29.1 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -72.97 160.82 31.51 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.007 0.523 . . . . 0.0 111.691 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -64.32 119.74 10.88 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.666 0.786 . . . . 0.0 112.202 -173.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 80.07 -3.48 70.99 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.498 0.498 . . . . 0.0 114.073 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -83.03 -176.0 6.12 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.358 0.663 . . . . 0.0 110.082 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -149.52 137.25 20.25 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.137 0.575 . . . . 0.0 110.823 -176.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.95 111.86 32.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 1.1 m -90.58 96.28 10.57 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 65.1 t -83.91 106.99 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . 0.51 ' HB2' HG22 ' A' ' 527' ' ' VAL . 51.5 m95 -99.02 172.36 7.45 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.286 0.634 . . . . 0.0 112.221 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -90.32 148.12 23.06 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.92 170.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.03 92.9 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.866 0.466 . . . . 0.0 110.678 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . 0.491 ' H ' ' HA ' ' A' ' 532' ' ' SER . . . -79.32 -1.22 85.63 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.697 -0.683 . . . . 0.0 114.329 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -69.38 -26.48 64.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.304 0.642 . . . . 0.0 110.925 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 80.88 38.12 17.04 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.753 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.95 150.63 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.483 1.113 . . . . 0.0 110.308 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -78.54 124.08 27.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.588 0.755 . . . . 0.0 110.694 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . 0.404 ' NE2' HD12 ' A' ' 526' ' ' LEU . 3.5 t-160 -72.91 110.8 7.49 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 14.0 m -128.71 84.5 62.94 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.366 0.666 . . . . 0.0 110.217 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.88 148.04 93.92 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.594 2.196 . . . . 0.0 112.347 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -85.64 -17.94 24.06 Favored 'Cis proline' 0 C--N 1.375 1.973 0 C-N-CA 124.62 -0.992 . . . . 0.0 113.769 -2.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 17.0 m -73.95 -15.12 61.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.85 0.86 . . . . 0.0 113.239 -166.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 66.1 m -135.27 96.94 3.58 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 30.0 tp -105.3 104.48 14.22 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 512' ' ' TRP . 76.2 t -93.36 120.45 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.009 0.524 . . . . 0.0 110.056 -173.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -68.57 97.81 0.82 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -68.41 126.86 30.93 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.493 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 112.46 -25.18 12.56 Favored Glycine 0 C--N 1.342 0.864 0 O-C-N 123.239 0.337 . . . . 0.0 112.912 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.15 114.22 27.95 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . 0.491 ' HA ' ' H ' ' A' ' 515' ' ' GLY . 66.3 p -79.14 -32.23 44.32 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.675 0.79 . . . . 0.0 111.369 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 536' ' ' THR . 49.8 m -98.08 -33.44 11.16 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -173.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.59 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 53.51 32.82 14.87 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.459 0.647 . . . . 0.0 109.84 -171.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 66.99 55.77 15.27 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.606 -0.724 . . . . 0.0 113.008 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 533' ' ' SER . 4.6 p -73.35 153.78 40.35 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.038 0.447 . . . . 0.0 110.285 170.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 165.28 -161.63 35.01 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.074 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -79.15 -61.8 1.9 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.415 0.686 . . . . 0.0 110.341 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 558' ' ' LYS . 15.8 p -132.66 127.96 35.99 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.232 1.013 . . . . 0.0 109.531 -170.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.99 133.92 14.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.176 0.59 . . . . 0.0 111.893 -170.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.09 99.52 6.97 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.822 1.249 . . . . 0.0 108.498 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . . . . . . . . . 26.9 m -92.03 113.09 25.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 39.8 t -119.67 141.28 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 123.949 0.9 . . . . 0.0 109.787 -174.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.0 tp -109.25 128.74 55.31 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 171.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.53 HG21 ' HE3' ' A' ' 484' ' ' LYS . 78.9 t -117.93 149.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.152 1.381 . . . . 0.0 108.684 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -103.49 -171.93 2.02 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.018 0.527 . . . . 0.0 111.199 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -61.1 -32.81 72.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.996 0.918 . . . . 0.0 113.394 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.87 -36.29 83.02 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.633 0.773 . . . . 0.0 111.65 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.0 -8.01 29.3 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.714 -0.492 . . . . 0.0 113.423 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.88 151.76 25.86 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 117.385 0.592 . . . . 0.0 110.76 172.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -80.21 113.38 18.34 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.024 0.93 . . . . 0.0 109.299 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 17.7 m -89.23 -25.81 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.978 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -144.93 148.89 34.36 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.527 0.731 . . . . 0.0 109.736 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . 0.511 ' HG3' HG22 ' A' ' 543' ' ' VAL . 25.9 ttt -151.97 136.32 16.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.589 0.756 . . . . 0.0 109.552 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -155.38 110.84 3.05 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.54 0.736 . . . . 0.0 109.118 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 91.6 m -95.95 117.28 30.32 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.509 0.724 . . . . 0.0 110.405 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . 0.431 HG21 ' HB ' ' A' ' 459' ' ' ILE . 85.5 t -107.05 128.19 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.551 0.74 . . . . 0.0 109.415 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 539' ' ' SER . 0.0 OUTLIER -117.95 157.71 26.24 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.313 1.045 . . . . 0.0 109.547 175.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.42 99.72 0.15 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.716 -173.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 16.9 p -169.17 84.88 0.14 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 125.265 1.426 . . . . 0.0 107.398 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . . . . . . . . . 44.3 p -64.33 112.59 3.14 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.454 -174.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 32.9 m -74.61 -21.41 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.372 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 45.5 mtm 73.31 124.39 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.222 1.409 . . . . 0.0 111.162 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 32.1 mmm180 -74.75 105.66 5.92 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.722 0.809 . . . . 0.0 109.256 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -101.63 171.2 7.7 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.513 0.725 . . . . 0.0 111.322 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.08 40.47 1.12 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 171.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.6 -42.65 99.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.181 0.993 . . . . 0.0 109.576 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -78.52 121.7 24.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.442 -1.254 . . . . 0.0 107.686 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.44 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.506 -176.511 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.414 0.15 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' ALA . . . . . . . . . . . . . . . -74.07 81.51 1.75 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.072 0.549 . . . . 0.0 110.35 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' SER . . . . . . . . . . . . . 18.8 p -76.79 96.67 4.32 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.281 1.033 . . . . 0.0 111.7 -174.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' GLY . . . . . . . . . . . . . . . 64.8 24.62 69.99 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.66 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 20.0 m -60.96 -34.42 74.73 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.845 0.858 . . . . 0.0 112.126 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.46 144.8 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 168.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 60.7 m -134.27 169.99 16.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.334 0.654 . . . . 0.0 110.542 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' ILE . . . . . . . . . . . . . 51.0 mt -91.74 113.09 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.374 0.67 . . . . 0.0 110.144 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' A' ' 458' ' ' GLU . 11.6 tp10 -81.37 -58.19 3.15 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.132 0.973 . . . . 0.0 110.265 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' A' ' 457' ' ' GLU . 31.4 mt-10 -135.01 162.67 31.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.564 0.746 . . . . 0.0 109.992 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 52.4 mt -144.26 135.53 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.68 142.07 51.57 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.861 0.464 . . . . 0.0 110.101 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.783 HD11 ' HG3' ' A' ' 563' ' ' MET . 3.2 pp -66.25 -39.55 89.58 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.894 0.478 . . . . 0.0 111.645 -177.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.56 ' HG3' HD12 ' A' ' 461' ' ' LEU . 43.3 mt-10 -72.66 -25.21 61.19 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.199 0.523 . . . . 0.0 110.144 174.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' GLY . . . . . . . . . . . . . . . 92.59 31.17 9.0 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.548 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -77.44 -19.85 55.39 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.825 0.85 . . . . 0.0 110.971 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -160.18 163.2 33.84 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 121.779 0.8 . . . . 0.0 112.789 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . 0.422 HG11 HG21 ' A' ' 542' ' ' THR . 93.7 t -126.93 130.65 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.006 1.722 . . . . 0.0 107.395 169.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLN . . . . . 0.4 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 5.8 tp-100 -98.49 133.96 42.12 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 171.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 76.2 mt -117.89 161.71 19.31 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.178 0.991 . . . . 0.0 108.84 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -146.89 131.82 18.12 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.63 ' HB2' ' HG ' ' A' ' 503' ' ' LEU . 65.2 t30 -81.89 117.4 22.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.229 0.612 . . . . 0.0 110.396 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -78.31 -23.74 46.97 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.269 0.628 . . . . 0.0 111.071 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 19.3 m -62.09 145.22 53.9 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.748 0.819 . . . . 0.0 111.266 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -86.75 17.88 3.74 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.88 0.872 . . . . 0.0 110.991 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.5 176.61 12.19 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 124.142 0.977 . . . . 0.0 110.05 -174.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.38 107.83 0.72 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.268 1.027 . . . . 0.0 111.082 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -88.69 111.31 21.81 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 170.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.6 p -63.53 113.4 3.28 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.012 0.525 . . . . 0.0 109.903 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 11.6 tp -104.27 155.97 18.3 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -175.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 499' ' ' PRO . . . 145.37 -55.96 0.54 Allowed Glycine 0 N--CA 1.473 1.125 0 CA-C-O 121.694 0.608 . . . . 0.0 112.141 -176.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -72.72 -11.36 60.59 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.976 0.91 . . . . 0.0 111.399 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -79.48 140.68 37.23 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.637 0.775 . . . . 0.0 109.042 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -133.4 130.42 38.7 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.956 0.502 . . . . 0.0 110.804 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.67 109.75 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.635 0.774 . . . . 0.0 110.03 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.538 ' HB2' ' HB ' ' A' ' 543' ' ' VAL . 62.7 mttm -79.15 100.44 7.44 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 167.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' ARG . . . . . 0.559 ' HB3' ' HA3' ' A' ' 535' ' ' GLY . 6.3 mmt85 -82.0 90.3 6.48 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 165.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' GLN . . . . . 0.481 ' HG2' ' HB3' ' A' ' 492' ' ' GLU . 21.3 tm0? -99.12 104.97 17.01 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.227 -173.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.46 126.28 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.6 -12.18 50.85 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.08 -6.62 40.58 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.337 1.055 . . . . 0.0 112.046 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 115.58 28.25 2.81 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 114.427 0.531 . . . . 0.0 114.427 167.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -135.48 141.44 45.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 116.998 0.399 . . . . 0.0 110.078 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.481 ' HB3' ' HG2' ' A' ' 486' ' ' GLN . 10.0 pt-20 -150.35 114.58 5.13 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.24 0.543 . . . . 0.0 109.727 174.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 28.5 pt -107.69 144.93 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -118.75 108.52 14.98 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.496 0.718 . . . . 0.0 109.637 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -89.23 104.89 17.4 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -84.22 134.81 34.54 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -69.5 164.9 22.12 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.851 0.86 . . . . 0.0 111.746 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' THR . . . . . . . . . . . . . 67.4 p -75.78 126.04 87.64 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' PRO . . . . . 0.465 ' HA ' ' HA3' ' A' ' 479' ' ' GLY . 60.2 Cg_endo -68.16 -12.46 35.15 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.647 2.231 . . . . 0.0 113.565 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -74.19 -23.53 59.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.738 0.815 . . . . 0.0 111.504 173.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -79.65 136.25 36.76 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-O 120.975 0.417 . . . . 0.0 109.91 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.71 130.01 74.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' LEU . . . . . 0.63 ' HG ' ' HB2' ' A' ' 470' ' ' ASN . 23.3 tp -95.54 113.4 25.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -76.55 164.0 26.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.214 1.005 . . . . 0.0 112.054 -172.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' ALA . . . . . . . . . . . . . . . -55.59 120.3 7.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.372 1.069 . . . . 0.0 112.566 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 72.73 -5.24 17.92 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 114.338 0.495 . . . . 0.0 114.338 176.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -84.92 154.72 22.03 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.147 0.579 . . . . 0.0 109.883 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 59.7 mtt -113.94 145.15 41.93 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.76 0.824 . . . . 0.0 110.585 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' VAL . . . . . . . . . . . . . 6.2 p -125.48 119.18 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.591 0.756 . . . . 0.0 109.225 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.81 107.01 19.41 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 16.8 t -87.0 98.88 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.571 0.749 . . . . 0.0 110.002 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' TRP . . . . . 0.522 ' HB2' HG22 ' A' ' 527' ' ' VAL . 39.5 m95 -90.14 174.19 7.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.603 0.761 . . . . 0.0 111.336 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 534' ' ' TRP . . . -101.51 152.42 20.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.025 172.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.03 75.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.038 0.535 . . . . 0.0 110.528 173.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' GLY . . . . . . . . . . . . . . . -72.62 -8.63 72.41 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.571 -0.74 . . . . 0.0 114.429 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . . . . . . . . . . . -76.28 -13.52 60.15 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.978 0.511 . . . . 0.0 111.28 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' GLY . . . . . . . . . . . . . . . 75.77 38.44 36.69 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-O 121.139 0.299 . . . . 0.0 112.503 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.11 140.04 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 124.107 0.963 . . . . 0.0 110.146 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -80.53 138.42 36.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.928 0.891 . . . . 0.0 110.751 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -64.36 110.7 2.34 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 123.246 0.618 . . . . 0.0 109.525 173.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.4 m -129.29 78.52 75.77 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.598 0.759 . . . . 0.0 110.02 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -69.28 156.39 64.74 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.443 2.095 . . . . 0.0 111.811 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -83.57 -14.28 35.64 Favored 'Cis proline' 0 C--N 1.377 2.039 0 CA-C-N 119.698 0.928 . . . . 0.0 113.968 -1.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.9 m -66.43 -31.72 72.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.962 0.905 . . . . 0.0 112.736 -171.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' THR . . . . . . . . . . . . . 94.2 m -136.59 102.1 4.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.295 0.638 . . . . 0.0 110.636 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 511' ' ' VAL . 67.1 mt -92.24 132.85 36.34 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 167.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 512' ' ' TRP . 99.4 t -118.92 126.44 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -70.54 100.95 1.9 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 172.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -66.59 133.13 49.67 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.151 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 89.57 -28.56 6.87 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 123.644 0.59 . . . . 0.0 113.591 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' GLN . . . . . 0.425 ' HG3' ' H ' ' A' ' 534' ' ' TRP . 45.7 tp60 -82.99 118.12 23.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.723 0.409 . . . . 0.0 109.987 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' SER . . . . . . . . . . . . . 33.4 m -96.28 -39.51 9.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.88 0.472 . . . . 0.0 111.248 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . 0.485 ' HB2' HG22 ' A' ' 536' ' ' THR . 67.0 p -79.04 -35.7 42.22 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.464 0.477 . . . . 0.0 111.848 -171.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' TRP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 513' ' ' ALA . 0.0 OUTLIER 52.39 31.19 9.19 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.119 0.967 . . . . 0.0 111.366 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 485' ' ' ARG . . . 70.4 59.17 5.48 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -174.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' THR . . . . . 0.485 HG22 ' HB2' ' A' ' 533' ' ' SER . 10.4 t -79.2 145.31 33.71 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.219 1.008 . . . . 0.0 110.151 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . -169.56 165.25 38.68 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.132 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -75.69 -30.94 59.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' SER . . . . . . . . . . . . . 50.8 m -146.29 118.42 8.3 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -142.37 -178.95 5.99 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.565 0.746 . . . . 0.0 110.802 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -147.98 128.33 13.92 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.39 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' THR . . . . . 0.422 HG21 HG11 ' A' ' 466' ' ' VAL . 87.3 m -86.69 128.07 34.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 484' ' ' LYS . 65.5 t -124.38 117.5 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' LEU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 553' ' ' ALA . 36.6 tp -90.84 107.95 19.52 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . 0.43 HG22 ' HG2' ' A' ' 551' ' ' GLU . 83.3 t -96.03 149.56 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.644 1.178 . . . . 0.0 108.585 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' ASN . . . . . 0.421 HD21 ' HG2' ' A' ' 550' ' ' GLU . 1.5 p30 -108.29 -172.84 2.14 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.475 0.31 . . . . 0.0 110.965 -178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' ALA . . . . . . . . . . . . . . . -52.16 -39.63 60.3 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.856 1.263 . . . . 0.0 113.27 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.34 -37.56 87.76 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.711 0.804 . . . . 0.0 112.424 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 111.21 -13.41 28.57 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.041 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' GLU . . . . . 0.421 ' HG2' HD21 ' A' ' 546' ' ' ASN . 11.1 pt-20 -75.1 148.89 39.32 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.278 0.539 . . . . 0.0 110.567 173.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.43 ' HG2' HG22 ' A' ' 545' ' ' VAL . 30.0 mt-10 -87.57 98.27 11.31 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.942 0.897 . . . . 0.0 109.027 -177.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 26.0 m -79.65 -19.06 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.05 -173.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.65 ' HB3' ' HB3' ' A' ' 544' ' ' LEU . . . -145.71 145.66 30.96 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.275 0.63 . . . . 0.0 109.425 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' MET . . . . . . . . . . . . . 16.9 ttt -151.64 110.55 3.86 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -125.52 106.87 10.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.917 0.887 . . . . 0.0 108.917 -173.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 53.2 m -86.24 140.02 30.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.14 0.576 . . . . 0.0 110.578 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' VAL . . . . . . . . . . . . . 2.3 p -144.97 111.02 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 124.43 1.092 . . . . 0.0 109.585 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -92.76 116.57 29.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 172.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' LYS . . . . . 0.596 ' HE2' HG12 ' A' ' 562' ' ' VAL . 86.7 tttt -66.38 100.63 0.66 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.339 1.055 . . . . 0.0 110.492 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' SER . . . . . . . . . . . . . 47.8 p -97.82 -7.03 31.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.125 0.97 . . . . 0.0 111.619 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 561' ' ' SER . . . . . 0.491 ' HB3' HD22 ' A' ' 461' ' ' LEU . 44.7 t -138.59 149.59 45.41 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.82 0.848 . . . . 0.0 109.691 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . 0.596 HG12 ' HE2' ' A' ' 559' ' ' LYS . 35.0 m -110.17 9.11 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.115 0.966 . . . . 0.0 109.924 172.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.783 ' HG3' HD11 ' A' ' 461' ' ' LEU . 66.7 mtt 63.22 -170.06 0.18 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.898 1.279 . . . . 0.0 110.571 -168.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 564' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -99.54 171.68 7.78 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.529 0.681 . . . . 0.0 111.067 173.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 565' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -85.23 25.76 0.96 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.993 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 566' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -72.77 80.18 1.13 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.373 0.669 . . . . 0.0 109.275 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 567' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -97.2 -38.43 9.7 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.633 1.173 . . . . 0.0 109.485 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 568' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -169.05 123.41 0.84 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.548 1.139 . . . . 0.0 107.987 -176.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 569' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 CA-C-O 118.832 -0.982 . . . . 0.0 111.313 -178.981 . . . . . . . . 0 0 . 1 stop_ save_